data_4aqz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 4aqz _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 . . . . . 0 N--CA 1.426 -1.653 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' THR . . . . . 0.602 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 5.6 m -56.04 126.49 26.17 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 124.384 1.074 . . . . 0.0 113.42 -171.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -152.95 168.17 26.72 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 116.345 -0.389 . . . . 0.0 109.979 -177.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.8 pp -134.35 165.53 31.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 123.114 0.565 . . . . 0.0 112.164 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 9.4 t70 -149.89 156.36 41.63 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -133.88 134.63 42.93 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 176.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -152.32 171.61 17.73 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.425 ' HE3' HG21 ' A' ' 284' ' ' THR . 57.4 mtpt -118.98 148.57 42.84 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 175.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -144.68 143.23 30.63 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 123.436 0.46 . . . . 0.0 109.934 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 74.01 -98.81 1.0 Allowed Glycine 0 N--CA 1.435 -1.39 0 O-C-N 124.048 0.842 . . . . 0.0 111.89 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -146.15 98.6 3.12 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 120.761 0.315 . . . . 0.0 110.202 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 63.18 22.65 13.49 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 173.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -89.05 137.36 32.39 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -96.59 113.09 4.59 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 1.9 mp -106.42 121.36 58.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 117.237 0.519 . . . . 0.0 109.869 -177.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.5 mp -105.75 117.31 51.24 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.409 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 39.0 mt-10 -94.91 146.04 24.5 Favored 'General case' 0 C--N 1.284 -2.245 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.02 174.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 12.4 tp -134.36 128.87 34.53 Favored 'General case' 0 C--N 1.27 -2.88 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.133 -173.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . 0.602 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -118.44 101.77 8.41 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -109.42 91.47 3.66 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.541 0.686 . . . . 0.0 109.493 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.94 111.41 13.77 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.562 -175.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 107.87 9.18 28.81 Favored Glycine 0 N--CA 1.431 -1.634 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.451 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' PHE . . . . . 1.62 ' HE2' ' CE1' ' A' ' 247' ' ' PHE . 55.6 t80 -115.32 107.72 15.61 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -115.14 95.24 5.1 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.369 0.604 . . . . 0.0 109.784 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 165.55 -150.22 17.57 Favored Glycine 0 N--CA 1.425 -2.08 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -124.48 136.18 27.47 Favored Pre-proline 0 C--N 1.3 -1.572 0 CA-C-N 117.39 0.595 . . . . 0.0 110.339 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.432 ' HB3' ' CD2' ' A' ' 264' ' ' LEU . 10.6 Cg_endo -74.32 172.37 16.2 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 C-N-CA 122.505 2.137 . . . . 0.0 112.41 176.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.522 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 11.6 t70 -91.94 105.63 17.84 Favored 'General case' 0 C--N 1.284 -2.283 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 175.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.401 HD12 ' HG2' ' A' ' 251' ' ' PRO . 5.3 mp -103.43 124.14 57.44 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 C-N-CA 119.484 -0.887 . . . . 0.0 109.894 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 25.1 t -106.27 120.21 41.25 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -100.13 109.41 21.69 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.948 -178.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -124.42 162.5 23.75 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 174.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -73.57 -33.33 64.6 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 120.991 0.424 . . . . 0.0 110.124 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -70.78 -42.92 69.75 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.842 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . 0.457 ' CB ' ' HA ' ' A' ' 303' ' ' THR . 53.1 p-80 -169.42 167.55 9.91 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.472 0.177 . . . . 0.0 111.067 178.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 17.3 mt -106.21 139.5 27.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 300' ' ' LEU . 3.4 mp -122.97 114.56 42.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 252' ' ' ASP . 0.8 OUTLIER -107.81 134.07 50.71 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 175.034 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 25.3 m -122.45 123.78 42.09 Favored 'General case' 0 C--N 1.267 -3.002 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.48 ' HB2' ' HB ' ' A' ' 298' ' ' THR . 29.6 mt -100.17 93.73 5.86 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.426 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 63.1 mmtt -63.1 126.94 29.03 Favored 'General case' 0 CA--C 1.478 -1.814 0 O-C-N 124.29 0.994 . . . . 0.0 113.075 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 9.8 t30 69.77 32.53 3.19 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.432 -1.713 . . . . 0.0 109.909 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -125.69 100.54 6.47 Favored 'General case' 0 C--O 1.2 -1.525 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 6.4 m -88.26 112.2 22.53 Favored 'General case' 0 C--N 1.277 -2.57 0 C-N-CA 119.635 -0.826 . . . . 0.0 111.889 -173.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . 0.439 HD23 HD21 ' A' ' 291' ' ' LEU . 37.6 tp -81.83 125.81 76.89 Favored Pre-proline 0 N--CA 1.444 -0.77 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.275 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -65.79 143.1 72.55 Favored 'Trans proline' 0 N--CA 1.44 -1.648 0 C-N-CA 122.105 1.87 . . . . 0.0 110.587 169.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 11.4 t -69.63 -12.71 61.86 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.388 0.613 . . . . 0.0 110.363 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 2.4 m -76.29 -16.57 59.76 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 123.961 0.904 . . . . 0.0 109.924 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.485 HD11 ' O ' ' A' ' 226' ' ' THR . 73.8 mt -110.88 -7.06 14.62 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.415 -177.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.498 ' HB2' ' O ' ' A' ' 291' ' ' LEU . 25.2 pt20 -81.35 115.64 20.81 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 119.101 -1.04 . . . . 0.0 109.61 -177.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 21.0 ptt180 -135.44 151.65 50.61 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 40.7 m -112.71 136.93 51.73 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.799 176.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.416 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 59.6 mt -105.67 116.47 32.0 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -61.02 -51.86 67.44 Favored 'General case' 0 C--N 1.311 -1.079 0 O-C-N 123.724 0.64 . . . . 0.0 110.419 -177.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . 0.263 26.9 m 46.19 25.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 116.856 2.169 . . . . 0.0 116.856 174.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -75.85 140.65 42.34 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 177.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 15.3 t70 73.02 20.99 3.31 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.701 1.2 . . . . 0.0 112.531 177.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 1.666 ' HD1' ' CD2' ' A' ' 282' ' ' PHE . 7.2 m-85 -79.74 -4.98 54.3 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.574 -0.704 . . . . 0.0 110.22 172.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 mptt 65.77 50.94 1.49 Allowed 'General case' 0 CA--C 1.503 -0.85 0 C-N-CA 124.248 1.019 . . . . 0.0 109.924 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' THR . . . . . 0.425 HG21 ' HE3' ' A' ' 232' ' ' LYS . 1.2 p -133.34 165.03 39.74 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -74.78 -4.91 16.12 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.196 1.931 . . . . 0.0 111.752 177.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 49.8 t -87.59 129.54 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -99.86 -30.35 12.08 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.208 -176.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 20.6 ttmm -167.13 143.79 4.47 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.416 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 43.3 t -112.64 130.22 66.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 174.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.474 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 98.2 m -136.18 117.87 15.0 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-O 121.262 0.554 . . . . 0.0 110.762 -178.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.498 ' O ' ' HB2' ' A' ' 274' ' ' GLN . 0.1 OUTLIER -91.47 114.13 26.58 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 104.244 -2.502 . . . . 0.0 104.244 174.861 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . 0.401 ' HD3' ' OE1' ' A' ' 274' ' ' GLN . 17.0 tppt? -116.15 129.6 56.4 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -177.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -78.42 140.37 38.68 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 175.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.527 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 21.7 tp -111.23 -173.14 2.17 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 175.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.527 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 3.2 t-20 -58.91 -66.66 0.47 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 119.172 0.896 . . . . 0.0 111.247 -177.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -115.86 -3.6 12.17 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 120.791 0.329 . . . . 0.0 111.147 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . 0.426 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 38.1 m-20 -115.23 172.69 6.92 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.397 0.618 . . . . 0.0 110.209 -177.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.48 ' HB ' ' HB2' ' A' ' 264' ' ' LEU . 92.8 m -116.98 132.11 56.79 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 176.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 42.1 tt0 -120.17 127.78 52.79 Favored 'General case' 0 N--CA 1.421 -1.894 0 C-N-CA 120.529 -0.469 . . . . 0.0 110.35 -175.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 261' ' ' ILE . 17.4 mt -100.08 127.7 46.27 Favored 'General case' 0 CA--C 1.443 -3.142 0 C-N-CA 120.127 -0.629 . . . . 0.0 111.462 172.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' ILE . . . . . 0.474 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 63.1 mt -115.19 109.23 27.65 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.373 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 50.9 mt -117.17 102.13 13.05 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.625 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' THR . . . . . 0.457 ' HA ' ' CB ' ' A' ' 259' ' ' HIS . 32.8 m -74.88 134.6 41.62 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.781 -175.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 19.0 p -133.74 179.72 6.06 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 123.189 0.595 . . . . 0.0 109.608 -177.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -159.59 148.47 17.86 Favored 'General case' 0 C--O 1.246 0.878 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 73.64 -142.4 31.05 Favored Glycine 0 C--O 1.243 0.675 0 O-C-N 123.613 0.571 . . . . 0.0 112.468 176.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -105.26 130.23 53.44 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' TRP . . . . . 0.675 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 60.7 p-90 -145.79 171.27 15.03 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -177.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -129.98 135.06 47.88 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.675 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 25.8 tp -111.25 120.95 43.97 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.269 -177.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.496 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 54.3 t -116.2 107.55 22.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 173.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -94.75 134.97 36.78 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -130.58 145.01 51.8 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.619 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 15.9 m -115.85 118.53 33.25 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 172.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -87.28 -24.83 24.22 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.605 0.716 . . . . 0.0 110.41 -177.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -170.24 162.59 6.34 Favored Pre-proline 0 C--N 1.307 -1.241 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -65.17 95.99 0.26 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.493 1.462 . . . . 0.0 110.504 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 133.52 -33.36 2.58 Favored Glycine 0 N--CA 1.421 -2.35 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.628 -177.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' TYR . . . . . 1.65 ' HE2' ' CE1' ' A' ' 319' ' ' TYR . 36.5 m-85 -99.89 116.44 31.96 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 122.036 -0.685 . . . . 0.0 109.87 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -119.3 163.94 16.4 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.932 -177.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 78.7 m -152.09 139.93 19.96 Favored 'General case' 0 C--N 1.269 -2.894 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.261 -178.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 1.655 ' HD1' ' CD2' ' A' ' 322' ' ' PHE . 77.5 m-85 -126.43 112.4 15.57 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . 0.496 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 61.8 tt0 -97.37 109.7 22.4 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 91.7 t -98.38 99.31 8.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 C-N-CA 123.501 0.72 . . . . 0.0 109.687 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -88.43 152.86 50.36 Favored Pre-proline 0 C--N 1.309 -1.153 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -80.35 128.67 7.22 Favored 'Trans proline' 0 C--O 1.252 1.209 0 C-N-CA 121.27 1.314 . . . . 0.0 109.956 171.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm . . . . . 0 CA--C 1.471 -2.06 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.686 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . 0.407 ' C ' HD21 ' A' ' 245' ' ' LEU . 5.7 tp-100 . . . . . 0 N--CA 1.436 -1.133 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 72.8 m -52.92 131.98 36.61 Favored 'General case' 0 C--O 1.208 -1.13 0 C-N-CA 124.178 0.991 . . . . 0.0 113.187 -172.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -162.54 175.59 11.29 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-O 121.023 0.44 . . . . 0.0 111.519 -174.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 1.8 pp -121.51 165.44 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.075 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . 0.403 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 6.6 t70 -150.37 152.16 33.96 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 1.596 ' HD1' ' CD2' ' A' ' 230' ' ' PHE . 88.6 t80 -134.06 127.59 32.52 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.098 176.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.449 ' HD3' ' HB ' ' A' ' 239' ' ' ILE . 0.3 OUTLIER -150.91 157.39 42.85 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.633 179.063 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -104.67 162.44 13.29 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . 0.457 ' O ' ' HB1' ' A' ' 237' ' ' ALA . 15.3 t70 -157.71 143.96 17.63 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 68.77 -118.89 9.36 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.486 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -135.35 111.89 9.93 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.97 0.385 . . . . 0.0 110.695 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 66.67 15.75 10.21 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.876 0.87 . . . . 0.0 112.403 174.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . 0.457 ' HB1' ' O ' ' A' ' 233' ' ' ASP . . . -92.41 132.04 37.09 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -103.35 113.91 4.67 Favored Glycine 0 CA--C 1.491 -1.427 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.449 ' HB ' ' HD3' ' A' ' 231' ' ' ARG . 2.4 mp -106.77 117.12 51.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-O 121.512 0.672 . . . . 0.0 110.263 -177.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.4 mp -101.08 109.04 24.59 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 43.1 mt-10 -89.73 132.81 35.0 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 176.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 8.9 tp -117.59 122.27 43.16 Favored 'General case' 0 C--N 1.269 -2.934 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.131 -174.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . 0.549 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -107.34 101.21 10.6 Favored 'General case' 0 N--CA 1.414 -2.259 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -106.8 91.87 3.85 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.615 0.722 . . . . 0.0 109.076 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.407 HD21 ' C ' ' A' ' 225' ' ' GLN . 3.0 mm? -81.71 114.18 20.2 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.278 -175.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 103.42 22.75 8.86 Favored Glycine 0 C--N 1.297 -1.615 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.121 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' PHE . . . . . 0.403 ' HE1' ' O ' ' A' ' 265' ' ' LYS . 20.0 t80 -115.74 127.41 55.09 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -102.28 -21.05 14.41 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -174.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -104.18 -141.38 11.06 Favored Glycine 0 C--N 1.314 -0.685 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.841 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -127.59 142.5 44.32 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.436 ' HB3' HD11 ' A' ' 264' ' ' LEU . 18.0 Cg_endo -68.35 172.31 11.43 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.717 2.278 . . . . 0.0 112.853 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.53 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 20.3 t70 -96.02 119.86 35.28 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 175.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 4.6 mp -108.41 108.95 26.54 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-O 121.995 0.902 . . . . 0.0 111.232 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' SER . . . . . 0.485 ' HB2' ' HB ' ' A' ' 261' ' ' ILE . 47.4 m -96.47 104.83 16.83 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 114.163 -1.381 . . . . 0.0 109.198 177.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -88.1 118.25 27.54 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.865 -176.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -124.66 157.05 36.49 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 167.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 60.6 m80 -74.34 -29.79 61.74 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.926 -0.709 . . . . 0.0 111.202 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -69.65 -42.11 74.68 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.955 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -167.23 163.82 15.45 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.73 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 18.3 mt -105.48 142.02 19.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . 0.554 ' HA ' ' O ' ' A' ' 300' ' ' LEU . 3.8 mp -119.99 110.23 28.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 299' ' ' GLN . 0.8 OUTLIER -108.64 142.28 21.66 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.741 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 298' ' ' THR . 31.9 m -134.86 126.62 29.13 Favored 'General case' 0 C--N 1.275 -2.643 0 O-C-N 121.726 -0.609 . . . . 0.0 111.13 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.436 HD11 ' HB3' ' A' ' 251' ' ' PRO . 2.1 mm? -98.17 101.84 13.42 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 177.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.44 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 25.8 mmtm -67.65 130.94 44.58 Favored 'General case' 0 C--N 1.286 -2.178 0 O-C-N 124.033 0.833 . . . . 0.0 111.283 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 6.6 t30 73.84 21.59 2.67 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 124.678 1.236 . . . . 0.0 109.999 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -121.13 100.59 7.14 Favored 'General case' 0 CA--C 1.484 -1.581 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 3.7 m -90.2 121.03 31.86 Favored 'General case' 0 C--N 1.271 -2.828 0 C-N-CA 120.076 -0.649 . . . . 0.0 110.837 -175.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . 0.434 HD23 ' CD2' ' A' ' 291' ' ' LEU . 24.8 tp -92.76 127.3 48.47 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.242 -177.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.76 149.07 91.63 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.285 1.99 . . . . 0.0 110.989 170.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' THR . . . . . 0.577 ' O ' ' HG2' ' A' ' 274' ' ' GLN . 22.2 p -66.32 -25.35 66.79 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.336 -177.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 10.2 m -72.51 -18.52 61.65 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.508 0.67 . . . . 0.0 111.056 -177.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.498 HD11 ' O ' ' A' ' 226' ' ' THR . 82.1 mt -99.29 -19.12 17.23 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.497 -177.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.577 ' HG2' ' O ' ' A' ' 271' ' ' THR . 21.9 pt20 -76.82 137.69 39.38 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -173.42 169.48 4.39 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -174.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 3.1 p -123.99 132.86 53.76 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-O 121.478 0.656 . . . . 0.0 112.101 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 60.3 mt -100.58 113.06 25.56 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 104.34 -2.467 . . . . 0.0 104.34 175.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -63.41 -53.05 58.38 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -174.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 34.5 m 44.71 37.05 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 176.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -69.4 133.42 47.77 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 20.2 t70 61.9 36.15 16.0 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 125.005 1.322 . . . . 0.0 110.692 177.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 1.617 ' HD1' ' CD2' ' A' ' 282' ' ' PHE . 0.2 OUTLIER -79.26 0.38 28.91 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.703 179.407 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt 69.01 59.03 0.35 Allowed 'General case' 0 CA--C 1.497 -1.095 0 C-N-CA 125.388 1.475 . . . . 0.0 111.478 177.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.35 152.66 11.02 Favored Pre-proline 0 C--N 1.295 -1.767 0 CA-C-N 113.851 -1.522 . . . . 0.0 108.675 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . 0.415 ' O ' ' HA ' ' A' ' 304' ' ' THR . 54.0 Cg_exo -50.14 -24.77 11.75 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.713 2.942 . . . . 0.0 113.55 175.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 46.9 t -74.06 118.33 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -94.64 -29.11 15.01 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.891 -178.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -170.21 135.23 1.29 Allowed 'General case' 0 N--CA 1.478 0.93 0 O-C-N 123.665 0.603 . . . . 0.0 110.863 -177.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 40.2 t -104.3 135.96 39.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.402 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 90.2 m -143.19 123.64 13.93 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 121.461 0.648 . . . . 0.0 111.09 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.434 ' CD2' HD23 ' A' ' 269' ' ' LEU . 0.1 OUTLIER -98.06 120.37 38.35 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 176.436 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . 0.483 ' HD3' ' OE1' ' A' ' 274' ' ' GLN . 4.0 tppp? -128.76 135.88 49.8 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -79.99 145.01 32.78 Favored 'General case' 0 N--CA 1.426 -1.627 0 C-N-CA 118.858 -1.137 . . . . 0.0 109.273 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.529 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 18.0 tp -108.44 -174.08 2.43 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 177.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.529 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 20.6 t-20 -56.65 -67.47 0.3 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.559 0.618 . . . . 0.0 111.688 -177.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -110.03 -4.28 15.97 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.825 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . 0.44 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 36.2 m-20 -119.81 176.4 5.42 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.599 0.714 . . . . 0.0 111.511 -169.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 263' ' ' THR . 90.1 m -113.73 133.4 55.37 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 176.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . 0.593 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 26.3 tt0 -124.08 132.07 53.62 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.13 -175.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.554 ' O ' ' HA ' ' A' ' 261' ' ' ILE . 25.4 mt -101.69 131.92 47.67 Favored 'General case' 0 CA--C 1.451 -2.86 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.967 173.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' ILE . . . . . 0.402 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 63.6 mt -116.26 108.63 25.6 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.697 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 175.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 65.2 mt -115.98 104.16 16.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 3.5 m -72.51 130.03 39.7 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 123.126 0.57 . . . . 0.0 109.641 -175.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 285' ' ' PRO . 8.7 p -136.02 176.71 8.44 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 122.319 0.248 . . . . 0.0 110.905 -178.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -147.73 148.94 31.52 Favored 'General case' 0 C--O 1.245 0.857 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 61.38 -148.61 46.61 Favored Glycine 0 N--CA 1.463 0.444 0 O-C-N 123.933 0.771 . . . . 0.0 113.089 177.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -97.72 144.4 27.39 Favored 'General case' 0 CA--C 1.47 -2.121 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' TRP . . . . . 0.652 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 65.9 p-90 -157.94 170.77 21.58 Favored 'General case' 0 C--N 1.27 -2.851 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -178.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . 0.428 ' HG2' ' HE2' ' A' ' 327' ' ' LYS . 4.6 mt-10 -122.26 129.83 52.6 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -176.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.652 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 23.3 tp -105.65 117.81 34.96 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 120.996 0.427 . . . . 0.0 111.207 -176.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.455 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 48.8 t -114.63 107.36 22.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 174.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -94.18 126.61 39.52 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . 0.407 ' HB2' ' HB ' ' A' ' 321' ' ' THR . 95.3 mttt -119.83 149.45 42.04 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.964 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 23.9 t -115.97 114.59 24.83 Favored 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 172.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -80.18 -32.35 38.73 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.572 0.701 . . . . 0.0 109.561 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -168.76 162.18 8.25 Favored Pre-proline 0 C--N 1.305 -1.355 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.5 102.19 0.33 Allowed 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 121.532 1.488 . . . . 0.0 110.497 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 129.73 -32.43 3.18 Favored Glycine 0 N--CA 1.427 -1.954 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -177.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' TYR . . . . . 1.669 ' HD1' ' CD2' ' A' ' 319' ' ' TYR . 30.8 m-85 -102.77 116.59 32.88 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' PHE . . . . . 1.636 ' HE2' ' CE1' ' A' ' 320' ' ' PHE . 90.3 m-85 -119.16 161.79 19.74 Favored 'General case' 0 C--N 1.277 -2.546 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.292 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.407 ' HB ' ' HB2' ' A' ' 313' ' ' LYS . 89.4 m -151.62 124.93 8.79 Favored 'General case' 0 C--N 1.263 -3.16 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.74 -174.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' A' ' 239' ' ' ILE . 69.9 m-85 -112.4 109.98 19.92 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . 0.455 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 8.8 tt0 -96.73 105.72 17.89 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . 0.606 HG13 ' CE3' ' A' ' 308' ' ' TRP . 94.0 t -95.01 100.41 11.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 C-N-CA 123.42 0.688 . . . . 0.0 110.228 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -92.42 153.33 42.74 Favored Pre-proline 0 C--N 1.313 -0.984 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -73.09 140.71 31.61 Favored 'Trans proline' 0 C--O 1.249 1.046 0 C-N-CA 121.765 1.643 . . . . 0.0 110.4 172.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . 0.428 ' HE2' ' HG2' ' A' ' 309' ' ' GLU . 14.8 ttmm . . . . . 0 CA--C 1.486 -1.511 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 8.1 pm0 . . . . . 0 N--CA 1.411 -2.376 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 28.7 m -59.93 128.62 37.78 Favored 'General case' 0 C--O 1.209 -1.028 0 O-C-N 124.121 0.888 . . . . 0.0 109.01 -179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -148.03 155.95 42.08 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.082 -170.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.7 pp -137.48 149.68 25.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 C-N-CA 124.134 0.974 . . . . 0.0 108.872 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -149.76 156.6 42.12 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 122.789 0.436 . . . . 0.0 111.038 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -127.0 139.18 53.21 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 120.97 0.414 . . . . 0.0 111.01 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 20.5 ptt85 -157.04 161.68 39.52 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 173.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -105.64 144.91 31.73 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 177.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . 0.524 ' O ' ' HB1' ' A' ' 237' ' ' ALA . 21.7 t70 -159.76 117.38 2.66 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -176.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 104.12 -157.14 17.25 Favored Glycine 0 C--N 1.296 -1.694 0 C-N-CA 120.203 -0.998 . . . . 0.0 111.179 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -91.53 97.49 11.09 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 116.7 0.25 . . . . 0.0 110.391 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . 0.513 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 3.4 m-20 60.92 23.26 13.36 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 124.197 0.936 . . . . 0.0 111.396 177.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . 0.524 ' HB1' ' O ' ' A' ' 233' ' ' ASP . . . -87.11 136.91 32.75 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.491 -174.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -101.94 116.51 5.55 Favored Glycine 0 N--CA 1.427 -1.915 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.1 mp -106.52 114.87 46.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-O 121.34 0.591 . . . . 0.0 111.127 -175.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.3 mp -103.49 112.77 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 176.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -94.4 138.77 31.95 Favored 'General case' 0 C--N 1.277 -2.549 0 CA-C-O 121.363 0.601 . . . . 0.0 109.487 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 12.0 tp -127.49 131.04 50.2 Favored 'General case' 0 C--N 1.269 -2.924 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.392 -175.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -122.37 102.18 7.95 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.013 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -108.84 91.07 3.49 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -73.15 109.72 6.89 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -173.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 111.99 -4.64 27.23 Favored Glycine 0 C--N 1.304 -1.204 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.132 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -94.62 107.73 19.71 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -108.58 97.11 6.82 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 160.74 -147.78 15.02 Favored Glycine 0 C--N 1.297 -1.604 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -126.74 135.65 27.61 Favored Pre-proline 0 C--N 1.311 -1.095 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.492 ' HB3' ' CD1' ' A' ' 264' ' ' LEU . 13.7 Cg_endo -70.38 171.98 14.11 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.361 2.041 . . . . 0.0 109.901 176.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -91.13 110.26 21.53 Favored 'General case' 0 C--N 1.27 -2.878 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 175.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 3.8 mp -97.73 108.46 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.76 0 CA-C-O 121.605 0.717 . . . . 0.0 109.57 178.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' SER . . . . . 0.507 ' HB2' ' HB ' ' A' ' 261' ' ' ILE . 31.8 m -102.99 110.76 22.79 Favored 'General case' 0 C--N 1.282 -2.369 0 CA-C-N 114.473 -1.24 . . . . 0.0 108.274 175.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . 0.428 HE21 HD21 ' A' ' 310' ' ' LEU . 70.4 mt-30 -100.18 117.36 34.26 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.48 -172.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -125.1 162.57 24.29 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 172.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -76.53 -31.16 57.48 Favored 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 119.015 -1.074 . . . . 0.0 112.068 178.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -73.91 -30.94 62.86 Favored 'General case' 0 C--N 1.319 -0.744 0 O-C-N 123.661 0.6 . . . . 0.0 111.476 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 39.4 p-80 -172.78 165.13 5.29 Favored 'General case' 0 CA--C 1.503 -0.864 0 O-C-N 122.252 -0.28 . . . . 0.0 110.623 175.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 18.4 mt -106.29 140.86 23.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . 0.507 ' HB ' ' HB2' ' A' ' 254' ' ' SER . 3.5 mp -116.64 108.69 25.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 299' ' ' GLN . 49.1 t -105.66 131.54 54.82 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.492 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 177.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' THR . . . . . 0.613 ' HA ' ' O ' ' A' ' 298' ' ' THR . 26.6 m -134.46 126.17 28.92 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 121.289 0.566 . . . . 0.0 111.066 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.492 ' CD1' ' HB3' ' A' ' 251' ' ' PRO . 2.0 mm? -98.38 108.58 21.31 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.496 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 30.5 mmmt -67.75 131.58 45.83 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-O 121.526 0.679 . . . . 0.0 112.384 -178.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 74.91 1.96 3.9 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 113.379 -1.737 . . . . 0.0 111.294 176.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -94.68 110.65 22.47 Favored 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -178.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 1.2 p -82.73 135.67 34.93 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-O 121.074 0.464 . . . . 0.0 111.405 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 270' ' ' PRO . 26.8 tp -112.88 124.11 32.36 Favored Pre-proline 0 N--CA 1.425 -1.698 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.125 176.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . 0.412 ' O ' ' HG ' ' A' ' 269' ' ' LEU . 23.3 Cg_exo -70.77 160.08 50.58 Favored 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 122.619 2.213 . . . . 0.0 111.659 170.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 3.6 p -66.95 -26.19 66.71 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 123.803 0.841 . . . . 0.0 111.456 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 6.7 m -64.23 -23.6 67.37 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.01 1.324 . . . . 0.0 112.438 -177.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -99.47 -8.92 24.02 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-O 121.344 0.592 . . . . 0.0 111.707 -174.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -72.96 138.67 46.24 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.288 -0.869 . . . . 0.0 108.803 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -169.09 170.9 8.5 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 177.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 62.0 m -130.8 152.54 50.03 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-O 121.394 0.616 . . . . 0.0 110.302 176.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.423 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 1.8 mm? -111.98 108.91 18.41 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 105.998 -1.852 . . . . 0.0 105.998 177.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -80.72 85.52 6.07 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 122.444 1.116 . . . . 0.0 109.213 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . 0.606 ' HA ' ' CE1' ' A' ' 282' ' ' PHE . 87.8 t -89.63 36.69 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-N 113.364 -1.744 . . . . 0.0 111.619 -173.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -80.84 142.5 33.6 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.432 174.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 18.6 t70 72.51 20.49 3.89 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 122.673 1.225 . . . . 0.0 110.259 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.606 ' CE1' ' HA ' ' A' ' 279' ' ' VAL . 21.1 m-85 -90.3 -18.4 25.66 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.588 -0.695 . . . . 0.0 110.589 176.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 65.39 35.02 7.71 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.691 0.796 . . . . 0.0 111.841 176.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 2.3 p -115.58 174.91 2.13 Favored Pre-proline 0 C--N 1.3 -1.558 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . 0.513 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 9.2 Cg_exo -75.57 -15.2 19.66 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.764 1.643 . . . . 0.0 111.693 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.8 p -93.21 128.74 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-O 121.639 0.733 . . . . 0.0 109.87 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -94.51 -39.61 10.31 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.155 -174.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -160.14 134.52 7.49 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.541 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 40.6 t -99.39 123.77 52.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 87.5 m -130.11 122.91 29.17 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 120.852 0.358 . . . . 0.0 110.885 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 46.5 tp -99.74 125.06 45.57 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -124.4 139.12 54.2 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -175.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -83.66 148.54 27.05 Favored 'General case' 0 C--N 1.289 -2.061 0 C-N-CA 118.832 -1.147 . . . . 0.0 108.218 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.469 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 17.8 tp -115.73 -174.49 2.54 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 173.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.469 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 4.6 t30 -76.0 -55.23 5.8 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 120.07 1.305 . . . . 0.0 111.891 -173.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -107.36 -8.91 16.17 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.686 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . 0.496 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 29.3 m-20 -132.1 173.12 11.56 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.975 -171.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.613 ' O ' ' HA ' ' A' ' 263' ' ' THR . 79.1 m -110.7 132.96 53.74 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 32.7 tt0 -117.14 126.62 53.09 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.799 0.809 . . . . 0.0 110.112 -177.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.405 ' CB ' ' HB ' ' A' ' 262' ' ' VAL . 0.5 OUTLIER -110.89 122.82 48.83 Favored 'General case' 0 C--N 1.274 -2.689 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.211 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 72.9 mt -109.12 109.22 27.56 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.368 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 59.9 mt -110.48 98.9 7.65 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 10.9 m -69.53 126.03 28.49 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 17.3 p -136.26 165.79 24.93 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 122.85 0.46 . . . . 0.0 110.98 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -149.63 138.68 21.19 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-O 120.631 0.253 . . . . 0.0 111.468 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 90.29 -168.28 33.53 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.242 176.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -84.12 127.81 34.15 Favored 'General case' 0 CA--C 1.482 -1.654 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' TRP . . . . . 0.631 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 68.4 p-90 -144.53 169.5 17.84 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -178.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -125.53 123.81 39.95 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -174.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.631 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 17.7 tp -100.19 122.36 42.89 Favored 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.137 -178.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.493 ' CG1' ' HB3' ' A' ' 323' ' ' GLN . 8.6 p -126.1 114.98 41.11 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-O 121.723 0.773 . . . . 0.0 109.558 171.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -102.51 129.9 49.18 Favored 'General case' 0 CA--C 1.437 -3.366 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.496 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -114.35 123.61 49.92 Favored 'General case' 1 N--CA 1.372 -4.334 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.874 -176.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 16.3 m -92.06 103.03 15.57 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 176.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -78.38 -34.15 48.4 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.88 -1.055 . . . . 0.0 112.539 -172.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.413 ' HB2' ' HD2' ' A' ' 317' ' ' PRO . . . -165.75 167.38 9.06 Favored Pre-proline 0 C--N 1.307 -1.273 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 -175.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 316' ' ' ALA . 25.2 Cg_endo -60.31 102.96 0.2 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.031 1.821 . . . . 0.0 112.088 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 105.83 -15.25 44.89 Favored Glycine 0 N--CA 1.436 -1.331 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.181 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' TYR . . . . . 1.663 ' HD1' ' CD2' ' A' ' 319' ' ' TYR . 94.0 m-85 -100.89 116.79 33.6 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 122.196 -0.59 . . . . 0.0 110.698 -178.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' PHE . . . . . 0.482 ' CZ ' ' HD3' ' A' ' 251' ' ' PRO . 75.2 m-85 -122.49 163.65 19.5 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.975 -177.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 88.4 m -152.8 110.66 3.62 Favored 'General case' 0 C--N 1.265 -3.076 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.194 -175.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -98.01 104.35 16.37 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . 0.493 ' HB3' ' CG1' ' A' ' 311' ' ' VAL . 42.6 tt0 -94.96 108.2 20.25 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 93.3 t -94.86 99.87 10.14 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.302 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.3 152.51 47.81 Favored Pre-proline 0 C--O 1.213 -0.836 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -77.33 137.39 16.78 Favored 'Trans proline' 0 C--O 1.249 1.069 0 C-N-CA 121.565 1.51 . . . . 0.0 110.18 172.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm . . . . . 0 CA--C 1.468 -2.205 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.742 -179.462 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 . . . . . 0 CA--C 1.555 1.167 0 N-CA-C 110.62 -0.141 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 24.4 m -57.16 114.34 2.11 Favored 'General case' 0 C--O 1.198 -1.633 0 C-N-CA 123.679 0.792 . . . . 0.0 111.866 -171.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -130.96 160.21 35.19 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.812 -169.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.2 pp -128.97 151.74 36.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 124.286 1.034 . . . . 0.0 109.762 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 5.0 t70 -143.47 156.5 44.65 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -176.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 1.646 ' HD1' ' CD2' ' A' ' 230' ' ' PHE . 77.3 t80 -137.91 139.32 39.75 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 110.27 -0.271 . . . . 0.0 110.27 178.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -165.1 175.01 9.75 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 123.952 0.901 . . . . 0.0 108.743 178.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.407 ' HE3' HG21 ' A' ' 284' ' ' THR . 54.5 mtpt -121.82 159.36 26.91 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 117.803 0.274 . . . . 0.0 110.552 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -164.38 148.23 9.46 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 82.43 -103.35 2.4 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 121.475 -0.393 . . . . 0.0 113.588 173.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -135.87 72.22 1.44 Allowed 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.14 0.495 . . . . 0.0 111.524 -176.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . 0.451 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 86.0 m-20 67.16 27.52 8.48 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.131 179.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -82.88 143.15 30.95 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.824 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -98.13 117.74 5.92 Favored Glycine 0 N--CA 1.437 -1.264 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 230' ' ' PHE . 2.3 mp -105.59 118.64 53.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-N 117.318 0.559 . . . . 0.0 110.288 -177.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.89 111.61 36.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 175.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.482 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 49.6 mt-10 -92.76 138.8 31.18 Favored 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 177.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 13.9 tp -121.91 117.48 26.56 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.358 -176.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -106.19 94.4 5.14 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -102.7 91.34 4.14 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.813 0.816 . . . . 0.0 109.98 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.485 ' N ' HD21 ' A' ' 245' ' ' LEU . 2.9 mm? -76.62 116.38 17.24 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.165 -176.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 114.1 -7.55 23.29 Favored Glycine 0 N--CA 1.429 -1.831 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.762 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' PHE . . . . . 1.663 ' HD2' ' CD1' ' A' ' 247' ' ' PHE . 24.5 t80 -102.48 145.79 29.06 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -136.09 -12.86 1.9 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.511 0.559 . . . . 0.0 112.511 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -92.5 -140.61 9.76 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.991 -178.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -122.72 134.25 24.88 Favored Pre-proline 0 C--N 1.311 -1.092 0 CA-C-O 120.517 0.199 . . . . 0.0 110.617 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.434 ' HB3' HD21 ' A' ' 264' ' ' LEU . 32.1 Cg_endo -77.79 172.43 15.7 Favored 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 122.66 2.24 . . . . 0.0 112.36 177.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -95.87 111.26 23.29 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.462 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 3.8 mp -105.48 124.72 60.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 8.8 t -115.94 117.44 30.15 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 174.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -99.76 107.16 19.16 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 121.187 0.518 . . . . 0.0 111.923 -176.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.45 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 27.2 mt-30 -115.87 161.12 19.26 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 175.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -73.91 -31.37 63.05 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.084 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -80.91 -26.54 36.72 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.707 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . 0.45 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 35.5 p-80 -174.03 161.48 3.66 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 120.878 0.37 . . . . 0.0 111.821 175.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 14.9 mt -106.67 142.75 18.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 177.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . 0.403 HD13 ' N ' ' A' ' 261' ' ' ILE . 3.1 mp -122.46 116.34 48.7 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.456 ' HB ' ' HB3' ' A' ' 300' ' ' LEU . 24.3 t -113.86 119.74 61.87 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 175.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 10.4 m -116.86 123.79 47.92 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 121.181 0.515 . . . . 0.0 110.168 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.437 ' HB2' ' HB ' ' A' ' 298' ' ' THR . 21.2 mt -99.02 99.77 10.84 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.578 ' HD3' ' OD1' ' A' ' 297' ' ' ASP . 48.7 mmtt -61.28 129.34 40.77 Favored 'General case' 0 C--N 1.317 -0.815 0 O-C-N 124.147 0.904 . . . . 0.0 113.398 -177.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 63.4 t30 67.59 22.54 9.11 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.839 175.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 48.4 t60 -110.25 112.08 23.81 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 18.4 p -86.27 124.46 32.67 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-O 121.251 0.548 . . . . 0.0 111.451 -178.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 32.6 tp -99.01 127.63 34.49 Favored Pre-proline 0 N--CA 1.418 -2.064 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.699 177.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.87 147.31 55.43 Favored 'Trans proline' 0 N--CA 1.432 -2.092 0 C-N-CA 121.382 1.388 . . . . 0.0 110.692 170.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 25.0 p -66.64 -15.06 63.2 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.424 0.63 . . . . 0.0 112.075 -177.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 12.2 m -74.58 -21.18 59.62 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.743 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 226' ' ' THR . 3.1 mm? -102.11 -13.97 17.27 Favored 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.077 -178.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -77.11 129.78 36.48 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 119.563 -0.855 . . . . 0.0 108.996 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -170.44 159.96 7.24 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -177.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 16.9 p -104.22 140.21 38.15 Favored 'General case' 0 N--CA 1.407 -2.613 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.735 173.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 82.4 mt -99.59 117.29 33.65 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 175.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -47.35 -68.97 0.14 Allowed 'General case' 0 C--N 1.316 -0.85 0 O-C-N 125.085 1.491 . . . . 0.0 110.594 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . 0.271 19.0 m 49.78 18.32 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 127.111 2.164 . . . . 0.0 116.697 173.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -73.75 132.79 43.01 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 22.2 t70 68.77 48.64 0.75 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 122.674 1.226 . . . . 0.0 112.327 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 1.658 ' HD1' ' CD2' ' A' ' 282' ' ' PHE . 4.8 m-85 -98.08 -1.62 42.0 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 168.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? 61.86 59.94 1.65 Allowed 'General case' 0 CA--C 1.503 -0.86 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.825 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' THR . . . . . 0.407 HG21 ' HE3' ' A' ' 232' ' ' LYS . 2.5 p -137.42 176.65 2.6 Favored Pre-proline 0 C--N 1.31 -1.14 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 3.3 Cg_exo -82.66 -7.1 11.6 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.077 1.852 . . . . 0.0 112.083 174.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.4 p -99.01 127.72 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 CA-C-O 121.623 0.725 . . . . 0.0 110.668 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -88.14 -44.65 10.76 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.441 -172.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -165.06 138.16 4.61 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.319 -176.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 30.7 t -104.39 140.58 22.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 276' ' ' SER . 75.4 m -142.42 116.35 9.34 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 122.031 -0.418 . . . . 0.0 111.177 177.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 56.2 tp -91.59 128.89 37.6 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 174.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -134.92 133.82 39.99 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 120.783 0.325 . . . . 0.0 110.971 -174.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 23.3 ttt180 -71.05 125.11 26.0 Favored 'General case' 0 N--CA 1.4 -2.962 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 171.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.457 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 14.9 tp -102.88 -174.33 2.53 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 176.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.457 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 39.4 t30 -46.64 -74.54 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -120.61 -3.87 9.81 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 122.319 1.057 . . . . 0.0 108.745 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . 0.578 ' OD1' ' HD3' ' A' ' 265' ' ' LYS . 39.7 m-20 -111.67 164.12 13.37 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.236 -175.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.437 ' HB ' ' HB2' ' A' ' 264' ' ' LEU . 91.7 m -104.77 128.61 52.96 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 174.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -113.36 129.68 56.47 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -178.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.456 ' HB3' ' HB ' ' A' ' 262' ' ' VAL . 50.5 tp -114.16 119.02 35.65 Favored 'General case' 0 C--N 1.273 -2.758 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 176.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 51.6 mt -104.44 112.01 36.32 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.128 -177.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 56.4 mt -112.6 103.83 16.06 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 3.7 m -77.8 130.38 36.62 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -174.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 15.5 p -135.56 -176.95 4.45 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 122.366 0.266 . . . . 0.0 111.286 -176.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -159.35 152.94 22.74 Favored 'General case' 0 C--O 1.247 0.946 0 C-N-CA 122.965 0.506 . . . . 0.0 110.169 175.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 74.85 -157.07 50.07 Favored Glycine 0 N--CA 1.444 -0.784 0 O-C-N 123.569 0.543 . . . . 0.0 112.955 175.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -92.39 131.28 37.69 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 177.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' TRP . . . . . 0.659 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 60.8 p-90 -148.77 166.3 28.84 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -178.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -124.76 135.99 53.46 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.659 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 27.0 tp -107.45 118.56 37.03 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.583 ' CG1' ' HB3' ' A' ' 323' ' ' GLN . 5.7 p -115.26 112.31 39.36 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.515 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 171.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -102.93 129.71 49.74 Favored 'General case' 0 N--CA 1.407 -2.586 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.075 -178.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -129.17 156.98 43.05 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.635 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 26.4 t -111.44 120.95 43.86 Favored 'General case' 0 N--CA 1.411 -2.417 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -88.91 -23.65 22.67 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.024 0.44 . . . . 0.0 110.726 -177.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -169.91 164.14 6.36 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.69 103.11 0.26 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 121.745 1.63 . . . . 0.0 111.238 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 115.01 -28.1 8.22 Favored Glycine 0 N--CA 1.436 -1.347 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -177.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -89.13 116.65 27.55 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.164 0.507 . . . . 0.0 110.339 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' PHE . . . . . 1.662 ' HD1' ' CD2' ' A' ' 320' ' ' PHE . 99.3 m-85 -116.28 165.74 12.84 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 115.377 -0.829 . . . . 0.0 108.865 177.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 89.6 m -152.05 130.18 11.91 Favored 'General case' 0 C--N 1.261 -3.278 0 C-N-CA 123.661 0.784 . . . . 0.0 108.894 -176.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -118.57 107.53 13.86 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . 0.583 ' HB3' ' CG1' ' A' ' 311' ' ' VAL . 35.9 tt0 -99.66 112.5 24.72 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 176.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 75.3 t -95.1 98.64 8.2 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.174 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -83.49 149.14 57.07 Favored Pre-proline 0 CA--C 1.512 -0.49 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -77.52 125.6 7.72 Favored 'Trans proline' 0 N--CA 1.44 -1.672 0 N-CA-C 108.498 -1.385 . . . . 0.0 108.498 170.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt . . . . . 0 C--N 1.294 -1.808 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -179.303 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . 0.419 ' O ' HD21 ' A' ' 245' ' ' LEU . 11.5 pm0 . . . . . 0 N--CA 1.43 -1.429 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 56.9 m -67.44 116.39 8.13 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -144.51 173.02 12.17 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.308 -172.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 1.4 pp -136.06 158.65 38.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 CA-C-N 114.145 -1.389 . . . . 0.0 109.361 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -150.23 151.32 32.85 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -129.84 133.75 47.12 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 173.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -153.39 152.81 31.48 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -104.15 153.19 21.23 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.442 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -151.61 162.61 40.7 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 64.7 -125.87 31.49 Favored Glycine 0 C--N 1.312 -0.751 0 O-C-N 123.454 0.471 . . . . 0.0 112.849 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -124.03 91.81 3.54 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . 0.552 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 95.9 m-20 66.66 21.25 10.66 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 177.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -79.79 138.26 37.21 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -99.18 110.4 3.98 Favored Glycine 0 N--CA 1.436 -1.325 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.1 mp -102.7 115.09 44.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 117.483 0.641 . . . . 0.0 109.917 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.5 mp -102.57 113.68 39.86 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -93.11 145.08 24.66 Favored 'General case' 0 C--N 1.283 -2.284 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.965 173.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 12.0 tp -135.6 134.09 38.95 Favored 'General case' 0 C--N 1.264 -3.14 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.67 -174.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -126.93 106.6 9.42 Favored 'General case' 0 C--N 1.278 -2.514 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.445 ' O ' ' HA2' ' A' ' 318' ' ' GLY . . . -108.75 91.01 3.47 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.419 HD21 ' O ' ' A' ' 225' ' ' GLN . 3.3 mm? -84.4 114.0 21.58 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.678 0.752 . . . . 0.0 111.141 -175.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 116.51 3.91 18.18 Favored Glycine 0 N--CA 1.429 -1.767 0 CA-C-N 114.239 -1.346 . . . . 0.0 110.175 -177.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' PHE . . . . . 0.444 ' HB2' ' ND1' ' A' ' 267' ' ' HIS . 65.8 t80 -113.12 115.63 28.59 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 121.016 0.436 . . . . 0.0 110.25 -177.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -112.98 100.03 8.32 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 154.43 -158.37 28.17 Favored Glycine 0 N--CA 1.432 -1.597 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -114.43 140.89 25.72 Favored Pre-proline 0 C--N 1.301 -1.511 0 CA-C-N 116.853 0.327 . . . . 0.0 110.359 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.464 ' HB3' HD11 ' A' ' 264' ' ' LEU . 17.9 Cg_endo -72.57 171.85 16.32 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.56 2.173 . . . . 0.0 111.112 175.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 18.0 t70 -88.45 109.93 20.43 Favored 'General case' 0 C--N 1.277 -2.58 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 4.1 mp -97.99 108.18 21.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 121.84 0.828 . . . . 0.0 110.102 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' SER . . . . . 0.505 ' HB2' ' HB ' ' A' ' 261' ' ' ILE . 47.3 m -109.99 107.18 16.97 Favored 'General case' 0 C--N 1.278 -2.526 0 CA-C-N 114.482 -1.236 . . . . 0.0 108.43 177.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -99.18 126.73 45.02 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 122.126 -0.359 . . . . 0.0 110.865 -175.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -124.21 171.68 9.65 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 171.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -76.59 -40.12 50.51 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 120.871 0.367 . . . . 0.0 110.994 -177.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -82.79 -20.37 35.92 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.826 -175.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -171.99 160.83 5.5 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.905 0.384 . . . . 0.0 111.448 176.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 16.7 mt -106.71 143.78 16.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' A' ' 254' ' ' SER . 3.9 mp -119.79 109.76 27.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 176.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.46 ' HB ' ' HB3' ' A' ' 300' ' ' LEU . 61.6 t -111.45 123.24 67.11 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.426 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 176.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 298' ' ' THR . 11.9 m -126.19 130.06 50.22 Favored 'General case' 0 C--N 1.285 -2.216 0 C-N-CA 120.096 -0.642 . . . . 0.0 111.029 -177.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.464 HD11 ' HB3' ' A' ' 251' ' ' PRO . 1.3 mm? -100.81 98.04 8.59 Favored 'General case' 0 N--CA 1.408 -2.574 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 177.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.443 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 58.6 mtpt -73.27 135.55 44.48 Favored 'General case' 0 C--N 1.267 -3.015 0 O-C-N 124.191 0.932 . . . . 0.0 110.81 -177.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 6.2 t30 72.85 20.65 3.55 Favored 'General case' 0 CA--C 1.55 0.961 0 O-C-N 124.539 1.15 . . . . 0.0 109.716 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' HIS . . . . . 0.444 ' ND1' ' HB2' ' A' ' 247' ' ' PHE . 54.5 t60 -114.85 100.1 7.97 Favored 'General case' 0 CA--C 1.495 -1.173 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 176.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.97 116.74 17.9 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-O 120.847 0.356 . . . . 0.0 110.436 -176.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 22.5 tp -99.29 123.08 49.86 Favored Pre-proline 0 N--CA 1.436 -1.175 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.769 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -67.73 158.0 59.2 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 122.429 2.086 . . . . 0.0 111.849 171.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' THR . . . . . 0.55 ' HA ' HE21 ' A' ' 274' ' ' GLN . 24.6 p -68.34 -26.3 65.53 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 15.4 m -72.53 -19.74 61.46 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.353 -177.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -95.15 -22.31 17.94 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.492 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.55 HE21 ' HA ' ' A' ' 271' ' ' THR . 5.4 pt20 -77.47 140.03 39.75 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -177.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -177.96 175.46 1.29 Allowed 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -175.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 32.9 t -125.62 143.07 51.19 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-O 121.527 0.679 . . . . 0.0 110.453 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.455 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 1.3 mm? -91.84 103.14 15.72 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 102.917 -2.994 . . . . 0.0 102.917 174.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -59.2 -50.55 73.6 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 123.727 0.642 . . . . 0.0 112.089 -173.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 25.8 m 44.9 30.1 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 173.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -72.52 134.32 45.2 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.646 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 73.59 19.62 3.26 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.069 1.348 . . . . 0.0 113.548 -174.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 1.647 ' HD2' ' CD1' ' A' ' 282' ' ' PHE . 10.4 m-85 -79.35 -21.94 45.14 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.345 170.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? 57.8 61.86 2.27 Favored 'General case' 0 CA--C 1.493 -1.212 0 CA-C-O 122.253 1.025 . . . . 0.0 113.641 174.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 4.8 p -125.3 -178.67 0.73 Allowed Pre-proline 0 C--N 1.275 -2.641 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . 0.552 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 14.4 Cg_exo -71.1 -16.91 31.93 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 CA-C-N 121.281 1.493 . . . . 0.0 110.637 174.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.5 p -95.75 126.61 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-O 122.25 1.024 . . . . 0.0 110.562 177.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -84.16 -47.31 10.99 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 113.938 -1.483 . . . . 0.0 110.278 -175.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -162.09 148.84 13.67 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 -177.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 62.0 t -116.39 122.71 70.37 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.669 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 53.7 m -123.86 120.33 32.25 Favored 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.951 -0.468 . . . . 0.0 111.951 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 48.2 tp -94.53 122.8 37.48 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 175.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -129.84 141.89 50.76 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -176.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -82.41 138.97 34.28 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 118.501 -1.279 . . . . 0.0 108.843 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.464 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 17.0 tp -108.25 -175.32 2.74 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 176.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.464 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 26.0 t-20 -49.03 -67.45 0.26 Allowed 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 118.918 0.781 . . . . 0.0 113.0 -177.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -119.44 -2.21 10.6 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 122.13 0.967 . . . . 0.0 108.462 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . 0.443 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 5.5 m-20 -117.07 168.51 10.2 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.094 -169.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 263' ' ' THR . 58.8 m -111.73 124.21 51.86 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 176.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -113.13 124.61 52.97 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-O 121.582 0.706 . . . . 0.0 109.476 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.46 ' HB3' ' HB ' ' A' ' 262' ' ' VAL . 58.6 tp -110.97 120.34 42.07 Favored 'General case' 0 C--N 1.274 -2.689 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 54.9 mt -106.42 109.77 29.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.245 -176.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 57.5 mt -107.96 103.18 15.08 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.496 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 8.4 m -77.1 131.1 38.17 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 -175.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 18.9 p -134.73 175.88 9.15 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 122.395 0.278 . . . . 0.0 111.719 -175.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -164.2 139.62 6.02 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.906 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 99.11 -151.87 19.52 Favored Glycine 0 N--CA 1.434 -1.479 0 C-N-CA 121.25 -0.5 . . . . 0.0 112.354 177.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -105.85 124.5 49.67 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 177.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' TRP . . . . . . . . . . . . . 69.1 p-90 -150.24 158.11 43.81 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.766 -176.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -115.62 137.88 51.63 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 1.4 tt -104.55 114.03 27.99 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.481 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 46.0 t -108.09 106.71 21.18 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 172.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -95.96 141.0 29.9 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . 0.415 ' HB2' ' HB ' ' A' ' 321' ' ' THR . 86.8 mttt -131.14 141.07 50.06 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -178.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 20.3 m -115.81 109.32 17.49 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -77.38 -33.41 55.17 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.586 0.707 . . . . 0.0 109.783 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -170.19 161.56 6.5 Favored Pre-proline 0 C--N 1.305 -1.364 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -65.24 96.97 0.29 Allowed 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 121.387 1.391 . . . . 0.0 110.245 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 244' ' ' ALA . . . 135.62 -16.81 4.02 Favored Glycine 0 N--CA 1.424 -2.107 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.74 -176.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -122.29 118.39 28.39 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 122.344 -0.503 . . . . 0.0 110.171 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' PHE . . . . . 1.609 ' HD1' ' CD2' ' A' ' 320' ' ' PHE . 90.8 m-85 -126.87 161.79 27.42 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.507 -178.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.415 ' HB ' ' HB2' ' A' ' 313' ' ' LYS . 49.3 m -151.87 138.62 18.85 Favored 'General case' 0 C--N 1.267 -2.999 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -176.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 1.646 ' HD1' ' CD2' ' A' ' 322' ' ' PHE . 57.9 m-85 -127.41 107.44 9.96 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . 0.493 HE21 HD23 ' A' ' 325' ' ' LEU . 45.9 tt0 -94.06 101.34 13.37 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 86.6 t -89.05 101.17 11.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.001 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.493 HD23 HE21 ' A' ' 323' ' ' GLN . 40.3 mt -95.59 145.39 29.45 Favored Pre-proline 0 C--N 1.299 -1.596 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.995 -176.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -72.25 123.61 9.32 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 121.102 1.201 . . . . 0.0 109.97 172.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt . . . . . 0 CA--C 1.474 -1.962 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.713 -175.493 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . 0.47 ' CG ' HD22 ' A' ' 273' ' ' LEU . 1.1 tp60 . . . . . 0 N--CA 1.431 -1.424 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 16.3 m -50.65 128.6 20.87 Favored 'General case' 0 CA--C 1.552 1.021 0 O-C-N 123.923 0.764 . . . . 0.0 110.73 177.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -146.07 156.6 43.57 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.048 0.452 . . . . 0.0 110.224 -174.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.547 HD11 ' O ' ' A' ' 228' ' ' ILE . 2.1 pp -138.73 146.04 26.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 C-N-CA 124.882 1.273 . . . . 0.0 109.491 -177.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -150.58 157.16 42.67 Favored 'General case' 0 C--N 1.29 -1.991 0 O-C-N 123.34 0.4 . . . . 0.0 111.103 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -126.67 138.01 53.36 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-O 120.811 0.339 . . . . 0.0 111.153 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -146.92 168.11 22.28 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 173.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -116.01 155.52 27.94 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 122.402 -0.186 . . . . 0.0 110.677 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -138.55 145.47 40.71 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 123.366 0.416 . . . . 0.0 110.175 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 56.33 -104.7 0.38 Allowed Glycine 0 N--CA 1.441 -0.97 0 O-C-N 124.566 1.166 . . . . 0.0 114.796 172.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -119.15 83.86 2.1 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-O 121.212 0.53 . . . . 0.0 109.852 -176.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . 0.425 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 94.9 m-20 61.37 23.05 13.35 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.646 -1.161 . . . . 0.0 114.075 172.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -78.32 136.63 37.75 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -99.45 114.57 5.06 Favored Glycine 0 N--CA 1.431 -1.697 0 N-CA-C 111.689 -0.564 . . . . 0.0 111.689 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.1 mp -107.49 115.84 49.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-O 121.35 0.595 . . . . 0.0 110.847 -177.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.3 mp -99.17 116.65 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.459 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 175.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -90.73 135.76 33.51 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 16.3 tp -130.86 131.85 44.81 Favored 'General case' 0 C--N 1.278 -2.514 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.057 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -128.74 102.36 6.53 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -111.21 92.25 3.97 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.479 0.656 . . . . 0.0 109.697 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.425 HD23 ' N ' ' A' ' 245' ' ' LEU . 3.1 mm? -76.42 114.59 15.29 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.224 -176.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 107.1 18.73 10.14 Favored Glycine 0 N--CA 1.431 -1.646 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.579 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -115.11 116.08 27.83 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -104.88 95.15 5.67 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.147 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 143.6 -166.17 26.97 Favored Glycine 0 C--N 1.299 -1.515 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 175.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -102.28 144.87 29.47 Favored Pre-proline 0 C--N 1.308 -1.205 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 177.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.411 ' HB3' ' CD2' ' A' ' 264' ' ' LEU . 21.5 Cg_endo -77.14 173.32 14.59 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.955 2.437 . . . . 0.0 112.38 178.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -97.76 118.0 33.33 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 3.2 mp -107.25 133.13 52.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-O 120.977 0.417 . . . . 0.0 111.18 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 23.2 t -115.81 111.35 20.37 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 173.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -90.86 105.05 17.56 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.342 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 74.8 mt-30 -125.14 152.52 44.32 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 176.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -60.1 -45.13 94.0 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -176.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -83.87 -20.14 33.61 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -174.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . 0.458 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 49.1 p-80 -171.8 158.75 5.0 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.083 0.468 . . . . 0.0 111.853 175.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 23.7 mt -106.72 144.14 16.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 3.5 mp -119.82 112.97 39.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.43 ' HB ' ' HB2' ' A' ' 300' ' ' LEU . 54.7 t -107.18 116.44 50.84 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 176.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 17.3 m -109.54 124.1 50.54 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-O 121.146 0.498 . . . . 0.0 110.19 -178.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.499 ' HB2' ' HB ' ' A' ' 298' ' ' THR . 18.2 mt -102.96 89.84 3.57 Favored 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 178.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.564 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 61.2 mtpt -65.68 131.28 45.94 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.667 -175.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 71.23 21.08 4.85 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 124.601 1.188 . . . . 0.0 109.843 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -117.99 102.02 8.73 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 177.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 2.5 m -91.43 115.41 28.01 Favored 'General case' 0 C--N 1.28 -2.455 0 C-N-CA 119.829 -0.749 . . . . 0.0 111.208 -173.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 270' ' ' PRO . 21.2 tp -89.89 130.3 43.23 Favored Pre-proline 0 N--CA 1.43 -1.466 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.761 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . 0.404 ' O ' ' HG ' ' A' ' 269' ' ' LEU . 6.7 Cg_exo -73.85 156.95 48.07 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 122.057 1.838 . . . . 0.0 110.603 170.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' THR . . . . . 0.452 ' HA ' ' HG2' ' A' ' 274' ' ' GLN . 7.1 p -73.55 -10.46 59.73 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.623 0.725 . . . . 0.0 112.186 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 15.4 m -73.59 -24.06 60.01 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.206 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.47 HD22 ' CG ' ' A' ' 225' ' ' GLN . 7.8 mp -101.95 -12.16 18.41 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.704 -174.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.455 ' O ' ' HG3' ' A' ' 274' ' ' GLN . 0.0 OUTLIER -81.12 127.37 32.57 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.0 -176.723 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -153.58 163.35 40.12 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 13.9 p -124.29 127.41 47.6 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-O 121.792 0.806 . . . . 0.0 111.714 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.424 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 2.1 mm? -81.25 118.45 22.61 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -84.39 92.89 8.15 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 118.66 -1.216 . . . . 0.0 108.543 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . 0.585 ' HA ' ' CD2' ' A' ' 282' ' ' PHE . 46.9 t -94.88 28.97 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 CA-C-O 123.328 1.537 . . . . 0.0 109.793 -175.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -79.74 149.92 30.99 Favored 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 175.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 28.1 t70 70.21 9.04 6.9 Favored 'General case' 0 CA--C 1.556 1.177 0 CA-C-O 122.156 0.979 . . . . 0.0 111.715 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.585 ' CD2' ' HA ' ' A' ' 279' ' ' VAL . 16.4 m-85 -83.38 -13.47 54.85 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 121.737 -0.602 . . . . 0.0 111.045 176.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 mptt 58.4 60.99 2.4 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.094 0.558 . . . . 0.0 111.132 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 1.5 p -136.64 174.74 4.12 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 13.9 Cg_exo -71.47 -19.52 28.46 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 121.739 1.626 . . . . 0.0 111.601 175.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.3 p -94.85 132.76 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-O 121.517 0.675 . . . . 0.0 110.21 178.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -100.01 -32.27 11.04 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.9 -174.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 40.2 tttp -162.86 134.48 5.11 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 120.051 -0.659 . . . . 0.0 109.8 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.424 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 42.0 t -103.48 110.14 29.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 174.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.451 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 93.8 m -112.57 113.55 25.76 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-O 121.004 0.43 . . . . 0.0 111.375 -176.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.432 ' O ' ' HB2' ' A' ' 274' ' ' GLN . 37.9 tp -94.93 122.71 37.86 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 173.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -140.84 144.4 35.33 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -79.02 149.9 32.08 Favored 'General case' 0 C--N 1.282 -2.339 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.468 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.528 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 15.8 tp -111.62 -173.98 2.36 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 176.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.528 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 64.0 t30 -51.78 -62.7 1.47 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.954 0.502 . . . . 0.0 112.091 -177.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -122.4 -3.21 8.91 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 121.154 0.502 . . . . 0.0 110.08 176.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . 0.564 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 11.8 m-20 -115.72 169.07 9.48 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.823 -170.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.499 ' HB ' ' HB2' ' A' ' 264' ' ' LEU . 86.7 m -106.28 135.32 47.96 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 176.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -122.68 127.71 49.64 Favored 'General case' 0 N--CA 1.417 -2.091 0 CA-C-O 121.522 0.677 . . . . 0.0 110.569 -176.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.43 ' HB2' ' HB ' ' A' ' 262' ' ' VAL . 1.8 mt -106.13 119.56 39.52 Favored 'General case' 0 C--N 1.273 -2.729 0 CA-C-N 115.32 -0.854 . . . . 0.0 108.902 175.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' ILE . . . . . 0.451 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 67.3 mt -108.0 109.26 27.59 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.796 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 61.1 mt -108.94 101.06 12.02 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 24.9 m -69.51 132.3 46.06 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 11.4 p -137.41 169.76 17.23 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 122.896 0.479 . . . . 0.0 111.023 -177.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -159.11 144.72 16.25 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 92.2 -152.69 21.41 Favored Glycine 0 N--CA 1.436 -1.358 0 O-C-N 123.892 0.745 . . . . 0.0 112.623 176.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' ASN . . . . . 0.57 ' HB2' ' O ' ' A' ' 327' ' ' LYS . 6.6 m120 -101.17 129.19 47.05 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' TRP . . . . . 0.407 ' CE3' HG13 ' A' ' 324' ' ' VAL . 67.4 p-90 -153.59 162.9 40.82 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.011 -177.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -122.62 135.36 54.59 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 1.5 tt -102.74 122.87 45.34 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.485 ' CG1' ' HB3' ' A' ' 323' ' ' GLN . 7.6 p -125.53 111.97 29.26 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 CA-C-O 121.883 0.849 . . . . 0.0 109.794 170.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -98.79 135.97 39.49 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.259 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -128.2 139.74 52.29 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.098 -176.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 35.9 p -115.99 122.24 44.65 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 176.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -81.16 -38.03 27.8 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.698 0.761 . . . . 0.0 109.321 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -163.27 162.21 17.76 Favored Pre-proline 0 C--N 1.308 -1.21 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -58.29 110.43 0.65 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.038 1.826 . . . . 0.0 110.811 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 113.86 -36.13 4.17 Favored Glycine 0 N--CA 1.424 -2.104 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' TYR . . . . . 1.621 ' HE1' ' CE2' ' A' ' 319' ' ' TYR . 91.5 m-85 -93.29 115.59 28.18 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' PHE . . . . . 1.64 ' HE1' ' CE2' ' A' ' 320' ' ' PHE . 74.4 m-85 -127.32 166.36 17.96 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-O 122.228 1.013 . . . . 0.0 111.407 -175.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 84.8 m -151.93 127.36 9.99 Favored 'General case' 0 C--N 1.278 -2.531 0 CA-C-N 113.988 -1.46 . . . . 0.0 108.604 -177.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 1.662 ' HE1' ' CE2' ' A' ' 322' ' ' PHE . 79.4 m-85 -116.55 111.49 20.0 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . 0.485 ' HB3' ' CG1' ' A' ' 311' ' ' VAL . 61.6 tt0 -97.76 104.28 16.29 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . 0.407 HG13 ' CE3' ' A' ' 308' ' ' TRP . 88.2 t -90.28 98.87 8.72 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 33.0 mt -87.05 148.61 45.62 Favored Pre-proline 0 C--N 1.292 -1.92 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.057 -178.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -77.43 143.46 21.92 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 121.62 1.547 . . . . 0.0 111.134 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . 0.57 ' O ' ' HB2' ' A' ' 307' ' ' ASN . 19.7 ttmm . . . . . 0 N--CA 1.434 -1.264 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . 0.507 ' O ' HD21 ' A' ' 245' ' ' LEU . 3.6 pt20 . . . . . 0 N--CA 1.42 -1.945 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 43.3 m -78.43 127.61 32.43 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 121.118 0.485 . . . . 0.0 112.198 -175.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -151.89 166.35 31.72 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.372 -177.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.3 pp -121.43 165.45 17.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.321 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 240' ' ' ILE . 2.4 t70 -150.25 156.46 41.62 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 1.658 ' HD2' ' CD1' ' A' ' 230' ' ' PHE . 71.7 t80 -133.39 130.6 38.96 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.234 0.54 . . . . 0.0 109.749 176.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.407 ' HD2' ' OE2' ' A' ' 241' ' ' GLU . 5.4 ptp180 -149.81 165.33 32.82 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.37 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -108.92 142.09 40.05 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . 0.532 ' O ' ' HB1' ' A' ' 237' ' ' ALA . 18.8 t70 -156.77 117.99 3.75 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -178.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 102.13 -143.43 15.95 Favored Glycine 0 C--N 1.301 -1.412 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -178.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -114.46 101.5 9.19 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 117.468 0.634 . . . . 0.0 110.032 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 18.9 m120 65.39 27.25 11.91 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.621 1.168 . . . . 0.0 111.896 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . 0.532 ' HB1' ' O ' ' A' ' 233' ' ' ASP . . . -97.94 134.74 40.64 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.304 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . 0.55 ' HA3' ' CG1' ' A' ' 286' ' ' VAL . . . -101.44 123.9 8.06 Favored Glycine 0 C--N 1.296 -1.671 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.1 mp -116.78 120.11 64.03 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-N 118.045 0.923 . . . . 0.0 111.045 -176.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' A' ' 229' ' ' ASP . 3.2 mp -104.21 109.49 27.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 176.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.407 ' OE2' ' HD2' ' A' ' 231' ' ' ARG . 5.4 mt-10 -93.59 128.53 39.79 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-O 121.435 0.636 . . . . 0.0 109.742 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 13.0 tp -115.24 126.64 54.78 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 115.186 -0.916 . . . . 0.0 112.092 -171.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . 0.568 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -108.27 104.11 13.43 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 175.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -112.25 91.88 3.82 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.432 0.634 . . . . 0.0 109.477 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.507 HD21 ' O ' ' A' ' 225' ' ' GLN . 3.5 mm? -85.36 116.83 23.92 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.769 -175.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 108.68 13.33 18.85 Favored Glycine 0 N--CA 1.424 -2.113 0 CA-C-N 114.24 -1.346 . . . . 0.0 110.16 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -114.86 115.26 26.68 Favored 'General case' 0 N--CA 1.423 -1.812 0 C-N-CA 120.6 -0.44 . . . . 0.0 109.875 -177.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -112.93 95.15 5.25 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.05 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 152.47 -157.33 27.22 Favored Glycine 0 C--N 1.296 -1.672 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -114.56 141.55 26.81 Favored Pre-proline 0 C--N 1.303 -1.43 0 CA-C-N 116.991 0.396 . . . . 0.0 110.325 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.455 ' HB3' ' CD1' ' A' ' 264' ' ' LEU . 12.7 Cg_endo -68.97 172.19 12.29 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.403 2.069 . . . . 0.0 111.053 175.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.406 ' HB3' ' HB ' ' A' ' 263' ' ' THR . 34.1 t0 -97.48 107.84 20.43 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 3.1 mp -95.11 116.23 36.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 3.1 t -119.28 111.27 18.0 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -97.58 128.74 44.54 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -174.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.456 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 18.4 mt-30 -125.24 163.13 23.17 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 170.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -76.45 -29.85 57.12 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.29 174.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -68.24 -48.56 64.77 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.308 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . 0.497 ' CB ' ' HA ' ' A' ' 303' ' ' THR . 27.6 p-80 -163.37 167.62 21.49 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 116.704 -0.225 . . . . 0.0 110.451 177.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 19.8 mt -105.83 143.1 17.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 3.5 mp -120.93 109.1 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 176.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.431 ' HB ' ' HB3' ' A' ' 300' ' ' LEU . 51.4 t -106.54 117.76 52.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 177.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' THR . . . . . 0.598 ' HA ' ' O ' ' A' ' 298' ' ' THR . 25.3 m -116.79 123.96 48.41 Favored 'General case' 0 C--N 1.278 -2.52 0 CA-C-O 121.773 0.797 . . . . 0.0 111.27 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.455 ' CD1' ' HB3' ' A' ' 251' ' ' PRO . 1.7 mm? -93.47 98.03 10.93 Favored 'General case' 0 N--CA 1.399 -2.99 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 174.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.505 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 0.5 OUTLIER -67.79 129.81 41.06 Favored 'General case' 0 N--CA 1.388 -3.569 0 O-C-N 124.756 1.285 . . . . 0.0 108.921 -174.832 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 66.6 t30 71.05 27.38 3.34 Favored 'General case' 0 CA--C 1.549 0.924 0 O-C-N 124.483 1.115 . . . . 0.0 110.444 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -121.77 113.18 19.33 Favored 'General case' 0 C--O 1.203 -1.362 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 3.9 p -90.71 129.15 36.83 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . 0.41 HD23 HD21 ' A' ' 291' ' ' LEU . 23.8 tp -107.39 129.56 24.09 Favored Pre-proline 0 N--CA 1.446 -0.664 0 C-N-CA 123.624 0.77 . . . . 0.0 109.873 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -64.63 151.34 86.0 Favored 'Trans proline' 0 C--N 1.318 -1.052 0 C-N-CA 122.36 2.04 . . . . 0.0 111.584 172.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' THR . . . . . 0.455 ' HA ' ' HG2' ' A' ' 274' ' ' GLN . 16.3 p -74.96 -13.91 60.57 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.776 0.798 . . . . 0.0 112.176 -178.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 25.0 m -81.09 -17.91 48.39 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 122.018 0.913 . . . . 0.0 110.038 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 96.0 mt -101.19 -19.99 15.48 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.944 -178.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.456 ' HB2' ' O ' ' A' ' 291' ' ' LEU . 11.9 pt20 -74.5 136.15 42.21 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -164.87 178.59 7.05 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -173.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 39.9 m -134.78 123.82 24.19 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.346 0.593 . . . . 0.0 110.872 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.414 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 53.2 mt -91.09 120.25 31.89 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 103.977 -2.601 . . . . 0.0 103.977 174.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -68.2 -42.57 79.7 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.783 -172.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . 0.334 34.0 m 42.65 26.74 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 N-CA-C 117.353 2.353 . . . . 0.0 117.353 175.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -74.6 142.86 44.59 Favored 'General case' 0 N--CA 1.415 -2.209 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 176.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 30.0 t70 72.59 22.94 3.15 Favored 'General case' 0 CA--C 1.553 1.059 0 O-C-N 124.229 0.956 . . . . 0.0 111.521 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -86.78 1.94 50.55 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 176.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? 60.77 59.81 2.04 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 1.1 t -164.95 150.95 8.87 Favored Pre-proline 0 N--CA 1.423 -1.795 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.363 177.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . 0.411 ' O ' ' HA ' ' A' ' 304' ' ' THR . 18.4 Cg_exo -44.2 -35.81 8.33 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 124.556 3.504 . . . . 0.0 114.06 174.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.55 ' CG1' ' HA3' ' A' ' 238' ' ' GLY . 0.2 OUTLIER -73.57 115.53 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 CA-C-O 121.767 0.794 . . . . 0.0 109.442 177.32 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -94.7 -37.07 11.47 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.714 -174.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -154.62 146.51 23.48 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -176.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.414 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 55.1 t -120.04 125.59 74.4 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.444 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 96.1 m -126.49 127.17 44.93 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-O 121.056 0.455 . . . . 0.0 110.434 178.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' A' ' 274' ' ' GLN . 0.1 OUTLIER -100.88 120.1 39.66 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 174.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -123.75 134.3 53.69 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . 0.406 ' HG2' ' OE1' ' A' ' 274' ' ' GLN . 9.0 ptm180 -81.32 148.62 29.31 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 117.609 -1.636 . . . . 0.0 108.308 173.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.57 HD11 ' N ' ' A' ' 295' ' ' ASN . 2.8 tm? -122.96 166.9 14.3 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.57 ' N ' HD11 ' A' ' 294' ' ' LEU . 0.2 OUTLIER -24.02 -70.35 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 127.349 2.26 . . . . 0.0 112.149 177.052 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -124.7 -2.15 7.88 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . 0.505 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 12.3 m-20 -119.04 171.37 8.31 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.578 -168.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.598 ' O ' ' HA ' ' A' ' 263' ' ' THR . 70.5 m -114.3 128.16 56.22 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 176.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -113.65 116.48 29.53 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -177.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.431 ' HB3' ' HB ' ' A' ' 262' ' ' VAL . 0.6 OUTLIER -101.52 120.25 40.01 Favored 'General case' 0 C--N 1.277 -2.587 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 177.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' ILE . . . . . 0.444 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 80.6 mt -110.76 115.19 49.19 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -176.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 45.8 mt -117.37 103.25 14.64 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.552 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' THR . . . . . 0.497 ' HA ' ' CB ' ' A' ' 259' ' ' HIS . 85.6 m -75.91 134.43 40.25 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 120.556 0.217 . . . . 0.0 110.416 -177.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 285' ' ' PRO . 9.1 p -132.76 -179.26 5.36 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 123.237 0.615 . . . . 0.0 110.932 -174.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -155.03 139.88 17.22 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 122.687 0.395 . . . . 0.0 110.162 177.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 77.15 -151.78 39.15 Favored Glycine 0 C--O 1.236 0.263 0 O-C-N 123.635 0.584 . . . . 0.0 112.384 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -96.59 137.11 36.17 Favored 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 176.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' TRP . . . . . . . . . . . . . 68.9 p-90 -154.13 165.43 36.25 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -175.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . 0.542 ' O ' ' HA ' ' A' ' 324' ' ' VAL . 5.6 mt-10 -122.03 136.82 54.95 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -178.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.25 124.21 49.43 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.522 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 58.3 t -115.88 107.34 22.38 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.637 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 173.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -92.84 124.92 37.18 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -123.46 149.95 44.46 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -177.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 12.9 p -115.69 122.27 45.03 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 177.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -89.81 -29.54 18.57 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.402 0.62 . . . . 0.0 110.494 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -164.29 163.12 15.36 Favored Pre-proline 0 C--N 1.309 -1.179 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -64.64 97.6 0.27 Allowed 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 121.537 1.491 . . . . 0.0 111.504 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 122.17 -20.63 7.97 Favored Glycine 0 C--O 1.218 -0.877 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.992 -177.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -103.17 116.34 32.29 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' PHE . . . . . 1.662 ' HD2' ' CD1' ' A' ' 320' ' ' PHE . 92.3 m-85 -121.45 168.27 11.89 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.674 0.749 . . . . 0.0 111.243 -175.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 60.6 m -151.2 129.23 11.79 Favored 'General case' 0 C--N 1.277 -2.569 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.37 -176.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 1.649 ' HE2' ' CE1' ' A' ' 322' ' ' PHE . 90.4 m-85 -117.53 108.76 15.89 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 177.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . 0.522 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 42.1 tt0 -98.9 105.33 17.46 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 309' ' ' GLU . 0.2 OUTLIER -100.97 105.83 18.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 CA-C-O 122.099 0.952 . . . . 0.0 110.102 178.039 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.7 mp -104.17 156.16 36.15 Favored Pre-proline 0 C--N 1.298 -1.637 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.803 -177.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -74.19 128.52 12.22 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 121.697 1.598 . . . . 0.0 112.082 177.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm . . . . . 0 CA--C 1.49 -1.342 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 177.509 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . 0.43 ' O ' HD21 ' A' ' 245' ' ' LEU . 17.7 pt20 . . . . . 0 N--CA 1.436 -1.166 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 88.8 m -78.73 131.83 36.74 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.172 177.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -166.91 175.49 7.65 Favored 'General case' 0 CA--C 1.479 -1.788 0 CA-C-O 121.131 0.491 . . . . 0.0 110.289 -175.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.6 pp -128.04 162.72 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.53 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.696 177.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . 0.452 ' HB2' ' HB2' ' A' ' 241' ' ' GLU . 4.8 m-20 -146.78 156.04 42.84 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 1.656 ' HE1' ' CE2' ' A' ' 230' ' ' PHE . 55.6 t80 -129.48 134.42 47.79 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.244 176.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 8.3 ptt-85 -144.15 169.33 18.07 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 175.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.424 ' HE3' HG21 ' A' ' 284' ' ' THR . 55.3 mtpt -114.93 150.2 36.07 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 175.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -152.56 152.06 31.41 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -177.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 73.57 -102.75 1.33 Allowed Glycine 0 C--N 1.314 -0.683 0 C-N-CA 121.285 -0.483 . . . . 0.0 113.748 176.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -152.98 104.26 2.82 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 123.2 0.6 . . . . 0.0 110.038 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . 0.638 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 89.6 m-20 61.21 20.7 11.23 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.112 0.965 . . . . 0.0 111.762 176.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.34 137.84 33.02 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 120.822 0.344 . . . . 0.0 110.259 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -99.91 117.59 5.92 Favored Glycine 0 N--CA 1.425 -2.066 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.1 mp -108.47 117.79 54.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 117.194 0.497 . . . . 0.0 110.797 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 2.9 mp -103.68 110.12 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.452 ' HB2' ' HB2' ' A' ' 229' ' ' ASP . 53.7 mt-10 -90.04 123.37 33.87 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 11.9 tp -112.14 124.23 51.98 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-O 120.981 0.42 . . . . 0.0 111.965 -174.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . 0.53 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -107.45 107.87 18.94 Favored 'General case' 0 C--O 1.206 -1.216 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 176.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -118.15 92.35 3.8 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.24 0.543 . . . . 0.0 111.519 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.43 HD21 ' O ' ' A' ' 225' ' ' GLN . 3.6 mm? -86.56 116.25 24.57 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.246 0.546 . . . . 0.0 111.079 -177.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 111.64 -7.79 28.02 Favored Glycine 0 C--N 1.297 -1.603 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.146 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' PHE . . . . . 1.611 ' HE2' ' CE1' ' A' ' 247' ' ' PHE . 47.9 t80 -98.56 128.15 44.77 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -107.57 -34.98 6.86 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -174.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -86.3 -150.1 15.2 Favored Glycine 0 CA--C 1.506 -0.479 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.457 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -115.01 141.13 26.48 Favored Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.453 ' HB3' HD21 ' A' ' 264' ' ' LEU . 10.2 Cg_endo -69.44 172.27 12.62 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.957 1.771 . . . . 0.0 113.951 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -97.49 105.37 17.51 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 176.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.44 HD12 ' HG2' ' A' ' 251' ' ' PRO . 4.8 mp -101.41 117.19 46.32 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 C-N-CA 119.122 -1.031 . . . . 0.0 109.738 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' SER . . . . . 0.43 ' HB3' ' HB ' ' A' ' 261' ' ' ILE . 24.6 t -97.79 112.32 24.27 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 176.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -97.67 101.98 13.63 Favored 'General case' 0 CA--C 1.497 -1.079 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.226 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -104.66 162.14 13.53 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 171.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -76.72 -33.48 58.17 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 120.624 0.249 . . . . 0.0 111.357 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -72.49 -39.3 67.77 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.889 -178.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . 0.413 ' HB3' ' HA ' ' A' ' 303' ' ' THR . 32.1 p-80 -166.7 165.96 16.18 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 301' ' ' ILE . 15.9 mt -106.83 142.73 18.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -177.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . 0.43 ' HB ' ' HB3' ' A' ' 254' ' ' SER . 3.6 mp -126.04 112.0 28.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 299' ' ' GLN . 0.8 OUTLIER -102.49 141.49 18.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 177.316 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 6.2 m -129.05 118.88 23.25 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-O 121.2 0.524 . . . . 0.0 109.639 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.522 ' HB2' ' HB ' ' A' ' 298' ' ' THR . 31.5 mt -96.76 95.36 7.85 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.416 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 31.6 mmtp -63.92 133.96 54.23 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.731 -1.122 . . . . 0.0 113.403 -174.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 69.56 9.07 7.08 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 113.533 -1.667 . . . . 0.0 110.801 176.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' HIS . . . . . 0.434 ' ND1' ' HB2' ' A' ' 247' ' ' PHE . 46.4 t60 -100.25 114.39 27.8 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.938 -176.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.89 118.19 28.42 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 31.4 tp -96.92 127.48 38.87 Favored Pre-proline 0 N--CA 1.439 -0.982 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.176 177.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -62.87 136.31 56.59 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.193 1.929 . . . . 0.0 111.26 170.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' THR . . . . . 0.439 ' O ' ' HG2' ' A' ' 274' ' ' GLN . 8.5 t -66.21 -14.12 61.38 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 122.262 1.029 . . . . 0.0 110.756 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 2.8 m -78.14 -18.94 54.96 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.007 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 88.6 mt -106.9 -8.54 16.63 Favored 'General case' 0 C--O 1.246 0.912 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.844 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 271' ' ' THR . 10.5 pt20 -83.11 148.9 27.22 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.9 169.82 8.04 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 15.8 m -119.62 117.02 27.2 Favored 'General case' 0 N--CA 1.406 -2.666 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 173.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 76.4 mt -81.53 117.9 22.31 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -79.3 89.5 4.94 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 122.224 1.011 . . . . 0.0 109.866 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . 0.597 ' HA ' ' CE1' ' A' ' 282' ' ' PHE . 47.3 t -98.74 27.34 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 CA-C-O 123.047 1.403 . . . . 0.0 109.658 -176.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -71.49 132.2 44.4 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.581 178.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 30.1 t70 68.53 28.49 5.88 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.461 1.504 . . . . 0.0 112.468 178.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 1.668 ' HD2' ' CD1' ' A' ' 282' ' ' PHE . 6.7 m-85 -84.25 -5.02 59.2 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.66 173.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? 60.97 50.36 5.18 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.691 0.758 . . . . 0.0 110.586 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' THR . . . . . 0.424 HG21 ' HE3' ' A' ' 232' ' ' LYS . 1.2 p -133.27 168.34 18.44 Favored Pre-proline 0 N--CA 1.433 -1.304 0 N-CA-C 104.314 -2.476 . . . . 0.0 104.314 177.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . 0.638 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 11.6 Cg_exo -75.05 -11.14 21.38 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 121.588 1.525 . . . . 0.0 110.889 176.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 57.9 t -86.04 129.9 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -92.36 -44.07 8.9 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.543 0.687 . . . . 0.0 109.175 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -164.21 134.54 4.16 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.814 -174.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 61.6 t -95.44 117.72 40.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 175.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.445 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 62.4 m -115.69 113.32 23.34 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-O 121.149 0.5 . . . . 0.0 110.359 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.438 ' O ' ' HB2' ' A' ' 274' ' ' GLN . 0.0 OUTLIER -98.78 120.79 39.82 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 179.374 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -123.65 131.06 53.52 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -176.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -75.81 133.08 40.73 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 172.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.45 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 31.9 tp -110.39 -179.61 3.82 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -177.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.45 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 4.6 m-20 -35.31 -72.11 0.06 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.167 1.787 . . . . 0.0 112.881 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -123.7 -2.2 8.38 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . 0.416 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 12.9 m-20 -117.86 174.92 5.91 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.811 -170.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.522 ' HB ' ' HB2' ' A' ' 264' ' ' LEU . 83.5 m -117.4 126.97 53.56 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 175.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 36.3 tt0 -109.94 128.15 55.2 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -175.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 63.5 tp -116.38 117.39 29.82 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.644 177.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' A' ' 260' ' ' ILE . 51.1 mt -107.14 115.26 48.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.391 -176.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 56.0 mt -110.63 105.49 18.91 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.551 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' THR . . . . . 0.413 ' HA ' ' HB3' ' A' ' 259' ' ' HIS . 3.0 m -77.68 131.48 37.74 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -176.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 7.3 p -130.43 165.46 22.57 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -144.95 158.27 43.86 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 123.174 0.59 . . . . 0.0 109.89 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 74.54 -145.27 34.02 Favored Glycine 0 C--N 1.332 0.306 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -110.41 133.51 53.2 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 174.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' TRP . . . . . 0.641 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 57.0 p-90 -143.41 165.0 28.75 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 120.086 -0.646 . . . . 0.0 110.866 -175.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -126.18 134.85 51.15 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -177.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.641 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 18.5 tp -106.74 122.99 47.47 Favored 'General case' 0 CA--C 1.503 -0.841 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.788 -178.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.493 ' CG1' ' HB3' ' A' ' 323' ' ' GLN . 10.1 p -127.57 117.67 47.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-O 121.883 0.849 . . . . 0.0 109.461 171.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -106.11 136.18 46.26 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.466 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -129.58 151.28 50.37 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.374 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 43.2 t -116.05 112.79 22.28 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 177.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -70.13 -35.78 74.33 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.648 0.737 . . . . 0.0 109.105 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -164.83 157.61 14.19 Favored Pre-proline 0 N--CA 1.438 -1.054 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -63.17 100.48 0.26 Allowed 'Trans proline' 0 C--O 1.24 0.596 0 C-N-CA 121.778 1.652 . . . . 0.0 111.152 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 125.67 -9.99 7.61 Favored Glycine 0 N--CA 1.436 -1.329 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -176.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -127.01 116.18 20.35 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -121.54 168.53 11.63 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-O 121.573 0.701 . . . . 0.0 110.708 -174.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 91.8 m -151.48 123.56 8.17 Favored 'General case' 0 C--N 1.276 -2.602 0 C-N-CA 124.307 1.043 . . . . 0.0 108.817 -177.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 1.656 ' HE2' ' CE1' ' A' ' 322' ' ' PHE . 90.3 m-85 -109.52 113.35 26.08 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . 0.493 ' HB3' ' CG1' ' A' ' 311' ' ' VAL . 8.0 tt0 -101.6 110.96 23.06 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 93.3 t -100.04 99.3 8.22 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.297 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -86.86 156.45 55.36 Favored Pre-proline 0 C--N 1.315 -0.92 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.33 138.63 11.17 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 121.713 1.609 . . . . 0.0 110.574 172.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm . . . . . 0 C--N 1.296 -1.737 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.171 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 . . . . . 0 N--CA 1.432 -1.357 0 CA-C-O 121.015 0.436 . . . . 0.0 111.553 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 91.1 m -65.61 121.51 15.12 Favored 'General case' 0 C--O 1.195 -1.783 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.354 -176.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -143.19 170.4 15.81 Favored 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.229 -173.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.8 pp -128.05 163.51 31.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.898 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -149.77 155.67 40.53 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -176.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 1.648 ' HE1' ' CE2' ' A' ' 230' ' ' PHE . 77.1 t80 -136.78 132.64 35.01 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.096 0.474 . . . . 0.0 110.701 176.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.592 ' HD3' ' OE2' ' A' ' 241' ' ' GLU . 0.3 OUTLIER -149.55 174.41 12.55 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.055 178.23 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -119.62 144.3 47.21 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -150.72 176.59 10.88 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 176.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 53.72 -138.73 37.19 Favored Glycine 0 C--N 1.309 -0.957 0 O-C-N 123.721 0.638 . . . . 0.0 113.682 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -115.1 100.24 8.02 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 60.53 29.08 18.74 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 121.792 0.806 . . . . 0.0 111.533 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.73 135.3 36.37 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.454 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . 0.567 ' HA3' ' CG1' ' A' ' 286' ' ' VAL . . . -102.25 123.47 7.88 Favored Glycine 0 C--N 1.299 -1.526 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -177.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.5 mp -113.67 120.27 63.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 117.423 0.612 . . . . 0.0 111.258 -176.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.1 mp -106.42 107.85 23.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.592 ' OE2' ' HD3' ' A' ' 231' ' ' ARG . 42.9 mt-10 -95.01 111.22 23.04 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 122.408 1.099 . . . . 0.0 111.783 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 12.8 tp -94.3 136.05 35.02 Favored 'General case' 0 C--N 1.278 -2.519 0 CA-C-N 114.097 -1.41 . . . . 0.0 110.756 -175.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -121.56 98.72 6.1 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 176.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -103.16 91.34 4.06 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -79.37 112.8 16.96 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.314 -175.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 110.65 4.45 28.28 Favored Glycine 0 C--N 1.292 -1.875 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.138 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -111.98 108.71 18.14 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -104.51 100.45 10.13 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 159.78 -132.83 3.1 Favored Glycine 0 C--N 1.291 -1.922 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -153.69 132.65 6.95 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.453 ' HB3' ' CD1' ' A' ' 264' ' ' LEU . 14.0 Cg_endo -63.55 171.84 6.34 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.18 2.587 . . . . 0.0 113.111 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.502 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 29.5 t70 -96.01 105.88 17.97 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.009 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 4.4 mp -98.84 117.24 43.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-O 121.296 0.57 . . . . 0.0 111.034 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 13.5 t -102.49 116.84 33.42 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 176.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -92.52 109.8 21.21 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-O 121.359 0.599 . . . . 0.0 111.909 -176.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 78.3 mt-30 -125.25 149.83 47.63 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 174.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -77.21 -28.58 53.87 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 -174.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -79.91 -24.6 41.01 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.271 -0.971 . . . . 0.0 110.107 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . 0.462 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 39.8 p-80 -171.68 159.25 5.3 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.955 173.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 25.2 mt -105.58 142.21 19.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . 0.42 ' N ' HD13 ' A' ' 261' ' ' ILE . 2.9 mp -122.01 113.72 39.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 299' ' ' GLN . 1.9 m -110.99 135.69 49.33 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.496 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 298' ' ' THR . 29.2 m -129.58 125.07 35.35 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-O 121.589 0.709 . . . . 0.0 110.699 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.453 ' CD1' ' HB3' ' A' ' 251' ' ' PRO . 1.9 mm? -98.59 98.06 9.27 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 175.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.516 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 51.9 mtpt -71.55 131.52 43.38 Favored 'General case' 0 C--N 1.274 -2.7 0 O-C-N 124.005 0.816 . . . . 0.0 111.95 -178.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 9.4 t30 73.61 24.65 2.18 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 124.894 1.371 . . . . 0.0 109.931 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 54.6 t60 -117.16 117.8 30.59 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 121.45 -0.781 . . . . 0.0 109.179 178.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 10.9 p -88.5 130.02 35.31 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-O 120.975 0.417 . . . . 0.0 111.689 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 29.1 tp -115.97 124.95 29.11 Favored Pre-proline 0 N--CA 1.429 -1.496 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.086 177.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -68.6 156.72 64.59 Favored 'Trans proline' 0 C--N 1.321 -0.893 0 C-N-CA 122.66 2.24 . . . . 0.0 112.326 171.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' THR . . . . . 0.486 ' HA ' ' OE1' ' A' ' 274' ' ' GLN . 37.1 p -64.09 -31.48 72.68 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.351 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 2.2 m -64.21 -23.78 67.43 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.24 1.016 . . . . 0.0 112.606 -175.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 226' ' ' THR . 3.3 mm? -95.46 -10.13 30.7 Favored 'General case' 0 CA--C 1.498 -1.036 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.494 -176.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.486 ' OE1' ' HA ' ' A' ' 271' ' ' THR . 50.9 mt-30 -72.73 111.94 8.33 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.962 178.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -142.09 150.44 41.18 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' SER . . . . . 0.544 ' HA ' ' O ' ' A' ' 289' ' ' VAL . 36.9 m -118.99 114.05 21.94 Favored 'General case' 0 N--CA 1.417 -2.09 0 O-C-N 123.594 0.559 . . . . 0.0 109.736 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 66.6 mt -85.8 112.85 21.48 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.221 -177.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -80.4 90.97 5.64 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 174.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . 0.461 ' O ' ' HB2' ' A' ' 282' ' ' PHE . 17.2 m -109.97 25.76 2.96 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 CA-C-N 114.565 -1.198 . . . . 0.0 112.202 -173.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -70.02 150.76 46.31 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 174.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 24.6 t70 73.36 15.69 4.24 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 122.579 1.18 . . . . 0.0 110.955 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 1.663 ' HE2' ' CE1' ' A' ' 282' ' ' PHE . 1.6 m-85 -85.52 -0.07 53.92 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.915 173.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? 62.37 61.17 1.3 Allowed 'General case' 0 CA--C 1.491 -1.326 0 CA-C-O 121.708 0.765 . . . . 0.0 112.649 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 1.8 t -164.21 148.7 8.39 Favored Pre-proline 0 N--CA 1.403 -2.823 0 CA-C-N 113.618 -1.628 . . . . 0.0 108.961 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . 0.416 ' O ' ' HA ' ' A' ' 304' ' ' THR . 14.7 Cg_exo -44.01 -35.48 7.45 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 124.68 3.587 . . . . 0.0 114.098 174.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.567 ' CG1' ' HA3' ' A' ' 238' ' ' GLY . 0.3 OUTLIER -75.87 117.74 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-O 121.989 0.9 . . . . 0.0 110.831 178.044 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -101.47 -37.98 8.19 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.152 -1.385 . . . . 0.0 111.857 -172.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -151.23 140.0 20.82 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.874 -0.516 . . . . 0.0 111.041 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 276' ' ' SER . 46.9 t -110.24 110.08 30.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 175.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 89.0 m -111.83 115.24 28.69 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 58.4 tp -95.87 118.65 32.91 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 176.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . 0.401 ' HA ' HE21 ' A' ' 274' ' ' GLN . 40.8 ttmt -121.89 136.2 54.92 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 121.107 0.479 . . . . 0.0 110.484 -176.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -80.84 139.92 35.69 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 176.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.481 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 19.8 tp -113.0 -178.93 3.5 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 177.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.481 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 20.2 t-20 -53.39 -68.29 0.19 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.113 0.87 . . . . 0.0 112.5 -176.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -109.51 -3.79 16.73 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.032 0.444 . . . . 0.0 110.102 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . 0.516 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 13.1 m-20 -124.0 173.11 8.46 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.406 -168.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 263' ' ' THR . 31.8 m -114.92 130.72 56.97 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 175.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . 0.527 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 9.7 tt0 -118.66 124.2 46.81 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -177.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 67.3 tp -107.22 122.01 45.67 Favored 'General case' 0 N--CA 1.412 -2.371 0 C-N-CA 120.361 -0.535 . . . . 0.0 109.844 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 64.0 mt -110.03 109.73 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.264 -176.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 61.6 mt -106.58 107.56 23.01 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.521 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 13.3 m -79.38 131.08 36.0 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -175.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 285' ' ' PRO . 8.9 p -135.64 175.96 9.12 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 122.721 0.408 . . . . 0.0 110.866 -176.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -161.18 141.66 11.09 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 89.52 -163.36 31.12 Favored Glycine 0 C--O 1.25 1.11 0 C-N-CA 121.459 -0.4 . . . . 0.0 113.179 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -91.37 125.38 36.1 Favored 'General case' 0 CA--C 1.486 -1.496 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' TRP . . . . . 0.643 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 59.8 p-90 -150.15 170.65 18.43 Favored 'General case' 0 N--CA 1.413 -2.29 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -177.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -128.91 131.39 47.57 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -176.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.643 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 24.7 tp -105.63 137.3 43.7 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 119.625 -0.83 . . . . 0.0 109.98 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.503 ' CG1' ' HB3' ' A' ' 323' ' ' GLN . 6.5 p -137.21 126.91 37.42 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.31 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 172.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -111.44 145.27 39.27 Favored 'General case' 0 N--CA 1.418 -2.032 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.421 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -139.62 158.01 44.84 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.986 -176.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 32.2 t -115.63 128.31 55.83 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 170.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -84.56 -43.34 14.59 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.706 0.765 . . . . 0.0 108.984 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -153.12 161.47 28.99 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -59.8 100.08 0.13 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.294 1.996 . . . . 0.0 112.336 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 121.38 -29.47 5.69 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' TYR . . . . . 1.642 ' HD2' ' CD1' ' A' ' 319' ' ' TYR . 95.6 m-85 -95.48 122.72 38.51 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' PHE . . . . . 1.665 ' HD2' ' CD1' ' A' ' 320' ' ' PHE . 95.1 m-85 -121.94 169.98 10.26 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 121.802 0.811 . . . . 0.0 110.907 -176.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 72.8 m -152.1 128.72 10.78 Favored 'General case' 0 C--N 1.272 -2.787 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.376 -175.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 1.667 ' HD1' ' CD2' ' A' ' 322' ' ' PHE . 68.2 m-85 -117.77 109.38 16.53 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 175.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . 0.503 ' HB3' ' CG1' ' A' ' 311' ' ' VAL . 9.3 tt0 -100.67 114.2 27.72 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 1.5 m -100.76 113.33 36.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 177.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -91.51 151.59 42.72 Favored Pre-proline 0 C--N 1.304 -1.378 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -81.68 134.01 8.42 Favored 'Trans proline' 0 N--CA 1.436 -1.887 0 C-N-CA 121.393 1.395 . . . . 0.0 109.948 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm . . . . . 0 N--CA 1.413 -2.291 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 175.99 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . 0.71 ' O ' HD21 ' A' ' 245' ' ' LEU . 12.8 pt20 . . . . . 0 C--O 1.199 -1.571 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 16.6 m -75.23 110.94 9.98 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 166.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.406 ' HB3' ' HB1' ' A' ' 243' ' ' ALA . 38.9 t30 -139.52 151.72 46.36 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.8 -166.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.5 pp -133.94 144.54 35.3 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.388 0 CA-C-N 114.265 -1.334 . . . . 0.0 107.941 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . 0.527 ' O ' ' HA ' ' A' ' 240' ' ' ILE . 8.4 t0 -145.02 157.44 44.12 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -172.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 1.647 ' HD1' ' CD2' ' A' ' 230' ' ' PHE . 85.4 t80 -136.95 135.05 37.37 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . 0.439 HH11 ' HB3' ' A' ' 231' ' ' ARG . 1.0 OUTLIER -156.77 174.29 15.7 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 176.869 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -118.07 153.92 32.93 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 120.462 0.172 . . . . 0.0 110.8 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -155.32 146.93 23.08 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 124.091 0.87 . . . . 0.0 109.019 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 69.96 -109.33 2.82 Favored Glycine 0 N--CA 1.447 -0.611 0 O-C-N 123.569 0.543 . . . . 0.0 113.735 174.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -123.76 83.49 2.14 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -177.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 61.03 24.15 14.28 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 176.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -80.46 140.56 35.87 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.16 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -100.17 109.54 3.73 Favored Glycine 0 N--CA 1.426 -1.998 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 230' ' ' PHE . 2.1 mp -98.6 114.51 36.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-N 117.144 0.472 . . . . 0.0 110.207 -176.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . 0.527 ' HA ' ' O ' ' A' ' 229' ' ' ASP . 3.7 mp -102.68 111.62 33.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 176.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -88.51 143.82 26.73 Favored 'General case' 0 N--CA 1.412 -2.334 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.629 175.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 13.5 tp -131.69 119.27 21.14 Favored 'General case' 0 C--N 1.27 -2.881 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.14 -177.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -114.16 105.22 12.92 Favored 'General case' 0 C--N 1.276 -2.625 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -111.32 90.61 3.38 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.71 HD21 ' O ' ' A' ' 225' ' ' GLN . 4.0 mm? -81.92 118.25 22.8 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.257 -176.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 103.97 15.64 21.45 Favored Glycine 0 C--N 1.3 -1.471 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.361 178.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' PHE . . . . . 1.669 ' HD2' ' CD1' ' A' ' 247' ' ' PHE . 67.0 t80 -115.15 116.23 28.05 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 121.067 0.46 . . . . 0.0 110.065 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -106.81 94.54 5.17 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.299 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 159.12 -161.98 32.38 Favored Glycine 0 N--CA 1.425 -2.087 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -118.36 140.76 28.58 Favored Pre-proline 0 C--N 1.298 -1.667 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.475 ' HD3' ' CZ ' ' A' ' 320' ' ' PHE . 27.7 Cg_endo -73.67 165.42 32.37 Favored 'Trans proline' 0 N--CA 1.437 -1.796 0 C-N-CA 121.104 1.203 . . . . 0.0 110.17 176.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.596 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 11.9 t70 -87.63 106.56 18.1 Favored 'General case' 0 C--N 1.27 -2.866 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 177.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 5.3 mp -95.9 109.21 22.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 C-N-CA 119.354 -0.938 . . . . 0.0 109.669 175.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' SER . . . . . 0.511 ' HB2' ' HB ' ' A' ' 261' ' ' ILE . 26.5 m -99.61 117.6 34.33 Favored 'General case' 0 C--N 1.277 -2.546 0 C-N-CA 125.001 1.32 . . . . 0.0 108.48 177.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -100.02 124.89 45.89 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -175.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.49 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 14.5 mm100 -122.62 171.07 9.4 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 171.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 61.2 m-70 -76.89 -41.03 45.37 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.743 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -81.03 -24.83 37.62 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.618 -173.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . 0.49 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 45.7 p-80 -165.08 163.17 20.58 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.039 0.447 . . . . 0.0 111.151 177.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 21.3 mt -107.15 141.87 21.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . 0.511 ' HB ' ' HB2' ' A' ' 254' ' ' SER . 3.8 mp -119.21 117.26 53.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.596 ' HA ' ' O ' ' A' ' 252' ' ' ASP . 0.7 OUTLIER -114.95 142.48 27.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 C-N-CA 119.207 -0.997 . . . . 0.0 108.814 176.816 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 298' ' ' THR . 7.5 m -135.47 124.31 24.0 Favored 'General case' 0 C--N 1.291 -1.941 0 C-N-CA 119.825 -0.75 . . . . 0.0 112.064 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.474 ' CD1' ' HB3' ' A' ' 251' ' ' PRO . 1.9 mm? -97.2 100.24 11.71 Favored 'General case' 0 CA--C 1.467 -2.218 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 175.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.515 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 51.6 mtpt -68.39 126.67 30.34 Favored 'General case' 0 N--CA 1.405 -2.676 0 O-C-N 124.34 1.025 . . . . 0.0 113.235 -173.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 77.67 3.68 3.01 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 113.925 -1.489 . . . . 0.0 111.808 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -86.12 95.66 9.63 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 177.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.84 109.2 6.24 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.286 0.565 . . . . 0.0 111.592 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 23.8 tp -95.64 128.99 35.86 Favored Pre-proline 0 N--CA 1.433 -1.295 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.633 -178.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -71.69 154.87 59.33 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.157 2.571 . . . . 0.0 111.831 170.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 19.3 p -67.6 -29.45 68.79 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 123.206 0.602 . . . . 0.0 112.592 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 11.9 m -62.96 -22.03 66.51 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 123.714 0.806 . . . . 0.0 111.36 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 8.2 mp -96.94 -8.11 31.5 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.375 -175.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.472 HE21 ' HA ' ' A' ' 292' ' ' LYS . 47.7 mt-30 -77.78 136.35 38.11 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.755 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -161.13 165.72 29.1 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 176.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 16.9 m -134.46 138.26 44.61 Favored 'General case' 0 N--CA 1.414 -2.249 0 CA-C-O 121.351 0.596 . . . . 0.0 109.668 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -95.25 101.41 13.14 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -83.84 55.59 3.32 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.728 0.775 . . . . 0.0 109.567 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . 0.454 HG13 ' CD2' ' A' ' 230' ' ' PHE . 13.3 m -81.17 59.56 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.218 -1.355 . . . . 0.0 112.751 -174.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -74.44 121.54 21.61 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.597 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . 0.367 20.4 m-20 58.42 51.91 7.71 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 179.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 1.647 ' HE2' ' CE1' ' A' ' 282' ' ' PHE . 5.9 m-85 -85.38 -2.08 57.71 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 165.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 25.7 mmmt 67.02 61.16 0.5 Allowed 'General case' 0 CA--C 1.485 -1.536 0 CA-C-N 113.222 -1.808 . . . . 0.0 109.996 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.91 165.09 34.91 Favored Pre-proline 0 N--CA 1.42 -1.938 0 N-CA-C 103.565 -2.754 . . . . 0.0 103.565 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -69.12 -15.55 39.58 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.323 1.349 . . . . 0.0 111.405 177.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 42.5 t -84.04 129.55 37.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -96.92 -39.56 9.33 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.261 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -160.36 140.54 11.46 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.223 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 41.8 t -104.67 126.36 59.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 173.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.468 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 48.2 m -128.58 122.74 31.67 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 117.957 0.344 . . . . 0.0 110.69 -177.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 52.0 tp -103.41 108.27 19.44 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . 0.472 ' HA ' HE21 ' A' ' 274' ' ' GLN . 24.5 ttmm -112.06 125.47 54.13 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.286 -177.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . 0.424 ' H ' ' NE2' ' A' ' 274' ' ' GLN . 1.9 ptm180 -68.72 137.94 54.5 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 174.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.585 HD11 ' N ' ' A' ' 295' ' ' ASN . 2.6 tm? -117.4 162.8 17.34 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 -174.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.585 ' N ' HD11 ' A' ' 294' ' ' LEU . 66.5 t30 -14.92 -70.98 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 127.541 2.336 . . . . 0.0 112.972 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -125.46 -2.28 7.44 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 175.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . 0.515 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 10.9 m-20 -118.09 178.61 4.36 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.485 -165.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.568 ' O ' ' HA ' ' A' ' 263' ' ' THR . 42.3 m -114.93 125.53 53.74 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 173.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . 0.589 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 9.0 tt0 -115.16 129.89 56.78 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 120.949 0.404 . . . . 0.0 111.157 -176.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' A' ' 261' ' ' ILE . 12.6 mt -100.58 132.0 46.19 Favored 'General case' 0 CA--C 1.451 -2.862 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.043 172.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' ILE . . . . . 0.468 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 65.5 mt -118.24 108.1 23.51 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.238 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 174.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 66.0 mt -109.89 105.21 18.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.364 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 4.0 m -78.56 129.33 34.7 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -174.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 8.4 p -131.57 153.13 50.19 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -175.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -131.16 147.28 52.59 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.859 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 75.26 -160.21 52.2 Favored Glycine 0 N--CA 1.438 -1.187 0 O-C-N 123.994 0.809 . . . . 0.0 113.07 176.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -93.97 132.64 38.24 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' TRP . . . . . . . . . . . . . 62.0 p-90 -148.05 168.0 23.48 Favored 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.083 -175.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -130.14 127.91 40.71 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -178.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 1.4 tt -96.25 125.89 41.08 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.509 ' CG1' ' HB3' ' A' ' 323' ' ' GLN . 7.2 p -130.17 112.54 23.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 169.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -103.58 141.83 35.35 Favored 'General case' 0 CA--C 1.45 -2.89 0 C-N-CA 119.584 -0.847 . . . . 0.0 111.17 -176.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -119.36 121.43 39.53 Favored 'General case' 1 N--CA 1.369 -4.488 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.659 -178.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 16.8 m -95.83 106.47 18.61 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 173.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -84.96 -32.71 22.89 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.079 -175.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -165.42 164.69 12.13 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -177.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.68 94.98 0.15 Allowed 'Trans proline' 0 C--O 1.243 0.736 0 C-N-CA 122.058 1.839 . . . . 0.0 111.143 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 124.89 -23.55 6.2 Favored Glycine 0 N--CA 1.423 -2.171 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.417 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -101.71 116.19 32.19 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 122.048 -0.678 . . . . 0.0 110.685 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' PHE . . . . . 0.475 ' CZ ' ' HD3' ' A' ' 251' ' ' PRO . 68.7 m-85 -130.53 159.13 38.04 Favored 'General case' 0 N--CA 1.428 -1.547 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.412 -177.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 61.6 m -152.67 111.93 3.85 Favored 'General case' 0 C--N 1.273 -2.726 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.354 -176.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -98.05 105.32 17.45 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . 0.509 ' HB3' ' CG1' ' A' ' 311' ' ' VAL . 46.3 tt0 -91.21 100.36 13.19 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 93.4 t -88.08 98.83 8.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.519 0.676 . . . . 0.0 109.456 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.421 HD22 ' NE2' ' A' ' 323' ' ' GLN . 20.9 mt -87.74 152.46 51.53 Favored Pre-proline 0 C--N 1.285 -2.208 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.197 -178.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -81.83 138.2 10.35 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 121.503 1.468 . . . . 0.0 109.812 172.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm . . . . . 0 CA--C 1.497 -1.078 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.587 -177.11 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . 0.464 ' CG ' HD22 ' A' ' 273' ' ' LEU . 1.8 tp60 . . . . . 0 N--CA 1.438 -1.036 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 16.4 m -62.33 126.25 26.69 Favored 'General case' 0 C--N 1.314 -0.974 0 O-C-N 123.572 0.545 . . . . 0.0 110.791 -178.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -153.33 173.36 15.71 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.254 -178.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.425 HD11 ' CD2' ' A' ' 277' ' ' LEU . 2.1 pp -137.66 156.89 32.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 C-N-CA 124.731 1.212 . . . . 0.0 109.394 -178.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -150.59 156.99 42.46 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -127.79 137.2 52.32 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -153.31 161.98 41.78 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.402 ' HE3' HG21 ' A' ' 284' ' ' THR . 56.9 mtpt -110.65 158.01 19.07 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.597 178.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -155.12 168.22 27.75 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 55.92 -124.71 34.94 Favored Glycine 0 C--N 1.321 -0.29 0 O-C-N 123.704 0.628 . . . . 0.0 113.091 177.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -122.87 100.68 7.02 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 176.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . 0.601 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 94.0 m-20 63.02 24.55 14.59 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 124.16 0.912 . . . . 0.0 112.939 176.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -82.59 141.03 32.89 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -103.47 110.09 3.59 Favored Glycine 0 N--CA 1.429 -1.827 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 322' ' ' PHE . 2.0 mp -104.2 119.91 53.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 121.171 0.51 . . . . 0.0 110.223 -177.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.7 mp -104.14 114.08 42.78 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 175.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -89.43 142.97 27.19 Favored 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 175.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 15.3 tp -134.44 134.29 41.43 Favored 'General case' 0 C--N 1.276 -2.614 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.691 -175.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -127.25 110.33 12.74 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.174 178.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -115.05 91.6 3.67 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.417 0.627 . . . . 0.0 109.891 178.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -83.48 115.32 22.02 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.895 -177.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 111.62 13.81 12.33 Favored Glycine 0 C--N 1.299 -1.527 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.526 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' PHE . . . . . 1.653 ' HD1' ' CD2' ' A' ' 247' ' ' PHE . 52.8 t80 -116.08 124.18 49.76 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -107.13 93.83 4.77 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 143.97 -157.81 27.21 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 177.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -113.88 148.85 40.8 Favored Pre-proline 0 C--N 1.314 -0.942 0 C-N-CA 123.06 0.544 . . . . 0.0 109.754 177.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.567 ' HD3' ' CZ ' ' A' ' 320' ' ' PHE . 14.2 Cg_endo -74.24 172.14 16.62 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.698 2.265 . . . . 0.0 112.192 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.497 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 34.4 t70 -95.37 111.72 23.55 Favored 'General case' 0 C--N 1.286 -2.191 0 C-N-CA 124.275 1.03 . . . . 0.0 108.694 177.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 4.1 mp -104.91 128.03 58.96 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.329 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 14.1 t -111.43 124.58 52.55 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 174.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -102.63 102.55 12.77 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.14 0.495 . . . . 0.0 112.052 -173.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.496 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 78.8 mt-30 -109.8 158.47 18.11 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 172.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 50.9 m80 -73.42 -36.08 65.91 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -176.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -85.67 -16.1 40.19 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.405 -0.518 . . . . 0.0 112.241 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . 0.496 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 45.4 p-80 -170.69 156.03 5.07 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-O 121.044 0.449 . . . . 0.0 111.717 176.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . 0.442 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 39.6 mt -106.95 141.73 21.44 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . 0.418 ' N ' HD13 ' A' ' 261' ' ' ILE . 3.1 mp -121.66 116.3 49.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 252' ' ' ASP . 1.9 m -112.5 139.31 37.99 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.526 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 177.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 298' ' ' THR . 19.3 m -135.0 127.82 31.2 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-O 121.3 0.572 . . . . 0.0 110.855 178.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.47 ' CD1' ' HB3' ' A' ' 251' ' ' PRO . 1.9 mm? -97.91 106.38 18.67 Favored 'General case' 0 CA--C 1.47 -2.107 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 176.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.555 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 31.8 mmmt -68.82 127.94 34.9 Favored 'General case' 0 N--CA 1.414 -2.247 0 O-C-N 124.309 1.006 . . . . 0.0 113.149 -174.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 62.8 t30 65.65 26.29 11.51 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 112.771 -2.013 . . . . 0.0 110.699 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 45.8 t60 -106.98 112.18 25.02 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.95 125.04 28.76 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 27.0 tp -111.14 125.32 30.82 Favored Pre-proline 0 N--CA 1.435 -1.216 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.251 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . 0.414 ' HD2' HD23 ' A' ' 273' ' ' LEU . 24.1 Cg_exo -68.35 148.13 73.21 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.585 2.19 . . . . 0.0 111.399 170.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' THR . . . . . 0.477 ' O ' ' HG2' ' A' ' 274' ' ' GLN . 6.1 t -71.47 -11.1 60.7 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.327 0.584 . . . . 0.0 112.112 -177.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 19.3 m -79.76 -21.15 44.77 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.521 0.677 . . . . 0.0 110.366 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.464 HD22 ' CG ' ' A' ' 225' ' ' GLN . 8.0 mp -96.59 -13.24 23.04 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.391 -174.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' A' ' 271' ' ' THR . 18.7 pt20 -83.01 107.55 15.69 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-O 122.023 0.916 . . . . 0.0 109.135 -178.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -134.33 176.49 8.56 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 24.1 p -133.62 138.31 45.88 Favored 'General case' 0 N--CA 1.413 -2.289 0 CA-C-O 121.395 0.617 . . . . 0.0 111.06 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.431 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 2.1 mm? -87.19 122.34 30.86 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 103.823 -2.658 . . . . 0.0 103.823 173.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -67.65 -41.02 84.46 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . 0.445 ' HA ' ' CD1' ' A' ' 282' ' ' PHE . 14.8 p 41.65 27.25 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 127.489 2.316 . . . . 0.0 114.46 173.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -82.46 135.41 35.14 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.844 177.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 3.0 t70 72.59 25.76 2.59 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 125.269 1.428 . . . . 0.0 111.386 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.445 ' CD1' ' HA ' ' A' ' 279' ' ' VAL . 5.1 m-85 -88.43 -7.51 56.49 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.642 174.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? 55.09 60.64 3.33 Favored 'General case' 0 CA--C 1.509 -0.625 0 C-N-CA 124.56 1.144 . . . . 0.0 112.027 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' THR . . . . . 0.402 HG21 ' HE3' ' A' ' 232' ' ' LYS . 2.4 p -133.11 173.94 5.29 Favored Pre-proline 0 C--N 1.302 -1.47 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 178.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . 0.601 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 6.6 Cg_exo -77.65 -5.07 15.18 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 121.954 1.769 . . . . 0.0 110.796 176.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 54.4 t -90.72 137.94 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -99.44 -43.45 6.54 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.786 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . 0.411 ' HA ' ' CG1' ' A' ' 279' ' ' VAL . 22.6 ttmm -163.07 134.79 5.07 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -178.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 44.4 t -99.08 120.18 48.07 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.329 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 176.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 32.2 m -127.01 115.32 19.03 Favored 'General case' 0 C--N 1.284 -2.259 0 O-C-N 122.111 -0.368 . . . . 0.0 111.53 -176.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 49.1 tp -94.17 133.84 37.25 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -130.55 134.1 46.75 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -175.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . 0.451 ' HD2' ' HB ' ' A' ' 271' ' ' THR . 3.8 ptm180 -79.41 137.95 37.45 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 173.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.522 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 23.4 tp -111.57 178.98 4.15 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.522 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 63.0 t30 -49.68 -63.72 1.02 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 124.125 0.97 . . . . 0.0 112.517 -177.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -118.66 -2.91 10.89 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 120.673 0.273 . . . . 0.0 111.22 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . 0.555 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 20.6 m-20 -124.88 177.93 5.76 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.707 0.765 . . . . 0.0 110.9 -170.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.546 ' O ' ' HA ' ' A' ' 263' ' ' THR . 50.2 m -114.3 127.77 56.03 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 174.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 27.8 tt0 -116.05 126.13 53.36 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -176.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 63.7 tp -110.77 120.24 41.76 Favored 'General case' 0 N--CA 1.417 -2.119 0 CA-C-O 121.164 0.507 . . . . 0.0 110.125 178.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 57.8 mt -106.65 109.84 29.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -177.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . 0.442 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 66.5 mt -108.01 107.78 23.65 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 18.1 m -77.77 133.46 38.25 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 12.5 p -135.18 173.85 11.26 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 122.831 0.452 . . . . 0.0 111.081 -175.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -156.28 147.08 21.93 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 120.526 0.203 . . . . 0.0 110.57 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 80.83 -159.23 41.75 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 115.701 -0.682 . . . . 0.0 113.651 174.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' ASN . . . . . 0.422 ' HB3' ' HB3' ' A' ' 327' ' ' LYS . 0.7 OUTLIER -90.34 123.29 33.97 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 176.141 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -149.12 162.79 39.27 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -177.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . 0.471 ' HG2' ' HE2' ' A' ' 327' ' ' LYS . 8.6 mt-10 -119.04 137.52 53.49 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -178.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 1.1 tt -104.91 118.3 36.2 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 32.4 t -118.71 107.78 22.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 174.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -95.75 139.35 32.11 Favored 'General case' 0 C--N 1.311 -1.109 0 C-N-CA 119.093 -1.043 . . . . 0.0 109.207 177.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -125.86 134.93 51.47 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -177.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 28.6 t -115.74 111.88 21.2 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -80.03 -28.42 39.33 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.734 0.778 . . . . 0.0 109.82 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -166.75 160.15 11.5 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -64.71 101.13 0.36 Allowed 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 121.66 1.573 . . . . 0.0 109.837 176.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 127.81 -27.65 4.58 Favored Glycine 0 N--CA 1.426 -1.982 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.96 -176.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 319' ' ' TYR . . . . . 1.65 ' HD2' ' CD1' ' A' ' 319' ' ' TYR . 60.5 m-85 -108.36 118.43 36.75 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.864 -0.786 . . . . 0.0 110.818 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' PHE . . . . . 1.668 ' HE2' ' CE1' ' A' ' 320' ' ' PHE . 48.2 m-85 -128.46 165.76 20.05 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-O 122.143 0.973 . . . . 0.0 110.902 -174.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 70.0 m -152.36 136.82 16.78 Favored 'General case' 0 C--N 1.269 -2.909 0 CA-C-N 114.518 -1.219 . . . . 0.0 107.848 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 1.651 ' HD1' ' CD2' ' A' ' 322' ' ' PHE . 79.8 m-85 -119.88 117.69 28.79 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . 0.433 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 33.9 tt0 -101.55 100.26 10.66 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 91.3 t -88.79 102.03 12.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 50.8 mt -95.07 140.46 22.45 Favored Pre-proline 0 C--N 1.29 -1.988 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.161 -176.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -72.36 126.95 12.09 Favored 'Trans proline' 0 C--O 1.251 1.129 0 C-N-CA 121.431 1.421 . . . . 0.0 109.806 174.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . 0.471 ' HE2' ' HG2' ' A' ' 309' ' ' GLU . 38.2 ttmt . . . . . 0 C--N 1.305 -1.365 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 . . . . . 0 N--CA 1.444 -0.763 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 59.5 m -61.39 129.72 42.59 Favored 'General case' 0 C--O 1.208 -1.125 0 C-N-CA 125.153 1.381 . . . . 0.0 111.632 -173.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -157.3 171.59 20.13 Favored 'General case' 0 CA--C 1.488 -1.43 0 CA-C-O 121.022 0.439 . . . . 0.0 110.462 -176.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.8 pp -130.27 155.65 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.199 179.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . 0.401 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 18.8 t0 -144.64 156.27 44.03 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 -177.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 1.649 ' HE2' ' CE1' ' A' ' 230' ' ' PHE . 61.8 t80 -131.91 138.6 48.45 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 175.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -155.11 157.55 37.65 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -104.57 151.86 23.11 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.603 175.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -168.05 -174.87 2.47 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 61.81 -117.88 12.92 Favored Glycine 0 N--CA 1.445 -0.761 0 O-C-N 123.446 0.466 . . . . 0.0 113.03 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -126.96 79.91 1.91 Allowed 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -178.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 58.9 29.26 18.63 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.557 0.694 . . . . 0.0 111.249 -177.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -84.24 148.44 26.71 Favored 'General case' 0 N--CA 1.416 -2.168 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.305 -176.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -98.81 108.17 3.55 Favored Glycine 0 N--CA 1.418 -2.534 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.6 mp -101.49 118.84 48.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-N 117.391 0.596 . . . . 0.0 110.193 -177.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 229' ' ' ASP . 3.8 mp -104.73 110.94 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.401 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 176.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.401 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 41.2 mt-10 -87.83 143.23 27.25 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 173.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 14.5 tp -132.12 125.97 32.59 Favored 'General case' 0 C--N 1.273 -2.719 0 CA-C-O 121.52 0.676 . . . . 0.0 111.044 -174.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -113.73 105.73 13.65 Favored 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . 0.424 ' HA ' HG21 ' A' ' 226' ' ' THR . . . -112.32 91.72 3.76 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.601 0.715 . . . . 0.0 109.119 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -81.73 112.52 18.97 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.398 -173.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 107.97 3.41 34.04 Favored Glycine 0 N--CA 1.427 -1.936 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.378 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' PHE . . . . . 0.429 ' HB2' ' ND1' ' A' ' 267' ' ' HIS . 37.8 t80 -115.82 107.96 15.7 Favored 'General case' 0 C--O 1.212 -0.908 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -102.22 3.28 38.13 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.006 0.431 . . . . 0.0 112.093 -177.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -95.35 -153.74 30.3 Favored Glycine 0 C--N 1.308 -1.012 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.638 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -116.16 137.64 23.6 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 177.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.443 ' HB3' HD11 ' A' ' 264' ' ' LEU . 17.4 Cg_endo -71.83 172.09 15.22 Favored 'Trans proline' 0 N--CA 1.439 -1.711 0 C-N-CA 122.029 1.819 . . . . 0.0 110.904 175.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -99.94 109.57 21.92 Favored 'General case' 0 C--N 1.275 -2.659 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 176.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 4.0 mp -100.11 124.19 53.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-O 121.079 0.466 . . . . 0.0 110.131 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 9.4 t -113.31 106.03 14.12 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 174.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -79.87 103.74 9.97 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.677 178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.506 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 77.8 mt-30 -124.16 152.06 43.28 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 175.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -71.07 -42.44 69.4 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -173.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -76.07 -24.63 55.1 Favored 'General case' 0 C--N 1.314 -0.978 0 O-C-N 123.442 0.464 . . . . 0.0 111.523 -176.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . 0.506 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 43.0 p-80 -170.19 158.38 6.82 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-O 120.549 0.214 . . . . 0.0 110.898 175.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 16.6 mt -105.94 141.45 21.23 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . 0.414 ' N ' HD13 ' A' ' 261' ' ' ILE . 3.1 mp -116.81 113.11 41.98 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 300' ' ' LEU . 54.6 t -113.6 115.91 51.09 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 176.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 298' ' ' THR . 41.6 m -121.65 126.24 48.55 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-O 121.48 0.657 . . . . 0.0 112.218 -177.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.443 HD11 ' HB3' ' A' ' 251' ' ' PRO . 1.6 mm? -94.38 104.09 16.08 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 177.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.569 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 30.1 mtpt -69.05 127.57 33.6 Favored 'General case' 0 N--CA 1.41 -2.446 0 O-C-N 124.204 0.94 . . . . 0.0 113.487 -173.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 64.4 t30 68.26 16.66 9.33 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 113.817 -1.538 . . . . 0.0 111.386 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' HIS . . . . . 0.429 ' ND1' ' HB2' ' A' ' 247' ' ' PHE . 54.6 t60 -95.46 107.74 19.91 Favored 'General case' 0 C--O 1.213 -0.821 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 174.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 1.2 p -82.92 109.79 17.34 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-O 120.889 0.376 . . . . 0.0 111.618 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . 0.411 HD23 ' CD2' ' A' ' 291' ' ' LEU . 23.4 tp -93.22 127.49 46.71 Favored Pre-proline 0 N--CA 1.436 -1.128 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.543 178.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -68.54 159.31 54.05 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 122.381 2.054 . . . . 0.0 111.544 171.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 19.6 p -66.69 -37.13 84.11 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.063 0.459 . . . . 0.0 111.544 -177.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 3.0 m -59.21 -19.35 44.7 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 124.66 1.184 . . . . 0.0 112.456 -178.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.404 HD13 ' O ' ' A' ' 226' ' ' THR . 3.9 mm? -95.96 -12.82 24.45 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 122.195 -0.316 . . . . 0.0 111.044 -176.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -72.31 142.11 48.85 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -163.86 155.38 16.52 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 175.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 16.6 m -122.84 123.7 41.6 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 64.4 mt -95.17 113.27 24.93 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -177.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -76.81 81.5 3.4 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.937 0.875 . . . . 0.0 108.95 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . 0.282 1.5 p -98.37 69.75 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 CA-C-O 123.723 1.725 . . . . 0.0 111.642 -178.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -114.69 145.67 41.78 Favored 'General case' 0 N--CA 1.419 -1.993 0 CA-C-N 113.026 -1.897 . . . . 0.0 106.846 177.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 23.3 t70 68.19 18.22 9.3 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 122.494 1.14 . . . . 0.0 110.879 -178.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 1.633 ' HE1' ' CE2' ' A' ' 282' ' ' PHE . 31.2 m-85 -86.18 -13.84 45.79 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.599 -0.688 . . . . 0.0 109.344 174.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.79 60.62 1.55 Allowed 'General case' 0 CA--C 1.493 -1.22 0 C-N-CA 123.606 0.762 . . . . 0.0 110.822 -178.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -137.02 168.94 14.68 Favored Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 104.109 -2.552 . . . . 0.0 104.109 178.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -71.06 -13.19 31.24 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 121.482 1.455 . . . . 0.0 111.773 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 47.1 t -85.88 132.39 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 123.428 0.691 . . . . 0.0 109.343 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -101.57 -29.2 12.09 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.405 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -171.92 134.32 0.77 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.736 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 59.8 t -96.69 132.12 41.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 173.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 98.8 m -136.72 117.49 14.05 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.803 -0.56 . . . . 0.0 111.772 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.411 ' CD2' HD23 ' A' ' 269' ' ' LEU . 0.1 OUTLIER -97.41 116.77 30.24 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 179.385 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -126.21 136.45 52.84 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -78.74 144.44 35.22 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 176.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.569 HD11 ' N ' ' A' ' 295' ' ' ASN . 2.6 tm? -118.06 163.25 16.89 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 105.942 -1.874 . . . . 0.0 105.942 -178.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.569 ' N ' HD11 ' A' ' 294' ' ' LEU . 4.5 t30 -29.39 -58.33 0.15 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.355 1.862 . . . . 0.0 113.754 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.58 -6.31 7.52 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . 0.569 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 6.0 m-20 -125.39 174.63 8.04 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.595 -160.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.59 ' O ' ' HA ' ' A' ' 263' ' ' THR . 56.1 m -115.34 120.09 38.45 Favored 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 175.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -110.92 117.31 33.03 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-O 121.696 0.76 . . . . 0.0 109.747 -176.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.403 ' HB3' ' HB ' ' A' ' 262' ' ' VAL . 46.1 tp -103.53 117.97 35.67 Favored 'General case' 0 C--N 1.263 -3.188 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 63.3 mt -102.38 109.74 27.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 CA-C-N 114.566 -1.197 . . . . 0.0 107.88 -177.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 58.0 mt -108.71 100.3 10.47 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 27.7 m -72.52 132.17 43.48 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 7.4 p -138.49 174.82 10.14 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 123.482 0.713 . . . . 0.0 110.498 -176.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -158.55 137.43 11.27 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 117.514 0.143 . . . . 0.0 110.996 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 91.66 -157.68 24.7 Favored Glycine 0 N--CA 1.442 -0.908 0 O-C-N 123.508 0.505 . . . . 0.0 112.836 174.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -93.2 124.07 36.92 Favored 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' TRP . . . . . . . . . . . . . 70.3 p-90 -148.32 166.09 29.07 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -124.32 130.26 52.18 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -175.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 1.7 tt -100.73 122.67 43.75 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.548 ' CG1' ' HB3' ' A' ' 323' ' ' GLN . 7.6 p -123.34 114.77 43.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.612 171.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -98.32 144.82 27.31 Favored 'General case' 0 N--CA 1.424 -1.748 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.037 -178.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -131.58 141.06 49.59 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -178.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 78.0 p -111.64 115.43 29.11 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 173.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -76.16 -35.85 59.01 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -166.84 162.92 11.0 Favored Pre-proline 0 C--N 1.309 -1.19 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.77 97.06 0.32 Allowed 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.712 1.608 . . . . 0.0 110.177 176.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 129.37 -15.23 5.8 Favored Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -176.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 319' ' ' TYR . . . . . 1.658 ' HD1' ' CD2' ' A' ' 319' ' ' TYR . 84.2 m-85 -122.58 116.33 23.68 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 122.372 -0.487 . . . . 0.0 109.821 178.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' PHE . . . . . 1.669 ' HD1' ' CD2' ' A' ' 320' ' ' PHE . 95.2 m-85 -124.31 164.6 19.26 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.827 0.823 . . . . 0.0 110.661 -175.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 91.3 m -152.44 135.71 15.83 Favored 'General case' 0 C--N 1.267 -3.002 0 CA-C-N 114.871 -1.058 . . . . 0.0 108.846 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 1.667 ' HD1' ' CD2' ' A' ' 322' ' ' PHE . 72.8 m-85 -124.06 117.86 25.66 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . 0.548 ' HB3' ' CG1' ' A' ' 311' ' ' VAL . 45.8 tt0 -102.26 103.43 13.91 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 92.7 t -87.13 98.94 7.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.41 HD22 HE21 ' A' ' 323' ' ' GLN . 32.1 mt -87.47 143.57 34.33 Favored Pre-proline 0 C--N 1.294 -1.813 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.667 -177.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -75.6 132.55 14.75 Favored 'Trans proline' 0 N--CA 1.458 -0.618 0 C-N-CA 121.93 1.753 . . . . 0.0 109.965 173.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm . . . . . 0 C--N 1.301 -1.525 0 C-N-CA 120.056 -0.657 . . . . 0.0 110.417 -178.509 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . 0.409 ' O ' HD21 ' A' ' 245' ' ' LEU . 3.9 pt20 . . . . . 0 N--CA 1.431 -1.424 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 21.2 m -64.48 116.28 5.98 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 176.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -148.68 158.19 43.97 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.301 -170.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.517 ' O ' ' HD2' ' A' ' 275' ' ' ARG . 2.7 pp -137.04 147.61 26.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -142.02 157.27 45.13 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 123.533 0.733 . . . . 0.0 109.991 -174.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 0.442 ' HA ' ' O ' ' A' ' 239' ' ' ILE . 56.3 t80 -133.21 138.52 46.57 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.217 0.532 . . . . 0.0 111.254 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -155.94 164.53 38.37 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 172.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -104.48 162.58 13.12 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.929 178.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' A' ' 237' ' ' ALA . 15.8 t70 -157.97 125.62 5.21 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 81.53 -126.63 7.5 Favored Glycine 0 C--N 1.297 -1.586 0 C-N-CA 121.143 -0.551 . . . . 0.0 113.441 174.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -105.14 90.9 3.58 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -174.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . 0.517 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 17.6 m120 62.83 17.15 9.68 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.023 -0.99 . . . . 0.0 112.724 175.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . 0.478 ' HB2' ' O ' ' A' ' 233' ' ' ASP . . . -83.51 140.93 31.99 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -176.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . 0.428 ' C ' HD13 ' A' ' 239' ' ' ILE . . . -101.64 130.27 10.18 Favored Glycine 0 N--CA 1.432 -1.596 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 178.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 230' ' ' PHE . 2.3 mp -118.45 117.28 54.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 117.651 0.725 . . . . 0.0 110.985 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.0 mp -104.16 109.43 27.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 176.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -91.39 118.23 30.35 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-O 121.558 0.694 . . . . 0.0 109.348 178.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 9.8 tp -108.7 117.06 33.19 Favored 'General case' 0 C--N 1.272 -2.775 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.754 -175.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . 0.576 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -103.19 94.4 5.5 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 176.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -101.92 90.93 4.15 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.69 0.757 . . . . 0.0 109.455 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.409 HD21 ' O ' ' A' ' 225' ' ' GLN . 3.6 mm? -88.09 115.29 25.46 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.672 0.749 . . . . 0.0 110.804 -177.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 123.21 -8.27 9.07 Favored Glycine 0 N--CA 1.423 -2.178 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.517 -176.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -115.4 127.0 55.07 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -109.4 -19.15 13.37 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.901 -177.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -87.48 -140.99 6.8 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.921 -177.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -125.14 132.37 24.3 Favored Pre-proline 0 C--N 1.314 -0.943 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.471 ' HD3' ' CZ ' ' A' ' 320' ' ' PHE . 14.1 Cg_endo -69.63 171.68 13.89 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.534 2.156 . . . . 0.0 111.679 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.627 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 33.3 t70 -91.32 105.88 18.1 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 176.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 5.2 mp -101.74 108.99 24.84 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.636 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' SER . . . . . 0.428 ' HB3' ' HB ' ' A' ' 261' ' ' ILE . 23.3 t -91.18 112.17 23.97 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -89.42 103.22 15.87 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.204 0.526 . . . . 0.0 111.241 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.624 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 13.9 mm100 -119.51 154.94 33.05 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 177.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -76.67 -30.91 56.98 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.329 0.585 . . . . 0.0 109.662 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -68.3 -39.48 82.05 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.681 -1.145 . . . . 0.0 112.151 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . 0.624 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 39.5 p-80 -175.6 166.82 3.23 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 20.7 mt -105.87 133.21 50.89 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 106.552 -1.648 . . . . 0.0 106.552 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 300' ' ' LEU . 3.4 mp -114.96 115.9 50.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 179.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.627 ' HA ' ' O ' ' A' ' 252' ' ' ASP . 0.8 OUTLIER -113.89 140.64 33.35 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.394 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 298' ' ' THR . 20.2 m -134.09 124.04 25.48 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.517 0.675 . . . . 0.0 111.887 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.46 HD11 ' HB3' ' A' ' 251' ' ' PRO . 1.8 mm? -98.14 108.12 20.75 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.475 ' HD3' ' OD1' ' A' ' 297' ' ' ASP . 59.4 mmtt -67.28 131.49 45.85 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 124.213 0.946 . . . . 0.0 113.549 -177.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 73.68 6.75 5.0 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.565 -1.652 . . . . 0.0 110.357 176.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -95.72 99.61 11.43 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.084 -174.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 19.3 p -77.56 108.96 11.11 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-O 121.224 0.535 . . . . 0.0 111.03 -178.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 30.1 tp -89.92 128.38 50.27 Favored Pre-proline 0 N--CA 1.43 -1.438 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.12 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -70.83 157.7 57.6 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.643 2.228 . . . . 0.0 111.905 171.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' THR . . . . . 0.471 ' HA ' ' OE1' ' A' ' 274' ' ' GLN . 6.7 p -66.87 -38.35 86.17 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.582 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 11.4 m -59.88 -26.3 65.77 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 124.656 1.182 . . . . 0.0 112.516 -178.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 8.5 mp -96.27 2.48 52.93 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.566 0.698 . . . . 0.0 110.814 -172.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.511 HE21 ' HA ' ' A' ' 292' ' ' LYS . 50.7 mt-30 -84.45 123.54 30.36 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.121 178.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . 0.517 ' HD2' ' O ' ' A' ' 228' ' ' ILE . 3.7 ptp180 -137.33 162.4 33.68 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 177.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 289' ' ' VAL . 24.5 t -139.86 126.77 20.79 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.459 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 1.1 mm? -98.16 111.43 23.76 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 124.925 1.29 . . . . 0.0 108.728 -176.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -86.62 92.68 8.99 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 11.8 m -102.32 28.03 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 CA-C-N 114.404 -1.271 . . . . 0.0 112.187 -175.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -67.4 140.49 57.18 Favored 'General case' 0 N--CA 1.403 -2.82 0 CA-C-N 114.062 -1.427 . . . . 0.0 107.591 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 34.4 t70 73.71 4.02 4.62 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 124.892 1.277 . . . . 0.0 113.119 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 1.663 ' HE1' ' CE2' ' A' ' 282' ' ' PHE . 19.8 m-85 -75.61 -3.32 33.76 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.475 -0.766 . . . . 0.0 111.492 174.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm 60.64 58.41 2.45 Favored 'General case' 0 CA--C 1.504 -0.81 0 C-N-CA 124.171 0.989 . . . . 0.0 111.007 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 1.4 p -136.57 168.47 16.87 Favored Pre-proline 0 N--CA 1.428 -1.546 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . 0.517 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 15.7 Cg_exo -71.58 -14.58 30.52 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 121.863 1.709 . . . . 0.0 110.892 176.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 21.4 t -84.18 139.75 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -103.18 -45.36 4.94 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.164 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 277' ' ' LEU . 7.3 ttpm? -163.22 137.61 6.18 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.437 -179.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.459 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 39.9 t -100.67 122.75 53.05 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.34 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 57.7 m -129.26 124.81 35.39 Favored 'General case' 0 C--N 1.28 -2.433 0 CA-C-O 121.217 0.532 . . . . 0.0 110.98 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 45.8 tp -100.04 113.38 25.94 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . 0.511 ' HA ' HE21 ' A' ' 274' ' ' GLN . 40.8 ttmt -115.23 129.34 56.61 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -178.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . 0.445 ' H ' ' NE2' ' A' ' 274' ' ' GLN . 13.8 ptt180 -72.95 142.83 47.82 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 175.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.552 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 19.3 tp -108.38 -173.46 2.28 Favored 'General case' 0 C--N 1.274 -2.692 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.552 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 3.8 t-20 -52.57 -64.02 0.95 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.327 0.584 . . . . 0.0 112.079 -177.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -125.07 -3.49 7.57 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.817 0.818 . . . . 0.0 109.323 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . 0.475 ' OD1' ' HD3' ' A' ' 265' ' ' LYS . 49.6 m-20 -117.05 171.72 7.74 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.054 -175.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.574 ' O ' ' HA ' ' A' ' 263' ' ' THR . 27.2 m -108.05 133.7 51.98 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . 0.615 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 8.2 tt0 -121.44 131.71 54.32 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 118.462 0.574 . . . . 0.0 111.304 -177.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 261' ' ' ILE . 9.1 mt -100.45 135.41 41.93 Favored 'General case' 0 CA--C 1.45 -2.902 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.39 170.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 62.6 mt -121.18 108.11 21.83 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 173.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 56.0 mt -113.22 97.8 6.18 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.733 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' THR . . . . . 0.4 ' HA ' ' CB ' ' A' ' 259' ' ' HIS . 13.7 m -67.7 130.31 42.62 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -176.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 16.8 p -133.26 167.58 20.12 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 123.279 0.362 . . . . 0.0 110.671 -177.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -152.58 141.0 20.66 Favored 'General case' 0 C--O 1.248 0.976 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 87.24 -168.22 38.43 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 121.376 -0.44 . . . . 0.0 112.259 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -86.48 131.96 34.05 Favored 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 177.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' TRP . . . . . 0.638 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 63.4 p-90 -150.34 164.08 36.72 Favored 'General case' 0 N--CA 1.418 -2.036 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.119 -177.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -122.21 135.45 54.77 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 -178.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.638 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 19.8 tp -107.28 115.26 29.86 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.406 -178.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.466 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 28.3 t -116.22 105.26 18.04 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 174.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . 0.419 ' HA ' ' O ' ' A' ' 321' ' ' THR . 25.6 t30 -98.45 134.39 41.5 Favored 'General case' 0 CA--C 1.432 -3.574 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 177.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 54.4 mttm -119.38 120.58 37.3 Favored 'General case' 1 N--CA 1.362 -4.826 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.541 -177.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 39.2 m -82.97 103.53 12.5 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 172.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -71.74 -31.71 66.96 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.992 -177.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . 0.419 ' HB2' ' HD2' ' A' ' 317' ' ' PRO . . . -170.12 166.55 5.24 Favored Pre-proline 0 C--N 1.311 -1.09 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 -178.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' A' ' 316' ' ' ALA . 23.2 Cg_endo -60.02 104.78 0.25 Allowed 'Trans proline' 0 C--O 1.246 0.913 0 C-N-CA 121.988 1.792 . . . . 0.0 112.137 178.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 107.77 -13.83 38.34 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.134 -178.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -108.56 116.19 31.51 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.991 -0.711 . . . . 0.0 109.136 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' PHE . . . . . 0.471 ' CZ ' ' HD3' ' A' ' 251' ' ' PRO . 83.5 m-85 -121.49 160.34 24.4 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.593 0.711 . . . . 0.0 110.137 -176.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 312' ' ' ASN . 94.8 m -152.96 105.88 2.98 Favored 'General case' 0 C--N 1.273 -2.738 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.335 -175.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 1.662 ' HD2' ' CD1' ' A' ' 322' ' ' PHE . 72.9 m-85 -94.1 110.47 22.18 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 -178.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . 0.466 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 51.2 tt0 -97.63 99.98 11.37 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 176.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -96.26 104.07 15.43 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.323 0 CA-C-O 122.642 1.21 . . . . 0.0 110.052 179.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 21.3 mt -95.22 149.54 36.35 Favored Pre-proline 0 C--N 1.296 -1.745 0 CA-C-N 113.238 -1.801 . . . . 0.0 109.555 -174.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -76.35 123.84 7.38 Favored 'Trans proline' 0 C--O 1.247 0.971 0 C-N-CA 121.78 1.653 . . . . 0.0 109.937 173.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm . . . . . 0 C--N 1.306 -1.312 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.363 -176.584 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 . . . . . 0 N--CA 1.451 -0.419 0 N-CA-C 104.254 -2.499 . . . . 0.0 104.254 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' THR . . . . . 0.566 ' O ' HD11 ' A' ' 273' ' ' LEU . 11.0 m -64.88 147.72 52.78 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 118.454 0.57 . . . . 0.0 111.05 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -173.92 169.42 4.08 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 120.919 0.39 . . . . 0.0 110.323 173.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.8 pp -124.25 158.81 30.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . 0.471 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 4.4 t70 -150.38 156.21 41.07 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 1.659 ' HD2' ' CD1' ' A' ' 230' ' ' PHE . 68.1 t80 -138.37 136.51 36.4 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 118.145 0.429 . . . . 0.0 111.368 177.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -149.43 166.38 29.25 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.573 173.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -103.92 139.72 38.69 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -151.39 169.57 21.69 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 59.3 -129.51 49.26 Favored Glycine 0 C--N 1.304 -1.233 0 N-CA-C 114.275 0.47 . . . . 0.0 114.275 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -118.33 89.44 3.12 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 123.889 0.876 . . . . 0.0 109.506 -176.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 54.08 33.8 18.52 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 122.221 1.01 . . . . 0.0 112.338 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.3 140.55 29.64 Favored 'General case' 0 N--CA 1.405 -2.685 0 CA-C-N 114.124 -1.398 . . . . 0.0 108.496 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -100.77 124.64 8.32 Favored Glycine 0 N--CA 1.422 -2.285 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.2 mp -112.62 118.34 57.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-N 117.602 0.701 . . . . 0.0 110.416 -177.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.0 mp -105.02 112.44 38.64 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 177.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.471 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 52.8 mt-10 -90.34 142.47 27.69 Favored 'General case' 0 C--N 1.279 -2.47 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 174.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 11.8 tp -129.99 117.82 20.65 Favored 'General case' 0 C--N 1.265 -3.074 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.275 -175.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -103.89 106.24 16.68 Favored 'General case' 0 C--N 1.282 -2.345 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 177.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -117.88 90.36 3.32 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 121.603 0.716 . . . . 0.0 110.228 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -87.0 113.91 23.16 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.4 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 122.4 1.31 10.16 Favored Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -176.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -115.54 128.99 56.38 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -104.68 -30.82 9.69 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -176.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -94.26 -141.92 11.82 Favored Glycine 0 CA--C 1.493 -1.34 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.318 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -118.4 142.41 31.31 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -177.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.488 ' HB3' ' CD2' ' A' ' 264' ' ' LEU . 44.0 Cg_endo -79.58 172.34 14.51 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.812 2.341 . . . . 0.0 112.488 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -89.26 109.55 20.42 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.39 108.79 20.91 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 177.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' SER . . . . . 0.448 ' HB2' ' HB ' ' A' ' 261' ' ' ILE . 16.9 m -105.72 111.4 24.07 Favored 'General case' 0 N--CA 1.407 -2.619 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.6 176.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -94.34 112.51 24.3 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.496 -176.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.7 ' HB3' ' O ' ' A' ' 259' ' ' HIS . 6.8 tp60 -116.5 159.73 21.64 Favored 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -76.89 -37.19 55.93 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.145 -177.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -71.23 -34.41 70.76 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.697 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . 0.7 ' O ' ' HB3' ' A' ' 256' ' ' GLN . 35.0 p-80 -168.08 171.22 9.74 Favored 'General case' 0 C--O 1.201 -1.451 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -178.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 21.7 mt -106.38 139.26 28.35 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . 0.448 ' HB ' ' HB2' ' A' ' 254' ' ' SER . 3.6 mp -115.35 108.49 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.926 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.451 ' HB ' ' HB3' ' A' ' 300' ' ' LEU . 43.3 t -106.68 120.93 58.69 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.628 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 175.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' THR . . . . . 0.564 HG21 ' OD1' ' A' ' 297' ' ' ASP . 1.1 m -115.32 130.36 56.88 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.723 -177.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.488 ' CD2' ' HB3' ' A' ' 251' ' ' PRO . 25.5 mt -116.04 83.38 1.93 Allowed 'General case' 0 CA--C 1.474 -1.976 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -178.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.435 ' HA ' ' OD2' ' A' ' 297' ' ' ASP . 26.4 mmtm -61.65 140.88 58.11 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.6 -175.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 10.9 t30 66.68 15.05 10.02 Favored 'General case' 0 CA--C 1.552 1.027 0 O-C-N 124.792 1.307 . . . . 0.0 110.802 175.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 50.2 t60 -109.89 93.92 4.75 Favored 'General case' 0 C--O 1.187 -2.216 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 176.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 2.0 m -86.64 114.7 23.57 Favored 'General case' 0 C--N 1.28 -2.431 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.334 -173.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 19.6 tp -87.84 135.76 33.36 Favored Pre-proline 0 C--N 1.312 -1.037 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.47 -178.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -78.65 159.91 28.26 Favored 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 122.25 1.967 . . . . 0.0 111.413 171.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' THR . . . . . 0.479 ' HA ' ' OE1' ' A' ' 274' ' ' GLN . 23.5 p -64.0 -28.31 69.72 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.727 0.775 . . . . 0.0 111.081 -179.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 30.1 m -56.86 -26.29 58.29 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 125.693 1.597 . . . . 0.0 113.379 -177.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.566 HD11 ' O ' ' A' ' 226' ' ' THR . 64.7 mt -105.6 -2.27 23.69 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 121.965 -0.459 . . . . 0.0 111.537 -174.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.479 ' OE1' ' HA ' ' A' ' 271' ' ' THR . 55.3 mt-30 -77.9 108.31 11.06 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.971 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -138.26 153.34 49.08 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 20.2 m -117.77 131.99 56.52 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 63.9 mt -100.2 125.82 46.41 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -49.41 -69.11 0.13 Allowed 'General case' 0 N--CA 1.471 0.623 0 O-C-N 124.559 1.162 . . . . 0.0 111.642 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . 0.649 ' HA ' ' CD2' ' A' ' 282' ' ' PHE . 39.1 t 56.12 24.72 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.79 0 O-C-N 124.332 1.02 . . . . 0.0 112.247 176.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -79.5 138.27 37.49 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 120.637 -1.289 . . . . 0.0 109.991 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 60.21 38.68 19.93 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 123.92 0.762 . . . . 0.0 111.514 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 1.635 ' HD1' ' CD2' ' A' ' 282' ' ' PHE . 0.2 OUTLIER -88.59 -2.94 58.86 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.856 179.85 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 65.36 61.24 0.72 Allowed 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.894 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.9 153.45 10.82 Favored Pre-proline 0 C--N 1.298 -1.634 0 CA-C-N 114.127 -1.397 . . . . 0.0 108.966 179.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . 0.461 ' O ' ' HA ' ' A' ' 304' ' ' THR . 62.1 Cg_exo -50.31 -28.13 19.78 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.671 2.914 . . . . 0.0 112.948 173.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 42.4 t -69.57 124.39 25.37 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.946 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -98.71 -44.0 6.58 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.263 -177.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -161.64 139.17 8.85 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 47.0 t -100.89 130.89 49.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 176.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 62.6 m -139.72 117.0 11.24 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.119 0.485 . . . . 0.0 110.772 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 54.9 tp -97.47 115.58 28.04 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -114.63 129.01 56.62 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -176.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . 0.413 ' H ' ' NE2' ' A' ' 274' ' ' GLN . 5.7 ptm180 -79.46 140.18 37.41 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.166 -1.013 . . . . 0.0 108.572 176.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.584 HD11 ' N ' ' A' ' 295' ' ' ASN . 2.7 tm? -120.29 158.48 26.97 Favored 'General case' 0 N--CA 1.416 -2.149 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.584 ' N ' HD11 ' A' ' 294' ' ' LEU . 21.3 t-20 -14.86 -71.43 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 127.583 2.353 . . . . 0.0 114.032 177.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -125.2 -3.47 7.49 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . 0.564 ' OD1' HG21 ' A' ' 263' ' ' THR . 7.0 t70 -108.58 -177.65 3.38 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.242 1.017 . . . . 0.0 108.471 -169.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.431 ' HB ' ' HB2' ' A' ' 264' ' ' LEU . 58.3 m -134.18 109.55 8.97 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 174.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -103.23 119.17 38.37 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-O 121.708 0.766 . . . . 0.0 109.648 -175.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.451 ' HB3' ' HB ' ' A' ' 262' ' ' VAL . 59.9 tp -105.13 124.26 49.22 Favored 'General case' 0 C--N 1.271 -2.805 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.831 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 66.6 mt -107.16 109.85 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.641 -178.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 61.6 mt -108.36 105.14 18.23 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' THR . . . . . 0.4 ' HA ' ' CB ' ' A' ' 259' ' ' HIS . 11.9 m -74.77 135.36 41.72 Favored 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.832 -174.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 285' ' ' PRO . 17.3 p -134.34 -177.04 4.41 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 123.051 0.54 . . . . 0.0 110.308 -177.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -166.75 149.9 6.76 Favored 'General case' 0 C--O 1.247 0.937 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 71.92 -161.05 54.22 Favored Glycine 0 C--O 1.243 0.659 0 O-C-N 123.672 0.608 . . . . 0.0 112.541 177.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -88.32 128.84 35.5 Favored 'General case' 0 CA--C 1.494 -1.197 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' TRP . . . . . 0.649 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 56.8 p-90 -147.83 167.59 24.36 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -177.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' A' ' 324' ' ' VAL . 15.8 mt-10 -123.69 144.58 49.56 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -177.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.649 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 33.1 tp -120.83 117.52 27.61 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.916 0.389 . . . . 0.0 111.514 -176.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.504 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 58.8 t -110.87 108.27 25.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 174.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -98.46 129.64 45.07 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -135.08 158.71 43.65 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 120.807 0.337 . . . . 0.0 110.223 -178.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 12.0 p -116.5 138.88 51.04 Favored 'General case' 0 N--CA 1.414 -2.247 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.908 172.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -96.55 -22.97 16.75 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -172.39 163.3 4.11 Favored Pre-proline 0 C--N 1.313 -1.001 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -65.11 97.57 0.29 Allowed 'Trans proline' 0 C--O 1.247 0.948 0 C-N-CA 121.63 1.554 . . . . 0.0 111.172 177.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 120.9 -5.15 11.42 Favored Glycine 0 C--O 1.208 -1.521 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.433 -177.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -123.7 116.68 23.45 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.944 -0.739 . . . . 0.0 109.749 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -119.19 166.3 13.13 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.829 0.823 . . . . 0.0 110.749 -176.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 58.5 m -151.97 136.68 17.05 Favored 'General case' 0 C--N 1.281 -2.37 0 C-N-CA 124.259 1.024 . . . . 0.0 109.085 -177.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -123.03 116.26 23.22 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . 0.504 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 8.9 tt0 -103.53 105.87 16.23 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 309' ' ' GLU . 1.3 m -99.59 110.72 27.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-O 121.301 0.572 . . . . 0.0 109.8 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -92.1 156.89 41.73 Favored Pre-proline 0 C--N 1.313 -1.015 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.374 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -83.0 138.51 9.13 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 C-N-CA 121.814 1.676 . . . . 0.0 109.915 171.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt . . . . . 0 C--N 1.295 -1.768 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.965 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . 0.43 ' HG2' ' H ' ' A' ' 226' ' ' THR . 42.1 tt0 . . . . . 0 N--CA 1.424 -1.769 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' THR . . . . . 0.599 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 24.7 m -63.83 125.64 25.02 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 123.403 0.681 . . . . 0.0 112.595 -170.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -152.55 171.81 17.55 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.18 -176.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.5 pp -133.7 158.85 42.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 C-N-CA 123.45 0.7 . . . . 0.0 110.868 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -149.85 156.63 42.11 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -175.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -138.08 138.28 38.59 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.153 0.501 . . . . 0.0 111.086 176.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 21.1 ptt85 -153.76 168.2 27.09 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 172.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.43 ' CE ' ' HA ' ' A' ' 236' ' ' ASN . 54.4 mtpt -113.53 154.41 27.14 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -144.14 117.67 9.15 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 81.48 -117.23 4.37 Favored Glycine 0 C--N 1.294 -1.793 0 C-N-CA 121.186 -0.53 . . . . 0.0 113.956 175.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -101.33 80.22 2.07 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.332 0.587 . . . . 0.0 111.801 -173.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . 0.45 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 91.9 m-20 57.85 18.07 4.69 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 176.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -73.19 136.11 44.69 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . 0.463 ' HA3' ' CG1' ' A' ' 286' ' ' VAL . . . -91.59 123.86 7.37 Favored Glycine 0 N--CA 1.43 -1.752 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.6 mp -117.69 112.43 38.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 117.792 0.796 . . . . 0.0 110.77 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.1 mp -101.0 112.15 32.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -96.93 104.96 17.02 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 122.635 1.207 . . . . 0.0 110.558 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 11.5 tp -95.24 127.45 41.3 Favored 'General case' 0 C--N 1.27 -2.849 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.621 -175.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . 0.599 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -115.78 102.82 10.06 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -109.6 90.97 3.46 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.433 HD23 ' N ' ' A' ' 245' ' ' LEU . 2.9 mm? -78.62 115.82 18.58 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.725 -177.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 108.31 12.15 22.23 Favored Glycine 0 N--CA 1.425 -2.08 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.783 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' PHE . . . . . 0.436 ' HE1' ' O ' ' A' ' 265' ' ' LYS . 42.2 t80 -115.81 107.85 15.57 Favored 'General case' 0 N--CA 1.421 -1.905 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.803 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -103.76 94.71 5.58 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.409 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 156.76 -139.8 6.75 Favored Glycine 0 C--N 1.299 -1.473 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . 0.418 ' HA ' ' OE1' ' A' ' 250' ' ' GLN . 13.7 mm-40 -129.51 139.88 36.99 Favored Pre-proline 0 C--N 1.305 -1.357 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.445 ' HB3' HD11 ' A' ' 264' ' ' LEU . 9.1 Cg_endo -69.7 172.14 13.11 Favored 'Trans proline' 0 N--CA 1.434 -2.018 0 C-N-CA 121.212 1.275 . . . . 0.0 110.75 176.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -100.72 105.09 16.4 Favored 'General case' 0 C--N 1.267 -3.015 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 4.8 mp -102.37 138.66 25.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-O 121.043 0.449 . . . . 0.0 111.329 -176.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' SER . . . . . 0.441 ' HB3' ' HB ' ' A' ' 261' ' ' ILE . 33.3 t -127.57 124.98 39.44 Favored 'General case' 0 N--CA 1.425 -1.725 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 175.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -102.92 114.65 29.11 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.177 0.513 . . . . 0.0 111.932 -177.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -117.88 160.73 20.93 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 171.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -76.6 -30.89 57.15 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.658 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -68.56 -42.21 78.66 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.939 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . 0.532 ' CB ' ' HA ' ' A' ' 303' ' ' THR . 38.7 p-80 -168.73 168.69 10.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.665 178.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 20.2 mt -106.17 142.36 19.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . 0.441 ' HB ' ' HB3' ' A' ' 254' ' ' SER . 3.3 mp -122.64 122.89 67.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 299' ' ' GLN . 1.4 m -120.14 141.09 41.94 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 175.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 298' ' ' THR . 26.0 m -135.19 126.92 29.15 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-O 121.475 0.655 . . . . 0.0 110.86 177.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.445 HD11 ' HB3' ' A' ' 251' ' ' PRO . 1.5 mm? -94.17 99.3 11.59 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 177.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.558 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 13.2 mptt -59.7 125.4 23.5 Favored 'General case' 0 C--N 1.285 -2.225 0 O-C-N 124.838 1.336 . . . . 0.0 112.451 -178.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 66.4 t30 63.76 35.74 11.06 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.138 0.975 . . . . 0.0 110.402 178.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -121.26 119.09 31.25 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 2.8 p -87.27 144.79 26.64 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.031 0.443 . . . . 0.0 111.946 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 27.1 tp -130.26 129.98 22.97 Favored Pre-proline 0 N--CA 1.427 -1.608 0 C-N-CA 123.77 0.828 . . . . 0.0 109.301 178.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -72.86 152.34 52.18 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.021 1.814 . . . . 0.0 111.586 171.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 34.7 p -68.89 -19.56 64.22 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.942 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 13.6 m -74.97 -18.53 60.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.555 0.693 . . . . 0.0 109.686 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 89.9 mt -106.41 -7.11 17.78 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.065 -176.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -86.57 102.39 14.1 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.67 158.32 44.31 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.656 -177.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 33.9 p -114.59 145.87 41.46 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.566 -175.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 64.2 mt -112.44 119.36 37.95 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -85.88 94.24 9.12 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-O 121.889 0.852 . . . . 0.0 108.714 177.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . 0.568 ' HA ' ' CE1' ' A' ' 282' ' ' PHE . 17.6 t -105.83 30.18 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 CA-C-N 113.943 -1.48 . . . . 0.0 109.902 -173.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -82.0 144.96 30.51 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 35.8 t70 72.37 20.85 3.92 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 122.46 1.124 . . . . 0.0 110.789 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 1.639 ' HE2' ' CE1' ' A' ' 282' ' ' PHE . 19.5 m-85 -90.07 -1.73 58.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.858 173.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 73.23 13.45 4.71 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.539 1.136 . . . . 0.0 111.54 175.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 1.2 p -96.63 174.93 2.94 Favored Pre-proline 0 C--N 1.309 -1.157 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -175.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 7.9 Cg_exo -76.36 -15.26 17.94 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 121.854 1.703 . . . . 0.0 110.768 173.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.463 ' CG1' ' HA3' ' A' ' 238' ' ' GLY . 1.4 m -90.46 138.06 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' GLN . . . . . 0.466 ' OE1' ' HB3' ' A' ' 305' ' ' ALA . 11.3 mt-30 -104.82 -32.44 8.83 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.239 0.542 . . . . 0.0 110.814 -179.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 36.8 tttp -162.29 133.84 5.29 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.204 -174.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 45.3 t -99.46 132.93 43.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 172.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 97.2 m -142.8 118.92 10.73 Favored 'General case' 0 C--N 1.29 -2.009 0 O-C-N 121.631 -0.668 . . . . 0.0 111.087 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 42.7 tp -96.74 125.03 40.91 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -121.91 129.19 52.35 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.532 -174.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 41.9 ttt-85 -74.54 127.68 33.67 Favored 'General case' 0 N--CA 1.407 -2.584 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 173.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.469 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 19.4 tp -107.99 179.28 4.27 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 176.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.469 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 27.4 t-20 -46.54 -67.76 0.25 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.662 0.785 . . . . 0.0 112.883 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -123.83 -2.09 8.32 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.544 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . 0.558 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 15.9 m-20 -117.43 168.31 10.48 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -177.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.549 ' O ' ' HA ' ' A' ' 263' ' ' THR . 49.5 m -112.9 127.96 56.34 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 176.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . 0.472 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 41.4 tt0 -111.55 129.64 56.0 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -175.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 63.2 tp -111.15 124.61 52.53 Favored 'General case' 0 N--CA 1.415 -2.207 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 176.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 54.2 mt -112.5 121.01 64.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -177.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 53.7 mt -121.43 101.76 10.92 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 178.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' THR . . . . . 0.532 ' HA ' ' CB ' ' A' ' 259' ' ' HIS . 16.8 m -69.34 139.82 54.26 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 10.9 p -134.22 166.04 23.7 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -176.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . 0.466 ' HB3' ' OE1' ' A' ' 287' ' ' GLN . . . -144.66 143.91 30.98 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.315 0.646 . . . . 0.0 110.177 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 77.65 -159.62 48.23 Favored Glycine 0 C--O 1.245 0.801 0 O-C-N 123.897 0.748 . . . . 0.0 112.319 178.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 327' ' ' LYS . 28.9 m-80 -92.67 136.5 33.18 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 176.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' TRP . . . . . 0.665 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 59.3 p-90 -150.47 160.4 43.79 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.781 -0.767 . . . . 0.0 111.157 -175.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 324' ' ' VAL . 16.1 mt-10 -118.14 133.14 56.17 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -177.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.665 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 24.3 tp -108.35 120.92 43.77 Favored 'General case' 0 CA--C 1.498 -1.039 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.825 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.495 ' CG1' ' HB3' ' A' ' 323' ' ' GLN . 7.5 p -122.17 112.12 33.37 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-O 121.964 0.888 . . . . 0.0 109.395 172.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -94.94 139.58 31.13 Favored 'General case' 0 N--CA 1.414 -2.267 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.594 -177.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . 0.435 ' HB2' ' HB ' ' A' ' 321' ' ' THR . 67.0 mttm -130.92 151.32 51.47 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.342 -177.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 27.0 m -116.02 126.75 54.22 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 172.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -87.9 -34.62 18.1 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -167.41 163.77 9.7 Favored Pre-proline 0 C--N 1.307 -1.25 0 N-CA-C 104.74 -2.318 . . . . 0.0 104.74 -178.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.68 95.42 0.28 Allowed 'Trans proline' 0 C--O 1.244 0.813 0 C-N-CA 121.535 1.49 . . . . 0.0 111.266 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 131.79 -32.4 2.91 Favored Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -177.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -97.84 116.51 30.2 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' PHE . . . . . 1.645 ' HE2' ' CE1' ' A' ' 320' ' ' PHE . 61.0 m-85 -119.2 165.03 14.73 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-O 122.188 0.994 . . . . 0.0 110.449 -175.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.435 ' HB ' ' HB2' ' A' ' 313' ' ' LYS . 59.3 m -151.72 128.72 11.05 Favored 'General case' 0 C--N 1.264 -3.135 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.619 -177.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -116.44 114.53 24.36 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . 0.495 ' HB3' ' CG1' ' A' ' 311' ' ' VAL . 34.9 tt0 -104.24 111.87 24.66 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 309' ' ' GLU . 0.2 OUTLIER -105.96 103.65 15.74 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.713 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.261 179.205 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.08 153.0 56.78 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.229 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -78.55 129.76 9.48 Favored 'Trans proline' 0 N--CA 1.447 -1.226 0 C-N-CA 121.669 1.58 . . . . 0.0 109.491 173.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 307' ' ' ASN . 41.1 ttmt . . . . . 0 C--N 1.295 -1.795 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 . . . . . 0 N--CA 1.436 -1.141 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 31.1 m -61.5 133.47 55.76 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -167.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -162.17 170.99 18.12 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.177 -178.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.431 ' CG1' ' HB2' ' A' ' 291' ' ' LEU . 2.8 pp -136.56 157.34 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.183 178.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -145.61 157.61 43.95 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 123.992 0.917 . . . . 0.0 110.147 -175.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 1.633 ' HE1' ' CE2' ' A' ' 230' ' ' PHE . 91.5 t80 -124.0 145.58 49.09 Favored 'General case' 0 C--N 1.31 -1.13 0 O-C-N 123.202 0.314 . . . . 0.0 110.549 177.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -155.52 165.22 37.25 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 170.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . 0.482 ' CE ' ' HA ' ' A' ' 236' ' ' ASN . 55.2 mtpt -115.38 151.23 35.06 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 120.696 0.284 . . . . 0.0 110.586 176.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -136.68 140.51 42.75 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.96 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 66.14 -97.61 0.33 Allowed Glycine 0 N--CA 1.438 -1.188 0 O-C-N 124.3 1.0 . . . . 0.0 114.32 172.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -136.3 92.34 2.77 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-O 120.862 0.363 . . . . 0.0 110.074 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . 0.482 ' HA ' ' CE ' ' A' ' 232' ' ' LYS . 92.4 m-20 65.3 12.9 8.43 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 172.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -74.73 130.87 40.25 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -97.1 113.84 4.82 Favored Glycine 0 C--O 1.21 -1.385 0 O-C-N 123.696 0.623 . . . . 0.0 111.845 -177.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.7 mp -106.96 117.56 53.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 117.834 0.817 . . . . 0.0 111.015 -177.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.4 mp -103.66 112.57 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.919 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 175.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -91.43 128.31 37.21 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 12.8 tp -116.08 123.69 48.52 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-O 121.054 0.454 . . . . 0.0 111.409 -175.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -109.93 104.4 13.31 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -117.43 91.08 3.48 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.03 115.37 19.57 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.139 -174.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 113.08 2.24 25.04 Favored Glycine 0 N--CA 1.432 -1.612 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.718 178.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' PHE . . . . . 0.424 ' HB2' ' ND1' ' A' ' 267' ' ' HIS . 40.9 t80 -114.96 114.21 25.14 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -178.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -106.91 -10.05 16.11 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -84.1 -154.57 19.66 Favored Glycine 0 C--N 1.318 -0.435 0 C-N-CA 121.425 -0.417 . . . . 0.0 112.464 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -119.69 134.43 23.88 Favored Pre-proline 0 C--N 1.311 -1.082 0 O-C-N 122.485 -0.42 . . . . 0.0 109.872 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.405 ' HB3' ' CD2' ' A' ' 264' ' ' LEU . 32.9 Cg_endo -74.21 171.99 16.9 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.523 2.149 . . . . 0.0 113.042 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -94.71 113.24 25.0 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.104 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 2.2 mp -97.86 108.47 21.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 122.113 0.958 . . . . 0.0 110.191 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' SER . . . . . 0.49 ' HB2' ' HB ' ' A' ' 261' ' ' ILE . 36.6 m -108.98 111.67 23.46 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.37 -1.287 . . . . 0.0 108.856 176.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -104.87 124.18 49.01 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -174.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.441 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 14.3 mm-40 -124.77 167.86 14.01 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 173.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -76.95 -36.28 56.66 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 120.304 -0.558 . . . . 0.0 109.986 177.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -71.91 -37.75 70.03 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.942 -177.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . 0.441 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 55.0 p-80 -167.6 166.01 14.22 Favored 'General case' 0 C--N 1.318 -0.768 0 O-C-N 122.143 -0.348 . . . . 0.0 110.968 178.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . 0.418 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 19.1 mt -106.43 143.75 16.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . 0.49 ' HB ' ' HB2' ' A' ' 254' ' ' SER . 4.2 mp -121.76 111.76 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 177.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 43.1 t -110.12 117.01 53.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 176.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 23.5 m -112.76 124.22 52.09 Favored 'General case' 0 C--N 1.285 -2.233 0 C-N-CA 119.951 -0.7 . . . . 0.0 110.943 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.469 ' HB2' ' HB ' ' A' ' 298' ' ' THR . 17.1 mt -99.82 100.08 10.97 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.486 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 30.7 mmtp -65.7 129.43 39.73 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -174.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 6.4 t30 64.33 23.82 13.12 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 113.532 -1.667 . . . . 0.0 110.202 177.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' HIS . . . . . 0.424 ' ND1' ' HB2' ' A' ' 247' ' ' PHE . 54.9 t60 -112.05 107.69 16.73 Favored 'General case' 0 CA--C 1.476 -1.883 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 2.8 m -94.5 138.51 32.33 Favored 'General case' 0 C--N 1.263 -3.169 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.627 -175.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 29.7 tp -113.79 128.26 25.93 Favored Pre-proline 0 N--CA 1.431 -1.388 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.186 -176.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -62.21 135.7 55.92 Favored 'Trans proline' 0 C--O 1.248 0.98 0 C-N-CA 122.312 2.008 . . . . 0.0 110.705 169.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' THR . . . . . 0.433 ' O ' ' HG2' ' A' ' 274' ' ' GLN . 9.2 t -67.5 -13.11 61.75 Favored 'General case' 0 CA--C 1.56 1.36 0 CA-C-O 121.814 0.816 . . . . 0.0 111.223 -178.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 27.3 m -74.59 -23.99 58.83 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.81 178.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 96.7 mt -100.95 -9.27 21.67 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.128 -174.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.51 ' HB2' ' O ' ' A' ' 291' ' ' LEU . 3.2 pt20 -77.27 94.37 4.14 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-O 122.698 1.237 . . . . 0.0 109.647 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -100.72 166.53 10.83 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.094 -177.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 19.9 m -137.27 127.36 26.03 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.404 ' O ' ' HG3' ' A' ' 288' ' ' LYS . 2.2 mm? -89.83 130.5 36.06 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 179.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -70.44 -42.1 71.98 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . 0.55 ' HA ' ' CD1' ' A' ' 282' ' ' PHE 0.257 10.4 p 40.35 34.3 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.548 0 C-N-CA 126.051 1.74 . . . . 0.0 112.609 177.969 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -89.61 137.66 32.14 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.1 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 14.2 t70 69.2 14.47 8.65 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 125.328 1.451 . . . . 0.0 109.887 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.55 ' CD1' ' HA ' ' A' ' 279' ' ' VAL . 7.9 m-85 -75.82 -20.45 58.17 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.39 174.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp 62.3 60.56 1.41 Allowed 'General case' 0 CA--C 1.5 -0.965 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.981 174.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 1.1 p -133.06 172.32 7.61 Favored Pre-proline 0 C--N 1.286 -2.163 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 177.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . 0.449 ' O ' ' HA ' ' A' ' 304' ' ' THR . 23.8 Cg_exo -65.9 -24.65 53.29 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.51 1.473 . . . . 0.0 110.958 175.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.2 p -87.64 120.22 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 CA-C-O 122.206 1.003 . . . . 0.0 110.077 176.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -90.95 -37.76 13.3 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 114.111 -1.404 . . . . 0.0 111.062 -173.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . 0.46 ' HA ' ' CG1' ' A' ' 279' ' ' VAL . 86.6 tttt -154.29 134.79 13.46 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.013 178.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 35.8 t -102.03 116.56 45.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 175.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.427 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 27.2 m -124.37 121.28 34.51 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 120.729 0.299 . . . . 0.0 110.811 -176.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . 0.51 ' O ' ' HB2' ' A' ' 274' ' ' GLN . 27.7 tp -96.9 126.79 42.3 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 175.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . 0.493 ' HA ' ' NE2' ' A' ' 274' ' ' GLN . 21.5 tptp -125.59 121.98 35.16 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -172.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -77.9 128.25 33.65 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 118.579 -1.248 . . . . 0.0 108.607 177.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.475 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 15.1 tp -101.88 -173.91 2.46 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.475 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 51.1 t-20 -53.95 -67.05 0.29 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 118.311 0.505 . . . . 0.0 111.033 -177.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.43 -4.05 9.89 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.722 178.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . 0.486 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 30.3 m-20 -113.32 164.77 13.14 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.512 -175.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.469 ' HB ' ' HB2' ' A' ' 264' ' ' LEU . 98.9 m -108.09 124.86 50.86 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 174.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -112.97 128.33 56.46 Favored 'General case' 0 N--CA 1.416 -2.167 0 CA-C-O 121.59 0.71 . . . . 0.0 109.239 -176.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.18 127.62 53.67 Favored 'General case' 0 C--N 1.271 -2.83 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 176.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 301' ' ' ILE . . . . . 0.427 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 58.1 mt -115.57 109.49 28.48 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . 0.418 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 63.3 mt -110.84 101.05 12.0 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 25.8 m -70.81 134.33 47.27 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 -177.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 285' ' ' PRO . 15.4 p -138.0 171.23 14.72 Favored 'General case' 0 C--N 1.31 -1.111 0 O-C-N 123.256 0.347 . . . . 0.0 111.322 -176.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -154.69 139.75 17.4 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 90.1 -153.41 22.91 Favored Glycine 0 C--N 1.314 -0.656 0 C-N-CA 121.256 -0.497 . . . . 0.0 111.866 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 327' ' ' LYS . 30.4 m-80 -104.3 139.99 38.51 Favored 'General case' 0 C--O 1.255 1.361 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 175.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' TRP . . . . . 0.411 ' HZ3' ' CB ' ' A' ' 310' ' ' LEU . 67.9 p-90 -155.63 166.3 33.93 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.356 -177.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -117.88 134.39 54.98 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.411 ' CB ' ' HZ3' ' A' ' 308' ' ' TRP . 1.1 tt -102.85 123.42 46.47 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 176.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.605 ' CG1' ' HB3' ' A' ' 323' ' ' GLN . 6.5 p -117.34 108.16 24.08 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 CA-C-O 122.065 0.936 . . . . 0.0 109.419 170.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -98.48 115.93 29.62 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.915 -175.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -116.14 149.77 38.49 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.926 -176.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 48.4 t -111.65 113.78 26.38 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 172.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -79.71 -35.98 38.16 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.533 0.682 . . . . 0.0 109.95 -177.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -168.16 161.59 9.24 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 -178.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -62.09 102.45 0.26 Allowed 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 121.574 1.516 . . . . 0.0 111.497 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 117.03 -9.4 15.73 Favored Glycine 0 N--CA 1.434 -1.45 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.629 -178.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 319' ' ' TYR . . . . . 1.609 ' HD2' ' CD1' ' A' ' 319' ' ' TYR . 84.1 m-85 -120.08 116.31 25.45 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 122.004 -0.703 . . . . 0.0 110.035 178.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 320' ' ' PHE . . . . . 1.634 ' HD1' ' CD2' ' A' ' 320' ' ' PHE . 97.9 m-85 -120.63 165.82 14.51 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.697 -178.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 50.4 m -151.64 132.02 13.75 Favored 'General case' 0 C--N 1.274 -2.711 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.386 -176.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 1.655 ' HD1' ' CD2' ' A' ' 322' ' ' PHE . 66.5 m-85 -120.29 107.33 12.84 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 177.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . 0.605 ' HB3' ' CG1' ' A' ' 311' ' ' VAL . 62.7 tt0 -98.67 115.89 29.69 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 92.0 t -100.05 99.16 7.95 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.803 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -88.04 144.8 35.1 Favored Pre-proline 0 C--N 1.318 -0.762 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -68.79 131.0 21.62 Favored 'Trans proline' 0 C--O 1.243 0.764 0 C-N-CA 121.443 1.429 . . . . 0.0 110.076 173.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 307' ' ' ASN . 37.7 ttmt . . . . . 0 CA--C 1.495 -1.157 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . 0.458 ' O ' HD21 ' A' ' 245' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.439 -0.983 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 10.5 m -69.79 117.18 11.06 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -151.23 173.02 14.93 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.265 -176.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.455 HD12 ' CD2' ' A' ' 277' ' ' LEU . 2.2 pp -133.48 159.37 42.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.33 -178.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -150.83 156.49 41.36 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -178.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -130.38 134.52 47.21 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.552 175.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -145.26 166.95 24.01 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 173.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -110.82 146.42 36.45 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 174.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . 0.428 ' O ' ' HB1' ' A' ' 237' ' ' ALA . 18.2 t70 -152.88 117.76 5.1 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -177.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 99.25 -131.32 10.52 Favored Glycine 0 N--CA 1.434 -1.467 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.263 178.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -101.39 85.59 2.82 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 122.686 0.395 . . . . 0.0 110.166 -177.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . 0.464 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 91.2 m-20 57.8 21.4 7.44 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 177.049 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . 0.428 ' HB1' ' O ' ' A' ' 233' ' ' ASP . . . -79.18 138.4 37.84 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.907 -178.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -97.27 114.88 5.1 Favored Glycine 0 N--CA 1.421 -2.348 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.2 mp -107.19 111.96 37.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-O 121.505 0.669 . . . . 0.0 110.581 -177.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.5 mp -97.35 112.53 29.6 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 176.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -92.38 136.76 32.93 Favored 'General case' 0 C--N 1.277 -2.548 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 11.8 tp -127.98 127.78 43.86 Favored 'General case' 0 C--N 1.276 -2.598 0 C-N-CA 123.836 0.854 . . . . 0.0 110.359 -174.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . 0.568 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -113.25 101.19 9.18 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -108.28 90.78 3.4 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.458 HD21 ' O ' ' A' ' 225' ' ' GLN . 3.8 mm? -80.52 115.57 20.11 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.998 -174.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 105.87 14.22 21.67 Favored Glycine 0 N--CA 1.431 -1.675 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.597 178.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -114.98 118.21 32.79 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 -178.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -116.43 91.11 3.49 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.842 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 164.89 -148.51 14.33 Favored Glycine 0 N--CA 1.436 -1.305 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -126.42 138.6 32.69 Favored Pre-proline 0 C--N 1.31 -1.116 0 CA-C-N 117.277 0.539 . . . . 0.0 109.603 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.448 ' HB3' HD11 ' A' ' 264' ' ' LEU . 12.0 Cg_endo -71.5 172.1 14.93 Favored 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 121.683 1.589 . . . . 0.0 110.904 175.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.547 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 34.3 t70 -95.64 108.69 20.99 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.403 HD12 ' HG2' ' A' ' 251' ' ' PRO . 4.5 mp -105.84 116.25 49.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-O 121.302 0.572 . . . . 0.0 111.312 -178.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 19.3 t -95.51 111.8 23.64 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 175.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -88.76 95.68 10.37 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 121.468 0.651 . . . . 0.0 111.684 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.484 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 78.4 mt-30 -108.54 144.36 36.31 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 172.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -74.52 -19.98 60.14 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 119.769 -0.772 . . . . 0.0 112.109 -174.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -73.86 -47.24 39.64 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 123.875 0.734 . . . . 0.0 109.942 177.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . 0.484 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 44.3 p-80 -162.67 162.27 26.89 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.158 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 301' ' ' ILE . 29.5 mt -106.05 143.02 17.71 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -177.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 3.4 mp -125.51 114.7 40.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 178.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 252' ' ' ASP . 1.4 m -110.0 140.48 28.79 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.271 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 298' ' ' THR . 24.4 m -135.2 123.99 23.9 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-O 121.131 0.491 . . . . 0.0 111.14 177.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.448 HD11 ' HB3' ' A' ' 251' ' ' PRO . 1.7 mm? -93.98 107.75 19.63 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 176.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.423 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 30.3 mmtp -69.6 129.53 39.9 Favored 'General case' 0 C--N 1.29 -2.001 0 O-C-N 123.927 0.767 . . . . 0.0 112.689 -177.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 14.0 t30 70.1 22.62 5.57 Favored 'General case' 0 CA--C 1.554 1.113 0 O-C-N 124.952 1.407 . . . . 0.0 111.189 176.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 38.0 t60 -112.79 110.27 20.28 Favored 'General case' 0 C--O 1.213 -0.821 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 10.9 p -77.83 142.79 38.34 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.19 0.519 . . . . 0.0 112.158 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 35.9 tp -121.98 121.12 28.15 Favored Pre-proline 0 N--CA 1.431 -1.403 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.543 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -59.62 134.62 58.99 Favored 'Trans proline' 0 C--N 1.321 -0.91 0 C-N-CA 122.672 2.248 . . . . 0.0 111.276 170.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' THR . . . . . 0.512 ' HB ' ' HD3' ' A' ' 293' ' ' ARG . 6.5 t -66.3 -9.3 31.49 Favored 'General case' 0 CA--C 1.554 1.108 0 CA-C-O 121.823 0.82 . . . . 0.0 112.092 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 27.2 m -83.22 -14.95 52.21 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 121.642 0.734 . . . . 0.0 109.902 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.435 HD11 ' O ' ' A' ' 226' ' ' THR . 82.4 mt -106.23 -6.39 18.51 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.171 -176.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . 0.501 ' OE1' ' HG2' ' A' ' 293' ' ' ARG . 8.5 pt20 -82.92 101.39 11.0 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 121.844 0.83 . . . . 0.0 109.637 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -129.25 179.09 5.97 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 48.8 m -125.44 164.87 19.49 Favored 'General case' 0 N--CA 1.409 -2.476 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 176.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.46 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 2.9 mm? -122.29 115.91 23.17 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -77.98 92.37 4.32 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 174.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . 0.611 ' HA ' ' CD2' ' A' ' 282' ' ' PHE . 92.3 t -100.51 18.77 2.91 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 CA-C-O 123.124 1.44 . . . . 0.0 109.357 -176.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -70.19 137.07 50.63 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-N 114.583 -1.19 . . . . 0.0 107.967 176.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 72.94 19.27 3.81 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.961 0.904 . . . . 0.0 112.883 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 0.611 ' CD2' ' HA ' ' A' ' 279' ' ' VAL . 9.4 m-85 -85.69 -13.81 47.34 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.799 172.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.27 60.66 1.99 Allowed 'General case' 0 CA--C 1.492 -1.262 0 CA-C-O 121.838 0.828 . . . . 0.0 110.648 -177.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 2.9 p -136.12 173.3 5.79 Favored Pre-proline 0 N--CA 1.421 -1.924 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 178.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 2.8 Cg_exo -79.02 -5.98 14.78 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.404 1.402 . . . . 0.0 112.211 176.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.3 p -101.53 125.44 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-O 121.38 0.61 . . . . 0.0 110.446 178.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -86.93 -40.89 14.39 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.911 -175.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -159.16 134.26 8.27 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.939 -174.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.46 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 35.6 t -95.14 135.65 28.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 172.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 96.0 m -139.69 121.97 15.95 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 118.094 0.407 . . . . 0.0 110.531 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 45.7 tp -103.79 135.98 44.32 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 176.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -134.22 134.93 42.58 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -177.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . 0.512 ' HD3' ' HB ' ' A' ' 271' ' ' THR . 17.4 ptt180 -73.54 138.06 44.76 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 173.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.519 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 22.6 tp -115.29 -175.47 2.71 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.519 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 16.2 m120 -35.98 -75.94 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.944 1.698 . . . . 0.0 112.543 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -125.4 -1.27 7.55 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 174.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . 0.423 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 11.5 m-20 -108.49 171.79 7.21 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.594 -171.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.569 ' O ' ' HA ' ' A' ' 263' ' ' THR . 91.8 m -114.35 129.07 56.63 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 176.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . 0.52 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 36.3 tt0 -114.05 127.27 55.86 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -176.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 70.1 tp -114.94 123.08 48.21 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.503 178.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 301' ' ' ILE . . . . . 0.467 ' HA ' ' O ' ' A' ' 260' ' ' ILE . 62.5 mt -111.24 118.9 58.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-O 121.429 0.633 . . . . 0.0 109.487 -177.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 65.7 mt -114.87 108.83 26.43 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.533 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 14.6 m -82.59 131.66 35.21 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -176.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 6.9 p -126.67 164.82 20.44 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -174.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -145.98 134.65 22.24 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 123.534 0.734 . . . . 0.0 109.894 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 88.74 -166.8 34.45 Favored Glycine 0 C--O 1.252 1.263 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.237 176.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 327' ' ' LYS . 69.5 m-20 -86.27 126.18 34.12 Favored 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -144.54 165.43 28.02 Favored 'General case' 0 C--N 1.286 -2.152 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.553 -175.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -125.39 145.36 50.08 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.88 122.7 48.51 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -178.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 21.7 t -122.07 106.23 17.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 169.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -100.39 113.02 25.43 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.789 0.804 . . . . 0.0 110.277 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -106.91 150.99 25.85 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.906 -174.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 36.0 t -115.53 102.91 10.22 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 175.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -69.17 -30.96 69.29 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.525 0.679 . . . . 0.0 110.063 -176.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -167.16 159.85 10.73 Favored Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -64.22 95.26 0.21 Allowed 'Trans proline' 0 C--O 1.247 0.953 0 C-N-CA 121.724 1.616 . . . . 0.0 110.858 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 135.38 -33.87 2.37 Favored Glycine 0 N--CA 1.427 -1.963 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.307 -177.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -100.44 117.09 33.89 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 122.188 -0.596 . . . . 0.0 110.171 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 320' ' ' PHE . . . . . 1.666 ' HE2' ' CE1' ' A' ' 320' ' ' PHE . 92.0 m-85 -117.14 160.59 20.79 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 121.751 0.786 . . . . 0.0 110.04 -179.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 89.6 m -151.77 124.09 8.26 Favored 'General case' 0 C--N 1.268 -2.941 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.713 -176.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -109.82 109.49 20.17 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -97.62 107.84 20.42 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 83.9 t -97.6 99.02 8.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.623 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -88.02 154.93 52.61 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -81.51 142.83 13.28 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 121.44 1.427 . . . . 0.0 109.343 171.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . 0.423 ' O ' ' HB2' ' A' ' 307' ' ' ASN . 37.3 ttmt . . . . . 0 C--N 1.303 -1.434 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -177.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 . . . . . 0 N--CA 1.421 -1.896 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' THR . . . . . 0.682 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 52.5 m -63.47 112.61 2.84 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.679 0.752 . . . . 0.0 113.026 -174.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.49 165.69 27.86 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.85 -175.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . 0.459 HD13 ' CG ' ' A' ' 275' ' ' ARG . 1.6 pp -115.5 161.97 13.87 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.076 178.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . 0.437 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 7.1 t70 -151.26 155.91 39.75 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 1.661 ' HE2' ' CE1' ' A' ' 230' ' ' PHE . 75.4 t80 -132.87 135.57 45.68 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 173.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -149.45 168.84 22.33 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 174.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -117.19 139.91 50.19 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 174.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -149.0 117.78 6.64 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -175.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 99.55 -119.33 6.47 Favored Glycine 0 N--CA 1.428 -1.868 0 C-N-CA 120.608 -0.805 . . . . 0.0 113.127 177.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -113.34 85.35 2.17 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 122.88 -0.188 . . . . 0.0 110.833 -175.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . 0.543 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 5.9 m-20 56.2 21.8 5.57 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 124.705 1.202 . . . . 0.0 113.258 177.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -79.58 142.37 35.74 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.019 -176.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . 0.487 ' HA3' ' CG1' ' A' ' 286' ' ' VAL . . . -92.48 115.99 4.97 Favored Glycine 0 N--CA 1.418 -2.504 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 176.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.6 mp -110.0 109.7 29.39 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-N 118.065 0.932 . . . . 0.0 110.267 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.0 mp -98.96 109.61 24.54 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 N-CA-C 107.427 -1.324 . . . . 0.0 107.427 178.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 44.7 mt-10 -90.78 138.43 31.59 Favored 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 176.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 12.3 tp -128.47 131.48 48.36 Favored 'General case' 0 C--N 1.267 -3.022 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.561 -173.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . 0.682 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -116.41 106.25 13.41 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -118.19 90.91 3.43 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -83.25 113.87 20.98 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.538 0.685 . . . . 0.0 110.864 -174.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 122.99 -5.14 9.66 Favored Glycine 0 N--CA 1.428 -1.873 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.13 -175.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' PHE . . . . . 1.66 ' HD2' ' CD1' ' A' ' 247' ' ' PHE . 21.4 t80 -115.99 113.09 22.76 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 176.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -114.96 16.77 17.13 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 120.852 0.358 . . . . 0.0 111.437 -175.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -116.68 -162.84 13.01 Favored Glycine 0 C--N 1.302 -1.352 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -101.28 132.51 21.79 Favored Pre-proline 0 C--N 1.301 -1.501 0 CA-C-N 117.798 0.799 . . . . 0.0 110.724 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.433 ' HB3' ' CD2' ' A' ' 264' ' ' LEU . 9.5 Cg_endo -71.73 172.52 14.27 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.429 2.086 . . . . 0.0 112.443 176.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 30.2 t70 -97.07 105.47 17.62 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.406 HD12 ' HG2' ' A' ' 251' ' ' PRO . 4.7 mp -104.86 118.09 51.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.566 -178.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' SER . . . . . 0.405 ' HB3' ' HB ' ' A' ' 261' ' ' ILE . 22.9 t -101.0 123.23 44.87 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 175.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -107.93 95.61 5.8 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -176.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -103.35 164.39 11.67 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -60.93 -48.16 83.07 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 117.851 0.296 . . . . 0.0 111.344 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -76.08 -33.17 59.53 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.255 -173.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . 0.424 ' CB ' ' HA ' ' A' ' 303' ' ' THR . 41.8 p-80 -164.64 166.47 20.1 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 119.908 -0.717 . . . . 0.0 112.677 176.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . 0.421 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 18.6 mt -106.41 144.71 15.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . 0.405 ' HB ' ' HB3' ' A' ' 254' ' ' SER . 3.3 mp -128.94 114.13 31.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 299' ' ' GLN . 1.3 m -107.6 132.74 54.38 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.527 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 175.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 19.5 m -120.83 120.97 37.1 Favored 'General case' 0 C--N 1.281 -2.396 0 CA-C-O 121.211 0.529 . . . . 0.0 109.718 177.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.433 ' CD2' ' HB3' ' A' ' 251' ' ' PRO . 24.0 mt -100.91 94.74 6.18 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 179.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -57.8 126.57 27.97 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -175.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 63.78 19.24 11.63 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 113.263 -1.789 . . . . 0.0 111.283 176.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 53.5 t60 -98.56 117.73 33.66 Favored 'General case' 0 C--O 1.21 -1.006 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 5.4 p -92.7 118.62 31.25 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -176.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 21.5 tp -99.5 129.91 28.0 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.093 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.96 160.0 37.38 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.28 1.987 . . . . 0.0 111.971 176.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 19.6 p -62.66 -41.24 98.97 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 123.548 0.739 . . . . 0.0 112.485 -174.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 32.2 m -63.15 -23.35 67.39 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 124.573 1.149 . . . . 0.0 113.094 -176.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.541 HD11 ' O ' ' A' ' 226' ' ' THR . 95.4 mt -95.96 -10.11 29.48 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.583 -174.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -74.3 133.39 42.58 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 175.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . 0.459 ' CG ' HD13 ' A' ' 228' ' ' ILE . 5.4 ptp180 -171.58 172.5 5.0 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 177.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 11.8 p -130.39 148.45 52.21 Favored 'General case' 0 N--CA 1.402 -2.845 0 CA-C-O 121.293 0.568 . . . . 0.0 111.008 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.414 HD21 ' HB ' ' A' ' 289' ' ' VAL . 1.3 mm? -95.79 117.31 30.31 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 103.058 -2.942 . . . . 0.0 103.058 174.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -63.54 -38.85 92.7 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . 0.458 ' CG1' ' HA ' ' A' ' 288' ' ' LYS 0.259 12.2 p 40.61 34.91 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.336 0 C-N-CA 127.139 2.176 . . . . 0.0 114.1 174.823 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -85.26 140.47 30.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 115.069 -0.968 . . . . 0.0 108.776 177.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 32.9 t70 72.52 7.65 5.62 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.285 1.034 . . . . 0.0 111.354 178.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . 1.65 ' HD1' ' CD2' ' A' ' 282' ' ' PHE . 11.2 m-85 -73.22 -19.58 61.05 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.198 174.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm 61.85 60.7 1.52 Allowed 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 124.259 1.024 . . . . 0.0 112.032 174.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 4.9 p -128.26 178.25 1.73 Allowed Pre-proline 0 C--N 1.288 -2.108 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . 0.543 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 7.8 Cg_exo -75.36 -10.08 20.51 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 CA-C-N 121.172 1.454 . . . . 0.0 110.714 174.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . 0.487 ' CG1' ' HA3' ' A' ' 238' ' ' GLY . 0.8 OUTLIER -90.54 140.84 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.425 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 179.03 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -99.19 -51.02 3.95 Favored 'General case' 0 C--N 1.279 -2.459 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.425 -177.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . 0.458 ' HA ' ' CG1' ' A' ' 279' ' ' VAL . 86.8 tttt -155.45 135.49 12.94 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.414 ' HB ' HD21 ' A' ' 277' ' ' LEU . 42.9 t -102.44 126.18 56.59 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.927 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 60.8 m -132.49 125.72 31.3 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 121.001 0.429 . . . . 0.0 111.236 -177.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.78 124.78 45.39 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 178.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -128.78 138.12 51.91 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.053 0.454 . . . . 0.0 110.112 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -80.82 144.72 31.85 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 174.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.471 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 32.4 tp -122.93 -179.76 4.37 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.471 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 88.2 m-20 -31.43 -71.92 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 126.514 1.926 . . . . 0.0 112.874 -178.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -126.26 -1.63 6.98 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 173.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -110.87 172.8 6.66 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 114.166 -1.379 . . . . 0.0 109.445 -169.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.42 ' HB ' ' HB2' ' A' ' 264' ' ' LEU . 88.8 m -116.71 134.97 54.16 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 174.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . 0.559 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 27.5 tt0 -122.17 125.29 45.8 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 120.975 0.416 . . . . 0.0 109.926 -175.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.415 ' HB3' ' CG1' ' A' ' 262' ' ' VAL . 62.5 tp -108.42 120.52 42.65 Favored 'General case' 0 C--N 1.284 -2.267 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.083 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 72.2 mt -106.95 114.8 46.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.795 -175.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . 0.421 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 52.0 mt -116.51 105.51 18.48 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.326 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 178.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' THR . . . . . 0.424 ' HA ' ' CB ' ' A' ' 259' ' ' HIS . 18.2 m -73.67 138.19 44.58 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -178.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 10.3 p -137.06 177.86 7.53 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 122.803 0.441 . . . . 0.0 111.691 -174.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -156.81 143.33 18.33 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 122.418 0.287 . . . . 0.0 111.168 178.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 77.72 -152.27 38.78 Favored Glycine 0 C--O 1.247 0.951 0 O-C-N 123.523 0.515 . . . . 0.0 113.819 173.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -93.22 129.01 39.41 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 177.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' TRP . . . . . 0.452 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 69.2 p-90 -157.56 160.29 38.01 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -177.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -119.67 130.88 55.26 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -176.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.452 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 1.6 tm? -97.76 136.53 37.96 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.481 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 57.3 t -135.42 111.79 13.27 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -101.16 131.52 47.08 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -130.65 143.78 50.98 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -178.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 13.8 m -111.23 116.38 30.95 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -80.35 -40.84 25.87 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.798 -176.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -159.75 165.86 17.15 Favored Pre-proline 0 C--N 1.301 -1.517 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 -177.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -62.14 102.47 0.27 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 121.679 1.586 . . . . 0.0 111.018 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 116.39 -27.15 8.21 Favored Glycine 0 N--CA 1.426 -1.974 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.648 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 319' ' ' TYR . . . . . 1.647 ' HE1' ' CE2' ' A' ' 319' ' ' TYR . 70.6 m-85 -98.11 116.57 30.6 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.922 -0.752 . . . . 0.0 110.762 -178.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -118.63 166.68 12.44 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.474 -177.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 59.6 m -152.0 131.18 12.74 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.387 -176.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 1.665 ' HD1' ' CD2' ' A' ' 322' ' ' PHE . 72.9 m-85 -118.56 114.14 22.36 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 176.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . 0.481 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 7.2 tt0 -101.18 102.94 13.95 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -98.11 101.97 12.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 CA-C-O 122.46 1.124 . . . . 0.0 109.736 177.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 28.0 mt -91.05 145.55 31.89 Favored Pre-proline 0 C--N 1.302 -1.473 0 CA-C-N 113.479 -1.692 . . . . 0.0 109.922 -175.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -72.6 144.4 39.88 Favored 'Trans proline' 0 C--O 1.245 0.856 0 C-N-CA 121.648 1.565 . . . . 0.0 109.442 174.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt . . . . . 0 C--N 1.307 -1.276 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.474 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . 0.445 ' O ' HD21 ' A' ' 245' ' ' LEU . 5.7 tp-100 . . . . . 0 N--CA 1.421 -1.89 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 28.3 m -74.1 123.86 25.22 Favored 'General case' 0 C--O 1.202 -1.41 0 C-N-CA 124.495 1.118 . . . . 0.0 113.696 -169.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -143.69 169.05 18.49 Favored 'General case' 0 CA--C 1.474 -1.976 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -175.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.8 pp -135.54 160.15 39.95 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 175.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . 0.456 ' O ' ' HA ' ' A' ' 240' ' ' ILE . 24.0 t70 -148.3 156.49 42.6 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -173.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -125.82 139.06 53.81 Favored 'General case' 0 N--CA 1.427 -1.598 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.016 173.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -155.14 164.16 39.22 Favored 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 124.803 1.241 . . . . 0.0 108.076 177.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -115.94 144.74 43.64 Favored 'General case' 0 CA--C 1.486 -1.516 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 177.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . 0.509 ' O ' ' HB1' ' A' ' 237' ' ' ALA . 32.7 t70 -149.71 124.83 10.05 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 123.716 0.635 . . . . 0.0 110.632 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 81.44 -133.12 11.75 Favored Glycine 0 C--N 1.3 -1.436 0 C-N-CA 120.966 -0.635 . . . . 0.0 114.258 175.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -86.34 76.2 9.7 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 122.843 0.457 . . . . 0.0 111.502 -171.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 58.22 20.04 6.76 Favored 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 124.128 0.971 . . . . 0.0 112.445 177.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . 0.509 ' HB1' ' O ' ' A' ' 233' ' ' ASP . . . -78.58 140.43 38.48 Favored 'General case' 0 N--CA 1.421 -1.899 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.982 -175.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . 0.462 ' C ' HD13 ' A' ' 239' ' ' ILE . . . -95.81 131.35 10.63 Favored Glycine 0 N--CA 1.416 -2.634 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 177.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . 0.462 HD13 ' C ' ' A' ' 238' ' ' GLY . 2.3 mp -120.52 115.74 47.98 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 CA-C-N 117.907 0.854 . . . . 0.0 110.403 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 229' ' ' ASP . 3.2 mp -100.1 106.92 19.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 176.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -86.88 141.72 28.56 Favored 'General case' 0 N--CA 1.417 -2.116 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.667 175.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 10.3 tp -128.78 125.34 37.62 Favored 'General case' 0 C--N 1.26 -3.308 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.208 -175.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . 0.631 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -112.46 97.61 6.72 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -107.15 91.56 3.71 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.62 0.724 . . . . 0.0 109.685 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.445 HD21 ' O ' ' A' ' 225' ' ' GLN . 3.0 mm? -80.58 115.48 20.11 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.377 -176.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 110.87 2.63 28.56 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.5 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -115.94 140.85 48.84 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -138.91 15.39 2.67 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 120.676 -0.409 . . . . 0.0 111.66 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -117.21 -163.18 12.91 Favored Glycine 0 CA--C 1.495 -1.207 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -105.64 133.11 20.35 Favored Pre-proline 0 C--N 1.3 -1.577 0 CA-C-N 117.538 0.669 . . . . 0.0 110.022 -177.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.505 ' HB3' ' CD2' ' A' ' 264' ' ' LEU . 25.6 Cg_endo -73.69 169.21 22.88 Favored 'Trans proline' 0 CA--C 1.506 -0.903 0 C-N-CA 122.322 2.015 . . . . 0.0 112.79 177.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.635 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 27.9 t70 -82.1 104.89 12.76 Favored 'General case' 0 CA--C 1.472 -2.023 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 174.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . 0.416 ' CG2' HE21 ' A' ' 255' ' ' GLN . 7.1 mt -102.89 116.65 47.01 Favored 'Isoleucine or valine' 0 C--N 1.245 -3.966 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 7.8 t -125.51 129.7 50.28 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . 0.419 HE22 ' CG2' ' A' ' 260' ' ' ILE . 70.4 mm-40 -110.36 131.73 54.8 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -175.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.521 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 28.3 mm-40 -119.74 163.48 17.38 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 171.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -73.19 -35.89 66.44 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -88.19 -17.14 31.53 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.674 -173.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . 0.521 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 51.2 p-80 -171.94 162.41 5.97 Favored 'General case' 0 C--O 1.213 -0.841 0 O-C-N 122.093 -0.379 . . . . 0.0 111.74 178.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . 0.523 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 17.5 mt -107.52 144.72 15.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 300' ' ' LEU . 3.5 mp -124.79 125.86 70.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 176.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.635 ' HA ' ' O ' ' A' ' 252' ' ' ASP . 0.8 OUTLIER -122.16 139.8 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.717 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 172.686 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' THR . . . . . 0.401 ' HB ' ' HB3' ' A' ' 252' ' ' ASP . 24.7 m -131.05 123.54 28.92 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 118.527 0.603 . . . . 0.0 110.654 177.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.505 ' CD2' ' HB3' ' A' ' 251' ' ' PRO . 25.5 mt -100.54 96.48 7.41 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 24.1 mmtm -57.79 125.57 23.59 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -176.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 2.4 t30 62.6 26.87 15.92 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 126.064 1.746 . . . . 0.0 110.894 177.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -103.61 106.33 16.81 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 7.8 p -79.7 130.79 35.65 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.157 0.503 . . . . 0.0 112.226 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . 0.433 HD11 ' HD2' ' A' ' 270' ' ' PRO . 30.3 tp -116.92 136.28 23.23 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . 0.433 ' HD2' HD11 ' A' ' 269' ' ' LEU . 84.5 Cg_endo -78.71 158.29 28.15 Favored 'Trans proline' 0 N--CA 1.438 -1.76 0 C-N-CA 121.204 1.269 . . . . 0.0 110.391 173.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 5.9 p -64.5 -29.02 70.06 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.476 0.655 . . . . 0.0 111.298 -177.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 7.1 m -61.84 -29.36 70.12 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 125.393 1.477 . . . . 0.0 112.255 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.436 HD21 ' O ' ' A' ' 226' ' ' THR . 10.4 mp -101.37 0.08 36.41 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.381 0.61 . . . . 0.0 111.913 -172.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -75.72 142.32 42.46 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 174.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -164.52 171.05 15.07 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -177.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 23.2 m -140.99 133.36 28.29 Favored 'General case' 0 N--CA 1.418 -2.052 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 176.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.455 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 1.5 mm? -100.14 111.26 23.55 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.4 79.61 9.4 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-O 123.501 1.619 . . . . 0.0 109.518 175.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . 0.25 1.9 p -86.29 63.69 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.403 -2.815 0 CA-C-N 111.558 -2.565 . . . . 0.0 111.41 -175.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -105.97 144.93 32.0 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 113.07 -1.877 . . . . 0.0 106.911 177.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 31.7 t70 68.0 19.45 9.35 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 123.157 1.456 . . . . 0.0 110.538 -178.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -91.88 -13.1 31.84 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.101 173.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? 56.76 61.88 2.47 Favored 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 123.586 0.754 . . . . 0.0 112.569 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 1.5 p -136.24 170.62 10.48 Favored Pre-proline 0 N--CA 1.433 -1.32 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 178.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.46 -10.35 17.4 Favored 'Trans proline' 0 C--O 1.241 0.652 0 C-N-CA 122.018 1.812 . . . . 0.0 111.802 177.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.6 p -99.15 121.53 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.016 0 CA-C-O 121.991 0.9 . . . . 0.0 111.071 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -87.92 -41.57 13.08 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.199 -1.364 . . . . 0.0 112.522 -170.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -155.54 132.6 10.76 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -177.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 39.1 t -96.78 129.89 46.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 172.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 57.1 m -136.38 128.16 29.11 Favored 'General case' 0 C--N 1.293 -1.89 0 O-C-N 121.822 -0.549 . . . . 0.0 111.037 -178.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 53.5 tp -109.92 123.91 50.45 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -131.05 130.88 43.81 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . 0.425 ' HB3' HD21 ' A' ' 269' ' ' LEU . 17.7 ptt180 -79.51 137.18 37.1 Favored 'General case' 0 N--CA 1.415 -2.198 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.488 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 16.1 tp -99.96 -177.35 3.52 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.488 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 17.7 t-20 -45.22 -66.26 0.42 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.217 1.007 . . . . 0.0 112.078 -177.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -118.67 -3.54 10.82 Favored 'General case' 0 CA--C 1.498 -1.02 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.062 174.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -110.22 173.17 6.45 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.308 -170.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.408 ' HB ' HD13 ' A' ' 264' ' ' LEU . 86.5 m -115.19 131.96 56.76 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 174.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . 0.579 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 20.4 tt0 -124.84 130.82 53.13 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.172 -174.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 261' ' ' ILE . 1.2 mm? -94.71 142.27 27.65 Favored 'General case' 0 CA--C 1.467 -2.212 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.01 172.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 50.7 mt -129.01 108.51 17.19 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.568 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 172.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . 0.523 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 58.7 mt -114.14 103.38 15.27 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.813 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -177.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 5.5 m -75.79 129.93 37.81 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -174.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 15.4 p -128.38 172.18 11.34 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 122.587 0.355 . . . . 0.0 110.817 -177.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -156.22 137.53 13.86 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 90.69 -169.65 34.25 Favored Glycine 0 N--CA 1.436 -1.344 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -87.33 129.78 34.88 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 177.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' TRP . . . . . 0.662 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 57.4 p-90 -147.24 163.87 35.0 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.476 -174.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -125.63 142.64 51.41 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -178.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . 0.662 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 19.1 tp -116.87 139.35 50.73 Favored 'General case' 0 C--O 1.249 1.045 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.952 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.466 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 89.8 t -134.68 108.96 11.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 174.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . 0.586 ' HA ' ' O ' ' A' ' 321' ' ' THR . 19.7 t30 -98.45 129.28 45.06 Favored 'General case' 0 CA--C 1.454 -2.749 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.006 177.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -119.93 121.42 38.95 Favored 'General case' 0 N--CA 1.384 -3.763 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.932 -178.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 22.1 t -84.75 105.81 15.82 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 174.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -73.69 -36.93 65.34 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.717 0.77 . . . . 0.0 110.481 -176.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -156.32 162.5 27.37 Favored Pre-proline 0 C--N 1.295 -1.802 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 -177.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.39 96.19 0.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 121.505 1.47 . . . . 0.0 111.56 -178.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 125.72 -24.93 5.7 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 319' ' ' TYR . . . . . 1.667 ' HD2' ' CD1' ' A' ' 319' ' ' TYR . 91.8 m-85 -100.08 116.22 31.59 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 122.244 -0.562 . . . . 0.0 109.638 -179.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -116.45 164.97 13.77 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.811 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 321' ' ' THR . . . . . 0.586 ' O ' ' HA ' ' A' ' 312' ' ' ASN . 90.8 m -152.68 108.9 3.38 Favored 'General case' 0 C--N 1.275 -2.665 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.455 -173.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 1.655 ' HD2' ' CD1' ' A' ' 322' ' ' PHE . 81.2 m-85 -97.03 108.18 20.86 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . 0.466 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 37.0 tt0 -96.25 108.04 20.47 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -179.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -101.86 105.25 17.63 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 CA-C-O 121.3 0.572 . . . . 0.0 110.951 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.93 157.57 36.44 Favored Pre-proline 0 N--CA 1.466 0.346 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.57 131.81 8.56 Favored 'Trans proline' 0 C--O 1.246 0.925 0 C-N-CA 121.988 1.792 . . . . 0.0 110.133 172.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . 0.468 ' HE3' ' O ' ' A' ' 308' ' ' TRP . 41.0 ttmt . . . . . 0 C--N 1.303 -1.447 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.587 -175.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' GLN . . . . . 0.435 ' C ' HD21 ' A' ' 245' ' ' LEU . 5.6 tp60 . . . . . 0 CA--C 1.555 1.159 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' THR . . . . . 0.684 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 7.0 m -59.11 114.89 2.82 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -168.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -142.44 168.45 19.7 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.343 -177.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.2 pp -128.13 163.09 32.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.766 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -151.41 157.33 42.25 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' PHE . . . . . 1.638 ' HE1' ' CE2' ' A' ' 230' ' ' PHE . 87.7 t80 -129.7 135.47 48.53 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.31 177.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 -154.7 155.58 34.85 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 124.095 0.958 . . . . 0.0 108.993 177.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -105.27 157.74 17.09 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 175.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -155.72 153.06 29.35 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 72.8 -114.31 4.77 Favored Glycine 0 N--CA 1.437 -1.28 0 C-N-CA 121.189 -0.529 . . . . 0.0 111.785 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -134.53 93.91 3.12 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 120.539 0.209 . . . . 0.0 110.869 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' ASN . . . . . 0.409 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 93.4 m-20 66.93 17.6 10.54 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 174.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -82.15 140.4 33.79 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -99.31 113.49 4.74 Favored Glycine 0 N--CA 1.432 -1.604 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.3 mp -105.13 111.53 34.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 121.618 0.723 . . . . 0.0 110.263 -178.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.6 mp -97.93 112.66 30.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 174.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -89.3 143.77 26.59 Favored 'General case' 0 N--CA 1.408 -2.548 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 176.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 12.2 tp -133.14 130.39 39.15 Favored 'General case' 0 C--N 1.263 -3.175 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.099 -176.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' ALA . . . . . 0.684 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -116.86 102.24 9.22 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 176.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -109.43 91.15 3.53 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' LEU . . . . . 0.435 HD21 ' C ' ' A' ' 225' ' ' GLN . 2.7 mm? -77.68 113.18 15.27 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.547 -175.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 114.79 -10.85 21.06 Favored Glycine 0 C--N 1.298 -1.531 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.319 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' PHE . . . . . 1.668 ' HD2' ' CD1' ' A' ' 247' ' ' PHE . 21.7 t80 -100.73 124.31 46.17 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -178.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -103.82 -29.64 10.88 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -175.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -85.89 -161.51 35.18 Favored Glycine 0 CA--C 1.503 -0.68 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -103.48 143.02 25.79 Favored Pre-proline 0 C--N 1.303 -1.43 0 CA-C-N 117.847 0.824 . . . . 0.0 110.688 176.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.49 ' HB3' ' CD1' ' A' ' 264' ' ' LEU . 10.7 Cg_endo -64.6 172.03 7.4 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.108 2.539 . . . . 0.0 111.267 175.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -89.93 119.65 30.48 Favored 'General case' 0 C--N 1.274 -2.681 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 2.7 mp -102.46 127.65 55.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-O 121.57 0.7 . . . . 0.0 111.385 178.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' SER . . . . . 0.555 ' HB2' ' HB ' ' A' ' 261' ' ' ILE . 73.6 m -115.73 115.48 26.41 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 125.297 1.439 . . . . 0.0 108.217 175.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -101.15 113.85 27.26 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -175.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' GLN . . . . . 0.617 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 14.5 mm100 -116.92 166.03 12.64 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 174.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -77.07 -41.99 40.07 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.488 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -84.04 -14.75 49.79 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -174.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . 0.617 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 49.8 p-80 -171.77 162.31 6.17 Favored 'General case' 0 C--O 1.21 -0.995 0 CA-C-O 120.628 0.251 . . . . 0.0 111.041 175.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 19.5 mt -106.9 145.2 14.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 177.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' ILE . . . . . 0.555 ' HB ' ' HB2' ' A' ' 254' ' ' SER . 3.6 mp -122.11 123.4 68.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 175.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.422 ' HB ' ' HB2' ' A' ' 300' ' ' LEU . 37.8 t -124.7 128.19 73.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 298' ' ' THR . 7.6 m -124.27 124.04 41.55 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-O 121.538 0.685 . . . . 0.0 111.503 -177.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.49 ' CD1' ' HB3' ' A' ' 251' ' ' PRO . 1.9 mm? -95.32 103.13 14.98 Favored 'General case' 0 CA--C 1.47 -2.119 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 173.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' LYS . . . . . 0.525 ' HG3' ' OD2' ' A' ' 297' ' ' ASP . 17.3 ttmm -76.38 137.95 40.11 Favored 'General case' 0 N--CA 1.383 -3.788 0 O-C-N 123.72 0.638 . . . . 0.0 110.779 -177.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 8.7 t30 70.44 27.71 3.87 Favored 'General case' 0 CA--C 1.548 0.881 0 O-C-N 124.864 1.352 . . . . 0.0 109.957 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 36.1 t60 -124.27 108.02 11.8 Favored 'General case' 0 C--O 1.206 -1.185 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -178.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 7.2 p -90.48 114.66 26.88 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -176.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' LEU . . . . . 0.446 HD13 ' HD2' ' A' ' 270' ' ' PRO . 19.7 tp -93.3 133.19 28.87 Favored Pre-proline 0 C--N 1.318 -0.8 0 C-N-CA 123.077 0.551 . . . . 0.0 110.468 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' PRO . . . . . 0.446 ' HD2' HD13 ' A' ' 269' ' ' LEU . 80.9 Cg_endo -78.98 157.03 26.94 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.218 1.945 . . . . 0.0 112.117 173.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 23.6 p -62.36 -35.04 77.89 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -177.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 13.7 m -65.85 -18.3 65.24 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 123.707 0.803 . . . . 0.0 111.709 -176.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' LEU . . . . . 0.4 HD11 ' O ' ' A' ' 226' ' ' THR . 95.0 mt -105.21 -13.91 15.54 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.446 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -83.78 114.38 21.58 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -144.94 175.96 9.83 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -174.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 48.9 m -134.4 138.55 44.92 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-O 121.275 0.559 . . . . 0.0 110.177 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.516 ' O ' ' HG3' ' A' ' 288' ' ' LYS . 2.0 mm? -91.96 150.38 21.04 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 174.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -86.49 -60.69 1.92 Allowed 'General case' 0 C--N 1.274 -2.693 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' VAL . . . . . 0.551 HG13 ' CD2' ' A' ' 230' ' ' PHE 0.342 30.8 m 49.41 19.32 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 174.016 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -74.19 140.2 44.95 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 173.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 28.8 t70 73.77 16.92 3.71 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.935 1.294 . . . . 0.0 111.402 -178.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -80.61 -11.86 59.58 Favored 'General case' 0 CA--C 1.514 -0.414 0 O-C-N 121.351 -0.843 . . . . 0.0 111.016 173.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' LYS . . . . . 0.485 ' HZ2' ' HB2' ' A' ' 283' ' ' LYS . 0.2 OUTLIER 60.98 61.26 1.66 Allowed 'General case' 0 CA--C 1.497 -1.062 0 C-N-CA 123.336 0.654 . . . . 0.0 111.361 -178.419 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 1.6 p -137.6 168.06 17.97 Favored Pre-proline 0 C--N 1.292 -1.911 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 177.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 18.4 Cg_exo -69.46 -23.35 32.27 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 121.467 1.445 . . . . 0.0 110.822 176.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.0 p -85.31 122.31 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 CA-C-O 122.254 1.026 . . . . 0.0 110.401 179.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -89.23 -37.93 14.61 Favored 'General case' 0 C--N 1.284 -2.252 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.465 -174.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' ' 277' ' ' LEU . 56.3 tttp -159.47 137.6 10.36 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.67 -178.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 42.8 t -103.47 128.86 56.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' THR . . . . . 0.408 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 90.6 m -135.14 121.26 20.04 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 120.743 0.306 . . . . 0.0 110.591 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -101.08 122.96 44.49 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 177.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -119.56 135.26 54.87 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -176.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -83.58 142.59 30.73 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 174.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' LEU . . . . . 0.422 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 12.9 tp -120.13 -174.17 2.72 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 176.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' ASN . . . . . 0.422 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 20.2 t-20 -72.35 -51.55 20.09 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 118.908 0.776 . . . . 0.0 111.565 -172.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -115.55 -3.94 12.3 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.611 -177.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' ASP . . . . . 0.525 ' OD2' ' HG3' ' A' ' 265' ' ' LYS . 3.7 m-20 -133.13 169.3 17.06 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.58 0.705 . . . . 0.0 110.671 -170.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 263' ' ' THR . 62.6 m -113.37 126.74 55.69 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 172.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -119.71 122.57 41.75 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-O 121.441 0.639 . . . . 0.0 110.099 -173.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.422 ' HB2' ' HB ' ' A' ' 262' ' ' VAL . 0.1 OUTLIER -97.63 135.87 38.82 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.149 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 301' ' ' ILE . . . . . 0.408 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 48.7 mt -124.83 109.73 23.1 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 68.5 mt -114.65 101.24 12.11 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -178.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 21.0 m -68.91 134.14 49.17 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -177.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 10.6 p -136.98 167.32 21.72 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -177.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -148.87 151.16 34.21 Favored 'General case' 0 C--O 1.251 1.173 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.321 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 76.71 -157.18 47.13 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.087 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -99.98 141.99 32.06 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 176.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 308' ' ' TRP . . . . . . . . . . . . . 68.6 p-90 -154.84 167.58 29.79 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.756 -176.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -122.57 135.59 54.67 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 1.3 tt -104.69 113.99 27.92 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.715 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' VAL . . . . . 0.492 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 98.4 t -108.08 107.3 22.46 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 172.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -98.07 121.15 39.65 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.781 0.8 . . . . 0.0 110.429 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -122.91 148.62 45.23 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.777 -175.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 32.6 t -115.63 116.63 28.44 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 170.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -77.92 -34.83 51.14 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 122.152 0.977 . . . . 0.0 109.036 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -161.43 155.31 18.65 Favored Pre-proline 0 C--N 1.29 -2.016 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -60.73 94.93 0.11 Allowed 'Trans proline' 0 C--O 1.244 0.804 0 C-N-CA 122.239 1.96 . . . . 0.0 112.339 -176.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 136.16 -25.7 3.16 Favored Glycine 0 N--CA 1.433 -1.528 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.24 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 319' ' ' TYR . . . . . 1.611 ' HE2' ' CE1' ' A' ' 319' ' ' TYR . 96.0 m-85 -107.32 116.32 31.72 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -178.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -116.28 164.61 14.25 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-O 122.138 0.97 . . . . 0.0 111.037 -175.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 39.6 m -151.49 125.45 9.17 Favored 'General case' 0 C--N 1.269 -2.902 0 CA-C-N 114.394 -1.275 . . . . 0.0 108.893 -177.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 322' ' ' PHE . . . . . 1.632 ' HE2' ' CE1' ' A' ' 322' ' ' PHE . 68.1 m-85 -109.69 105.07 14.19 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 175.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 323' ' ' GLN . . . . . 0.492 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 7.3 tt0 -94.17 103.11 15.16 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -178.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 86.7 t -94.71 99.37 9.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.9 151.41 45.29 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -77.97 132.84 11.99 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 121.546 1.497 . . . . 0.0 110.513 174.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt . . . . . 0 CA--C 1.484 -1.582 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 178.584 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 46.4 tpp . . . . . 0 C--O 1.237 0.438 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 154.39 -177.59 31.67 Favored Glycine 0 N--CA 1.432 -1.598 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 17.5 p -94.47 -82.94 0.35 Allowed 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 116.857 0.328 . . . . 0.0 111.491 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 13.2 t -116.47 -14.67 10.94 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.349 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 50.8 m80 63.68 -164.01 0.26 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.115 0.566 . . . . 0.0 110.174 -176.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 19.8 p-80 52.99 34.0 16.0 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.417 1.087 . . . . 0.0 112.138 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -80.2 -34.59 37.26 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.262 -1.336 . . . . 0.0 109.247 -177.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -139.01 4.94 2.3 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.899 0.856 . . . . 0.0 109.081 176.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -127.04 96.01 4.48 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -64.69 -54.77 26.36 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.815 0.34 . . . . 0.0 110.549 -177.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 133.42 44.31 0.13 Allowed Glycine 0 N--CA 1.437 -1.283 0 C-N-CA 119.747 -1.216 . . . . 0.0 112.919 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 6.1 tt -85.85 110.74 19.61 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 29.1 m -103.38 115.82 63.16 Favored Pre-proline 0 C--N 1.301 -1.54 0 CA-C-O 120.861 0.362 . . . . 0.0 111.207 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -75.93 162.97 34.04 Favored 'Trans proline' 0 C--O 1.249 1.032 0 C-N-CA 122.306 2.004 . . . . 0.0 111.167 176.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -143.74 34.84 1.27 Allowed 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.027 0.441 . . . . 0.0 111.467 -176.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 128.61 -166.83 20.99 Favored Glycine 0 C--N 1.301 -1.393 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 37.8 t -126.63 164.92 20.19 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 117.148 0.474 . . . . 0.0 110.521 -177.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 29.3 m-70 -115.46 0.47 13.38 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 175.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 84.2 mtp -89.09 114.44 25.69 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.861 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -177.07 -27.77 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 124.657 1.183 . . . . 0.0 108.133 -176.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 7.4 m -55.05 129.11 36.71 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.785 1.234 . . . . 0.0 110.958 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 61.8 mtt -100.06 95.93 7.17 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 28.4 m -74.33 97.13 2.96 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 157.01 152.44 6.31 Favored Glycine 0 N--CA 1.417 -2.595 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -152.28 -56.65 0.01 OUTLIER Glycine 0 N--CA 1.428 -1.836 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -93.7 175.1 6.86 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 176.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -75.97 -62.74 1.5 Allowed 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 50.6 ttm -179.07 -55.55 0.01 OUTLIER 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.148 0.979 . . . . 0.0 110.031 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -157.97 -147.95 4.99 Favored Glycine 0 N--CA 1.432 -1.612 0 N-CA-C 111.614 -0.594 . . . . 0.0 111.614 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -130.15 -46.1 1.12 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 120.938 0.399 . . . . 0.0 111.028 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -117.71 38.89 2.79 Favored Glycine 0 C--N 1.308 -1.016 0 N-CA-C 107.767 -2.133 . . . . 0.0 107.767 176.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.7 p -86.0 86.11 7.36 Favored 'General case' 0 N--CA 1.412 -2.355 0 CA-C-N 114.126 -1.037 . . . . 0.0 113.418 -174.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -128.15 -79.24 0.58 Allowed 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 170.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -155.21 176.17 12.91 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 177.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.602 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 5.6 m -56.04 126.49 26.17 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 124.384 1.074 . . . . 0.0 113.42 -171.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -152.95 168.17 26.72 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 116.345 -0.389 . . . . 0.0 109.979 -177.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.8 pp -134.35 165.53 31.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 123.114 0.565 . . . . 0.0 112.164 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 9.4 t70 -149.89 156.36 41.63 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -133.88 134.63 42.93 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 176.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -152.32 171.61 17.73 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.425 ' HE3' HG21 ' A' ' 284' ' ' THR . 57.4 mtpt -118.98 148.57 42.84 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 175.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -144.68 143.23 30.63 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 123.436 0.46 . . . . 0.0 109.934 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 74.01 -98.81 1.0 Allowed Glycine 0 N--CA 1.435 -1.39 0 O-C-N 124.048 0.842 . . . . 0.0 111.89 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -146.15 98.6 3.12 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 120.761 0.315 . . . . 0.0 110.202 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 63.18 22.65 13.49 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 173.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -89.05 137.36 32.39 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -96.59 113.09 4.59 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 1.9 mp -106.42 121.36 58.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 117.237 0.519 . . . . 0.0 109.869 -177.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.5 mp -105.75 117.31 51.24 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.409 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 39.0 mt-10 -94.91 146.04 24.5 Favored 'General case' 0 C--N 1.284 -2.245 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.02 174.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 12.4 tp -134.36 128.87 34.53 Favored 'General case' 0 C--N 1.27 -2.88 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.133 -173.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . 0.602 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -118.44 101.77 8.41 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -109.42 91.47 3.66 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.541 0.686 . . . . 0.0 109.493 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.94 111.41 13.77 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.562 -175.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 107.87 9.18 28.81 Favored Glycine 0 N--CA 1.431 -1.634 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.451 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . 1.62 ' HE2' ' CE1' ' A' ' 247' ' ' PHE . 55.6 t80 -115.32 107.72 15.61 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 176.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -115.14 95.24 5.1 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.369 0.604 . . . . 0.0 109.784 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 165.55 -150.22 17.57 Favored Glycine 0 N--CA 1.425 -2.08 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -124.48 136.18 27.47 Favored Pre-proline 0 C--N 1.3 -1.572 0 CA-C-N 117.39 0.595 . . . . 0.0 110.339 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.432 ' HB3' ' CD2' ' A' ' 264' ' ' LEU . 10.6 Cg_endo -74.32 172.37 16.2 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 C-N-CA 122.505 2.137 . . . . 0.0 112.41 176.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.522 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 11.6 t70 -91.94 105.63 17.84 Favored 'General case' 0 C--N 1.284 -2.283 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 175.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.401 HD12 ' HG2' ' A' ' 251' ' ' PRO . 5.3 mp -103.43 124.14 57.44 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 C-N-CA 119.484 -0.887 . . . . 0.0 109.894 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 25.1 t -106.27 120.21 41.25 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -100.13 109.41 21.69 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.948 -178.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -124.42 162.5 23.75 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 174.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -73.57 -33.33 64.6 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 120.991 0.424 . . . . 0.0 110.124 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -70.78 -42.92 69.75 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.842 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . 0.457 ' CB ' ' HA ' ' A' ' 303' ' ' THR . 53.1 p-80 -169.42 167.55 9.91 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.472 0.177 . . . . 0.0 111.067 178.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 17.3 mt -106.21 139.5 27.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . 0.507 ' HA ' ' O ' ' A' ' 300' ' ' LEU . 3.4 mp -122.97 114.56 42.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 252' ' ' ASP . 0.8 OUTLIER -107.81 134.07 50.71 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 175.034 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 25.3 m -122.45 123.78 42.09 Favored 'General case' 0 C--N 1.267 -3.002 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.48 ' HB2' ' HB ' ' A' ' 298' ' ' THR . 29.6 mt -100.17 93.73 5.86 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.426 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 63.1 mmtt -63.1 126.94 29.03 Favored 'General case' 0 CA--C 1.478 -1.814 0 O-C-N 124.29 0.994 . . . . 0.0 113.075 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 9.8 t30 69.77 32.53 3.19 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.432 -1.713 . . . . 0.0 109.909 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -125.69 100.54 6.47 Favored 'General case' 0 C--O 1.2 -1.525 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 6.4 m -88.26 112.2 22.53 Favored 'General case' 0 C--N 1.277 -2.57 0 C-N-CA 119.635 -0.826 . . . . 0.0 111.889 -173.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . 0.439 HD23 HD21 ' A' ' 291' ' ' LEU . 37.6 tp -81.83 125.81 76.89 Favored Pre-proline 0 N--CA 1.444 -0.77 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.275 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -65.79 143.1 72.55 Favored 'Trans proline' 0 N--CA 1.44 -1.648 0 C-N-CA 122.105 1.87 . . . . 0.0 110.587 169.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 11.4 t -69.63 -12.71 61.86 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.388 0.613 . . . . 0.0 110.363 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 2.4 m -76.29 -16.57 59.76 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 123.961 0.904 . . . . 0.0 109.924 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.485 HD11 ' O ' ' A' ' 226' ' ' THR . 73.8 mt -110.88 -7.06 14.62 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.415 -177.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.498 ' HB2' ' O ' ' A' ' 291' ' ' LEU . 25.2 pt20 -81.35 115.64 20.81 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 119.101 -1.04 . . . . 0.0 109.61 -177.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 21.0 ptt180 -135.44 151.65 50.61 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 40.7 m -112.71 136.93 51.73 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.799 176.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.416 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 59.6 mt -105.67 116.47 32.0 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -61.02 -51.86 67.44 Favored 'General case' 0 C--N 1.311 -1.079 0 O-C-N 123.724 0.64 . . . . 0.0 110.419 -177.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . 0.263 26.9 m 46.19 25.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 116.856 2.169 . . . . 0.0 116.856 174.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -75.85 140.65 42.34 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 177.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 15.3 t70 73.02 20.99 3.31 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.701 1.2 . . . . 0.0 112.531 177.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 1.666 ' HD1' ' CD2' ' A' ' 282' ' ' PHE . 7.2 m-85 -79.74 -4.98 54.3 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.574 -0.704 . . . . 0.0 110.22 172.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 mptt 65.77 50.94 1.49 Allowed 'General case' 0 CA--C 1.503 -0.85 0 C-N-CA 124.248 1.019 . . . . 0.0 109.924 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' THR . . . . . 0.425 HG21 ' HE3' ' A' ' 232' ' ' LYS . 1.2 p -133.34 165.03 39.74 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -74.78 -4.91 16.12 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.196 1.931 . . . . 0.0 111.752 177.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 49.8 t -87.59 129.54 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -99.86 -30.35 12.08 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.208 -176.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 20.6 ttmm -167.13 143.79 4.47 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.416 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 43.3 t -112.64 130.22 66.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 174.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.474 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 98.2 m -136.18 117.87 15.0 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-O 121.262 0.554 . . . . 0.0 110.762 -178.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.498 ' O ' ' HB2' ' A' ' 274' ' ' GLN . 0.1 OUTLIER -91.47 114.13 26.58 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 104.244 -2.502 . . . . 0.0 104.244 174.861 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . 0.401 ' HD3' ' OE1' ' A' ' 274' ' ' GLN . 17.0 tppt? -116.15 129.6 56.4 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -177.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -78.42 140.37 38.68 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 175.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.527 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 21.7 tp -111.23 -173.14 2.17 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 175.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.527 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 3.2 t-20 -58.91 -66.66 0.47 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 119.172 0.896 . . . . 0.0 111.247 -177.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -115.86 -3.6 12.17 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 120.791 0.329 . . . . 0.0 111.147 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . 0.426 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 38.1 m-20 -115.23 172.69 6.92 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.397 0.618 . . . . 0.0 110.209 -177.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.48 ' HB ' ' HB2' ' A' ' 264' ' ' LEU . 92.8 m -116.98 132.11 56.79 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 176.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 42.1 tt0 -120.17 127.78 52.79 Favored 'General case' 0 N--CA 1.421 -1.894 0 C-N-CA 120.529 -0.469 . . . . 0.0 110.35 -175.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 261' ' ' ILE . 17.4 mt -100.08 127.7 46.27 Favored 'General case' 0 CA--C 1.443 -3.142 0 C-N-CA 120.127 -0.629 . . . . 0.0 111.462 172.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' ILE . . . . . 0.474 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 63.1 mt -115.19 109.23 27.65 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.373 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 50.9 mt -117.17 102.13 13.05 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.625 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' THR . . . . . 0.457 ' HA ' ' CB ' ' A' ' 259' ' ' HIS . 32.8 m -74.88 134.6 41.62 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.781 -175.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 19.0 p -133.74 179.72 6.06 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 123.189 0.595 . . . . 0.0 109.608 -177.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -159.59 148.47 17.86 Favored 'General case' 0 C--O 1.246 0.878 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 73.64 -142.4 31.05 Favored Glycine 0 C--O 1.243 0.675 0 O-C-N 123.613 0.571 . . . . 0.0 112.468 176.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -105.26 130.23 53.44 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' TRP . . . . . 0.675 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 60.7 p-90 -145.79 171.27 15.03 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -177.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -129.98 135.06 47.88 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.675 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 25.8 tp -111.25 120.95 43.97 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.269 -177.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.496 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 54.3 t -116.2 107.55 22.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 173.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -94.75 134.97 36.78 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -130.58 145.01 51.8 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.619 -176.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 15.9 m -115.85 118.53 33.25 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 172.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -87.28 -24.83 24.22 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.605 0.716 . . . . 0.0 110.41 -177.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -170.24 162.59 6.34 Favored Pre-proline 0 C--N 1.307 -1.241 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -65.17 95.99 0.26 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.493 1.462 . . . . 0.0 110.504 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 133.52 -33.36 2.58 Favored Glycine 0 N--CA 1.421 -2.35 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.628 -177.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . 1.65 ' HE2' ' CE1' ' A' ' 319' ' ' TYR . 36.5 m-85 -99.89 116.44 31.96 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 122.036 -0.685 . . . . 0.0 109.87 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -119.3 163.94 16.4 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.932 -177.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 78.7 m -152.09 139.93 19.96 Favored 'General case' 0 C--N 1.269 -2.894 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.261 -178.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 1.655 ' HD1' ' CD2' ' A' ' 322' ' ' PHE . 77.5 m-85 -126.43 112.4 15.57 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . 0.496 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 61.8 tt0 -97.37 109.7 22.4 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 91.7 t -98.38 99.31 8.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 C-N-CA 123.501 0.72 . . . . 0.0 109.687 179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -88.43 152.86 50.36 Favored Pre-proline 0 C--N 1.309 -1.153 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -80.35 128.67 7.22 Favored 'Trans proline' 0 C--O 1.252 1.209 0 C-N-CA 121.27 1.314 . . . . 0.0 109.956 171.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -85.45 101.8 12.93 Favored 'General case' 0 CA--C 1.471 -2.06 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -88.54 122.87 32.47 Favored 'General case' 0 C--N 1.271 -2.82 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.994 -169.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 . . . . . 0 C--N 1.293 -1.88 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 176.056 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 N--CA 1.475 0.825 0 CA-C-O 120.654 0.264 . . . . 0.0 111.374 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 102.43 34.93 4.0 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 7.7 m -130.91 20.81 4.97 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -178.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 15.6 m -61.0 -24.46 66.18 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -173.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 42.7 m170 -104.24 5.66 34.91 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -142.45 -67.0 0.38 Allowed 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 61.9 m80 74.86 170.06 0.29 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.158 1.383 . . . . 0.0 109.614 -177.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -86.35 77.36 9.51 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 171.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -52.63 -46.41 67.08 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.853 -1.067 . . . . 0.0 113.759 -168.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -115.94 25.11 10.96 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.749 0.785 . . . . 0.0 109.147 176.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -124.75 51.89 0.81 Allowed Glycine 0 N--CA 1.437 -1.276 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.504 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 96.9 mt -94.62 0.74 55.38 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.083 0.468 . . . . 0.0 110.216 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 7.7 p -113.37 102.24 54.56 Favored Pre-proline 0 C--N 1.305 -1.327 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.604 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.31 96.7 1.08 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.421 2.081 . . . . 0.0 108.792 172.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -108.34 -14.64 14.64 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.829 -172.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 140.98 -134.41 6.36 Favored Glycine 0 N--CA 1.436 -1.305 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.119 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 16.4 m -70.27 126.93 31.07 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 122.903 0.481 . . . . 0.0 110.598 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -113.72 108.32 16.95 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.204 0.526 . . . . 0.0 110.652 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 53.5 ttp -92.67 155.29 17.82 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . 70.42 170.55 0.31 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 124.625 1.17 . . . . 0.0 111.415 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 15.3 m -92.92 129.49 38.82 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -71.43 128.97 37.62 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 176.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 17.9 m -47.89 120.12 3.25 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.586 0.755 . . . . 0.0 111.299 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -177.08 41.17 0.1 OUTLIER Glycine 0 N--CA 1.438 -1.189 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -169.36 39.66 0.21 Allowed Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -94.29 -23.17 17.95 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.272 0.558 . . . . 0.0 110.323 -177.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . 0.429 ' HB3' ' HD2' ' A' ' 221' ' ' ARG . 21.8 mm-40 -135.39 32.68 3.08 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 123.786 0.835 . . . . 0.0 110.116 -176.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -69.41 -46.36 67.02 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.934 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -101.83 102.01 2.28 Favored Glycine 0 N--CA 1.431 -1.663 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . 0.429 ' HD2' ' HB3' ' A' ' 218' ' ' GLN . 66.2 mtp180 -124.21 98.89 5.97 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.029 0.442 . . . . 0.0 110.181 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -88.6 82.89 1.49 Allowed Glycine 0 C--N 1.3 -1.422 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 22.7 m -106.84 24.44 12.73 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 122.552 -0.381 . . . . 0.0 111.792 -175.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -64.73 -49.9 69.03 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . 0.407 ' C ' HD21 ' A' ' 245' ' ' LEU . 5.7 tp-100 -171.98 174.27 4.17 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 175.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 72.8 m -52.92 131.98 36.61 Favored 'General case' 0 C--O 1.208 -1.13 0 C-N-CA 124.178 0.991 . . . . 0.0 113.187 -172.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -162.54 175.59 11.29 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-O 121.023 0.44 . . . . 0.0 111.519 -174.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 1.8 pp -121.51 165.44 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.075 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . 0.403 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 6.6 t70 -150.37 152.16 33.96 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 1.596 ' HD1' ' CD2' ' A' ' 230' ' ' PHE . 88.6 t80 -134.06 127.59 32.52 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.098 176.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.449 ' HD3' ' HB ' ' A' ' 239' ' ' ILE . 0.3 OUTLIER -150.91 157.39 42.85 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.633 179.063 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -104.67 162.44 13.29 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . 0.457 ' O ' ' HB1' ' A' ' 237' ' ' ALA . 15.3 t70 -157.71 143.96 17.63 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 68.77 -118.89 9.36 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.486 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -135.35 111.89 9.93 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.97 0.385 . . . . 0.0 110.695 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 66.67 15.75 10.21 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.876 0.87 . . . . 0.0 112.403 174.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . 0.457 ' HB1' ' O ' ' A' ' 233' ' ' ASP . . . -92.41 132.04 37.09 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -103.35 113.91 4.67 Favored Glycine 0 CA--C 1.491 -1.427 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.449 ' HB ' ' HD3' ' A' ' 231' ' ' ARG . 2.4 mp -106.77 117.12 51.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-O 121.512 0.672 . . . . 0.0 110.263 -177.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.4 mp -101.08 109.04 24.59 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.403 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 43.1 mt-10 -89.73 132.81 35.0 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 176.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 8.9 tp -117.59 122.27 43.16 Favored 'General case' 0 C--N 1.269 -2.934 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.131 -174.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . 0.549 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -107.34 101.21 10.6 Favored 'General case' 0 N--CA 1.414 -2.259 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -106.8 91.87 3.85 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.615 0.722 . . . . 0.0 109.076 178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.407 HD21 ' C ' ' A' ' 225' ' ' GLN . 3.0 mm? -81.71 114.18 20.2 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.278 -175.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 103.42 22.75 8.86 Favored Glycine 0 C--N 1.297 -1.615 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.121 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . 0.403 ' HE1' ' O ' ' A' ' 265' ' ' LYS . 20.0 t80 -115.74 127.41 55.09 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -102.28 -21.05 14.41 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -174.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -104.18 -141.38 11.06 Favored Glycine 0 C--N 1.314 -0.685 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.841 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -127.59 142.5 44.32 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.436 ' HB3' HD11 ' A' ' 264' ' ' LEU . 18.0 Cg_endo -68.35 172.31 11.43 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.717 2.278 . . . . 0.0 112.853 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.53 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 20.3 t70 -96.02 119.86 35.28 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 175.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 4.6 mp -108.41 108.95 26.54 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-O 121.995 0.902 . . . . 0.0 111.232 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' SER . . . . . 0.485 ' HB2' ' HB ' ' A' ' 261' ' ' ILE . 47.4 m -96.47 104.83 16.83 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 114.163 -1.381 . . . . 0.0 109.198 177.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -88.1 118.25 27.54 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.865 -176.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -124.66 157.05 36.49 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 167.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 60.6 m80 -74.34 -29.79 61.74 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.926 -0.709 . . . . 0.0 111.202 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -69.65 -42.11 74.68 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.955 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -167.23 163.82 15.45 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.73 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 18.3 mt -105.48 142.02 19.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . 0.554 ' HA ' ' O ' ' A' ' 300' ' ' LEU . 3.8 mp -119.99 110.23 28.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 299' ' ' GLN . 0.8 OUTLIER -108.64 142.28 21.66 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.741 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' THR . . . . . 0.532 ' HA ' ' O ' ' A' ' 298' ' ' THR . 31.9 m -134.86 126.62 29.13 Favored 'General case' 0 C--N 1.275 -2.643 0 O-C-N 121.726 -0.609 . . . . 0.0 111.13 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.436 HD11 ' HB3' ' A' ' 251' ' ' PRO . 2.1 mm? -98.17 101.84 13.42 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 177.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.44 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 25.8 mmtm -67.65 130.94 44.58 Favored 'General case' 0 C--N 1.286 -2.178 0 O-C-N 124.033 0.833 . . . . 0.0 111.283 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 6.6 t30 73.84 21.59 2.67 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 124.678 1.236 . . . . 0.0 109.999 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -121.13 100.59 7.14 Favored 'General case' 0 CA--C 1.484 -1.581 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 3.7 m -90.2 121.03 31.86 Favored 'General case' 0 C--N 1.271 -2.828 0 C-N-CA 120.076 -0.649 . . . . 0.0 110.837 -175.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . 0.434 HD23 ' CD2' ' A' ' 291' ' ' LEU . 24.8 tp -92.76 127.3 48.47 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.242 -177.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.76 149.07 91.63 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.285 1.99 . . . . 0.0 110.989 170.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' THR . . . . . 0.577 ' O ' ' HG2' ' A' ' 274' ' ' GLN . 22.2 p -66.32 -25.35 66.79 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.336 -177.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 10.2 m -72.51 -18.52 61.65 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.508 0.67 . . . . 0.0 111.056 -177.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.498 HD11 ' O ' ' A' ' 226' ' ' THR . 82.1 mt -99.29 -19.12 17.23 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.497 -177.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.577 ' HG2' ' O ' ' A' ' 271' ' ' THR . 21.9 pt20 -76.82 137.69 39.38 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -173.42 169.48 4.39 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -174.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 3.1 p -123.99 132.86 53.76 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-O 121.478 0.656 . . . . 0.0 112.101 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 60.3 mt -100.58 113.06 25.56 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 104.34 -2.467 . . . . 0.0 104.34 175.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -63.41 -53.05 58.38 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -174.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 34.5 m 44.71 37.05 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 176.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -69.4 133.42 47.77 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 20.2 t70 61.9 36.15 16.0 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 125.005 1.322 . . . . 0.0 110.692 177.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 1.617 ' HD1' ' CD2' ' A' ' 282' ' ' PHE . 0.2 OUTLIER -79.26 0.38 28.91 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.703 179.407 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt 69.01 59.03 0.35 Allowed 'General case' 0 CA--C 1.497 -1.095 0 C-N-CA 125.388 1.475 . . . . 0.0 111.478 177.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.35 152.66 11.02 Favored Pre-proline 0 C--N 1.295 -1.767 0 CA-C-N 113.851 -1.522 . . . . 0.0 108.675 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . 0.415 ' O ' ' HA ' ' A' ' 304' ' ' THR . 54.0 Cg_exo -50.14 -24.77 11.75 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.713 2.942 . . . . 0.0 113.55 175.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 46.9 t -74.06 118.33 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -94.64 -29.11 15.01 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.891 -178.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -170.21 135.23 1.29 Allowed 'General case' 0 N--CA 1.478 0.93 0 O-C-N 123.665 0.603 . . . . 0.0 110.863 -177.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 40.2 t -104.3 135.96 39.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.402 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 90.2 m -143.19 123.64 13.93 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 121.461 0.648 . . . . 0.0 111.09 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.434 ' CD2' HD23 ' A' ' 269' ' ' LEU . 0.1 OUTLIER -98.06 120.37 38.35 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 176.436 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . 0.483 ' HD3' ' OE1' ' A' ' 274' ' ' GLN . 4.0 tppp? -128.76 135.88 49.8 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -79.99 145.01 32.78 Favored 'General case' 0 N--CA 1.426 -1.627 0 C-N-CA 118.858 -1.137 . . . . 0.0 109.273 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.529 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 18.0 tp -108.44 -174.08 2.43 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 177.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.529 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 20.6 t-20 -56.65 -67.47 0.3 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.559 0.618 . . . . 0.0 111.688 -177.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -110.03 -4.28 15.97 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.825 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . 0.44 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 36.2 m-20 -119.81 176.4 5.42 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.599 0.714 . . . . 0.0 111.511 -169.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 263' ' ' THR . 90.1 m -113.73 133.4 55.37 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 176.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . 0.593 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 26.3 tt0 -124.08 132.07 53.62 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.13 -175.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.554 ' O ' ' HA ' ' A' ' 261' ' ' ILE . 25.4 mt -101.69 131.92 47.67 Favored 'General case' 0 CA--C 1.451 -2.86 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.967 173.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' ILE . . . . . 0.402 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 63.6 mt -116.26 108.63 25.6 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.697 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 175.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 65.2 mt -115.98 104.16 16.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 3.5 m -72.51 130.03 39.7 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 123.126 0.57 . . . . 0.0 109.641 -175.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 285' ' ' PRO . 8.7 p -136.02 176.71 8.44 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 122.319 0.248 . . . . 0.0 110.905 -178.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -147.73 148.94 31.52 Favored 'General case' 0 C--O 1.245 0.857 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 61.38 -148.61 46.61 Favored Glycine 0 N--CA 1.463 0.444 0 O-C-N 123.933 0.771 . . . . 0.0 113.089 177.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -97.72 144.4 27.39 Favored 'General case' 0 CA--C 1.47 -2.121 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' TRP . . . . . 0.652 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 65.9 p-90 -157.94 170.77 21.58 Favored 'General case' 0 C--N 1.27 -2.851 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -178.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . 0.428 ' HG2' ' HE2' ' A' ' 327' ' ' LYS . 4.6 mt-10 -122.26 129.83 52.6 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -176.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.652 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 23.3 tp -105.65 117.81 34.96 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 120.996 0.427 . . . . 0.0 111.207 -176.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.455 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 48.8 t -114.63 107.36 22.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 174.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -94.18 126.61 39.52 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . 0.407 ' HB2' ' HB ' ' A' ' 321' ' ' THR . 95.3 mttt -119.83 149.45 42.04 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.964 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 23.9 t -115.97 114.59 24.83 Favored 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 172.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -80.18 -32.35 38.73 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.572 0.701 . . . . 0.0 109.561 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -168.76 162.18 8.25 Favored Pre-proline 0 C--N 1.305 -1.355 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.5 102.19 0.33 Allowed 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 121.532 1.488 . . . . 0.0 110.497 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 129.73 -32.43 3.18 Favored Glycine 0 N--CA 1.427 -1.954 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -177.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . 1.669 ' HD1' ' CD2' ' A' ' 319' ' ' TYR . 30.8 m-85 -102.77 116.59 32.88 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . 1.636 ' HE2' ' CE1' ' A' ' 320' ' ' PHE . 90.3 m-85 -119.16 161.79 19.74 Favored 'General case' 0 C--N 1.277 -2.546 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.292 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.407 ' HB ' ' HB2' ' A' ' 313' ' ' LYS . 89.4 m -151.62 124.93 8.79 Favored 'General case' 0 C--N 1.263 -3.16 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.74 -174.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' A' ' 239' ' ' ILE . 69.9 m-85 -112.4 109.98 19.92 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . 0.455 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 8.8 tt0 -96.73 105.72 17.89 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.606 HG13 ' CE3' ' A' ' 308' ' ' TRP . 94.0 t -95.01 100.41 11.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 C-N-CA 123.42 0.688 . . . . 0.0 110.228 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -92.42 153.33 42.74 Favored Pre-proline 0 C--N 1.313 -0.984 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -73.09 140.71 31.61 Favored 'Trans proline' 0 C--O 1.249 1.046 0 C-N-CA 121.765 1.643 . . . . 0.0 110.4 172.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . 0.428 ' HE2' ' HG2' ' A' ' 309' ' ' GLU . 14.8 ttmm -100.54 125.72 46.91 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -176.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -93.53 98.92 11.49 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 173.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' GLN . . . . . 0.427 ' H ' ' NE2' ' A' ' 329' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.286 -2.176 0 CA-C-O 118.646 -0.692 . . . . 0.0 109.723 -177.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 69.3 mtm . . . . . 0 CA--C 1.519 -0.237 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 150.51 176.52 23.58 Favored Glycine 0 N--CA 1.439 -1.107 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -178.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 38.8 m -103.44 130.42 50.77 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 117.836 0.818 . . . . 0.0 110.052 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 36.4 t -174.46 -41.36 0.01 OUTLIER 'General case' 0 C--O 1.235 0.326 0 O-C-N 123.469 0.481 . . . . 0.0 110.25 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 71.8 5.09 5.26 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.376 1.07 . . . . 0.0 110.642 -177.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 28.4 t60 58.6 70.69 0.63 Allowed 'General case' 0 C--O 1.241 0.62 0 C-N-CA 125.081 1.352 . . . . 0.0 109.961 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -150.5 121.26 7.54 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -177.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 -68.88 132.24 46.41 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.134 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -92.67 -16.97 24.9 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.283 0.563 . . . . 0.0 111.396 -175.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -115.61 135.56 53.94 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 149.31 13.27 0.11 Allowed Glycine 0 C--N 1.312 -0.805 0 C-N-CA 119.678 -1.249 . . . . 0.0 113.255 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 79.3 mt -102.13 14.06 33.0 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.987 0.422 . . . . 0.0 111.012 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.408 ' O ' ' HD2' ' A' ' 206' ' ' ARG . 55.2 t -62.13 -44.84 90.41 Favored Pre-proline 0 CA--C 1.566 1.565 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.715 176.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -86.94 90.31 0.6 Allowed 'Trans proline' 0 N--CA 1.429 -2.269 0 CA-C-N 120.293 1.14 . . . . 0.0 110.517 170.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.408 ' HD2' ' O ' ' A' ' 204' ' ' VAL . 4.0 mpt_? -76.2 -37.12 58.22 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 162.39 65.82 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 8.4 t -114.39 10.84 17.12 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-O 121.361 0.601 . . . . 0.0 109.763 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -95.67 0.66 52.91 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.359 0.6 . . . . 0.0 110.382 173.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -154.59 118.55 4.67 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 105.842 -1.911 . . . . 0.0 105.842 177.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . 70.74 103.44 0.06 Allowed 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.701 1.201 . . . . 0.0 111.831 -177.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 18.8 m 67.68 86.79 0.13 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.24 -1.346 . . . . 0.0 112.646 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 65.2 mtm -87.31 89.78 8.12 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 6.7 m -151.68 9.31 0.53 Allowed 'General case' 0 CA--C 1.558 1.251 0 CA-C-O 121.828 0.823 . . . . 0.0 109.83 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 81.67 -62.9 4.45 Favored Glycine 0 C--O 1.242 0.608 0 O-C-N 121.685 -0.634 . . . . 0.0 111.92 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 140.28 25.38 0.25 Allowed Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.957 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -104.44 -70.52 0.77 Allowed 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 119.904 -0.719 . . . . 0.0 109.672 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -91.76 84.79 5.47 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 17.1 tpt -166.28 122.47 1.28 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.314 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -82.34 62.96 4.5 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 177.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 12.9 ttp180 -84.49 133.17 34.48 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 174.28 -87.88 0.08 OUTLIER Glycine 0 N--CA 1.422 -2.254 0 N-CA-C 108.425 -1.87 . . . . 0.0 108.425 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 15.6 m -77.24 103.23 7.05 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 174.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -125.57 -9.54 6.82 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.748 0.785 . . . . 0.0 109.656 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 8.1 pm0 -122.72 148.54 45.19 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.426 -175.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 28.7 m -59.93 128.62 37.78 Favored 'General case' 0 C--O 1.209 -1.028 0 O-C-N 124.121 0.888 . . . . 0.0 109.01 -179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -148.03 155.95 42.08 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.082 -170.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.7 pp -137.48 149.68 25.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 C-N-CA 124.134 0.974 . . . . 0.0 108.872 179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -149.76 156.6 42.12 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 122.789 0.436 . . . . 0.0 111.038 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -127.0 139.18 53.21 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 120.97 0.414 . . . . 0.0 111.01 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 20.5 ptt85 -157.04 161.68 39.52 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 173.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 53.2 mtpt -105.64 144.91 31.73 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 177.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . 0.524 ' O ' ' HB1' ' A' ' 237' ' ' ALA . 21.7 t70 -159.76 117.38 2.66 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -176.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 104.12 -157.14 17.25 Favored Glycine 0 C--N 1.296 -1.694 0 C-N-CA 120.203 -0.998 . . . . 0.0 111.179 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -91.53 97.49 11.09 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 116.7 0.25 . . . . 0.0 110.391 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.513 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 3.4 m-20 60.92 23.26 13.36 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 124.197 0.936 . . . . 0.0 111.396 177.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . 0.524 ' HB1' ' O ' ' A' ' 233' ' ' ASP . . . -87.11 136.91 32.75 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.491 -174.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -101.94 116.51 5.55 Favored Glycine 0 N--CA 1.427 -1.915 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.1 mp -106.52 114.87 46.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-O 121.34 0.591 . . . . 0.0 111.127 -175.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.3 mp -103.49 112.77 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 176.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -94.4 138.77 31.95 Favored 'General case' 0 C--N 1.277 -2.549 0 CA-C-O 121.363 0.601 . . . . 0.0 109.487 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 12.0 tp -127.49 131.04 50.2 Favored 'General case' 0 C--N 1.269 -2.924 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.392 -175.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . . . . . . . . . . . -122.37 102.18 7.95 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.013 178.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -108.84 91.07 3.49 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -73.15 109.72 6.89 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -173.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 111.99 -4.64 27.23 Favored Glycine 0 C--N 1.304 -1.204 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.132 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -94.62 107.73 19.71 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -108.58 97.11 6.82 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 160.74 -147.78 15.02 Favored Glycine 0 C--N 1.297 -1.604 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -126.74 135.65 27.61 Favored Pre-proline 0 C--N 1.311 -1.095 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.492 ' HB3' ' CD1' ' A' ' 264' ' ' LEU . 13.7 Cg_endo -70.38 171.98 14.11 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.361 2.041 . . . . 0.0 109.901 176.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -91.13 110.26 21.53 Favored 'General case' 0 C--N 1.27 -2.878 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 175.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 3.8 mp -97.73 108.46 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.76 0 CA-C-O 121.605 0.717 . . . . 0.0 109.57 178.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' SER . . . . . 0.507 ' HB2' ' HB ' ' A' ' 261' ' ' ILE . 31.8 m -102.99 110.76 22.79 Favored 'General case' 0 C--N 1.282 -2.369 0 CA-C-N 114.473 -1.24 . . . . 0.0 108.274 175.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . 0.428 HE21 HD21 ' A' ' 310' ' ' LEU . 70.4 mt-30 -100.18 117.36 34.26 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.48 -172.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -125.1 162.57 24.29 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 172.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -76.53 -31.16 57.48 Favored 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 119.015 -1.074 . . . . 0.0 112.068 178.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -73.91 -30.94 62.86 Favored 'General case' 0 C--N 1.319 -0.744 0 O-C-N 123.661 0.6 . . . . 0.0 111.476 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 39.4 p-80 -172.78 165.13 5.29 Favored 'General case' 0 CA--C 1.503 -0.864 0 O-C-N 122.252 -0.28 . . . . 0.0 110.623 175.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 18.4 mt -106.29 140.86 23.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . 0.507 ' HB ' ' HB2' ' A' ' 254' ' ' SER . 3.5 mp -116.64 108.69 25.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 299' ' ' GLN . 49.1 t -105.66 131.54 54.82 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.492 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 177.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' THR . . . . . 0.613 ' HA ' ' O ' ' A' ' 298' ' ' THR . 26.6 m -134.46 126.17 28.92 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 121.289 0.566 . . . . 0.0 111.066 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.492 ' CD1' ' HB3' ' A' ' 251' ' ' PRO . 2.0 mm? -98.38 108.58 21.31 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.496 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 30.5 mmmt -67.75 131.58 45.83 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-O 121.526 0.679 . . . . 0.0 112.384 -178.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 74.91 1.96 3.9 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 113.379 -1.737 . . . . 0.0 111.294 176.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -94.68 110.65 22.47 Favored 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -178.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 1.2 p -82.73 135.67 34.93 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-O 121.074 0.464 . . . . 0.0 111.405 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 270' ' ' PRO . 26.8 tp -112.88 124.11 32.36 Favored Pre-proline 0 N--CA 1.425 -1.698 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.125 176.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . 0.412 ' O ' ' HG ' ' A' ' 269' ' ' LEU . 23.3 Cg_exo -70.77 160.08 50.58 Favored 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 122.619 2.213 . . . . 0.0 111.659 170.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 3.6 p -66.95 -26.19 66.71 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 123.803 0.841 . . . . 0.0 111.456 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 6.7 m -64.23 -23.6 67.37 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.01 1.324 . . . . 0.0 112.438 -177.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -99.47 -8.92 24.02 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-O 121.344 0.592 . . . . 0.0 111.707 -174.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -72.96 138.67 46.24 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.288 -0.869 . . . . 0.0 108.803 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -169.09 170.9 8.5 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 177.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 62.0 m -130.8 152.54 50.03 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-O 121.394 0.616 . . . . 0.0 110.302 176.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.423 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 1.8 mm? -111.98 108.91 18.41 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 105.998 -1.852 . . . . 0.0 105.998 177.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -80.72 85.52 6.07 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 122.444 1.116 . . . . 0.0 109.213 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . 0.606 ' HA ' ' CE1' ' A' ' 282' ' ' PHE . 87.8 t -89.63 36.69 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-N 113.364 -1.744 . . . . 0.0 111.619 -173.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -80.84 142.5 33.6 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.432 174.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 18.6 t70 72.51 20.49 3.89 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 122.673 1.225 . . . . 0.0 110.259 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.606 ' CE1' ' HA ' ' A' ' 279' ' ' VAL . 21.1 m-85 -90.3 -18.4 25.66 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.588 -0.695 . . . . 0.0 110.589 176.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 65.39 35.02 7.71 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.691 0.796 . . . . 0.0 111.841 176.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 2.3 p -115.58 174.91 2.13 Favored Pre-proline 0 C--N 1.3 -1.558 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . 0.513 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 9.2 Cg_exo -75.57 -15.2 19.66 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.764 1.643 . . . . 0.0 111.693 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.8 p -93.21 128.74 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-O 121.639 0.733 . . . . 0.0 109.87 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -94.51 -39.61 10.31 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.155 -174.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -160.14 134.52 7.49 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.541 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 40.6 t -99.39 123.77 52.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 87.5 m -130.11 122.91 29.17 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 120.852 0.358 . . . . 0.0 110.885 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 46.5 tp -99.74 125.06 45.57 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -124.4 139.12 54.2 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -175.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -83.66 148.54 27.05 Favored 'General case' 0 C--N 1.289 -2.061 0 C-N-CA 118.832 -1.147 . . . . 0.0 108.218 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.469 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 17.8 tp -115.73 -174.49 2.54 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 173.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.469 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 4.6 t30 -76.0 -55.23 5.8 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 120.07 1.305 . . . . 0.0 111.891 -173.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -107.36 -8.91 16.17 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.686 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . 0.496 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 29.3 m-20 -132.1 173.12 11.56 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.975 -171.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.613 ' O ' ' HA ' ' A' ' 263' ' ' THR . 79.1 m -110.7 132.96 53.74 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 32.7 tt0 -117.14 126.62 53.09 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.799 0.809 . . . . 0.0 110.112 -177.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.405 ' CB ' ' HB ' ' A' ' 262' ' ' VAL . 0.5 OUTLIER -110.89 122.82 48.83 Favored 'General case' 0 C--N 1.274 -2.689 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.211 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 72.9 mt -109.12 109.22 27.56 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.368 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -177.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 59.9 mt -110.48 98.9 7.65 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 10.9 m -69.53 126.03 28.49 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 17.3 p -136.26 165.79 24.93 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 122.85 0.46 . . . . 0.0 110.98 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -149.63 138.68 21.19 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-O 120.631 0.253 . . . . 0.0 111.468 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 90.29 -168.28 33.53 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.242 176.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -84.12 127.81 34.15 Favored 'General case' 0 CA--C 1.482 -1.654 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' TRP . . . . . 0.631 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 68.4 p-90 -144.53 169.5 17.84 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -178.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -125.53 123.81 39.95 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -174.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.631 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 17.7 tp -100.19 122.36 42.89 Favored 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.137 -178.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.493 ' CG1' ' HB3' ' A' ' 323' ' ' GLN . 8.6 p -126.1 114.98 41.11 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-O 121.723 0.773 . . . . 0.0 109.558 171.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -102.51 129.9 49.18 Favored 'General case' 0 CA--C 1.437 -3.366 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.496 179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -114.35 123.61 49.92 Favored 'General case' 1 N--CA 1.372 -4.334 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.874 -176.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 16.3 m -92.06 103.03 15.57 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 176.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -78.38 -34.15 48.4 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.88 -1.055 . . . . 0.0 112.539 -172.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.413 ' HB2' ' HD2' ' A' ' 317' ' ' PRO . . . -165.75 167.38 9.06 Favored Pre-proline 0 C--N 1.307 -1.273 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 -175.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 316' ' ' ALA . 25.2 Cg_endo -60.31 102.96 0.2 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.031 1.821 . . . . 0.0 112.088 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 105.83 -15.25 44.89 Favored Glycine 0 N--CA 1.436 -1.331 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.181 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . 1.663 ' HD1' ' CD2' ' A' ' 319' ' ' TYR . 94.0 m-85 -100.89 116.79 33.6 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 122.196 -0.59 . . . . 0.0 110.698 -178.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . 0.482 ' CZ ' ' HD3' ' A' ' 251' ' ' PRO . 75.2 m-85 -122.49 163.65 19.5 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.975 -177.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 88.4 m -152.8 110.66 3.62 Favored 'General case' 0 C--N 1.265 -3.076 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.194 -175.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -98.01 104.35 16.37 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . 0.493 ' HB3' ' CG1' ' A' ' 311' ' ' VAL . 42.6 tt0 -94.96 108.2 20.25 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 93.3 t -94.86 99.87 10.14 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.302 -178.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.3 152.51 47.81 Favored Pre-proline 0 C--O 1.213 -0.836 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -77.33 137.39 16.78 Favored 'Trans proline' 0 C--O 1.249 1.069 0 C-N-CA 121.565 1.51 . . . . 0.0 110.18 172.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -84.31 126.29 33.06 Favored 'General case' 0 CA--C 1.468 -2.205 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.742 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 24.7 mtmm -95.19 26.93 3.47 Favored 'General case' 0 C--N 1.271 -2.836 0 CA-C-N 113.817 -1.538 . . . . 0.0 110.942 -170.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 . . . . . 0 C--N 1.294 -1.84 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.648 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 N--CA 1.467 0.39 0 CA-C-O 120.586 0.232 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -142.34 30.89 2.08 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.32 -178.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 14.5 t -123.19 11.51 9.45 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 176.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 15.0 m -78.78 93.55 4.98 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.43 -176.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.577 ' HA ' ' O ' ' A' ' 199' ' ' HIS . 12.1 p-80 -95.53 80.56 3.47 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.373 -0.83 . . . . 0.0 113.215 -174.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -92.13 -58.54 2.36 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 175.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -155.6 20.18 0.4 Allowed 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 174.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . 0.577 ' O ' ' HA ' ' A' ' 196' ' ' HIS . 93.7 m-70 -155.49 173.94 15.97 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 103.801 -2.666 . . . . 0.0 103.801 178.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -100.65 -36.82 9.01 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.789 0.804 . . . . 0.0 109.588 173.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -121.47 -53.85 1.99 Allowed 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 83.46 -152.42 29.17 Favored Glycine 0 N--CA 1.424 -2.12 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 -176.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.4 tt 61.35 42.88 11.2 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 8.9 p -164.4 130.5 2.2 Favored Pre-proline 0 C--N 1.313 -1.013 0 CA-C-N 114.196 -1.366 . . . . 0.0 107.575 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -70.16 94.96 0.57 Allowed 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 122.013 1.809 . . . . 0.0 112.491 -178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 34.1 mmt180 -132.21 94.26 3.42 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.782 176.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -137.83 -156.44 7.19 Favored Glycine 0 N--CA 1.425 -2.054 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.9 p -113.33 160.56 18.23 Favored 'General case' 0 C--N 1.28 -2.437 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -73.74 106.86 5.67 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 174.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 23.5 ttt 74.39 148.28 0.09 Allowed 'General case' 0 C--O 1.251 1.184 0 O-C-N 124.448 1.093 . . . . 0.0 110.528 -174.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . 0.416 ' HB2' ' HG2' ' A' ' 217' ' ' GLN . . . -77.57 92.98 4.11 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 173.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 22.4 t -108.43 40.09 1.85 Allowed 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.969 -172.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 57.4 mtm 65.49 22.7 11.86 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.041 0.924 . . . . 0.0 108.972 -176.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 1.4 p -91.35 31.28 1.16 Allowed 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 125.92 1.688 . . . . 0.0 110.499 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 152.81 -174.36 31.63 Favored Glycine 0 N--CA 1.411 -2.99 0 N-CA-C 108.456 -1.858 . . . . 0.0 108.456 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -76.7 118.65 5.26 Favored Glycine 0 N--CA 1.425 -2.074 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 176.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . 0.416 ' HG2' ' HB2' ' A' ' 211' ' ' ALA . 22.9 mt-30 -78.99 -30.84 44.58 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.007 0.432 . . . . 0.0 109.939 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -121.2 83.74 2.13 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 173.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 66.2 mtm -89.35 -51.69 5.43 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 175.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 72.7 157.87 4.0 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 114.357 -1.292 . . . . 0.0 114.011 176.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -162.24 3.0 0.05 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.321 -0.439 . . . . 0.0 111.096 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 77.88 18.52 76.89 Favored Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.941 -177.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.6 m -129.08 6.81 5.44 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.39 0.614 . . . . 0.0 110.388 -176.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -96.3 101.6 13.26 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 69.4 173.89 0.29 Allowed 'General case' 0 CA--C 1.555 1.167 0 O-C-N 125.02 1.45 . . . . 0.0 110.62 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 24.4 m -57.16 114.34 2.11 Favored 'General case' 0 C--O 1.198 -1.633 0 C-N-CA 123.679 0.792 . . . . 0.0 111.866 -171.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -130.96 160.21 35.19 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.812 -169.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.2 pp -128.97 151.74 36.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 124.286 1.034 . . . . 0.0 109.762 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 5.0 t70 -143.47 156.5 44.65 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -176.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 1.646 ' HD1' ' CD2' ' A' ' 230' ' ' PHE . 77.3 t80 -137.91 139.32 39.75 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 110.27 -0.271 . . . . 0.0 110.27 178.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -165.1 175.01 9.75 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 123.952 0.901 . . . . 0.0 108.743 178.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.407 ' HE3' HG21 ' A' ' 284' ' ' THR . 54.5 mtpt -121.82 159.36 26.91 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 117.803 0.274 . . . . 0.0 110.552 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -164.38 148.23 9.46 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 82.43 -103.35 2.4 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 121.475 -0.393 . . . . 0.0 113.588 173.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -135.87 72.22 1.44 Allowed 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.14 0.495 . . . . 0.0 111.524 -176.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.451 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 86.0 m-20 67.16 27.52 8.48 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.131 179.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -82.88 143.15 30.95 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.824 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -98.13 117.74 5.92 Favored Glycine 0 N--CA 1.437 -1.264 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 230' ' ' PHE . 2.3 mp -105.59 118.64 53.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-N 117.318 0.559 . . . . 0.0 110.288 -177.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.89 111.61 36.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 175.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.482 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 49.6 mt-10 -92.76 138.8 31.18 Favored 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 177.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 13.9 tp -121.91 117.48 26.56 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.358 -176.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -106.19 94.4 5.14 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -102.7 91.34 4.14 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.813 0.816 . . . . 0.0 109.98 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.485 ' N ' HD21 ' A' ' 245' ' ' LEU . 2.9 mm? -76.62 116.38 17.24 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.165 -176.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 114.1 -7.55 23.29 Favored Glycine 0 N--CA 1.429 -1.831 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.762 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . 1.663 ' HD2' ' CD1' ' A' ' 247' ' ' PHE . 24.5 t80 -102.48 145.79 29.06 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -136.09 -12.86 1.9 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.511 0.559 . . . . 0.0 112.511 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -92.5 -140.61 9.76 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.991 -178.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -122.72 134.25 24.88 Favored Pre-proline 0 C--N 1.311 -1.092 0 CA-C-O 120.517 0.199 . . . . 0.0 110.617 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.434 ' HB3' HD21 ' A' ' 264' ' ' LEU . 32.1 Cg_endo -77.79 172.43 15.7 Favored 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 122.66 2.24 . . . . 0.0 112.36 177.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -95.87 111.26 23.29 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.462 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 3.8 mp -105.48 124.72 60.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 8.8 t -115.94 117.44 30.15 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 174.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -99.76 107.16 19.16 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 121.187 0.518 . . . . 0.0 111.923 -176.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.45 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 27.2 mt-30 -115.87 161.12 19.26 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 175.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -73.91 -31.37 63.05 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.084 179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -80.91 -26.54 36.72 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.707 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . 0.45 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 35.5 p-80 -174.03 161.48 3.66 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 120.878 0.37 . . . . 0.0 111.821 175.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 14.9 mt -106.67 142.75 18.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 177.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . 0.403 HD13 ' N ' ' A' ' 261' ' ' ILE . 3.1 mp -122.46 116.34 48.7 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.456 ' HB ' ' HB3' ' A' ' 300' ' ' LEU . 24.3 t -113.86 119.74 61.87 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 175.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 10.4 m -116.86 123.79 47.92 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 121.181 0.515 . . . . 0.0 110.168 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.437 ' HB2' ' HB ' ' A' ' 298' ' ' THR . 21.2 mt -99.02 99.77 10.84 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.578 ' HD3' ' OD1' ' A' ' 297' ' ' ASP . 48.7 mmtt -61.28 129.34 40.77 Favored 'General case' 0 C--N 1.317 -0.815 0 O-C-N 124.147 0.904 . . . . 0.0 113.398 -177.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 63.4 t30 67.59 22.54 9.11 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.839 175.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 48.4 t60 -110.25 112.08 23.81 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 18.4 p -86.27 124.46 32.67 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-O 121.251 0.548 . . . . 0.0 111.451 -178.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 32.6 tp -99.01 127.63 34.49 Favored Pre-proline 0 N--CA 1.418 -2.064 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.699 177.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.87 147.31 55.43 Favored 'Trans proline' 0 N--CA 1.432 -2.092 0 C-N-CA 121.382 1.388 . . . . 0.0 110.692 170.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 25.0 p -66.64 -15.06 63.2 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.424 0.63 . . . . 0.0 112.075 -177.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 12.2 m -74.58 -21.18 59.62 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.743 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 226' ' ' THR . 3.1 mm? -102.11 -13.97 17.27 Favored 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.077 -178.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -77.11 129.78 36.48 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 119.563 -0.855 . . . . 0.0 108.996 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -170.44 159.96 7.24 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -177.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 16.9 p -104.22 140.21 38.15 Favored 'General case' 0 N--CA 1.407 -2.613 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.735 173.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 82.4 mt -99.59 117.29 33.65 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 175.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -47.35 -68.97 0.14 Allowed 'General case' 0 C--N 1.316 -0.85 0 O-C-N 125.085 1.491 . . . . 0.0 110.594 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . 0.271 19.0 m 49.78 18.32 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 127.111 2.164 . . . . 0.0 116.697 173.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -73.75 132.79 43.01 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 22.2 t70 68.77 48.64 0.75 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 122.674 1.226 . . . . 0.0 112.327 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 1.658 ' HD1' ' CD2' ' A' ' 282' ' ' PHE . 4.8 m-85 -98.08 -1.62 42.0 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 168.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? 61.86 59.94 1.65 Allowed 'General case' 0 CA--C 1.503 -0.86 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.825 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' THR . . . . . 0.407 HG21 ' HE3' ' A' ' 232' ' ' LYS . 2.5 p -137.42 176.65 2.6 Favored Pre-proline 0 C--N 1.31 -1.14 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 3.3 Cg_exo -82.66 -7.1 11.6 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.077 1.852 . . . . 0.0 112.083 174.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.4 p -99.01 127.72 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 CA-C-O 121.623 0.725 . . . . 0.0 110.668 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -88.14 -44.65 10.76 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.441 -172.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -165.06 138.16 4.61 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.319 -176.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 30.7 t -104.39 140.58 22.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 276' ' ' SER . 75.4 m -142.42 116.35 9.34 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 122.031 -0.418 . . . . 0.0 111.177 177.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 56.2 tp -91.59 128.89 37.6 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 174.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -134.92 133.82 39.99 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 120.783 0.325 . . . . 0.0 110.971 -174.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 23.3 ttt180 -71.05 125.11 26.0 Favored 'General case' 0 N--CA 1.4 -2.962 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 171.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.457 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 14.9 tp -102.88 -174.33 2.53 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 176.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.457 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 39.4 t30 -46.64 -74.54 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -120.61 -3.87 9.81 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 122.319 1.057 . . . . 0.0 108.745 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . 0.578 ' OD1' ' HD3' ' A' ' 265' ' ' LYS . 39.7 m-20 -111.67 164.12 13.37 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.236 -175.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.437 ' HB ' ' HB2' ' A' ' 264' ' ' LEU . 91.7 m -104.77 128.61 52.96 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 174.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -113.36 129.68 56.47 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -178.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.456 ' HB3' ' HB ' ' A' ' 262' ' ' VAL . 50.5 tp -114.16 119.02 35.65 Favored 'General case' 0 C--N 1.273 -2.758 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 176.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 51.6 mt -104.44 112.01 36.32 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.128 -177.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 56.4 mt -112.6 103.83 16.06 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 3.7 m -77.8 130.38 36.62 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -174.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 15.5 p -135.56 -176.95 4.45 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 122.366 0.266 . . . . 0.0 111.286 -176.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -159.35 152.94 22.74 Favored 'General case' 0 C--O 1.247 0.946 0 C-N-CA 122.965 0.506 . . . . 0.0 110.169 175.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 74.85 -157.07 50.07 Favored Glycine 0 N--CA 1.444 -0.784 0 O-C-N 123.569 0.543 . . . . 0.0 112.955 175.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 -92.39 131.28 37.69 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 177.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' TRP . . . . . 0.659 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 60.8 p-90 -148.77 166.3 28.84 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -178.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -124.76 135.99 53.46 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.659 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 27.0 tp -107.45 118.56 37.03 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.583 ' CG1' ' HB3' ' A' ' 323' ' ' GLN . 5.7 p -115.26 112.31 39.36 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.515 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 171.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -102.93 129.71 49.74 Favored 'General case' 0 N--CA 1.407 -2.586 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.075 -178.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -129.17 156.98 43.05 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.635 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 26.4 t -111.44 120.95 43.86 Favored 'General case' 0 N--CA 1.411 -2.417 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -88.91 -23.65 22.67 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.024 0.44 . . . . 0.0 110.726 -177.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -169.91 164.14 6.36 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.69 103.11 0.26 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 121.745 1.63 . . . . 0.0 111.238 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 115.01 -28.1 8.22 Favored Glycine 0 N--CA 1.436 -1.347 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -177.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -89.13 116.65 27.55 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.164 0.507 . . . . 0.0 110.339 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . 1.662 ' HD1' ' CD2' ' A' ' 320' ' ' PHE . 99.3 m-85 -116.28 165.74 12.84 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 115.377 -0.829 . . . . 0.0 108.865 177.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 89.6 m -152.05 130.18 11.91 Favored 'General case' 0 C--N 1.261 -3.278 0 C-N-CA 123.661 0.784 . . . . 0.0 108.894 -176.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -118.57 107.53 13.86 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . 0.583 ' HB3' ' CG1' ' A' ' 311' ' ' VAL . 35.9 tt0 -99.66 112.5 24.72 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 176.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 75.3 t -95.1 98.64 8.2 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.174 -178.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -83.49 149.14 57.07 Favored Pre-proline 0 CA--C 1.512 -0.49 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -77.52 125.6 7.72 Favored 'Trans proline' 0 N--CA 1.44 -1.672 0 N-CA-C 108.498 -1.385 . . . . 0.0 108.498 170.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -86.83 102.8 14.64 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -121.07 115.26 22.77 Favored 'General case' 0 N--CA 1.407 -2.583 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.502 -176.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 . . . . . 0 C--N 1.289 -2.039 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.973 -175.944 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 69.9 mtm . . . . . 0 N--CA 1.467 0.401 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 85.06 162.03 34.97 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.517 177.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 15.1 t -98.17 69.04 1.99 Allowed 'General case' 0 N--CA 1.413 -2.32 0 CA-C-O 122.076 0.941 . . . . 0.0 108.682 178.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 17.3 m -114.29 -45.98 3.01 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 114.533 -1.212 . . . . 0.0 108.61 176.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -141.18 114.91 9.0 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.587 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 -131.98 176.72 8.12 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 171.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 69.8 t60 63.15 80.97 0.22 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 122.012 0.911 . . . . 0.0 109.921 -177.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -73.91 73.63 1.63 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.949 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 24.7 m80 64.18 -163.71 0.26 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.795 0.838 . . . . 0.0 110.158 -174.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -154.18 -72.76 0.13 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 175.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 66.47 -105.12 1.2 Allowed Glycine 0 N--CA 1.435 -1.413 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -176.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 29.8 tp -119.95 7.35 10.9 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.624 0.726 . . . . 0.0 109.766 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 46.8 t -122.45 128.25 25.53 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.918 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -66.02 132.84 31.3 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 121.968 1.779 . . . . 0.0 109.323 174.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.433 ' NE ' ' HA ' ' A' ' 206' ' ' ARG . 1.6 mmp_? -118.72 105.39 11.52 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.107 0.48 . . . . 0.0 110.221 -174.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 79.87 18.33 72.88 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.743 -176.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 32.0 m -137.35 4.34 2.65 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.413 -0.394 . . . . 0.0 112.001 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -104.56 100.29 9.96 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.961 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 23.1 ptt? -178.6 104.73 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.526 1.131 . . . . 0.0 109.974 175.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -84.87 -23.12 29.12 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 122.128 0.965 . . . . 0.0 108.966 177.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 20.2 t -154.09 162.36 41.25 Favored 'General case' 0 N--CA 1.414 -2.264 0 N-CA-C 104.705 -2.332 . . . . 0.0 104.705 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' MET . . . . . 0.415 ' C ' ' HG1' ' A' ' 214' ' ' THR . 16.4 tpt -121.29 134.82 55.16 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -177.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.415 ' HG1' ' C ' ' A' ' 213' ' ' MET 0.264 48.4 p 65.63 -60.72 0.27 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.968 1.707 . . . . 0.0 115.298 179.285 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -158.64 101.39 0.2 Allowed Glycine 0 N--CA 1.431 -1.657 0 C-N-CA 120.105 -1.045 . . . . 0.0 112.905 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -98.04 -45.88 2.34 Favored Glycine 0 C--N 1.3 -1.454 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 175.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -112.37 105.18 13.39 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -144.06 -55.97 0.37 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 65.9 mtt -106.28 -179.69 4.01 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.773 -178.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -118.33 -161.25 11.81 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 110.181 -1.167 . . . . 0.0 110.181 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -72.11 -35.66 69.22 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 117.274 0.537 . . . . 0.0 110.576 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -130.6 -89.86 0.53 Allowed Glycine 0 N--CA 1.436 -1.366 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 178.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.489 ' HB3' ' OH ' ' A' ' 319' ' ' TYR . 51.0 m 65.72 15.71 10.17 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 113.809 1.041 . . . . 0.0 113.809 176.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -125.69 1.11 7.49 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.547 0.689 . . . . 0.0 110.615 178.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . 0.419 ' O ' HD21 ' A' ' 245' ' ' LEU . 11.5 pm0 -140.9 156.87 46.01 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 56.9 m -67.44 116.39 8.13 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -144.51 173.02 12.17 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.308 -172.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 1.4 pp -136.06 158.65 38.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 CA-C-N 114.145 -1.389 . . . . 0.0 109.361 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -150.23 151.32 32.85 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -129.84 133.75 47.12 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 173.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -153.39 152.81 31.48 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -104.15 153.19 21.23 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.442 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -151.61 162.61 40.7 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 64.7 -125.87 31.49 Favored Glycine 0 C--N 1.312 -0.751 0 O-C-N 123.454 0.471 . . . . 0.0 112.849 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -124.03 91.81 3.54 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.552 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 95.9 m-20 66.66 21.25 10.66 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 177.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -79.79 138.26 37.21 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -99.18 110.4 3.98 Favored Glycine 0 N--CA 1.436 -1.325 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.1 mp -102.7 115.09 44.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 117.483 0.641 . . . . 0.0 109.917 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.5 mp -102.57 113.68 39.86 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -93.11 145.08 24.66 Favored 'General case' 0 C--N 1.283 -2.284 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.965 173.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 12.0 tp -135.6 134.09 38.95 Favored 'General case' 0 C--N 1.264 -3.14 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.67 -174.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . 0.543 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -126.93 106.6 9.42 Favored 'General case' 0 C--N 1.278 -2.514 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.445 ' O ' ' HA2' ' A' ' 318' ' ' GLY . . . -108.75 91.01 3.47 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.419 HD21 ' O ' ' A' ' 225' ' ' GLN . 3.3 mm? -84.4 114.0 21.58 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.678 0.752 . . . . 0.0 111.141 -175.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 116.51 3.91 18.18 Favored Glycine 0 N--CA 1.429 -1.767 0 CA-C-N 114.239 -1.346 . . . . 0.0 110.175 -177.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . 0.444 ' HB2' ' ND1' ' A' ' 267' ' ' HIS . 65.8 t80 -113.12 115.63 28.59 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 121.016 0.436 . . . . 0.0 110.25 -177.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -112.98 100.03 8.32 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 154.43 -158.37 28.17 Favored Glycine 0 N--CA 1.432 -1.597 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -114.43 140.89 25.72 Favored Pre-proline 0 C--N 1.301 -1.511 0 CA-C-N 116.853 0.327 . . . . 0.0 110.359 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.464 ' HB3' HD11 ' A' ' 264' ' ' LEU . 17.9 Cg_endo -72.57 171.85 16.32 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.56 2.173 . . . . 0.0 111.112 175.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.455 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 18.0 t70 -88.45 109.93 20.43 Favored 'General case' 0 C--N 1.277 -2.58 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 4.1 mp -97.99 108.18 21.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 121.84 0.828 . . . . 0.0 110.102 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' SER . . . . . 0.505 ' HB2' ' HB ' ' A' ' 261' ' ' ILE . 47.3 m -109.99 107.18 16.97 Favored 'General case' 0 C--N 1.278 -2.526 0 CA-C-N 114.482 -1.236 . . . . 0.0 108.43 177.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -99.18 126.73 45.02 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 122.126 -0.359 . . . . 0.0 110.865 -175.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -124.21 171.68 9.65 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 171.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -76.59 -40.12 50.51 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 120.871 0.367 . . . . 0.0 110.994 -177.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -82.79 -20.37 35.92 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.826 -175.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -171.99 160.83 5.5 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.905 0.384 . . . . 0.0 111.448 176.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 16.7 mt -106.71 143.78 16.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 178.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' A' ' 254' ' ' SER . 3.9 mp -119.79 109.76 27.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 176.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.46 ' HB ' ' HB3' ' A' ' 300' ' ' LEU . 61.6 t -111.45 123.24 67.11 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.426 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 176.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' THR . . . . . 0.496 ' HA ' ' O ' ' A' ' 298' ' ' THR . 11.9 m -126.19 130.06 50.22 Favored 'General case' 0 C--N 1.285 -2.216 0 C-N-CA 120.096 -0.642 . . . . 0.0 111.029 -177.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.464 HD11 ' HB3' ' A' ' 251' ' ' PRO . 1.3 mm? -100.81 98.04 8.59 Favored 'General case' 0 N--CA 1.408 -2.574 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 177.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.443 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 58.6 mtpt -73.27 135.55 44.48 Favored 'General case' 0 C--N 1.267 -3.015 0 O-C-N 124.191 0.932 . . . . 0.0 110.81 -177.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 6.2 t30 72.85 20.65 3.55 Favored 'General case' 0 CA--C 1.55 0.961 0 O-C-N 124.539 1.15 . . . . 0.0 109.716 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' HIS . . . . . 0.444 ' ND1' ' HB2' ' A' ' 247' ' ' PHE . 54.5 t60 -114.85 100.1 7.97 Favored 'General case' 0 CA--C 1.495 -1.173 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 176.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.97 116.74 17.9 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-O 120.847 0.356 . . . . 0.0 110.436 -176.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 22.5 tp -99.29 123.08 49.86 Favored Pre-proline 0 N--CA 1.436 -1.175 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.769 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -67.73 158.0 59.2 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 122.429 2.086 . . . . 0.0 111.849 171.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' THR . . . . . 0.55 ' HA ' HE21 ' A' ' 274' ' ' GLN . 24.6 p -68.34 -26.3 65.53 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 15.4 m -72.53 -19.74 61.46 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.353 -177.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -95.15 -22.31 17.94 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.492 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.55 HE21 ' HA ' ' A' ' 271' ' ' THR . 5.4 pt20 -77.47 140.03 39.75 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -177.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -177.96 175.46 1.29 Allowed 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -175.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 32.9 t -125.62 143.07 51.19 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-O 121.527 0.679 . . . . 0.0 110.453 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.455 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 1.3 mm? -91.84 103.14 15.72 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 102.917 -2.994 . . . . 0.0 102.917 174.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -59.2 -50.55 73.6 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 123.727 0.642 . . . . 0.0 112.089 -173.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 25.8 m 44.9 30.1 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 173.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -72.52 134.32 45.2 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.646 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 73.59 19.62 3.26 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.069 1.348 . . . . 0.0 113.548 -174.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 1.647 ' HD2' ' CD1' ' A' ' 282' ' ' PHE . 10.4 m-85 -79.35 -21.94 45.14 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.345 170.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? 57.8 61.86 2.27 Favored 'General case' 0 CA--C 1.493 -1.212 0 CA-C-O 122.253 1.025 . . . . 0.0 113.641 174.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 4.8 p -125.3 -178.67 0.73 Allowed Pre-proline 0 C--N 1.275 -2.641 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . 0.552 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 14.4 Cg_exo -71.1 -16.91 31.93 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 CA-C-N 121.281 1.493 . . . . 0.0 110.637 174.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.5 p -95.75 126.61 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-O 122.25 1.024 . . . . 0.0 110.562 177.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -84.16 -47.31 10.99 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 113.938 -1.483 . . . . 0.0 110.278 -175.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -162.09 148.84 13.67 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 -177.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 62.0 t -116.39 122.71 70.37 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.669 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 53.7 m -123.86 120.33 32.25 Favored 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.951 -0.468 . . . . 0.0 111.951 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 48.2 tp -94.53 122.8 37.48 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 175.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -129.84 141.89 50.76 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -176.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -82.41 138.97 34.28 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 118.501 -1.279 . . . . 0.0 108.843 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.464 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 17.0 tp -108.25 -175.32 2.74 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 176.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.464 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 26.0 t-20 -49.03 -67.45 0.26 Allowed 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 118.918 0.781 . . . . 0.0 113.0 -177.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -119.44 -2.21 10.6 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 122.13 0.967 . . . . 0.0 108.462 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . 0.443 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 5.5 m-20 -117.07 168.51 10.2 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.094 -169.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.496 ' O ' ' HA ' ' A' ' 263' ' ' THR . 58.8 m -111.73 124.21 51.86 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 176.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -113.13 124.61 52.97 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-O 121.582 0.706 . . . . 0.0 109.476 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.46 ' HB3' ' HB ' ' A' ' 262' ' ' VAL . 58.6 tp -110.97 120.34 42.07 Favored 'General case' 0 C--N 1.274 -2.689 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 54.9 mt -106.42 109.77 29.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.245 -176.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 57.5 mt -107.96 103.18 15.08 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.496 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 8.4 m -77.1 131.1 38.17 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 -175.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 18.9 p -134.73 175.88 9.15 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 122.395 0.278 . . . . 0.0 111.719 -175.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -164.2 139.62 6.02 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.906 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 99.11 -151.87 19.52 Favored Glycine 0 N--CA 1.434 -1.479 0 C-N-CA 121.25 -0.5 . . . . 0.0 112.354 177.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 64.4 m-20 -105.85 124.5 49.67 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 177.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' TRP . . . . . . . . . . . . . 69.1 p-90 -150.24 158.11 43.81 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.766 -176.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -115.62 137.88 51.63 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 1.4 tt -104.55 114.03 27.99 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.481 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 46.0 t -108.09 106.71 21.18 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 172.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -95.96 141.0 29.9 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . 0.415 ' HB2' ' HB ' ' A' ' 321' ' ' THR . 86.8 mttt -131.14 141.07 50.06 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -178.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 20.3 m -115.81 109.32 17.49 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -77.38 -33.41 55.17 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.586 0.707 . . . . 0.0 109.783 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -170.19 161.56 6.5 Favored Pre-proline 0 C--N 1.305 -1.364 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -65.24 96.97 0.29 Allowed 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 121.387 1.391 . . . . 0.0 110.245 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . 0.445 ' HA2' ' O ' ' A' ' 244' ' ' ALA . . . 135.62 -16.81 4.02 Favored Glycine 0 N--CA 1.424 -2.107 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.74 -176.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . 0.489 ' OH ' ' HB3' ' A' ' 223' ' ' SER . 54.9 m-85 -122.29 118.39 28.39 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 122.344 -0.503 . . . . 0.0 110.171 178.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . 1.609 ' HD1' ' CD2' ' A' ' 320' ' ' PHE . 90.8 m-85 -126.87 161.79 27.42 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.507 -178.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.415 ' HB ' ' HB2' ' A' ' 313' ' ' LYS . 49.3 m -151.87 138.62 18.85 Favored 'General case' 0 C--N 1.267 -2.999 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -176.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 1.646 ' HD1' ' CD2' ' A' ' 322' ' ' PHE . 57.9 m-85 -127.41 107.44 9.96 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . 0.493 HE21 HD23 ' A' ' 325' ' ' LEU . 45.9 tt0 -94.06 101.34 13.37 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 86.6 t -89.05 101.17 11.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.001 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.493 HD23 HE21 ' A' ' 323' ' ' GLN . 40.3 mt -95.59 145.39 29.45 Favored Pre-proline 0 C--N 1.299 -1.596 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.995 -176.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -72.25 123.61 9.32 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 121.102 1.201 . . . . 0.0 109.97 172.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -80.82 132.23 35.47 Favored 'General case' 0 CA--C 1.474 -1.962 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.713 -175.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -89.69 104.69 17.22 Favored 'General case' 0 N--CA 1.404 -2.736 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.582 -178.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 . . . . . 0 C--N 1.304 -1.396 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 -179.176 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 88.0 mtp . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 81.58 26.49 50.59 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.062 -1.066 . . . . 0.0 110.482 -177.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 18.7 m -71.1 -19.07 62.5 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 123.408 0.683 . . . . 0.0 112.232 -175.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 16.9 m -84.84 -9.45 58.13 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.488 0.661 . . . . 0.0 110.354 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -87.99 76.9 8.54 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.274 0.559 . . . . 0.0 112.083 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -151.25 88.71 1.46 Allowed 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 174.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -137.74 155.21 49.31 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -68.18 131.44 45.39 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.975 0.893 . . . . 0.0 111.602 -177.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -84.61 92.94 8.27 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 114.66 -1.154 . . . . 0.0 109.281 -176.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -97.58 23.66 7.51 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 114.348 -1.296 . . . . 0.0 110.489 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 117.2 125.86 3.69 Favored Glycine 0 N--CA 1.43 -1.713 0 N-CA-C 108.629 -1.789 . . . . 0.0 108.629 -174.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 72.49 159.37 0.21 Allowed 'General case' 0 C--O 1.247 0.961 0 C-N-CA 124.407 1.083 . . . . 0.0 111.53 -174.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 5.4 m -122.56 109.9 32.4 Favored Pre-proline 0 C--N 1.299 -1.594 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.678 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -51.16 111.43 0.56 Allowed 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.49 2.794 . . . . 0.0 112.902 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 78.15 -17.29 0.59 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.436 1.894 . . . . 0.0 112.017 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -68.88 -45.23 64.87 Favored Glycine 0 N--CA 1.451 -0.348 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 175.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 11.8 p -95.27 101.41 13.14 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 170.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -69.67 -49.54 52.62 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -170.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 64.2 mtm 70.81 107.13 0.06 Allowed 'General case' 0 N--CA 1.479 1.001 0 O-C-N 124.575 1.172 . . . . 0.0 108.314 -171.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -71.42 -34.86 70.69 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 18.0 p -153.95 112.18 3.58 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 120.567 0.222 . . . . 0.0 110.668 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 67.1 mtt -66.76 95.48 0.36 Allowed 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 51.2 m -87.54 107.04 18.39 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 121.361 0.6 . . . . 0.0 110.683 -177.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -139.28 -94.36 0.28 Allowed Glycine 0 N--CA 1.425 -2.05 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -80.02 87.82 1.27 Allowed Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -107.77 101.06 10.38 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -139.41 11.29 2.54 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.552 -176.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 27.9 ttt -133.16 16.26 4.14 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 121.82 0.819 . . . . 0.0 110.53 -176.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -160.32 77.96 0.17 Allowed Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 119.552 -1.309 . . . . 0.0 112.55 -178.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -100.19 -16.68 17.69 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 153.8 -62.16 0.37 Allowed Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.25 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 22.9 t -97.85 118.69 34.98 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.296 0.57 . . . . 0.0 110.524 -176.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -146.24 -48.14 0.2 Allowed 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.666 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . 0.47 ' CG ' HD22 ' A' ' 273' ' ' LEU . 1.1 tp60 -121.53 168.65 11.49 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -176.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 16.3 m -50.65 128.6 20.87 Favored 'General case' 0 CA--C 1.552 1.021 0 O-C-N 123.923 0.764 . . . . 0.0 110.73 177.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -146.07 156.6 43.57 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.048 0.452 . . . . 0.0 110.224 -174.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.547 HD11 ' O ' ' A' ' 228' ' ' ILE . 2.1 pp -138.73 146.04 26.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 C-N-CA 124.882 1.273 . . . . 0.0 109.491 -177.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -150.58 157.16 42.67 Favored 'General case' 0 C--N 1.29 -1.991 0 O-C-N 123.34 0.4 . . . . 0.0 111.103 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -126.67 138.01 53.36 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-O 120.811 0.339 . . . . 0.0 111.153 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -146.92 168.11 22.28 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 173.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -116.01 155.52 27.94 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 122.402 -0.186 . . . . 0.0 110.677 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -138.55 145.47 40.71 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 123.366 0.416 . . . . 0.0 110.175 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 56.33 -104.7 0.38 Allowed Glycine 0 N--CA 1.441 -0.97 0 O-C-N 124.566 1.166 . . . . 0.0 114.796 172.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -119.15 83.86 2.1 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-O 121.212 0.53 . . . . 0.0 109.852 -176.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.425 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 94.9 m-20 61.37 23.05 13.35 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.646 -1.161 . . . . 0.0 114.075 172.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -78.32 136.63 37.75 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -99.45 114.57 5.06 Favored Glycine 0 N--CA 1.431 -1.697 0 N-CA-C 111.689 -0.564 . . . . 0.0 111.689 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.1 mp -107.49 115.84 49.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-O 121.35 0.595 . . . . 0.0 110.847 -177.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.3 mp -99.17 116.65 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.459 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 175.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -90.73 135.76 33.51 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 16.3 tp -130.86 131.85 44.81 Favored 'General case' 0 C--N 1.278 -2.514 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.057 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -128.74 102.36 6.53 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -111.21 92.25 3.97 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.479 0.656 . . . . 0.0 109.697 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.425 HD23 ' N ' ' A' ' 245' ' ' LEU . 3.1 mm? -76.42 114.59 15.29 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.224 -176.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 107.1 18.73 10.14 Favored Glycine 0 N--CA 1.431 -1.646 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.579 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -115.11 116.08 27.83 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -104.88 95.15 5.67 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.147 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 143.6 -166.17 26.97 Favored Glycine 0 C--N 1.299 -1.515 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 175.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -102.28 144.87 29.47 Favored Pre-proline 0 C--N 1.308 -1.205 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 177.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.411 ' HB3' ' CD2' ' A' ' 264' ' ' LEU . 21.5 Cg_endo -77.14 173.32 14.59 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.955 2.437 . . . . 0.0 112.38 178.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -97.76 118.0 33.33 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 3.2 mp -107.25 133.13 52.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-O 120.977 0.417 . . . . 0.0 111.18 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 23.2 t -115.81 111.35 20.37 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 173.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -90.86 105.05 17.56 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.342 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 74.8 mt-30 -125.14 152.52 44.32 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 176.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -60.1 -45.13 94.0 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -176.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -83.87 -20.14 33.61 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -174.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . 0.458 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 49.1 p-80 -171.8 158.75 5.0 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.083 0.468 . . . . 0.0 111.853 175.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 23.7 mt -106.72 144.14 16.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 3.5 mp -119.82 112.97 39.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 176.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.43 ' HB ' ' HB2' ' A' ' 300' ' ' LEU . 54.7 t -107.18 116.44 50.84 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 176.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 17.3 m -109.54 124.1 50.54 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-O 121.146 0.498 . . . . 0.0 110.19 -178.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.499 ' HB2' ' HB ' ' A' ' 298' ' ' THR . 18.2 mt -102.96 89.84 3.57 Favored 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 178.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.564 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 61.2 mtpt -65.68 131.28 45.94 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.667 -175.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 71.23 21.08 4.85 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 124.601 1.188 . . . . 0.0 109.843 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -117.99 102.02 8.73 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 177.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 2.5 m -91.43 115.41 28.01 Favored 'General case' 0 C--N 1.28 -2.455 0 C-N-CA 119.829 -0.749 . . . . 0.0 111.208 -173.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 270' ' ' PRO . 21.2 tp -89.89 130.3 43.23 Favored Pre-proline 0 N--CA 1.43 -1.466 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.761 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . 0.404 ' O ' ' HG ' ' A' ' 269' ' ' LEU . 6.7 Cg_exo -73.85 156.95 48.07 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 122.057 1.838 . . . . 0.0 110.603 170.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' THR . . . . . 0.452 ' HA ' ' HG2' ' A' ' 274' ' ' GLN . 7.1 p -73.55 -10.46 59.73 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.623 0.725 . . . . 0.0 112.186 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 15.4 m -73.59 -24.06 60.01 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.206 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.47 HD22 ' CG ' ' A' ' 225' ' ' GLN . 7.8 mp -101.95 -12.16 18.41 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.704 -174.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.455 ' O ' ' HG3' ' A' ' 274' ' ' GLN . 0.0 OUTLIER -81.12 127.37 32.57 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.0 -176.723 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -153.58 163.35 40.12 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 13.9 p -124.29 127.41 47.6 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-O 121.792 0.806 . . . . 0.0 111.714 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.424 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 2.1 mm? -81.25 118.45 22.61 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -84.39 92.89 8.15 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 118.66 -1.216 . . . . 0.0 108.543 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . 0.585 ' HA ' ' CD2' ' A' ' 282' ' ' PHE . 46.9 t -94.88 28.97 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 CA-C-O 123.328 1.537 . . . . 0.0 109.793 -175.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -79.74 149.92 30.99 Favored 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 175.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 28.1 t70 70.21 9.04 6.9 Favored 'General case' 0 CA--C 1.556 1.177 0 CA-C-O 122.156 0.979 . . . . 0.0 111.715 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.585 ' CD2' ' HA ' ' A' ' 279' ' ' VAL . 16.4 m-85 -83.38 -13.47 54.85 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 121.737 -0.602 . . . . 0.0 111.045 176.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 mptt 58.4 60.99 2.4 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.094 0.558 . . . . 0.0 111.132 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 1.5 p -136.64 174.74 4.12 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 178.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 13.9 Cg_exo -71.47 -19.52 28.46 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 121.739 1.626 . . . . 0.0 111.601 175.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.3 p -94.85 132.76 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-O 121.517 0.675 . . . . 0.0 110.21 178.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -100.01 -32.27 11.04 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.9 -174.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 40.2 tttp -162.86 134.48 5.11 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 120.051 -0.659 . . . . 0.0 109.8 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.424 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 42.0 t -103.48 110.14 29.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 174.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.451 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 93.8 m -112.57 113.55 25.76 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-O 121.004 0.43 . . . . 0.0 111.375 -176.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.432 ' O ' ' HB2' ' A' ' 274' ' ' GLN . 37.9 tp -94.93 122.71 37.86 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 173.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -140.84 144.4 35.33 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -79.02 149.9 32.08 Favored 'General case' 0 C--N 1.282 -2.339 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.468 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.528 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 15.8 tp -111.62 -173.98 2.36 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 176.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.528 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 64.0 t30 -51.78 -62.7 1.47 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.954 0.502 . . . . 0.0 112.091 -177.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -122.4 -3.21 8.91 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 121.154 0.502 . . . . 0.0 110.08 176.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . 0.564 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 11.8 m-20 -115.72 169.07 9.48 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.823 -170.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.499 ' HB ' ' HB2' ' A' ' 264' ' ' LEU . 86.7 m -106.28 135.32 47.96 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 176.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -122.68 127.71 49.64 Favored 'General case' 0 N--CA 1.417 -2.091 0 CA-C-O 121.522 0.677 . . . . 0.0 110.569 -176.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.43 ' HB2' ' HB ' ' A' ' 262' ' ' VAL . 1.8 mt -106.13 119.56 39.52 Favored 'General case' 0 C--N 1.273 -2.729 0 CA-C-N 115.32 -0.854 . . . . 0.0 108.902 175.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' ILE . . . . . 0.451 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 67.3 mt -108.0 109.26 27.59 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.796 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 61.1 mt -108.94 101.06 12.02 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 24.9 m -69.51 132.3 46.06 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 11.4 p -137.41 169.76 17.23 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 122.896 0.479 . . . . 0.0 111.023 -177.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -159.11 144.72 16.25 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 92.2 -152.69 21.41 Favored Glycine 0 N--CA 1.436 -1.358 0 O-C-N 123.892 0.745 . . . . 0.0 112.623 176.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' ASN . . . . . 0.57 ' HB2' ' O ' ' A' ' 327' ' ' LYS . 6.6 m120 -101.17 129.19 47.05 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' TRP . . . . . 0.407 ' CE3' HG13 ' A' ' 324' ' ' VAL . 67.4 p-90 -153.59 162.9 40.82 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.011 -177.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -122.62 135.36 54.59 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 1.5 tt -102.74 122.87 45.34 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.485 ' CG1' ' HB3' ' A' ' 323' ' ' GLN . 7.6 p -125.53 111.97 29.26 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 CA-C-O 121.883 0.849 . . . . 0.0 109.794 170.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -98.79 135.97 39.49 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.259 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -128.2 139.74 52.29 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.098 -176.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 35.9 p -115.99 122.24 44.65 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 176.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -81.16 -38.03 27.8 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.698 0.761 . . . . 0.0 109.321 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -163.27 162.21 17.76 Favored Pre-proline 0 C--N 1.308 -1.21 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -58.29 110.43 0.65 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.038 1.826 . . . . 0.0 110.811 178.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 113.86 -36.13 4.17 Favored Glycine 0 N--CA 1.424 -2.104 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . 1.621 ' HE1' ' CE2' ' A' ' 319' ' ' TYR . 91.5 m-85 -93.29 115.59 28.18 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . 1.64 ' HE1' ' CE2' ' A' ' 320' ' ' PHE . 74.4 m-85 -127.32 166.36 17.96 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-O 122.228 1.013 . . . . 0.0 111.407 -175.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 84.8 m -151.93 127.36 9.99 Favored 'General case' 0 C--N 1.278 -2.531 0 CA-C-N 113.988 -1.46 . . . . 0.0 108.604 -177.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 1.662 ' HE1' ' CE2' ' A' ' 322' ' ' PHE . 79.4 m-85 -116.55 111.49 20.0 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.073 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . 0.485 ' HB3' ' CG1' ' A' ' 311' ' ' VAL . 61.6 tt0 -97.76 104.28 16.29 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.407 HG13 ' CE3' ' A' ' 308' ' ' TRP . 88.2 t -90.28 98.87 8.72 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 33.0 mt -87.05 148.61 45.62 Favored Pre-proline 0 C--N 1.292 -1.92 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.057 -178.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -77.43 143.46 21.92 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 121.62 1.547 . . . . 0.0 111.134 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . 0.57 ' O ' ' HB2' ' A' ' 307' ' ' ASN . 19.7 ttmm -124.14 154.68 39.68 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -152.16 122.45 7.22 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.71 -0.618 . . . . 0.0 110.511 173.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 . . . . . 0 N--CA 1.417 -2.121 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 177.308 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.469 0.477 0 CA-C-O 120.358 0.123 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 90.77 52.86 2.36 Favored Glycine 0 CA--C 1.489 -1.587 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 -175.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 11.3 m -70.43 90.27 0.71 Allowed 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.818 -0.691 . . . . 0.0 112.042 -174.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 7.5 t -121.95 131.64 54.12 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 174.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -52.45 -54.21 35.34 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 123.711 0.632 . . . . 0.0 112.169 -173.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -167.67 -37.6 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.842 0.353 . . . . 0.0 110.122 176.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -75.73 159.13 31.41 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.423 177.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -114.05 134.72 54.68 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 177.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 31.4 t-80 -66.05 -8.16 21.64 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.046 0.938 . . . . 0.0 111.815 -175.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 11.0 t60 71.36 108.34 0.06 Allowed 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 125.694 1.598 . . . . 0.0 111.195 176.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 145.33 -161.41 28.17 Favored Glycine 0 N--CA 1.416 -2.69 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 6.2 mp -97.92 -31.19 12.31 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 121.391 0.615 . . . . 0.0 109.442 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 21.9 t -133.61 126.84 19.28 Favored Pre-proline 0 C--N 1.313 -1.006 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.97 -50.34 6.46 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.58 2.187 . . . . 0.0 111.065 176.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -145.95 129.05 16.58 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 175.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -157.4 -163.27 12.37 Favored Glycine 0 N--CA 1.426 -1.973 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 20.6 m -84.95 -30.65 24.12 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 116.856 0.328 . . . . 0.0 110.313 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . 0.526 ' O ' ' HG3' ' A' ' 210' ' ' MET . 45.2 t-80 -86.97 73.4 9.92 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.689 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' MET . . . . . 0.526 ' HG3' ' O ' ' A' ' 209' ' ' HIS . 36.2 mtm 170.55 129.49 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 129.069 2.948 . . . . 0.0 106.271 176.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . 67.14 98.21 0.05 Allowed 'General case' 0 C--O 1.242 0.686 0 O-C-N 124.421 1.076 . . . . 0.0 111.485 -177.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 21.9 m -78.71 146.05 34.16 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.03 178.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 43.2 tpp -79.69 106.77 11.95 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 1.7 p -82.5 90.83 6.79 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -172.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 73.97 -38.85 0.95 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 116.413 1.325 . . . . 0.0 116.413 172.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -72.43 68.64 1.18 Allowed Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 116.03 1.172 . . . . 0.0 116.03 -173.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -135.75 76.79 1.63 Allowed 'General case' 0 C--O 1.246 0.905 0 CA-C-O 121.06 0.457 . . . . 0.0 110.513 174.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -120.69 -40.4 2.66 Favored 'General case' 0 C--O 1.207 -1.165 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.589 175.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 26.3 mmt 64.24 123.11 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 176.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 64.59 -92.12 0.12 Allowed Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.262 -0.881 . . . . 0.0 113.755 176.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -136.24 17.29 3.19 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.088 0.47 . . . . 0.0 110.667 -177.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 107.99 84.58 1.66 Allowed Glycine 0 CA--C 1.488 -1.63 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 -177.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.494 ' OG ' HD22 ' A' ' 245' ' ' LEU . 35.7 t -71.4 73.27 0.71 Allowed 'General case' 0 N--CA 1.428 -1.573 0 CA-C-O 122.323 1.059 . . . . 0.0 112.9 -174.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -128.22 5.7 5.84 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 169.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . 0.507 ' O ' HD21 ' A' ' 245' ' ' LEU . 3.6 pt20 -142.86 157.34 44.69 Favored 'General case' 0 N--CA 1.42 -1.945 0 CA-C-N 113.505 -1.679 . . . . 0.0 108.025 -174.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 43.3 m -78.43 127.61 32.43 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 121.118 0.485 . . . . 0.0 112.198 -175.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -151.89 166.35 31.72 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.372 -177.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.3 pp -121.43 165.45 17.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.321 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' A' ' 240' ' ' ILE . 2.4 t70 -150.25 156.46 41.62 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 1.658 ' HD2' ' CD1' ' A' ' 230' ' ' PHE . 71.7 t80 -133.39 130.6 38.96 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.234 0.54 . . . . 0.0 109.749 176.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.407 ' HD2' ' OE2' ' A' ' 241' ' ' GLU . 5.4 ptp180 -149.81 165.33 32.82 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.37 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -108.92 142.09 40.05 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . 0.532 ' O ' ' HB1' ' A' ' 237' ' ' ALA . 18.8 t70 -156.77 117.99 3.75 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -178.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 102.13 -143.43 15.95 Favored Glycine 0 C--N 1.301 -1.412 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -178.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -114.46 101.5 9.19 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 117.468 0.634 . . . . 0.0 110.032 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 18.9 m120 65.39 27.25 11.91 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.621 1.168 . . . . 0.0 111.896 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . 0.532 ' HB1' ' O ' ' A' ' 233' ' ' ASP . . . -97.94 134.74 40.64 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.304 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . 0.55 ' HA3' ' CG1' ' A' ' 286' ' ' VAL . . . -101.44 123.9 8.06 Favored Glycine 0 C--N 1.296 -1.671 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.1 mp -116.78 120.11 64.03 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-N 118.045 0.923 . . . . 0.0 111.045 -176.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . 0.403 ' HA ' ' O ' ' A' ' 229' ' ' ASP . 3.2 mp -104.21 109.49 27.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 176.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.407 ' OE2' ' HD2' ' A' ' 231' ' ' ARG . 5.4 mt-10 -93.59 128.53 39.79 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-O 121.435 0.636 . . . . 0.0 109.742 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 13.0 tp -115.24 126.64 54.78 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 115.186 -0.916 . . . . 0.0 112.092 -171.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . 0.568 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -108.27 104.11 13.43 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 175.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -112.25 91.88 3.82 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.432 0.634 . . . . 0.0 109.477 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.507 HD21 ' O ' ' A' ' 225' ' ' GLN . 3.5 mm? -85.36 116.83 23.92 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.769 -175.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 108.68 13.33 18.85 Favored Glycine 0 N--CA 1.424 -2.113 0 CA-C-N 114.24 -1.346 . . . . 0.0 110.16 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -114.86 115.26 26.68 Favored 'General case' 0 N--CA 1.423 -1.812 0 C-N-CA 120.6 -0.44 . . . . 0.0 109.875 -177.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -112.93 95.15 5.25 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.05 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 152.47 -157.33 27.22 Favored Glycine 0 C--N 1.296 -1.672 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -114.56 141.55 26.81 Favored Pre-proline 0 C--N 1.303 -1.43 0 CA-C-N 116.991 0.396 . . . . 0.0 110.325 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.455 ' HB3' ' CD1' ' A' ' 264' ' ' LEU . 12.7 Cg_endo -68.97 172.19 12.29 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.403 2.069 . . . . 0.0 111.053 175.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.406 ' HB3' ' HB ' ' A' ' 263' ' ' THR . 34.1 t0 -97.48 107.84 20.43 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 3.1 mp -95.11 116.23 36.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 3.1 t -119.28 111.27 18.0 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -97.58 128.74 44.54 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -174.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.456 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 18.4 mt-30 -125.24 163.13 23.17 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 170.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -76.45 -29.85 57.12 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.29 174.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -68.24 -48.56 64.77 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.308 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . 0.497 ' CB ' ' HA ' ' A' ' 303' ' ' THR . 27.6 p-80 -163.37 167.62 21.49 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 116.704 -0.225 . . . . 0.0 110.451 177.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 19.8 mt -105.83 143.1 17.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 3.5 mp -120.93 109.1 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 176.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.431 ' HB ' ' HB3' ' A' ' 300' ' ' LEU . 51.4 t -106.54 117.76 52.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 177.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' THR . . . . . 0.598 ' HA ' ' O ' ' A' ' 298' ' ' THR . 25.3 m -116.79 123.96 48.41 Favored 'General case' 0 C--N 1.278 -2.52 0 CA-C-O 121.773 0.797 . . . . 0.0 111.27 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.455 ' CD1' ' HB3' ' A' ' 251' ' ' PRO . 1.7 mm? -93.47 98.03 10.93 Favored 'General case' 0 N--CA 1.399 -2.99 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 174.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.505 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 0.5 OUTLIER -67.79 129.81 41.06 Favored 'General case' 0 N--CA 1.388 -3.569 0 O-C-N 124.756 1.285 . . . . 0.0 108.921 -174.832 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 66.6 t30 71.05 27.38 3.34 Favored 'General case' 0 CA--C 1.549 0.924 0 O-C-N 124.483 1.115 . . . . 0.0 110.444 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -121.77 113.18 19.33 Favored 'General case' 0 C--O 1.203 -1.362 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 3.9 p -90.71 129.15 36.83 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . 0.41 HD23 HD21 ' A' ' 291' ' ' LEU . 23.8 tp -107.39 129.56 24.09 Favored Pre-proline 0 N--CA 1.446 -0.664 0 C-N-CA 123.624 0.77 . . . . 0.0 109.873 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -64.63 151.34 86.0 Favored 'Trans proline' 0 C--N 1.318 -1.052 0 C-N-CA 122.36 2.04 . . . . 0.0 111.584 172.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' THR . . . . . 0.455 ' HA ' ' HG2' ' A' ' 274' ' ' GLN . 16.3 p -74.96 -13.91 60.57 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.776 0.798 . . . . 0.0 112.176 -178.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 25.0 m -81.09 -17.91 48.39 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 122.018 0.913 . . . . 0.0 110.038 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 96.0 mt -101.19 -19.99 15.48 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.944 -178.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.456 ' HB2' ' O ' ' A' ' 291' ' ' LEU . 11.9 pt20 -74.5 136.15 42.21 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -164.87 178.59 7.05 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -173.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 39.9 m -134.78 123.82 24.19 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.346 0.593 . . . . 0.0 110.872 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.414 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 53.2 mt -91.09 120.25 31.89 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 103.977 -2.601 . . . . 0.0 103.977 174.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -68.2 -42.57 79.7 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.783 -172.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . 0.334 34.0 m 42.65 26.74 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 N-CA-C 117.353 2.353 . . . . 0.0 117.353 175.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -74.6 142.86 44.59 Favored 'General case' 0 N--CA 1.415 -2.209 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 176.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 30.0 t70 72.59 22.94 3.15 Favored 'General case' 0 CA--C 1.553 1.059 0 O-C-N 124.229 0.956 . . . . 0.0 111.521 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -86.78 1.94 50.55 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 176.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? 60.77 59.81 2.04 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 1.1 t -164.95 150.95 8.87 Favored Pre-proline 0 N--CA 1.423 -1.795 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.363 177.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . 0.411 ' O ' ' HA ' ' A' ' 304' ' ' THR . 18.4 Cg_exo -44.2 -35.81 8.33 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 124.556 3.504 . . . . 0.0 114.06 174.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.55 ' CG1' ' HA3' ' A' ' 238' ' ' GLY . 0.2 OUTLIER -73.57 115.53 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 CA-C-O 121.767 0.794 . . . . 0.0 109.442 177.32 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -94.7 -37.07 11.47 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.714 -174.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -154.62 146.51 23.48 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -176.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.414 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 55.1 t -120.04 125.59 74.4 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.444 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 96.1 m -126.49 127.17 44.93 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-O 121.056 0.455 . . . . 0.0 110.434 178.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.456 ' O ' ' HB2' ' A' ' 274' ' ' GLN . 0.1 OUTLIER -100.88 120.1 39.66 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 174.902 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -123.75 134.3 53.69 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . 0.406 ' HG2' ' OE1' ' A' ' 274' ' ' GLN . 9.0 ptm180 -81.32 148.62 29.31 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 117.609 -1.636 . . . . 0.0 108.308 173.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.57 HD11 ' N ' ' A' ' 295' ' ' ASN . 2.8 tm? -122.96 166.9 14.3 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.57 ' N ' HD11 ' A' ' 294' ' ' LEU . 0.2 OUTLIER -24.02 -70.35 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 127.349 2.26 . . . . 0.0 112.149 177.052 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -124.7 -2.15 7.88 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . 0.505 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 12.3 m-20 -119.04 171.37 8.31 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.578 -168.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.598 ' O ' ' HA ' ' A' ' 263' ' ' THR . 70.5 m -114.3 128.16 56.22 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 176.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -113.65 116.48 29.53 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -177.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.431 ' HB3' ' HB ' ' A' ' 262' ' ' VAL . 0.6 OUTLIER -101.52 120.25 40.01 Favored 'General case' 0 C--N 1.277 -2.587 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 177.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' ILE . . . . . 0.444 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 80.6 mt -110.76 115.19 49.19 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -176.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 45.8 mt -117.37 103.25 14.64 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.552 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' THR . . . . . 0.497 ' HA ' ' CB ' ' A' ' 259' ' ' HIS . 85.6 m -75.91 134.43 40.25 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 120.556 0.217 . . . . 0.0 110.416 -177.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 285' ' ' PRO . 9.1 p -132.76 -179.26 5.36 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 123.237 0.615 . . . . 0.0 110.932 -174.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -155.03 139.88 17.22 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 122.687 0.395 . . . . 0.0 110.162 177.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 77.15 -151.78 39.15 Favored Glycine 0 C--O 1.236 0.263 0 O-C-N 123.635 0.584 . . . . 0.0 112.384 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -96.59 137.11 36.17 Favored 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 176.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' TRP . . . . . . . . . . . . . 68.9 p-90 -154.13 165.43 36.25 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -175.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . 0.542 ' O ' ' HA ' ' A' ' 324' ' ' VAL . 5.6 mt-10 -122.03 136.82 54.95 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -178.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.25 124.21 49.43 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.522 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 58.3 t -115.88 107.34 22.38 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.637 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 173.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -92.84 124.92 37.18 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -123.46 149.95 44.46 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -177.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 12.9 p -115.69 122.27 45.03 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 177.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -89.81 -29.54 18.57 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.402 0.62 . . . . 0.0 110.494 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -164.29 163.12 15.36 Favored Pre-proline 0 C--N 1.309 -1.179 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -64.64 97.6 0.27 Allowed 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 121.537 1.491 . . . . 0.0 111.504 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 122.17 -20.63 7.97 Favored Glycine 0 C--O 1.218 -0.877 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.992 -177.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -103.17 116.34 32.29 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . 1.662 ' HD2' ' CD1' ' A' ' 320' ' ' PHE . 92.3 m-85 -121.45 168.27 11.89 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.674 0.749 . . . . 0.0 111.243 -175.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 60.6 m -151.2 129.23 11.79 Favored 'General case' 0 C--N 1.277 -2.569 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.37 -176.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 1.649 ' HE2' ' CE1' ' A' ' 322' ' ' PHE . 90.4 m-85 -117.53 108.76 15.89 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 177.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . 0.522 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 42.1 tt0 -98.9 105.33 17.46 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 309' ' ' GLU . 0.2 OUTLIER -100.97 105.83 18.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 CA-C-O 122.099 0.952 . . . . 0.0 110.102 178.039 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.7 mp -104.17 156.16 36.15 Favored Pre-proline 0 C--N 1.298 -1.637 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.803 -177.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -74.19 128.52 12.22 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 121.697 1.598 . . . . 0.0 112.082 177.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -91.91 116.8 29.22 Favored 'General case' 0 CA--C 1.49 -1.342 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 177.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -146.64 157.57 43.74 Favored 'General case' 0 N--CA 1.414 -2.273 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.486 -173.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 . . . . . 0 C--N 1.302 -1.486 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 176.085 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 15.2 tpt . . . . . 0 N--CA 1.464 0.249 0 N-CA-C 111.131 0.048 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -145.42 -60.38 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.586 0 C-N-CA 120.029 -1.082 . . . . 0.0 112.025 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 16.6 m -85.12 8.51 17.85 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.392 0.615 . . . . 0.0 110.428 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 7.5 m -65.05 120.8 13.32 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.097 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -85.63 -21.72 28.3 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.465 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -76.25 137.71 40.12 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 173.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -82.79 97.12 8.44 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -177.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -56.84 113.68 1.76 Allowed 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.102 -1.408 . . . . 0.0 111.566 -175.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 34.6 m-70 -65.15 126.66 28.79 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 175.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -63.36 -41.02 98.81 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 123.803 0.689 . . . . 0.0 112.613 -171.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -174.38 122.36 0.89 Allowed Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 4.6 pp -111.27 8.64 21.56 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.25 0.548 . . . . 0.0 111.044 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 5.8 m -119.8 105.85 42.53 Favored Pre-proline 0 C--N 1.312 -1.059 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.983 -178.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -62.54 127.77 21.71 Favored 'Trans proline' 0 C--O 1.246 0.902 0 C-N-CA 122.519 2.146 . . . . 0.0 110.616 176.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -136.04 165.04 26.62 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -175.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 154.4 156.09 7.54 Favored Glycine 0 N--CA 1.419 -2.461 0 C-N-CA 119.876 -1.154 . . . . 0.0 112.203 176.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 20.0 m -80.58 87.83 5.73 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-O 121.805 0.812 . . . . 0.0 109.205 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 -79.68 129.52 34.55 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.865 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 56.4 ttp -104.68 88.03 2.83 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 175.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -84.17 -44.09 14.31 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 17.9 m -89.27 121.02 31.15 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 175.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 44.9 tpp -61.03 107.06 0.67 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.096 0.474 . . . . 0.0 111.599 -177.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 14.1 m -101.75 -12.8 18.06 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.724 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -94.3 127.38 9.06 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.937 -177.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 112.42 179.75 19.59 Favored Glycine 0 N--CA 1.437 -1.239 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.738 177.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 64.1 84.75 0.14 Allowed 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 124.851 1.26 . . . . 0.0 114.35 177.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -119.72 85.3 2.35 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 171.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 19.9 ptp -67.18 116.4 7.93 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.997 -173.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 87.3 -61.25 4.26 Favored Glycine 0 N--CA 1.437 -1.283 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.226 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . 0.45 ' NE ' ' HA ' ' A' ' 221' ' ' ARG . 3.3 mmp_? -152.91 -161.99 1.4 Allowed 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -74.1 52.32 2.12 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-O 121.641 0.578 . . . . 0.0 111.729 176.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 9.0 m -98.85 105.82 18.01 Favored 'General case' 0 N--CA 1.417 -2.117 0 C-N-CA 124.393 1.077 . . . . 0.0 109.154 -177.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -144.78 11.5 1.42 Allowed 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . 0.43 ' O ' HD21 ' A' ' 245' ' ' LEU . 17.7 pt20 -124.27 130.52 52.66 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.492 -172.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 88.8 m -78.73 131.83 36.74 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.172 177.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -166.91 175.49 7.65 Favored 'General case' 0 CA--C 1.479 -1.788 0 CA-C-O 121.131 0.491 . . . . 0.0 110.289 -175.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.6 pp -128.04 162.72 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.53 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.696 177.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . 0.452 ' HB2' ' HB2' ' A' ' 241' ' ' GLU . 4.8 m-20 -146.78 156.04 42.84 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 1.656 ' HE1' ' CE2' ' A' ' 230' ' ' PHE . 55.6 t80 -129.48 134.42 47.79 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.244 176.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 8.3 ptt-85 -144.15 169.33 18.07 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 175.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.424 ' HE3' HG21 ' A' ' 284' ' ' THR . 55.3 mtpt -114.93 150.2 36.07 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 175.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -152.56 152.06 31.41 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -177.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 73.57 -102.75 1.33 Allowed Glycine 0 C--N 1.314 -0.683 0 C-N-CA 121.285 -0.483 . . . . 0.0 113.748 176.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -152.98 104.26 2.82 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 123.2 0.6 . . . . 0.0 110.038 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.638 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 89.6 m-20 61.21 20.7 11.23 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.112 0.965 . . . . 0.0 111.762 176.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.34 137.84 33.02 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 120.822 0.344 . . . . 0.0 110.259 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -99.91 117.59 5.92 Favored Glycine 0 N--CA 1.425 -2.066 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.1 mp -108.47 117.79 54.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 117.194 0.497 . . . . 0.0 110.797 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 2.9 mp -103.68 110.12 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 176.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.452 ' HB2' ' HB2' ' A' ' 229' ' ' ASP . 53.7 mt-10 -90.04 123.37 33.87 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 11.9 tp -112.14 124.23 51.98 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-O 120.981 0.42 . . . . 0.0 111.965 -174.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . 0.53 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -107.45 107.87 18.94 Favored 'General case' 0 C--O 1.206 -1.216 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 176.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -118.15 92.35 3.8 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.24 0.543 . . . . 0.0 111.519 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.43 HD21 ' O ' ' A' ' 225' ' ' GLN . 3.6 mm? -86.56 116.25 24.57 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.246 0.546 . . . . 0.0 111.079 -177.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 111.64 -7.79 28.02 Favored Glycine 0 C--N 1.297 -1.603 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.146 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . 1.611 ' HE2' ' CE1' ' A' ' 247' ' ' PHE . 47.9 t80 -98.56 128.15 44.77 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -107.57 -34.98 6.86 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -174.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -86.3 -150.1 15.2 Favored Glycine 0 CA--C 1.506 -0.479 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.457 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -115.01 141.13 26.48 Favored Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.453 ' HB3' HD21 ' A' ' 264' ' ' LEU . 10.2 Cg_endo -69.44 172.27 12.62 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.957 1.771 . . . . 0.0 113.951 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -97.49 105.37 17.51 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 176.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.44 HD12 ' HG2' ' A' ' 251' ' ' PRO . 4.8 mp -101.41 117.19 46.32 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 C-N-CA 119.122 -1.031 . . . . 0.0 109.738 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' SER . . . . . 0.43 ' HB3' ' HB ' ' A' ' 261' ' ' ILE . 24.6 t -97.79 112.32 24.27 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 176.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -97.67 101.98 13.63 Favored 'General case' 0 CA--C 1.497 -1.079 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.226 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -104.66 162.14 13.53 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 171.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -76.72 -33.48 58.17 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 120.624 0.249 . . . . 0.0 111.357 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -72.49 -39.3 67.77 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.889 -178.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . 0.413 ' HB3' ' HA ' ' A' ' 303' ' ' THR . 32.1 p-80 -166.7 165.96 16.18 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . 0.459 ' O ' ' HA ' ' A' ' 301' ' ' ILE . 15.9 mt -106.83 142.73 18.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -177.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . 0.43 ' HB ' ' HB3' ' A' ' 254' ' ' SER . 3.6 mp -126.04 112.0 28.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 299' ' ' GLN . 0.8 OUTLIER -102.49 141.49 18.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 177.316 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 6.2 m -129.05 118.88 23.25 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-O 121.2 0.524 . . . . 0.0 109.639 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.522 ' HB2' ' HB ' ' A' ' 298' ' ' THR . 31.5 mt -96.76 95.36 7.85 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.416 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 31.6 mmtp -63.92 133.96 54.23 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.731 -1.122 . . . . 0.0 113.403 -174.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 69.56 9.07 7.08 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 113.533 -1.667 . . . . 0.0 110.801 176.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' HIS . . . . . 0.434 ' ND1' ' HB2' ' A' ' 247' ' ' PHE . 46.4 t60 -100.25 114.39 27.8 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.938 -176.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.89 118.19 28.42 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 31.4 tp -96.92 127.48 38.87 Favored Pre-proline 0 N--CA 1.439 -0.982 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.176 177.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -62.87 136.31 56.59 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.193 1.929 . . . . 0.0 111.26 170.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' THR . . . . . 0.439 ' O ' ' HG2' ' A' ' 274' ' ' GLN . 8.5 t -66.21 -14.12 61.38 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 122.262 1.029 . . . . 0.0 110.756 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 2.8 m -78.14 -18.94 54.96 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.007 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 88.6 mt -106.9 -8.54 16.63 Favored 'General case' 0 C--O 1.246 0.912 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.844 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 271' ' ' THR . 10.5 pt20 -83.11 148.9 27.22 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.9 169.82 8.04 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 15.8 m -119.62 117.02 27.2 Favored 'General case' 0 N--CA 1.406 -2.666 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 173.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 76.4 mt -81.53 117.9 22.31 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -79.3 89.5 4.94 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 122.224 1.011 . . . . 0.0 109.866 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . 0.597 ' HA ' ' CE1' ' A' ' 282' ' ' PHE . 47.3 t -98.74 27.34 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 CA-C-O 123.047 1.403 . . . . 0.0 109.658 -176.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -71.49 132.2 44.4 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.581 178.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 30.1 t70 68.53 28.49 5.88 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.461 1.504 . . . . 0.0 112.468 178.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 1.668 ' HD2' ' CD1' ' A' ' 282' ' ' PHE . 6.7 m-85 -84.25 -5.02 59.2 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.66 173.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? 60.97 50.36 5.18 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.691 0.758 . . . . 0.0 110.586 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' THR . . . . . 0.424 HG21 ' HE3' ' A' ' 232' ' ' LYS . 1.2 p -133.27 168.34 18.44 Favored Pre-proline 0 N--CA 1.433 -1.304 0 N-CA-C 104.314 -2.476 . . . . 0.0 104.314 177.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . 0.638 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 11.6 Cg_exo -75.05 -11.14 21.38 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 121.588 1.525 . . . . 0.0 110.889 176.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 57.9 t -86.04 129.9 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -92.36 -44.07 8.9 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.543 0.687 . . . . 0.0 109.175 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -164.21 134.54 4.16 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.814 -174.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 61.6 t -95.44 117.72 40.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 175.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.445 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 62.4 m -115.69 113.32 23.34 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-O 121.149 0.5 . . . . 0.0 110.359 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.438 ' O ' ' HB2' ' A' ' 274' ' ' GLN . 0.0 OUTLIER -98.78 120.79 39.82 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 179.374 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -123.65 131.06 53.52 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -176.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -75.81 133.08 40.73 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 172.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.45 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 31.9 tp -110.39 -179.61 3.82 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -177.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.45 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 4.6 m-20 -35.31 -72.11 0.06 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.167 1.787 . . . . 0.0 112.881 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -123.7 -2.2 8.38 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . 0.416 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 12.9 m-20 -117.86 174.92 5.91 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.811 -170.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.522 ' HB ' ' HB2' ' A' ' 264' ' ' LEU . 83.5 m -117.4 126.97 53.56 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 175.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 36.3 tt0 -109.94 128.15 55.2 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -175.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 63.5 tp -116.38 117.39 29.82 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.644 177.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' A' ' 260' ' ' ILE . 51.1 mt -107.14 115.26 48.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.391 -176.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 56.0 mt -110.63 105.49 18.91 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.551 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' THR . . . . . 0.413 ' HA ' ' HB3' ' A' ' 259' ' ' HIS . 3.0 m -77.68 131.48 37.74 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -176.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 7.3 p -130.43 165.46 22.57 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -144.95 158.27 43.86 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 123.174 0.59 . . . . 0.0 109.89 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 74.54 -145.27 34.02 Favored Glycine 0 C--N 1.332 0.306 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 31.9 m-80 -110.41 133.51 53.2 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 174.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' TRP . . . . . 0.641 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 57.0 p-90 -143.41 165.0 28.75 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 120.086 -0.646 . . . . 0.0 110.866 -175.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -126.18 134.85 51.15 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -177.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.641 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 18.5 tp -106.74 122.99 47.47 Favored 'General case' 0 CA--C 1.503 -0.841 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.788 -178.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.493 ' CG1' ' HB3' ' A' ' 323' ' ' GLN . 10.1 p -127.57 117.67 47.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-O 121.883 0.849 . . . . 0.0 109.461 171.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -106.11 136.18 46.26 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.466 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -129.58 151.28 50.37 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.374 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 43.2 t -116.05 112.79 22.28 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 177.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -70.13 -35.78 74.33 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.648 0.737 . . . . 0.0 109.105 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -164.83 157.61 14.19 Favored Pre-proline 0 N--CA 1.438 -1.054 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -63.17 100.48 0.26 Allowed 'Trans proline' 0 C--O 1.24 0.596 0 C-N-CA 121.778 1.652 . . . . 0.0 111.152 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 125.67 -9.99 7.61 Favored Glycine 0 N--CA 1.436 -1.329 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -176.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -127.01 116.18 20.35 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -121.54 168.53 11.63 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-O 121.573 0.701 . . . . 0.0 110.708 -174.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 91.8 m -151.48 123.56 8.17 Favored 'General case' 0 C--N 1.276 -2.602 0 C-N-CA 124.307 1.043 . . . . 0.0 108.817 -177.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 1.656 ' HE2' ' CE1' ' A' ' 322' ' ' PHE . 90.3 m-85 -109.52 113.35 26.08 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . 0.493 ' HB3' ' CG1' ' A' ' 311' ' ' VAL . 8.0 tt0 -101.6 110.96 23.06 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 93.3 t -100.04 99.3 8.22 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.297 -179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -86.86 156.45 55.36 Favored Pre-proline 0 C--N 1.315 -0.92 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -81.33 138.63 11.17 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 121.713 1.609 . . . . 0.0 110.574 172.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -108.99 154.97 21.43 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 27.4 tptp 82.31 101.41 0.05 Allowed 'General case' 0 C--N 1.307 -1.256 0 O-C-N 124.794 1.309 . . . . 0.0 113.179 172.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 . . . . . 0 N--CA 1.425 -1.707 0 CA-C-N 115.018 -0.992 . . . . 0.0 108.596 174.502 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 CA--C 1.523 -0.082 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -62.84 -18.55 59.76 Favored Glycine 0 C--O 1.217 -0.946 0 N-CA-C 114.82 0.688 . . . . 0.0 114.82 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 15.8 m -58.52 -36.58 74.04 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 117.563 0.682 . . . . 0.0 112.714 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 29.5 p -93.37 13.62 20.96 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-O 122.051 0.929 . . . . 0.0 110.6 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -135.88 25.86 3.33 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -79.0 111.04 14.8 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.567 -1.197 . . . . 0.0 111.211 -172.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -94.86 -176.37 3.84 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 177.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 70.85 27.33 3.54 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 122.188 0.994 . . . . 0.0 108.674 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -131.35 121.74 25.18 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -76.18 102.46 5.79 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -141.91 87.7 0.18 Allowed Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 119.913 -1.137 . . . . 0.0 112.973 -176.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 4.3 tt -88.81 105.39 17.69 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 105.005 -2.22 . . . . 0.0 105.005 175.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 30.5 m -120.73 134.53 24.28 Favored Pre-proline 0 C--N 1.301 -1.537 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -173.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -70.09 126.27 12.9 Favored 'Trans proline' 0 C--O 1.243 0.738 0 C-N-CA 122.401 2.067 . . . . 0.0 109.943 172.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -83.88 84.22 7.65 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.725 0.774 . . . . 0.0 112.772 -177.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -143.73 26.48 2.09 Favored Glycine 0 C--N 1.294 -1.795 0 N-CA-C 107.63 -2.188 . . . . 0.0 107.63 175.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 4.8 m -81.46 -39.72 24.39 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 113.692 -1.254 . . . . 0.0 111.608 -172.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 63.41 -153.08 0.33 Allowed 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 -170.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 27.7 ttt 68.52 -79.38 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.279 0.631 . . . . 0.0 111.361 176.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -94.21 74.16 3.98 Favored 'General case' 0 C--N 1.273 -2.757 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 39.7 m -150.68 105.94 3.35 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.399 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 26.3 ptm -75.36 4.55 7.04 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 121.286 0.565 . . . . 0.0 111.484 177.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 56.3 m -144.06 106.84 4.45 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -125.38 -131.27 3.59 Favored Glycine 0 CA--C 1.493 -1.304 0 N-CA-C 109.016 -1.633 . . . . 0.0 109.016 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -74.66 -32.34 57.48 Favored Glycine 0 C--N 1.311 -0.834 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 174.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 22.6 mp0 -107.22 139.02 42.33 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 114.37 -0.915 . . . . 0.0 108.994 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -115.87 -55.8 2.39 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 23.3 ptm -144.1 130.16 19.56 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 114.843 -1.072 . . . . 0.0 108.71 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -101.05 114.95 5.15 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -98.37 131.26 44.81 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 95.37 -77.13 0.85 Allowed Glycine 0 N--CA 1.427 -1.952 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 29.5 p 49.1 31.46 3.46 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.486 1.514 . . . . 0.0 114.34 172.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -132.39 6.66 4.15 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.409 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -133.73 128.8 35.67 Favored 'General case' 0 N--CA 1.432 -1.357 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.553 -177.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 91.1 m -65.61 121.51 15.12 Favored 'General case' 0 C--O 1.195 -1.783 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.354 -176.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -143.19 170.4 15.81 Favored 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.229 -173.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.8 pp -128.05 163.51 31.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.898 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -149.77 155.67 40.53 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -176.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 1.648 ' HE1' ' CE2' ' A' ' 230' ' ' PHE . 77.1 t80 -136.78 132.64 35.01 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.096 0.474 . . . . 0.0 110.701 176.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.592 ' HD3' ' OE2' ' A' ' 241' ' ' GLU . 0.3 OUTLIER -149.55 174.41 12.55 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.055 178.23 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -119.62 144.3 47.21 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -150.72 176.59 10.88 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 176.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 53.72 -138.73 37.19 Favored Glycine 0 C--N 1.309 -0.957 0 O-C-N 123.721 0.638 . . . . 0.0 113.682 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -115.1 100.24 8.02 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 60.53 29.08 18.74 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 121.792 0.806 . . . . 0.0 111.533 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.73 135.3 36.37 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.454 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . 0.567 ' HA3' ' CG1' ' A' ' 286' ' ' VAL . . . -102.25 123.47 7.88 Favored Glycine 0 C--N 1.299 -1.526 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -177.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.5 mp -113.67 120.27 63.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 117.423 0.612 . . . . 0.0 111.258 -176.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.1 mp -106.42 107.85 23.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.592 ' OE2' ' HD3' ' A' ' 231' ' ' ARG . 42.9 mt-10 -95.01 111.22 23.04 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 122.408 1.099 . . . . 0.0 111.783 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 12.8 tp -94.3 136.05 35.02 Favored 'General case' 0 C--N 1.278 -2.519 0 CA-C-N 114.097 -1.41 . . . . 0.0 110.756 -175.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -121.56 98.72 6.1 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 176.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -103.16 91.34 4.06 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -79.37 112.8 16.96 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.314 -175.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 110.65 4.45 28.28 Favored Glycine 0 C--N 1.292 -1.875 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.138 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -111.98 108.71 18.14 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -104.51 100.45 10.13 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 159.78 -132.83 3.1 Favored Glycine 0 C--N 1.291 -1.922 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -153.69 132.65 6.95 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.453 ' HB3' ' CD1' ' A' ' 264' ' ' LEU . 14.0 Cg_endo -63.55 171.84 6.34 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.18 2.587 . . . . 0.0 113.111 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.502 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 29.5 t70 -96.01 105.88 17.97 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.009 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 4.4 mp -98.84 117.24 43.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-O 121.296 0.57 . . . . 0.0 111.034 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 13.5 t -102.49 116.84 33.42 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 176.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 76.0 mt-30 -92.52 109.8 21.21 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-O 121.359 0.599 . . . . 0.0 111.909 -176.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 78.3 mt-30 -125.25 149.83 47.63 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 174.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -77.21 -28.58 53.87 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 -174.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -79.91 -24.6 41.01 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.271 -0.971 . . . . 0.0 110.107 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . 0.462 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 39.8 p-80 -171.68 159.25 5.3 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.955 173.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 25.2 mt -105.58 142.21 19.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . 0.42 ' N ' HD13 ' A' ' 261' ' ' ILE . 2.9 mp -122.01 113.72 39.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 299' ' ' GLN . 1.9 m -110.99 135.69 49.33 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.496 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 298' ' ' THR . 29.2 m -129.58 125.07 35.35 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-O 121.589 0.709 . . . . 0.0 110.699 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.453 ' CD1' ' HB3' ' A' ' 251' ' ' PRO . 1.9 mm? -98.59 98.06 9.27 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 175.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.516 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 51.9 mtpt -71.55 131.52 43.38 Favored 'General case' 0 C--N 1.274 -2.7 0 O-C-N 124.005 0.816 . . . . 0.0 111.95 -178.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 9.4 t30 73.61 24.65 2.18 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 124.894 1.371 . . . . 0.0 109.931 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 54.6 t60 -117.16 117.8 30.59 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 121.45 -0.781 . . . . 0.0 109.179 178.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 10.9 p -88.5 130.02 35.31 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-O 120.975 0.417 . . . . 0.0 111.689 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 29.1 tp -115.97 124.95 29.11 Favored Pre-proline 0 N--CA 1.429 -1.496 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.086 177.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -68.6 156.72 64.59 Favored 'Trans proline' 0 C--N 1.321 -0.893 0 C-N-CA 122.66 2.24 . . . . 0.0 112.326 171.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' THR . . . . . 0.486 ' HA ' ' OE1' ' A' ' 274' ' ' GLN . 37.1 p -64.09 -31.48 72.68 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.351 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 2.2 m -64.21 -23.78 67.43 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.24 1.016 . . . . 0.0 112.606 -175.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 226' ' ' THR . 3.3 mm? -95.46 -10.13 30.7 Favored 'General case' 0 CA--C 1.498 -1.036 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.494 -176.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.486 ' OE1' ' HA ' ' A' ' 271' ' ' THR . 50.9 mt-30 -72.73 111.94 8.33 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.962 178.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -142.09 150.44 41.18 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' SER . . . . . 0.544 ' HA ' ' O ' ' A' ' 289' ' ' VAL . 36.9 m -118.99 114.05 21.94 Favored 'General case' 0 N--CA 1.417 -2.09 0 O-C-N 123.594 0.559 . . . . 0.0 109.736 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 66.6 mt -85.8 112.85 21.48 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.221 -177.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -80.4 90.97 5.64 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 174.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . 0.461 ' O ' ' HB2' ' A' ' 282' ' ' PHE . 17.2 m -109.97 25.76 2.96 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 CA-C-N 114.565 -1.198 . . . . 0.0 112.202 -173.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -70.02 150.76 46.31 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 174.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 24.6 t70 73.36 15.69 4.24 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 122.579 1.18 . . . . 0.0 110.955 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 1.663 ' HE2' ' CE1' ' A' ' 282' ' ' PHE . 1.6 m-85 -85.52 -0.07 53.92 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.915 173.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? 62.37 61.17 1.3 Allowed 'General case' 0 CA--C 1.491 -1.326 0 CA-C-O 121.708 0.765 . . . . 0.0 112.649 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 1.8 t -164.21 148.7 8.39 Favored Pre-proline 0 N--CA 1.403 -2.823 0 CA-C-N 113.618 -1.628 . . . . 0.0 108.961 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . 0.416 ' O ' ' HA ' ' A' ' 304' ' ' THR . 14.7 Cg_exo -44.01 -35.48 7.45 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 124.68 3.587 . . . . 0.0 114.098 174.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.567 ' CG1' ' HA3' ' A' ' 238' ' ' GLY . 0.3 OUTLIER -75.87 117.74 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-O 121.989 0.9 . . . . 0.0 110.831 178.044 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -101.47 -37.98 8.19 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.152 -1.385 . . . . 0.0 111.857 -172.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -151.23 140.0 20.82 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.874 -0.516 . . . . 0.0 111.041 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 276' ' ' SER . 46.9 t -110.24 110.08 30.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 175.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 89.0 m -111.83 115.24 28.69 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 58.4 tp -95.87 118.65 32.91 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 176.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . 0.401 ' HA ' HE21 ' A' ' 274' ' ' GLN . 40.8 ttmt -121.89 136.2 54.92 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 121.107 0.479 . . . . 0.0 110.484 -176.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -80.84 139.92 35.69 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 176.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.481 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 19.8 tp -113.0 -178.93 3.5 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 177.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.481 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 20.2 t-20 -53.39 -68.29 0.19 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.113 0.87 . . . . 0.0 112.5 -176.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -109.51 -3.79 16.73 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.032 0.444 . . . . 0.0 110.102 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . 0.516 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 13.1 m-20 -124.0 173.11 8.46 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.406 -168.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.463 ' O ' ' HA ' ' A' ' 263' ' ' THR . 31.8 m -114.92 130.72 56.97 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 175.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . 0.527 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 9.7 tt0 -118.66 124.2 46.81 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -177.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 67.3 tp -107.22 122.01 45.67 Favored 'General case' 0 N--CA 1.412 -2.371 0 C-N-CA 120.361 -0.535 . . . . 0.0 109.844 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 64.0 mt -110.03 109.73 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.264 -176.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 61.6 mt -106.58 107.56 23.01 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.521 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 13.3 m -79.38 131.08 36.0 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -175.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 285' ' ' PRO . 8.9 p -135.64 175.96 9.12 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 122.721 0.408 . . . . 0.0 110.866 -176.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -161.18 141.66 11.09 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 89.52 -163.36 31.12 Favored Glycine 0 C--O 1.25 1.11 0 C-N-CA 121.459 -0.4 . . . . 0.0 113.179 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -91.37 125.38 36.1 Favored 'General case' 0 CA--C 1.486 -1.496 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' TRP . . . . . 0.643 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 59.8 p-90 -150.15 170.65 18.43 Favored 'General case' 0 N--CA 1.413 -2.29 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -177.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -128.91 131.39 47.57 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -176.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.643 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 24.7 tp -105.63 137.3 43.7 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 119.625 -0.83 . . . . 0.0 109.98 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.503 ' CG1' ' HB3' ' A' ' 323' ' ' GLN . 6.5 p -137.21 126.91 37.42 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.31 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 172.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -111.44 145.27 39.27 Favored 'General case' 0 N--CA 1.418 -2.032 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.421 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -139.62 158.01 44.84 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.986 -176.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 32.2 t -115.63 128.31 55.83 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 170.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -84.56 -43.34 14.59 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.706 0.765 . . . . 0.0 108.984 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -153.12 161.47 28.99 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -59.8 100.08 0.13 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.294 1.996 . . . . 0.0 112.336 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 121.38 -29.47 5.69 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . 1.642 ' HD2' ' CD1' ' A' ' 319' ' ' TYR . 95.6 m-85 -95.48 122.72 38.51 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . 1.665 ' HD2' ' CD1' ' A' ' 320' ' ' PHE . 95.1 m-85 -121.94 169.98 10.26 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 121.802 0.811 . . . . 0.0 110.907 -176.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 72.8 m -152.1 128.72 10.78 Favored 'General case' 0 C--N 1.272 -2.787 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.376 -175.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 1.667 ' HD1' ' CD2' ' A' ' 322' ' ' PHE . 68.2 m-85 -117.77 109.38 16.53 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 175.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . 0.503 ' HB3' ' CG1' ' A' ' 311' ' ' VAL . 9.3 tt0 -100.67 114.2 27.72 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 1.5 m -100.76 113.33 36.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 177.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -91.51 151.59 42.72 Favored Pre-proline 0 C--N 1.304 -1.378 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -81.68 134.01 8.42 Favored 'Trans proline' 0 N--CA 1.436 -1.887 0 C-N-CA 121.393 1.395 . . . . 0.0 109.948 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -92.9 100.02 12.56 Favored 'General case' 0 N--CA 1.413 -2.291 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 175.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . 0.285 26.9 tptp -81.94 102.67 11.07 Favored 'General case' 0 N--CA 1.413 -2.305 0 C-N-CA 118.309 -1.356 . . . . 0.0 114.554 -169.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 . . . . . 0 N--CA 1.393 -3.295 0 CA-C-N 112.217 -2.265 . . . . 0.0 105.11 170.936 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 94.0 mmm . . . . . 0 C--O 1.235 0.331 0 N-CA-C 111.276 0.102 . . . . 0.0 111.276 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -72.88 98.28 0.86 Allowed Glycine 0 C--O 1.247 0.935 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 176.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 41.5 t 73.74 166.59 0.3 Allowed 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.471 1.109 . . . . 0.0 108.912 -171.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 37.3 t -89.72 5.86 44.04 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 72.63 89.77 0.09 Allowed 'General case' 0 C--N 1.346 0.426 0 C-N-CA 124.249 1.019 . . . . 0.0 110.631 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -93.92 118.59 31.68 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.592 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -142.39 119.37 11.3 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -93.46 118.27 31.12 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 120.121 -0.631 . . . . 0.0 110.312 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -82.76 -18.56 40.27 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -113.73 117.23 30.94 Favored 'General case' 0 C--O 1.249 1.07 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 120.31 39.56 0.62 Allowed Glycine 0 C--N 1.298 -1.543 0 C-N-CA 119.384 -1.389 . . . . 0.0 113.461 175.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 60.0 tp -81.11 99.09 8.32 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 176.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 16.9 m -108.4 106.13 58.06 Favored Pre-proline 0 C--N 1.305 -1.363 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.536 -178.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -91.34 -162.87 0.11 Allowed 'Trans proline' 0 N--CA 1.445 -1.348 0 C-N-CA 122.642 2.228 . . . . 0.0 111.621 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -133.54 93.79 3.2 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.724 0.773 . . . . 0.0 110.811 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -139.33 64.28 0.54 Allowed Glycine 0 N--CA 1.432 -1.598 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.312 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 38.6 m -143.99 67.37 1.27 Allowed 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 177.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -75.99 90.9 3.03 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.403 -178.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 40.8 tpp -96.28 107.81 20.22 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.005 177.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -96.76 -28.04 14.46 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 3.5 t 55.14 62.2 2.6 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.326 178.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -96.87 106.21 18.48 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -178.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 19.7 m -84.78 115.42 22.7 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -104.52 39.31 2.87 Favored Glycine 0 C--N 1.307 -1.074 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -132.5 114.09 1.39 Allowed Glycine 0 N--CA 1.422 -2.3 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -86.69 81.98 8.03 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.704 0.764 . . . . 0.0 111.424 -178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -142.17 85.06 1.9 Allowed 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.346 176.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 24.3 ptp -83.07 -32.92 26.54 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 159.79 -155.69 26.82 Favored Glycine 0 N--CA 1.418 -2.55 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -157.59 136.64 11.68 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 74.6 -74.54 1.3 Allowed Glycine 0 C--N 1.306 -1.1 0 C-N-CA 121.613 -0.327 . . . . 0.0 113.84 177.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.502 ' HB3' HD12 ' A' ' 245' ' ' LEU . 7.5 t -84.16 -170.66 3.2 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 123.648 0.779 . . . . 0.0 111.112 -176.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -84.49 82.79 8.25 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -171.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . 0.71 ' O ' HD21 ' A' ' 245' ' ' LEU . 12.8 pt20 44.08 -176.35 0.0 OUTLIER 'General case' 0 C--O 1.199 -1.571 0 C-N-CA 126.495 1.918 . . . . 0.0 115.017 172.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 16.6 m -75.23 110.94 9.98 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 166.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.406 ' HB3' ' HB1' ' A' ' 243' ' ' ALA . 38.9 t30 -139.52 151.72 46.36 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.8 -166.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.5 pp -133.94 144.54 35.3 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.388 0 CA-C-N 114.265 -1.334 . . . . 0.0 107.941 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . 0.527 ' O ' ' HA ' ' A' ' 240' ' ' ILE . 8.4 t0 -145.02 157.44 44.12 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -172.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 1.647 ' HD1' ' CD2' ' A' ' 230' ' ' PHE . 85.4 t80 -136.95 135.05 37.37 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . 0.439 HH11 ' HB3' ' A' ' 231' ' ' ARG . 1.0 OUTLIER -156.77 174.29 15.7 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 176.869 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -118.07 153.92 32.93 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 120.462 0.172 . . . . 0.0 110.8 178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -155.32 146.93 23.08 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 124.091 0.87 . . . . 0.0 109.019 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 69.96 -109.33 2.82 Favored Glycine 0 N--CA 1.447 -0.611 0 O-C-N 123.569 0.543 . . . . 0.0 113.735 174.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -123.76 83.49 2.14 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -177.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 61.03 24.15 14.28 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 176.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -80.46 140.56 35.87 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.16 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -100.17 109.54 3.73 Favored Glycine 0 N--CA 1.426 -1.998 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 230' ' ' PHE . 2.1 mp -98.6 114.51 36.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-N 117.144 0.472 . . . . 0.0 110.207 -176.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . 0.527 ' HA ' ' O ' ' A' ' 229' ' ' ASP . 3.7 mp -102.68 111.62 33.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 176.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -88.51 143.82 26.73 Favored 'General case' 0 N--CA 1.412 -2.334 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.629 175.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 13.5 tp -131.69 119.27 21.14 Favored 'General case' 0 C--N 1.27 -2.881 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.14 -177.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -114.16 105.22 12.92 Favored 'General case' 0 C--N 1.276 -2.625 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -111.32 90.61 3.38 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.71 HD21 ' O ' ' A' ' 225' ' ' GLN . 4.0 mm? -81.92 118.25 22.8 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.257 -176.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 103.97 15.64 21.45 Favored Glycine 0 C--N 1.3 -1.471 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.361 178.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . 1.669 ' HD2' ' CD1' ' A' ' 247' ' ' PHE . 67.0 t80 -115.15 116.23 28.05 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 121.067 0.46 . . . . 0.0 110.065 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -106.81 94.54 5.17 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.299 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 159.12 -161.98 32.38 Favored Glycine 0 N--CA 1.425 -2.087 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -118.36 140.76 28.58 Favored Pre-proline 0 C--N 1.298 -1.667 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.475 ' HD3' ' CZ ' ' A' ' 320' ' ' PHE . 27.7 Cg_endo -73.67 165.42 32.37 Favored 'Trans proline' 0 N--CA 1.437 -1.796 0 C-N-CA 121.104 1.203 . . . . 0.0 110.17 176.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.596 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 11.9 t70 -87.63 106.56 18.1 Favored 'General case' 0 C--N 1.27 -2.866 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 177.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 5.3 mp -95.9 109.21 22.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 C-N-CA 119.354 -0.938 . . . . 0.0 109.669 175.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' SER . . . . . 0.511 ' HB2' ' HB ' ' A' ' 261' ' ' ILE . 26.5 m -99.61 117.6 34.33 Favored 'General case' 0 C--N 1.277 -2.546 0 C-N-CA 125.001 1.32 . . . . 0.0 108.48 177.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -100.02 124.89 45.89 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -175.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.49 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 14.5 mm100 -122.62 171.07 9.4 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 171.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 61.2 m-70 -76.89 -41.03 45.37 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.743 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -81.03 -24.83 37.62 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.618 -173.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . 0.49 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 45.7 p-80 -165.08 163.17 20.58 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.039 0.447 . . . . 0.0 111.151 177.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 21.3 mt -107.15 141.87 21.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . 0.511 ' HB ' ' HB2' ' A' ' 254' ' ' SER . 3.8 mp -119.21 117.26 53.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.596 ' HA ' ' O ' ' A' ' 252' ' ' ASP . 0.7 OUTLIER -114.95 142.48 27.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 C-N-CA 119.207 -0.997 . . . . 0.0 108.814 176.816 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 298' ' ' THR . 7.5 m -135.47 124.31 24.0 Favored 'General case' 0 C--N 1.291 -1.941 0 C-N-CA 119.825 -0.75 . . . . 0.0 112.064 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.474 ' CD1' ' HB3' ' A' ' 251' ' ' PRO . 1.9 mm? -97.2 100.24 11.71 Favored 'General case' 0 CA--C 1.467 -2.218 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 175.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.515 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 51.6 mtpt -68.39 126.67 30.34 Favored 'General case' 0 N--CA 1.405 -2.676 0 O-C-N 124.34 1.025 . . . . 0.0 113.235 -173.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 77.67 3.68 3.01 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 113.925 -1.489 . . . . 0.0 111.808 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -86.12 95.66 9.63 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 177.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.84 109.2 6.24 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.286 0.565 . . . . 0.0 111.592 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 23.8 tp -95.64 128.99 35.86 Favored Pre-proline 0 N--CA 1.433 -1.295 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.633 -178.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -71.69 154.87 59.33 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.157 2.571 . . . . 0.0 111.831 170.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 19.3 p -67.6 -29.45 68.79 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 123.206 0.602 . . . . 0.0 112.592 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 11.9 m -62.96 -22.03 66.51 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 123.714 0.806 . . . . 0.0 111.36 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 8.2 mp -96.94 -8.11 31.5 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.375 -175.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.472 HE21 ' HA ' ' A' ' 292' ' ' LYS . 47.7 mt-30 -77.78 136.35 38.11 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.755 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -161.13 165.72 29.1 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 176.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 16.9 m -134.46 138.26 44.61 Favored 'General case' 0 N--CA 1.414 -2.249 0 CA-C-O 121.351 0.596 . . . . 0.0 109.668 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -95.25 101.41 13.14 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -83.84 55.59 3.32 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.728 0.775 . . . . 0.0 109.567 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . 0.454 HG13 ' CD2' ' A' ' 230' ' ' PHE . 13.3 m -81.17 59.56 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.218 -1.355 . . . . 0.0 112.751 -174.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -74.44 121.54 21.61 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.597 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . 0.367 20.4 m-20 58.42 51.91 7.71 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 179.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 1.647 ' HE2' ' CE1' ' A' ' 282' ' ' PHE . 5.9 m-85 -85.38 -2.08 57.71 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 165.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 25.7 mmmt 67.02 61.16 0.5 Allowed 'General case' 0 CA--C 1.485 -1.536 0 CA-C-N 113.222 -1.808 . . . . 0.0 109.996 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.91 165.09 34.91 Favored Pre-proline 0 N--CA 1.42 -1.938 0 N-CA-C 103.565 -2.754 . . . . 0.0 103.565 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -69.12 -15.55 39.58 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.323 1.349 . . . . 0.0 111.405 177.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 42.5 t -84.04 129.55 37.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -96.92 -39.56 9.33 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.261 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -160.36 140.54 11.46 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.223 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 41.8 t -104.67 126.36 59.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 173.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.468 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 48.2 m -128.58 122.74 31.67 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 117.957 0.344 . . . . 0.0 110.69 -177.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 52.0 tp -103.41 108.27 19.44 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . 0.472 ' HA ' HE21 ' A' ' 274' ' ' GLN . 24.5 ttmm -112.06 125.47 54.13 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.286 -177.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . 0.424 ' H ' ' NE2' ' A' ' 274' ' ' GLN . 1.9 ptm180 -68.72 137.94 54.5 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 174.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.585 HD11 ' N ' ' A' ' 295' ' ' ASN . 2.6 tm? -117.4 162.8 17.34 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 -174.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.585 ' N ' HD11 ' A' ' 294' ' ' LEU . 66.5 t30 -14.92 -70.98 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 127.541 2.336 . . . . 0.0 112.972 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -125.46 -2.28 7.44 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 175.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . 0.515 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 10.9 m-20 -118.09 178.61 4.36 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.485 -165.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.568 ' O ' ' HA ' ' A' ' 263' ' ' THR . 42.3 m -114.93 125.53 53.74 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 173.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . 0.589 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 9.0 tt0 -115.16 129.89 56.78 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 120.949 0.404 . . . . 0.0 111.157 -176.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' A' ' 261' ' ' ILE . 12.6 mt -100.58 132.0 46.19 Favored 'General case' 0 CA--C 1.451 -2.862 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.043 172.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' ILE . . . . . 0.468 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 65.5 mt -118.24 108.1 23.51 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.238 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 174.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 66.0 mt -109.89 105.21 18.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.364 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 4.0 m -78.56 129.33 34.7 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -174.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 8.4 p -131.57 153.13 50.19 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -175.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -131.16 147.28 52.59 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.859 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 75.26 -160.21 52.2 Favored Glycine 0 N--CA 1.438 -1.187 0 O-C-N 123.994 0.809 . . . . 0.0 113.07 176.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -93.97 132.64 38.24 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' TRP . . . . . . . . . . . . . 62.0 p-90 -148.05 168.0 23.48 Favored 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.083 -175.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -130.14 127.91 40.71 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -178.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 1.4 tt -96.25 125.89 41.08 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.509 ' CG1' ' HB3' ' A' ' 323' ' ' GLN . 7.2 p -130.17 112.54 23.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 169.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 22.4 t30 -103.58 141.83 35.35 Favored 'General case' 0 CA--C 1.45 -2.89 0 C-N-CA 119.584 -0.847 . . . . 0.0 111.17 -176.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -119.36 121.43 39.53 Favored 'General case' 1 N--CA 1.369 -4.488 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.659 -178.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 16.8 m -95.83 106.47 18.61 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 173.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -84.96 -32.71 22.89 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.079 -175.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -165.42 164.69 12.13 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -177.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.68 94.98 0.15 Allowed 'Trans proline' 0 C--O 1.243 0.736 0 C-N-CA 122.058 1.839 . . . . 0.0 111.143 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 124.89 -23.55 6.2 Favored Glycine 0 N--CA 1.423 -2.171 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.417 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . 0.487 ' HH ' ' CB ' ' A' ' 223' ' ' SER . 75.8 m-85 -101.71 116.19 32.19 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 122.048 -0.678 . . . . 0.0 110.685 -178.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . 0.475 ' CZ ' ' HD3' ' A' ' 251' ' ' PRO . 68.7 m-85 -130.53 159.13 38.04 Favored 'General case' 0 N--CA 1.428 -1.547 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.412 -177.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 61.6 m -152.67 111.93 3.85 Favored 'General case' 0 C--N 1.273 -2.726 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.354 -176.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -98.05 105.32 17.45 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . 0.509 ' HB3' ' CG1' ' A' ' 311' ' ' VAL . 46.3 tt0 -91.21 100.36 13.19 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 93.4 t -88.08 98.83 8.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.519 0.676 . . . . 0.0 109.456 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.421 HD22 ' NE2' ' A' ' 323' ' ' GLN . 20.9 mt -87.74 152.46 51.53 Favored Pre-proline 0 C--N 1.285 -2.208 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.197 -178.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -81.83 138.2 10.35 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 121.503 1.468 . . . . 0.0 109.812 172.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -96.72 118.06 32.35 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.587 -177.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 56.8 pttt -121.76 123.8 42.7 Favored 'General case' 0 C--N 1.288 -2.083 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.343 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 . . . . . 0 C--N 1.298 -1.643 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 177.714 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 67.1 mtt . . . . . 0 CA--C 1.504 -0.792 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 126.25 122.02 2.54 Favored Glycine 0 N--CA 1.431 -1.653 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 51.6 m -143.7 146.77 33.44 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 117.277 0.538 . . . . 0.0 111.4 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 24.2 m -106.84 78.18 1.23 Allowed 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 170.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -51.59 -25.2 6.44 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -172.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 46.7 t60 -123.57 83.3 2.12 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 36.1 p-80 -126.8 -0.67 6.68 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.652 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 6.7 t60 59.75 -88.76 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.437 1.095 . . . . 0.0 109.779 -176.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -149.06 13.95 0.89 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.792 0.806 . . . . 0.0 109.3 174.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 33.5 p80 -94.54 100.5 12.46 Favored 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.671 177.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 172.06 48.74 0.04 OUTLIER Glycine 0 N--CA 1.434 -1.494 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 3.7 tt -152.08 -66.43 0.17 Allowed 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 57.7 t -95.07 -59.5 0.19 Allowed Pre-proline 0 CA--C 1.551 1.014 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.4 125.31 8.97 Favored 'Trans proline' 0 C--N 1.364 1.365 0 C-N-CA 121.103 1.202 . . . . 0.0 110.218 171.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -134.1 -80.89 0.46 Allowed 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -87.37 -38.09 7.88 Favored Glycine 0 N--CA 1.436 -1.347 0 N-CA-C 108.331 -1.908 . . . . 0.0 108.331 174.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 4.1 m -83.43 137.38 33.94 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 174.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -135.5 138.54 43.21 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.992 -177.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 25.8 ttt -101.81 106.15 17.1 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 175.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -80.63 171.44 15.03 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 176.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 32.6 m 71.6 113.98 0.05 Allowed 'General case' 0 C--O 1.24 0.559 0 O-C-N 124.173 0.92 . . . . 0.0 109.856 -174.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 22.0 ptp -78.29 -23.82 47.0 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 21.8 m 59.45 77.92 0.29 Allowed 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.297 -176.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -91.55 112.98 4.25 Favored Glycine 0 N--CA 1.425 -2.096 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.48 -177.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -161.68 143.01 8.44 Favored Glycine 0 N--CA 1.423 -2.18 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 -78.13 -61.75 1.9 Allowed 'General case' 0 C--N 1.306 -1.298 0 O-C-N 123.548 0.205 . . . . 0.0 110.651 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -121.25 77.07 1.28 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.648 0.737 . . . . 0.0 112.241 -178.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 62.6 mtm -87.34 -10.26 52.67 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 122.883 1.325 . . . . 0.0 107.609 174.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -132.76 148.65 19.33 Favored Glycine 0 N--CA 1.406 -3.305 0 N-CA-C 105.024 -3.23 . . . . 0.0 105.024 171.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 41.7 mtp-105 -74.44 -26.87 60.32 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 117.936 0.868 . . . . 0.0 111.687 -175.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -172.88 -36.45 0.03 OUTLIER Glycine 0 N--CA 1.436 -1.35 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 23.9 m -76.39 29.45 0.12 Allowed 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 123.766 0.826 . . . . 0.0 112.899 -177.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . 0.439 ' HD3' ' HB2' ' A' ' 225' ' ' GLN . 0.0 OUTLIER -97.8 -4.89 35.98 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 175.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . 0.464 ' CG ' HD22 ' A' ' 273' ' ' LEU . 1.8 tp60 -151.51 171.92 16.82 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 178.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 16.4 m -62.33 126.25 26.69 Favored 'General case' 0 C--N 1.314 -0.974 0 O-C-N 123.572 0.545 . . . . 0.0 110.791 -178.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -153.33 173.36 15.71 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.254 -178.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.425 HD11 ' CD2' ' A' ' 277' ' ' LEU . 2.1 pp -137.66 156.89 32.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 C-N-CA 124.731 1.212 . . . . 0.0 109.394 -178.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -150.59 156.99 42.46 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -127.79 137.2 52.32 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -153.31 161.98 41.78 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.402 ' HE3' HG21 ' A' ' 284' ' ' THR . 56.9 mtpt -110.65 158.01 19.07 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.597 178.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -155.12 168.22 27.75 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 55.92 -124.71 34.94 Favored Glycine 0 C--N 1.321 -0.29 0 O-C-N 123.704 0.628 . . . . 0.0 113.091 177.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -122.87 100.68 7.02 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 176.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.601 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 94.0 m-20 63.02 24.55 14.59 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 124.16 0.912 . . . . 0.0 112.939 176.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -82.59 141.03 32.89 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -103.47 110.09 3.59 Favored Glycine 0 N--CA 1.429 -1.827 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 322' ' ' PHE . 2.0 mp -104.2 119.91 53.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 121.171 0.51 . . . . 0.0 110.223 -177.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.7 mp -104.14 114.08 42.78 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 175.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -89.43 142.97 27.19 Favored 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 175.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 15.3 tp -134.44 134.29 41.43 Favored 'General case' 0 C--N 1.276 -2.614 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.691 -175.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -127.25 110.33 12.74 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.174 178.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -115.05 91.6 3.67 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.417 0.627 . . . . 0.0 109.891 178.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -83.48 115.32 22.02 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.895 -177.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 111.62 13.81 12.33 Favored Glycine 0 C--N 1.299 -1.527 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.526 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . 1.653 ' HD1' ' CD2' ' A' ' 247' ' ' PHE . 52.8 t80 -116.08 124.18 49.76 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -107.13 93.83 4.77 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 143.97 -157.81 27.21 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 177.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -113.88 148.85 40.8 Favored Pre-proline 0 C--N 1.314 -0.942 0 C-N-CA 123.06 0.544 . . . . 0.0 109.754 177.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.567 ' HD3' ' CZ ' ' A' ' 320' ' ' PHE . 14.2 Cg_endo -74.24 172.14 16.62 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.698 2.265 . . . . 0.0 112.192 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.497 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 34.4 t70 -95.37 111.72 23.55 Favored 'General case' 0 C--N 1.286 -2.191 0 C-N-CA 124.275 1.03 . . . . 0.0 108.694 177.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 4.1 mp -104.91 128.03 58.96 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.329 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 14.1 t -111.43 124.58 52.55 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 174.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -102.63 102.55 12.77 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.14 0.495 . . . . 0.0 112.052 -173.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.496 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 78.8 mt-30 -109.8 158.47 18.11 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 172.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 50.9 m80 -73.42 -36.08 65.91 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -176.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -85.67 -16.1 40.19 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.405 -0.518 . . . . 0.0 112.241 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . 0.496 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 45.4 p-80 -170.69 156.03 5.07 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-O 121.044 0.449 . . . . 0.0 111.717 176.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . 0.442 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 39.6 mt -106.95 141.73 21.44 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . 0.418 ' N ' HD13 ' A' ' 261' ' ' ILE . 3.1 mp -121.66 116.3 49.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 252' ' ' ASP . 1.9 m -112.5 139.31 37.99 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.526 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 177.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 298' ' ' THR . 19.3 m -135.0 127.82 31.2 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-O 121.3 0.572 . . . . 0.0 110.855 178.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.47 ' CD1' ' HB3' ' A' ' 251' ' ' PRO . 1.9 mm? -97.91 106.38 18.67 Favored 'General case' 0 CA--C 1.47 -2.107 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 176.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.555 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 31.8 mmmt -68.82 127.94 34.9 Favored 'General case' 0 N--CA 1.414 -2.247 0 O-C-N 124.309 1.006 . . . . 0.0 113.149 -174.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 62.8 t30 65.65 26.29 11.51 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 112.771 -2.013 . . . . 0.0 110.699 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 45.8 t60 -106.98 112.18 25.02 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.95 125.04 28.76 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 27.0 tp -111.14 125.32 30.82 Favored Pre-proline 0 N--CA 1.435 -1.216 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.251 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . 0.414 ' HD2' HD23 ' A' ' 273' ' ' LEU . 24.1 Cg_exo -68.35 148.13 73.21 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.585 2.19 . . . . 0.0 111.399 170.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' THR . . . . . 0.477 ' O ' ' HG2' ' A' ' 274' ' ' GLN . 6.1 t -71.47 -11.1 60.7 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.327 0.584 . . . . 0.0 112.112 -177.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 19.3 m -79.76 -21.15 44.77 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.521 0.677 . . . . 0.0 110.366 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.464 HD22 ' CG ' ' A' ' 225' ' ' GLN . 8.0 mp -96.59 -13.24 23.04 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.391 -174.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.477 ' HG2' ' O ' ' A' ' 271' ' ' THR . 18.7 pt20 -83.01 107.55 15.69 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-O 122.023 0.916 . . . . 0.0 109.135 -178.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -134.33 176.49 8.56 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 24.1 p -133.62 138.31 45.88 Favored 'General case' 0 N--CA 1.413 -2.289 0 CA-C-O 121.395 0.617 . . . . 0.0 111.06 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.431 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 2.1 mm? -87.19 122.34 30.86 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 103.823 -2.658 . . . . 0.0 103.823 173.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -67.65 -41.02 84.46 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . 0.445 ' HA ' ' CD1' ' A' ' 282' ' ' PHE . 14.8 p 41.65 27.25 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 127.489 2.316 . . . . 0.0 114.46 173.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -82.46 135.41 35.14 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.844 177.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 3.0 t70 72.59 25.76 2.59 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 125.269 1.428 . . . . 0.0 111.386 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.445 ' CD1' ' HA ' ' A' ' 279' ' ' VAL . 5.1 m-85 -88.43 -7.51 56.49 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.642 174.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? 55.09 60.64 3.33 Favored 'General case' 0 CA--C 1.509 -0.625 0 C-N-CA 124.56 1.144 . . . . 0.0 112.027 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' THR . . . . . 0.402 HG21 ' HE3' ' A' ' 232' ' ' LYS . 2.4 p -133.11 173.94 5.29 Favored Pre-proline 0 C--N 1.302 -1.47 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 178.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . 0.601 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 6.6 Cg_exo -77.65 -5.07 15.18 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 121.954 1.769 . . . . 0.0 110.796 176.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 54.4 t -90.72 137.94 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -99.44 -43.45 6.54 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.786 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . 0.411 ' HA ' ' CG1' ' A' ' 279' ' ' VAL . 22.6 ttmm -163.07 134.79 5.07 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -178.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 44.4 t -99.08 120.18 48.07 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.329 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 176.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 32.2 m -127.01 115.32 19.03 Favored 'General case' 0 C--N 1.284 -2.259 0 O-C-N 122.111 -0.368 . . . . 0.0 111.53 -176.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 49.1 tp -94.17 133.84 37.25 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -130.55 134.1 46.75 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -175.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . 0.451 ' HD2' ' HB ' ' A' ' 271' ' ' THR . 3.8 ptm180 -79.41 137.95 37.45 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 173.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.522 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 23.4 tp -111.57 178.98 4.15 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.522 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 63.0 t30 -49.68 -63.72 1.02 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 124.125 0.97 . . . . 0.0 112.517 -177.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -118.66 -2.91 10.89 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 120.673 0.273 . . . . 0.0 111.22 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . 0.555 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 20.6 m-20 -124.88 177.93 5.76 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.707 0.765 . . . . 0.0 110.9 -170.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.546 ' O ' ' HA ' ' A' ' 263' ' ' THR . 50.2 m -114.3 127.77 56.03 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 174.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . 0.493 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 27.8 tt0 -116.05 126.13 53.36 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -176.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 63.7 tp -110.77 120.24 41.76 Favored 'General case' 0 N--CA 1.417 -2.119 0 CA-C-O 121.164 0.507 . . . . 0.0 110.125 178.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 57.8 mt -106.65 109.84 29.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -177.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . 0.442 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 66.5 mt -108.01 107.78 23.65 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 18.1 m -77.77 133.46 38.25 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 12.5 p -135.18 173.85 11.26 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 122.831 0.452 . . . . 0.0 111.081 -175.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -156.28 147.08 21.93 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 120.526 0.203 . . . . 0.0 110.57 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 80.83 -159.23 41.75 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 115.701 -0.682 . . . . 0.0 113.651 174.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' ASN . . . . . 0.422 ' HB3' ' HB3' ' A' ' 327' ' ' LYS . 0.7 OUTLIER -90.34 123.29 33.97 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 176.141 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -149.12 162.79 39.27 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -177.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . 0.471 ' HG2' ' HE2' ' A' ' 327' ' ' LYS . 8.6 mt-10 -119.04 137.52 53.49 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -178.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 1.1 tt -104.91 118.3 36.2 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 32.4 t -118.71 107.78 22.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 174.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -95.75 139.35 32.11 Favored 'General case' 0 C--N 1.311 -1.109 0 C-N-CA 119.093 -1.043 . . . . 0.0 109.207 177.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -125.86 134.93 51.47 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -177.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 28.6 t -115.74 111.88 21.2 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -80.03 -28.42 39.33 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.734 0.778 . . . . 0.0 109.82 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -166.75 160.15 11.5 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -64.71 101.13 0.36 Allowed 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 121.66 1.573 . . . . 0.0 109.837 176.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 127.81 -27.65 4.58 Favored Glycine 0 N--CA 1.426 -1.982 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.96 -176.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . 1.65 ' HD2' ' CD1' ' A' ' 319' ' ' TYR . 60.5 m-85 -108.36 118.43 36.75 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.864 -0.786 . . . . 0.0 110.818 179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . 1.668 ' HE2' ' CE1' ' A' ' 320' ' ' PHE . 48.2 m-85 -128.46 165.76 20.05 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-O 122.143 0.973 . . . . 0.0 110.902 -174.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 70.0 m -152.36 136.82 16.78 Favored 'General case' 0 C--N 1.269 -2.909 0 CA-C-N 114.518 -1.219 . . . . 0.0 107.848 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 1.651 ' HD1' ' CD2' ' A' ' 322' ' ' PHE . 79.8 m-85 -119.88 117.69 28.79 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . 0.433 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 33.9 tt0 -101.55 100.26 10.66 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 91.3 t -88.79 102.03 12.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 50.8 mt -95.07 140.46 22.45 Favored Pre-proline 0 C--N 1.29 -1.988 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.161 -176.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -72.36 126.95 12.09 Favored 'Trans proline' 0 C--O 1.251 1.129 0 C-N-CA 121.431 1.421 . . . . 0.0 109.806 174.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . 0.471 ' HE2' ' HG2' ' A' ' 309' ' ' GLU . 38.2 ttmt -95.06 105.84 17.79 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . 0.496 ' HZ1' ' HB2' ' A' ' 328' ' ' LYS . 0.0 OUTLIER -96.08 147.7 23.45 Favored 'General case' 0 N--CA 1.412 -2.355 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.915 -175.793 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 . . . . . 0 C--N 1.292 -1.929 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.643 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 23.3 ptp . . . . . 0 CA--C 1.512 -0.498 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -146.39 -176.79 20.52 Favored Glycine 0 N--CA 1.431 -1.673 0 C-N-CA 119.915 -1.136 . . . . 0.0 112.304 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 35.0 t -122.15 107.46 12.19 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-O 121.141 0.496 . . . . 0.0 110.381 -178.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 28.9 p -134.15 151.4 51.34 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -73.06 -47.29 45.95 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -123.05 119.05 29.18 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 175.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -75.24 161.52 29.26 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.586 -175.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 56.87 27.85 13.62 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.232 1.413 . . . . 0.0 112.323 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -68.99 -50.22 50.91 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 26.7 m170 57.63 -169.34 0.11 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-N 114.835 -1.075 . . . . 0.0 113.129 178.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 113.59 -18.25 20.23 Favored Glycine 0 C--N 1.303 -1.254 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 6.0 mp -74.2 143.7 45.06 Favored 'General case' 0 C--O 1.251 1.182 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 33.8 m -79.94 143.24 57.29 Favored Pre-proline 0 C--N 1.301 -1.509 0 C-N-CA 120.351 -0.539 . . . . 0.0 109.991 -179.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . 0.411 ' HB2' ' O ' ' A' ' 208' ' ' SER . 74.5 Cg_endo -74.37 158.54 44.48 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 122.099 1.866 . . . . 0.0 111.236 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -82.91 78.62 9.47 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.39 -60.0 4.92 Favored Glycine 0 C--N 1.317 -0.513 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 -177.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 205' ' ' PRO . 30.9 t -129.71 169.34 15.22 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 177.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 -71.21 -66.06 0.67 Allowed 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -177.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 56.7 ttp -136.33 1.05 2.61 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 121.906 0.86 . . . . 0.0 109.677 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -83.78 166.7 17.78 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.96 -178.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 33.3 p -75.28 101.6 4.75 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -177.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' MET . . . . . 0.403 ' O ' ' HB ' ' A' ' 214' ' ' THR . 15.6 tpt -135.39 84.17 2.07 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 173.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' A' ' 213' ' ' MET . 15.4 t 166.44 -13.29 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.199 1.4 . . . . 0.0 107.689 -176.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 100.73 -72.06 0.42 Allowed Glycine 0 N--CA 1.426 -2.003 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 151.14 90.97 0.08 OUTLIER Glycine 0 N--CA 1.426 -1.994 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -73.57 100.48 3.32 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.566 0.698 . . . . 0.0 110.372 -178.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -83.67 124.62 31.03 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.17 -174.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 94.7 mmm -80.61 -31.64 36.57 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 176.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 94.96 -143.56 16.67 Favored Glycine 0 N--CA 1.433 -1.518 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 -178.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -139.8 115.17 9.87 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.616 0.722 . . . . 0.0 109.314 174.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 157.4 -162.75 32.12 Favored Glycine 0 N--CA 1.422 -2.238 0 N-CA-C 107.591 -2.204 . . . . 0.0 107.591 -174.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 23.3 t 69.72 -46.56 0.59 Allowed 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.231 1.012 . . . . 0.0 112.818 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -63.98 -62.09 1.86 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 123.453 0.701 . . . . 0.0 110.642 -178.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -162.62 168.6 21.48 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 59.5 m -61.39 129.72 42.59 Favored 'General case' 0 C--O 1.208 -1.125 0 C-N-CA 125.153 1.381 . . . . 0.0 111.632 -173.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -157.3 171.59 20.13 Favored 'General case' 0 CA--C 1.488 -1.43 0 CA-C-O 121.022 0.439 . . . . 0.0 110.462 -176.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.8 pp -130.27 155.65 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.199 179.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . 0.401 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 18.8 t0 -144.64 156.27 44.03 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 -177.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 1.649 ' HE2' ' CE1' ' A' ' 230' ' ' PHE . 61.8 t80 -131.91 138.6 48.45 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 175.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -155.11 157.55 37.65 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -104.57 151.86 23.11 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.603 175.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -168.05 -174.87 2.47 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 61.81 -117.88 12.92 Favored Glycine 0 N--CA 1.445 -0.761 0 O-C-N 123.446 0.466 . . . . 0.0 113.03 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -126.96 79.91 1.91 Allowed 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -178.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 58.9 29.26 18.63 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.557 0.694 . . . . 0.0 111.249 -177.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -84.24 148.44 26.71 Favored 'General case' 0 N--CA 1.416 -2.168 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.305 -176.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -98.81 108.17 3.55 Favored Glycine 0 N--CA 1.418 -2.534 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.6 mp -101.49 118.84 48.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-N 117.391 0.596 . . . . 0.0 110.193 -177.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 229' ' ' ASP . 3.8 mp -104.73 110.94 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.401 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 176.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.401 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 41.2 mt-10 -87.83 143.23 27.25 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 173.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 14.5 tp -132.12 125.97 32.59 Favored 'General case' 0 C--N 1.273 -2.719 0 CA-C-O 121.52 0.676 . . . . 0.0 111.044 -174.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -113.73 105.73 13.65 Favored 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . 0.424 ' HA ' HG21 ' A' ' 226' ' ' THR . . . -112.32 91.72 3.76 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.601 0.715 . . . . 0.0 109.119 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -81.73 112.52 18.97 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.398 -173.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 107.97 3.41 34.04 Favored Glycine 0 N--CA 1.427 -1.936 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.378 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . 0.429 ' HB2' ' ND1' ' A' ' 267' ' ' HIS . 37.8 t80 -115.82 107.96 15.7 Favored 'General case' 0 C--O 1.212 -0.908 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -102.22 3.28 38.13 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.006 0.431 . . . . 0.0 112.093 -177.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -95.35 -153.74 30.3 Favored Glycine 0 C--N 1.308 -1.012 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.638 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -116.16 137.64 23.6 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 177.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.443 ' HB3' HD11 ' A' ' 264' ' ' LEU . 17.4 Cg_endo -71.83 172.09 15.22 Favored 'Trans proline' 0 N--CA 1.439 -1.711 0 C-N-CA 122.029 1.819 . . . . 0.0 110.904 175.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -99.94 109.57 21.92 Favored 'General case' 0 C--N 1.275 -2.659 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 176.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 4.0 mp -100.11 124.19 53.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-O 121.079 0.466 . . . . 0.0 110.131 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 9.4 t -113.31 106.03 14.12 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 174.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -79.87 103.74 9.97 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.677 178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.506 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 77.8 mt-30 -124.16 152.06 43.28 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 175.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -71.07 -42.44 69.4 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -173.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -76.07 -24.63 55.1 Favored 'General case' 0 C--N 1.314 -0.978 0 O-C-N 123.442 0.464 . . . . 0.0 111.523 -176.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . 0.506 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 43.0 p-80 -170.19 158.38 6.82 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-O 120.549 0.214 . . . . 0.0 110.898 175.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 16.6 mt -105.94 141.45 21.23 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . 0.414 ' N ' HD13 ' A' ' 261' ' ' ILE . 3.1 mp -116.81 113.11 41.98 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 300' ' ' LEU . 54.6 t -113.6 115.91 51.09 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 176.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 298' ' ' THR . 41.6 m -121.65 126.24 48.55 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-O 121.48 0.657 . . . . 0.0 112.218 -177.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.443 HD11 ' HB3' ' A' ' 251' ' ' PRO . 1.6 mm? -94.38 104.09 16.08 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 177.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.569 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 30.1 mtpt -69.05 127.57 33.6 Favored 'General case' 0 N--CA 1.41 -2.446 0 O-C-N 124.204 0.94 . . . . 0.0 113.487 -173.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 64.4 t30 68.26 16.66 9.33 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 113.817 -1.538 . . . . 0.0 111.386 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' HIS . . . . . 0.429 ' ND1' ' HB2' ' A' ' 247' ' ' PHE . 54.6 t60 -95.46 107.74 19.91 Favored 'General case' 0 C--O 1.213 -0.821 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 174.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 1.2 p -82.92 109.79 17.34 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-O 120.889 0.376 . . . . 0.0 111.618 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . 0.411 HD23 ' CD2' ' A' ' 291' ' ' LEU . 23.4 tp -93.22 127.49 46.71 Favored Pre-proline 0 N--CA 1.436 -1.128 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.543 178.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -68.54 159.31 54.05 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 122.381 2.054 . . . . 0.0 111.544 171.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 19.6 p -66.69 -37.13 84.11 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.063 0.459 . . . . 0.0 111.544 -177.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 3.0 m -59.21 -19.35 44.7 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 124.66 1.184 . . . . 0.0 112.456 -178.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.404 HD13 ' O ' ' A' ' 226' ' ' THR . 3.9 mm? -95.96 -12.82 24.45 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 122.195 -0.316 . . . . 0.0 111.044 -176.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -72.31 142.11 48.85 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -163.86 155.38 16.52 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 175.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 16.6 m -122.84 123.7 41.6 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 64.4 mt -95.17 113.27 24.93 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -177.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -76.81 81.5 3.4 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.937 0.875 . . . . 0.0 108.95 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . 0.282 1.5 p -98.37 69.75 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 CA-C-O 123.723 1.725 . . . . 0.0 111.642 -178.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -114.69 145.67 41.78 Favored 'General case' 0 N--CA 1.419 -1.993 0 CA-C-N 113.026 -1.897 . . . . 0.0 106.846 177.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 23.3 t70 68.19 18.22 9.3 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 122.494 1.14 . . . . 0.0 110.879 -178.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 1.633 ' HE1' ' CE2' ' A' ' 282' ' ' PHE . 31.2 m-85 -86.18 -13.84 45.79 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.599 -0.688 . . . . 0.0 109.344 174.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.79 60.62 1.55 Allowed 'General case' 0 CA--C 1.493 -1.22 0 C-N-CA 123.606 0.762 . . . . 0.0 110.822 -178.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -137.02 168.94 14.68 Favored Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 104.109 -2.552 . . . . 0.0 104.109 178.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -71.06 -13.19 31.24 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 121.482 1.455 . . . . 0.0 111.773 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 47.1 t -85.88 132.39 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 123.428 0.691 . . . . 0.0 109.343 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -101.57 -29.2 12.09 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.405 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -171.92 134.32 0.77 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.736 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 59.8 t -96.69 132.12 41.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 173.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 98.8 m -136.72 117.49 14.05 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.803 -0.56 . . . . 0.0 111.772 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.411 ' CD2' HD23 ' A' ' 269' ' ' LEU . 0.1 OUTLIER -97.41 116.77 30.24 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 179.385 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -126.21 136.45 52.84 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -78.74 144.44 35.22 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 176.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.569 HD11 ' N ' ' A' ' 295' ' ' ASN . 2.6 tm? -118.06 163.25 16.89 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 105.942 -1.874 . . . . 0.0 105.942 -178.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.569 ' N ' HD11 ' A' ' 294' ' ' LEU . 4.5 t30 -29.39 -58.33 0.15 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.355 1.862 . . . . 0.0 113.754 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.58 -6.31 7.52 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . 0.569 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 6.0 m-20 -125.39 174.63 8.04 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.595 -160.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.59 ' O ' ' HA ' ' A' ' 263' ' ' THR . 56.1 m -115.34 120.09 38.45 Favored 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 175.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -110.92 117.31 33.03 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-O 121.696 0.76 . . . . 0.0 109.747 -176.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.403 ' HB3' ' HB ' ' A' ' 262' ' ' VAL . 46.1 tp -103.53 117.97 35.67 Favored 'General case' 0 C--N 1.263 -3.188 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 63.3 mt -102.38 109.74 27.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 CA-C-N 114.566 -1.197 . . . . 0.0 107.88 -177.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 58.0 mt -108.71 100.3 10.47 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 27.7 m -72.52 132.17 43.48 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 7.4 p -138.49 174.82 10.14 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 123.482 0.713 . . . . 0.0 110.498 -176.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -158.55 137.43 11.27 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 117.514 0.143 . . . . 0.0 110.996 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 91.66 -157.68 24.7 Favored Glycine 0 N--CA 1.442 -0.908 0 O-C-N 123.508 0.505 . . . . 0.0 112.836 174.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -93.2 124.07 36.92 Favored 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' TRP . . . . . . . . . . . . . 70.3 p-90 -148.32 166.09 29.07 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -124.32 130.26 52.18 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -175.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 1.7 tt -100.73 122.67 43.75 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.548 ' CG1' ' HB3' ' A' ' 323' ' ' GLN . 7.6 p -123.34 114.77 43.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.612 171.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -98.32 144.82 27.31 Favored 'General case' 0 N--CA 1.424 -1.748 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.037 -178.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -131.58 141.06 49.59 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -178.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 78.0 p -111.64 115.43 29.11 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 173.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -76.16 -35.85 59.01 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -166.84 162.92 11.0 Favored Pre-proline 0 C--N 1.309 -1.19 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.77 97.06 0.32 Allowed 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.712 1.608 . . . . 0.0 110.177 176.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 129.37 -15.23 5.8 Favored Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -176.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . 1.658 ' HD1' ' CD2' ' A' ' 319' ' ' TYR . 84.2 m-85 -122.58 116.33 23.68 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 122.372 -0.487 . . . . 0.0 109.821 178.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . 1.669 ' HD1' ' CD2' ' A' ' 320' ' ' PHE . 95.2 m-85 -124.31 164.6 19.26 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.827 0.823 . . . . 0.0 110.661 -175.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 91.3 m -152.44 135.71 15.83 Favored 'General case' 0 C--N 1.267 -3.002 0 CA-C-N 114.871 -1.058 . . . . 0.0 108.846 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 1.667 ' HD1' ' CD2' ' A' ' 322' ' ' PHE . 72.8 m-85 -124.06 117.86 25.66 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . 0.548 ' HB3' ' CG1' ' A' ' 311' ' ' VAL . 45.8 tt0 -102.26 103.43 13.91 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 92.7 t -87.13 98.94 7.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.41 HD22 HE21 ' A' ' 323' ' ' GLN . 32.1 mt -87.47 143.57 34.33 Favored Pre-proline 0 C--N 1.294 -1.813 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.667 -177.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -75.6 132.55 14.75 Favored 'Trans proline' 0 N--CA 1.458 -0.618 0 C-N-CA 121.93 1.753 . . . . 0.0 109.965 173.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -97.09 101.26 12.79 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 120.056 -0.657 . . . . 0.0 110.417 -178.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 49.3 tptt -98.54 109.02 21.85 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 173.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 . . . . . 0 N--CA 1.419 -1.992 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 179.719 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 96.9 mmm . . . . . 0 CA--C 1.507 -0.693 0 CA-C-O 120.887 0.375 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -117.13 -20.64 4.75 Favored Glycine 0 N--CA 1.436 -1.318 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.608 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 18.5 p -77.05 -30.16 55.52 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.21 0.529 . . . . 0.0 110.952 178.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 42.8 t -146.71 133.26 19.79 Favored 'General case' 0 N--CA 1.419 -1.978 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.993 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -98.98 4.96 47.37 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 173.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 35.2 m-70 -69.29 -52.49 26.93 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 51.9 t60 -90.16 69.81 7.22 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 121.988 0.899 . . . . 0.0 108.933 178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 -150.16 12.82 0.76 Allowed 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -178.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -115.8 159.42 21.49 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.201 -0.908 . . . . 0.0 108.679 -174.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -148.41 102.74 3.36 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 177.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 85.02 176.23 50.79 Favored Glycine 0 C--O 1.248 0.988 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -177.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 6.0 tt -84.97 -49.75 8.06 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 36.0 m -100.91 152.74 37.92 Favored Pre-proline 0 C--N 1.308 -1.198 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 176.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -69.53 95.07 0.52 Allowed 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 121.96 1.773 . . . . 0.0 111.745 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 32.2 tpt180 -80.91 94.92 6.59 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -178.39 71.99 0.07 OUTLIER Glycine 0 N--CA 1.419 -2.464 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 30.9 p -79.76 92.59 5.45 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.234 0.54 . . . . 0.0 109.854 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -134.47 -45.51 0.75 Allowed 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.68 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 58.1 ttp -147.56 107.88 4.08 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 120.406 -0.517 . . . . 0.0 111.214 -177.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -118.23 116.1 26.11 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 173.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 215' ' ' GLY . 49.2 m -85.75 109.53 18.7 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.081 0.467 . . . . 0.0 111.99 -176.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 16.6 tpt -171.66 -79.3 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 124.322 1.049 . . . . 0.0 109.303 175.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 13.5 t -85.19 -3.35 58.78 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 122.041 0.924 . . . . 0.0 109.522 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 212' ' ' SER . . . -172.67 -164.6 28.39 Favored Glycine 0 N--CA 1.405 -3.371 0 N-CA-C 107.003 -2.439 . . . . 0.0 107.003 179.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 128.2 -24.22 5.07 Favored Glycine 0 C--N 1.294 -1.773 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.806 178.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 65.21 80.28 0.23 Allowed 'General case' 0 C--O 1.25 1.126 0 C-N-CA 124.106 0.962 . . . . 0.0 111.107 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -79.64 171.48 15.08 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.943 176.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 63.0 mtt -80.13 74.11 6.93 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.535 0.683 . . . . 0.0 110.273 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -168.34 53.53 0.22 Allowed Glycine 0 C--N 1.292 -1.896 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -65.82 113.02 4.03 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-N 114.332 -0.934 . . . . 0.0 110.696 -175.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -79.37 58.94 4.39 Favored Glycine 0 C--O 1.219 -0.786 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 39.9 m -137.37 17.3 2.95 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.613 0.721 . . . . 0.0 109.961 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -126.53 17.86 7.52 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 122.943 1.354 . . . . 0.0 107.445 176.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . 0.409 ' O ' HD21 ' A' ' 245' ' ' LEU . 3.9 pt20 -152.5 152.56 32.07 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 -177.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.576 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 21.2 m -64.48 116.28 5.98 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 176.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -148.68 158.19 43.97 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.301 -170.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.517 ' O ' ' HD2' ' A' ' 275' ' ' ARG . 2.7 pp -137.04 147.61 26.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -142.02 157.27 45.13 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 123.533 0.733 . . . . 0.0 109.991 -174.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 0.442 ' HA ' ' O ' ' A' ' 239' ' ' ILE . 56.3 t80 -133.21 138.52 46.57 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.217 0.532 . . . . 0.0 111.254 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -155.94 164.53 38.37 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 172.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -104.48 162.58 13.12 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.929 178.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' A' ' 237' ' ' ALA . 15.8 t70 -157.97 125.62 5.21 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 81.53 -126.63 7.5 Favored Glycine 0 C--N 1.297 -1.586 0 C-N-CA 121.143 -0.551 . . . . 0.0 113.441 174.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -105.14 90.9 3.58 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -174.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.517 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 17.6 m120 62.83 17.15 9.68 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.023 -0.99 . . . . 0.0 112.724 175.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . 0.478 ' HB2' ' O ' ' A' ' 233' ' ' ASP . . . -83.51 140.93 31.99 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -176.239 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . 0.428 ' C ' HD13 ' A' ' 239' ' ' ILE . . . -101.64 130.27 10.18 Favored Glycine 0 N--CA 1.432 -1.596 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 178.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 230' ' ' PHE . 2.3 mp -118.45 117.28 54.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 117.651 0.725 . . . . 0.0 110.985 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.0 mp -104.16 109.43 27.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 176.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -91.39 118.23 30.35 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-O 121.558 0.694 . . . . 0.0 109.348 178.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 9.8 tp -108.7 117.06 33.19 Favored 'General case' 0 C--N 1.272 -2.775 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.754 -175.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . 0.576 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -103.19 94.4 5.5 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 176.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -101.92 90.93 4.15 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.69 0.757 . . . . 0.0 109.455 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.409 HD21 ' O ' ' A' ' 225' ' ' GLN . 3.6 mm? -88.09 115.29 25.46 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.672 0.749 . . . . 0.0 110.804 -177.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 123.21 -8.27 9.07 Favored Glycine 0 N--CA 1.423 -2.178 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.517 -176.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -115.4 127.0 55.07 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -109.4 -19.15 13.37 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.901 -177.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -87.48 -140.99 6.8 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.921 -177.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -125.14 132.37 24.3 Favored Pre-proline 0 C--N 1.314 -0.943 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.471 ' HD3' ' CZ ' ' A' ' 320' ' ' PHE . 14.1 Cg_endo -69.63 171.68 13.89 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.534 2.156 . . . . 0.0 111.679 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.627 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 33.3 t70 -91.32 105.88 18.1 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 176.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 5.2 mp -101.74 108.99 24.84 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.636 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' SER . . . . . 0.428 ' HB3' ' HB ' ' A' ' 261' ' ' ILE . 23.3 t -91.18 112.17 23.97 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -89.42 103.22 15.87 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.204 0.526 . . . . 0.0 111.241 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.624 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 13.9 mm100 -119.51 154.94 33.05 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 177.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -76.67 -30.91 56.98 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.329 0.585 . . . . 0.0 109.662 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -68.3 -39.48 82.05 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.681 -1.145 . . . . 0.0 112.151 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . 0.624 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 39.5 p-80 -175.6 166.82 3.23 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 20.7 mt -105.87 133.21 50.89 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 106.552 -1.648 . . . . 0.0 106.552 -179.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . 0.492 ' HA ' ' O ' ' A' ' 300' ' ' LEU . 3.4 mp -114.96 115.9 50.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 179.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.627 ' HA ' ' O ' ' A' ' 252' ' ' ASP . 0.8 OUTLIER -113.89 140.64 33.35 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.394 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 298' ' ' THR . 20.2 m -134.09 124.04 25.48 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.517 0.675 . . . . 0.0 111.887 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.46 HD11 ' HB3' ' A' ' 251' ' ' PRO . 1.8 mm? -98.14 108.12 20.75 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.475 ' HD3' ' OD1' ' A' ' 297' ' ' ASP . 59.4 mmtt -67.28 131.49 45.85 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 124.213 0.946 . . . . 0.0 113.549 -177.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 73.68 6.75 5.0 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.565 -1.652 . . . . 0.0 110.357 176.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -95.72 99.61 11.43 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.084 -174.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 19.3 p -77.56 108.96 11.11 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-O 121.224 0.535 . . . . 0.0 111.03 -178.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 30.1 tp -89.92 128.38 50.27 Favored Pre-proline 0 N--CA 1.43 -1.438 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.12 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -70.83 157.7 57.6 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.643 2.228 . . . . 0.0 111.905 171.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' THR . . . . . 0.471 ' HA ' ' OE1' ' A' ' 274' ' ' GLN . 6.7 p -66.87 -38.35 86.17 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.582 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 11.4 m -59.88 -26.3 65.77 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 124.656 1.182 . . . . 0.0 112.516 -178.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 8.5 mp -96.27 2.48 52.93 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.566 0.698 . . . . 0.0 110.814 -172.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.511 HE21 ' HA ' ' A' ' 292' ' ' LYS . 50.7 mt-30 -84.45 123.54 30.36 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.121 178.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . 0.517 ' HD2' ' O ' ' A' ' 228' ' ' ILE . 3.7 ptp180 -137.33 162.4 33.68 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 177.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 289' ' ' VAL . 24.5 t -139.86 126.77 20.79 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.459 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 1.1 mm? -98.16 111.43 23.76 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 124.925 1.29 . . . . 0.0 108.728 -176.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -86.62 92.68 8.99 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 11.8 m -102.32 28.03 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 CA-C-N 114.404 -1.271 . . . . 0.0 112.187 -175.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -67.4 140.49 57.18 Favored 'General case' 0 N--CA 1.403 -2.82 0 CA-C-N 114.062 -1.427 . . . . 0.0 107.591 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 34.4 t70 73.71 4.02 4.62 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 124.892 1.277 . . . . 0.0 113.119 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 1.663 ' HE1' ' CE2' ' A' ' 282' ' ' PHE . 19.8 m-85 -75.61 -3.32 33.76 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.475 -0.766 . . . . 0.0 111.492 174.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm 60.64 58.41 2.45 Favored 'General case' 0 CA--C 1.504 -0.81 0 C-N-CA 124.171 0.989 . . . . 0.0 111.007 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 1.4 p -136.57 168.47 16.87 Favored Pre-proline 0 N--CA 1.428 -1.546 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . 0.517 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 15.7 Cg_exo -71.58 -14.58 30.52 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 121.863 1.709 . . . . 0.0 110.892 176.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 21.4 t -84.18 139.75 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -103.18 -45.36 4.94 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.164 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 277' ' ' LEU . 7.3 ttpm? -163.22 137.61 6.18 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.437 -179.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.459 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 39.9 t -100.67 122.75 53.05 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.34 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 57.7 m -129.26 124.81 35.39 Favored 'General case' 0 C--N 1.28 -2.433 0 CA-C-O 121.217 0.532 . . . . 0.0 110.98 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 45.8 tp -100.04 113.38 25.94 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . 0.511 ' HA ' HE21 ' A' ' 274' ' ' GLN . 40.8 ttmt -115.23 129.34 56.61 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -178.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . 0.445 ' H ' ' NE2' ' A' ' 274' ' ' GLN . 13.8 ptt180 -72.95 142.83 47.82 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 175.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.552 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 19.3 tp -108.38 -173.46 2.28 Favored 'General case' 0 C--N 1.274 -2.692 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.552 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 3.8 t-20 -52.57 -64.02 0.95 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.327 0.584 . . . . 0.0 112.079 -177.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -125.07 -3.49 7.57 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.817 0.818 . . . . 0.0 109.323 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . 0.475 ' OD1' ' HD3' ' A' ' 265' ' ' LYS . 49.6 m-20 -117.05 171.72 7.74 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.054 -175.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.574 ' O ' ' HA ' ' A' ' 263' ' ' THR . 27.2 m -108.05 133.7 51.98 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . 0.615 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 8.2 tt0 -121.44 131.71 54.32 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 118.462 0.574 . . . . 0.0 111.304 -177.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 261' ' ' ILE . 9.1 mt -100.45 135.41 41.93 Favored 'General case' 0 CA--C 1.45 -2.902 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.39 170.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 62.6 mt -121.18 108.11 21.83 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 173.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 56.0 mt -113.22 97.8 6.18 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.733 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' THR . . . . . 0.4 ' HA ' ' CB ' ' A' ' 259' ' ' HIS . 13.7 m -67.7 130.31 42.62 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -176.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 16.8 p -133.26 167.58 20.12 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 123.279 0.362 . . . . 0.0 110.671 -177.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -152.58 141.0 20.66 Favored 'General case' 0 C--O 1.248 0.976 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 87.24 -168.22 38.43 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 121.376 -0.44 . . . . 0.0 112.259 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -86.48 131.96 34.05 Favored 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 177.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' TRP . . . . . 0.638 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 63.4 p-90 -150.34 164.08 36.72 Favored 'General case' 0 N--CA 1.418 -2.036 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.119 -177.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -122.21 135.45 54.77 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 -178.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.638 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 19.8 tp -107.28 115.26 29.86 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.406 -178.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.466 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 28.3 t -116.22 105.26 18.04 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 174.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . 0.419 ' HA ' ' O ' ' A' ' 321' ' ' THR . 25.6 t30 -98.45 134.39 41.5 Favored 'General case' 0 CA--C 1.432 -3.574 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 177.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 54.4 mttm -119.38 120.58 37.3 Favored 'General case' 1 N--CA 1.362 -4.826 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.541 -177.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 39.2 m -82.97 103.53 12.5 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 172.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -71.74 -31.71 66.96 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.992 -177.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . 0.419 ' HB2' ' HD2' ' A' ' 317' ' ' PRO . . . -170.12 166.55 5.24 Favored Pre-proline 0 C--N 1.311 -1.09 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 -178.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' A' ' 316' ' ' ALA . 23.2 Cg_endo -60.02 104.78 0.25 Allowed 'Trans proline' 0 C--O 1.246 0.913 0 C-N-CA 121.988 1.792 . . . . 0.0 112.137 178.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 107.77 -13.83 38.34 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.134 -178.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -108.56 116.19 31.51 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.991 -0.711 . . . . 0.0 109.136 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . 0.471 ' CZ ' ' HD3' ' A' ' 251' ' ' PRO . 83.5 m-85 -121.49 160.34 24.4 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.593 0.711 . . . . 0.0 110.137 -176.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' A' ' 312' ' ' ASN . 94.8 m -152.96 105.88 2.98 Favored 'General case' 0 C--N 1.273 -2.738 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.335 -175.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 1.662 ' HD2' ' CD1' ' A' ' 322' ' ' PHE . 72.9 m-85 -94.1 110.47 22.18 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 -178.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . 0.466 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 51.2 tt0 -97.63 99.98 11.37 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 176.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -96.26 104.07 15.43 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.323 0 CA-C-O 122.642 1.21 . . . . 0.0 110.052 179.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 21.3 mt -95.22 149.54 36.35 Favored Pre-proline 0 C--N 1.296 -1.745 0 CA-C-N 113.238 -1.801 . . . . 0.0 109.555 -174.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -76.35 123.84 7.38 Favored 'Trans proline' 0 C--O 1.247 0.971 0 C-N-CA 121.78 1.653 . . . . 0.0 109.937 173.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -85.55 108.05 17.76 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.363 -176.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -133.01 4.31 3.78 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.897 174.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 . . . . . 0 C--N 1.287 -2.137 0 CA-C-N 113.646 -1.616 . . . . 0.0 107.01 -179.513 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' MET . . . . . 0.473 ' H1 ' ' CG ' ' A' ' 229' ' ' ASP . 53.9 tpp . . . . . 0 N--CA 1.446 -0.651 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -89.2 -125.45 2.64 Favored Glycine 0 N--CA 1.429 -1.791 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 177.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 21.6 p -69.72 140.18 53.46 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 15.6 m -96.08 -169.53 1.94 Allowed 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.392 -177.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -74.1 126.08 29.76 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -175.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -101.51 135.8 42.43 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.98 -174.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -91.97 -38.91 11.98 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 175.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -83.39 90.74 7.22 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . 0.446 ' C ' ' HG2' ' A' ' 205' ' ' PRO . 24.5 t-80 -166.32 25.69 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.484 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -150.41 173.77 13.65 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 122.024 -0.423 . . . . 0.0 110.486 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 84.65 -61.09 4.74 Favored Glycine 0 C--O 1.226 -0.35 0 C-N-CA 121.641 -0.314 . . . . 0.0 113.249 175.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 4.6 mp -83.67 17.36 2.29 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 123.098 0.559 . . . . 0.0 111.458 -176.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . 0.293 33.8 m 43.18 68.85 2.63 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 124.977 1.311 . . . . 0.0 112.396 -173.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . 0.446 ' HG2' ' C ' ' A' ' 200' ' ' HIS . 2.7 Cg_exo -80.49 39.96 0.92 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.982 3.122 . . . . 0.0 113.519 -173.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -80.67 127.55 32.61 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 176.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -58.6 102.52 0.27 Allowed Glycine 0 N--CA 1.435 -1.394 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 178.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 19.4 m -80.74 16.28 1.47 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.844 0.831 . . . . 0.0 111.974 -173.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 72.7 m-70 -108.26 17.67 21.95 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 172.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 26.0 mmt 70.21 82.19 0.16 Allowed 'General case' 0 CA--C 1.503 -0.829 0 C-N-CA 125.881 1.672 . . . . 0.0 111.787 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -93.34 36.55 1.06 Allowed 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.513 -1.222 . . . . 0.0 110.055 -177.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 2.1 p -73.02 -40.75 64.91 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.558 0.694 . . . . 0.0 110.224 178.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 95.8 mmm -126.19 84.21 2.25 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 175.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 29.0 m -78.23 -45.74 22.17 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.767 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 139.19 171.56 12.26 Favored Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -74.52 -33.33 56.3 Favored Glycine 0 C--O 1.245 0.817 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -89.07 138.43 31.42 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -84.28 -38.88 19.89 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 174.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 42.4 ttm -109.24 87.24 2.45 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 176.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 132.66 166.7 11.57 Favored Glycine 0 C--N 1.294 -1.768 0 C-N-CA 120.167 -1.016 . . . . 0.0 111.434 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.9 mtp-105 -138.17 32.07 2.39 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -177.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 112.89 -25.17 11.93 Favored Glycine 0 CA--C 1.497 -1.068 0 N-CA-C 108.462 -1.855 . . . . 0.0 108.462 -175.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 19.8 m -135.89 163.11 31.0 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 174.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . 0.484 ' H ' ' HG ' ' A' ' 245' ' ' LEU . 4.7 tmmm? -159.83 -79.16 0.06 Allowed 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -177.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 175.09 168.63 0.3 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 104.254 -2.499 . . . . 0.0 104.254 178.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.566 ' O ' HD11 ' A' ' 273' ' ' LEU . 11.0 m -64.88 147.72 52.78 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 118.454 0.57 . . . . 0.0 111.05 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -173.92 169.42 4.08 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 120.919 0.39 . . . . 0.0 110.323 173.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.8 pp -124.25 158.81 30.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . 0.473 ' CG ' ' H1 ' ' A' ' 192' ' ' MET . 4.4 t70 -150.38 156.21 41.07 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 1.659 ' HD2' ' CD1' ' A' ' 230' ' ' PHE . 68.1 t80 -138.37 136.51 36.4 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 118.145 0.429 . . . . 0.0 111.368 177.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -149.43 166.38 29.25 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.573 173.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -103.92 139.72 38.69 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -151.39 169.57 21.69 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 59.3 -129.51 49.26 Favored Glycine 0 C--N 1.304 -1.233 0 N-CA-C 114.275 0.47 . . . . 0.0 114.275 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -118.33 89.44 3.12 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 123.889 0.876 . . . . 0.0 109.506 -176.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 54.08 33.8 18.52 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 122.221 1.01 . . . . 0.0 112.338 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.3 140.55 29.64 Favored 'General case' 0 N--CA 1.405 -2.685 0 CA-C-N 114.124 -1.398 . . . . 0.0 108.496 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -100.77 124.64 8.32 Favored Glycine 0 N--CA 1.422 -2.285 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.2 mp -112.62 118.34 57.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-N 117.602 0.701 . . . . 0.0 110.416 -177.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.0 mp -105.02 112.44 38.64 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 177.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.471 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 52.8 mt-10 -90.34 142.47 27.69 Favored 'General case' 0 C--N 1.279 -2.47 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 174.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 11.8 tp -129.99 117.82 20.65 Favored 'General case' 0 C--N 1.265 -3.074 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.275 -175.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . 0.538 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -103.89 106.24 16.68 Favored 'General case' 0 C--N 1.282 -2.345 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 177.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -117.88 90.36 3.32 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 121.603 0.716 . . . . 0.0 110.228 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.484 ' HG ' ' H ' ' A' ' 224' ' ' LYS . 3.9 mm? -87.0 113.91 23.16 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.4 -178.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 122.4 1.31 10.16 Favored Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -176.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -115.54 128.99 56.38 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -104.68 -30.82 9.69 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -176.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -94.26 -141.92 11.82 Favored Glycine 0 CA--C 1.493 -1.34 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.318 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -118.4 142.41 31.31 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -177.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.488 ' HB3' ' CD2' ' A' ' 264' ' ' LEU . 44.0 Cg_endo -79.58 172.34 14.51 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.812 2.341 . . . . 0.0 112.488 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -89.26 109.55 20.42 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.39 108.79 20.91 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 177.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' SER . . . . . 0.448 ' HB2' ' HB ' ' A' ' 261' ' ' ILE . 16.9 m -105.72 111.4 24.07 Favored 'General case' 0 N--CA 1.407 -2.619 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.6 176.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -94.34 112.51 24.3 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.496 -176.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.7 ' HB3' ' O ' ' A' ' 259' ' ' HIS . 6.8 tp60 -116.5 159.73 21.64 Favored 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -76.89 -37.19 55.93 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.145 -177.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -71.23 -34.41 70.76 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.697 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . 0.7 ' O ' ' HB3' ' A' ' 256' ' ' GLN . 35.0 p-80 -168.08 171.22 9.74 Favored 'General case' 0 C--O 1.201 -1.451 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -178.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 21.7 mt -106.38 139.26 28.35 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . 0.448 ' HB ' ' HB2' ' A' ' 254' ' ' SER . 3.6 mp -115.35 108.49 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.926 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.451 ' HB ' ' HB3' ' A' ' 300' ' ' LEU . 43.3 t -106.68 120.93 58.69 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.628 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 175.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' THR . . . . . 0.564 HG21 ' OD1' ' A' ' 297' ' ' ASP . 1.1 m -115.32 130.36 56.88 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.723 -177.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.488 ' CD2' ' HB3' ' A' ' 251' ' ' PRO . 25.5 mt -116.04 83.38 1.93 Allowed 'General case' 0 CA--C 1.474 -1.976 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -178.292 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.435 ' HA ' ' OD2' ' A' ' 297' ' ' ASP . 26.4 mmtm -61.65 140.88 58.11 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.6 -175.221 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 10.9 t30 66.68 15.05 10.02 Favored 'General case' 0 CA--C 1.552 1.027 0 O-C-N 124.792 1.307 . . . . 0.0 110.802 175.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 50.2 t60 -109.89 93.92 4.75 Favored 'General case' 0 C--O 1.187 -2.216 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 176.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 2.0 m -86.64 114.7 23.57 Favored 'General case' 0 C--N 1.28 -2.431 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.334 -173.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 19.6 tp -87.84 135.76 33.36 Favored Pre-proline 0 C--N 1.312 -1.037 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.47 -178.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -78.65 159.91 28.26 Favored 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 122.25 1.967 . . . . 0.0 111.413 171.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' THR . . . . . 0.479 ' HA ' ' OE1' ' A' ' 274' ' ' GLN . 23.5 p -64.0 -28.31 69.72 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.727 0.775 . . . . 0.0 111.081 -179.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 30.1 m -56.86 -26.29 58.29 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 125.693 1.597 . . . . 0.0 113.379 -177.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.566 HD11 ' O ' ' A' ' 226' ' ' THR . 64.7 mt -105.6 -2.27 23.69 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 121.965 -0.459 . . . . 0.0 111.537 -174.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.479 ' OE1' ' HA ' ' A' ' 271' ' ' THR . 55.3 mt-30 -77.9 108.31 11.06 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.971 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -138.26 153.34 49.08 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 20.2 m -117.77 131.99 56.52 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 63.9 mt -100.2 125.82 46.41 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -49.41 -69.11 0.13 Allowed 'General case' 0 N--CA 1.471 0.623 0 O-C-N 124.559 1.162 . . . . 0.0 111.642 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . 0.649 ' HA ' ' CD2' ' A' ' 282' ' ' PHE . 39.1 t 56.12 24.72 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.79 0 O-C-N 124.332 1.02 . . . . 0.0 112.247 176.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -79.5 138.27 37.49 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 120.637 -1.289 . . . . 0.0 109.991 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 60.21 38.68 19.93 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 123.92 0.762 . . . . 0.0 111.514 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 1.635 ' HD1' ' CD2' ' A' ' 282' ' ' PHE . 0.2 OUTLIER -88.59 -2.94 58.86 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.856 179.85 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 65.36 61.24 0.72 Allowed 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.894 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.9 153.45 10.82 Favored Pre-proline 0 C--N 1.298 -1.634 0 CA-C-N 114.127 -1.397 . . . . 0.0 108.966 179.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . 0.461 ' O ' ' HA ' ' A' ' 304' ' ' THR . 62.1 Cg_exo -50.31 -28.13 19.78 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.671 2.914 . . . . 0.0 112.948 173.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 42.4 t -69.57 124.39 25.37 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.946 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -98.71 -44.0 6.58 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.263 -177.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -161.64 139.17 8.85 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 47.0 t -100.89 130.89 49.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 176.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 62.6 m -139.72 117.0 11.24 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.119 0.485 . . . . 0.0 110.772 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 54.9 tp -97.47 115.58 28.04 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? -114.63 129.01 56.62 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -176.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . 0.413 ' H ' ' NE2' ' A' ' 274' ' ' GLN . 5.7 ptm180 -79.46 140.18 37.41 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.166 -1.013 . . . . 0.0 108.572 176.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.584 HD11 ' N ' ' A' ' 295' ' ' ASN . 2.7 tm? -120.29 158.48 26.97 Favored 'General case' 0 N--CA 1.416 -2.149 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.584 ' N ' HD11 ' A' ' 294' ' ' LEU . 21.3 t-20 -14.86 -71.43 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 127.583 2.353 . . . . 0.0 114.032 177.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -125.2 -3.47 7.49 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . 0.564 ' OD1' HG21 ' A' ' 263' ' ' THR . 7.0 t70 -108.58 -177.65 3.38 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.242 1.017 . . . . 0.0 108.471 -169.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.431 ' HB ' ' HB2' ' A' ' 264' ' ' LEU . 58.3 m -134.18 109.55 8.97 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 174.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -103.23 119.17 38.37 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-O 121.708 0.766 . . . . 0.0 109.648 -175.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.451 ' HB3' ' HB ' ' A' ' 262' ' ' VAL . 59.9 tp -105.13 124.26 49.22 Favored 'General case' 0 C--N 1.271 -2.805 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.831 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 66.6 mt -107.16 109.85 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.641 -178.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 61.6 mt -108.36 105.14 18.23 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' THR . . . . . 0.4 ' HA ' ' CB ' ' A' ' 259' ' ' HIS . 11.9 m -74.77 135.36 41.72 Favored 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.832 -174.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 285' ' ' PRO . 17.3 p -134.34 -177.04 4.41 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 123.051 0.54 . . . . 0.0 110.308 -177.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -166.75 149.9 6.76 Favored 'General case' 0 C--O 1.247 0.937 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 71.92 -161.05 54.22 Favored Glycine 0 C--O 1.243 0.659 0 O-C-N 123.672 0.608 . . . . 0.0 112.541 177.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 83.6 m-20 -88.32 128.84 35.5 Favored 'General case' 0 CA--C 1.494 -1.197 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' TRP . . . . . 0.649 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 56.8 p-90 -147.83 167.59 24.36 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -177.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' A' ' 324' ' ' VAL . 15.8 mt-10 -123.69 144.58 49.56 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -177.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.649 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 33.1 tp -120.83 117.52 27.61 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.916 0.389 . . . . 0.0 111.514 -176.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.504 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 58.8 t -110.87 108.27 25.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 174.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -98.46 129.64 45.07 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -135.08 158.71 43.65 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 120.807 0.337 . . . . 0.0 110.223 -178.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 12.0 p -116.5 138.88 51.04 Favored 'General case' 0 N--CA 1.414 -2.247 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.908 172.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -96.55 -22.97 16.75 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -172.39 163.3 4.11 Favored Pre-proline 0 C--N 1.313 -1.001 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -65.11 97.57 0.29 Allowed 'Trans proline' 0 C--O 1.247 0.948 0 C-N-CA 121.63 1.554 . . . . 0.0 111.172 177.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 120.9 -5.15 11.42 Favored Glycine 0 C--O 1.208 -1.521 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.433 -177.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -123.7 116.68 23.45 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.944 -0.739 . . . . 0.0 109.749 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -119.19 166.3 13.13 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.829 0.823 . . . . 0.0 110.749 -176.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 58.5 m -151.97 136.68 17.05 Favored 'General case' 0 C--N 1.281 -2.37 0 C-N-CA 124.259 1.024 . . . . 0.0 109.085 -177.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -123.03 116.26 23.22 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . 0.504 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 8.9 tt0 -103.53 105.87 16.23 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 309' ' ' GLU . 1.3 m -99.59 110.72 27.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-O 121.301 0.572 . . . . 0.0 109.8 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -92.1 156.89 41.73 Favored Pre-proline 0 C--N 1.313 -1.015 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.374 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -83.0 138.51 9.13 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 C-N-CA 121.814 1.676 . . . . 0.0 109.915 171.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -114.07 138.79 49.94 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -134.91 149.35 50.26 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 . . . . . 0 C--O 1.255 1.372 0 CA-C-O 118.088 -0.958 . . . . 0.0 110.921 -179.095 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 CA--C 1.51 -0.581 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 175.98 -68.85 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 177.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 20.0 m -96.51 134.65 39.44 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 28.1 m -81.76 -37.64 26.89 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 35.5 p-80 -133.82 107.47 7.89 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 176.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -96.45 -34.02 11.66 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 -175.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -71.45 144.04 49.86 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 121.546 0.688 . . . . 0.0 111.257 -177.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -134.33 106.43 7.1 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.522 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 47.8 t-80 -156.41 136.64 12.9 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -102.79 167.07 10.11 Favored 'General case' 0 C--N 1.29 -2.003 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.454 -177.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 87.87 -101.25 2.69 Favored Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 64.34 -171.47 0.18 Allowed 'General case' 0 C--O 1.25 1.125 0 C-N-CA 123.647 0.779 . . . . 0.0 110.731 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 9.2 p -145.71 127.62 7.78 Favored Pre-proline 0 N--CA 1.415 -2.207 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 176.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.55 -50.76 2.29 Favored 'Trans proline' 0 C--O 1.246 0.881 0 C-N-CA 121.711 1.608 . . . . 0.0 109.688 176.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 18.4 ttm-85 -166.45 -24.24 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.238 175.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 103.88 -96.7 1.33 Allowed Glycine 0 CA--C 1.489 -1.588 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 176.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 32.8 t -89.98 136.14 33.22 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 174.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -55.18 112.49 1.09 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.382 0.61 . . . . 0.0 112.185 -177.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 12.9 tpt 58.69 77.66 0.29 Allowed 'General case' 0 C--O 1.245 0.84 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.02 -173.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -139.83 18.25 2.49 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.218 -1.356 . . . . 0.0 108.865 176.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 29.8 t -163.78 129.82 3.11 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 58.1 ttp -152.14 -59.09 0.15 Allowed 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 4.5 m -85.04 -24.77 28.01 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -64.05 145.45 49.71 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.645 177.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 96.66 66.98 0.94 Allowed Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -177.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -103.93 174.15 6.0 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 120.604 0.24 . . . . 0.0 110.931 -178.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 11.5 tm0? -77.69 100.75 6.32 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 177.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 60.9 mtt -118.49 174.7 6.1 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.273 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 109.09 -16.46 32.75 Favored Glycine 0 N--CA 1.435 -1.402 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 -115.39 -48.91 2.78 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 122.549 -0.383 . . . . 0.0 110.446 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 81.41 -33.08 2.53 Favored Glycine 0 N--CA 1.461 0.305 0 C-N-CA 121.33 -0.462 . . . . 0.0 112.23 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.419 ' OG ' HD22 ' A' ' 245' ' ' LEU . 25.3 t -111.38 96.57 6.19 Favored 'General case' 0 N--CA 1.414 -2.225 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -103.81 -29.86 10.74 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . 0.43 ' HG2' ' H ' ' A' ' 226' ' ' THR . 42.1 tt0 -172.49 -163.79 0.24 Allowed 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 -176.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.599 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 24.7 m -63.83 125.64 25.02 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 123.403 0.681 . . . . 0.0 112.595 -170.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -152.55 171.81 17.55 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.18 -176.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.5 pp -133.7 158.85 42.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 C-N-CA 123.45 0.7 . . . . 0.0 110.868 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -149.85 156.63 42.11 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -175.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -138.08 138.28 38.59 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.153 0.501 . . . . 0.0 111.086 176.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 21.1 ptt85 -153.76 168.2 27.09 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 172.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.43 ' CE ' ' HA ' ' A' ' 236' ' ' ASN . 54.4 mtpt -113.53 154.41 27.14 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -144.14 117.67 9.15 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 81.48 -117.23 4.37 Favored Glycine 0 C--N 1.294 -1.793 0 C-N-CA 121.186 -0.53 . . . . 0.0 113.956 175.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -101.33 80.22 2.07 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.332 0.587 . . . . 0.0 111.801 -173.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.45 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 91.9 m-20 57.85 18.07 4.69 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 176.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -73.19 136.11 44.69 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . 0.463 ' HA3' ' CG1' ' A' ' 286' ' ' VAL . . . -91.59 123.86 7.37 Favored Glycine 0 N--CA 1.43 -1.752 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.6 mp -117.69 112.43 38.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 117.792 0.796 . . . . 0.0 110.77 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.1 mp -101.0 112.15 32.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -96.93 104.96 17.02 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 122.635 1.207 . . . . 0.0 110.558 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 11.5 tp -95.24 127.45 41.3 Favored 'General case' 0 C--N 1.27 -2.849 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.621 -175.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . 0.599 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -115.78 102.82 10.06 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -109.6 90.97 3.46 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.433 HD23 ' N ' ' A' ' 245' ' ' LEU . 2.9 mm? -78.62 115.82 18.58 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.725 -177.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 108.31 12.15 22.23 Favored Glycine 0 N--CA 1.425 -2.08 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.783 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . 0.436 ' HE1' ' O ' ' A' ' 265' ' ' LYS . 42.2 t80 -115.81 107.85 15.57 Favored 'General case' 0 N--CA 1.421 -1.905 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.803 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -103.76 94.71 5.58 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.409 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 156.76 -139.8 6.75 Favored Glycine 0 C--N 1.299 -1.473 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . 0.418 ' HA ' ' OE1' ' A' ' 250' ' ' GLN . 13.7 mm-40 -129.51 139.88 36.99 Favored Pre-proline 0 C--N 1.305 -1.357 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.445 ' HB3' HD11 ' A' ' 264' ' ' LEU . 9.1 Cg_endo -69.7 172.14 13.11 Favored 'Trans proline' 0 N--CA 1.434 -2.018 0 C-N-CA 121.212 1.275 . . . . 0.0 110.75 176.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -100.72 105.09 16.4 Favored 'General case' 0 C--N 1.267 -3.015 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 4.8 mp -102.37 138.66 25.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-O 121.043 0.449 . . . . 0.0 111.329 -176.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' SER . . . . . 0.441 ' HB3' ' HB ' ' A' ' 261' ' ' ILE . 33.3 t -127.57 124.98 39.44 Favored 'General case' 0 N--CA 1.425 -1.725 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 175.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -102.92 114.65 29.11 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.177 0.513 . . . . 0.0 111.932 -177.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -117.88 160.73 20.93 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 171.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -76.6 -30.89 57.15 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.658 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -68.56 -42.21 78.66 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.939 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . 0.532 ' CB ' ' HA ' ' A' ' 303' ' ' THR . 38.7 p-80 -168.73 168.69 10.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.665 178.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 20.2 mt -106.17 142.36 19.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . 0.441 ' HB ' ' HB3' ' A' ' 254' ' ' SER . 3.3 mp -122.64 122.89 67.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 299' ' ' GLN . 1.4 m -120.14 141.09 41.94 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 175.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 298' ' ' THR . 26.0 m -135.19 126.92 29.15 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-O 121.475 0.655 . . . . 0.0 110.86 177.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.445 HD11 ' HB3' ' A' ' 251' ' ' PRO . 1.5 mm? -94.17 99.3 11.59 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 177.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.558 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 13.2 mptt -59.7 125.4 23.5 Favored 'General case' 0 C--N 1.285 -2.225 0 O-C-N 124.838 1.336 . . . . 0.0 112.451 -178.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 66.4 t30 63.76 35.74 11.06 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.138 0.975 . . . . 0.0 110.402 178.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -121.26 119.09 31.25 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 2.8 p -87.27 144.79 26.64 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.031 0.443 . . . . 0.0 111.946 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 27.1 tp -130.26 129.98 22.97 Favored Pre-proline 0 N--CA 1.427 -1.608 0 C-N-CA 123.77 0.828 . . . . 0.0 109.301 178.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -72.86 152.34 52.18 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.021 1.814 . . . . 0.0 111.586 171.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 34.7 p -68.89 -19.56 64.22 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.942 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 13.6 m -74.97 -18.53 60.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.555 0.693 . . . . 0.0 109.686 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 89.9 mt -106.41 -7.11 17.78 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.065 -176.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -86.57 102.39 14.1 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.67 158.32 44.31 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.656 -177.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 33.9 p -114.59 145.87 41.46 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.566 -175.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 64.2 mt -112.44 119.36 37.95 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -85.88 94.24 9.12 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-O 121.889 0.852 . . . . 0.0 108.714 177.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . 0.568 ' HA ' ' CE1' ' A' ' 282' ' ' PHE . 17.6 t -105.83 30.18 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 CA-C-N 113.943 -1.48 . . . . 0.0 109.902 -173.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -82.0 144.96 30.51 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 35.8 t70 72.37 20.85 3.92 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 122.46 1.124 . . . . 0.0 110.789 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 1.639 ' HE2' ' CE1' ' A' ' 282' ' ' PHE . 19.5 m-85 -90.07 -1.73 58.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.858 173.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 73.23 13.45 4.71 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.539 1.136 . . . . 0.0 111.54 175.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 1.2 p -96.63 174.93 2.94 Favored Pre-proline 0 C--N 1.309 -1.157 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -175.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 7.9 Cg_exo -76.36 -15.26 17.94 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 121.854 1.703 . . . . 0.0 110.768 173.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.463 ' CG1' ' HA3' ' A' ' 238' ' ' GLY . 1.4 m -90.46 138.06 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . 0.466 ' OE1' ' HB3' ' A' ' 305' ' ' ALA . 11.3 mt-30 -104.82 -32.44 8.83 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.239 0.542 . . . . 0.0 110.814 -179.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 36.8 tttp -162.29 133.84 5.29 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.204 -174.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 45.3 t -99.46 132.93 43.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 172.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 97.2 m -142.8 118.92 10.73 Favored 'General case' 0 C--N 1.29 -2.009 0 O-C-N 121.631 -0.668 . . . . 0.0 111.087 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 42.7 tp -96.74 125.03 40.91 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -121.91 129.19 52.35 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.532 -174.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 41.9 ttt-85 -74.54 127.68 33.67 Favored 'General case' 0 N--CA 1.407 -2.584 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 173.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.469 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 19.4 tp -107.99 179.28 4.27 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 176.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.469 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 27.4 t-20 -46.54 -67.76 0.25 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.662 0.785 . . . . 0.0 112.883 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -123.83 -2.09 8.32 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.544 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . 0.558 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 15.9 m-20 -117.43 168.31 10.48 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -177.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.549 ' O ' ' HA ' ' A' ' 263' ' ' THR . 49.5 m -112.9 127.96 56.34 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 176.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . 0.472 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 41.4 tt0 -111.55 129.64 56.0 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -175.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 63.2 tp -111.15 124.61 52.53 Favored 'General case' 0 N--CA 1.415 -2.207 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 176.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 54.2 mt -112.5 121.01 64.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -177.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 53.7 mt -121.43 101.76 10.92 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 178.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' THR . . . . . 0.532 ' HA ' ' CB ' ' A' ' 259' ' ' HIS . 16.8 m -69.34 139.82 54.26 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 10.9 p -134.22 166.04 23.7 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -176.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . 0.466 ' HB3' ' OE1' ' A' ' 287' ' ' GLN . . . -144.66 143.91 30.98 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.315 0.646 . . . . 0.0 110.177 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 77.65 -159.62 48.23 Favored Glycine 0 C--O 1.245 0.801 0 O-C-N 123.897 0.748 . . . . 0.0 112.319 178.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 327' ' ' LYS . 28.9 m-80 -92.67 136.5 33.18 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 176.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' TRP . . . . . 0.665 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 59.3 p-90 -150.47 160.4 43.79 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.781 -0.767 . . . . 0.0 111.157 -175.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 324' ' ' VAL . 16.1 mt-10 -118.14 133.14 56.17 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -177.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.665 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 24.3 tp -108.35 120.92 43.77 Favored 'General case' 0 CA--C 1.498 -1.039 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.825 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.495 ' CG1' ' HB3' ' A' ' 323' ' ' GLN . 7.5 p -122.17 112.12 33.37 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-O 121.964 0.888 . . . . 0.0 109.395 172.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -94.94 139.58 31.13 Favored 'General case' 0 N--CA 1.414 -2.267 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.594 -177.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . 0.435 ' HB2' ' HB ' ' A' ' 321' ' ' THR . 67.0 mttm -130.92 151.32 51.47 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.342 -177.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 27.0 m -116.02 126.75 54.22 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 172.068 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -87.9 -34.62 18.1 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -167.41 163.77 9.7 Favored Pre-proline 0 C--N 1.307 -1.25 0 N-CA-C 104.74 -2.318 . . . . 0.0 104.74 -178.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.68 95.42 0.28 Allowed 'Trans proline' 0 C--O 1.244 0.813 0 C-N-CA 121.535 1.49 . . . . 0.0 111.266 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 131.79 -32.4 2.91 Favored Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -177.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -97.84 116.51 30.2 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . 1.645 ' HE2' ' CE1' ' A' ' 320' ' ' PHE . 61.0 m-85 -119.2 165.03 14.73 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-O 122.188 0.994 . . . . 0.0 110.449 -175.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.435 ' HB ' ' HB2' ' A' ' 313' ' ' LYS . 59.3 m -151.72 128.72 11.05 Favored 'General case' 0 C--N 1.264 -3.135 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.619 -177.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -116.44 114.53 24.36 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . 0.495 ' HB3' ' CG1' ' A' ' 311' ' ' VAL . 34.9 tt0 -104.24 111.87 24.66 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 309' ' ' GLU . 0.2 OUTLIER -105.96 103.65 15.74 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.713 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.261 179.205 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.08 153.0 56.78 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.229 179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -78.55 129.76 9.48 Favored 'Trans proline' 0 N--CA 1.447 -1.226 0 C-N-CA 121.669 1.58 . . . . 0.0 109.491 173.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 307' ' ' ASN . 41.1 ttmt -97.99 118.3 34.26 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -118.58 108.58 15.13 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 175.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 . . . . . 0 C--N 1.281 -2.386 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.423 -178.61 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 95.6 mmm . . . . . 0 CA--C 1.512 -0.481 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -99.08 59.36 0.84 Allowed Glycine 0 C--N 1.314 -0.674 0 N-CA-C 110.871 -0.891 . . . . 0.0 110.871 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 48.9 m 60.06 76.86 0.34 Allowed 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.209 1.004 . . . . 0.0 111.926 -177.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 31.4 t -100.8 -32.51 10.66 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.532 -178.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 68.17 115.53 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.409 1.084 . . . . 0.0 110.823 -176.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 42.0 t60 -77.11 116.74 18.01 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -119.25 105.13 11.04 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -97.07 87.05 4.11 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 174.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 33.0 m170 68.53 -177.93 0.21 Allowed 'General case' 0 C--O 1.241 0.619 0 C-N-CA 124.752 1.221 . . . . 0.0 108.795 -172.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -132.55 93.13 3.18 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 121.747 0.784 . . . . 0.0 110.466 176.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -134.29 163.53 24.6 Favored Glycine 0 N--CA 1.426 -1.981 0 N-CA-C 108.183 -1.967 . . . . 0.0 108.183 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -166.68 -31.49 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 117.798 0.799 . . . . 0.0 110.154 -175.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . 0.337 12.2 m 61.56 106.18 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.537 0 C-N-CA 126.376 1.871 . . . . 0.0 111.608 -173.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -31.04 -62.98 0.11 Allowed 'Trans proline' 0 C--N 1.372 1.798 1 C-N-CA 125.598 4.199 . . . . 0.0 116.003 -172.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -128.5 95.95 4.28 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.27 0.557 . . . . 0.0 110.224 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -162.25 38.29 0.37 Allowed Glycine 0 N--CA 1.436 -1.358 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 178.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 11.5 m -81.87 116.32 21.47 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . 0.472 ' HA ' ' OG ' ' A' ' 212' ' ' SER . 15.3 t-80 -84.62 -2.33 57.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.795 0.807 . . . . 0.0 110.272 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 27.9 ttt -82.28 89.69 6.57 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 170.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . 64.85 67.99 0.53 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.36 -175.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' SER . . . . . 0.472 ' OG ' ' HA ' ' A' ' 209' ' ' HIS . 61.0 m -65.66 -32.36 73.88 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.823 0.821 . . . . 0.0 108.865 175.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 10.8 tmm? -135.85 102.7 5.14 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 103.31 -2.848 . . . . 0.0 103.31 173.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 31.4 m -68.44 -61.22 1.93 Allowed 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.252 0.548 . . . . 0.0 110.256 -176.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 113.06 -64.92 0.27 Allowed Glycine 0 N--CA 1.416 -2.645 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -176.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 117.84 -68.29 0.32 Allowed Glycine 0 N--CA 1.421 -2.337 0 N-CA-C 111.324 -0.711 . . . . 0.0 111.324 177.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . 0.473 ' HA ' ' SD ' ' A' ' 219' ' ' MET . 1.9 mp0 -81.19 104.89 11.98 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.218 0.532 . . . . 0.0 110.349 -177.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -125.57 4.83 7.55 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' MET . . . . . 0.473 ' SD ' ' HA ' ' A' ' 217' ' ' GLN . 1.5 mpt? -55.37 133.59 49.78 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-N 114.469 -1.241 . . . . 0.0 113.472 -171.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 124.78 111.06 1.87 Allowed Glycine 0 N--CA 1.41 -3.049 0 N-CA-C 107.966 -2.054 . . . . 0.0 107.966 -173.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -70.84 -17.29 62.75 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.332 0.586 . . . . 0.0 110.697 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -178.49 86.87 0.07 OUTLIER Glycine 0 N--CA 1.423 -2.21 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 177.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 41.0 m -156.22 -29.89 0.09 Allowed 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 120.655 0.264 . . . . 0.0 111.207 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -81.18 -35.5 31.33 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.696 -176.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -142.57 177.62 8.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.537 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 31.1 m -61.5 133.47 55.76 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -167.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -162.17 170.99 18.12 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.177 -178.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.431 ' CG1' ' HB2' ' A' ' 291' ' ' LEU . 2.8 pp -136.56 157.34 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.183 178.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -145.61 157.61 43.95 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 123.992 0.917 . . . . 0.0 110.147 -175.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 1.633 ' HE1' ' CE2' ' A' ' 230' ' ' PHE . 91.5 t80 -124.0 145.58 49.09 Favored 'General case' 0 C--N 1.31 -1.13 0 O-C-N 123.202 0.314 . . . . 0.0 110.549 177.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -155.52 165.22 37.25 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 170.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.482 ' CE ' ' HA ' ' A' ' 236' ' ' ASN . 55.2 mtpt -115.38 151.23 35.06 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 120.696 0.284 . . . . 0.0 110.586 176.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -136.68 140.51 42.75 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.96 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 66.14 -97.61 0.33 Allowed Glycine 0 N--CA 1.438 -1.188 0 O-C-N 124.3 1.0 . . . . 0.0 114.32 172.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -136.3 92.34 2.77 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-O 120.862 0.363 . . . . 0.0 110.074 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.482 ' HA ' ' CE ' ' A' ' 232' ' ' LYS . 92.4 m-20 65.3 12.9 8.43 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 172.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -74.73 130.87 40.25 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -97.1 113.84 4.82 Favored Glycine 0 C--O 1.21 -1.385 0 O-C-N 123.696 0.623 . . . . 0.0 111.845 -177.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.7 mp -106.96 117.56 53.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 117.834 0.817 . . . . 0.0 111.015 -177.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.4 mp -103.66 112.57 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.919 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 175.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -91.43 128.31 37.21 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 12.8 tp -116.08 123.69 48.52 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-O 121.054 0.454 . . . . 0.0 111.409 -175.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -109.93 104.4 13.31 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -117.43 91.08 3.48 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.03 115.37 19.57 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.139 -174.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 113.08 2.24 25.04 Favored Glycine 0 N--CA 1.432 -1.612 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.718 178.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . 0.424 ' HB2' ' ND1' ' A' ' 267' ' ' HIS . 40.9 t80 -114.96 114.21 25.14 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -178.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -106.91 -10.05 16.11 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -84.1 -154.57 19.66 Favored Glycine 0 C--N 1.318 -0.435 0 C-N-CA 121.425 -0.417 . . . . 0.0 112.464 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -119.69 134.43 23.88 Favored Pre-proline 0 C--N 1.311 -1.082 0 O-C-N 122.485 -0.42 . . . . 0.0 109.872 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.405 ' HB3' ' CD2' ' A' ' 264' ' ' LEU . 32.9 Cg_endo -74.21 171.99 16.9 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.523 2.149 . . . . 0.0 113.042 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -94.71 113.24 25.0 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.104 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 2.2 mp -97.86 108.47 21.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 122.113 0.958 . . . . 0.0 110.191 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' SER . . . . . 0.49 ' HB2' ' HB ' ' A' ' 261' ' ' ILE . 36.6 m -108.98 111.67 23.46 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.37 -1.287 . . . . 0.0 108.856 176.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -104.87 124.18 49.01 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -174.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.441 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 14.3 mm-40 -124.77 167.86 14.01 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 173.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -76.95 -36.28 56.66 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 120.304 -0.558 . . . . 0.0 109.986 177.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -71.91 -37.75 70.03 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.942 -177.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . 0.441 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 55.0 p-80 -167.6 166.01 14.22 Favored 'General case' 0 C--N 1.318 -0.768 0 O-C-N 122.143 -0.348 . . . . 0.0 110.968 178.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . 0.418 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 19.1 mt -106.43 143.75 16.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . 0.49 ' HB ' ' HB2' ' A' ' 254' ' ' SER . 4.2 mp -121.76 111.76 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 177.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 43.1 t -110.12 117.01 53.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 176.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 23.5 m -112.76 124.22 52.09 Favored 'General case' 0 C--N 1.285 -2.233 0 C-N-CA 119.951 -0.7 . . . . 0.0 110.943 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.469 ' HB2' ' HB ' ' A' ' 298' ' ' THR . 17.1 mt -99.82 100.08 10.97 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.486 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 30.7 mmtp -65.7 129.43 39.73 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -174.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 6.4 t30 64.33 23.82 13.12 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 113.532 -1.667 . . . . 0.0 110.202 177.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' HIS . . . . . 0.424 ' ND1' ' HB2' ' A' ' 247' ' ' PHE . 54.9 t60 -112.05 107.69 16.73 Favored 'General case' 0 CA--C 1.476 -1.883 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 2.8 m -94.5 138.51 32.33 Favored 'General case' 0 C--N 1.263 -3.169 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.627 -175.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 29.7 tp -113.79 128.26 25.93 Favored Pre-proline 0 N--CA 1.431 -1.388 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.186 -176.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -62.21 135.7 55.92 Favored 'Trans proline' 0 C--O 1.248 0.98 0 C-N-CA 122.312 2.008 . . . . 0.0 110.705 169.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' THR . . . . . 0.433 ' O ' ' HG2' ' A' ' 274' ' ' GLN . 9.2 t -67.5 -13.11 61.75 Favored 'General case' 0 CA--C 1.56 1.36 0 CA-C-O 121.814 0.816 . . . . 0.0 111.223 -178.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 27.3 m -74.59 -23.99 58.83 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.81 178.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 96.7 mt -100.95 -9.27 21.67 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.128 -174.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.51 ' HB2' ' O ' ' A' ' 291' ' ' LEU . 3.2 pt20 -77.27 94.37 4.14 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-O 122.698 1.237 . . . . 0.0 109.647 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -100.72 166.53 10.83 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.094 -177.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 19.9 m -137.27 127.36 26.03 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.404 ' O ' ' HG3' ' A' ' 288' ' ' LYS . 2.2 mm? -89.83 130.5 36.06 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 179.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -70.44 -42.1 71.98 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . 0.55 ' HA ' ' CD1' ' A' ' 282' ' ' PHE 0.257 10.4 p 40.35 34.3 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.548 0 C-N-CA 126.051 1.74 . . . . 0.0 112.609 177.969 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -89.61 137.66 32.14 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.1 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 14.2 t70 69.2 14.47 8.65 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 125.328 1.451 . . . . 0.0 109.887 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.55 ' CD1' ' HA ' ' A' ' 279' ' ' VAL . 7.9 m-85 -75.82 -20.45 58.17 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.39 174.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp 62.3 60.56 1.41 Allowed 'General case' 0 CA--C 1.5 -0.965 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.981 174.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 1.1 p -133.06 172.32 7.61 Favored Pre-proline 0 C--N 1.286 -2.163 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 177.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . 0.449 ' O ' ' HA ' ' A' ' 304' ' ' THR . 23.8 Cg_exo -65.9 -24.65 53.29 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.51 1.473 . . . . 0.0 110.958 175.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.2 p -87.64 120.22 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 CA-C-O 122.206 1.003 . . . . 0.0 110.077 176.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -90.95 -37.76 13.3 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 114.111 -1.404 . . . . 0.0 111.062 -173.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . 0.46 ' HA ' ' CG1' ' A' ' 279' ' ' VAL . 86.6 tttt -154.29 134.79 13.46 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.013 178.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 35.8 t -102.03 116.56 45.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 175.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.427 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 27.2 m -124.37 121.28 34.51 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 120.729 0.299 . . . . 0.0 110.811 -176.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . 0.51 ' O ' ' HB2' ' A' ' 274' ' ' GLN . 27.7 tp -96.9 126.79 42.3 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 175.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . 0.493 ' HA ' ' NE2' ' A' ' 274' ' ' GLN . 21.5 tptp -125.59 121.98 35.16 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -172.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -77.9 128.25 33.65 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 118.579 -1.248 . . . . 0.0 108.607 177.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.475 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 15.1 tp -101.88 -173.91 2.46 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.475 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 51.1 t-20 -53.95 -67.05 0.29 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 118.311 0.505 . . . . 0.0 111.033 -177.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.43 -4.05 9.89 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.722 178.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . 0.486 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 30.3 m-20 -113.32 164.77 13.14 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.512 -175.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.469 ' HB ' ' HB2' ' A' ' 264' ' ' LEU . 98.9 m -108.09 124.86 50.86 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 174.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -112.97 128.33 56.46 Favored 'General case' 0 N--CA 1.416 -2.167 0 CA-C-O 121.59 0.71 . . . . 0.0 109.239 -176.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -107.18 127.62 53.67 Favored 'General case' 0 C--N 1.271 -2.83 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 176.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' ILE . . . . . 0.427 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 58.1 mt -115.57 109.49 28.48 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . 0.418 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 63.3 mt -110.84 101.05 12.0 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 25.8 m -70.81 134.33 47.27 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 -177.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 285' ' ' PRO . 15.4 p -138.0 171.23 14.72 Favored 'General case' 0 C--N 1.31 -1.111 0 O-C-N 123.256 0.347 . . . . 0.0 111.322 -176.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -154.69 139.75 17.4 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 90.1 -153.41 22.91 Favored Glycine 0 C--N 1.314 -0.656 0 C-N-CA 121.256 -0.497 . . . . 0.0 111.866 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 327' ' ' LYS . 30.4 m-80 -104.3 139.99 38.51 Favored 'General case' 0 C--O 1.255 1.361 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 175.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' TRP . . . . . 0.411 ' HZ3' ' CB ' ' A' ' 310' ' ' LEU . 67.9 p-90 -155.63 166.3 33.93 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.356 -177.057 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -117.88 134.39 54.98 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.411 ' CB ' ' HZ3' ' A' ' 308' ' ' TRP . 1.1 tt -102.85 123.42 46.47 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 176.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.605 ' CG1' ' HB3' ' A' ' 323' ' ' GLN . 6.5 p -117.34 108.16 24.08 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 CA-C-O 122.065 0.936 . . . . 0.0 109.419 170.183 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -98.48 115.93 29.62 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.915 -175.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -116.14 149.77 38.49 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.926 -176.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 48.4 t -111.65 113.78 26.38 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 172.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -79.71 -35.98 38.16 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.533 0.682 . . . . 0.0 109.95 -177.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -168.16 161.59 9.24 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 -178.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -62.09 102.45 0.26 Allowed 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 121.574 1.516 . . . . 0.0 111.497 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 117.03 -9.4 15.73 Favored Glycine 0 N--CA 1.434 -1.45 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.629 -178.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . 1.609 ' HD2' ' CD1' ' A' ' 319' ' ' TYR . 84.1 m-85 -120.08 116.31 25.45 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 122.004 -0.703 . . . . 0.0 110.035 178.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . 1.634 ' HD1' ' CD2' ' A' ' 320' ' ' PHE . 97.9 m-85 -120.63 165.82 14.51 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.697 -178.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 50.4 m -151.64 132.02 13.75 Favored 'General case' 0 C--N 1.274 -2.711 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.386 -176.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 1.655 ' HD1' ' CD2' ' A' ' 322' ' ' PHE . 66.5 m-85 -120.29 107.33 12.84 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 177.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . 0.605 ' HB3' ' CG1' ' A' ' 311' ' ' VAL . 62.7 tt0 -98.67 115.89 29.69 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 92.0 t -100.05 99.16 7.95 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.803 -179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -88.04 144.8 35.1 Favored Pre-proline 0 C--N 1.318 -0.762 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -68.79 131.0 21.62 Favored 'Trans proline' 0 C--O 1.243 0.764 0 C-N-CA 121.443 1.429 . . . . 0.0 110.076 173.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 307' ' ' ASN . 37.7 ttmt -102.02 115.7 31.1 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -179.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -102.46 144.65 30.64 Favored 'General case' 0 C--N 1.285 -2.207 0 C-N-CA 118.715 -1.194 . . . . 0.0 108.997 177.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 . . . . . 0 C--N 1.285 -2.199 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -177.7 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 64.9 mtt . . . . . 0 CA--C 1.509 -0.603 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 148.85 -32.22 1.19 Allowed Glycine 0 CA--C 1.493 -1.312 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 13.2 m -58.23 -41.21 83.65 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 123.635 0.774 . . . . 0.0 111.398 -179.329 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 22.2 p -85.05 -6.63 59.32 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -177.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -125.45 104.76 8.61 Favored 'General case' 0 CA--C 1.495 -1.139 0 O-C-N 121.829 -0.544 . . . . 0.0 110.438 -175.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 65.7 t60 -122.74 -40.16 2.46 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.646 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 71.03 99.87 0.06 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.311 1.044 . . . . 0.0 111.95 -179.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 29.7 t-80 -145.75 112.48 5.96 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.38 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -134.2 118.43 17.62 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 172.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -82.15 100.97 10.13 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 125.34 126.24 2.99 Favored Glycine 0 C--N 1.295 -1.701 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -178.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . 0.413 HD11 ' H ' ' A' ' 203' ' ' LEU . 0.0 OUTLIER -115.84 -3.35 12.21 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 120.508 -0.477 . . . . 0.0 112.207 -178.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 8.7 p -127.85 123.25 22.75 Favored Pre-proline 0 C--N 1.307 -1.254 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.295 -178.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -72.89 131.97 17.75 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.343 2.029 . . . . 0.0 110.358 174.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -85.77 110.91 19.68 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 110.65 45.5 0.9 Allowed Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -177.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 21.3 m -65.95 24.03 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -172.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -101.19 -15.61 17.28 Favored 'General case' 0 C--N 1.308 -1.232 0 O-C-N 121.758 -0.589 . . . . 0.0 109.833 174.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -173.31 10.36 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 177.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -84.75 48.69 1.58 Allowed 'General case' 0 C--O 1.24 0.604 0 O-C-N 121.143 -0.973 . . . . 0.0 111.704 -176.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 8.0 t -65.21 -35.74 82.0 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 21.2 mmt -104.21 83.65 2.11 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 175.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 10.5 m -67.17 103.75 1.29 Allowed 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.017 -175.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 133.15 -16.13 4.7 Favored Glycine 0 N--CA 1.433 -1.522 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.731 -178.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -129.42 116.22 2.11 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -84.07 -33.62 24.37 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.948 0.404 . . . . 0.0 110.372 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -87.85 91.04 8.61 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 3.4 ppp? -100.03 -4.47 29.89 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.826 -176.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 147.08 146.13 4.31 Favored Glycine 0 N--CA 1.424 -2.114 0 C-N-CA 119.906 -1.14 . . . . 0.0 112.748 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -162.63 98.06 0.98 Allowed 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 177.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -155.9 64.89 0.32 Allowed Glycine 0 N--CA 1.418 -2.51 0 C-N-CA 119.151 -1.499 . . . . 0.0 113.145 -177.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 11.4 m -93.68 49.68 1.38 Allowed 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 174.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -107.59 8.16 29.05 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.907 -173.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . 0.458 ' O ' HD21 ' A' ' 245' ' ' LEU . 0.3 OUTLIER -155.63 166.29 33.95 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -177.301 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.568 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 10.5 m -69.79 117.18 11.06 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -151.23 173.02 14.93 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.265 -176.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.455 HD12 ' CD2' ' A' ' 277' ' ' LEU . 2.2 pp -133.48 159.37 42.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.33 -178.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -150.83 156.49 41.36 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -178.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -130.38 134.52 47.21 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.552 175.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -145.26 166.95 24.01 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 173.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 55.2 mtpt -110.82 146.42 36.45 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 174.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . 0.428 ' O ' ' HB1' ' A' ' 237' ' ' ALA . 18.2 t70 -152.88 117.76 5.1 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -177.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 99.25 -131.32 10.52 Favored Glycine 0 N--CA 1.434 -1.467 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.263 178.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -101.39 85.59 2.82 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 122.686 0.395 . . . . 0.0 110.166 -177.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.464 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 91.2 m-20 57.8 21.4 7.44 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 177.049 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . 0.428 ' HB1' ' O ' ' A' ' 233' ' ' ASP . . . -79.18 138.4 37.84 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.907 -178.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -97.27 114.88 5.1 Favored Glycine 0 N--CA 1.421 -2.348 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.2 mp -107.19 111.96 37.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-O 121.505 0.669 . . . . 0.0 110.581 -177.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.5 mp -97.35 112.53 29.6 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 176.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -92.38 136.76 32.93 Favored 'General case' 0 C--N 1.277 -2.548 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 11.8 tp -127.98 127.78 43.86 Favored 'General case' 0 C--N 1.276 -2.598 0 C-N-CA 123.836 0.854 . . . . 0.0 110.359 -174.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . 0.568 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -113.25 101.19 9.18 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -108.28 90.78 3.4 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.458 HD21 ' O ' ' A' ' 225' ' ' GLN . 3.8 mm? -80.52 115.57 20.11 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.998 -174.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 105.87 14.22 21.67 Favored Glycine 0 N--CA 1.431 -1.675 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.597 178.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -114.98 118.21 32.79 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 -178.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -116.43 91.11 3.49 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.842 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 164.89 -148.51 14.33 Favored Glycine 0 N--CA 1.436 -1.305 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -126.42 138.6 32.69 Favored Pre-proline 0 C--N 1.31 -1.116 0 CA-C-N 117.277 0.539 . . . . 0.0 109.603 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.448 ' HB3' HD11 ' A' ' 264' ' ' LEU . 12.0 Cg_endo -71.5 172.1 14.93 Favored 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 121.683 1.589 . . . . 0.0 110.904 175.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.547 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 34.3 t70 -95.64 108.69 20.99 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.403 HD12 ' HG2' ' A' ' 251' ' ' PRO . 4.5 mp -105.84 116.25 49.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-O 121.302 0.572 . . . . 0.0 111.312 -178.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 19.3 t -95.51 111.8 23.64 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 175.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -88.76 95.68 10.37 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 121.468 0.651 . . . . 0.0 111.684 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.484 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 78.4 mt-30 -108.54 144.36 36.31 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 172.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -74.52 -19.98 60.14 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 119.769 -0.772 . . . . 0.0 112.109 -174.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -73.86 -47.24 39.64 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 123.875 0.734 . . . . 0.0 109.942 177.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . 0.484 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 44.3 p-80 -162.67 162.27 26.89 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.158 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 301' ' ' ILE . 29.5 mt -106.05 143.02 17.71 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -177.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 3.4 mp -125.51 114.7 40.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 178.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 252' ' ' ASP . 1.4 m -110.0 140.48 28.79 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.271 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 298' ' ' THR . 24.4 m -135.2 123.99 23.9 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-O 121.131 0.491 . . . . 0.0 111.14 177.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.448 HD11 ' HB3' ' A' ' 251' ' ' PRO . 1.7 mm? -93.98 107.75 19.63 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 176.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.423 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 30.3 mmtp -69.6 129.53 39.9 Favored 'General case' 0 C--N 1.29 -2.001 0 O-C-N 123.927 0.767 . . . . 0.0 112.689 -177.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 14.0 t30 70.1 22.62 5.57 Favored 'General case' 0 CA--C 1.554 1.113 0 O-C-N 124.952 1.407 . . . . 0.0 111.189 176.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 38.0 t60 -112.79 110.27 20.28 Favored 'General case' 0 C--O 1.213 -0.821 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 10.9 p -77.83 142.79 38.34 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.19 0.519 . . . . 0.0 112.158 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 35.9 tp -121.98 121.12 28.15 Favored Pre-proline 0 N--CA 1.431 -1.403 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.543 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -59.62 134.62 58.99 Favored 'Trans proline' 0 C--N 1.321 -0.91 0 C-N-CA 122.672 2.248 . . . . 0.0 111.276 170.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' THR . . . . . 0.512 ' HB ' ' HD3' ' A' ' 293' ' ' ARG . 6.5 t -66.3 -9.3 31.49 Favored 'General case' 0 CA--C 1.554 1.108 0 CA-C-O 121.823 0.82 . . . . 0.0 112.092 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 27.2 m -83.22 -14.95 52.21 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 121.642 0.734 . . . . 0.0 109.902 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.435 HD11 ' O ' ' A' ' 226' ' ' THR . 82.4 mt -106.23 -6.39 18.51 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.171 -176.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . 0.501 ' OE1' ' HG2' ' A' ' 293' ' ' ARG . 8.5 pt20 -82.92 101.39 11.0 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 121.844 0.83 . . . . 0.0 109.637 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -129.25 179.09 5.97 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 48.8 m -125.44 164.87 19.49 Favored 'General case' 0 N--CA 1.409 -2.476 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 176.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.46 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 2.9 mm? -122.29 115.91 23.17 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -77.98 92.37 4.32 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 174.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . 0.611 ' HA ' ' CD2' ' A' ' 282' ' ' PHE . 92.3 t -100.51 18.77 2.91 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 CA-C-O 123.124 1.44 . . . . 0.0 109.357 -176.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -70.19 137.07 50.63 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-N 114.583 -1.19 . . . . 0.0 107.967 176.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 72.94 19.27 3.81 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.961 0.904 . . . . 0.0 112.883 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 0.611 ' CD2' ' HA ' ' A' ' 279' ' ' VAL . 9.4 m-85 -85.69 -13.81 47.34 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.799 172.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.27 60.66 1.99 Allowed 'General case' 0 CA--C 1.492 -1.262 0 CA-C-O 121.838 0.828 . . . . 0.0 110.648 -177.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 2.9 p -136.12 173.3 5.79 Favored Pre-proline 0 N--CA 1.421 -1.924 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 178.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 2.8 Cg_exo -79.02 -5.98 14.78 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.404 1.402 . . . . 0.0 112.211 176.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.3 p -101.53 125.44 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-O 121.38 0.61 . . . . 0.0 110.446 178.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -86.93 -40.89 14.39 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.911 -175.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -159.16 134.26 8.27 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.939 -174.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.46 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 35.6 t -95.14 135.65 28.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 172.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 96.0 m -139.69 121.97 15.95 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 118.094 0.407 . . . . 0.0 110.531 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 45.7 tp -103.79 135.98 44.32 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 176.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -134.22 134.93 42.58 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -177.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . 0.512 ' HD3' ' HB ' ' A' ' 271' ' ' THR . 17.4 ptt180 -73.54 138.06 44.76 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 173.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.519 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 22.6 tp -115.29 -175.47 2.71 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.519 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 16.2 m120 -35.98 -75.94 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.944 1.698 . . . . 0.0 112.543 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -125.4 -1.27 7.55 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 174.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . 0.423 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 11.5 m-20 -108.49 171.79 7.21 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.594 -171.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.569 ' O ' ' HA ' ' A' ' 263' ' ' THR . 91.8 m -114.35 129.07 56.63 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 176.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . 0.52 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 36.3 tt0 -114.05 127.27 55.86 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -176.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 70.1 tp -114.94 123.08 48.21 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.503 178.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' ILE . . . . . 0.467 ' HA ' ' O ' ' A' ' 260' ' ' ILE . 62.5 mt -111.24 118.9 58.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-O 121.429 0.633 . . . . 0.0 109.487 -177.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 65.7 mt -114.87 108.83 26.43 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.533 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 14.6 m -82.59 131.66 35.21 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -176.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 6.9 p -126.67 164.82 20.44 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -174.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -145.98 134.65 22.24 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 123.534 0.734 . . . . 0.0 109.894 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 88.74 -166.8 34.45 Favored Glycine 0 C--O 1.252 1.263 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.237 176.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 327' ' ' LYS . 69.5 m-20 -86.27 126.18 34.12 Favored 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -144.54 165.43 28.02 Favored 'General case' 0 C--N 1.286 -2.152 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.553 -175.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -125.39 145.36 50.08 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.88 122.7 48.51 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -178.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . . . . . . . . . 21.7 t -122.07 106.23 17.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 169.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -100.39 113.02 25.43 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.789 0.804 . . . . 0.0 110.277 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -106.91 150.99 25.85 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.906 -174.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 36.0 t -115.53 102.91 10.22 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 175.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -69.17 -30.96 69.29 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.525 0.679 . . . . 0.0 110.063 -176.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -167.16 159.85 10.73 Favored Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -64.22 95.26 0.21 Allowed 'Trans proline' 0 C--O 1.247 0.953 0 C-N-CA 121.724 1.616 . . . . 0.0 110.858 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 135.38 -33.87 2.37 Favored Glycine 0 N--CA 1.427 -1.963 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.307 -177.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -100.44 117.09 33.89 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 122.188 -0.596 . . . . 0.0 110.171 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . 1.666 ' HE2' ' CE1' ' A' ' 320' ' ' PHE . 92.0 m-85 -117.14 160.59 20.79 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 121.751 0.786 . . . . 0.0 110.04 -179.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 89.6 m -151.77 124.09 8.26 Favored 'General case' 0 C--N 1.268 -2.941 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.713 -176.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -109.82 109.49 20.17 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -97.62 107.84 20.42 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 83.9 t -97.6 99.02 8.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.623 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -88.02 154.93 52.61 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -81.51 142.83 13.28 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 121.44 1.427 . . . . 0.0 109.343 171.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . 0.423 ' O ' ' HB2' ' A' ' 307' ' ' ASN . 37.3 ttmt -111.82 104.44 12.75 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -177.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 13.7 ttpp -112.77 23.91 12.98 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 . . . . . 0 C--N 1.324 -0.538 0 CA-C-N 113.573 -1.649 . . . . 0.0 111.104 179.995 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 51.7 tpp . . . . . 0 C--O 1.236 0.369 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 142.73 -147.14 18.5 Favored Glycine 0 N--CA 1.434 -1.442 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -178.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 50.8 m -115.97 92.08 3.79 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 117.403 0.602 . . . . 0.0 109.923 177.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 49.3 m -82.75 90.39 6.88 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.059 -178.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 27.4 m80 -157.23 -166.62 2.1 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 125.559 1.543 . . . . 0.0 106.846 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 39.1 t60 -97.24 -11.15 24.53 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 119.729 -0.788 . . . . 0.0 111.429 -178.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 40.3 m80 75.04 107.54 0.07 Allowed 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 124.237 1.015 . . . . 0.0 113.675 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -87.76 -57.13 3.06 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 170.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -76.9 99.0 5.07 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 173.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -79.18 -76.4 0.21 Allowed 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.201 -177.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -92.74 0.23 69.95 Favored Glycine 0 N--CA 1.435 -1.417 0 C-N-CA 120.118 -1.039 . . . . 0.0 112.079 -179.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -82.13 83.87 7.21 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.631 0.729 . . . . 0.0 111.623 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 41.3 t -106.3 139.36 20.22 Favored Pre-proline 0 C--N 1.296 -1.76 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 175.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.62 -61.9 0.39 Allowed 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.015 1.81 . . . . 0.0 111.077 176.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -132.21 89.46 2.67 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.126 0.488 . . . . 0.0 110.232 176.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -110.79 104.6 1.79 Allowed Glycine 0 C--N 1.303 -1.265 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 177.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 20.1 m 63.6 -164.95 0.24 Allowed 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -174.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -158.92 -35.37 0.06 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.557 1.071 . . . . 0.0 113.703 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 15.6 tpt -88.83 -4.29 58.53 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 122.778 1.275 . . . . 0.0 109.398 -178.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -168.05 158.5 10.45 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 104.184 -2.524 . . . . 0.0 104.184 176.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 18.0 m -118.77 5.24 11.52 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 122.083 0.944 . . . . 0.0 108.777 177.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.64 160.46 43.11 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.322 -176.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 59.8 m -105.72 103.35 12.83 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 173.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -143.59 -152.37 5.64 Favored Glycine 0 N--CA 1.418 -2.544 0 C-N-CA 119.269 -1.443 . . . . 0.0 113.813 -174.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 124.72 -32.06 4.16 Favored Glycine 0 N--CA 1.428 -1.873 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -177.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . 0.51 ' O ' ' HB2' ' A' ' 221' ' ' ARG . 26.7 mt-30 -72.63 -24.16 61.02 Favored 'General case' 0 C--O 1.209 -1.076 0 CA-C-O 120.781 0.324 . . . . 0.0 111.071 -179.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -65.53 -32.02 73.4 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 176.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' MET . . . . . 0.477 ' O ' ' HA ' ' A' ' 224' ' ' LYS . 50.9 ttm -85.59 -56.23 3.61 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.726 -179.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -93.5 57.85 2.29 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 121.207 -0.521 . . . . 0.0 112.827 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . 0.51 ' HB2' ' O ' ' A' ' 217' ' ' GLN . 44.0 ttm180 -103.85 77.9 1.5 Allowed 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 82.08 -52.46 4.63 Favored Glycine 0 C--N 1.312 -0.788 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.129 -178.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 16.6 m -131.79 132.12 43.5 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 219' ' ' MET . 37.2 mtmm -86.05 -154.9 0.22 Allowed 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -111.05 173.81 6.16 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 176.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.682 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 52.5 m -63.47 112.61 2.84 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.679 0.752 . . . . 0.0 113.026 -174.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -145.49 165.69 27.86 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.85 -175.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . 0.459 HD13 ' CG ' ' A' ' 275' ' ' ARG . 1.6 pp -115.5 161.97 13.87 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.076 178.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . 0.437 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 7.1 t70 -151.26 155.91 39.75 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 1.661 ' HE2' ' CE1' ' A' ' 230' ' ' PHE . 75.4 t80 -132.87 135.57 45.68 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 173.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -149.45 168.84 22.33 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 174.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -117.19 139.91 50.19 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 174.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -149.0 117.78 6.64 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -175.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 99.55 -119.33 6.47 Favored Glycine 0 N--CA 1.428 -1.868 0 C-N-CA 120.608 -0.805 . . . . 0.0 113.127 177.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -113.34 85.35 2.17 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 122.88 -0.188 . . . . 0.0 110.833 -175.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.543 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 5.9 m-20 56.2 21.8 5.57 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 124.705 1.202 . . . . 0.0 113.258 177.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -79.58 142.37 35.74 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.019 -176.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . 0.487 ' HA3' ' CG1' ' A' ' 286' ' ' VAL . . . -92.48 115.99 4.97 Favored Glycine 0 N--CA 1.418 -2.504 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 176.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.6 mp -110.0 109.7 29.39 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-N 118.065 0.932 . . . . 0.0 110.267 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.0 mp -98.96 109.61 24.54 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 N-CA-C 107.427 -1.324 . . . . 0.0 107.427 178.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 44.7 mt-10 -90.78 138.43 31.59 Favored 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 176.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 12.3 tp -128.47 131.48 48.36 Favored 'General case' 0 C--N 1.267 -3.022 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.561 -173.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . 0.682 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -116.41 106.25 13.41 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -118.19 90.91 3.43 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -83.25 113.87 20.98 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.538 0.685 . . . . 0.0 110.864 -174.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 122.99 -5.14 9.66 Favored Glycine 0 N--CA 1.428 -1.873 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.13 -175.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . 1.66 ' HD2' ' CD1' ' A' ' 247' ' ' PHE . 21.4 t80 -115.99 113.09 22.76 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 176.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -114.96 16.77 17.13 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 120.852 0.358 . . . . 0.0 111.437 -175.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -116.68 -162.84 13.01 Favored Glycine 0 C--N 1.302 -1.352 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -101.28 132.51 21.79 Favored Pre-proline 0 C--N 1.301 -1.501 0 CA-C-N 117.798 0.799 . . . . 0.0 110.724 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.433 ' HB3' ' CD2' ' A' ' 264' ' ' LEU . 9.5 Cg_endo -71.73 172.52 14.27 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.429 2.086 . . . . 0.0 112.443 176.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 30.2 t70 -97.07 105.47 17.62 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.406 HD12 ' HG2' ' A' ' 251' ' ' PRO . 4.7 mp -104.86 118.09 51.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.566 -178.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' SER . . . . . 0.405 ' HB3' ' HB ' ' A' ' 261' ' ' ILE . 22.9 t -101.0 123.23 44.87 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 175.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -107.93 95.61 5.8 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -176.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -103.35 164.39 11.67 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -60.93 -48.16 83.07 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 117.851 0.296 . . . . 0.0 111.344 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -76.08 -33.17 59.53 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.255 -173.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . 0.424 ' CB ' ' HA ' ' A' ' 303' ' ' THR . 41.8 p-80 -164.64 166.47 20.1 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 119.908 -0.717 . . . . 0.0 112.677 176.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . 0.421 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 18.6 mt -106.41 144.71 15.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . 0.405 ' HB ' ' HB3' ' A' ' 254' ' ' SER . 3.3 mp -128.94 114.13 31.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 299' ' ' GLN . 1.3 m -107.6 132.74 54.38 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.527 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 175.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 19.5 m -120.83 120.97 37.1 Favored 'General case' 0 C--N 1.281 -2.396 0 CA-C-O 121.211 0.529 . . . . 0.0 109.718 177.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.433 ' CD2' ' HB3' ' A' ' 251' ' ' PRO . 24.0 mt -100.91 94.74 6.18 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 179.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -57.8 126.57 27.97 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -175.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 63.78 19.24 11.63 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 113.263 -1.789 . . . . 0.0 111.283 176.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 53.5 t60 -98.56 117.73 33.66 Favored 'General case' 0 C--O 1.21 -1.006 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 5.4 p -92.7 118.62 31.25 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -176.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 21.5 tp -99.5 129.91 28.0 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.093 -179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -75.96 160.0 37.38 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.28 1.987 . . . . 0.0 111.971 176.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 19.6 p -62.66 -41.24 98.97 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 123.548 0.739 . . . . 0.0 112.485 -174.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 32.2 m -63.15 -23.35 67.39 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 124.573 1.149 . . . . 0.0 113.094 -176.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.541 HD11 ' O ' ' A' ' 226' ' ' THR . 95.4 mt -95.96 -10.11 29.48 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.583 -174.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -74.3 133.39 42.58 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 175.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . 0.459 ' CG ' HD13 ' A' ' 228' ' ' ILE . 5.4 ptp180 -171.58 172.5 5.0 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 177.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 11.8 p -130.39 148.45 52.21 Favored 'General case' 0 N--CA 1.402 -2.845 0 CA-C-O 121.293 0.568 . . . . 0.0 111.008 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.414 HD21 ' HB ' ' A' ' 289' ' ' VAL . 1.3 mm? -95.79 117.31 30.31 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 103.058 -2.942 . . . . 0.0 103.058 174.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -63.54 -38.85 92.7 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . 0.458 ' CG1' ' HA ' ' A' ' 288' ' ' LYS 0.259 12.2 p 40.61 34.91 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.336 0 C-N-CA 127.139 2.176 . . . . 0.0 114.1 174.823 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -85.26 140.47 30.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 115.069 -0.968 . . . . 0.0 108.776 177.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 32.9 t70 72.52 7.65 5.62 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.285 1.034 . . . . 0.0 111.354 178.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . 1.65 ' HD1' ' CD2' ' A' ' 282' ' ' PHE . 11.2 m-85 -73.22 -19.58 61.05 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.198 174.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm 61.85 60.7 1.52 Allowed 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 124.259 1.024 . . . . 0.0 112.032 174.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 4.9 p -128.26 178.25 1.73 Allowed Pre-proline 0 C--N 1.288 -2.108 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . 0.543 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 7.8 Cg_exo -75.36 -10.08 20.51 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 CA-C-N 121.172 1.454 . . . . 0.0 110.714 174.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . 0.487 ' CG1' ' HA3' ' A' ' 238' ' ' GLY . 0.8 OUTLIER -90.54 140.84 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.425 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 179.03 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -99.19 -51.02 3.95 Favored 'General case' 0 C--N 1.279 -2.459 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.425 -177.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . 0.458 ' HA ' ' CG1' ' A' ' 279' ' ' VAL . 86.8 tttt -155.45 135.49 12.94 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.414 ' HB ' HD21 ' A' ' 277' ' ' LEU . 42.9 t -102.44 126.18 56.59 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.927 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 60.8 m -132.49 125.72 31.3 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 121.001 0.429 . . . . 0.0 111.236 -177.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.78 124.78 45.39 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 178.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -128.78 138.12 51.91 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.053 0.454 . . . . 0.0 110.112 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -80.82 144.72 31.85 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 174.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.471 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 32.4 tp -122.93 -179.76 4.37 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.471 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 88.2 m-20 -31.43 -71.92 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 126.514 1.926 . . . . 0.0 112.874 -178.124 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -126.26 -1.63 6.98 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 173.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -110.87 172.8 6.66 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 114.166 -1.379 . . . . 0.0 109.445 -169.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.42 ' HB ' ' HB2' ' A' ' 264' ' ' LEU . 88.8 m -116.71 134.97 54.16 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 174.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . 0.559 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 27.5 tt0 -122.17 125.29 45.8 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 120.975 0.416 . . . . 0.0 109.926 -175.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.415 ' HB3' ' CG1' ' A' ' 262' ' ' VAL . 62.5 tp -108.42 120.52 42.65 Favored 'General case' 0 C--N 1.284 -2.267 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.083 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 72.2 mt -106.95 114.8 46.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.795 -175.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . 0.421 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 52.0 mt -116.51 105.51 18.48 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.326 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 178.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' THR . . . . . 0.424 ' HA ' ' CB ' ' A' ' 259' ' ' HIS . 18.2 m -73.67 138.19 44.58 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -178.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 10.3 p -137.06 177.86 7.53 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 122.803 0.441 . . . . 0.0 111.691 -174.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -156.81 143.33 18.33 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 122.418 0.287 . . . . 0.0 111.168 178.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 77.72 -152.27 38.78 Favored Glycine 0 C--O 1.247 0.951 0 O-C-N 123.523 0.515 . . . . 0.0 113.819 173.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -93.22 129.01 39.41 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 177.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' TRP . . . . . 0.452 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 69.2 p-90 -157.56 160.29 38.01 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -177.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -119.67 130.88 55.26 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -176.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.452 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 1.6 tm? -97.76 136.53 37.96 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.481 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 57.3 t -135.42 111.79 13.27 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -101.16 131.52 47.08 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -130.65 143.78 50.98 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -178.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 13.8 m -111.23 116.38 30.95 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -80.35 -40.84 25.87 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.798 -176.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -159.75 165.86 17.15 Favored Pre-proline 0 C--N 1.301 -1.517 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 -177.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -62.14 102.47 0.27 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 121.679 1.586 . . . . 0.0 111.018 179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 116.39 -27.15 8.21 Favored Glycine 0 N--CA 1.426 -1.974 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.648 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . 1.647 ' HE1' ' CE2' ' A' ' 319' ' ' TYR . 70.6 m-85 -98.11 116.57 30.6 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.922 -0.752 . . . . 0.0 110.762 -178.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -118.63 166.68 12.44 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.474 -177.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 59.6 m -152.0 131.18 12.74 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.387 -176.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 1.665 ' HD1' ' CD2' ' A' ' 322' ' ' PHE . 72.9 m-85 -118.56 114.14 22.36 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 176.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . 0.481 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 7.2 tt0 -101.18 102.94 13.95 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -98.11 101.97 12.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 CA-C-O 122.46 1.124 . . . . 0.0 109.736 177.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 28.0 mt -91.05 145.55 31.89 Favored Pre-proline 0 C--N 1.302 -1.473 0 CA-C-N 113.479 -1.692 . . . . 0.0 109.922 -175.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -72.6 144.4 39.88 Favored 'Trans proline' 0 C--O 1.245 0.856 0 C-N-CA 121.648 1.565 . . . . 0.0 109.442 174.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -123.44 148.35 46.25 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -110.23 129.34 55.74 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 171.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 . . . . . 0 C--N 1.291 -1.967 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 179.467 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 49.8 tpp . . . . . 0 CA--C 1.516 -0.336 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -134.07 -50.31 0.08 OUTLIER Glycine 0 N--CA 1.433 -1.564 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 23.2 m -67.82 98.97 0.77 Allowed 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 120.938 0.399 . . . . 0.0 110.041 178.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 48.1 m -160.15 114.43 2.23 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 123.679 0.792 . . . . 0.0 109.122 -178.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -76.86 -40.48 47.48 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 174.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 81.8 t60 174.19 147.95 0.07 Allowed 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 124.459 1.104 . . . . 0.0 108.467 176.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -121.92 141.52 51.21 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 175.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 6.7 p-80 -130.48 -9.49 4.11 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 -144.52 71.99 1.33 Allowed 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.649 0.737 . . . . 0.0 109.287 -178.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -171.21 127.49 0.69 Allowed 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.669 -1.15 . . . . 0.0 108.236 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -95.77 92.09 1.4 Allowed Glycine 0 N--CA 1.424 -2.149 0 C-N-CA 119.894 -1.146 . . . . 0.0 112.055 178.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 59.7 tp -92.59 -49.57 6.04 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 175.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 64.7 t -88.35 -56.55 0.3 Allowed Pre-proline 0 CA--C 1.55 0.967 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.619 176.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -64.71 140.62 68.74 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 121.059 1.173 . . . . 0.0 109.794 176.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . 0.409 ' HD3' ' O ' ' A' ' 206' ' ' ARG . 0.0 OUTLIER -93.55 138.14 32.11 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 120.969 0.414 . . . . 0.0 112.044 -176.473 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 153.72 68.5 0.01 OUTLIER Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -177.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 43.2 t -113.98 -5.61 13.16 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -176.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -79.6 -70.93 0.48 Allowed 'General case' 0 CA--C 1.51 -0.596 0 CA-C-O 120.989 0.423 . . . . 0.0 111.095 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -111.51 136.69 50.34 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -65.47 89.73 0.1 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.48 0.657 . . . . 0.0 112.402 -177.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 22.6 m -137.07 127.78 27.1 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 23.7 ptp -156.04 171.72 19.63 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 24.3 p -92.56 80.11 4.84 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.397 0.618 . . . . 0.0 110.776 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -110.57 -45.92 0.88 Allowed Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.558 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 166.74 -137.96 4.93 Favored Glycine 0 C--N 1.292 -1.869 0 N-CA-C 108.159 -1.977 . . . . 0.0 108.159 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 63.42 21.77 12.93 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.312 0.645 . . . . 0.0 111.396 175.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -78.43 -4.54 48.86 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.068 -174.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 24.0 ptp -109.25 -6.74 15.43 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.246 -0.581 . . . . 0.0 109.86 173.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -108.4 74.57 0.21 Allowed Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 121.222 -0.513 . . . . 0.0 112.223 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.5 163.48 24.02 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 178.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . 0.458 ' C ' ' H ' ' A' ' 224' ' ' LYS . . . 75.89 -80.83 1.05 Allowed Glycine 0 C--N 1.312 -0.789 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 22.9 t -73.84 11.84 0.79 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.816 1.247 . . . . 0.0 110.237 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . 0.458 ' H ' ' C ' ' A' ' 222' ' ' GLY . 60.1 tttp -74.65 -27.38 60.41 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 172.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . 0.445 ' O ' HD21 ' A' ' 245' ' ' LEU . 5.7 tp-100 -131.54 -178.65 4.96 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 115.256 -0.883 . . . . 0.0 108.953 -176.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 28.3 m -74.1 123.86 25.22 Favored 'General case' 0 C--O 1.202 -1.41 0 C-N-CA 124.495 1.118 . . . . 0.0 113.696 -169.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -143.69 169.05 18.49 Favored 'General case' 0 CA--C 1.474 -1.976 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -175.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.8 pp -135.54 160.15 39.95 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 175.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . 0.456 ' O ' ' HA ' ' A' ' 240' ' ' ILE . 24.0 t70 -148.3 156.49 42.6 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -173.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -125.82 139.06 53.81 Favored 'General case' 0 N--CA 1.427 -1.598 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.016 173.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -155.14 164.16 39.22 Favored 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 124.803 1.241 . . . . 0.0 108.076 177.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -115.94 144.74 43.64 Favored 'General case' 0 CA--C 1.486 -1.516 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 177.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . 0.509 ' O ' ' HB1' ' A' ' 237' ' ' ALA . 32.7 t70 -149.71 124.83 10.05 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 123.716 0.635 . . . . 0.0 110.632 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 81.44 -133.12 11.75 Favored Glycine 0 C--N 1.3 -1.436 0 C-N-CA 120.966 -0.635 . . . . 0.0 114.258 175.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -86.34 76.2 9.7 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 122.843 0.457 . . . . 0.0 111.502 -171.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 58.22 20.04 6.76 Favored 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 124.128 0.971 . . . . 0.0 112.445 177.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . 0.509 ' HB1' ' O ' ' A' ' 233' ' ' ASP . . . -78.58 140.43 38.48 Favored 'General case' 0 N--CA 1.421 -1.899 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.982 -175.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . 0.462 ' C ' HD13 ' A' ' 239' ' ' ILE . . . -95.81 131.35 10.63 Favored Glycine 0 N--CA 1.416 -2.634 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 177.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . 0.462 HD13 ' C ' ' A' ' 238' ' ' GLY . 2.3 mp -120.52 115.74 47.98 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 CA-C-N 117.907 0.854 . . . . 0.0 110.403 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 229' ' ' ASP . 3.2 mp -100.1 106.92 19.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 176.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 -86.88 141.72 28.56 Favored 'General case' 0 N--CA 1.417 -2.116 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.667 175.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 10.3 tp -128.78 125.34 37.62 Favored 'General case' 0 C--N 1.26 -3.308 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.208 -175.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . 0.631 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -112.46 97.61 6.72 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -107.15 91.56 3.71 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.62 0.724 . . . . 0.0 109.685 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.445 HD21 ' O ' ' A' ' 225' ' ' GLN . 3.0 mm? -80.58 115.48 20.11 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.377 -176.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 110.87 2.63 28.56 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.5 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -115.94 140.85 48.84 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -138.91 15.39 2.67 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 120.676 -0.409 . . . . 0.0 111.66 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -117.21 -163.18 12.91 Favored Glycine 0 CA--C 1.495 -1.207 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -105.64 133.11 20.35 Favored Pre-proline 0 C--N 1.3 -1.577 0 CA-C-N 117.538 0.669 . . . . 0.0 110.022 -177.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.505 ' HB3' ' CD2' ' A' ' 264' ' ' LEU . 25.6 Cg_endo -73.69 169.21 22.88 Favored 'Trans proline' 0 CA--C 1.506 -0.903 0 C-N-CA 122.322 2.015 . . . . 0.0 112.79 177.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.635 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 27.9 t70 -82.1 104.89 12.76 Favored 'General case' 0 CA--C 1.472 -2.023 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 174.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . 0.416 ' CG2' HE21 ' A' ' 255' ' ' GLN . 7.1 mt -102.89 116.65 47.01 Favored 'Isoleucine or valine' 0 C--N 1.245 -3.966 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 7.8 t -125.51 129.7 50.28 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . 0.419 HE22 ' CG2' ' A' ' 260' ' ' ILE . 70.4 mm-40 -110.36 131.73 54.8 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -175.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.521 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 28.3 mm-40 -119.74 163.48 17.38 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 171.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -73.19 -35.89 66.44 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -88.19 -17.14 31.53 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.674 -173.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . 0.521 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 51.2 p-80 -171.94 162.41 5.97 Favored 'General case' 0 C--O 1.213 -0.841 0 O-C-N 122.093 -0.379 . . . . 0.0 111.74 178.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . 0.523 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 17.5 mt -107.52 144.72 15.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' A' ' 300' ' ' LEU . 3.5 mp -124.79 125.86 70.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 176.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.635 ' HA ' ' O ' ' A' ' 252' ' ' ASP . 0.8 OUTLIER -122.16 139.8 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.717 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 172.686 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' THR . . . . . 0.401 ' HB ' ' HB3' ' A' ' 252' ' ' ASP . 24.7 m -131.05 123.54 28.92 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 118.527 0.603 . . . . 0.0 110.654 177.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.505 ' CD2' ' HB3' ' A' ' 251' ' ' PRO . 25.5 mt -100.54 96.48 7.41 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 24.1 mmtm -57.79 125.57 23.59 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -176.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 2.4 t30 62.6 26.87 15.92 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 126.064 1.746 . . . . 0.0 110.894 177.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -103.61 106.33 16.81 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 7.8 p -79.7 130.79 35.65 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.157 0.503 . . . . 0.0 112.226 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . 0.433 HD11 ' HD2' ' A' ' 270' ' ' PRO . 30.3 tp -116.92 136.28 23.23 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . 0.433 ' HD2' HD11 ' A' ' 269' ' ' LEU . 84.5 Cg_endo -78.71 158.29 28.15 Favored 'Trans proline' 0 N--CA 1.438 -1.76 0 C-N-CA 121.204 1.269 . . . . 0.0 110.391 173.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 5.9 p -64.5 -29.02 70.06 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.476 0.655 . . . . 0.0 111.298 -177.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 7.1 m -61.84 -29.36 70.12 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 125.393 1.477 . . . . 0.0 112.255 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.436 HD21 ' O ' ' A' ' 226' ' ' THR . 10.4 mp -101.37 0.08 36.41 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.381 0.61 . . . . 0.0 111.913 -172.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -75.72 142.32 42.46 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 174.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -164.52 171.05 15.07 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -177.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 23.2 m -140.99 133.36 28.29 Favored 'General case' 0 N--CA 1.418 -2.052 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 176.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.455 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 1.5 mm? -100.14 111.26 23.55 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.4 79.61 9.4 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-O 123.501 1.619 . . . . 0.0 109.518 175.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . 0.25 1.9 p -86.29 63.69 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.403 -2.815 0 CA-C-N 111.558 -2.565 . . . . 0.0 111.41 -175.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -105.97 144.93 32.0 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 113.07 -1.877 . . . . 0.0 106.911 177.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 31.7 t70 68.0 19.45 9.35 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 123.157 1.456 . . . . 0.0 110.538 -178.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -91.88 -13.1 31.84 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.101 173.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? 56.76 61.88 2.47 Favored 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 123.586 0.754 . . . . 0.0 112.569 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 1.5 p -136.24 170.62 10.48 Favored Pre-proline 0 N--CA 1.433 -1.32 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 178.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.46 -10.35 17.4 Favored 'Trans proline' 0 C--O 1.241 0.652 0 C-N-CA 122.018 1.812 . . . . 0.0 111.802 177.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.6 p -99.15 121.53 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.016 0 CA-C-O 121.991 0.9 . . . . 0.0 111.071 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -87.92 -41.57 13.08 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.199 -1.364 . . . . 0.0 112.522 -170.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -155.54 132.6 10.76 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -177.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . 0.455 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 39.1 t -96.78 129.89 46.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 172.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 57.1 m -136.38 128.16 29.11 Favored 'General case' 0 C--N 1.293 -1.89 0 O-C-N 121.822 -0.549 . . . . 0.0 111.037 -178.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 53.5 tp -109.92 123.91 50.45 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -131.05 130.88 43.81 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . 0.425 ' HB3' HD21 ' A' ' 269' ' ' LEU . 17.7 ptt180 -79.51 137.18 37.1 Favored 'General case' 0 N--CA 1.415 -2.198 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.488 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 16.1 tp -99.96 -177.35 3.52 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.488 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 17.7 t-20 -45.22 -66.26 0.42 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.217 1.007 . . . . 0.0 112.078 -177.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -118.67 -3.54 10.82 Favored 'General case' 0 CA--C 1.498 -1.02 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.062 174.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -110.22 173.17 6.45 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.308 -170.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.408 ' HB ' HD13 ' A' ' 264' ' ' LEU . 86.5 m -115.19 131.96 56.76 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 174.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . 0.579 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 20.4 tt0 -124.84 130.82 53.13 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.172 -174.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 261' ' ' ILE . 1.2 mm? -94.71 142.27 27.65 Favored 'General case' 0 CA--C 1.467 -2.212 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.01 172.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 50.7 mt -129.01 108.51 17.19 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.568 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 172.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . 0.523 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 58.7 mt -114.14 103.38 15.27 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.813 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -177.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 5.5 m -75.79 129.93 37.81 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -174.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 15.4 p -128.38 172.18 11.34 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 122.587 0.355 . . . . 0.0 110.817 -177.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -156.22 137.53 13.86 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 90.69 -169.65 34.25 Favored Glycine 0 N--CA 1.436 -1.344 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -87.33 129.78 34.88 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 177.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' TRP . . . . . 0.662 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 57.4 p-90 -147.24 163.87 35.0 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.476 -174.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -125.63 142.64 51.41 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -178.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . 0.662 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 19.1 tp -116.87 139.35 50.73 Favored 'General case' 0 C--O 1.249 1.045 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.952 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.466 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 89.8 t -134.68 108.96 11.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 174.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . 0.586 ' HA ' ' O ' ' A' ' 321' ' ' THR . 19.7 t30 -98.45 129.28 45.06 Favored 'General case' 0 CA--C 1.454 -2.749 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.006 177.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -119.93 121.42 38.95 Favored 'General case' 0 N--CA 1.384 -3.763 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.932 -178.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 22.1 t -84.75 105.81 15.82 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 174.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -73.69 -36.93 65.34 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.717 0.77 . . . . 0.0 110.481 -176.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -156.32 162.5 27.37 Favored Pre-proline 0 C--N 1.295 -1.802 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 -177.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.39 96.19 0.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 121.505 1.47 . . . . 0.0 111.56 -178.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 125.72 -24.93 5.7 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . 1.667 ' HD2' ' CD1' ' A' ' 319' ' ' TYR . 91.8 m-85 -100.08 116.22 31.59 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 122.244 -0.562 . . . . 0.0 109.638 -179.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -116.45 164.97 13.77 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.811 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' THR . . . . . 0.586 ' O ' ' HA ' ' A' ' 312' ' ' ASN . 90.8 m -152.68 108.9 3.38 Favored 'General case' 0 C--N 1.275 -2.665 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.455 -173.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 1.655 ' HD2' ' CD1' ' A' ' 322' ' ' PHE . 81.2 m-85 -97.03 108.18 20.86 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . 0.466 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 37.0 tt0 -96.25 108.04 20.47 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -179.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -101.86 105.25 17.63 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 CA-C-O 121.3 0.572 . . . . 0.0 110.951 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.93 157.57 36.44 Favored Pre-proline 0 N--CA 1.466 0.346 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.57 131.81 8.56 Favored 'Trans proline' 0 C--O 1.246 0.925 0 C-N-CA 121.988 1.792 . . . . 0.0 110.133 172.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . 0.468 ' HE3' ' O ' ' A' ' 308' ' ' TRP . 41.0 ttmt -96.13 123.27 39.68 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.587 -175.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -121.72 18.61 11.12 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 122.121 0.962 . . . . 0.0 109.451 172.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 . . . . . 0 C--N 1.295 -1.771 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.809 -179.788 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 66.9 mtt . . . . . 0 N--CA 1.471 0.597 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -90.76 -29.67 12.94 Favored Glycine 0 C--N 1.307 -1.048 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.739 -178.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 18.1 t -99.91 159.52 15.01 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -177.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 16.6 m -81.19 127.56 32.8 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.616 -177.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -89.74 140.38 29.64 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 172.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 71.16 90.14 0.1 Allowed 'General case' 0 CA--C 1.5 -0.953 0 O-C-N 124.414 1.071 . . . . 0.0 108.285 -166.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' HIS . . . . . 0.416 ' O ' ' HD2' ' A' ' 200' ' ' HIS . 72.3 m-70 -81.24 -4.21 54.8 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.766 -175.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 61.6 m80 68.05 37.87 2.87 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.911 0.884 . . . . 0.0 111.041 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . 0.416 ' HD2' ' O ' ' A' ' 198' ' ' HIS . 55.9 m-70 -129.03 149.13 50.98 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.784 177.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -132.02 110.47 10.76 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.84 177.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -93.92 -83.22 1.57 Allowed Glycine 0 C--N 1.303 -1.296 0 N-CA-C 108.241 -1.944 . . . . 0.0 108.241 171.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.49 -33.82 0.05 OUTLIER 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.53 -0.335 . . . . 0.0 110.865 172.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . 0.294 34.5 m 50.25 98.47 0.04 OUTLIER Pre-proline 0 N--CA 1.485 1.276 0 C-N-CA 124.974 1.31 . . . . 0.0 113.642 -177.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -58.42 -47.92 17.51 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.212 1.942 . . . . 0.0 110.689 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -141.71 130.78 23.28 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 176.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -112.92 148.6 18.52 Favored Glycine 0 C--N 1.297 -1.597 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 177.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 32.7 t -131.19 92.71 3.24 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-O 121.313 0.577 . . . . 0.0 110.856 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -124.85 -12.55 7.05 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.598 174.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 26.0 mmt 66.12 0.52 1.67 Allowed 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 125.593 1.557 . . . . 0.0 112.983 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -93.24 4.56 53.78 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-O 120.981 0.42 . . . . 0.0 111.314 -176.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 16.4 m -81.88 85.41 6.67 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 121.389 0.614 . . . . 0.0 109.484 178.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 48.6 ttp -75.99 -42.48 48.07 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.451 -177.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 33.2 m -82.71 120.61 25.81 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -66.75 -38.88 93.41 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.609 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 135.98 -20.58 3.6 Favored Glycine 0 C--N 1.307 -1.056 0 C-N-CA 120.142 -1.028 . . . . 0.0 112.27 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -94.67 111.9 23.66 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 176.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 68.84 103.78 0.06 Allowed 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 123.928 0.891 . . . . 0.0 112.827 -177.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 24.9 mmt -81.71 79.55 8.25 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 176.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -109.16 -132.78 6.61 Favored Glycine 0 N--CA 1.43 -1.725 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.123 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -169.77 137.07 1.65 Allowed 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 123.737 0.815 . . . . 0.0 110.593 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -95.75 112.7 4.47 Favored Glycine 0 N--CA 1.426 -2.033 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 27.3 t -100.97 95.22 6.45 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -178.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -100.72 6.65 44.01 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . 0.435 ' C ' HD21 ' A' ' 245' ' ' LEU . 5.6 tp60 69.04 170.73 0.3 Allowed 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 124.745 1.218 . . . . 0.0 109.399 -174.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' THR . . . . . 0.684 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 7.0 m -59.11 114.89 2.82 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -168.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -142.44 168.45 19.7 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.343 -177.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.2 pp -128.13 163.09 32.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.766 179.161 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -151.41 157.33 42.25 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' PHE . . . . . 1.638 ' HE1' ' CE2' ' A' ' 230' ' ' PHE . 87.7 t80 -129.7 135.47 48.53 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.31 177.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 -154.7 155.58 34.85 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 124.095 0.958 . . . . 0.0 108.993 177.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 53.5 mtpt -105.27 157.74 17.09 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 175.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -155.72 153.06 29.35 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 72.8 -114.31 4.77 Favored Glycine 0 N--CA 1.437 -1.28 0 C-N-CA 121.189 -0.529 . . . . 0.0 111.785 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -134.53 93.91 3.12 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 120.539 0.209 . . . . 0.0 110.869 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' ASN . . . . . 0.409 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 93.4 m-20 66.93 17.6 10.54 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 174.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -82.15 140.4 33.79 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -99.31 113.49 4.74 Favored Glycine 0 N--CA 1.432 -1.604 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.3 mp -105.13 111.53 34.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 121.618 0.723 . . . . 0.0 110.263 -178.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.6 mp -97.93 112.66 30.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 174.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -89.3 143.77 26.59 Favored 'General case' 0 N--CA 1.408 -2.548 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 176.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 12.2 tp -133.14 130.39 39.15 Favored 'General case' 0 C--N 1.263 -3.175 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.099 -176.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' ALA . . . . . 0.684 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -116.86 102.24 9.22 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 176.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -109.43 91.15 3.53 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . 0.435 HD21 ' C ' ' A' ' 225' ' ' GLN . 2.7 mm? -77.68 113.18 15.27 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.547 -175.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 114.79 -10.85 21.06 Favored Glycine 0 C--N 1.298 -1.531 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.319 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' PHE . . . . . 1.668 ' HD2' ' CD1' ' A' ' 247' ' ' PHE . 21.7 t80 -100.73 124.31 46.17 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -178.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -103.82 -29.64 10.88 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -175.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -85.89 -161.51 35.18 Favored Glycine 0 CA--C 1.503 -0.68 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -103.48 143.02 25.79 Favored Pre-proline 0 C--N 1.303 -1.43 0 CA-C-N 117.847 0.824 . . . . 0.0 110.688 176.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.49 ' HB3' ' CD1' ' A' ' 264' ' ' LEU . 10.7 Cg_endo -64.6 172.03 7.4 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.108 2.539 . . . . 0.0 111.267 175.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -89.93 119.65 30.48 Favored 'General case' 0 C--N 1.274 -2.681 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 2.7 mp -102.46 127.65 55.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-O 121.57 0.7 . . . . 0.0 111.385 178.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' SER . . . . . 0.555 ' HB2' ' HB ' ' A' ' 261' ' ' ILE . 73.6 m -115.73 115.48 26.41 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 125.297 1.439 . . . . 0.0 108.217 175.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -101.15 113.85 27.26 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -175.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' GLN . . . . . 0.617 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 14.5 mm100 -116.92 166.03 12.64 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 174.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -77.07 -41.99 40.07 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.488 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -84.04 -14.75 49.79 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -174.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . 0.617 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 49.8 p-80 -171.77 162.31 6.17 Favored 'General case' 0 C--O 1.21 -0.995 0 CA-C-O 120.628 0.251 . . . . 0.0 111.041 175.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 19.5 mt -106.9 145.2 14.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 177.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' ILE . . . . . 0.555 ' HB ' ' HB2' ' A' ' 254' ' ' SER . 3.6 mp -122.11 123.4 68.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 175.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.422 ' HB ' ' HB2' ' A' ' 300' ' ' LEU . 37.8 t -124.7 128.19 73.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 298' ' ' THR . 7.6 m -124.27 124.04 41.55 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-O 121.538 0.685 . . . . 0.0 111.503 -177.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.49 ' CD1' ' HB3' ' A' ' 251' ' ' PRO . 1.9 mm? -95.32 103.13 14.98 Favored 'General case' 0 CA--C 1.47 -2.119 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 173.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' LYS . . . . . 0.525 ' HG3' ' OD2' ' A' ' 297' ' ' ASP . 17.3 ttmm -76.38 137.95 40.11 Favored 'General case' 0 N--CA 1.383 -3.788 0 O-C-N 123.72 0.638 . . . . 0.0 110.779 -177.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 8.7 t30 70.44 27.71 3.87 Favored 'General case' 0 CA--C 1.548 0.881 0 O-C-N 124.864 1.352 . . . . 0.0 109.957 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 36.1 t60 -124.27 108.02 11.8 Favored 'General case' 0 C--O 1.206 -1.185 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -178.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 7.2 p -90.48 114.66 26.88 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -176.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' LEU . . . . . 0.446 HD13 ' HD2' ' A' ' 270' ' ' PRO . 19.7 tp -93.3 133.19 28.87 Favored Pre-proline 0 C--N 1.318 -0.8 0 C-N-CA 123.077 0.551 . . . . 0.0 110.468 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' PRO . . . . . 0.446 ' HD2' HD13 ' A' ' 269' ' ' LEU . 80.9 Cg_endo -78.98 157.03 26.94 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.218 1.945 . . . . 0.0 112.117 173.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 23.6 p -62.36 -35.04 77.89 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -177.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 13.7 m -65.85 -18.3 65.24 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 123.707 0.803 . . . . 0.0 111.709 -176.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' LEU . . . . . 0.4 HD11 ' O ' ' A' ' 226' ' ' THR . 95.0 mt -105.21 -13.91 15.54 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.446 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -83.78 114.38 21.58 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -144.94 175.96 9.83 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -174.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 48.9 m -134.4 138.55 44.92 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-O 121.275 0.559 . . . . 0.0 110.177 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.516 ' O ' ' HG3' ' A' ' 288' ' ' LYS . 2.0 mm? -91.96 150.38 21.04 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 174.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -86.49 -60.69 1.92 Allowed 'General case' 0 C--N 1.274 -2.693 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' VAL . . . . . 0.551 HG13 ' CD2' ' A' ' 230' ' ' PHE 0.342 30.8 m 49.41 19.32 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 174.016 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -74.19 140.2 44.95 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 173.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 28.8 t70 73.77 16.92 3.71 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.935 1.294 . . . . 0.0 111.402 -178.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -80.61 -11.86 59.58 Favored 'General case' 0 CA--C 1.514 -0.414 0 O-C-N 121.351 -0.843 . . . . 0.0 111.016 173.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . 0.485 ' HZ2' ' HB2' ' A' ' 283' ' ' LYS . 0.2 OUTLIER 60.98 61.26 1.66 Allowed 'General case' 0 CA--C 1.497 -1.062 0 C-N-CA 123.336 0.654 . . . . 0.0 111.361 -178.419 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 1.6 p -137.6 168.06 17.97 Favored Pre-proline 0 C--N 1.292 -1.911 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 177.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 18.4 Cg_exo -69.46 -23.35 32.27 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 121.467 1.445 . . . . 0.0 110.822 176.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.0 p -85.31 122.31 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 CA-C-O 122.254 1.026 . . . . 0.0 110.401 179.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -89.23 -37.93 14.61 Favored 'General case' 0 C--N 1.284 -2.252 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.465 -174.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' ' 277' ' ' LEU . 56.3 tttp -159.47 137.6 10.36 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.67 -178.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 42.8 t -103.47 128.86 56.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' THR . . . . . 0.408 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 90.6 m -135.14 121.26 20.04 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 120.743 0.306 . . . . 0.0 110.591 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -101.08 122.96 44.49 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 177.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -119.56 135.26 54.87 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -176.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -83.58 142.59 30.73 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 174.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . 0.422 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 12.9 tp -120.13 -174.17 2.72 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 176.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' ASN . . . . . 0.422 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 20.2 t-20 -72.35 -51.55 20.09 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 118.908 0.776 . . . . 0.0 111.565 -172.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -115.55 -3.94 12.3 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.611 -177.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' ASP . . . . . 0.525 ' OD2' ' HG3' ' A' ' 265' ' ' LYS . 3.7 m-20 -133.13 169.3 17.06 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.58 0.705 . . . . 0.0 110.671 -170.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 263' ' ' THR . 62.6 m -113.37 126.74 55.69 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 172.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -119.71 122.57 41.75 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-O 121.441 0.639 . . . . 0.0 110.099 -173.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.422 ' HB2' ' HB ' ' A' ' 262' ' ' VAL . 0.1 OUTLIER -97.63 135.87 38.82 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.149 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' ILE . . . . . 0.408 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 48.7 mt -124.83 109.73 23.1 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 68.5 mt -114.65 101.24 12.11 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -178.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 21.0 m -68.91 134.14 49.17 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -177.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 10.6 p -136.98 167.32 21.72 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -177.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -148.87 151.16 34.21 Favored 'General case' 0 C--O 1.251 1.173 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.321 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 76.71 -157.18 47.13 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.087 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -99.98 141.99 32.06 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 176.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' TRP . . . . . . . . . . . . . 68.6 p-90 -154.84 167.58 29.79 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.756 -176.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -122.57 135.59 54.67 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 1.3 tt -104.69 113.99 27.92 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.715 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' VAL . . . . . 0.492 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 98.4 t -108.08 107.3 22.46 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 172.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -98.07 121.15 39.65 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.781 0.8 . . . . 0.0 110.429 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -122.91 148.62 45.23 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.777 -175.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 32.6 t -115.63 116.63 28.44 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 170.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -77.92 -34.83 51.14 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 122.152 0.977 . . . . 0.0 109.036 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -161.43 155.31 18.65 Favored Pre-proline 0 C--N 1.29 -2.016 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -60.73 94.93 0.11 Allowed 'Trans proline' 0 C--O 1.244 0.804 0 C-N-CA 122.239 1.96 . . . . 0.0 112.339 -176.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 136.16 -25.7 3.16 Favored Glycine 0 N--CA 1.433 -1.528 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.24 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' TYR . . . . . 1.611 ' HE2' ' CE1' ' A' ' 319' ' ' TYR . 96.0 m-85 -107.32 116.32 31.72 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -178.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -116.28 164.61 14.25 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-O 122.138 0.97 . . . . 0.0 111.037 -175.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 39.6 m -151.49 125.45 9.17 Favored 'General case' 0 C--N 1.269 -2.902 0 CA-C-N 114.394 -1.275 . . . . 0.0 108.893 -177.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' PHE . . . . . 1.632 ' HE2' ' CE1' ' A' ' 322' ' ' PHE . 68.1 m-85 -109.69 105.07 14.19 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 175.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' GLN . . . . . 0.492 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 7.3 tt0 -94.17 103.11 15.16 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -178.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 86.7 t -94.71 99.37 9.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.9 151.41 45.29 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -77.97 132.84 11.99 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 121.546 1.497 . . . . 0.0 110.513 174.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -104.35 127.14 51.96 Favored 'General case' 0 CA--C 1.484 -1.582 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 178.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -96.5 165.9 11.94 Favored 'General case' 0 C--N 1.268 -2.958 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 20.7 mp0 . . . . . 0 C--N 1.313 -1.004 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -178.323 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 225' ' ' GLN . . . . . 0.437 ' HB3' HD11 ' A' ' 273' ' ' LEU . 47.0 tp60 . . . . . 0 N--CA 1.426 -1.653 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.636 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 5.6 m -56.04 126.49 26.17 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 124.384 1.074 . . . . 0.0 113.42 -171.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -152.95 168.17 26.72 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 116.345 -0.389 . . . . 0.0 109.979 -177.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.671 HG21 HD21 ' A' ' 300' ' ' LEU . 2.8 pp -134.35 165.53 31.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 123.114 0.565 . . . . 0.0 112.164 -178.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' ASP . . . . . 0.514 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 9.4 t70 -149.89 156.36 41.63 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -133.88 134.63 42.93 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 176.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -152.32 171.61 17.73 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.437 ' HE3' HG22 ' A' ' 284' ' ' THR . 57.4 mtpt -118.98 148.57 42.84 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 175.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -144.68 143.23 30.63 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 123.436 0.46 . . . . 0.0 109.934 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 74.01 -98.81 1.0 Allowed Glycine 0 N--CA 1.435 -1.39 0 O-C-N 124.048 0.842 . . . . 0.0 111.89 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -146.15 98.6 3.12 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 120.761 0.315 . . . . 0.0 110.202 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 63.18 22.65 13.49 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 173.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -89.05 137.36 32.39 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -96.59 113.09 4.59 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 1.9 mp -106.42 121.36 58.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 117.237 0.519 . . . . 0.0 109.869 -177.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.5 mp -105.75 117.31 51.24 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 39.0 mt-10 -94.91 146.04 24.5 Favored 'General case' 0 C--N 1.284 -2.245 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.02 174.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 12.4 tp -134.36 128.87 34.53 Favored 'General case' 0 C--N 1.27 -2.88 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.133 -173.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' ALA . . . . . 0.636 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -118.44 101.77 8.41 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -109.42 91.47 3.66 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.541 0.686 . . . . 0.0 109.493 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.94 111.41 13.77 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.562 -175.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 107.87 9.18 28.81 Favored Glycine 0 N--CA 1.431 -1.634 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.451 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -115.32 107.72 15.61 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 176.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -115.14 95.24 5.1 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.369 0.604 . . . . 0.0 109.784 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 165.55 -150.22 17.57 Favored Glycine 0 N--CA 1.425 -2.08 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -124.48 136.18 27.47 Favored Pre-proline 0 C--N 1.3 -1.572 0 CA-C-N 117.39 0.595 . . . . 0.0 110.339 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.657 ' HB3' HD23 ' A' ' 264' ' ' LEU . 10.6 Cg_endo -74.32 172.37 16.2 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 C-N-CA 122.505 2.137 . . . . 0.0 112.41 176.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.506 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 11.6 t70 -91.94 105.63 17.84 Favored 'General case' 0 C--N 1.284 -2.283 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 175.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.477 HD11 ' HG2' ' A' ' 251' ' ' PRO . 5.3 mp -103.43 124.14 57.44 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 C-N-CA 119.484 -0.887 . . . . 0.0 109.894 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' SER . . . . . 0.491 ' HB3' ' HB ' ' A' ' 261' ' ' ILE . 25.1 t -106.27 120.21 41.25 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -100.13 109.41 21.69 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.948 -178.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -124.42 162.5 23.75 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 174.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -73.57 -33.33 64.6 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 120.991 0.424 . . . . 0.0 110.124 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -70.78 -42.92 69.75 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.842 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' HIS . . . . . 0.459 ' CB ' ' HA ' ' A' ' 303' ' ' THR . 53.1 p-80 -169.42 167.55 9.91 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.472 0.177 . . . . 0.0 111.067 178.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 17.3 mt -106.21 139.5 27.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' ILE . . . . . 0.491 ' HB ' ' HB3' ' A' ' 254' ' ' SER . 3.4 mp -122.97 114.56 42.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 299' ' ' GLN . 0.8 OUTLIER -107.81 134.07 50.71 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 175.034 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 25.3 m -122.45 123.78 42.09 Favored 'General case' 0 C--N 1.267 -3.002 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.657 HD23 ' HB3' ' A' ' 251' ' ' PRO . 29.6 mt -100.17 93.73 5.86 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.441 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 63.1 mmtt -63.1 126.94 29.03 Favored 'General case' 0 CA--C 1.478 -1.814 0 O-C-N 124.29 0.994 . . . . 0.0 113.075 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 9.8 t30 69.77 32.53 3.19 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.432 -1.713 . . . . 0.0 109.909 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -125.69 100.54 6.47 Favored 'General case' 0 C--O 1.2 -1.525 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 6.4 m -88.26 112.2 22.53 Favored 'General case' 0 C--N 1.277 -2.57 0 C-N-CA 119.635 -0.826 . . . . 0.0 111.889 -173.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' LEU . . . . . 0.687 HD22 HD22 ' A' ' 291' ' ' LEU . 37.6 tp -81.83 125.81 76.89 Favored Pre-proline 0 N--CA 1.444 -0.77 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.275 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.408 ' HD2' HD12 ' A' ' 269' ' ' LEU . 31.3 Cg_exo -65.79 143.1 72.55 Favored 'Trans proline' 0 N--CA 1.44 -1.648 0 C-N-CA 122.105 1.87 . . . . 0.0 110.587 169.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 11.4 t -69.63 -12.71 61.86 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.388 0.613 . . . . 0.0 110.363 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 2.4 m -76.29 -16.57 59.76 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 123.961 0.904 . . . . 0.0 109.924 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.505 HD13 ' O ' ' A' ' 226' ' ' THR . 73.8 mt -110.88 -7.06 14.62 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.415 -177.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.521 ' HB2' ' O ' ' A' ' 291' ' ' LEU . 25.2 pt20 -81.35 115.64 20.81 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 119.101 -1.04 . . . . 0.0 109.61 -177.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 21.0 ptt180 -135.44 151.65 50.61 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 40.7 m -112.71 136.93 51.73 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.799 176.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.458 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 59.6 mt -105.67 116.47 32.0 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -61.02 -51.86 67.44 Favored 'General case' 0 C--N 1.311 -1.079 0 O-C-N 123.724 0.64 . . . . 0.0 110.419 -177.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . 0.263 26.9 m 46.19 25.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 116.856 2.169 . . . . 0.0 116.856 174.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -75.85 140.65 42.34 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 177.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 15.3 t70 73.02 20.99 3.31 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.701 1.2 . . . . 0.0 112.531 177.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -79.74 -4.98 54.3 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.574 -0.704 . . . . 0.0 110.22 172.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 mptt 65.77 50.94 1.49 Allowed 'General case' 0 CA--C 1.503 -0.85 0 C-N-CA 124.248 1.019 . . . . 0.0 109.924 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' THR . . . . . 0.437 HG22 ' HE3' ' A' ' 232' ' ' LYS . 1.2 p -133.34 165.03 39.74 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -74.78 -4.91 16.12 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.196 1.931 . . . . 0.0 111.752 177.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 49.8 t -87.59 129.54 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -99.86 -30.35 12.08 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.208 -176.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 20.6 ttmm -167.13 143.79 4.47 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.458 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 43.3 t -112.64 130.22 66.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 174.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.527 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 98.2 m -136.18 117.87 15.0 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-O 121.262 0.554 . . . . 0.0 110.762 -178.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.687 HD22 HD22 ' A' ' 269' ' ' LEU . 0.1 OUTLIER -91.47 114.13 26.58 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 104.244 -2.502 . . . . 0.0 104.244 174.861 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.407 ' HD3' ' OE1' ' A' ' 274' ' ' GLN . 17.0 tppt? -116.15 129.6 56.4 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -177.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -78.42 140.37 38.68 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 175.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.559 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 21.7 tp -111.23 -173.14 2.17 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 175.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.559 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 63.9 t30 -58.91 -66.66 0.47 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 119.172 0.896 . . . . 0.0 111.247 -177.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -115.86 -3.6 12.17 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 120.791 0.329 . . . . 0.0 111.147 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' ASP . . . . . 0.441 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 38.1 m-20 -115.23 172.69 6.92 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.397 0.618 . . . . 0.0 110.209 -177.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.515 ' HB ' ' HB2' ' A' ' 264' ' ' LEU . 92.8 m -116.98 132.11 56.79 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 176.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 299' ' ' GLN . . . . . 0.529 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 42.1 tt0 -120.17 127.78 52.79 Favored 'General case' 0 N--CA 1.421 -1.894 0 C-N-CA 120.529 -0.469 . . . . 0.0 110.35 -175.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.671 HD21 HG21 ' A' ' 228' ' ' ILE . 17.4 mt -100.08 127.7 46.27 Favored 'General case' 0 CA--C 1.443 -3.142 0 C-N-CA 120.127 -0.629 . . . . 0.0 111.462 172.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 301' ' ' ILE . . . . . 0.527 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 63.1 mt -115.19 109.23 27.65 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.373 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 302' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 50.9 mt -117.17 102.13 13.05 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.625 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 303' ' ' THR . . . . . 0.459 ' HA ' ' CB ' ' A' ' 259' ' ' HIS . 32.8 m -74.88 134.6 41.62 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.781 -175.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 19.0 p -133.74 179.72 6.06 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 123.189 0.595 . . . . 0.0 109.608 -177.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -159.59 148.47 17.86 Favored 'General case' 0 C--O 1.246 0.878 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 73.64 -142.4 31.05 Favored Glycine 0 C--O 1.243 0.675 0 O-C-N 123.613 0.571 . . . . 0.0 112.468 176.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -105.26 130.23 53.44 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 308' ' ' TRP . . . . . 0.73 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 60.7 p-90 -145.79 171.27 15.03 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -177.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -129.98 135.06 47.88 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.73 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 25.8 tp -111.25 120.95 43.97 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.269 -177.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.554 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 54.3 t -116.2 107.55 22.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 173.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -94.75 134.97 36.78 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' LYS . . . . . 0.426 ' HB2' ' HB ' ' A' ' 321' ' ' THR . 67.6 mttm -130.58 145.01 51.8 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.619 -176.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 15.9 m -115.85 118.53 33.25 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 172.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -87.28 -24.83 24.22 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.605 0.716 . . . . 0.0 110.41 -177.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -170.24 162.59 6.34 Favored Pre-proline 0 C--N 1.307 -1.241 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -65.17 95.99 0.26 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.493 1.462 . . . . 0.0 110.504 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 133.52 -33.36 2.58 Favored Glycine 0 N--CA 1.421 -2.35 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.628 -177.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -99.89 116.44 31.96 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 122.036 -0.685 . . . . 0.0 109.87 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -119.3 163.94 16.4 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.932 -177.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.426 ' HB ' ' HB2' ' A' ' 313' ' ' LYS . 78.7 m -152.09 139.93 19.96 Favored 'General case' 0 C--N 1.269 -2.894 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.261 -178.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -126.43 112.4 15.57 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' GLN . . . . . 0.554 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 61.8 tt0 -97.37 109.7 22.4 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.598 HG13 ' CE3' ' A' ' 308' ' ' TRP . 91.7 t -98.38 99.31 8.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 C-N-CA 123.501 0.72 . . . . 0.0 109.687 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -88.43 152.86 50.36 Favored Pre-proline 0 C--N 1.309 -1.153 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -80.35 128.67 7.22 Favored 'Trans proline' 0 C--O 1.252 1.209 0 C-N-CA 121.27 1.314 . . . . 0.0 109.956 171.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm . . . . . 0 CA--C 1.471 -2.06 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.686 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 225' ' ' GLN . . . . . 0.409 ' C ' HD23 ' A' ' 245' ' ' LEU . 5.7 tp-100 . . . . . 0 N--CA 1.436 -1.133 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.573 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 72.8 m -52.92 131.98 36.61 Favored 'General case' 0 C--O 1.208 -1.13 0 C-N-CA 124.178 0.991 . . . . 0.0 113.187 -172.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -162.54 175.59 11.29 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-O 121.023 0.44 . . . . 0.0 111.519 -174.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.439 HG21 HD21 ' A' ' 300' ' ' LEU . 1.8 pp -121.51 165.44 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.075 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' ASP . . . . . 0.501 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 6.6 t70 -150.37 152.16 33.96 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -134.06 127.59 32.52 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.098 176.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.503 ' HD3' ' HB ' ' A' ' 239' ' ' ILE . 0.3 OUTLIER -150.91 157.39 42.85 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.633 179.063 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -104.67 162.44 13.29 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' ASP . . . . . 0.453 ' O ' ' HB3' ' A' ' 237' ' ' ALA . 15.3 t70 -157.71 143.96 17.63 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 68.77 -118.89 9.36 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.486 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -135.35 111.89 9.93 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.97 0.385 . . . . 0.0 110.695 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 66.67 15.75 10.21 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.876 0.87 . . . . 0.0 112.403 174.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 233' ' ' ASP . . . -92.41 132.04 37.09 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -103.35 113.91 4.67 Favored Glycine 0 CA--C 1.491 -1.427 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.503 ' HB ' ' HD3' ' A' ' 231' ' ' ARG . 2.4 mp -106.77 117.12 51.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-O 121.512 0.672 . . . . 0.0 110.263 -177.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.4 mp -101.08 109.04 24.59 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.501 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 43.1 mt-10 -89.73 132.81 35.0 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 176.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 8.9 tp -117.59 122.27 43.16 Favored 'General case' 0 C--N 1.269 -2.934 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.131 -174.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' ALA . . . . . 0.573 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -107.34 101.21 10.6 Favored 'General case' 0 N--CA 1.414 -2.259 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.452 ' HA ' HG23 ' A' ' 226' ' ' THR . . . -106.8 91.87 3.85 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.615 0.722 . . . . 0.0 109.076 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.409 HD23 ' C ' ' A' ' 225' ' ' GLN . 3.0 mm? -81.71 114.18 20.2 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.278 -175.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 103.42 22.75 8.86 Favored Glycine 0 C--N 1.297 -1.615 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.121 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' PHE . . . . . 0.403 ' HE1' ' O ' ' A' ' 265' ' ' LYS . 20.0 t80 -115.74 127.41 55.09 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -102.28 -21.05 14.41 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -174.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -104.18 -141.38 11.06 Favored Glycine 0 C--N 1.314 -0.685 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.841 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -127.59 142.5 44.32 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.7 ' HB3' HD13 ' A' ' 264' ' ' LEU . 18.0 Cg_endo -68.35 172.31 11.43 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.717 2.278 . . . . 0.0 112.853 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.525 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 20.3 t70 -96.02 119.86 35.28 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 175.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 4.6 mp -108.41 108.95 26.54 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-O 121.995 0.902 . . . . 0.0 111.232 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' SER . . . . . 0.651 ' HB2' ' HB ' ' A' ' 261' ' ' ILE . 47.4 m -96.47 104.83 16.83 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 114.163 -1.381 . . . . 0.0 109.198 177.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -88.1 118.25 27.54 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.865 -176.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 48.5 mt-30 -124.66 157.05 36.49 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 167.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 60.6 m80 -74.34 -29.79 61.74 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.926 -0.709 . . . . 0.0 111.202 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -69.65 -42.11 74.68 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.955 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' HIS . . . . . 0.403 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 49.9 p-80 -167.23 163.82 15.45 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.73 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 18.3 mt -105.48 142.02 19.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' ILE . . . . . 0.651 ' HB ' ' HB2' ' A' ' 254' ' ' SER . 3.8 mp -119.99 110.23 28.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.6 ' O ' ' HA ' ' A' ' 299' ' ' GLN . 0.8 OUTLIER -108.64 142.28 21.66 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.741 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 263' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 298' ' ' THR . 31.9 m -134.86 126.62 29.13 Favored 'General case' 0 C--N 1.275 -2.643 0 O-C-N 121.726 -0.609 . . . . 0.0 111.13 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.7 HD13 ' HB3' ' A' ' 251' ' ' PRO . 2.1 mm? -98.17 101.84 13.42 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 177.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.454 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 25.8 mmtm -67.65 130.94 44.58 Favored 'General case' 0 C--N 1.286 -2.178 0 O-C-N 124.033 0.833 . . . . 0.0 111.283 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 6.6 t30 73.84 21.59 2.67 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 124.678 1.236 . . . . 0.0 109.999 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -121.13 100.59 7.14 Favored 'General case' 0 CA--C 1.484 -1.581 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 3.7 m -90.2 121.03 31.86 Favored 'General case' 0 C--N 1.271 -2.828 0 C-N-CA 120.076 -0.649 . . . . 0.0 110.837 -175.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' LEU . . . . . 0.541 HD22 HD22 ' A' ' 291' ' ' LEU . 24.8 tp -92.76 127.3 48.47 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.242 -177.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.76 149.07 91.63 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.285 1.99 . . . . 0.0 110.989 170.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' THR . . . . . 0.609 ' O ' ' HG2' ' A' ' 274' ' ' GLN . 22.2 p -66.32 -25.35 66.79 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.336 -177.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 10.2 m -72.51 -18.52 61.65 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.508 0.67 . . . . 0.0 111.056 -177.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.511 HD13 ' O ' ' A' ' 226' ' ' THR . 82.1 mt -99.29 -19.12 17.23 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.497 -177.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.609 ' HG2' ' O ' ' A' ' 271' ' ' THR . 21.9 pt20 -76.82 137.69 39.38 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -173.42 169.48 4.39 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -174.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 3.1 p -123.99 132.86 53.76 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-O 121.478 0.656 . . . . 0.0 112.101 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 60.3 mt -100.58 113.06 25.56 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 104.34 -2.467 . . . . 0.0 104.34 175.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -63.41 -53.05 58.38 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -174.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 34.5 m 44.71 37.05 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 176.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -69.4 133.42 47.77 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 20.2 t70 61.9 36.15 16.0 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 125.005 1.322 . . . . 0.0 110.692 177.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.26 0.38 28.91 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.703 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt 69.01 59.03 0.35 Allowed 'General case' 0 CA--C 1.497 -1.095 0 C-N-CA 125.388 1.475 . . . . 0.0 111.478 177.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.35 152.66 11.02 Favored Pre-proline 0 C--N 1.295 -1.767 0 CA-C-N 113.851 -1.522 . . . . 0.0 108.675 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 285' ' ' PRO . . . . . 0.433 ' O ' ' HA ' ' A' ' 304' ' ' THR . 54.0 Cg_exo -50.14 -24.77 11.75 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.713 2.942 . . . . 0.0 113.55 175.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 46.9 t -74.06 118.33 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -94.64 -29.11 15.01 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.891 -178.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -170.21 135.23 1.29 Allowed 'General case' 0 N--CA 1.478 0.93 0 O-C-N 123.665 0.603 . . . . 0.0 110.863 -177.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 40.2 t -104.3 135.96 39.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.447 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 90.2 m -143.19 123.64 13.93 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 121.461 0.648 . . . . 0.0 111.09 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.541 HD22 HD22 ' A' ' 269' ' ' LEU . 0.1 OUTLIER -98.06 120.37 38.35 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 176.436 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.493 ' HD3' ' OE1' ' A' ' 274' ' ' GLN . 4.0 tppp? -128.76 135.88 49.8 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -79.99 145.01 32.78 Favored 'General case' 0 N--CA 1.426 -1.627 0 C-N-CA 118.858 -1.137 . . . . 0.0 109.273 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.548 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 18.0 tp -108.44 -174.08 2.43 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 177.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.548 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 5.8 t30 -56.65 -67.47 0.3 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.559 0.618 . . . . 0.0 111.688 -177.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -110.03 -4.28 15.97 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.825 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' ASP . . . . . 0.454 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 36.2 m-20 -119.81 176.4 5.42 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.599 0.714 . . . . 0.0 111.511 -169.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 263' ' ' THR . 90.1 m -113.73 133.4 55.37 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 176.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 299' ' ' GLN . . . . . 0.6 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 26.3 tt0 -124.08 132.07 53.62 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.13 -175.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.523 ' O ' ' HA ' ' A' ' 261' ' ' ILE . 25.4 mt -101.69 131.92 47.67 Favored 'General case' 0 CA--C 1.451 -2.86 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.967 173.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 301' ' ' ILE . . . . . 0.447 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 63.6 mt -116.26 108.63 25.6 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.697 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 175.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 65.2 mt -115.98 104.16 16.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 3.5 m -72.51 130.03 39.7 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 123.126 0.57 . . . . 0.0 109.641 -175.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 304' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 285' ' ' PRO . 8.7 p -136.02 176.71 8.44 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 122.319 0.248 . . . . 0.0 110.905 -178.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -147.73 148.94 31.52 Favored 'General case' 0 C--O 1.245 0.857 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 61.38 -148.61 46.61 Favored Glycine 0 N--CA 1.463 0.444 0 O-C-N 123.933 0.771 . . . . 0.0 113.089 177.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -97.72 144.4 27.39 Favored 'General case' 0 CA--C 1.47 -2.121 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 308' ' ' TRP . . . . . 0.718 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 65.9 p-90 -157.94 170.77 21.58 Favored 'General case' 0 C--N 1.27 -2.851 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -178.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 309' ' ' GLU . . . . . 0.467 ' HG2' ' HE2' ' A' ' 327' ' ' LYS . 4.6 mt-10 -122.26 129.83 52.6 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -176.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.718 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 23.3 tp -105.65 117.81 34.96 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 120.996 0.427 . . . . 0.0 111.207 -176.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.5 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 48.8 t -114.63 107.36 22.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 174.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -94.18 126.61 39.52 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 313' ' ' LYS . . . . . 0.435 ' HB2' ' HB ' ' A' ' 321' ' ' THR . 95.3 mttt -119.83 149.45 42.04 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.964 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 23.9 t -115.97 114.59 24.83 Favored 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 172.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -80.18 -32.35 38.73 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.572 0.701 . . . . 0.0 109.561 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -168.76 162.18 8.25 Favored Pre-proline 0 C--N 1.305 -1.355 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.5 102.19 0.33 Allowed 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 121.532 1.488 . . . . 0.0 110.497 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 129.73 -32.43 3.18 Favored Glycine 0 N--CA 1.427 -1.954 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -177.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -102.77 116.59 32.88 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -119.16 161.79 19.74 Favored 'General case' 0 C--N 1.277 -2.546 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.292 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.435 ' HB ' ' HB2' ' A' ' 313' ' ' LYS . 89.4 m -151.62 124.93 8.79 Favored 'General case' 0 C--N 1.263 -3.16 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.74 -174.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' A' ' 239' ' ' ILE . 69.9 m-85 -112.4 109.98 19.92 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 323' ' ' GLN . . . . . 0.5 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 56.2 tt0 -96.73 105.72 17.89 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.617 HG13 ' CE3' ' A' ' 308' ' ' TRP . 94.0 t -95.01 100.41 11.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 C-N-CA 123.42 0.688 . . . . 0.0 110.228 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -92.42 153.33 42.74 Favored Pre-proline 0 C--N 1.313 -0.984 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -73.09 140.71 31.61 Favored 'Trans proline' 0 C--O 1.249 1.046 0 C-N-CA 121.765 1.643 . . . . 0.0 110.4 172.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.467 ' HE2' ' HG2' ' A' ' 309' ' ' GLU . 14.8 ttmm . . . . . 0 CA--C 1.486 -1.511 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' GLN . . . . . 0.883 HE21 ' N ' ' A' ' 225' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.411 -2.376 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 28.7 m -59.93 128.62 37.78 Favored 'General case' 0 C--O 1.209 -1.028 0 O-C-N 124.121 0.888 . . . . 0.0 109.01 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -148.03 155.95 42.08 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.082 -170.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.657 HG12 ' HB2' ' A' ' 291' ' ' LEU . 2.7 pp -137.48 149.68 25.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 C-N-CA 124.134 0.974 . . . . 0.0 108.872 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -149.76 156.6 42.12 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 122.789 0.436 . . . . 0.0 111.038 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -127.0 139.18 53.21 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 120.97 0.414 . . . . 0.0 111.01 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 20.5 ptt85 -157.04 161.68 39.52 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 173.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.403 ' HE3' HG22 ' A' ' 284' ' ' THR . 53.2 mtpt -105.64 144.91 31.73 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 177.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' ASP . . . . . 0.521 ' O ' ' HB3' ' A' ' 237' ' ' ALA . 21.7 t70 -159.76 117.38 2.66 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -176.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 104.12 -157.14 17.25 Favored Glycine 0 C--N 1.296 -1.694 0 C-N-CA 120.203 -0.998 . . . . 0.0 111.179 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -91.53 97.49 11.09 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 116.7 0.25 . . . . 0.0 110.391 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' ASN . . . . . 0.538 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 3.4 m-20 60.92 23.26 13.36 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 124.197 0.936 . . . . 0.0 111.396 177.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 233' ' ' ASP . . . -87.11 136.91 32.75 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.491 -174.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -101.94 116.51 5.55 Favored Glycine 0 N--CA 1.427 -1.915 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.43 HG13 ' HG3' ' A' ' 323' ' ' GLN . 2.1 mp -106.52 114.87 46.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-O 121.34 0.591 . . . . 0.0 111.127 -175.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.3 mp -103.49 112.77 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 176.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -94.4 138.77 31.95 Favored 'General case' 0 C--N 1.277 -2.549 0 CA-C-O 121.363 0.601 . . . . 0.0 109.487 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 12.0 tp -127.49 131.04 50.2 Favored 'General case' 0 C--N 1.269 -2.924 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.392 -175.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -122.37 102.18 7.95 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.013 178.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -108.84 91.07 3.49 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -73.15 109.72 6.89 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -173.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 111.99 -4.64 27.23 Favored Glycine 0 C--N 1.304 -1.204 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.132 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -94.62 107.73 19.71 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -108.58 97.11 6.82 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 160.74 -147.78 15.02 Favored Glycine 0 C--N 1.297 -1.604 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -126.74 135.65 27.61 Favored Pre-proline 0 C--N 1.311 -1.095 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.822 ' HB3' HD13 ' A' ' 264' ' ' LEU . 13.7 Cg_endo -70.38 171.98 14.11 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.361 2.041 . . . . 0.0 109.901 176.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -91.13 110.26 21.53 Favored 'General case' 0 C--N 1.27 -2.878 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 175.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 3.8 mp -97.73 108.46 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.76 0 CA-C-O 121.605 0.717 . . . . 0.0 109.57 178.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' SER . . . . . 0.669 ' HB2' ' HB ' ' A' ' 261' ' ' ILE . 31.8 m -102.99 110.76 22.79 Favored 'General case' 0 C--N 1.282 -2.369 0 CA-C-N 114.473 -1.24 . . . . 0.0 108.274 175.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -100.18 117.36 34.26 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.48 -172.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -125.1 162.57 24.29 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 172.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' HIS . . . . . 0.402 ' HA ' ' HE1' ' A' ' 308' ' ' TRP . 13.1 m170 -76.53 -31.16 57.48 Favored 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 119.015 -1.074 . . . . 0.0 112.068 178.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -73.91 -30.94 62.86 Favored 'General case' 0 C--N 1.319 -0.744 0 O-C-N 123.661 0.6 . . . . 0.0 111.476 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' HIS . . . . . 0.447 ' CD2' HG23 ' A' ' 301' ' ' ILE . 39.4 p-80 -172.78 165.13 5.29 Favored 'General case' 0 CA--C 1.503 -0.864 0 O-C-N 122.252 -0.28 . . . . 0.0 110.623 175.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 18.4 mt -106.29 140.86 23.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' ILE . . . . . 0.669 ' HB ' ' HB2' ' A' ' 254' ' ' SER . 3.5 mp -116.64 108.69 25.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.442 ' HB ' ' HB2' ' A' ' 300' ' ' LEU . 49.1 t -105.66 131.54 54.82 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.492 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 177.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 263' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 298' ' ' THR . 26.6 m -134.46 126.17 28.92 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 121.289 0.566 . . . . 0.0 111.066 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.822 HD13 ' HB3' ' A' ' 251' ' ' PRO . 2.0 mm? -98.38 108.58 21.31 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.498 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 30.5 mmmt -67.75 131.58 45.83 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-O 121.526 0.679 . . . . 0.0 112.384 -178.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 65.1 t30 74.91 1.96 3.9 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 113.379 -1.737 . . . . 0.0 111.294 176.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -94.68 110.65 22.47 Favored 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -178.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 1.2 p -82.73 135.67 34.93 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-O 121.074 0.464 . . . . 0.0 111.405 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' LEU . . . . . 0.484 HD11 ' HB2' ' A' ' 273' ' ' LEU . 26.8 tp -112.88 124.11 32.36 Favored Pre-proline 0 N--CA 1.425 -1.698 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.125 176.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.42 ' O ' ' HG ' ' A' ' 269' ' ' LEU . 23.3 Cg_exo -70.77 160.08 50.58 Favored 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 122.619 2.213 . . . . 0.0 111.659 170.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 3.6 p -66.95 -26.19 66.71 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 123.803 0.841 . . . . 0.0 111.456 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 6.7 m -64.23 -23.6 67.37 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.01 1.324 . . . . 0.0 112.438 -177.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.484 ' HB2' HD11 ' A' ' 269' ' ' LEU . 3.2 mm? -99.47 -8.92 24.02 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-O 121.344 0.592 . . . . 0.0 111.707 -174.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -72.96 138.67 46.24 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.288 -0.869 . . . . 0.0 108.803 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -169.09 170.9 8.5 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 177.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 62.0 m -130.8 152.54 50.03 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-O 121.394 0.616 . . . . 0.0 110.302 176.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.468 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 1.8 mm? -111.98 108.91 18.41 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 105.998 -1.852 . . . . 0.0 105.998 177.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -80.72 85.52 6.07 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 122.444 1.116 . . . . 0.0 109.213 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' VAL . . . . . 0.641 ' HA ' ' CE1' ' A' ' 282' ' ' PHE . 87.8 t -89.63 36.69 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-N 113.364 -1.744 . . . . 0.0 111.619 -173.365 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -80.84 142.5 33.6 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.432 174.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 18.6 t70 72.51 20.49 3.89 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 122.673 1.225 . . . . 0.0 110.259 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.641 ' CE1' ' HA ' ' A' ' 279' ' ' VAL . 21.1 m-85 -90.3 -18.4 25.66 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.588 -0.695 . . . . 0.0 110.589 176.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 65.39 35.02 7.71 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.691 0.796 . . . . 0.0 111.841 176.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 284' ' ' THR . . . . . 0.403 HG22 ' HE3' ' A' ' 232' ' ' LYS . 2.3 p -115.58 174.91 2.13 Favored Pre-proline 0 C--N 1.3 -1.558 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 285' ' ' PRO . . . . . 0.538 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 9.2 Cg_exo -75.57 -15.2 19.66 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.764 1.643 . . . . 0.0 111.693 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.8 p -93.21 128.74 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-O 121.639 0.733 . . . . 0.0 109.87 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -94.51 -39.61 10.31 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.155 -174.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -160.14 134.52 7.49 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.541 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.468 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 40.6 t -99.39 123.77 52.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 87.5 m -130.11 122.91 29.17 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 120.852 0.358 . . . . 0.0 110.885 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.657 ' HB2' HG12 ' A' ' 228' ' ' ILE . 46.5 tp -99.74 125.06 45.57 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -124.4 139.12 54.2 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -175.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -83.66 148.54 27.05 Favored 'General case' 0 C--N 1.289 -2.061 0 C-N-CA 118.832 -1.147 . . . . 0.0 108.218 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.484 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 17.8 tp -115.73 -174.49 2.54 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 173.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.484 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 4.6 t30 -76.0 -55.23 5.8 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 120.07 1.305 . . . . 0.0 111.891 -173.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -107.36 -8.91 16.17 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.686 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' ASP . . . . . 0.498 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 29.3 m-20 -132.1 173.12 11.56 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.975 -171.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.609 ' O ' ' HA ' ' A' ' 263' ' ' THR . 79.1 m -110.7 132.96 53.74 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 299' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 32.7 tt0 -117.14 126.62 53.09 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.799 0.809 . . . . 0.0 110.112 -177.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.442 ' HB2' ' HB ' ' A' ' 262' ' ' VAL . 0.5 OUTLIER -110.89 122.82 48.83 Favored 'General case' 0 C--N 1.274 -2.689 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.211 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 301' ' ' ILE . . . . . 0.447 HG23 ' CD2' ' A' ' 259' ' ' HIS . 72.9 mt -109.12 109.22 27.56 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.368 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -177.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 59.9 mt -110.48 98.9 7.65 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 10.9 m -69.53 126.03 28.49 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 17.3 p -136.26 165.79 24.93 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 122.85 0.46 . . . . 0.0 110.98 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -149.63 138.68 21.19 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-O 120.631 0.253 . . . . 0.0 111.468 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 90.29 -168.28 33.53 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.242 176.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -84.12 127.81 34.15 Favored 'General case' 0 CA--C 1.482 -1.654 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 308' ' ' TRP . . . . . 0.708 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 68.4 p-90 -144.53 169.5 17.84 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -178.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -125.53 123.81 39.95 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -174.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.708 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 17.7 tp -100.19 122.36 42.89 Favored 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.137 -178.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.617 HG13 ' HB3' ' A' ' 323' ' ' GLN . 8.6 p -126.1 114.98 41.11 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-O 121.723 0.773 . . . . 0.0 109.558 171.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 312' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 321' ' ' THR . 11.4 t30 -102.51 129.9 49.18 Favored 'General case' 0 CA--C 1.437 -3.366 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.496 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -114.35 123.61 49.92 Favored 'General case' 1 N--CA 1.372 -4.334 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.874 -176.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 16.3 m -92.06 103.03 15.57 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 176.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -78.38 -34.15 48.4 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.88 -1.055 . . . . 0.0 112.539 -172.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.482 ' HB1' ' HD2' ' A' ' 317' ' ' PRO . . . -165.75 167.38 9.06 Favored Pre-proline 0 C--N 1.307 -1.273 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 -175.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 317' ' ' PRO . . . . . 0.482 ' HD2' ' HB1' ' A' ' 316' ' ' ALA . 25.2 Cg_endo -60.31 102.96 0.2 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.031 1.821 . . . . 0.0 112.088 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 105.83 -15.25 44.89 Favored Glycine 0 N--CA 1.436 -1.331 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.181 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -100.89 116.79 33.6 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 122.196 -0.59 . . . . 0.0 110.698 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 320' ' ' PHE . . . . . 0.497 ' CZ ' ' HD3' ' A' ' 251' ' ' PRO . 75.2 m-85 -122.49 163.65 19.5 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.975 -177.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 312' ' ' ASN . 88.4 m -152.8 110.66 3.62 Favored 'General case' 0 C--N 1.265 -3.076 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.194 -175.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -98.01 104.35 16.37 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 323' ' ' GLN . . . . . 0.617 ' HB3' HG13 ' A' ' 311' ' ' VAL . 42.6 tt0 -94.96 108.2 20.25 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.593 HG13 ' CE3' ' A' ' 308' ' ' TRP . 93.3 t -94.86 99.87 10.14 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.302 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.3 152.51 47.81 Favored Pre-proline 0 C--O 1.213 -0.836 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 326' ' ' PRO . . . . . 0.447 ' HG3' ' HB2' ' A' ' 236' ' ' ASN . 57.5 Cg_endo -77.33 137.39 16.78 Favored 'Trans proline' 0 C--O 1.249 1.069 0 C-N-CA 121.565 1.51 . . . . 0.0 110.18 172.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm . . . . . 0 CA--C 1.468 -2.205 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.742 -179.462 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 . . . . . 0 CA--C 1.555 1.167 0 N-CA-C 110.62 -0.141 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 24.4 m -57.16 114.34 2.11 Favored 'General case' 0 C--O 1.198 -1.633 0 C-N-CA 123.679 0.792 . . . . 0.0 111.866 -171.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.412 ' HB3' ' HB3' ' A' ' 243' ' ' ALA . 48.2 t30 -130.96 160.21 35.19 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.812 -169.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.2 pp -128.97 151.74 36.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 124.286 1.034 . . . . 0.0 109.762 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' ASP . . . . . 0.571 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 5.0 t70 -143.47 156.5 44.65 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -176.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 239' ' ' ILE . 77.3 t80 -137.91 139.32 39.75 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 110.27 -0.271 . . . . 0.0 110.27 178.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -165.1 175.01 9.75 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 123.952 0.901 . . . . 0.0 108.743 178.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.405 ' HE3' HG22 ' A' ' 284' ' ' THR . 54.5 mtpt -121.82 159.36 26.91 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 117.803 0.274 . . . . 0.0 110.552 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -164.38 148.23 9.46 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 82.43 -103.35 2.4 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 121.475 -0.393 . . . . 0.0 113.588 173.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -135.87 72.22 1.44 Allowed 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.14 0.495 . . . . 0.0 111.524 -176.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' ASN . . . . . 0.465 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 86.0 m-20 67.16 27.52 8.48 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.131 179.007 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -82.88 143.15 30.95 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.824 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -98.13 117.74 5.92 Favored Glycine 0 N--CA 1.437 -1.264 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 230' ' ' PHE . 2.3 mp -105.59 118.64 53.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-N 117.318 0.559 . . . . 0.0 110.288 -177.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.89 111.61 36.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 175.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.571 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 49.6 mt-10 -92.76 138.8 31.18 Favored 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 177.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 13.9 tp -121.91 117.48 26.56 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.358 -176.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' ALA . . . . . 0.579 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -106.19 94.4 5.14 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -102.7 91.34 4.14 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.813 0.816 . . . . 0.0 109.98 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -76.62 116.38 17.24 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.165 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 114.1 -7.55 23.29 Favored Glycine 0 N--CA 1.429 -1.831 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.762 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -102.48 145.79 29.06 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -136.09 -12.86 1.9 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.511 0.559 . . . . 0.0 112.511 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -92.5 -140.61 9.76 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.991 -178.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -122.72 134.25 24.88 Favored Pre-proline 0 C--N 1.311 -1.092 0 CA-C-O 120.517 0.199 . . . . 0.0 110.617 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.655 ' HB3' HD23 ' A' ' 264' ' ' LEU . 32.1 Cg_endo -77.79 172.43 15.7 Favored 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 122.66 2.24 . . . . 0.0 112.36 177.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.411 ' HB3' ' HB ' ' A' ' 263' ' ' THR . 34.3 t70 -95.87 111.26 23.29 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.462 177.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 3.8 mp -105.48 124.72 60.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 8.8 t -115.94 117.44 30.15 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 174.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -99.76 107.16 19.16 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 121.187 0.518 . . . . 0.0 111.923 -176.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.453 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 27.2 mt-30 -115.87 161.12 19.26 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 175.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' HIS . . . . . 0.443 ' HA ' ' HE1' ' A' ' 308' ' ' TRP . 30.6 m170 -73.91 -31.37 63.05 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.084 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -80.91 -26.54 36.72 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.707 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' HIS . . . . . 0.453 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 35.5 p-80 -174.03 161.48 3.66 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 120.878 0.37 . . . . 0.0 111.821 175.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.45 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 14.9 mt -106.67 142.75 18.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 177.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 3.1 mp -122.46 116.34 48.7 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' A' ' 300' ' ' LEU . 24.3 t -113.86 119.74 61.87 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 175.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 263' ' ' THR . . . . . 0.411 ' HB ' ' HB3' ' A' ' 252' ' ' ASP . 10.4 m -116.86 123.79 47.92 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 121.181 0.515 . . . . 0.0 110.168 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.655 HD23 ' HB3' ' A' ' 251' ' ' PRO . 21.2 mt -99.02 99.77 10.84 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.585 ' HD3' ' OD1' ' A' ' 297' ' ' ASP . 48.7 mmtt -61.28 129.34 40.77 Favored 'General case' 0 C--N 1.317 -0.815 0 O-C-N 124.147 0.904 . . . . 0.0 113.398 -177.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 63.4 t30 67.59 22.54 9.11 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.839 175.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 48.4 t60 -110.25 112.08 23.81 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 18.4 p -86.27 124.46 32.67 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-O 121.251 0.548 . . . . 0.0 111.451 -178.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 32.6 tp -99.01 127.63 34.49 Favored Pre-proline 0 N--CA 1.418 -2.064 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.699 177.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.87 147.31 55.43 Favored 'Trans proline' 0 N--CA 1.432 -2.092 0 C-N-CA 121.382 1.388 . . . . 0.0 110.692 170.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' THR . . . . . 0.422 ' O ' ' HG2' ' A' ' 274' ' ' GLN . 25.0 p -66.64 -15.06 63.2 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.424 0.63 . . . . 0.0 112.075 -177.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 12.2 m -74.58 -21.18 59.62 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.743 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 226' ' ' THR . 3.1 mm? -102.11 -13.97 17.27 Favored 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.077 -178.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 271' ' ' THR . 9.4 pt20 -77.11 129.78 36.48 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 119.563 -0.855 . . . . 0.0 108.996 -178.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -170.44 159.96 7.24 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -177.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 276' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 16.9 p -104.22 140.21 38.15 Favored 'General case' 0 N--CA 1.407 -2.613 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.735 173.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 82.4 mt -99.59 117.29 33.65 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 175.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -47.35 -68.97 0.14 Allowed 'General case' 0 C--N 1.316 -0.85 0 O-C-N 125.085 1.491 . . . . 0.0 110.594 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . 0.271 19.0 m 49.78 18.32 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 127.111 2.164 . . . . 0.0 116.697 173.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -73.75 132.79 43.01 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 22.2 t70 68.77 48.64 0.75 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 122.674 1.226 . . . . 0.0 112.327 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -98.08 -1.62 42.0 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 168.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? 61.86 59.94 1.65 Allowed 'General case' 0 CA--C 1.503 -0.86 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.825 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 284' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 236' ' ' ASN . 2.5 p -137.42 176.65 2.6 Favored Pre-proline 0 C--N 1.31 -1.14 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 285' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 3.3 Cg_exo -82.66 -7.1 11.6 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.077 1.852 . . . . 0.0 112.083 174.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.4 p -99.01 127.72 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 CA-C-O 121.623 0.725 . . . . 0.0 110.668 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -88.14 -44.65 10.76 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.441 -172.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -165.06 138.16 4.61 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.319 -176.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 30.7 t -104.39 140.58 22.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -178.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 276' ' ' SER . 75.4 m -142.42 116.35 9.34 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 122.031 -0.418 . . . . 0.0 111.177 177.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 56.2 tp -91.59 128.89 37.6 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 174.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -134.92 133.82 39.99 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 120.783 0.325 . . . . 0.0 110.971 -174.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 293' ' ' ARG . 23.3 ttt180 -71.05 125.11 26.0 Favored 'General case' 0 N--CA 1.4 -2.962 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 171.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.488 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 14.9 tp -102.88 -174.33 2.53 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 176.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.488 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 39.4 t30 -46.64 -74.54 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -120.61 -3.87 9.81 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 122.319 1.057 . . . . 0.0 108.745 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' ASP . . . . . 0.585 ' OD1' ' HD3' ' A' ' 265' ' ' LYS . 39.7 m-20 -111.67 164.12 13.37 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.236 -175.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.462 ' HB ' ' HB2' ' A' ' 264' ' ' LEU . 91.7 m -104.77 128.61 52.96 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 174.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -113.36 129.68 56.47 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -178.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.502 ' HB3' ' HB ' ' A' ' 262' ' ' VAL . 50.5 tp -114.16 119.02 35.65 Favored 'General case' 0 C--N 1.273 -2.758 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 176.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 51.6 mt -104.44 112.01 36.32 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.128 -177.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 302' ' ' ILE . . . . . 0.45 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 56.4 mt -112.6 103.83 16.06 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 3.7 m -77.8 130.38 36.62 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -174.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 15.5 p -135.56 -176.95 4.45 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 122.366 0.266 . . . . 0.0 111.286 -176.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -159.35 152.94 22.74 Favored 'General case' 0 C--O 1.247 0.946 0 C-N-CA 122.965 0.506 . . . . 0.0 110.169 175.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 74.85 -157.07 50.07 Favored Glycine 0 N--CA 1.444 -0.784 0 O-C-N 123.569 0.543 . . . . 0.0 112.955 175.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 307' ' ' ASN . . . . . 0.497 ' HB3' ' HB3' ' A' ' 327' ' ' LYS . 40.8 m-80 -92.39 131.28 37.69 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 177.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 308' ' ' TRP . . . . . 0.707 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 60.8 p-90 -148.77 166.3 28.84 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -178.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -124.76 135.99 53.46 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.707 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 27.0 tp -107.45 118.56 37.03 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.65 HG13 ' HB3' ' A' ' 323' ' ' GLN . 5.7 p -115.26 112.31 39.36 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.515 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 171.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -102.93 129.71 49.74 Favored 'General case' 0 N--CA 1.407 -2.586 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.075 -178.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -129.17 156.98 43.05 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.635 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 26.4 t -111.44 120.95 43.86 Favored 'General case' 0 N--CA 1.411 -2.417 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -88.91 -23.65 22.67 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.024 0.44 . . . . 0.0 110.726 -177.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -169.91 164.14 6.36 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.69 103.11 0.26 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 121.745 1.63 . . . . 0.0 111.238 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 115.01 -28.1 8.22 Favored Glycine 0 N--CA 1.436 -1.347 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -177.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -89.13 116.65 27.55 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.164 0.507 . . . . 0.0 110.339 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -116.28 165.74 12.84 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 115.377 -0.829 . . . . 0.0 108.865 177.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 89.6 m -152.05 130.18 11.91 Favored 'General case' 0 C--N 1.261 -3.278 0 C-N-CA 123.661 0.784 . . . . 0.0 108.894 -176.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -118.57 107.53 13.86 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' GLN . . . . . 0.65 ' HB3' HG13 ' A' ' 311' ' ' VAL . 35.9 tt0 -99.66 112.5 24.72 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 176.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.63 HG13 ' CE3' ' A' ' 308' ' ' TRP . 75.3 t -95.1 98.64 8.2 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.174 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -83.49 149.14 57.07 Favored Pre-proline 0 CA--C 1.512 -0.49 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -77.52 125.6 7.72 Favored 'Trans proline' 0 N--CA 1.44 -1.672 0 N-CA-C 108.498 -1.385 . . . . 0.0 108.498 170.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.497 ' HB3' ' HB3' ' A' ' 307' ' ' ASN . 40.1 ttmt . . . . . 0 C--N 1.294 -1.808 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' GLN . . . . . 0.892 HE21 ' N ' ' A' ' 225' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.43 -1.429 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 56.9 m -67.44 116.39 8.13 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.407 ' ND2' ' HB3' ' A' ' 243' ' ' ALA . 10.0 p30 -144.51 173.02 12.17 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.308 -172.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.58 HD13 HD21 ' A' ' 277' ' ' LEU . 1.4 pp -136.06 158.65 38.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 CA-C-N 114.145 -1.389 . . . . 0.0 109.361 -178.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 229' ' ' ASP . . . . . 0.463 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 12.8 t70 -150.23 151.32 32.85 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.51 ' CD2' HG11 ' A' ' 279' ' ' VAL . 86.4 t80 -129.84 133.75 47.12 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 173.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -153.39 152.81 31.48 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -104.15 153.19 21.23 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.442 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -151.61 162.61 40.7 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 64.7 -125.87 31.49 Favored Glycine 0 C--N 1.312 -0.751 0 O-C-N 123.454 0.471 . . . . 0.0 112.849 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -124.03 91.81 3.54 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' ASN . . . . . 0.581 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 95.9 m-20 66.66 21.25 10.66 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 177.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -79.79 138.26 37.21 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -99.18 110.4 3.98 Favored Glycine 0 N--CA 1.436 -1.325 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.1 mp -102.7 115.09 44.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 117.483 0.641 . . . . 0.0 109.917 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.5 mp -102.57 113.68 39.86 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 35.1 mt-10 -93.11 145.08 24.66 Favored 'General case' 0 C--N 1.283 -2.284 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.965 173.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 12.0 tp -135.6 134.09 38.95 Favored 'General case' 0 C--N 1.264 -3.14 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.67 -174.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -126.93 106.6 9.42 Favored 'General case' 0 C--N 1.278 -2.514 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.464 ' O ' ' HA2' ' A' ' 318' ' ' GLY . . . -108.75 91.01 3.47 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.427 HD23 ' O ' ' A' ' 225' ' ' GLN . 3.3 mm? -84.4 114.0 21.58 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.678 0.752 . . . . 0.0 111.141 -175.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 116.51 3.91 18.18 Favored Glycine 0 N--CA 1.429 -1.767 0 CA-C-N 114.239 -1.346 . . . . 0.0 110.175 -177.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' PHE . . . . . 0.455 ' HB2' ' ND1' ' A' ' 267' ' ' HIS . 65.8 t80 -113.12 115.63 28.59 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 121.016 0.436 . . . . 0.0 110.25 -177.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -112.98 100.03 8.32 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 154.43 -158.37 28.17 Favored Glycine 0 N--CA 1.432 -1.597 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -114.43 140.89 25.72 Favored Pre-proline 0 C--N 1.301 -1.511 0 CA-C-N 116.853 0.327 . . . . 0.0 110.359 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.798 ' HB3' HD13 ' A' ' 264' ' ' LEU . 17.9 Cg_endo -72.57 171.85 16.32 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.56 2.173 . . . . 0.0 111.112 175.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 18.0 t70 -88.45 109.93 20.43 Favored 'General case' 0 C--N 1.277 -2.58 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 4.1 mp -97.99 108.18 21.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 121.84 0.828 . . . . 0.0 110.102 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' SER . . . . . 0.656 ' HB2' ' HB ' ' A' ' 261' ' ' ILE . 47.3 m -109.99 107.18 16.97 Favored 'General case' 0 C--N 1.278 -2.526 0 CA-C-N 114.482 -1.236 . . . . 0.0 108.43 177.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -99.18 126.73 45.02 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 122.126 -0.359 . . . . 0.0 110.865 -175.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -124.21 171.68 9.65 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 171.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -76.59 -40.12 50.51 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 120.871 0.367 . . . . 0.0 110.994 -177.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -82.79 -20.37 35.92 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.826 -175.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -171.99 160.83 5.5 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.905 0.384 . . . . 0.0 111.448 176.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.459 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 16.7 mt -106.71 143.78 16.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 261' ' ' ILE . . . . . 0.656 ' HB ' ' HB2' ' A' ' 254' ' ' SER . 3.9 mp -119.79 109.76 27.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 176.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.482 ' HB ' ' HB3' ' A' ' 300' ' ' LEU . 61.6 t -111.45 123.24 67.11 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.426 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 176.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 298' ' ' THR . 11.9 m -126.19 130.06 50.22 Favored 'General case' 0 C--N 1.285 -2.216 0 C-N-CA 120.096 -0.642 . . . . 0.0 111.029 -177.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.798 HD13 ' HB3' ' A' ' 251' ' ' PRO . 1.3 mm? -100.81 98.04 8.59 Favored 'General case' 0 N--CA 1.408 -2.574 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 177.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.493 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 58.6 mtpt -73.27 135.55 44.48 Favored 'General case' 0 C--N 1.267 -3.015 0 O-C-N 124.191 0.932 . . . . 0.0 110.81 -177.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 6.2 t30 72.85 20.65 3.55 Favored 'General case' 0 CA--C 1.55 0.961 0 O-C-N 124.539 1.15 . . . . 0.0 109.716 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 267' ' ' HIS . . . . . 0.455 ' ND1' ' HB2' ' A' ' 247' ' ' PHE . 54.5 t60 -114.85 100.1 7.97 Favored 'General case' 0 CA--C 1.495 -1.173 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 176.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.97 116.74 17.9 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-O 120.847 0.356 . . . . 0.0 110.436 -176.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 22.5 tp -99.29 123.08 49.86 Favored Pre-proline 0 N--CA 1.436 -1.175 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.769 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -67.73 158.0 59.2 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 122.429 2.086 . . . . 0.0 111.849 171.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 271' ' ' THR . . . . . 0.418 ' O ' ' HG2' ' A' ' 274' ' ' GLN . 24.6 p -68.34 -26.3 65.53 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 15.4 m -72.53 -19.74 61.46 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.353 -177.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -95.15 -22.31 17.94 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.492 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 271' ' ' THR . 9.2 pt20 -77.47 140.03 39.75 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -177.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -177.96 175.46 1.29 Allowed 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -175.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 32.9 t -125.62 143.07 51.19 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-O 121.527 0.679 . . . . 0.0 110.453 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.58 HD21 HD13 ' A' ' 228' ' ' ILE . 1.3 mm? -91.84 103.14 15.72 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 102.917 -2.994 . . . . 0.0 102.917 174.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -59.2 -50.55 73.6 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 123.727 0.642 . . . . 0.0 112.089 -173.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' VAL . . . . . 0.51 HG11 ' CD2' ' A' ' 230' ' ' PHE . 25.8 m 44.9 30.1 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 173.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -72.52 134.32 45.2 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.646 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 73.59 19.62 3.26 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.069 1.348 . . . . 0.0 113.548 -174.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -79.35 -21.94 45.14 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.345 170.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? 57.8 61.86 2.27 Favored 'General case' 0 CA--C 1.493 -1.212 0 CA-C-O 122.253 1.025 . . . . 0.0 113.641 174.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 4.8 p -125.3 -178.67 0.73 Allowed Pre-proline 0 C--N 1.275 -2.641 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 285' ' ' PRO . . . . . 0.581 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 14.4 Cg_exo -71.1 -16.91 31.93 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 CA-C-N 121.281 1.493 . . . . 0.0 110.637 174.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.5 p -95.75 126.61 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-O 122.25 1.024 . . . . 0.0 110.562 177.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -84.16 -47.31 10.99 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 113.938 -1.483 . . . . 0.0 110.278 -175.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -162.09 148.84 13.67 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 -177.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.502 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 62.0 t -116.39 122.71 70.37 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.669 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 53.7 m -123.86 120.33 32.25 Favored 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.951 -0.468 . . . . 0.0 111.951 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 48.2 tp -94.53 122.8 37.48 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 175.243 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -129.84 141.89 50.76 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -176.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -82.41 138.97 34.28 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 118.501 -1.279 . . . . 0.0 108.843 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.481 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 17.0 tp -108.25 -175.32 2.74 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 176.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.481 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 26.0 t-20 -49.03 -67.45 0.26 Allowed 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 118.918 0.781 . . . . 0.0 113.0 -177.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -119.44 -2.21 10.6 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 122.13 0.967 . . . . 0.0 108.462 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' ASP . . . . . 0.493 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 5.5 m-20 -117.07 168.51 10.2 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.094 -169.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 263' ' ' THR . 58.8 m -111.73 124.21 51.86 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 176.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -113.13 124.61 52.97 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-O 121.582 0.706 . . . . 0.0 109.476 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.482 ' HB3' ' HB ' ' A' ' 262' ' ' VAL . 58.6 tp -110.97 120.34 42.07 Favored 'General case' 0 C--N 1.274 -2.689 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 54.9 mt -106.42 109.77 29.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.245 -176.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' ILE . . . . . 0.459 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 57.5 mt -107.96 103.18 15.08 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.496 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 8.4 m -77.1 131.1 38.17 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 -175.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 18.9 p -134.73 175.88 9.15 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 122.395 0.278 . . . . 0.0 111.719 -175.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -164.2 139.62 6.02 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.906 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 99.11 -151.87 19.52 Favored Glycine 0 N--CA 1.434 -1.479 0 C-N-CA 121.25 -0.5 . . . . 0.0 112.354 177.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 307' ' ' ASN . . . . . 0.45 ' HB3' ' HB3' ' A' ' 327' ' ' LYS . 64.4 m-20 -105.85 124.5 49.67 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 177.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 308' ' ' TRP . . . . . . . . . . . . . 69.1 p-90 -150.24 158.11 43.81 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.766 -176.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -115.62 137.88 51.63 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 1.4 tt -104.55 114.03 27.99 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 46.0 t -108.09 106.71 21.18 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 172.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -95.96 141.0 29.9 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 313' ' ' LYS . . . . . 0.429 ' HB2' ' HB ' ' A' ' 321' ' ' THR . 86.8 mttt -131.14 141.07 50.06 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -178.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 20.3 m -115.81 109.32 17.49 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -77.38 -33.41 55.17 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.586 0.707 . . . . 0.0 109.783 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -170.19 161.56 6.5 Favored Pre-proline 0 C--N 1.305 -1.364 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -65.24 96.97 0.29 Allowed 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 121.387 1.391 . . . . 0.0 110.245 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 318' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 244' ' ' ALA . . . 135.62 -16.81 4.02 Favored Glycine 0 N--CA 1.424 -2.107 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.74 -176.154 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -122.29 118.39 28.39 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 122.344 -0.503 . . . . 0.0 110.171 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -126.87 161.79 27.42 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.507 -178.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.429 ' HB ' ' HB2' ' A' ' 313' ' ' LYS . 49.3 m -151.87 138.62 18.85 Favored 'General case' 0 C--N 1.267 -2.999 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -176.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -127.41 107.44 9.96 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 323' ' ' GLN . . . . . 0.618 HE21 HD21 ' A' ' 325' ' ' LEU . 45.9 tt0 -94.06 101.34 13.37 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 86.6 t -89.05 101.17 11.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.001 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.618 HD21 HE21 ' A' ' 323' ' ' GLN . 40.3 mt -95.59 145.39 29.45 Favored Pre-proline 0 C--N 1.299 -1.596 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.995 -176.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -72.25 123.61 9.32 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 121.102 1.201 . . . . 0.0 109.97 172.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 307' ' ' ASN . 41.0 ttmt . . . . . 0 CA--C 1.474 -1.962 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.713 -175.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' GLN . . . . . 0.485 ' CG ' HD21 ' A' ' 273' ' ' LEU . 1.1 tp60 . . . . . 0 N--CA 1.431 -1.424 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.556 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 16.3 m -50.65 128.6 20.87 Favored 'General case' 0 CA--C 1.552 1.021 0 O-C-N 123.923 0.764 . . . . 0.0 110.73 177.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -146.07 156.6 43.57 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.048 0.452 . . . . 0.0 110.224 -174.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.566 HG12 ' HB2' ' A' ' 291' ' ' LEU . 2.1 pp -138.73 146.04 26.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 C-N-CA 124.882 1.273 . . . . 0.0 109.491 -177.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -150.58 157.16 42.67 Favored 'General case' 0 C--N 1.29 -1.991 0 O-C-N 123.34 0.4 . . . . 0.0 111.103 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -126.67 138.01 53.36 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-O 120.811 0.339 . . . . 0.0 111.153 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -146.92 168.11 22.28 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 173.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.423 ' HE3' HG22 ' A' ' 284' ' ' THR . 55.4 mtpt -116.01 155.52 27.94 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 122.402 -0.186 . . . . 0.0 110.677 178.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -138.55 145.47 40.71 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 123.366 0.416 . . . . 0.0 110.175 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 56.33 -104.7 0.38 Allowed Glycine 0 N--CA 1.441 -0.97 0 O-C-N 124.566 1.166 . . . . 0.0 114.796 172.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -119.15 83.86 2.1 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-O 121.212 0.53 . . . . 0.0 109.852 -176.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' ASN . . . . . 0.452 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 94.9 m-20 61.37 23.05 13.35 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.646 -1.161 . . . . 0.0 114.075 172.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -78.32 136.63 37.75 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -99.45 114.57 5.06 Favored Glycine 0 N--CA 1.431 -1.697 0 N-CA-C 111.689 -0.564 . . . . 0.0 111.689 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.1 mp -107.49 115.84 49.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-O 121.35 0.595 . . . . 0.0 110.847 -177.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.3 mp -99.17 116.65 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.459 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 175.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -90.73 135.76 33.51 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 16.3 tp -130.86 131.85 44.81 Favored 'General case' 0 C--N 1.278 -2.514 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.057 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' ALA . . . . . 0.556 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -128.74 102.36 6.53 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -111.21 92.25 3.97 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.479 0.656 . . . . 0.0 109.697 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -76.42 114.59 15.29 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.224 -176.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 107.1 18.73 10.14 Favored Glycine 0 N--CA 1.431 -1.646 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.579 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -115.11 116.08 27.83 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -104.88 95.15 5.67 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.147 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 143.6 -166.17 26.97 Favored Glycine 0 C--N 1.299 -1.515 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 175.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -102.28 144.87 29.47 Favored Pre-proline 0 C--N 1.308 -1.205 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 177.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.625 ' HB3' HD23 ' A' ' 264' ' ' LEU . 21.5 Cg_endo -77.14 173.32 14.59 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.955 2.437 . . . . 0.0 112.38 178.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -97.76 118.0 33.33 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 3.2 mp -107.25 133.13 52.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-O 120.977 0.417 . . . . 0.0 111.18 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 254' ' ' SER . . . . . 0.495 ' HB3' ' HB ' ' A' ' 261' ' ' ILE . 23.2 t -115.81 111.35 20.37 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 173.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -90.86 105.05 17.56 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.342 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 74.8 mt-30 -125.14 152.52 44.32 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 176.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -60.1 -45.13 94.0 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -176.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -83.87 -20.14 33.61 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -174.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' HIS . . . . . 0.459 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 49.1 p-80 -171.8 158.75 5.0 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.083 0.468 . . . . 0.0 111.853 175.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.442 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 23.7 mt -106.72 144.14 16.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' ILE . . . . . 0.495 ' HB ' ' HB3' ' A' ' 254' ' ' SER . 3.5 mp -119.82 112.97 39.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 176.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.497 ' HB ' ' HB2' ' A' ' 300' ' ' LEU . 54.7 t -107.18 116.44 50.84 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 176.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 17.3 m -109.54 124.1 50.54 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-O 121.146 0.498 . . . . 0.0 110.19 -178.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.625 HD23 ' HB3' ' A' ' 251' ' ' PRO . 18.2 mt -102.96 89.84 3.57 Favored 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 178.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.605 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 61.2 mtpt -65.68 131.28 45.94 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.667 -175.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 71.23 21.08 4.85 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 124.601 1.188 . . . . 0.0 109.843 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -117.99 102.02 8.73 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 177.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 2.5 m -91.43 115.41 28.01 Favored 'General case' 0 C--N 1.28 -2.455 0 C-N-CA 119.829 -0.749 . . . . 0.0 111.208 -173.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 269' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 270' ' ' PRO . 21.2 tp -89.89 130.3 43.23 Favored Pre-proline 0 N--CA 1.43 -1.466 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.761 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.419 ' O ' ' HG ' ' A' ' 269' ' ' LEU . 6.7 Cg_exo -73.85 156.95 48.07 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 122.057 1.838 . . . . 0.0 110.603 170.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 271' ' ' THR . . . . . 0.508 ' HA ' ' HG2' ' A' ' 274' ' ' GLN . 7.1 p -73.55 -10.46 59.73 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.623 0.725 . . . . 0.0 112.186 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 15.4 m -73.59 -24.06 60.01 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.206 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.485 HD21 ' CG ' ' A' ' 225' ' ' GLN . 7.8 mp -101.95 -12.16 18.41 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.704 -174.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.508 ' HG2' ' HA ' ' A' ' 271' ' ' THR . 4.2 pt20 -81.12 127.37 32.57 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.0 -176.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -153.58 163.35 40.12 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 13.9 p -124.29 127.41 47.6 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-O 121.792 0.806 . . . . 0.0 111.714 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.565 HD21 HD13 ' A' ' 228' ' ' ILE . 2.1 mm? -81.25 118.45 22.61 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -84.39 92.89 8.15 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 118.66 -1.216 . . . . 0.0 108.543 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 279' ' ' VAL . . . . . 0.638 ' HA ' ' CD2' ' A' ' 282' ' ' PHE . 46.9 t -94.88 28.97 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 CA-C-O 123.328 1.537 . . . . 0.0 109.793 -175.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -79.74 149.92 30.99 Favored 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 175.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 28.1 t70 70.21 9.04 6.9 Favored 'General case' 0 CA--C 1.556 1.177 0 CA-C-O 122.156 0.979 . . . . 0.0 111.715 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.638 ' CD2' ' HA ' ' A' ' 279' ' ' VAL . 16.4 m-85 -83.38 -13.47 54.85 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 121.737 -0.602 . . . . 0.0 111.045 176.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 mptt 58.4 60.99 2.4 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.094 0.558 . . . . 0.0 111.132 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 284' ' ' THR . . . . . 0.423 HG22 ' HE3' ' A' ' 232' ' ' LYS . 1.5 p -136.64 174.74 4.12 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 285' ' ' PRO . . . . . 0.456 ' HB3' ' HB3' ' A' ' 308' ' ' TRP . 13.9 Cg_exo -71.47 -19.52 28.46 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 121.739 1.626 . . . . 0.0 111.601 175.243 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.3 p -94.85 132.76 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-O 121.517 0.675 . . . . 0.0 110.21 178.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -100.01 -32.27 11.04 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.9 -174.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 40.2 tttp -162.86 134.48 5.11 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 120.051 -0.659 . . . . 0.0 109.8 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.458 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 42.0 t -103.48 110.14 29.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 174.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.511 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 93.8 m -112.57 113.55 25.76 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-O 121.004 0.43 . . . . 0.0 111.375 -176.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.566 ' HB2' HG12 ' A' ' 228' ' ' ILE . 37.9 tp -94.93 122.71 37.86 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 173.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -140.84 144.4 35.33 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -79.02 149.9 32.08 Favored 'General case' 0 C--N 1.282 -2.339 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.468 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.554 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 15.8 tp -111.62 -173.98 2.36 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 176.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.554 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 64.0 t30 -51.78 -62.7 1.47 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.954 0.502 . . . . 0.0 112.091 -177.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -122.4 -3.21 8.91 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 121.154 0.502 . . . . 0.0 110.08 176.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' ASP . . . . . 0.605 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 11.8 m-20 -115.72 169.07 9.48 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.823 -170.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.527 ' HB ' ' HB2' ' A' ' 264' ' ' LEU . 86.7 m -106.28 135.32 47.96 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 176.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -122.68 127.71 49.64 Favored 'General case' 0 N--CA 1.417 -2.091 0 CA-C-O 121.522 0.677 . . . . 0.0 110.569 -176.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.497 ' HB2' ' HB ' ' A' ' 262' ' ' VAL . 1.8 mt -106.13 119.56 39.52 Favored 'General case' 0 C--N 1.273 -2.729 0 CA-C-N 115.32 -0.854 . . . . 0.0 108.902 175.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 301' ' ' ILE . . . . . 0.511 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 67.3 mt -108.0 109.26 27.59 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.796 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 302' ' ' ILE . . . . . 0.442 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 61.1 mt -108.94 101.06 12.02 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 24.9 m -69.51 132.3 46.06 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 11.4 p -137.41 169.76 17.23 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 122.896 0.479 . . . . 0.0 111.023 -177.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -159.11 144.72 16.25 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 92.2 -152.69 21.41 Favored Glycine 0 N--CA 1.436 -1.358 0 O-C-N 123.892 0.745 . . . . 0.0 112.623 176.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 307' ' ' ASN . . . . . 0.572 ' HB2' ' O ' ' A' ' 327' ' ' LYS . 6.6 m120 -101.17 129.19 47.05 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 308' ' ' TRP . . . . . 0.456 ' HB3' ' HB3' ' A' ' 285' ' ' PRO . 67.4 p-90 -153.59 162.9 40.82 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.011 -177.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 309' ' ' GLU . . . . . 0.416 ' HG2' ' HE2' ' A' ' 327' ' ' LYS . 3.4 mt-10 -122.62 135.36 54.59 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -178.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 1.5 tt -102.74 122.87 45.34 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.683 HG13 ' HB3' ' A' ' 323' ' ' GLN . 7.6 p -125.53 111.97 29.26 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 CA-C-O 121.883 0.849 . . . . 0.0 109.794 170.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -98.79 135.97 39.49 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.259 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -128.2 139.74 52.29 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.098 -176.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 35.9 p -115.99 122.24 44.65 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 176.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -81.16 -38.03 27.8 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.698 0.761 . . . . 0.0 109.321 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.401 ' HB1' ' HD2' ' A' ' 317' ' ' PRO . . . -163.27 162.21 17.76 Favored Pre-proline 0 C--N 1.308 -1.21 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 317' ' ' PRO . . . . . 0.401 ' HD2' ' HB1' ' A' ' 316' ' ' ALA . 16.5 Cg_endo -58.29 110.43 0.65 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.038 1.826 . . . . 0.0 110.811 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 113.86 -36.13 4.17 Favored Glycine 0 N--CA 1.424 -2.104 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -93.29 115.59 28.18 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 320' ' ' PHE . . . . . 0.409 ' CZ ' ' HD3' ' A' ' 251' ' ' PRO . 74.4 m-85 -127.32 166.36 17.96 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-O 122.228 1.013 . . . . 0.0 111.407 -175.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 84.8 m -151.93 127.36 9.99 Favored 'General case' 0 C--N 1.278 -2.531 0 CA-C-N 113.988 -1.46 . . . . 0.0 108.604 -177.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -116.55 111.49 20.0 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 323' ' ' GLN . . . . . 0.683 ' HB3' HG13 ' A' ' 311' ' ' VAL . 61.6 tt0 -97.76 104.28 16.29 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.415 HG13 ' CE3' ' A' ' 308' ' ' TRP . 88.2 t -90.28 98.87 8.72 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 33.0 mt -87.05 148.61 45.62 Favored Pre-proline 0 C--N 1.292 -1.92 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.057 -178.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -77.43 143.46 21.92 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 121.62 1.547 . . . . 0.0 111.134 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.572 ' O ' ' HB2' ' A' ' 307' ' ' ASN . 19.7 ttmm . . . . . 0 N--CA 1.434 -1.264 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' GLN . . . . . 0.506 ' O ' HD23 ' A' ' 245' ' ' LEU . 12.7 pt20 . . . . . 0 N--CA 1.42 -1.945 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.594 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 43.3 m -78.43 127.61 32.43 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 121.118 0.485 . . . . 0.0 112.198 -175.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -151.89 166.35 31.72 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.372 -177.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.3 pp -121.43 165.45 17.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.321 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -150.25 156.46 41.62 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -133.39 130.6 38.96 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.234 0.54 . . . . 0.0 109.749 176.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.42 ' HD2' ' OE2' ' A' ' 241' ' ' GLU . 5.4 ptp180 -149.81 165.33 32.82 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.37 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -108.92 142.09 40.05 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' ASP . . . . . 0.542 ' O ' ' HB3' ' A' ' 237' ' ' ALA . 18.8 t70 -156.77 117.99 3.75 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -178.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 102.13 -143.43 15.95 Favored Glycine 0 C--N 1.301 -1.412 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -178.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -114.46 101.5 9.19 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 117.468 0.634 . . . . 0.0 110.032 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 18.9 m120 65.39 27.25 11.91 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.621 1.168 . . . . 0.0 111.896 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 233' ' ' ASP . . . -97.94 134.74 40.64 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.304 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' GLY . . . . . 0.556 ' HA3' ' CG1' ' A' ' 286' ' ' VAL . . . -101.44 123.9 8.06 Favored Glycine 0 C--N 1.296 -1.671 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.414 HD12 ' C ' ' A' ' 238' ' ' GLY . 2.1 mp -116.78 120.11 64.03 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-N 118.045 0.923 . . . . 0.0 111.045 -176.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' ILE . . . . . 0.404 HD12 ' N ' ' A' ' 240' ' ' ILE . 3.2 mp -104.21 109.49 27.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 176.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.42 ' OE2' ' HD2' ' A' ' 231' ' ' ARG . 5.4 mt-10 -93.59 128.53 39.79 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-O 121.435 0.636 . . . . 0.0 109.742 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 13.0 tp -115.24 126.64 54.78 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 115.186 -0.916 . . . . 0.0 112.092 -171.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' ALA . . . . . 0.594 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -108.27 104.11 13.43 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 175.015 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -112.25 91.88 3.82 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.432 0.634 . . . . 0.0 109.477 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.506 HD23 ' O ' ' A' ' 225' ' ' GLN . 3.5 mm? -85.36 116.83 23.92 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.769 -175.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 108.68 13.33 18.85 Favored Glycine 0 N--CA 1.424 -2.113 0 CA-C-N 114.24 -1.346 . . . . 0.0 110.16 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -114.86 115.26 26.68 Favored 'General case' 0 N--CA 1.423 -1.812 0 C-N-CA 120.6 -0.44 . . . . 0.0 109.875 -177.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -112.93 95.15 5.25 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.05 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 152.47 -157.33 27.22 Favored Glycine 0 C--N 1.296 -1.672 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -114.56 141.55 26.81 Favored Pre-proline 0 C--N 1.303 -1.43 0 CA-C-N 116.991 0.396 . . . . 0.0 110.325 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.761 ' HB3' HD13 ' A' ' 264' ' ' LEU . 12.7 Cg_endo -68.97 172.19 12.29 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.403 2.069 . . . . 0.0 111.053 175.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.451 ' HB3' ' HB ' ' A' ' 263' ' ' THR . 34.1 t0 -97.48 107.84 20.43 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 3.1 mp -95.11 116.23 36.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 3.1 t -119.28 111.27 18.0 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -97.58 128.74 44.54 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -174.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 83.3 mt-30 -125.24 163.13 23.17 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 170.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -76.45 -29.85 57.12 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.29 174.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -68.24 -48.56 64.77 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.308 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' HIS . . . . . 0.506 ' CB ' ' HA ' ' A' ' 303' ' ' THR . 27.6 p-80 -163.37 167.62 21.49 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 116.704 -0.225 . . . . 0.0 110.451 177.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 19.8 mt -105.83 143.1 17.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 3.5 mp -120.93 109.1 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 176.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.511 ' HB ' ' HB3' ' A' ' 300' ' ' LEU . 51.4 t -106.54 117.76 52.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 177.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 263' ' ' THR . . . . . 0.57 ' HA ' ' O ' ' A' ' 298' ' ' THR . 25.3 m -116.79 123.96 48.41 Favored 'General case' 0 C--N 1.278 -2.52 0 CA-C-O 121.773 0.797 . . . . 0.0 111.27 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.761 HD13 ' HB3' ' A' ' 251' ' ' PRO . 1.7 mm? -93.47 98.03 10.93 Favored 'General case' 0 N--CA 1.399 -2.99 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 174.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.546 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 0.5 OUTLIER -67.79 129.81 41.06 Favored 'General case' 0 N--CA 1.388 -3.569 0 O-C-N 124.756 1.285 . . . . 0.0 108.921 -174.832 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 66.6 t30 71.05 27.38 3.34 Favored 'General case' 0 CA--C 1.549 0.924 0 O-C-N 124.483 1.115 . . . . 0.0 110.444 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -121.77 113.18 19.33 Favored 'General case' 0 C--O 1.203 -1.362 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 3.9 p -90.71 129.15 36.83 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' LEU . . . . . 0.575 HD22 HD22 ' A' ' 291' ' ' LEU . 23.8 tp -107.39 129.56 24.09 Favored Pre-proline 0 N--CA 1.446 -0.664 0 C-N-CA 123.624 0.77 . . . . 0.0 109.873 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -64.63 151.34 86.0 Favored 'Trans proline' 0 C--N 1.318 -1.052 0 C-N-CA 122.36 2.04 . . . . 0.0 111.584 172.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' THR . . . . . 0.499 ' HA ' ' HG2' ' A' ' 274' ' ' GLN . 16.3 p -74.96 -13.91 60.57 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.776 0.798 . . . . 0.0 112.176 -178.129 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 25.0 m -81.09 -17.91 48.39 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 122.018 0.913 . . . . 0.0 110.038 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.43 HD11 ' HB2' ' A' ' 225' ' ' GLN . 96.0 mt -101.19 -19.99 15.48 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.944 -178.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.499 ' HG2' ' HA ' ' A' ' 271' ' ' THR . 11.9 pt20 -74.5 136.15 42.21 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -164.87 178.59 7.05 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -173.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 39.9 m -134.78 123.82 24.19 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.346 0.593 . . . . 0.0 110.872 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.447 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 53.2 mt -91.09 120.25 31.89 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 103.977 -2.601 . . . . 0.0 103.977 174.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -68.2 -42.57 79.7 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.783 -172.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . 0.334 34.0 m 42.65 26.74 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 N-CA-C 117.353 2.353 . . . . 0.0 117.353 175.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -74.6 142.86 44.59 Favored 'General case' 0 N--CA 1.415 -2.209 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 176.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 30.0 t70 72.59 22.94 3.15 Favored 'General case' 0 CA--C 1.553 1.059 0 O-C-N 124.229 0.956 . . . . 0.0 111.521 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -86.78 1.94 50.55 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 176.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? 60.77 59.81 2.04 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 1.1 t -164.95 150.95 8.87 Favored Pre-proline 0 N--CA 1.423 -1.795 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.363 177.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' PRO . . . . . 0.416 ' O ' ' HA ' ' A' ' 304' ' ' THR . 18.4 Cg_exo -44.2 -35.81 8.33 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 124.556 3.504 . . . . 0.0 114.06 174.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.556 ' CG1' ' HA3' ' A' ' 238' ' ' GLY . 0.2 OUTLIER -73.57 115.53 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 CA-C-O 121.767 0.794 . . . . 0.0 109.442 177.32 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -94.7 -37.07 11.47 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.714 -174.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -154.62 146.51 23.48 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -176.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 55.1 t -120.04 125.59 74.4 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.499 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 96.1 m -126.49 127.17 44.93 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-O 121.056 0.455 . . . . 0.0 110.434 178.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.575 HD22 HD22 ' A' ' 269' ' ' LEU . 0.1 OUTLIER -100.88 120.1 39.66 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 174.902 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -123.75 134.3 53.69 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' ARG . . . . . 0.415 ' HG2' ' OE1' ' A' ' 274' ' ' GLN . 9.0 ptm180 -81.32 148.62 29.31 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 117.609 -1.636 . . . . 0.0 108.308 173.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.579 HD13 ' N ' ' A' ' 295' ' ' ASN . 2.8 tm? -122.96 166.9 14.3 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.579 ' N ' HD13 ' A' ' 294' ' ' LEU . 30.3 t-20 -24.02 -70.35 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 127.349 2.26 . . . . 0.0 112.149 177.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -124.7 -2.15 7.88 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 297' ' ' ASP . . . . . 0.546 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 12.3 m-20 -119.04 171.37 8.31 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.578 -168.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 263' ' ' THR . 70.5 m -114.3 128.16 56.22 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 176.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -113.65 116.48 29.53 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -177.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.511 ' HB3' ' HB ' ' A' ' 262' ' ' VAL . 0.6 OUTLIER -101.52 120.25 40.01 Favored 'General case' 0 C--N 1.277 -2.587 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 177.87 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 301' ' ' ILE . . . . . 0.499 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 80.6 mt -110.76 115.19 49.19 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -176.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 45.8 mt -117.37 103.25 14.64 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.552 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 303' ' ' THR . . . . . 0.506 ' HA ' ' CB ' ' A' ' 259' ' ' HIS . 85.6 m -75.91 134.43 40.25 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 120.556 0.217 . . . . 0.0 110.416 -177.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 304' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 285' ' ' PRO . 9.1 p -132.76 -179.26 5.36 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 123.237 0.615 . . . . 0.0 110.932 -174.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -155.03 139.88 17.22 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 122.687 0.395 . . . . 0.0 110.162 177.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 77.15 -151.78 39.15 Favored Glycine 0 C--O 1.236 0.263 0 O-C-N 123.635 0.584 . . . . 0.0 112.384 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 307' ' ' ASN . . . . . 0.421 ' HB3' ' HB3' ' A' ' 327' ' ' LYS . 39.4 m-80 -96.59 137.11 36.17 Favored 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 176.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 308' ' ' TRP . . . . . . . . . . . . . 68.9 p-90 -154.13 165.43 36.25 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -175.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 309' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 324' ' ' VAL . 5.6 mt-10 -122.03 136.82 54.95 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -178.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.414 HD21 ' HB3' ' A' ' 322' ' ' PHE . 0.5 OUTLIER -107.25 124.21 49.43 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.961 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.57 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 58.3 t -115.88 107.34 22.38 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.637 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 173.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -92.84 124.92 37.18 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -123.46 149.95 44.46 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -177.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 12.9 p -115.69 122.27 45.03 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 177.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -89.81 -29.54 18.57 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.402 0.62 . . . . 0.0 110.494 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -164.29 163.12 15.36 Favored Pre-proline 0 C--N 1.309 -1.179 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -64.64 97.6 0.27 Allowed 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 121.537 1.491 . . . . 0.0 111.504 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 122.17 -20.63 7.97 Favored Glycine 0 C--O 1.218 -0.877 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.992 -177.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -103.17 116.34 32.29 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -121.45 168.27 11.89 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.674 0.749 . . . . 0.0 111.243 -175.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 60.6 m -151.2 129.23 11.79 Favored 'General case' 0 C--N 1.277 -2.569 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.37 -176.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 0.414 ' HB3' HD21 ' A' ' 310' ' ' LEU . 90.4 m-85 -117.53 108.76 15.89 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 177.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 323' ' ' GLN . . . . . 0.57 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 42.1 tt0 -98.9 105.33 17.46 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 309' ' ' GLU . 0.2 OUTLIER -100.97 105.83 18.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 CA-C-O 122.099 0.952 . . . . 0.0 110.102 178.039 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.7 mp -104.17 156.16 36.15 Favored Pre-proline 0 C--N 1.298 -1.637 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.803 -177.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -74.19 128.52 12.22 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 121.697 1.598 . . . . 0.0 112.082 177.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.421 ' HB3' ' HB3' ' A' ' 307' ' ' ASN . 23.1 ttmm . . . . . 0 CA--C 1.49 -1.342 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' GLN . . . . . 0.442 ' O ' HD23 ' A' ' 245' ' ' LEU . 17.7 pt20 . . . . . 0 N--CA 1.436 -1.166 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.544 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 88.8 m -78.73 131.83 36.74 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.172 177.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -166.91 175.49 7.65 Favored 'General case' 0 CA--C 1.479 -1.788 0 CA-C-O 121.131 0.491 . . . . 0.0 110.289 -175.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.464 HG21 HD13 ' A' ' 300' ' ' LEU . 2.6 pp -128.04 162.72 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.53 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.696 177.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 229' ' ' ASP . . . . . 0.528 ' HB2' ' HB2' ' A' ' 241' ' ' GLU . 4.8 m-20 -146.78 156.04 42.84 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -129.48 134.42 47.79 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.244 176.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 8.3 ptt-85 -144.15 169.33 18.07 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 175.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.453 ' HE3' HG22 ' A' ' 284' ' ' THR . 55.3 mtpt -114.93 150.2 36.07 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 175.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -152.56 152.06 31.41 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -177.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 73.57 -102.75 1.33 Allowed Glycine 0 C--N 1.314 -0.683 0 C-N-CA 121.285 -0.483 . . . . 0.0 113.748 176.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -152.98 104.26 2.82 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 123.2 0.6 . . . . 0.0 110.038 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' ASN . . . . . 0.649 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 89.6 m-20 61.21 20.7 11.23 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.112 0.965 . . . . 0.0 111.762 176.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.34 137.84 33.02 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 120.822 0.344 . . . . 0.0 110.259 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -99.91 117.59 5.92 Favored Glycine 0 N--CA 1.425 -2.066 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.1 mp -108.47 117.79 54.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 117.194 0.497 . . . . 0.0 110.797 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' ILE . . . . . 0.408 HD12 ' N ' ' A' ' 240' ' ' ILE . 2.9 mp -103.68 110.12 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 176.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 229' ' ' ASP . 53.7 mt-10 -90.04 123.37 33.87 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 11.9 tp -112.14 124.23 51.98 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-O 120.981 0.42 . . . . 0.0 111.965 -174.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' ALA . . . . . 0.544 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -107.45 107.87 18.94 Favored 'General case' 0 C--O 1.206 -1.216 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 176.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.43 ' HA ' HG23 ' A' ' 226' ' ' THR . . . -118.15 92.35 3.8 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.24 0.543 . . . . 0.0 111.519 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 225' ' ' GLN . 3.6 mm? -86.56 116.25 24.57 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.246 0.546 . . . . 0.0 111.079 -177.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 111.64 -7.79 28.02 Favored Glycine 0 C--N 1.297 -1.603 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.146 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' PHE . . . . . 0.441 ' HB2' ' ND1' ' A' ' 267' ' ' HIS . 47.9 t80 -98.56 128.15 44.77 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -107.57 -34.98 6.86 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -174.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -86.3 -150.1 15.2 Favored Glycine 0 CA--C 1.506 -0.479 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.457 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -115.01 141.13 26.48 Favored Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.766 ' HB3' HD23 ' A' ' 264' ' ' LEU . 10.2 Cg_endo -69.44 172.27 12.62 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.957 1.771 . . . . 0.0 113.951 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.425 ' HB3' ' HB ' ' A' ' 263' ' ' THR . 11.5 t70 -97.49 105.37 17.51 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 176.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.473 HD11 ' HG2' ' A' ' 251' ' ' PRO . 4.8 mp -101.41 117.19 46.32 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 C-N-CA 119.122 -1.031 . . . . 0.0 109.738 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' SER . . . . . 0.498 ' HB3' ' HB ' ' A' ' 261' ' ' ILE . 24.6 t -97.79 112.32 24.27 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 176.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -97.67 101.98 13.63 Favored 'General case' 0 CA--C 1.497 -1.079 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.226 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -104.66 162.14 13.53 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 171.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -76.72 -33.48 58.17 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 120.624 0.249 . . . . 0.0 111.357 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -72.49 -39.3 67.77 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.889 -178.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' HIS . . . . . 0.42 ' CB ' ' HA ' ' A' ' 303' ' ' THR . 32.1 p-80 -166.7 165.96 16.18 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 301' ' ' ILE . 15.9 mt -106.83 142.73 18.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -177.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 261' ' ' ILE . . . . . 0.498 ' HB ' ' HB3' ' A' ' 254' ' ' SER . 3.6 mp -126.04 112.0 28.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 299' ' ' GLN . 0.8 OUTLIER -102.49 141.49 18.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 177.316 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 263' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 252' ' ' ASP . 6.2 m -129.05 118.88 23.25 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-O 121.2 0.524 . . . . 0.0 109.639 176.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.766 HD23 ' HB3' ' A' ' 251' ' ' PRO . 31.5 mt -96.76 95.36 7.85 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.428 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 31.6 mmtp -63.92 133.96 54.23 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.731 -1.122 . . . . 0.0 113.403 -174.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 65.9 t30 69.56 9.07 7.08 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 113.533 -1.667 . . . . 0.0 110.801 176.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 267' ' ' HIS . . . . . 0.441 ' ND1' ' HB2' ' A' ' 247' ' ' PHE . 46.4 t60 -100.25 114.39 27.8 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.938 -176.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.89 118.19 28.42 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 269' ' ' LEU . . . . . 0.409 HD22 HD22 ' A' ' 291' ' ' LEU . 31.4 tp -96.92 127.48 38.87 Favored Pre-proline 0 N--CA 1.439 -0.982 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.176 177.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -62.87 136.31 56.59 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.193 1.929 . . . . 0.0 111.26 170.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' THR . . . . . 0.497 ' HB ' ' HD2' ' A' ' 293' ' ' ARG . 8.5 t -66.21 -14.12 61.38 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 122.262 1.029 . . . . 0.0 110.756 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 2.8 m -78.14 -18.94 54.96 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.007 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 88.6 mt -106.9 -8.54 16.63 Favored 'General case' 0 C--O 1.246 0.912 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.844 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.483 ' HA ' HD13 ' A' ' 291' ' ' LEU . 10.5 pt20 -83.11 148.9 27.22 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.9 169.82 8.04 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 276' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 289' ' ' VAL . 15.8 m -119.62 117.02 27.2 Favored 'General case' 0 N--CA 1.406 -2.666 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 173.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 76.4 mt -81.53 117.9 22.31 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -79.3 89.5 4.94 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 122.224 1.011 . . . . 0.0 109.866 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' VAL . . . . . 0.623 ' HA ' ' CE1' ' A' ' 282' ' ' PHE . 47.3 t -98.74 27.34 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 CA-C-O 123.047 1.403 . . . . 0.0 109.658 -176.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -71.49 132.2 44.4 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.581 178.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 30.1 t70 68.53 28.49 5.88 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.461 1.504 . . . . 0.0 112.468 178.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.623 ' CE1' ' HA ' ' A' ' 279' ' ' VAL . 6.7 m-85 -84.25 -5.02 59.2 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.66 173.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? 60.97 50.36 5.18 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.691 0.758 . . . . 0.0 110.586 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 284' ' ' THR . . . . . 0.453 HG22 ' HE3' ' A' ' 232' ' ' LYS . 1.2 p -133.27 168.34 18.44 Favored Pre-proline 0 N--CA 1.433 -1.304 0 N-CA-C 104.314 -2.476 . . . . 0.0 104.314 177.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 285' ' ' PRO . . . . . 0.649 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 11.6 Cg_exo -75.05 -11.14 21.38 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 121.588 1.525 . . . . 0.0 110.889 176.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 57.9 t -86.04 129.9 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -92.36 -44.07 8.9 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.543 0.687 . . . . 0.0 109.175 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -164.21 134.54 4.16 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.814 -174.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 276' ' ' SER . 61.6 t -95.44 117.72 40.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 175.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.487 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 62.4 m -115.69 113.32 23.34 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-O 121.149 0.5 . . . . 0.0 110.359 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.483 HD13 ' HA ' ' A' ' 274' ' ' GLN . 0.0 OUTLIER -98.78 120.79 39.82 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 179.374 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -123.65 131.06 53.52 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -176.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' ARG . . . . . 0.497 ' HD2' ' HB ' ' A' ' 271' ' ' THR . 4.6 ptm180 -75.81 133.08 40.73 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 172.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.506 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 31.9 tp -110.39 -179.61 3.82 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -177.312 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.506 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 4.6 m-20 -35.31 -72.11 0.06 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.167 1.787 . . . . 0.0 112.881 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -123.7 -2.2 8.38 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' ASP . . . . . 0.428 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 12.9 m-20 -117.86 174.92 5.91 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.811 -170.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.559 ' HB ' ' HB2' ' A' ' 264' ' ' LEU . 83.5 m -117.4 126.97 53.56 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 175.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 299' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 36.3 tt0 -109.94 128.15 55.2 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -175.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.464 HD13 HG21 ' A' ' 228' ' ' ILE . 63.5 tp -116.38 117.39 29.82 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.644 177.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 301' ' ' ILE . . . . . 0.487 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 51.1 mt -107.14 115.26 48.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.391 -176.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 302' ' ' ILE . . . . . 0.401 ' HB ' HD12 ' A' ' 260' ' ' ILE . 56.0 mt -110.63 105.49 18.91 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.551 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 303' ' ' THR . . . . . 0.42 ' HA ' ' CB ' ' A' ' 259' ' ' HIS . 3.0 m -77.68 131.48 37.74 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -176.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 7.3 p -130.43 165.46 22.57 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -144.95 158.27 43.86 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 123.174 0.59 . . . . 0.0 109.89 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 74.54 -145.27 34.02 Favored Glycine 0 C--N 1.332 0.306 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 307' ' ' ASN . . . . . 0.421 ' HB3' ' HB3' ' A' ' 327' ' ' LYS . 31.9 m-80 -110.41 133.51 53.2 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 174.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 308' ' ' TRP . . . . . 0.724 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 57.0 p-90 -143.41 165.0 28.75 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 120.086 -0.646 . . . . 0.0 110.866 -175.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -126.18 134.85 51.15 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -177.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.724 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 18.5 tp -106.74 122.99 47.47 Favored 'General case' 0 CA--C 1.503 -0.841 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.788 -178.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.603 HG13 ' HB3' ' A' ' 323' ' ' GLN . 10.1 p -127.57 117.67 47.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-O 121.883 0.849 . . . . 0.0 109.461 171.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -106.11 136.18 46.26 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.466 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -129.58 151.28 50.37 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.374 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 43.2 t -116.05 112.79 22.28 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 177.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -70.13 -35.78 74.33 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.648 0.737 . . . . 0.0 109.105 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -164.83 157.61 14.19 Favored Pre-proline 0 N--CA 1.438 -1.054 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -63.17 100.48 0.26 Allowed 'Trans proline' 0 C--O 1.24 0.596 0 C-N-CA 121.778 1.652 . . . . 0.0 111.152 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 125.67 -9.99 7.61 Favored Glycine 0 N--CA 1.436 -1.329 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -176.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -127.01 116.18 20.35 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -121.54 168.53 11.63 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-O 121.573 0.701 . . . . 0.0 110.708 -174.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 91.8 m -151.48 123.56 8.17 Favored 'General case' 0 C--N 1.276 -2.602 0 C-N-CA 124.307 1.043 . . . . 0.0 108.817 -177.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -109.52 113.35 26.08 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 323' ' ' GLN . . . . . 0.603 ' HB3' HG13 ' A' ' 311' ' ' VAL . 8.0 tt0 -101.6 110.96 23.06 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.577 HG13 ' CE3' ' A' ' 308' ' ' TRP . 93.3 t -100.04 99.3 8.22 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.297 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -86.86 156.45 55.36 Favored Pre-proline 0 C--N 1.315 -0.92 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 326' ' ' PRO . . . . . 0.429 ' HG3' ' HB2' ' A' ' 236' ' ' ASN . 73.2 Cg_endo -81.33 138.63 11.17 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 121.713 1.609 . . . . 0.0 110.574 172.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.421 ' HB3' ' HB3' ' A' ' 307' ' ' ASN . 23.6 ttmm . . . . . 0 C--N 1.296 -1.737 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 . . . . . 0 N--CA 1.432 -1.357 0 CA-C-O 121.015 0.436 . . . . 0.0 111.553 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 91.1 m -65.61 121.51 15.12 Favored 'General case' 0 C--O 1.195 -1.783 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.354 -176.074 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -143.19 170.4 15.81 Favored 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.229 -173.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.518 HG21 HD13 ' A' ' 300' ' ' LEU . 2.8 pp -128.05 163.51 31.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.898 179.032 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -149.77 155.67 40.53 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -176.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -136.78 132.64 35.01 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.096 0.474 . . . . 0.0 110.701 176.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.605 ' HD3' ' OE2' ' A' ' 241' ' ' GLU . 0.3 OUTLIER -149.55 174.41 12.55 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.055 178.23 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -119.62 144.3 47.21 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -150.72 176.59 10.88 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 176.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 53.72 -138.73 37.19 Favored Glycine 0 C--N 1.309 -0.957 0 O-C-N 123.721 0.638 . . . . 0.0 113.682 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -115.1 100.24 8.02 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' ASN . . . . . 0.413 ' HB2' ' HG3' ' A' ' 326' ' ' PRO . 5.1 m-20 60.53 29.08 18.74 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 121.792 0.806 . . . . 0.0 111.533 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.73 135.3 36.37 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.454 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' GLY . . . . . 0.563 ' HA3' ' CG1' ' A' ' 286' ' ' VAL . . . -102.25 123.47 7.88 Favored Glycine 0 C--N 1.299 -1.526 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -177.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.5 mp -113.67 120.27 63.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 117.423 0.612 . . . . 0.0 111.258 -176.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' ILE . . . . . 0.402 ' N ' HD12 ' A' ' 240' ' ' ILE . 3.1 mp -106.42 107.85 23.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.605 ' OE2' ' HD3' ' A' ' 231' ' ' ARG . 42.9 mt-10 -95.01 111.22 23.04 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 122.408 1.099 . . . . 0.0 111.783 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 12.8 tp -94.3 136.05 35.02 Favored 'General case' 0 C--N 1.278 -2.519 0 CA-C-N 114.097 -1.41 . . . . 0.0 110.756 -175.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' ALA . . . . . 0.517 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -121.56 98.72 6.1 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 176.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -103.16 91.34 4.06 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -79.37 112.8 16.96 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.314 -175.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 110.65 4.45 28.28 Favored Glycine 0 C--N 1.292 -1.875 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.138 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -111.98 108.71 18.14 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -104.51 100.45 10.13 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 159.78 -132.83 3.1 Favored Glycine 0 C--N 1.291 -1.922 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -153.69 132.65 6.95 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.661 ' HB3' HD13 ' A' ' 264' ' ' LEU . 14.0 Cg_endo -63.55 171.84 6.34 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.18 2.587 . . . . 0.0 113.111 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 29.5 t70 -96.01 105.88 17.97 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.009 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 4.4 mp -98.84 117.24 43.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-O 121.296 0.57 . . . . 0.0 111.034 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 13.5 t -102.49 116.84 33.42 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 176.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' GLN . . . . . 0.41 ' HG2' HD23 ' A' ' 310' ' ' LEU . 76.0 mt-30 -92.52 109.8 21.21 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-O 121.359 0.599 . . . . 0.0 111.909 -176.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 78.3 mt-30 -125.25 149.83 47.63 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 174.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -77.21 -28.58 53.87 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 -174.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -79.91 -24.6 41.01 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.271 -0.971 . . . . 0.0 110.107 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' HIS . . . . . 0.466 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 39.8 p-80 -171.68 159.25 5.3 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.955 173.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 25.2 mt -105.58 142.21 19.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 261' ' ' ILE . 2.9 mp -122.01 113.72 39.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 299' ' ' GLN . 1.9 m -110.99 135.69 49.33 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.496 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 263' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 298' ' ' THR . 29.2 m -129.58 125.07 35.35 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-O 121.589 0.709 . . . . 0.0 110.699 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.661 HD13 ' HB3' ' A' ' 251' ' ' PRO . 1.9 mm? -98.59 98.06 9.27 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 175.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.535 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 51.9 mtpt -71.55 131.52 43.38 Favored 'General case' 0 C--N 1.274 -2.7 0 O-C-N 124.005 0.816 . . . . 0.0 111.95 -178.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 9.4 t30 73.61 24.65 2.18 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 124.894 1.371 . . . . 0.0 109.931 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 54.6 t60 -117.16 117.8 30.59 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 121.45 -0.781 . . . . 0.0 109.179 178.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 10.9 p -88.5 130.02 35.31 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-O 120.975 0.417 . . . . 0.0 111.689 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 29.1 tp -115.97 124.95 29.11 Favored Pre-proline 0 N--CA 1.429 -1.496 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.086 177.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -68.6 156.72 64.59 Favored 'Trans proline' 0 C--N 1.321 -0.893 0 C-N-CA 122.66 2.24 . . . . 0.0 112.326 171.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' THR . . . . . 0.491 ' HA ' ' OE1' ' A' ' 274' ' ' GLN . 37.1 p -64.09 -31.48 72.68 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.351 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 2.2 m -64.21 -23.78 67.43 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.24 1.016 . . . . 0.0 112.606 -175.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -95.46 -10.13 30.7 Favored 'General case' 0 CA--C 1.498 -1.036 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.494 -176.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.504 HE21 ' HA ' ' A' ' 292' ' ' LYS . 50.9 mt-30 -72.73 111.94 8.33 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.962 178.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -142.09 150.44 41.18 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 276' ' ' SER . . . . . 0.568 ' HA ' ' O ' ' A' ' 289' ' ' VAL . 36.9 m -118.99 114.05 21.94 Favored 'General case' 0 N--CA 1.417 -2.09 0 O-C-N 123.594 0.559 . . . . 0.0 109.736 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 66.6 mt -85.8 112.85 21.48 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.221 -177.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -80.4 90.97 5.64 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 174.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 279' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 282' ' ' PHE . 17.2 m -109.97 25.76 2.96 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 CA-C-N 114.565 -1.198 . . . . 0.0 112.202 -173.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -70.02 150.76 46.31 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 174.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 24.6 t70 73.36 15.69 4.24 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 122.579 1.18 . . . . 0.0 110.955 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.457 ' HB2' ' O ' ' A' ' 279' ' ' VAL . 1.6 m-85 -85.52 -0.07 53.92 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.915 173.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? 62.37 61.17 1.3 Allowed 'General case' 0 CA--C 1.491 -1.326 0 CA-C-O 121.708 0.765 . . . . 0.0 112.649 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 1.8 t -164.21 148.7 8.39 Favored Pre-proline 0 N--CA 1.403 -2.823 0 CA-C-N 113.618 -1.628 . . . . 0.0 108.961 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' PRO . . . . . 0.424 ' O ' ' HA ' ' A' ' 304' ' ' THR . 14.7 Cg_exo -44.01 -35.48 7.45 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 124.68 3.587 . . . . 0.0 114.098 174.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.563 ' CG1' ' HA3' ' A' ' 238' ' ' GLY . 0.3 OUTLIER -75.87 117.74 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-O 121.989 0.9 . . . . 0.0 110.831 178.044 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -101.47 -37.98 8.19 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.152 -1.385 . . . . 0.0 111.857 -172.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -151.23 140.0 20.82 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.874 -0.516 . . . . 0.0 111.041 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 276' ' ' SER . 46.9 t -110.24 110.08 30.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 175.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.44 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 89.0 m -111.83 115.24 28.69 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 58.4 tp -95.87 118.65 32.91 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 176.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.504 ' HA ' HE21 ' A' ' 274' ' ' GLN . 40.8 ttmt -121.89 136.2 54.92 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 121.107 0.479 . . . . 0.0 110.484 -176.109 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -80.84 139.92 35.69 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 176.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.506 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 19.8 tp -113.0 -178.93 3.5 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 177.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.506 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 20.2 t-20 -53.39 -68.29 0.19 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.113 0.87 . . . . 0.0 112.5 -176.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -109.51 -3.79 16.73 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.032 0.444 . . . . 0.0 110.102 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 297' ' ' ASP . . . . . 0.535 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 13.1 m-20 -124.0 173.11 8.46 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.406 -168.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 263' ' ' THR . 31.8 m -114.92 130.72 56.97 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 175.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 299' ' ' GLN . . . . . 0.533 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 50.5 tt0 -118.66 124.2 46.81 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -177.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.518 HD13 HG21 ' A' ' 228' ' ' ILE . 67.3 tp -107.22 122.01 45.67 Favored 'General case' 0 N--CA 1.412 -2.371 0 C-N-CA 120.361 -0.535 . . . . 0.0 109.844 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 301' ' ' ILE . . . . . 0.441 HG23 ' CD2' ' A' ' 259' ' ' HIS . 64.0 mt -110.03 109.73 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.264 -176.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 61.6 mt -106.58 107.56 23.01 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.521 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 13.3 m -79.38 131.08 36.0 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -175.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 304' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 285' ' ' PRO . 8.9 p -135.64 175.96 9.12 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 122.721 0.408 . . . . 0.0 110.866 -176.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -161.18 141.66 11.09 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 89.52 -163.36 31.12 Favored Glycine 0 C--O 1.25 1.11 0 C-N-CA 121.459 -0.4 . . . . 0.0 113.179 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -91.37 125.38 36.1 Favored 'General case' 0 CA--C 1.486 -1.496 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 308' ' ' TRP . . . . . 0.694 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 59.8 p-90 -150.15 170.65 18.43 Favored 'General case' 0 N--CA 1.413 -2.29 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -177.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -128.91 131.39 47.57 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -176.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.694 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 24.7 tp -105.63 137.3 43.7 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 119.625 -0.83 . . . . 0.0 109.98 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.647 HG13 ' HB3' ' A' ' 323' ' ' GLN . 6.5 p -137.21 126.91 37.42 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.31 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 172.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -111.44 145.27 39.27 Favored 'General case' 0 N--CA 1.418 -2.032 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.421 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 313' ' ' LYS . . . . . 0.411 ' HB2' ' HB ' ' A' ' 321' ' ' THR . 65.1 mttm -139.62 158.01 44.84 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.986 -176.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 32.2 t -115.63 128.31 55.83 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 170.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -84.56 -43.34 14.59 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.706 0.765 . . . . 0.0 108.984 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -153.12 161.47 28.99 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -59.8 100.08 0.13 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.294 1.996 . . . . 0.0 112.336 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 121.38 -29.47 5.69 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -95.48 122.72 38.51 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -121.94 169.98 10.26 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 121.802 0.811 . . . . 0.0 110.907 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.411 ' HB ' ' HB2' ' A' ' 313' ' ' LYS . 72.8 m -152.1 128.72 10.78 Favored 'General case' 0 C--N 1.272 -2.787 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.376 -175.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -117.77 109.38 16.53 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 175.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 323' ' ' GLN . . . . . 0.647 ' HB3' HG13 ' A' ' 311' ' ' VAL . 60.4 tt0 -100.67 114.2 27.72 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 1.5 m -100.76 113.33 36.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 177.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -91.51 151.59 42.72 Favored Pre-proline 0 C--N 1.304 -1.378 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 326' ' ' PRO . . . . . 0.413 ' HG3' ' HB2' ' A' ' 236' ' ' ASN . 70.9 Cg_endo -81.68 134.01 8.42 Favored 'Trans proline' 0 N--CA 1.436 -1.887 0 C-N-CA 121.393 1.395 . . . . 0.0 109.948 173.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm . . . . . 0 N--CA 1.413 -2.291 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 175.99 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 225' ' ' GLN . . . . . 0.71 ' O ' HD23 ' A' ' 245' ' ' LEU . 12.8 pt20 . . . . . 0 C--O 1.199 -1.571 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 16.6 m -75.23 110.94 9.98 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 166.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.416 ' HB3' ' HB3' ' A' ' 243' ' ' ALA . 38.9 t30 -139.52 151.72 46.36 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.8 -166.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.748 HG21 HD21 ' A' ' 300' ' ' LEU . 2.5 pp -133.94 144.54 35.3 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.388 0 CA-C-N 114.265 -1.334 . . . . 0.0 107.941 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' A' ' 240' ' ' ILE . 8.4 t0 -145.02 157.44 44.12 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -172.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.476 ' CD2' HG11 ' A' ' 279' ' ' VAL . 85.4 t80 -136.95 135.05 37.37 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ARG . . . . . 0.495 HH11 ' HB3' ' A' ' 231' ' ' ARG . 1.0 OUTLIER -156.77 174.29 15.7 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 176.869 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.447 ' HE3' HG22 ' A' ' 284' ' ' THR . 54.4 mtpt -118.07 153.92 32.93 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 120.462 0.172 . . . . 0.0 110.8 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -155.32 146.93 23.08 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 124.091 0.87 . . . . 0.0 109.019 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 69.96 -109.33 2.82 Favored Glycine 0 N--CA 1.447 -0.611 0 O-C-N 123.569 0.543 . . . . 0.0 113.735 174.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -123.76 83.49 2.14 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -177.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 61.03 24.15 14.28 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 176.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -80.46 140.56 35.87 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.16 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -100.17 109.54 3.73 Favored Glycine 0 N--CA 1.426 -1.998 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 230' ' ' PHE . 2.1 mp -98.6 114.51 36.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-N 117.144 0.472 . . . . 0.0 110.207 -176.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' ILE . . . . . 0.493 ' HA ' ' O ' ' A' ' 229' ' ' ASP . 3.7 mp -102.68 111.62 33.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 176.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 34.0 mt-10 -88.51 143.82 26.73 Favored 'General case' 0 N--CA 1.412 -2.334 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.629 175.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 13.5 tp -131.69 119.27 21.14 Favored 'General case' 0 C--N 1.27 -2.881 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.14 -177.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' ALA . . . . . 0.43 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -114.16 105.22 12.92 Favored 'General case' 0 C--N 1.276 -2.625 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -111.32 90.61 3.38 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.71 HD23 ' O ' ' A' ' 225' ' ' GLN . 4.0 mm? -81.92 118.25 22.8 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.257 -176.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 103.97 15.64 21.45 Favored Glycine 0 C--N 1.3 -1.471 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.361 178.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -115.15 116.23 28.05 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 121.067 0.46 . . . . 0.0 110.065 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -106.81 94.54 5.17 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.299 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 159.12 -161.98 32.38 Favored Glycine 0 N--CA 1.425 -2.087 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -118.36 140.76 28.58 Favored Pre-proline 0 C--N 1.298 -1.667 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.724 ' HB3' HD13 ' A' ' 264' ' ' LEU . 27.7 Cg_endo -73.67 165.42 32.37 Favored 'Trans proline' 0 N--CA 1.437 -1.796 0 C-N-CA 121.104 1.203 . . . . 0.0 110.17 176.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.582 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 11.9 t70 -87.63 106.56 18.1 Favored 'General case' 0 C--N 1.27 -2.866 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 177.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.431 HD11 ' HG2' ' A' ' 251' ' ' PRO . 5.3 mp -95.9 109.21 22.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 C-N-CA 119.354 -0.938 . . . . 0.0 109.669 175.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' SER . . . . . 0.655 ' HB2' ' HB ' ' A' ' 261' ' ' ILE . 26.5 m -99.61 117.6 34.33 Favored 'General case' 0 C--N 1.277 -2.546 0 C-N-CA 125.001 1.32 . . . . 0.0 108.48 177.155 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -100.02 124.89 45.89 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -175.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.494 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 14.5 mm100 -122.62 171.07 9.4 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 171.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 61.2 m-70 -76.89 -41.03 45.37 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.743 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -81.03 -24.83 37.62 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.618 -173.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' HIS . . . . . 0.494 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 45.7 p-80 -165.08 163.17 20.58 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.039 0.447 . . . . 0.0 111.151 177.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 21.3 mt -107.15 141.87 21.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' ILE . . . . . 0.655 ' HB ' ' HB2' ' A' ' 254' ' ' SER . 3.8 mp -119.21 117.26 53.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 299' ' ' GLN . 0.7 OUTLIER -114.95 142.48 27.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 C-N-CA 119.207 -0.997 . . . . 0.0 108.814 176.816 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 263' ' ' THR . . . . . 0.556 ' HA ' ' O ' ' A' ' 298' ' ' THR . 7.5 m -135.47 124.31 24.0 Favored 'General case' 0 C--N 1.291 -1.941 0 C-N-CA 119.825 -0.75 . . . . 0.0 112.064 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.724 HD13 ' HB3' ' A' ' 251' ' ' PRO . 1.9 mm? -97.2 100.24 11.71 Favored 'General case' 0 CA--C 1.467 -2.218 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 175.127 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.561 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 51.6 mtpt -68.39 126.67 30.34 Favored 'General case' 0 N--CA 1.405 -2.676 0 O-C-N 124.34 1.025 . . . . 0.0 113.235 -173.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 77.67 3.68 3.01 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 113.925 -1.489 . . . . 0.0 111.808 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -86.12 95.66 9.63 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 177.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.84 109.2 6.24 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.286 0.565 . . . . 0.0 111.592 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 23.8 tp -95.64 128.99 35.86 Favored Pre-proline 0 N--CA 1.433 -1.295 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.633 -178.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -71.69 154.87 59.33 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.157 2.571 . . . . 0.0 111.831 170.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 19.3 p -67.6 -29.45 68.79 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 123.206 0.602 . . . . 0.0 112.592 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 11.9 m -62.96 -22.03 66.51 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 123.714 0.806 . . . . 0.0 111.36 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 8.2 mp -96.94 -8.11 31.5 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.375 -175.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.585 HE21 ' HA ' ' A' ' 292' ' ' LYS . 47.7 mt-30 -77.78 136.35 38.11 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.755 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -161.13 165.72 29.1 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 176.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 16.9 m -134.46 138.26 44.61 Favored 'General case' 0 N--CA 1.414 -2.249 0 CA-C-O 121.351 0.596 . . . . 0.0 109.668 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.45 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 2.9 mm? -95.25 101.41 13.14 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -83.84 55.59 3.32 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.728 0.775 . . . . 0.0 109.567 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' VAL . . . . . 0.476 HG11 ' CD2' ' A' ' 230' ' ' PHE . 13.3 m -81.17 59.56 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.218 -1.355 . . . . 0.0 112.751 -174.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -74.44 121.54 21.61 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.597 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . 0.367 20.4 m-20 58.42 51.91 7.71 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 179.152 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -85.38 -2.08 57.71 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 165.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 25.7 mmmt 67.02 61.16 0.5 Allowed 'General case' 0 CA--C 1.485 -1.536 0 CA-C-N 113.222 -1.808 . . . . 0.0 109.996 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 284' ' ' THR . . . . . 0.447 HG22 ' HE3' ' A' ' 232' ' ' LYS . 0.7 OUTLIER -138.91 165.09 34.91 Favored Pre-proline 0 N--CA 1.42 -1.938 0 N-CA-C 103.565 -2.754 . . . . 0.0 103.565 179.243 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 285' ' ' PRO . . . . . 0.401 ' HB3' ' HB3' ' A' ' 308' ' ' TRP . 18.3 Cg_exo -69.12 -15.55 39.58 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.323 1.349 . . . . 0.0 111.405 177.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.408 HG21 HD11 ' A' ' 240' ' ' ILE . 42.5 t -84.04 129.55 37.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -96.92 -39.56 9.33 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.261 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -160.36 140.54 11.46 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.223 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.45 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 41.8 t -104.67 126.36 59.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 173.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.519 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 48.2 m -128.58 122.74 31.67 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 117.957 0.344 . . . . 0.0 110.69 -177.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.561 ' HB2' HG12 ' A' ' 228' ' ' ILE . 52.0 tp -103.41 108.27 19.44 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.585 ' HA ' HE21 ' A' ' 274' ' ' GLN . 24.5 ttmm -112.06 125.47 54.13 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.286 -177.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 293' ' ' ARG . . . . . 0.414 ' H ' ' NE2' ' A' ' 274' ' ' GLN . 1.9 ptm180 -68.72 137.94 54.5 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 174.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.585 HD13 ' N ' ' A' ' 295' ' ' ASN . 2.6 tm? -117.4 162.8 17.34 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 -174.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.585 ' N ' HD13 ' A' ' 294' ' ' LEU . 66.5 t30 -14.92 -70.98 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 127.541 2.336 . . . . 0.0 112.972 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -125.46 -2.28 7.44 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 175.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 297' ' ' ASP . . . . . 0.561 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 10.9 m-20 -118.09 178.61 4.36 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.485 -165.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' A' ' 263' ' ' THR . 42.3 m -114.93 125.53 53.74 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 173.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 299' ' ' GLN . . . . . 0.591 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 9.0 tt0 -115.16 129.89 56.78 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 120.949 0.404 . . . . 0.0 111.157 -176.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.748 HD21 HG21 ' A' ' 228' ' ' ILE . 12.6 mt -100.58 132.0 46.19 Favored 'General case' 0 CA--C 1.451 -2.862 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.043 172.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 301' ' ' ILE . . . . . 0.519 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 65.5 mt -118.24 108.1 23.51 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.238 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 174.137 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 66.0 mt -109.89 105.21 18.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.364 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 4.0 m -78.56 129.33 34.7 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -174.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 8.4 p -131.57 153.13 50.19 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -175.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -131.16 147.28 52.59 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.859 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 75.26 -160.21 52.2 Favored Glycine 0 N--CA 1.438 -1.187 0 O-C-N 123.994 0.809 . . . . 0.0 113.07 176.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 307' ' ' ASN . . . . . 0.41 ' HB3' ' HB3' ' A' ' 327' ' ' LYS . 31.0 m-80 -93.97 132.64 38.24 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 308' ' ' TRP . . . . . 0.435 ' CE3' HG13 ' A' ' 324' ' ' VAL . 62.0 p-90 -148.05 168.0 23.48 Favored 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.083 -175.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -130.14 127.91 40.71 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -178.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 1.4 tt -96.25 125.89 41.08 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.697 HG13 ' HB3' ' A' ' 323' ' ' GLN . 7.2 p -130.17 112.54 23.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 169.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 312' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 321' ' ' THR . 22.4 t30 -103.58 141.83 35.35 Favored 'General case' 0 CA--C 1.45 -2.89 0 C-N-CA 119.584 -0.847 . . . . 0.0 111.17 -176.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -119.36 121.43 39.53 Favored 'General case' 1 N--CA 1.369 -4.488 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.659 -178.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 16.8 m -95.83 106.47 18.61 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 173.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -84.96 -32.71 22.89 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.079 -175.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.416 ' HB1' ' HD2' ' A' ' 317' ' ' PRO . . . -165.42 164.69 12.13 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -177.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 317' ' ' PRO . . . . . 0.416 ' HD2' ' HB1' ' A' ' 316' ' ' ALA . 28.1 Cg_endo -62.68 94.98 0.15 Allowed 'Trans proline' 0 C--O 1.243 0.736 0 C-N-CA 122.058 1.839 . . . . 0.0 111.143 177.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 124.89 -23.55 6.2 Favored Glycine 0 N--CA 1.423 -2.171 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.417 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -101.71 116.19 32.19 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 122.048 -0.678 . . . . 0.0 110.685 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 320' ' ' PHE . . . . . 0.498 ' CZ ' ' HD3' ' A' ' 251' ' ' PRO . 68.7 m-85 -130.53 159.13 38.04 Favored 'General case' 0 N--CA 1.428 -1.547 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.412 -177.82 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 312' ' ' ASN . 61.6 m -152.67 111.93 3.85 Favored 'General case' 0 C--N 1.273 -2.726 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.354 -176.032 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -98.05 105.32 17.45 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 323' ' ' GLN . . . . . 0.697 ' HB3' HG13 ' A' ' 311' ' ' VAL . 46.3 tt0 -91.21 100.36 13.19 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.435 HG13 ' CE3' ' A' ' 308' ' ' TRP . 93.4 t -88.08 98.83 8.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.519 0.676 . . . . 0.0 109.456 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.505 HD21 HE21 ' A' ' 323' ' ' GLN . 20.9 mt -87.74 152.46 51.53 Favored Pre-proline 0 C--N 1.285 -2.208 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.197 -178.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -81.83 138.2 10.35 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 121.503 1.468 . . . . 0.0 109.812 172.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 307' ' ' ASN . 23.5 ttmm . . . . . 0 CA--C 1.497 -1.078 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.587 -177.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' GLN . . . . . 0.484 ' CG ' HD21 ' A' ' 273' ' ' LEU . 1.8 tp60 . . . . . 0 N--CA 1.438 -1.036 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 16.4 m -62.33 126.25 26.69 Favored 'General case' 0 C--N 1.314 -0.974 0 O-C-N 123.572 0.545 . . . . 0.0 110.791 -178.096 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -153.33 173.36 15.71 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.254 -178.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.506 HG21 HD13 ' A' ' 300' ' ' LEU . 2.1 pp -137.66 156.89 32.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 C-N-CA 124.731 1.212 . . . . 0.0 109.394 -178.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' ASP . . . . . 0.458 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 1.1 t70 -150.59 156.99 42.46 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -127.79 137.2 52.32 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -153.31 161.98 41.78 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.441 ' HE3' HG22 ' A' ' 284' ' ' THR . 56.9 mtpt -110.65 158.01 19.07 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.597 178.218 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -155.12 168.22 27.75 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 55.92 -124.71 34.94 Favored Glycine 0 C--N 1.321 -0.29 0 O-C-N 123.704 0.628 . . . . 0.0 113.091 177.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -122.87 100.68 7.02 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 176.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' ASN . . . . . 0.617 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 94.0 m-20 63.02 24.55 14.59 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 124.16 0.912 . . . . 0.0 112.939 176.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -82.59 141.03 32.89 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -103.47 110.09 3.59 Favored Glycine 0 N--CA 1.429 -1.827 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.441 ' HA ' ' O ' ' A' ' 322' ' ' PHE . 2.0 mp -104.2 119.91 53.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 121.171 0.51 . . . . 0.0 110.223 -177.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.7 mp -104.14 114.08 42.78 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 175.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 49.2 mt-10 -89.43 142.97 27.19 Favored 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 175.349 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 15.3 tp -134.44 134.29 41.43 Favored 'General case' 0 C--N 1.276 -2.614 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.691 -175.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 243' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -127.25 110.33 12.74 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.174 178.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -115.05 91.6 3.67 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.417 0.627 . . . . 0.0 109.891 178.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -83.48 115.32 22.02 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.895 -177.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 111.62 13.81 12.33 Favored Glycine 0 C--N 1.299 -1.527 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.526 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -116.08 124.18 49.76 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -107.13 93.83 4.77 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 143.97 -157.81 27.21 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 177.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -113.88 148.85 40.8 Favored Pre-proline 0 C--N 1.314 -0.942 0 C-N-CA 123.06 0.544 . . . . 0.0 109.754 177.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.732 ' HB3' HD13 ' A' ' 264' ' ' LEU . 14.2 Cg_endo -74.24 172.14 16.62 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.698 2.265 . . . . 0.0 112.192 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.489 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 34.4 t70 -95.37 111.72 23.55 Favored 'General case' 0 C--N 1.286 -2.191 0 C-N-CA 124.275 1.03 . . . . 0.0 108.694 177.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 4.1 mp -104.91 128.03 58.96 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.329 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 254' ' ' SER . . . . . 0.433 ' HB3' ' HB ' ' A' ' 261' ' ' ILE . 14.1 t -111.43 124.58 52.55 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 174.059 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -102.63 102.55 12.77 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.14 0.495 . . . . 0.0 112.052 -173.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.5 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 78.8 mt-30 -109.8 158.47 18.11 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 172.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 50.9 m80 -73.42 -36.08 65.91 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -176.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -85.67 -16.1 40.19 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.405 -0.518 . . . . 0.0 112.241 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 259' ' ' HIS . . . . . 0.5 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 45.4 p-80 -170.69 156.03 5.07 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-O 121.044 0.449 . . . . 0.0 111.717 176.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.489 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 39.6 mt -106.95 141.73 21.44 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 261' ' ' ILE . . . . . 0.433 ' HB ' ' HB3' ' A' ' 254' ' ' SER . 3.1 mp -121.66 116.3 49.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 299' ' ' GLN . 1.9 m -112.5 139.31 37.99 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.526 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 177.162 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 263' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 298' ' ' THR . 19.3 m -135.0 127.82 31.2 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-O 121.3 0.572 . . . . 0.0 110.855 178.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.732 HD13 ' HB3' ' A' ' 251' ' ' PRO . 1.9 mm? -97.91 106.38 18.67 Favored 'General case' 0 CA--C 1.47 -2.107 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 176.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.564 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 31.8 mmmt -68.82 127.94 34.9 Favored 'General case' 0 N--CA 1.414 -2.247 0 O-C-N 124.309 1.006 . . . . 0.0 113.149 -174.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 62.8 t30 65.65 26.29 11.51 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 112.771 -2.013 . . . . 0.0 110.699 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 45.8 t60 -106.98 112.18 25.02 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.95 125.04 28.76 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 27.0 tp -111.14 125.32 30.82 Favored Pre-proline 0 N--CA 1.435 -1.216 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.251 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.485 ' HD2' HD22 ' A' ' 273' ' ' LEU . 24.1 Cg_exo -68.35 148.13 73.21 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.585 2.19 . . . . 0.0 111.399 170.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 271' ' ' THR . . . . . 0.55 ' HB ' ' HD2' ' A' ' 293' ' ' ARG . 6.1 t -71.47 -11.1 60.7 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.327 0.584 . . . . 0.0 112.112 -177.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 19.3 m -79.76 -21.15 44.77 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.521 0.677 . . . . 0.0 110.366 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.485 HD22 ' HD2' ' A' ' 270' ' ' PRO . 8.0 mp -96.59 -13.24 23.04 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.391 -174.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 271' ' ' THR . 18.7 pt20 -83.01 107.55 15.69 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-O 122.023 0.916 . . . . 0.0 109.135 -178.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -134.33 176.49 8.56 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 24.1 p -133.62 138.31 45.88 Favored 'General case' 0 N--CA 1.413 -2.289 0 CA-C-O 121.395 0.617 . . . . 0.0 111.06 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.491 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 2.1 mm? -87.19 122.34 30.86 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 103.823 -2.658 . . . . 0.0 103.823 173.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -67.65 -41.02 84.46 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 279' ' ' VAL . . . . . 0.486 ' HA ' ' CD1' ' A' ' 282' ' ' PHE . 14.8 p 41.65 27.25 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 127.489 2.316 . . . . 0.0 114.46 173.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -82.46 135.41 35.14 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.844 177.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 3.0 t70 72.59 25.76 2.59 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 125.269 1.428 . . . . 0.0 111.386 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.486 ' CD1' ' HA ' ' A' ' 279' ' ' VAL . 5.1 m-85 -88.43 -7.51 56.49 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.642 174.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? 55.09 60.64 3.33 Favored 'General case' 0 CA--C 1.509 -0.625 0 C-N-CA 124.56 1.144 . . . . 0.0 112.027 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 284' ' ' THR . . . . . 0.441 HG22 ' HE3' ' A' ' 232' ' ' LYS . 2.4 p -133.11 173.94 5.29 Favored Pre-proline 0 C--N 1.302 -1.47 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 178.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 285' ' ' PRO . . . . . 0.617 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 6.6 Cg_exo -77.65 -5.07 15.18 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 121.954 1.769 . . . . 0.0 110.796 176.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 54.4 t -90.72 137.94 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -99.44 -43.45 6.54 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.786 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 288' ' ' LYS . . . . . 0.425 ' HA ' HG12 ' A' ' 279' ' ' VAL . 22.6 ttmm -163.07 134.79 5.07 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -178.272 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.491 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 44.4 t -99.08 120.18 48.07 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.329 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 176.086 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 32.2 m -127.01 115.32 19.03 Favored 'General case' 0 C--N 1.284 -2.259 0 O-C-N 122.111 -0.368 . . . . 0.0 111.53 -176.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.499 ' HB2' HG12 ' A' ' 228' ' ' ILE . 49.1 tp -94.17 133.84 37.25 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.211 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -130.55 134.1 46.75 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -175.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 293' ' ' ARG . . . . . 0.55 ' HD2' ' HB ' ' A' ' 271' ' ' THR . 3.8 ptm180 -79.41 137.95 37.45 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 173.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.559 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 23.4 tp -111.57 178.98 4.15 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.559 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 63.0 t30 -49.68 -63.72 1.02 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 124.125 0.97 . . . . 0.0 112.517 -177.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -118.66 -2.91 10.89 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 120.673 0.273 . . . . 0.0 111.22 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 297' ' ' ASP . . . . . 0.564 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 20.6 m-20 -124.88 177.93 5.76 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.707 0.765 . . . . 0.0 110.9 -170.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.539 ' O ' ' HA ' ' A' ' 263' ' ' THR . 50.2 m -114.3 127.77 56.03 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 174.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 299' ' ' GLN . . . . . 0.508 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 37.0 tt0 -116.05 126.13 53.36 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -176.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.506 HD13 HG21 ' A' ' 228' ' ' ILE . 63.7 tp -110.77 120.24 41.76 Favored 'General case' 0 N--CA 1.417 -2.119 0 CA-C-O 121.164 0.507 . . . . 0.0 110.125 178.106 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 57.8 mt -106.65 109.84 29.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -177.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 302' ' ' ILE . . . . . 0.489 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 66.5 mt -108.01 107.78 23.65 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 18.1 m -77.77 133.46 38.25 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 12.5 p -135.18 173.85 11.26 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 122.831 0.452 . . . . 0.0 111.081 -175.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -156.28 147.08 21.93 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 120.526 0.203 . . . . 0.0 110.57 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 80.83 -159.23 41.75 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 115.701 -0.682 . . . . 0.0 113.651 174.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 307' ' ' ASN . . . . . 0.509 ' HB3' ' HB3' ' A' ' 327' ' ' LYS . 3.2 m-20 -90.34 123.29 33.97 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 176.141 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 308' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -149.12 162.79 39.27 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -177.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 309' ' ' GLU . . . . . 0.565 ' HG2' ' HE2' ' A' ' 327' ' ' LYS . 8.6 mt-10 -119.04 137.52 53.49 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -178.069 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 1.1 tt -104.91 118.3 36.2 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.473 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 32.4 t -118.71 107.78 22.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 174.116 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -95.75 139.35 32.11 Favored 'General case' 0 C--N 1.311 -1.109 0 C-N-CA 119.093 -1.043 . . . . 0.0 109.207 177.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -125.86 134.93 51.47 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -177.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 28.6 t -115.74 111.88 21.2 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -80.03 -28.42 39.33 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.734 0.778 . . . . 0.0 109.82 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -166.75 160.15 11.5 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -64.71 101.13 0.36 Allowed 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 121.66 1.573 . . . . 0.0 109.837 176.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 127.81 -27.65 4.58 Favored Glycine 0 N--CA 1.426 -1.982 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.96 -176.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -108.36 118.43 36.75 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.864 -0.786 . . . . 0.0 110.818 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 320' ' ' PHE . . . . . 0.583 ' CZ ' ' HD3' ' A' ' 251' ' ' PRO . 48.2 m-85 -128.46 165.76 20.05 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-O 122.143 0.973 . . . . 0.0 110.902 -174.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 70.0 m -152.36 136.82 16.78 Favored 'General case' 0 C--N 1.269 -2.909 0 CA-C-N 114.518 -1.219 . . . . 0.0 107.848 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 0.441 ' O ' ' HA ' ' A' ' 239' ' ' ILE . 79.8 m-85 -119.88 117.69 28.79 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.061 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 323' ' ' GLN . . . . . 0.473 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 33.9 tt0 -101.55 100.26 10.66 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 91.3 t -88.79 102.03 12.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 50.8 mt -95.07 140.46 22.45 Favored Pre-proline 0 C--N 1.29 -1.988 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.161 -176.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -72.36 126.95 12.09 Favored 'Trans proline' 0 C--O 1.251 1.129 0 C-N-CA 121.431 1.421 . . . . 0.0 109.806 174.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.565 ' HE2' ' HG2' ' A' ' 309' ' ' GLU . 38.2 ttmt . . . . . 0 C--N 1.305 -1.365 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 . . . . . 0 N--CA 1.444 -0.763 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.526 HG23 ' HA ' ' A' ' 244' ' ' ALA . 59.5 m -61.39 129.72 42.59 Favored 'General case' 0 C--O 1.208 -1.125 0 C-N-CA 125.153 1.381 . . . . 0.0 111.632 -173.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -157.3 171.59 20.13 Favored 'General case' 0 CA--C 1.488 -1.43 0 CA-C-O 121.022 0.439 . . . . 0.0 110.462 -176.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.614 HG21 HD13 ' A' ' 300' ' ' LEU . 2.8 pp -130.27 155.65 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.199 179.022 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 229' ' ' ASP . . . . . 0.487 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 18.8 t0 -144.64 156.27 44.03 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 -177.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.451 ' CE2' HG21 ' A' ' 279' ' ' VAL . 61.8 t80 -131.91 138.6 48.45 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 175.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -155.11 157.55 37.65 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -104.57 151.86 23.11 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.603 175.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -168.05 -174.87 2.47 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 61.81 -117.88 12.92 Favored Glycine 0 N--CA 1.445 -0.761 0 O-C-N 123.446 0.466 . . . . 0.0 113.03 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' LYS . . . . . 0.415 ' HE2' ' HB2' ' A' ' 235' ' ' LYS . 13.7 tppt? -126.96 79.91 1.91 Allowed 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -178.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 58.9 29.26 18.63 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.557 0.694 . . . . 0.0 111.249 -177.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.436 ' HB2' HD23 ' A' ' 325' ' ' LEU . . . -84.24 148.44 26.71 Favored 'General case' 0 N--CA 1.416 -2.168 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.305 -176.111 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -98.81 108.17 3.55 Favored Glycine 0 N--CA 1.418 -2.534 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.451 HG13 ' HG3' ' A' ' 323' ' ' GLN . 2.6 mp -101.49 118.84 48.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-N 117.391 0.596 . . . . 0.0 110.193 -177.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.8 mp -104.73 110.94 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.401 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 176.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.487 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 41.2 mt-10 -87.83 143.23 27.25 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 173.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 14.5 tp -132.12 125.97 32.59 Favored 'General case' 0 C--N 1.273 -2.719 0 CA-C-O 121.52 0.676 . . . . 0.0 111.044 -174.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 243' ' ' ALA . . . . . 0.48 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -113.73 105.73 13.65 Favored 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.526 ' HA ' HG23 ' A' ' 226' ' ' THR . . . -112.32 91.72 3.76 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.601 0.715 . . . . 0.0 109.119 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -81.73 112.52 18.97 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.398 -173.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 107.97 3.41 34.04 Favored Glycine 0 N--CA 1.427 -1.936 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.378 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 247' ' ' PHE . . . . . 0.457 ' CD2' HD12 ' A' ' 264' ' ' LEU . 37.8 t80 -115.82 107.96 15.7 Favored 'General case' 0 C--O 1.212 -0.908 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -102.22 3.28 38.13 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.006 0.431 . . . . 0.0 112.093 -177.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -95.35 -153.74 30.3 Favored Glycine 0 C--N 1.308 -1.012 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.638 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -116.16 137.64 23.6 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 177.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.774 ' HB3' HD13 ' A' ' 264' ' ' LEU . 17.4 Cg_endo -71.83 172.09 15.22 Favored 'Trans proline' 0 N--CA 1.439 -1.711 0 C-N-CA 122.029 1.819 . . . . 0.0 110.904 175.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -99.94 109.57 21.92 Favored 'General case' 0 C--N 1.275 -2.659 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 176.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 4.0 mp -100.11 124.19 53.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-O 121.079 0.466 . . . . 0.0 110.131 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 9.4 t -113.31 106.03 14.12 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 174.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -79.87 103.74 9.97 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.677 178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.512 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 77.8 mt-30 -124.16 152.06 43.28 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 175.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -71.07 -42.44 69.4 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -173.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -76.07 -24.63 55.1 Favored 'General case' 0 C--N 1.314 -0.978 0 O-C-N 123.442 0.464 . . . . 0.0 111.523 -176.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 259' ' ' HIS . . . . . 0.512 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 43.0 p-80 -170.19 158.38 6.82 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-O 120.549 0.214 . . . . 0.0 110.898 175.041 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 16.6 mt -105.94 141.45 21.23 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 261' ' ' ILE . . . . . 0.42 HD12 ' N ' ' A' ' 261' ' ' ILE . 3.1 mp -116.81 113.11 41.98 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.432 ' HB ' ' HB3' ' A' ' 300' ' ' LEU . 54.6 t -113.6 115.91 51.09 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 176.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 263' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' A' ' 298' ' ' THR . 41.6 m -121.65 126.24 48.55 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-O 121.48 0.657 . . . . 0.0 112.218 -177.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.774 HD13 ' HB3' ' A' ' 251' ' ' PRO . 1.6 mm? -94.38 104.09 16.08 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 177.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.588 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 30.1 mtpt -69.05 127.57 33.6 Favored 'General case' 0 N--CA 1.41 -2.446 0 O-C-N 124.204 0.94 . . . . 0.0 113.487 -173.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 64.4 t30 68.26 16.66 9.33 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 113.817 -1.538 . . . . 0.0 111.386 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 267' ' ' HIS . . . . . 0.44 ' ND1' ' HB2' ' A' ' 247' ' ' PHE . 54.6 t60 -95.46 107.74 19.91 Favored 'General case' 0 C--O 1.213 -0.821 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 174.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 1.2 p -82.92 109.79 17.34 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-O 120.889 0.376 . . . . 0.0 111.618 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 269' ' ' LEU . . . . . 0.413 HD22 HD22 ' A' ' 291' ' ' LEU . 23.4 tp -93.22 127.49 46.71 Favored Pre-proline 0 N--CA 1.436 -1.128 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.543 178.012 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -68.54 159.31 54.05 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 122.381 2.054 . . . . 0.0 111.544 171.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 19.6 p -66.69 -37.13 84.11 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.063 0.459 . . . . 0.0 111.544 -177.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 3.0 m -59.21 -19.35 44.7 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 124.66 1.184 . . . . 0.0 112.456 -178.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -95.96 -12.82 24.45 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 122.195 -0.316 . . . . 0.0 111.044 -176.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -72.31 142.11 48.85 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -163.86 155.38 16.52 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 175.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 16.6 m -122.84 123.7 41.6 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 64.4 mt -95.17 113.27 24.93 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -177.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -76.81 81.5 3.4 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.937 0.875 . . . . 0.0 108.95 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 279' ' ' VAL . . . . . 0.48 HG23 ' CG ' ' A' ' 282' ' ' PHE 0.282 1.5 p -98.37 69.75 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 CA-C-O 123.723 1.725 . . . . 0.0 111.642 -178.532 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -114.69 145.67 41.78 Favored 'General case' 0 N--CA 1.419 -1.993 0 CA-C-N 113.026 -1.897 . . . . 0.0 106.846 177.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 23.3 t70 68.19 18.22 9.3 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 122.494 1.14 . . . . 0.0 110.879 -178.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.48 ' CG ' HG23 ' A' ' 279' ' ' VAL . 31.2 m-85 -86.18 -13.84 45.79 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.599 -0.688 . . . . 0.0 109.344 174.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.79 60.62 1.55 Allowed 'General case' 0 CA--C 1.493 -1.22 0 C-N-CA 123.606 0.762 . . . . 0.0 110.822 -178.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -137.02 168.94 14.68 Favored Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 104.109 -2.552 . . . . 0.0 104.109 178.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -71.06 -13.19 31.24 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 121.482 1.455 . . . . 0.0 111.773 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 47.1 t -85.88 132.39 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 123.428 0.691 . . . . 0.0 109.343 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -101.57 -29.2 12.09 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.405 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -171.92 134.32 0.77 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.736 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 59.8 t -96.69 132.12 41.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 173.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.42 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 98.8 m -136.72 117.49 14.05 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.803 -0.56 . . . . 0.0 111.772 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.523 ' HB2' HG12 ' A' ' 228' ' ' ILE . 0.1 OUTLIER -97.41 116.77 30.24 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 179.385 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -126.21 136.45 52.84 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -78.74 144.44 35.22 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 176.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.583 HD13 ' N ' ' A' ' 295' ' ' ASN . 2.6 tm? -118.06 163.25 16.89 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 105.942 -1.874 . . . . 0.0 105.942 -178.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.583 ' N ' HD13 ' A' ' 294' ' ' LEU . 4.7 t-20 -29.39 -58.33 0.15 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.355 1.862 . . . . 0.0 113.754 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.58 -6.31 7.52 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 297' ' ' ASP . . . . . 0.588 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 6.0 m-20 -125.39 174.63 8.04 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.595 -160.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 263' ' ' THR . 56.1 m -115.34 120.09 38.45 Favored 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 175.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -110.92 117.31 33.03 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-O 121.696 0.76 . . . . 0.0 109.747 -176.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.614 HD13 HG21 ' A' ' 228' ' ' ILE . 46.1 tp -103.53 117.97 35.67 Favored 'General case' 0 C--N 1.263 -3.188 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 301' ' ' ILE . . . . . 0.42 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 63.3 mt -102.38 109.74 27.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 CA-C-N 114.566 -1.197 . . . . 0.0 107.88 -177.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 58.0 mt -108.71 100.3 10.47 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 27.7 m -72.52 132.17 43.48 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 7.4 p -138.49 174.82 10.14 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 123.482 0.713 . . . . 0.0 110.498 -176.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -158.55 137.43 11.27 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 117.514 0.143 . . . . 0.0 110.996 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 91.66 -157.68 24.7 Favored Glycine 0 N--CA 1.442 -0.908 0 O-C-N 123.508 0.505 . . . . 0.0 112.836 174.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 307' ' ' ASN . . . . . 0.414 ' HB3' ' HB3' ' A' ' 327' ' ' LYS . 76.5 m-20 -93.2 124.07 36.92 Favored 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 308' ' ' TRP . . . . . 0.465 ' CE3' HG13 ' A' ' 324' ' ' VAL . 70.3 p-90 -148.32 166.09 29.07 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -178.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -124.32 130.26 52.18 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -175.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 1.7 tt -100.73 122.67 43.75 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.598 HG13 ' HB3' ' A' ' 323' ' ' GLN . 7.6 p -123.34 114.77 43.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.612 171.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -98.32 144.82 27.31 Favored 'General case' 0 N--CA 1.424 -1.748 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.037 -178.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -131.58 141.06 49.59 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -178.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 78.0 p -111.64 115.43 29.11 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 173.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -76.16 -35.85 59.01 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -166.84 162.92 11.0 Favored Pre-proline 0 C--N 1.309 -1.19 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.77 97.06 0.32 Allowed 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.712 1.608 . . . . 0.0 110.177 176.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 129.37 -15.23 5.8 Favored Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -176.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -122.58 116.33 23.68 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 122.372 -0.487 . . . . 0.0 109.821 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -124.31 164.6 19.26 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.827 0.823 . . . . 0.0 110.661 -175.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 91.3 m -152.44 135.71 15.83 Favored 'General case' 0 C--N 1.267 -3.002 0 CA-C-N 114.871 -1.058 . . . . 0.0 108.846 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -124.06 117.86 25.66 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 323' ' ' GLN . . . . . 0.598 ' HB3' HG13 ' A' ' 311' ' ' VAL . 45.8 tt0 -102.26 103.43 13.91 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.465 HG13 ' CE3' ' A' ' 308' ' ' TRP . 92.7 t -87.13 98.94 7.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.054 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.507 HD21 HE21 ' A' ' 323' ' ' GLN . 32.1 mt -87.47 143.57 34.33 Favored Pre-proline 0 C--N 1.294 -1.813 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.667 -177.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -75.6 132.55 14.75 Favored 'Trans proline' 0 N--CA 1.458 -0.618 0 C-N-CA 121.93 1.753 . . . . 0.0 109.965 173.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.414 ' HB3' ' HB3' ' A' ' 307' ' ' ASN . 23.6 ttmm . . . . . 0 C--N 1.301 -1.525 0 C-N-CA 120.056 -0.657 . . . . 0.0 110.417 -178.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' GLN . . . . . 0.421 ' O ' HD23 ' A' ' 245' ' ' LEU . 13.2 pt20 . . . . . 0 N--CA 1.431 -1.424 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.575 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 21.2 m -64.48 116.28 5.98 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 176.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -148.68 158.19 43.97 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.301 -170.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.624 HG21 HD21 ' A' ' 300' ' ' LEU . 2.7 pp -137.04 147.61 26.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -142.02 157.27 45.13 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 123.533 0.733 . . . . 0.0 109.991 -174.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.542 ' CD1' HG11 ' A' ' 279' ' ' VAL . 56.3 t80 -133.21 138.52 46.57 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.217 0.532 . . . . 0.0 111.254 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -155.94 164.53 38.37 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 172.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.423 ' HE3' HG22 ' A' ' 284' ' ' THR . 55.7 mtpt -104.48 162.58 13.12 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.929 178.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 233' ' ' ASP . . . . . 0.52 ' O ' ' HB3' ' A' ' 237' ' ' ALA . 15.8 t70 -157.97 125.62 5.21 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 81.53 -126.63 7.5 Favored Glycine 0 C--N 1.297 -1.586 0 C-N-CA 121.143 -0.551 . . . . 0.0 113.441 174.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -105.14 90.9 3.58 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -174.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' ASN . . . . . 0.539 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 17.6 m120 62.83 17.15 9.68 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.023 -0.99 . . . . 0.0 112.724 175.148 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 233' ' ' ASP . . . -83.51 140.93 31.99 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -176.239 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' GLY . . . . . 0.431 ' C ' HD12 ' A' ' 239' ' ' ILE . . . -101.64 130.27 10.18 Favored Glycine 0 N--CA 1.432 -1.596 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 178.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 230' ' ' PHE . 2.3 mp -118.45 117.28 54.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 117.651 0.725 . . . . 0.0 110.985 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.0 mp -104.16 109.43 27.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 176.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -91.39 118.23 30.35 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-O 121.558 0.694 . . . . 0.0 109.348 178.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 9.8 tp -108.7 117.06 33.19 Favored 'General case' 0 C--N 1.272 -2.775 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.754 -175.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' ALA . . . . . 0.575 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -103.19 94.4 5.5 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 176.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -101.92 90.93 4.15 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.69 0.757 . . . . 0.0 109.455 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.421 HD23 ' O ' ' A' ' 225' ' ' GLN . 3.6 mm? -88.09 115.29 25.46 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.672 0.749 . . . . 0.0 110.804 -177.161 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 123.21 -8.27 9.07 Favored Glycine 0 N--CA 1.423 -2.178 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.517 -176.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 247' ' ' PHE . . . . . 0.474 ' CD2' HD12 ' A' ' 264' ' ' LEU . 30.4 t80 -115.4 127.0 55.07 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -109.4 -19.15 13.37 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.901 -177.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -87.48 -140.99 6.8 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.921 -177.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -125.14 132.37 24.3 Favored Pre-proline 0 C--N 1.314 -0.943 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.718 ' HB3' HD13 ' A' ' 264' ' ' LEU . 14.1 Cg_endo -69.63 171.68 13.89 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.534 2.156 . . . . 0.0 111.679 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.619 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 33.3 t70 -91.32 105.88 18.1 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 176.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.544 HD11 ' HG2' ' A' ' 251' ' ' PRO . 5.2 mp -101.74 108.99 24.84 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.636 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 254' ' ' SER . . . . . 0.538 ' HB3' ' HB ' ' A' ' 261' ' ' ILE . 23.3 t -91.18 112.17 23.97 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.118 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -89.42 103.22 15.87 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.204 0.526 . . . . 0.0 111.241 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.634 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 13.9 mm100 -119.51 154.94 33.05 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 177.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 257' ' ' HIS . . . . . 0.426 ' HA ' ' HE1' ' A' ' 308' ' ' TRP . 37.4 m80 -76.67 -30.91 56.98 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.329 0.585 . . . . 0.0 109.662 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -68.3 -39.48 82.05 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.681 -1.145 . . . . 0.0 112.151 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 259' ' ' HIS . . . . . 0.634 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 39.5 p-80 -175.6 166.82 3.23 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.402 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 20.7 mt -105.87 133.21 50.89 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 106.552 -1.648 . . . . 0.0 106.552 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 261' ' ' ILE . . . . . 0.538 ' HB ' ' HB3' ' A' ' 254' ' ' SER . 3.4 mp -114.96 115.9 50.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 179.002 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.619 ' HA ' ' O ' ' A' ' 252' ' ' ASP . 0.8 OUTLIER -113.89 140.64 33.35 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.394 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 263' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 298' ' ' THR . 20.2 m -134.09 124.04 25.48 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.517 0.675 . . . . 0.0 111.887 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.718 HD13 ' HB3' ' A' ' 251' ' ' PRO . 1.8 mm? -98.14 108.12 20.75 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.482 ' HD3' ' OD1' ' A' ' 297' ' ' ASP . 59.4 mmtt -67.28 131.49 45.85 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 124.213 0.946 . . . . 0.0 113.549 -177.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 73.68 6.75 5.0 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.565 -1.652 . . . . 0.0 110.357 176.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -95.72 99.61 11.43 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.084 -174.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 19.3 p -77.56 108.96 11.11 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-O 121.224 0.535 . . . . 0.0 111.03 -178.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 269' ' ' LEU . . . . . 0.452 HD12 ' HD2' ' A' ' 270' ' ' PRO . 30.1 tp -89.92 128.38 50.27 Favored Pre-proline 0 N--CA 1.43 -1.438 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.12 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.452 ' HD2' HD12 ' A' ' 269' ' ' LEU . 16.0 Cg_exo -70.83 157.7 57.6 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.643 2.228 . . . . 0.0 111.905 171.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 271' ' ' THR . . . . . 0.474 ' HA ' ' OE1' ' A' ' 274' ' ' GLN . 6.7 p -66.87 -38.35 86.17 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.582 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 11.4 m -59.88 -26.3 65.77 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 124.656 1.182 . . . . 0.0 112.516 -178.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 8.5 mp -96.27 2.48 52.93 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.566 0.698 . . . . 0.0 110.814 -172.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.627 HE21 ' HA ' ' A' ' 292' ' ' LYS . 50.7 mt-30 -84.45 123.54 30.36 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.121 178.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 275' ' ' ARG . . . . . 0.534 ' HD2' ' O ' ' A' ' 228' ' ' ILE . 3.7 ptp180 -137.33 162.4 33.68 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 177.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 276' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 289' ' ' VAL . 24.5 t -139.86 126.77 20.79 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.528 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 1.1 mm? -98.16 111.43 23.76 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 124.925 1.29 . . . . 0.0 108.728 -176.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -86.62 92.68 8.99 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 279' ' ' VAL . . . . . 0.542 HG11 ' CD1' ' A' ' 230' ' ' PHE . 11.8 m -102.32 28.03 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 CA-C-N 114.404 -1.271 . . . . 0.0 112.187 -175.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -67.4 140.49 57.18 Favored 'General case' 0 N--CA 1.403 -2.82 0 CA-C-N 114.062 -1.427 . . . . 0.0 107.591 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 34.4 t70 73.71 4.02 4.62 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 124.892 1.277 . . . . 0.0 113.119 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -75.61 -3.32 33.76 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.475 -0.766 . . . . 0.0 111.492 174.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm 60.64 58.41 2.45 Favored 'General case' 0 CA--C 1.504 -0.81 0 C-N-CA 124.171 0.989 . . . . 0.0 111.007 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 284' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 236' ' ' ASN . 1.4 p -136.57 168.47 16.87 Favored Pre-proline 0 N--CA 1.428 -1.546 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 285' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 15.7 Cg_exo -71.58 -14.58 30.52 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 121.863 1.709 . . . . 0.0 110.892 176.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 21.4 t -84.18 139.75 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -103.18 -45.36 4.94 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.164 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 288' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 277' ' ' LEU . 7.3 ttpm? -163.22 137.61 6.18 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.437 -179.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.528 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 39.9 t -100.67 122.75 53.05 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.34 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 57.7 m -129.26 124.81 35.39 Favored 'General case' 0 C--N 1.28 -2.433 0 CA-C-O 121.217 0.532 . . . . 0.0 110.98 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.612 ' HB2' HG12 ' A' ' 228' ' ' ILE . 45.8 tp -100.04 113.38 25.94 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.627 ' HA ' HE21 ' A' ' 274' ' ' GLN . 40.8 ttmt -115.23 129.34 56.61 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -178.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 293' ' ' ARG . . . . . 0.455 ' H ' ' NE2' ' A' ' 274' ' ' GLN . 13.8 ptt180 -72.95 142.83 47.82 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 175.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.585 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 19.3 tp -108.38 -173.46 2.28 Favored 'General case' 0 C--N 1.274 -2.692 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.585 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 3.8 t-20 -52.57 -64.02 0.95 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.327 0.584 . . . . 0.0 112.079 -177.15 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -125.07 -3.49 7.57 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.817 0.818 . . . . 0.0 109.323 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 297' ' ' ASP . . . . . 0.482 ' OD1' ' HD3' ' A' ' 265' ' ' LYS . 49.6 m-20 -117.05 171.72 7.74 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.054 -175.163 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.572 ' O ' ' HA ' ' A' ' 263' ' ' THR . 27.2 m -108.05 133.7 51.98 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.045 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 299' ' ' GLN . . . . . 0.614 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 43.6 tt0 -121.44 131.71 54.32 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 118.462 0.574 . . . . 0.0 111.304 -177.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.624 HD21 HG21 ' A' ' 228' ' ' ILE . 9.1 mt -100.45 135.41 41.93 Favored 'General case' 0 CA--C 1.45 -2.902 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.39 170.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 62.6 mt -121.18 108.11 21.83 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 173.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 302' ' ' ILE . . . . . 0.402 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 56.0 mt -113.22 97.8 6.18 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.733 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 303' ' ' THR . . . . . 0.416 ' HA ' ' HB3' ' A' ' 259' ' ' HIS . 13.7 m -67.7 130.31 42.62 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -176.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 16.8 p -133.26 167.58 20.12 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 123.279 0.362 . . . . 0.0 110.671 -177.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -152.58 141.0 20.66 Favored 'General case' 0 C--O 1.248 0.976 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 87.24 -168.22 38.43 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 121.376 -0.44 . . . . 0.0 112.259 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -86.48 131.96 34.05 Favored 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 177.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 308' ' ' TRP . . . . . 0.711 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 63.4 p-90 -150.34 164.08 36.72 Favored 'General case' 0 N--CA 1.418 -2.036 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.119 -177.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 309' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 324' ' ' VAL . 10.2 mt-10 -122.21 135.45 54.77 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 -178.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.711 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 19.8 tp -107.28 115.26 29.86 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.406 -178.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 28.3 t -116.22 105.26 18.04 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 174.177 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 312' ' ' ASN . . . . . 0.405 ' HA ' ' O ' ' A' ' 321' ' ' THR . 25.6 t30 -98.45 134.39 41.5 Favored 'General case' 0 CA--C 1.432 -3.574 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 177.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 54.4 mttm -119.38 120.58 37.3 Favored 'General case' 1 N--CA 1.362 -4.826 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.541 -177.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 39.2 m -82.97 103.53 12.5 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 172.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -71.74 -31.71 66.96 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.992 -177.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.469 ' HB1' ' HD2' ' A' ' 317' ' ' PRO . . . -170.12 166.55 5.24 Favored Pre-proline 0 C--N 1.311 -1.09 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 -178.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 317' ' ' PRO . . . . . 0.469 ' HD2' ' HB1' ' A' ' 316' ' ' ALA . 23.2 Cg_endo -60.02 104.78 0.25 Allowed 'Trans proline' 0 C--O 1.246 0.913 0 C-N-CA 121.988 1.792 . . . . 0.0 112.137 178.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 107.77 -13.83 38.34 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.134 -178.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 319' ' ' TYR . . . . . 0.402 ' CD1' ' HB3' ' A' ' 316' ' ' ALA . 97.7 m-85 -108.56 116.19 31.51 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.991 -0.711 . . . . 0.0 109.136 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 320' ' ' PHE . . . . . 0.489 ' CZ ' ' HD3' ' A' ' 251' ' ' PRO . 83.5 m-85 -121.49 160.34 24.4 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.593 0.711 . . . . 0.0 110.137 -176.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 312' ' ' ASN . 94.8 m -152.96 105.88 2.98 Favored 'General case' 0 C--N 1.273 -2.738 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.335 -175.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -94.1 110.47 22.18 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 -178.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 323' ' ' GLN . . . . . 0.533 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 51.2 tt0 -97.63 99.98 11.37 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 176.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.41 HG23 ' CE3' ' A' ' 308' ' ' TRP . 0.1 OUTLIER -96.26 104.07 15.43 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.323 0 CA-C-O 122.642 1.21 . . . . 0.0 110.052 179.258 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 21.3 mt -95.22 149.54 36.35 Favored Pre-proline 0 C--N 1.296 -1.745 0 CA-C-N 113.238 -1.801 . . . . 0.0 109.555 -174.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -76.35 123.84 7.38 Favored 'Trans proline' 0 C--O 1.247 0.971 0 C-N-CA 121.78 1.653 . . . . 0.0 109.937 173.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm . . . . . 0 C--N 1.306 -1.312 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.363 -176.584 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 225' ' ' GLN . . . . . 0.427 ' HG2' HD11 ' A' ' 273' ' ' LEU . 7.1 tt0 . . . . . 0 N--CA 1.451 -0.419 0 N-CA-C 104.254 -2.499 . . . . 0.0 104.254 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.554 ' O ' HD13 ' A' ' 273' ' ' LEU . 11.0 m -64.88 147.72 52.78 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 118.454 0.57 . . . . 0.0 111.05 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -173.92 169.42 4.08 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 120.919 0.39 . . . . 0.0 110.323 173.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.443 HG21 HD13 ' A' ' 300' ' ' LEU . 2.8 pp -124.25 158.81 30.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 229' ' ' ASP . . . . . 0.552 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 4.4 t70 -150.38 156.21 41.07 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -138.37 136.51 36.4 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 118.145 0.429 . . . . 0.0 111.368 177.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -149.43 166.38 29.25 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.573 173.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -103.92 139.72 38.69 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -151.39 169.57 21.69 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 59.3 -129.51 49.26 Favored Glycine 0 C--N 1.304 -1.233 0 N-CA-C 114.275 0.47 . . . . 0.0 114.275 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -118.33 89.44 3.12 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 123.889 0.876 . . . . 0.0 109.506 -176.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 54.08 33.8 18.52 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 122.221 1.01 . . . . 0.0 112.338 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.3 140.55 29.64 Favored 'General case' 0 N--CA 1.405 -2.685 0 CA-C-N 114.124 -1.398 . . . . 0.0 108.496 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 238' ' ' GLY . . . . . 0.407 ' O ' HG13 ' A' ' 324' ' ' VAL . . . -100.77 124.64 8.32 Favored Glycine 0 N--CA 1.422 -2.285 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.2 mp -112.62 118.34 57.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-N 117.602 0.701 . . . . 0.0 110.416 -177.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.0 mp -105.02 112.44 38.64 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 177.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 52.8 mt-10 -90.34 142.47 27.69 Favored 'General case' 0 C--N 1.279 -2.47 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 174.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 11.8 tp -129.99 117.82 20.65 Favored 'General case' 0 C--N 1.265 -3.074 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.275 -175.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' ALA . . . . . 0.55 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -103.89 106.24 16.68 Favored 'General case' 0 C--N 1.282 -2.345 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 177.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -117.88 90.36 3.32 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 121.603 0.716 . . . . 0.0 110.228 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -87.0 113.91 23.16 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.4 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 122.4 1.31 10.16 Favored Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -176.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -115.54 128.99 56.38 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -104.68 -30.82 9.69 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -176.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -94.26 -141.92 11.82 Favored Glycine 0 CA--C 1.493 -1.34 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.318 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -118.4 142.41 31.31 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -177.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.585 ' HB3' HD23 ' A' ' 264' ' ' LEU . 44.0 Cg_endo -79.58 172.34 14.51 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.812 2.341 . . . . 0.0 112.488 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -89.26 109.55 20.42 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.39 108.79 20.91 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 177.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 254' ' ' SER . . . . . 0.538 ' HB2' ' HB ' ' A' ' 261' ' ' ILE . 16.9 m -105.72 111.4 24.07 Favored 'General case' 0 N--CA 1.407 -2.619 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.6 176.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -94.34 112.51 24.3 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.496 -176.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.711 ' HB3' ' O ' ' A' ' 259' ' ' HIS . 6.8 tp60 -116.5 159.73 21.64 Favored 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -76.89 -37.19 55.93 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.145 -177.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -71.23 -34.41 70.76 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.697 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 259' ' ' HIS . . . . . 0.711 ' O ' ' HB3' ' A' ' 256' ' ' GLN . 26.8 p80 -168.08 171.22 9.74 Favored 'General case' 0 C--O 1.201 -1.451 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -178.329 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.424 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 21.7 mt -106.38 139.26 28.35 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 178.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 261' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' A' ' 254' ' ' SER . 3.6 mp -115.35 108.49 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.926 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.485 ' HB ' ' HB3' ' A' ' 300' ' ' LEU . 43.3 t -106.68 120.93 58.69 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.628 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 175.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 263' ' ' THR . . . . . 0.537 HG22 ' OD2' ' A' ' 297' ' ' ASP . 1.1 m -115.32 130.36 56.88 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.723 -177.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.585 HD23 ' HB3' ' A' ' 251' ' ' PRO . 25.5 mt -116.04 83.38 1.93 Allowed 'General case' 0 CA--C 1.474 -1.976 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -178.292 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.447 ' HA ' ' OD2' ' A' ' 297' ' ' ASP . 26.4 mmtm -61.65 140.88 58.11 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.6 -175.221 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 10.9 t30 66.68 15.05 10.02 Favored 'General case' 0 CA--C 1.552 1.027 0 O-C-N 124.792 1.307 . . . . 0.0 110.802 175.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 50.2 t60 -109.89 93.92 4.75 Favored 'General case' 0 C--O 1.187 -2.216 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 176.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 2.0 m -86.64 114.7 23.57 Favored 'General case' 0 C--N 1.28 -2.431 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.334 -173.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 19.6 tp -87.84 135.76 33.36 Favored Pre-proline 0 C--N 1.312 -1.037 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.47 -178.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -78.65 159.91 28.26 Favored 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 122.25 1.967 . . . . 0.0 111.413 171.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 271' ' ' THR . . . . . 0.479 ' HA ' ' OE1' ' A' ' 274' ' ' GLN . 23.5 p -64.0 -28.31 69.72 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.727 0.775 . . . . 0.0 111.081 -179.283 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 30.1 m -56.86 -26.29 58.29 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 125.693 1.597 . . . . 0.0 113.379 -177.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.554 HD13 ' O ' ' A' ' 226' ' ' THR . 64.7 mt -105.6 -2.27 23.69 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 121.965 -0.459 . . . . 0.0 111.537 -174.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.479 ' OE1' ' HA ' ' A' ' 271' ' ' THR . 55.3 mt-30 -77.9 108.31 11.06 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.971 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -138.26 153.34 49.08 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 20.2 m -117.77 131.99 56.52 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 63.9 mt -100.2 125.82 46.41 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -49.41 -69.11 0.13 Allowed 'General case' 0 N--CA 1.471 0.623 0 O-C-N 124.559 1.162 . . . . 0.0 111.642 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 279' ' ' VAL . . . . . 0.711 ' HA ' ' CD2' ' A' ' 282' ' ' PHE . 39.1 t 56.12 24.72 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.79 0 O-C-N 124.332 1.02 . . . . 0.0 112.247 176.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -79.5 138.27 37.49 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 120.637 -1.289 . . . . 0.0 109.991 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 60.21 38.68 19.93 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 123.92 0.762 . . . . 0.0 111.514 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.711 ' CD2' ' HA ' ' A' ' 279' ' ' VAL . 0.2 OUTLIER -88.59 -2.94 58.86 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.856 179.85 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 65.36 61.24 0.72 Allowed 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.894 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.9 153.45 10.82 Favored Pre-proline 0 C--N 1.298 -1.634 0 CA-C-N 114.127 -1.397 . . . . 0.0 108.966 179.018 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 285' ' ' PRO . . . . . 0.475 ' O ' ' HA ' ' A' ' 304' ' ' THR . 62.1 Cg_exo -50.31 -28.13 19.78 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.671 2.914 . . . . 0.0 112.948 173.555 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 42.4 t -69.57 124.39 25.37 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.946 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -98.71 -44.0 6.58 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.263 -177.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -161.64 139.17 8.85 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 47.0 t -100.89 130.89 49.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 176.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 62.6 m -139.72 117.0 11.24 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.119 0.485 . . . . 0.0 110.772 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 54.9 tp -97.47 115.58 28.04 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 292' ' ' LYS . . . . . 0.425 ' HA ' HE21 ' A' ' 274' ' ' GLN . 16.3 tppt? -114.63 129.01 56.62 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -176.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 293' ' ' ARG . . . . . 0.436 ' H ' ' NE2' ' A' ' 274' ' ' GLN . 5.7 ptm180 -79.46 140.18 37.41 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.166 -1.013 . . . . 0.0 108.572 176.327 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.621 ' HB3' ' HB3' ' A' ' 297' ' ' ASP . 2.7 tm? -120.29 158.48 26.97 Favored 'General case' 0 N--CA 1.416 -2.149 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.6 ' N ' HD13 ' A' ' 294' ' ' LEU . 21.3 t-20 -14.86 -71.43 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 127.583 2.353 . . . . 0.0 114.032 177.238 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -125.2 -3.47 7.49 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 297' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 294' ' ' LEU . 7.0 t70 -108.58 -177.65 3.38 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.242 1.017 . . . . 0.0 108.471 -169.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.501 ' HB ' ' HB2' ' A' ' 264' ' ' LEU . 58.3 m -134.18 109.55 8.97 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 174.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -103.23 119.17 38.37 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-O 121.708 0.766 . . . . 0.0 109.648 -175.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.485 ' HB3' ' HB ' ' A' ' 262' ' ' VAL . 59.9 tp -105.13 124.26 49.22 Favored 'General case' 0 C--N 1.271 -2.805 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.831 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 66.6 mt -107.16 109.85 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.641 -178.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 302' ' ' ILE . . . . . 0.424 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 61.6 mt -108.36 105.14 18.23 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 303' ' ' THR . . . . . 0.401 ' HA ' ' CB ' ' A' ' 259' ' ' HIS . 11.9 m -74.77 135.36 41.72 Favored 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.832 -174.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 304' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 285' ' ' PRO . 17.3 p -134.34 -177.04 4.41 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 123.051 0.54 . . . . 0.0 110.308 -177.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -166.75 149.9 6.76 Favored 'General case' 0 C--O 1.247 0.937 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 71.92 -161.05 54.22 Favored Glycine 0 C--O 1.243 0.659 0 O-C-N 123.672 0.608 . . . . 0.0 112.541 177.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 307' ' ' ASN . . . . . 0.413 ' HB3' ' HB3' ' A' ' 327' ' ' LYS . 83.6 m-20 -88.32 128.84 35.5 Favored 'General case' 0 CA--C 1.494 -1.197 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 308' ' ' TRP . . . . . 0.687 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 56.8 p-90 -147.83 167.59 24.36 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -177.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 309' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 324' ' ' VAL . 15.8 mt-10 -123.69 144.58 49.56 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -177.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.687 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 33.1 tp -120.83 117.52 27.61 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.916 0.389 . . . . 0.0 111.514 -176.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 58.8 t -110.87 108.27 25.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 174.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -98.46 129.64 45.07 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -135.08 158.71 43.65 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 120.807 0.337 . . . . 0.0 110.223 -178.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 12.0 p -116.5 138.88 51.04 Favored 'General case' 0 N--CA 1.414 -2.247 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.908 172.034 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -96.55 -22.97 16.75 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -172.39 163.3 4.11 Favored Pre-proline 0 C--N 1.313 -1.001 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -65.11 97.57 0.29 Allowed 'Trans proline' 0 C--O 1.247 0.948 0 C-N-CA 121.63 1.554 . . . . 0.0 111.172 177.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 120.9 -5.15 11.42 Favored Glycine 0 C--O 1.208 -1.521 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.433 -177.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -123.7 116.68 23.45 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.944 -0.739 . . . . 0.0 109.749 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -119.19 166.3 13.13 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.829 0.823 . . . . 0.0 110.749 -176.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 58.5 m -151.97 136.68 17.05 Favored 'General case' 0 C--N 1.281 -2.37 0 C-N-CA 124.259 1.024 . . . . 0.0 109.085 -177.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -123.03 116.26 23.22 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 323' ' ' GLN . . . . . 0.533 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 8.9 tt0 -103.53 105.87 16.23 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 309' ' ' GLU . 1.3 m -99.59 110.72 27.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-O 121.301 0.572 . . . . 0.0 109.8 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -92.1 156.89 41.73 Favored Pre-proline 0 C--N 1.313 -1.015 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.374 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -83.0 138.51 9.13 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 C-N-CA 121.814 1.676 . . . . 0.0 109.915 171.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 307' ' ' ASN . 34.6 ttmt . . . . . 0 C--N 1.295 -1.768 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' GLN . . . . . 0.496 ' HG2' ' H ' ' A' ' 226' ' ' THR . 42.1 tt0 . . . . . 0 N--CA 1.424 -1.769 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.635 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 24.7 m -63.83 125.64 25.02 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 123.403 0.681 . . . . 0.0 112.595 -170.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -152.55 171.81 17.55 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.18 -176.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.52 HG21 HD13 ' A' ' 300' ' ' LEU . 2.5 pp -133.7 158.85 42.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 C-N-CA 123.45 0.7 . . . . 0.0 110.868 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 229' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 1.8 t70 -149.85 156.63 42.11 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -175.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -138.08 138.28 38.59 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.153 0.501 . . . . 0.0 111.086 176.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 21.1 ptt85 -153.76 168.2 27.09 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 172.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.495 ' HE3' HG22 ' A' ' 284' ' ' THR . 54.4 mtpt -113.53 154.41 27.14 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -144.14 117.67 9.15 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 81.48 -117.23 4.37 Favored Glycine 0 C--N 1.294 -1.793 0 C-N-CA 121.186 -0.53 . . . . 0.0 113.956 175.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -101.33 80.22 2.07 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.332 0.587 . . . . 0.0 111.801 -173.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' ASN . . . . . 0.474 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 91.9 m-20 57.85 18.07 4.69 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 176.147 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -73.19 136.11 44.69 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' GLY . . . . . 0.474 ' HA3' ' CG1' ' A' ' 286' ' ' VAL . . . -91.59 123.86 7.37 Favored Glycine 0 N--CA 1.43 -1.752 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.15 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.6 mp -117.69 112.43 38.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 117.792 0.796 . . . . 0.0 110.77 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.1 mp -101.0 112.15 32.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.455 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 51.4 mt-10 -96.93 104.96 17.02 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 122.635 1.207 . . . . 0.0 110.558 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 11.5 tp -95.24 127.45 41.3 Favored 'General case' 0 C--N 1.27 -2.849 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.621 -175.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 243' ' ' ALA . . . . . 0.635 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -115.78 102.82 10.06 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -109.6 90.97 3.46 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.434 HD23 ' C ' ' A' ' 225' ' ' GLN . 2.9 mm? -78.62 115.82 18.58 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.725 -177.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 108.31 12.15 22.23 Favored Glycine 0 N--CA 1.425 -2.08 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.783 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 247' ' ' PHE . . . . . 0.435 ' HE1' ' O ' ' A' ' 265' ' ' LYS . 42.2 t80 -115.81 107.85 15.57 Favored 'General case' 0 N--CA 1.421 -1.905 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.803 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -103.76 94.71 5.58 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.409 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 156.76 -139.8 6.75 Favored Glycine 0 C--N 1.299 -1.473 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 250' ' ' GLN . . . . . 0.438 ' HA ' ' OE1' ' A' ' 250' ' ' GLN . 13.7 mm-40 -129.51 139.88 36.99 Favored Pre-proline 0 C--N 1.305 -1.357 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.721 ' HB3' HD13 ' A' ' 264' ' ' LEU . 9.1 Cg_endo -69.7 172.14 13.11 Favored 'Trans proline' 0 N--CA 1.434 -2.018 0 C-N-CA 121.212 1.275 . . . . 0.0 110.75 176.281 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -100.72 105.09 16.4 Favored 'General case' 0 C--N 1.267 -3.015 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 4.8 mp -102.37 138.66 25.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-O 121.043 0.449 . . . . 0.0 111.329 -176.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 254' ' ' SER . . . . . 0.496 ' HB3' ' HB ' ' A' ' 261' ' ' ILE . 33.3 t -127.57 124.98 39.44 Favored 'General case' 0 N--CA 1.425 -1.725 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 175.159 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -102.92 114.65 29.11 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.177 0.513 . . . . 0.0 111.932 -177.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -117.88 160.73 20.93 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 171.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -76.6 -30.89 57.15 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.658 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -68.56 -42.21 78.66 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.939 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 259' ' ' HIS . . . . . 0.541 ' CB ' ' HA ' ' A' ' 303' ' ' THR . 38.7 p-80 -168.73 168.69 10.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.665 178.181 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 20.2 mt -106.17 142.36 19.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 261' ' ' ILE . . . . . 0.496 ' HB ' ' HB3' ' A' ' 254' ' ' SER . 3.3 mp -122.64 122.89 67.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 299' ' ' GLN . 1.4 m -120.14 141.09 41.94 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 175.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 263' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 298' ' ' THR . 26.0 m -135.19 126.92 29.15 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-O 121.475 0.655 . . . . 0.0 110.86 177.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.721 HD13 ' HB3' ' A' ' 251' ' ' PRO . 1.5 mm? -94.17 99.3 11.59 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 177.048 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.586 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 13.2 mptt -59.7 125.4 23.5 Favored 'General case' 0 C--N 1.285 -2.225 0 O-C-N 124.838 1.336 . . . . 0.0 112.451 -178.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 66.4 t30 63.76 35.74 11.06 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.138 0.975 . . . . 0.0 110.402 178.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -121.26 119.09 31.25 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 2.8 p -87.27 144.79 26.64 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.031 0.443 . . . . 0.0 111.946 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 27.1 tp -130.26 129.98 22.97 Favored Pre-proline 0 N--CA 1.427 -1.608 0 C-N-CA 123.77 0.828 . . . . 0.0 109.301 178.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -72.86 152.34 52.18 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.021 1.814 . . . . 0.0 111.586 171.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 34.7 p -68.89 -19.56 64.22 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.942 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 13.6 m -74.97 -18.53 60.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.555 0.693 . . . . 0.0 109.686 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.4 HD11 ' HB3' ' A' ' 225' ' ' GLN . 89.9 mt -106.41 -7.11 17.78 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.065 -176.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -86.57 102.39 14.1 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.67 158.32 44.31 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.656 -177.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 33.9 p -114.59 145.87 41.46 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.566 -175.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.435 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 64.2 mt -112.44 119.36 37.95 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -85.88 94.24 9.12 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-O 121.889 0.852 . . . . 0.0 108.714 177.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 279' ' ' VAL . . . . . 0.59 ' HA ' ' CE1' ' A' ' 282' ' ' PHE . 17.6 t -105.83 30.18 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 CA-C-N 113.943 -1.48 . . . . 0.0 109.902 -173.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -82.0 144.96 30.51 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 35.8 t70 72.37 20.85 3.92 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 122.46 1.124 . . . . 0.0 110.789 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.59 ' CE1' ' HA ' ' A' ' 279' ' ' VAL . 19.5 m-85 -90.07 -1.73 58.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.858 173.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 73.23 13.45 4.71 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.539 1.136 . . . . 0.0 111.54 175.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 284' ' ' THR . . . . . 0.495 HG22 ' HE3' ' A' ' 232' ' ' LYS . 1.2 p -96.63 174.93 2.94 Favored Pre-proline 0 C--N 1.309 -1.157 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -175.217 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 285' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 7.9 Cg_exo -76.36 -15.26 17.94 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 121.854 1.703 . . . . 0.0 110.768 173.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.474 ' CG1' ' HA3' ' A' ' 238' ' ' GLY . 1.4 m -90.46 138.06 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 287' ' ' GLN . . . . . 0.477 ' OE1' ' HB2' ' A' ' 305' ' ' ALA . 11.3 mt-30 -104.82 -32.44 8.83 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.239 0.542 . . . . 0.0 110.814 -179.011 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 36.8 tttp -162.29 133.84 5.29 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.204 -174.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.435 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 45.3 t -99.46 132.93 43.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 172.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 97.2 m -142.8 118.92 10.73 Favored 'General case' 0 C--N 1.29 -2.009 0 O-C-N 121.631 -0.668 . . . . 0.0 111.087 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.466 ' HB2' HG12 ' A' ' 228' ' ' ILE . 42.7 tp -96.74 125.03 40.91 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -121.91 129.19 52.35 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.532 -174.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 41.9 ttt-85 -74.54 127.68 33.67 Favored 'General case' 0 N--CA 1.407 -2.584 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 173.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.51 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 19.4 tp -107.99 179.28 4.27 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 176.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.51 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 27.4 t-20 -46.54 -67.76 0.25 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.662 0.785 . . . . 0.0 112.883 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -123.83 -2.09 8.32 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.544 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 297' ' ' ASP . . . . . 0.586 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 15.9 m-20 -117.43 168.31 10.48 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -177.085 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 263' ' ' THR . 49.5 m -112.9 127.96 56.34 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 176.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 299' ' ' GLN . . . . . 0.477 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 41.4 tt0 -111.55 129.64 56.0 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -175.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.52 HD13 HG21 ' A' ' 228' ' ' ILE . 63.2 tp -111.15 124.61 52.53 Favored 'General case' 0 N--CA 1.415 -2.207 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 176.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 54.2 mt -112.5 121.01 64.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -177.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 53.7 mt -121.43 101.76 10.92 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 178.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 303' ' ' THR . . . . . 0.541 ' HA ' ' CB ' ' A' ' 259' ' ' HIS . 16.8 m -69.34 139.82 54.26 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.01 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 10.9 p -134.22 166.04 23.7 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -176.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 305' ' ' ALA . . . . . 0.477 ' HB2' ' OE1' ' A' ' 287' ' ' GLN . . . -144.66 143.91 30.98 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.315 0.646 . . . . 0.0 110.177 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 77.65 -159.62 48.23 Favored Glycine 0 C--O 1.245 0.801 0 O-C-N 123.897 0.748 . . . . 0.0 112.319 178.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 307' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 327' ' ' LYS . 28.9 m-80 -92.67 136.5 33.18 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 176.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 308' ' ' TRP . . . . . 0.732 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 59.3 p-90 -150.47 160.4 43.79 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.781 -0.767 . . . . 0.0 111.157 -175.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 309' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 324' ' ' VAL . 16.1 mt-10 -118.14 133.14 56.17 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -177.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.732 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 24.3 tp -108.35 120.92 43.77 Favored 'General case' 0 CA--C 1.498 -1.039 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.825 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.674 HG13 ' HB3' ' A' ' 323' ' ' GLN . 7.5 p -122.17 112.12 33.37 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-O 121.964 0.888 . . . . 0.0 109.395 172.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -94.94 139.58 31.13 Favored 'General case' 0 N--CA 1.414 -2.267 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.594 -177.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 313' ' ' LYS . . . . . 0.466 ' HB2' ' HB ' ' A' ' 321' ' ' THR . 67.0 mttm -130.92 151.32 51.47 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.342 -177.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 27.0 m -116.02 126.75 54.22 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 172.068 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -87.9 -34.62 18.1 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -167.41 163.77 9.7 Favored Pre-proline 0 C--N 1.307 -1.25 0 N-CA-C 104.74 -2.318 . . . . 0.0 104.74 -178.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.68 95.42 0.28 Allowed 'Trans proline' 0 C--O 1.244 0.813 0 C-N-CA 121.535 1.49 . . . . 0.0 111.266 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 131.79 -32.4 2.91 Favored Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -177.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -97.84 116.51 30.2 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 320' ' ' PHE . . . . . 0.444 ' CZ ' ' HD3' ' A' ' 251' ' ' PRO . 61.0 m-85 -119.2 165.03 14.73 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-O 122.188 0.994 . . . . 0.0 110.449 -175.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.466 ' HB ' ' HB2' ' A' ' 313' ' ' LYS . 59.3 m -151.72 128.72 11.05 Favored 'General case' 0 C--N 1.264 -3.135 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.619 -177.323 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -116.44 114.53 24.36 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 323' ' ' GLN . . . . . 0.674 ' HB3' HG13 ' A' ' 311' ' ' VAL . 34.9 tt0 -104.24 111.87 24.66 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 309' ' ' GLU . 0.2 OUTLIER -105.96 103.65 15.74 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.713 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.261 179.205 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.417 HD22 ' H ' ' A' ' 325' ' ' LEU . 1.0 OUTLIER -86.08 153.0 56.78 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.229 179.77 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -78.55 129.76 9.48 Favored 'Trans proline' 0 N--CA 1.447 -1.226 0 C-N-CA 121.669 1.58 . . . . 0.0 109.491 173.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 307' ' ' ASN . 41.1 ttmt . . . . . 0 C--N 1.295 -1.795 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 . . . . . 0 N--CA 1.436 -1.141 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.559 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 31.1 m -61.5 133.47 55.76 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -167.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -162.17 170.99 18.12 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.177 -178.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.529 HG12 ' HB2' ' A' ' 291' ' ' LEU . 2.8 pp -136.56 157.34 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.183 178.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 229' ' ' ASP . . . . . 0.414 ' HB2' ' HB2' ' A' ' 241' ' ' GLU . 5.1 m-20 -145.61 157.61 43.95 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 123.992 0.917 . . . . 0.0 110.147 -175.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.403 ' HZ ' HG21 ' A' ' 284' ' ' THR . 91.5 t80 -124.0 145.58 49.09 Favored 'General case' 0 C--N 1.31 -1.13 0 O-C-N 123.202 0.314 . . . . 0.0 110.549 177.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -155.52 165.22 37.25 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 170.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.501 ' CE ' ' HA ' ' A' ' 236' ' ' ASN . 55.2 mtpt -115.38 151.23 35.06 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 120.696 0.284 . . . . 0.0 110.586 176.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -136.68 140.51 42.75 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.96 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 66.14 -97.61 0.33 Allowed Glycine 0 N--CA 1.438 -1.188 0 O-C-N 124.3 1.0 . . . . 0.0 114.32 172.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -136.3 92.34 2.77 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-O 120.862 0.363 . . . . 0.0 110.074 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' ASN . . . . . 0.501 ' HA ' ' CE ' ' A' ' 232' ' ' LYS . 92.4 m-20 65.3 12.9 8.43 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 172.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -74.73 130.87 40.25 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -97.1 113.84 4.82 Favored Glycine 0 C--O 1.21 -1.385 0 O-C-N 123.696 0.623 . . . . 0.0 111.845 -177.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.422 HG13 ' HG3' ' A' ' 323' ' ' GLN . 2.7 mp -106.96 117.56 53.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 117.834 0.817 . . . . 0.0 111.015 -177.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.4 mp -103.66 112.57 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.919 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 175.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 229' ' ' ASP . 45.3 mt-10 -91.43 128.31 37.21 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 12.8 tp -116.08 123.69 48.52 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-O 121.054 0.454 . . . . 0.0 111.409 -175.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 243' ' ' ALA . . . . . 0.559 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -109.93 104.4 13.31 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -117.43 91.08 3.48 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.03 115.37 19.57 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.139 -174.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 113.08 2.24 25.04 Favored Glycine 0 N--CA 1.432 -1.612 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.718 178.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 247' ' ' PHE . . . . . 0.425 ' HB2' ' ND1' ' A' ' 267' ' ' HIS . 40.9 t80 -114.96 114.21 25.14 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -178.218 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -106.91 -10.05 16.11 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -84.1 -154.57 19.66 Favored Glycine 0 C--N 1.318 -0.435 0 C-N-CA 121.425 -0.417 . . . . 0.0 112.464 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -119.69 134.43 23.88 Favored Pre-proline 0 C--N 1.311 -1.082 0 O-C-N 122.485 -0.42 . . . . 0.0 109.872 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.624 ' HB3' HD23 ' A' ' 264' ' ' LEU . 32.9 Cg_endo -74.21 171.99 16.9 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.523 2.149 . . . . 0.0 113.042 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -94.71 113.24 25.0 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.104 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 2.2 mp -97.86 108.47 21.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 122.113 0.958 . . . . 0.0 110.191 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 254' ' ' SER . . . . . 0.623 ' HB2' ' HB ' ' A' ' 261' ' ' ILE . 36.6 m -108.98 111.67 23.46 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.37 -1.287 . . . . 0.0 108.856 176.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -104.87 124.18 49.01 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -174.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.44 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 14.3 mm-40 -124.77 167.86 14.01 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 173.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -76.95 -36.28 56.66 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 120.304 -0.558 . . . . 0.0 109.986 177.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -71.91 -37.75 70.03 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.942 -177.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 259' ' ' HIS . . . . . 0.44 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 55.0 p-80 -167.6 166.01 14.22 Favored 'General case' 0 C--N 1.318 -0.768 0 O-C-N 122.143 -0.348 . . . . 0.0 110.968 178.056 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.475 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 19.1 mt -106.43 143.75 16.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 261' ' ' ILE . . . . . 0.623 ' HB ' ' HB2' ' A' ' 254' ' ' SER . 4.2 mp -121.76 111.76 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 177.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' A' ' 300' ' ' LEU . 43.1 t -110.12 117.01 53.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 176.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 23.5 m -112.76 124.22 52.09 Favored 'General case' 0 C--N 1.285 -2.233 0 C-N-CA 119.951 -0.7 . . . . 0.0 110.943 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.624 HD23 ' HB3' ' A' ' 251' ' ' PRO . 17.1 mt -99.82 100.08 10.97 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.507 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 30.7 mmtp -65.7 129.43 39.73 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -174.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 6.4 t30 64.33 23.82 13.12 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 113.532 -1.667 . . . . 0.0 110.202 177.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 267' ' ' HIS . . . . . 0.425 ' ND1' ' HB2' ' A' ' 247' ' ' PHE . 54.9 t60 -112.05 107.69 16.73 Favored 'General case' 0 CA--C 1.476 -1.883 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 2.8 m -94.5 138.51 32.33 Favored 'General case' 0 C--N 1.263 -3.169 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.627 -175.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 29.7 tp -113.79 128.26 25.93 Favored Pre-proline 0 N--CA 1.431 -1.388 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.186 -176.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -62.21 135.7 55.92 Favored 'Trans proline' 0 C--O 1.248 0.98 0 C-N-CA 122.312 2.008 . . . . 0.0 110.705 169.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 271' ' ' THR . . . . . 0.452 ' O ' ' HG2' ' A' ' 274' ' ' GLN . 9.2 t -67.5 -13.11 61.75 Favored 'General case' 0 CA--C 1.56 1.36 0 CA-C-O 121.814 0.816 . . . . 0.0 111.223 -178.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 27.3 m -74.59 -23.99 58.83 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.81 178.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 96.7 mt -100.95 -9.27 21.67 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.128 -174.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.539 ' HB2' ' O ' ' A' ' 291' ' ' LEU . 25.4 pt20 -77.27 94.37 4.14 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-O 122.698 1.237 . . . . 0.0 109.647 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -100.72 166.53 10.83 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.094 -177.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 19.9 m -137.27 127.36 26.03 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.447 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 2.2 mm? -89.83 130.5 36.06 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 179.078 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -70.44 -42.1 71.98 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 279' ' ' VAL . . . . . 0.604 ' HA ' ' CD1' ' A' ' 282' ' ' PHE 0.257 10.4 p 40.35 34.3 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.548 0 C-N-CA 126.051 1.74 . . . . 0.0 112.609 177.969 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -89.61 137.66 32.14 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.1 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 14.2 t70 69.2 14.47 8.65 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 125.328 1.451 . . . . 0.0 109.887 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.604 ' CD1' ' HA ' ' A' ' 279' ' ' VAL . 7.9 m-85 -75.82 -20.45 58.17 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.39 174.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp 62.3 60.56 1.41 Allowed 'General case' 0 CA--C 1.5 -0.965 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.981 174.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 284' ' ' THR . . . . . 0.455 HG22 ' HE3' ' A' ' 232' ' ' LYS . 1.1 p -133.06 172.32 7.61 Favored Pre-proline 0 C--N 1.286 -2.163 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 177.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 285' ' ' PRO . . . . . 0.452 ' O ' ' HA ' ' A' ' 304' ' ' THR . 23.8 Cg_exo -65.9 -24.65 53.29 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.51 1.473 . . . . 0.0 110.958 175.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.2 p -87.64 120.22 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 CA-C-O 122.206 1.003 . . . . 0.0 110.077 176.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 -90.95 -37.76 13.3 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 114.111 -1.404 . . . . 0.0 111.062 -173.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 288' ' ' LYS . . . . . 0.463 ' HA ' ' CG1' ' A' ' 279' ' ' VAL . 86.6 tttt -154.29 134.79 13.46 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.013 178.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 35.8 t -102.03 116.56 45.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 175.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.465 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 27.2 m -124.37 121.28 34.51 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 120.729 0.299 . . . . 0.0 110.811 -176.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.539 ' O ' ' HB2' ' A' ' 274' ' ' GLN . 27.7 tp -96.9 126.79 42.3 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 175.172 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 21.5 tptp -125.59 121.98 35.16 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -172.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -77.9 128.25 33.65 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 118.579 -1.248 . . . . 0.0 108.607 177.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.501 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 15.1 tp -101.88 -173.91 2.46 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.501 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 51.1 t-20 -53.95 -67.05 0.29 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 118.311 0.505 . . . . 0.0 111.033 -177.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -120.43 -4.05 9.89 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.722 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 297' ' ' ASP . . . . . 0.507 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 30.3 m-20 -113.32 164.77 13.14 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.512 -175.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.502 ' HB ' ' HB2' ' A' ' 264' ' ' LEU . 98.9 m -108.09 124.86 50.86 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 174.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -112.97 128.33 56.46 Favored 'General case' 0 N--CA 1.416 -2.167 0 CA-C-O 121.59 0.71 . . . . 0.0 109.239 -176.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.419 ' HB2' ' HB ' ' A' ' 262' ' ' VAL . 0.5 OUTLIER -107.18 127.62 53.67 Favored 'General case' 0 C--N 1.271 -2.83 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 176.712 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 301' ' ' ILE . . . . . 0.465 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 58.1 mt -115.57 109.49 28.48 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 302' ' ' ILE . . . . . 0.475 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 63.3 mt -110.84 101.05 12.0 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 25.8 m -70.81 134.33 47.27 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 -177.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 304' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 285' ' ' PRO . 15.4 p -138.0 171.23 14.72 Favored 'General case' 0 C--N 1.31 -1.111 0 O-C-N 123.256 0.347 . . . . 0.0 111.322 -176.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -154.69 139.75 17.4 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 90.1 -153.41 22.91 Favored Glycine 0 C--N 1.314 -0.656 0 C-N-CA 121.256 -0.497 . . . . 0.0 111.866 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 307' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 327' ' ' LYS . 30.4 m-80 -104.3 139.99 38.51 Favored 'General case' 0 C--O 1.255 1.361 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 175.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 308' ' ' TRP . . . . . 0.416 ' HZ3' ' CB ' ' A' ' 310' ' ' LEU . 67.9 p-90 -155.63 166.3 33.93 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.356 -177.057 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 309' ' ' GLU . . . . . 0.472 ' HG2' ' HE2' ' A' ' 327' ' ' LYS . 17.8 mt-10 -117.88 134.39 54.98 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.416 ' CB ' ' HZ3' ' A' ' 308' ' ' TRP . 1.1 tt -102.85 123.42 46.47 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 176.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.641 ' CG1' ' HB3' ' A' ' 323' ' ' GLN . 6.5 p -117.34 108.16 24.08 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 CA-C-O 122.065 0.936 . . . . 0.0 109.419 170.183 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -98.48 115.93 29.62 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.915 -175.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -116.14 149.77 38.49 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.926 -176.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 48.4 t -111.65 113.78 26.38 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 172.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -79.71 -35.98 38.16 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.533 0.682 . . . . 0.0 109.95 -177.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -168.16 161.59 9.24 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 -178.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -62.09 102.45 0.26 Allowed 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 121.574 1.516 . . . . 0.0 111.497 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 117.03 -9.4 15.73 Favored Glycine 0 N--CA 1.434 -1.45 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.629 -178.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -120.08 116.31 25.45 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 122.004 -0.703 . . . . 0.0 110.035 178.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -120.63 165.82 14.51 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.697 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 50.4 m -151.64 132.02 13.75 Favored 'General case' 0 C--N 1.274 -2.711 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.386 -176.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -120.29 107.33 12.84 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 177.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 323' ' ' GLN . . . . . 0.641 ' HB3' ' CG1' ' A' ' 311' ' ' VAL . 62.7 tt0 -98.67 115.89 29.69 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.41 HG13 ' CE3' ' A' ' 308' ' ' TRP . 92.0 t -100.05 99.16 7.95 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.803 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -88.04 144.8 35.1 Favored Pre-proline 0 C--N 1.318 -0.762 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -68.79 131.0 21.62 Favored 'Trans proline' 0 C--O 1.243 0.764 0 C-N-CA 121.443 1.429 . . . . 0.0 110.076 173.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.472 ' HE2' ' HG2' ' A' ' 309' ' ' GLU . 37.7 ttmt . . . . . 0 CA--C 1.495 -1.157 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' GLN . . . . . 0.466 ' O ' HD23 ' A' ' 245' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.439 -0.983 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.567 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 10.5 m -69.79 117.18 11.06 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -151.23 173.02 14.93 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.265 -176.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.54 HD13 HD21 ' A' ' 277' ' ' LEU . 2.2 pp -133.48 159.37 42.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.33 -178.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -150.83 156.49 41.36 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -178.256 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -130.38 134.52 47.21 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.552 175.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -145.26 166.95 24.01 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 173.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.453 ' HE3' HG22 ' A' ' 284' ' ' THR . 55.2 mtpt -110.82 146.42 36.45 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 174.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 233' ' ' ASP . . . . . 0.428 ' O ' ' HB3' ' A' ' 237' ' ' ALA . 18.2 t70 -152.88 117.76 5.1 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -177.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 99.25 -131.32 10.52 Favored Glycine 0 N--CA 1.434 -1.467 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.263 178.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -101.39 85.59 2.82 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 122.686 0.395 . . . . 0.0 110.166 -177.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' ASN . . . . . 0.486 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 91.2 m-20 57.8 21.4 7.44 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 177.049 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 233' ' ' ASP . . . -79.18 138.4 37.84 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.907 -178.101 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -97.27 114.88 5.1 Favored Glycine 0 N--CA 1.421 -2.348 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.2 mp -107.19 111.96 37.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-O 121.505 0.669 . . . . 0.0 110.581 -177.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.5 mp -97.35 112.53 29.6 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 176.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -92.38 136.76 32.93 Favored 'General case' 0 C--N 1.277 -2.548 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 11.8 tp -127.98 127.78 43.86 Favored 'General case' 0 C--N 1.276 -2.598 0 C-N-CA 123.836 0.854 . . . . 0.0 110.359 -174.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 243' ' ' ALA . . . . . 0.567 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -113.25 101.19 9.18 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -108.28 90.78 3.4 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 225' ' ' GLN . 3.8 mm? -80.52 115.57 20.11 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.998 -174.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 105.87 14.22 21.67 Favored Glycine 0 N--CA 1.431 -1.675 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.597 178.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -114.98 118.21 32.79 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 -178.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -116.43 91.11 3.49 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.842 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 164.89 -148.51 14.33 Favored Glycine 0 N--CA 1.436 -1.305 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -126.42 138.6 32.69 Favored Pre-proline 0 C--N 1.31 -1.116 0 CA-C-N 117.277 0.539 . . . . 0.0 109.603 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.723 ' HB3' HD13 ' A' ' 264' ' ' LEU . 12.0 Cg_endo -71.5 172.1 14.93 Favored 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 121.683 1.589 . . . . 0.0 110.904 175.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 34.3 t70 -95.64 108.69 20.99 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.45 HD11 ' HG2' ' A' ' 251' ' ' PRO . 4.5 mp -105.84 116.25 49.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-O 121.302 0.572 . . . . 0.0 111.312 -178.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 19.3 t -95.51 111.8 23.64 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 175.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -88.76 95.68 10.37 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 121.468 0.651 . . . . 0.0 111.684 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.488 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 78.4 mt-30 -108.54 144.36 36.31 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 172.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -74.52 -19.98 60.14 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 119.769 -0.772 . . . . 0.0 112.109 -174.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -73.86 -47.24 39.64 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 123.875 0.734 . . . . 0.0 109.942 177.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 259' ' ' HIS . . . . . 0.488 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 44.3 p-80 -162.67 162.27 26.89 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.158 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 301' ' ' ILE . 29.5 mt -106.05 143.02 17.71 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -177.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 3.4 mp -125.51 114.7 40.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 178.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.548 ' HA ' ' O ' ' A' ' 252' ' ' ASP . 1.4 m -110.0 140.48 28.79 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.271 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.224 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 263' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 298' ' ' THR . 24.4 m -135.2 123.99 23.9 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-O 121.131 0.491 . . . . 0.0 111.14 177.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.723 HD13 ' HB3' ' A' ' 251' ' ' PRO . 1.7 mm? -93.98 107.75 19.63 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 176.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.43 ' HD3' ' OD1' ' A' ' 297' ' ' ASP . 30.3 mmtp -69.6 129.53 39.9 Favored 'General case' 0 C--N 1.29 -2.001 0 O-C-N 123.927 0.767 . . . . 0.0 112.689 -177.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 14.0 t30 70.1 22.62 5.57 Favored 'General case' 0 CA--C 1.554 1.113 0 O-C-N 124.952 1.407 . . . . 0.0 111.189 176.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 38.0 t60 -112.79 110.27 20.28 Favored 'General case' 0 C--O 1.213 -0.821 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 10.9 p -77.83 142.79 38.34 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.19 0.519 . . . . 0.0 112.158 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 35.9 tp -121.98 121.12 28.15 Favored Pre-proline 0 N--CA 1.431 -1.403 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.543 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -59.62 134.62 58.99 Favored 'Trans proline' 0 C--N 1.321 -0.91 0 C-N-CA 122.672 2.248 . . . . 0.0 111.276 170.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 271' ' ' THR . . . . . 0.571 ' HB ' ' HD3' ' A' ' 293' ' ' ARG . 6.5 t -66.3 -9.3 31.49 Favored 'General case' 0 CA--C 1.554 1.108 0 CA-C-O 121.823 0.82 . . . . 0.0 112.092 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 27.2 m -83.22 -14.95 52.21 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 121.642 0.734 . . . . 0.0 109.902 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.443 HD13 ' O ' ' A' ' 226' ' ' THR . 82.4 mt -106.23 -6.39 18.51 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.171 -176.403 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.492 ' OE1' ' HG2' ' A' ' 293' ' ' ARG . 8.5 pt20 -82.92 101.39 11.0 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 121.844 0.83 . . . . 0.0 109.637 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 275' ' ' ARG . . . . . 0.461 ' HG3' HD11 ' A' ' 228' ' ' ILE . 14.0 ptm180 -129.25 179.09 5.97 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 48.8 m -125.44 164.87 19.49 Favored 'General case' 0 N--CA 1.409 -2.476 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 176.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.54 HD21 HD13 ' A' ' 228' ' ' ILE . 2.9 mm? -122.29 115.91 23.17 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.093 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -77.98 92.37 4.32 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 174.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 279' ' ' VAL . . . . . 0.676 ' HA ' ' CD2' ' A' ' 282' ' ' PHE . 92.3 t -100.51 18.77 2.91 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 CA-C-O 123.124 1.44 . . . . 0.0 109.357 -176.159 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -70.19 137.07 50.63 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-N 114.583 -1.19 . . . . 0.0 107.967 176.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 72.94 19.27 3.81 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.961 0.904 . . . . 0.0 112.883 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.676 ' CD2' ' HA ' ' A' ' 279' ' ' VAL . 9.4 m-85 -85.69 -13.81 47.34 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.799 172.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.27 60.66 1.99 Allowed 'General case' 0 CA--C 1.492 -1.262 0 CA-C-O 121.838 0.828 . . . . 0.0 110.648 -177.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 284' ' ' THR . . . . . 0.453 HG22 ' HE3' ' A' ' 232' ' ' LYS . 2.9 p -136.12 173.3 5.79 Favored Pre-proline 0 N--CA 1.421 -1.924 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 178.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 285' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 2.8 Cg_exo -79.02 -5.98 14.78 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.404 1.402 . . . . 0.0 112.211 176.125 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.3 p -101.53 125.44 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-O 121.38 0.61 . . . . 0.0 110.446 178.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -86.93 -40.89 14.39 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.911 -175.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -159.16 134.26 8.27 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.939 -174.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.511 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 35.6 t -95.14 135.65 28.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 172.125 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 96.0 m -139.69 121.97 15.95 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 118.094 0.407 . . . . 0.0 110.531 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.523 ' HB2' HG12 ' A' ' 228' ' ' ILE . 45.7 tp -103.79 135.98 44.32 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 176.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -134.22 134.93 42.58 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -177.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 293' ' ' ARG . . . . . 0.571 ' HD3' ' HB ' ' A' ' 271' ' ' THR . 17.4 ptt180 -73.54 138.06 44.76 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 173.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.561 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 22.6 tp -115.29 -175.47 2.71 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.561 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 16.2 m120 -35.98 -75.94 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.944 1.698 . . . . 0.0 112.543 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -125.4 -1.27 7.55 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 174.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 297' ' ' ASP . . . . . 0.43 ' OD1' ' HD3' ' A' ' 265' ' ' LYS . 11.5 m-20 -108.49 171.79 7.21 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.594 -171.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.55 ' O ' ' HA ' ' A' ' 263' ' ' THR . 91.8 m -114.35 129.07 56.63 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 176.011 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 299' ' ' GLN . . . . . 0.544 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 36.3 tt0 -114.05 127.27 55.86 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -176.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.476 HD13 HG21 ' A' ' 228' ' ' ILE . 70.1 tp -114.94 123.08 48.21 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.503 178.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 301' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 260' ' ' ILE . 62.5 mt -111.24 118.9 58.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-O 121.429 0.633 . . . . 0.0 109.487 -177.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 302' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 65.7 mt -114.87 108.83 26.43 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.533 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 14.6 m -82.59 131.66 35.21 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -176.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 6.9 p -126.67 164.82 20.44 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -174.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -145.98 134.65 22.24 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 123.534 0.734 . . . . 0.0 109.894 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 88.74 -166.8 34.45 Favored Glycine 0 C--O 1.252 1.263 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.237 176.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 307' ' ' ASN . . . . . 0.405 ' HB3' ' HB3' ' A' ' 327' ' ' LYS . 69.5 m-20 -86.27 126.18 34.12 Favored 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 308' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -144.54 165.43 28.02 Favored 'General case' 0 C--N 1.286 -2.152 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.553 -175.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 309' ' ' GLU . . . . . 0.441 ' HG2' ' HE2' ' A' ' 327' ' ' LYS . 15.2 mt-10 -125.39 145.36 50.08 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.88 122.7 48.51 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -178.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 21.7 t -122.07 106.23 17.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 169.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -100.39 113.02 25.43 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.789 0.804 . . . . 0.0 110.277 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -106.91 150.99 25.85 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.906 -174.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 36.0 t -115.53 102.91 10.22 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 175.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -69.17 -30.96 69.29 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.525 0.679 . . . . 0.0 110.063 -176.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -167.16 159.85 10.73 Favored Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -64.22 95.26 0.21 Allowed 'Trans proline' 0 C--O 1.247 0.953 0 C-N-CA 121.724 1.616 . . . . 0.0 110.858 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 135.38 -33.87 2.37 Favored Glycine 0 N--CA 1.427 -1.963 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.307 -177.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -100.44 117.09 33.89 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 122.188 -0.596 . . . . 0.0 110.171 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -117.14 160.59 20.79 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 121.751 0.786 . . . . 0.0 110.04 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 89.6 m -151.77 124.09 8.26 Favored 'General case' 0 C--N 1.268 -2.941 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.713 -176.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -109.82 109.49 20.17 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 323' ' ' GLN . . . . . 0.402 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 60.8 tt0 -97.62 107.84 20.42 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 309' ' ' GLU . 83.9 t -97.6 99.02 8.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.623 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -88.02 154.93 52.61 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -81.51 142.83 13.28 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 121.44 1.427 . . . . 0.0 109.343 171.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.441 ' HE2' ' HG2' ' A' ' 309' ' ' GLU . 37.3 ttmt . . . . . 0 C--N 1.303 -1.434 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -177.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 . . . . . 0 N--CA 1.421 -1.896 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.698 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 52.5 m -63.47 112.61 2.84 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.679 0.752 . . . . 0.0 113.026 -174.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -145.49 165.69 27.86 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.85 -175.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.616 HD13 HD21 ' A' ' 277' ' ' LEU . 1.6 pp -115.5 161.97 13.87 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.076 178.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 229' ' ' ASP . . . . . 0.52 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 7.1 t70 -151.26 155.91 39.75 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.404 ' HZ ' HG21 ' A' ' 284' ' ' THR . 75.4 t80 -132.87 135.57 45.68 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 173.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -149.45 168.84 22.33 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 174.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.526 ' HE3' HG22 ' A' ' 284' ' ' THR . 55.6 mtpt -117.19 139.91 50.19 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 174.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -149.0 117.78 6.64 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -175.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 99.55 -119.33 6.47 Favored Glycine 0 N--CA 1.428 -1.868 0 C-N-CA 120.608 -0.805 . . . . 0.0 113.127 177.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -113.34 85.35 2.17 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 122.88 -0.188 . . . . 0.0 110.833 -175.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' ASN . . . . . 0.564 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 5.9 m-20 56.2 21.8 5.57 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 124.705 1.202 . . . . 0.0 113.258 177.124 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.52 ' HB2' HD23 ' A' ' 325' ' ' LEU . . . -79.58 142.37 35.74 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.019 -176.117 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 238' ' ' GLY . . . . . 0.501 ' HA3' ' CG1' ' A' ' 286' ' ' VAL . . . -92.48 115.99 4.97 Favored Glycine 0 N--CA 1.418 -2.504 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 176.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.6 mp -110.0 109.7 29.39 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-N 118.065 0.932 . . . . 0.0 110.267 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.0 mp -98.96 109.61 24.54 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 N-CA-C 107.427 -1.324 . . . . 0.0 107.427 178.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.52 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 44.7 mt-10 -90.78 138.43 31.59 Favored 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 176.122 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 12.3 tp -128.47 131.48 48.36 Favored 'General case' 0 C--N 1.267 -3.022 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.561 -173.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 243' ' ' ALA . . . . . 0.698 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -116.41 106.25 13.41 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 244' ' ' ALA . . . . . 0.432 ' HA ' HG23 ' A' ' 226' ' ' THR . . . -118.19 90.91 3.43 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.093 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -83.25 113.87 20.98 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.538 0.685 . . . . 0.0 110.864 -174.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 122.99 -5.14 9.66 Favored Glycine 0 N--CA 1.428 -1.873 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.13 -175.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -115.99 113.09 22.76 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 176.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -114.96 16.77 17.13 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 120.852 0.358 . . . . 0.0 111.437 -175.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -116.68 -162.84 13.01 Favored Glycine 0 C--N 1.302 -1.352 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -101.28 132.51 21.79 Favored Pre-proline 0 C--N 1.301 -1.501 0 CA-C-N 117.798 0.799 . . . . 0.0 110.724 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.735 ' HB3' HD23 ' A' ' 264' ' ' LEU . 9.5 Cg_endo -71.73 172.52 14.27 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.429 2.086 . . . . 0.0 112.443 176.283 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 30.2 t70 -97.07 105.47 17.62 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.378 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.446 HD11 ' HG2' ' A' ' 251' ' ' PRO . 4.7 mp -104.86 118.09 51.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.566 -178.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 254' ' ' SER . . . . . 0.488 ' HB3' ' HB ' ' A' ' 261' ' ' ILE . 22.9 t -101.0 123.23 44.87 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 175.062 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -107.93 95.61 5.8 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -176.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -103.35 164.39 11.67 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -60.93 -48.16 83.07 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 117.851 0.296 . . . . 0.0 111.344 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -76.08 -33.17 59.53 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.255 -173.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 259' ' ' HIS . . . . . 0.421 ' CB ' ' HA ' ' A' ' 303' ' ' THR . 41.8 p-80 -164.64 166.47 20.1 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 119.908 -0.717 . . . . 0.0 112.677 176.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.467 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 18.6 mt -106.41 144.71 15.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 261' ' ' ILE . . . . . 0.488 ' HB ' ' HB3' ' A' ' 254' ' ' SER . 3.3 mp -128.94 114.13 31.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 299' ' ' GLN . 1.3 m -107.6 132.74 54.38 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.527 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 175.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 263' ' ' THR . . . . . 0.414 ' HB ' ' HB3' ' A' ' 252' ' ' ASP . 19.5 m -120.83 120.97 37.1 Favored 'General case' 0 C--N 1.281 -2.396 0 CA-C-O 121.211 0.529 . . . . 0.0 109.718 177.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.735 HD23 ' HB3' ' A' ' 251' ' ' PRO . 24.0 mt -100.91 94.74 6.18 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 179.189 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -57.8 126.57 27.97 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -175.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 4.5 t30 63.78 19.24 11.63 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 113.263 -1.789 . . . . 0.0 111.283 176.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 53.5 t60 -98.56 117.73 33.66 Favored 'General case' 0 C--O 1.21 -1.006 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 5.4 p -92.7 118.62 31.25 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -176.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 269' ' ' LEU . . . . . 0.513 HD12 ' HD2' ' A' ' 270' ' ' PRO . 21.5 tp -99.5 129.91 28.0 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.093 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.513 ' HD2' HD12 ' A' ' 269' ' ' LEU . 71.9 Cg_endo -75.96 160.0 37.38 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.28 1.987 . . . . 0.0 111.971 176.106 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 19.6 p -62.66 -41.24 98.97 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 123.548 0.739 . . . . 0.0 112.485 -174.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 32.2 m -63.15 -23.35 67.39 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 124.573 1.149 . . . . 0.0 113.094 -176.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.558 HD13 ' O ' ' A' ' 226' ' ' THR . 95.4 mt -95.96 -10.11 29.48 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.583 -174.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -74.3 133.39 42.58 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 175.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 275' ' ' ARG . . . . . 0.484 ' CG ' HD11 ' A' ' 228' ' ' ILE . 5.4 ptp180 -171.58 172.5 5.0 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 177.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 11.8 p -130.39 148.45 52.21 Favored 'General case' 0 N--CA 1.402 -2.845 0 CA-C-O 121.293 0.568 . . . . 0.0 111.008 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.616 HD21 HD13 ' A' ' 228' ' ' ILE . 1.3 mm? -95.79 117.31 30.31 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 103.058 -2.942 . . . . 0.0 103.058 174.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -63.54 -38.85 92.7 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 279' ' ' VAL . . . . . 0.479 ' HA ' ' CD1' ' A' ' 282' ' ' PHE 0.259 12.2 p 40.61 34.91 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.336 0 C-N-CA 127.139 2.176 . . . . 0.0 114.1 174.823 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -85.26 140.47 30.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 115.069 -0.968 . . . . 0.0 108.776 177.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 32.9 t70 72.52 7.65 5.62 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.285 1.034 . . . . 0.0 111.354 178.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.479 ' CD1' ' HA ' ' A' ' 279' ' ' VAL . 11.2 m-85 -73.22 -19.58 61.05 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.198 174.121 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm 61.85 60.7 1.52 Allowed 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 124.259 1.024 . . . . 0.0 112.032 174.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 284' ' ' THR . . . . . 0.526 HG22 ' HE3' ' A' ' 232' ' ' LYS . 4.9 p -128.26 178.25 1.73 Allowed Pre-proline 0 C--N 1.288 -2.108 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 285' ' ' PRO . . . . . 0.564 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 7.8 Cg_exo -75.36 -10.08 20.51 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 CA-C-N 121.172 1.454 . . . . 0.0 110.714 174.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 286' ' ' VAL . . . . . 0.501 ' CG1' ' HA3' ' A' ' 238' ' ' GLY . 0.8 OUTLIER -90.54 140.84 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.425 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 179.03 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -99.19 -51.02 3.95 Favored 'General case' 0 C--N 1.279 -2.459 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.425 -177.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 288' ' ' LYS . . . . . 0.45 ' HA ' ' CG1' ' A' ' 279' ' ' VAL . 86.8 tttt -155.45 135.49 12.94 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.454 ' HB ' HD23 ' A' ' 277' ' ' LEU . 42.9 t -102.44 126.18 56.59 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.927 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 60.8 m -132.49 125.72 31.3 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 121.001 0.429 . . . . 0.0 111.236 -177.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.423 ' HB2' HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -99.78 124.78 45.39 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 178.54 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -128.78 138.12 51.91 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.053 0.454 . . . . 0.0 110.112 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -80.82 144.72 31.85 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 174.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.507 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 32.4 tp -122.93 -179.76 4.37 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.507 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 88.2 m-20 -31.43 -71.92 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 126.514 1.926 . . . . 0.0 112.874 -178.124 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -126.26 -1.63 6.98 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 173.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -110.87 172.8 6.66 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 114.166 -1.379 . . . . 0.0 109.445 -169.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.498 ' HB ' HD12 ' A' ' 264' ' ' LEU . 88.8 m -116.71 134.97 54.16 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 174.478 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 299' ' ' GLN . . . . . 0.571 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 27.5 tt0 -122.17 125.29 45.8 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 120.975 0.416 . . . . 0.0 109.926 -175.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.467 ' HB3' HG13 ' A' ' 262' ' ' VAL . 62.5 tp -108.42 120.52 42.65 Favored 'General case' 0 C--N 1.284 -2.267 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.083 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 72.2 mt -106.95 114.8 46.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.795 -175.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 302' ' ' ILE . . . . . 0.467 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 52.0 mt -116.51 105.51 18.48 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.326 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 178.094 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 303' ' ' THR . . . . . 0.421 ' HA ' ' CB ' ' A' ' 259' ' ' HIS . 18.2 m -73.67 138.19 44.58 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -178.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 10.3 p -137.06 177.86 7.53 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 122.803 0.441 . . . . 0.0 111.691 -174.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -156.81 143.33 18.33 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 122.418 0.287 . . . . 0.0 111.168 178.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 77.72 -152.27 38.78 Favored Glycine 0 C--O 1.247 0.951 0 O-C-N 123.523 0.515 . . . . 0.0 113.819 173.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -93.22 129.01 39.41 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 177.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 308' ' ' TRP . . . . . 0.562 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 69.2 p-90 -157.56 160.29 38.01 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -177.218 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 309' ' ' GLU . . . . . 0.461 ' HG2' ' HE2' ' A' ' 327' ' ' LYS . 6.7 mt-10 -119.67 130.88 55.26 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -176.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.562 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 1.6 tm? -97.76 136.53 37.96 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 57.3 t -135.42 111.79 13.27 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -101.16 131.52 47.08 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -130.65 143.78 50.98 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -178.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 13.8 m -111.23 116.38 30.95 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -80.35 -40.84 25.87 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.798 -176.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 316' ' ' ALA . . . . . 0.428 ' HB1' ' HD2' ' A' ' 317' ' ' PRO . . . -159.75 165.86 17.15 Favored Pre-proline 0 C--N 1.301 -1.517 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 -177.09 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 317' ' ' PRO . . . . . 0.428 ' HD2' ' HB1' ' A' ' 316' ' ' ALA . 29.7 Cg_endo -62.14 102.47 0.27 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 121.679 1.586 . . . . 0.0 111.018 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 116.39 -27.15 8.21 Favored Glycine 0 N--CA 1.426 -1.974 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.648 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -98.11 116.57 30.6 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.922 -0.752 . . . . 0.0 110.762 -178.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -118.63 166.68 12.44 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.474 -177.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 59.6 m -152.0 131.18 12.74 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.387 -176.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -118.56 114.14 22.36 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 176.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 323' ' ' GLN . . . . . 0.529 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 50.2 tt0 -101.18 102.94 13.95 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -98.11 101.97 12.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 CA-C-O 122.46 1.124 . . . . 0.0 109.736 177.204 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.52 HD23 ' HB2' ' A' ' 237' ' ' ALA . 28.0 mt -91.05 145.55 31.89 Favored Pre-proline 0 C--N 1.302 -1.473 0 CA-C-N 113.479 -1.692 . . . . 0.0 109.922 -175.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -72.6 144.4 39.88 Favored 'Trans proline' 0 C--O 1.245 0.856 0 C-N-CA 121.648 1.565 . . . . 0.0 109.442 174.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.461 ' HE2' ' HG2' ' A' ' 309' ' ' GLU . 36.3 ttmt . . . . . 0 C--N 1.307 -1.276 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' GLN . . . . . 0.446 ' O ' HD23 ' A' ' 245' ' ' LEU . 5.7 tp-100 . . . . . 0 N--CA 1.421 -1.89 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.646 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 28.3 m -74.1 123.86 25.22 Favored 'General case' 0 C--O 1.202 -1.41 0 C-N-CA 124.495 1.118 . . . . 0.0 113.696 -169.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -143.69 169.05 18.49 Favored 'General case' 0 CA--C 1.474 -1.976 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -175.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.64 HG12 ' HB2' ' A' ' 291' ' ' LEU . 2.8 pp -135.54 160.15 39.95 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 175.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 229' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 240' ' ' ILE . 24.0 t70 -148.3 156.49 42.6 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -173.448 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.422 ' CE2' HG21 ' A' ' 279' ' ' VAL . 76.7 t80 -125.82 139.06 53.81 Favored 'General case' 0 N--CA 1.427 -1.598 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.016 173.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -155.14 164.16 39.22 Favored 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 124.803 1.241 . . . . 0.0 108.076 177.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -115.94 144.74 43.64 Favored 'General case' 0 CA--C 1.486 -1.516 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 177.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 237' ' ' ALA . 32.7 t70 -149.71 124.83 10.05 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 123.716 0.635 . . . . 0.0 110.632 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 81.44 -133.12 11.75 Favored Glycine 0 C--N 1.3 -1.436 0 C-N-CA 120.966 -0.635 . . . . 0.0 114.258 175.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -86.34 76.2 9.7 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 122.843 0.457 . . . . 0.0 111.502 -171.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 58.22 20.04 6.76 Favored 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 124.128 0.971 . . . . 0.0 112.445 177.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.525 ' HB3' ' O ' ' A' ' 233' ' ' ASP . . . -78.58 140.43 38.48 Favored 'General case' 0 N--CA 1.421 -1.899 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.982 -175.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 238' ' ' GLY . . . . . 0.473 ' C ' HD12 ' A' ' 239' ' ' ILE . . . -95.81 131.35 10.63 Favored Glycine 0 N--CA 1.416 -2.634 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 177.521 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 239' ' ' ILE . . . . . 0.473 HD12 ' C ' ' A' ' 238' ' ' GLY . 2.3 mp -120.52 115.74 47.98 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 CA-C-N 117.907 0.854 . . . . 0.0 110.403 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 240' ' ' ILE . . . . . 0.474 ' HB ' ' HB2' ' A' ' 322' ' ' PHE . 3.2 mp -100.1 106.92 19.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 176.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 241' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 30.9 mt-10 -86.88 141.72 28.56 Favored 'General case' 0 N--CA 1.417 -2.116 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.667 175.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 10.3 tp -128.78 125.34 37.62 Favored 'General case' 0 C--N 1.26 -3.308 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.208 -175.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 243' ' ' ALA . . . . . 0.646 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -112.46 97.61 6.72 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -107.15 91.56 3.71 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.62 0.724 . . . . 0.0 109.685 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 225' ' ' GLN . 3.0 mm? -80.58 115.48 20.11 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.377 -176.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 110.87 2.63 28.56 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.5 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -115.94 140.85 48.84 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -138.91 15.39 2.67 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 120.676 -0.409 . . . . 0.0 111.66 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -117.21 -163.18 12.91 Favored Glycine 0 CA--C 1.495 -1.207 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -105.64 133.11 20.35 Favored Pre-proline 0 C--N 1.3 -1.577 0 CA-C-N 117.538 0.669 . . . . 0.0 110.022 -177.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.734 ' HB3' HD23 ' A' ' 264' ' ' LEU . 25.6 Cg_endo -73.69 169.21 22.88 Favored 'Trans proline' 0 CA--C 1.506 -0.903 0 C-N-CA 122.322 2.015 . . . . 0.0 112.79 177.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.62 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 27.9 t70 -82.1 104.89 12.76 Favored 'General case' 0 CA--C 1.472 -2.023 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 174.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 253' ' ' ILE . . . . . 0.478 ' CG2' HE21 ' A' ' 255' ' ' GLN . 7.1 mt -102.89 116.65 47.01 Favored 'Isoleucine or valine' 0 C--N 1.245 -3.966 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 7.8 t -125.51 129.7 50.28 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 255' ' ' GLN . . . . . 0.666 HE22 HG23 ' A' ' 260' ' ' ILE . 70.4 mm-40 -110.36 131.73 54.8 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -175.418 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.521 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 28.3 mm-40 -119.74 163.48 17.38 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 171.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -73.19 -35.89 66.44 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -88.19 -17.14 31.53 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.674 -173.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 259' ' ' HIS . . . . . 0.521 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 51.2 p-80 -171.94 162.41 5.97 Favored 'General case' 0 C--O 1.213 -0.841 0 O-C-N 122.093 -0.379 . . . . 0.0 111.74 178.177 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.666 HG23 HE22 ' A' ' 255' ' ' GLN . 17.5 mt -107.52 144.72 15.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 261' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 300' ' ' LEU . 3.5 mp -124.79 125.86 70.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 176.143 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 252' ' ' ASP . 0.8 OUTLIER -122.16 139.8 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.717 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 172.686 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 263' ' ' THR . . . . . 0.48 ' HB ' ' HB3' ' A' ' 252' ' ' ASP . 24.7 m -131.05 123.54 28.92 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 118.527 0.603 . . . . 0.0 110.654 177.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.734 HD23 ' HB3' ' A' ' 251' ' ' PRO . 25.5 mt -100.54 96.48 7.41 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.318 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 24.1 mmtm -57.79 125.57 23.59 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -176.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 2.4 t30 62.6 26.87 15.92 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 126.064 1.746 . . . . 0.0 110.894 177.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -103.61 106.33 16.81 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 7.8 p -79.7 130.79 35.65 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.157 0.503 . . . . 0.0 112.226 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 269' ' ' LEU . . . . . 0.594 HD12 ' HD2' ' A' ' 270' ' ' PRO . 30.3 tp -116.92 136.28 23.23 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.115 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.594 ' HD2' HD12 ' A' ' 269' ' ' LEU . 84.5 Cg_endo -78.71 158.29 28.15 Favored 'Trans proline' 0 N--CA 1.438 -1.76 0 C-N-CA 121.204 1.269 . . . . 0.0 110.391 173.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 271' ' ' THR . . . . . 0.476 ' HA ' HE21 ' A' ' 274' ' ' GLN . 5.9 p -64.5 -29.02 70.06 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.476 0.655 . . . . 0.0 111.298 -177.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 7.1 m -61.84 -29.36 70.12 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 125.393 1.477 . . . . 0.0 112.255 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.546 HD13 ' HG2' ' A' ' 270' ' ' PRO . 10.4 mp -101.37 0.08 36.41 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.381 0.61 . . . . 0.0 111.913 -172.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 274' ' ' GLN . . . . . 0.476 HE21 ' HA ' ' A' ' 271' ' ' THR . 41.3 mt-30 -75.72 142.32 42.46 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 174.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -164.52 171.05 15.07 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -177.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 23.2 m -140.99 133.36 28.29 Favored 'General case' 0 N--CA 1.418 -2.052 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 176.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.516 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 1.5 mm? -100.14 111.26 23.55 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.4 79.61 9.4 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-O 123.501 1.619 . . . . 0.0 109.518 175.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 279' ' ' VAL . . . . . 0.422 HG21 ' CE2' ' A' ' 230' ' ' PHE 0.25 1.9 p -86.29 63.69 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.403 -2.815 0 CA-C-N 111.558 -2.565 . . . . 0.0 111.41 -175.555 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -105.97 144.93 32.0 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 113.07 -1.877 . . . . 0.0 106.911 177.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 31.7 t70 68.0 19.45 9.35 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 123.157 1.456 . . . . 0.0 110.538 -178.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 282' ' ' PHE . . . . . 0.405 ' CG ' HG23 ' A' ' 279' ' ' VAL . 41.1 m-85 -91.88 -13.1 31.84 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.101 173.005 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? 56.76 61.88 2.47 Favored 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 123.586 0.754 . . . . 0.0 112.569 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 1.5 p -136.24 170.62 10.48 Favored Pre-proline 0 N--CA 1.433 -1.32 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 178.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.46 -10.35 17.4 Favored 'Trans proline' 0 C--O 1.241 0.652 0 C-N-CA 122.018 1.812 . . . . 0.0 111.802 177.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.6 p -99.15 121.53 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.016 0 CA-C-O 121.991 0.9 . . . . 0.0 111.071 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -87.92 -41.57 13.08 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.199 -1.364 . . . . 0.0 112.522 -170.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -155.54 132.6 10.76 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -177.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 39.1 t -96.78 129.89 46.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 172.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 57.1 m -136.38 128.16 29.11 Favored 'General case' 0 C--N 1.293 -1.89 0 O-C-N 121.822 -0.549 . . . . 0.0 111.037 -178.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.64 ' HB2' HG12 ' A' ' 228' ' ' ILE . 53.5 tp -109.92 123.91 50.45 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -131.05 130.88 43.81 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 293' ' ' ARG . . . . . 0.466 ' HB3' HD23 ' A' ' 269' ' ' LEU . 17.7 ptt180 -79.51 137.18 37.1 Favored 'General case' 0 N--CA 1.415 -2.198 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.535 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 16.1 tp -99.96 -177.35 3.52 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.535 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 6.9 t30 -45.22 -66.26 0.42 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.217 1.007 . . . . 0.0 112.078 -177.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -118.67 -3.54 10.82 Favored 'General case' 0 CA--C 1.498 -1.02 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.062 174.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -110.22 173.17 6.45 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.308 -170.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.515 ' HB ' HD12 ' A' ' 264' ' ' LEU . 86.5 m -115.19 131.96 56.76 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 174.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 299' ' ' GLN . . . . . 0.577 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 20.4 tt0 -124.84 130.82 53.13 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.172 -174.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.581 HD11 HG21 ' A' ' 228' ' ' ILE . 1.2 mm? -94.71 142.27 27.65 Favored 'General case' 0 CA--C 1.467 -2.212 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.01 172.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 50.7 mt -129.01 108.51 17.19 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.568 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 172.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 302' ' ' ILE . . . . . 0.576 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 58.7 mt -114.14 103.38 15.27 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.813 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -177.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 5.5 m -75.79 129.93 37.81 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -174.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 15.4 p -128.38 172.18 11.34 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 122.587 0.355 . . . . 0.0 110.817 -177.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -156.22 137.53 13.86 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 90.69 -169.65 34.25 Favored Glycine 0 N--CA 1.436 -1.344 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -87.33 129.78 34.88 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 177.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 308' ' ' TRP . . . . . 0.704 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 57.4 p-90 -147.24 163.87 35.0 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.476 -174.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -125.63 142.64 51.41 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -178.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 310' ' ' LEU . . . . . 0.704 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 19.1 tp -116.87 139.35 50.73 Favored 'General case' 0 C--O 1.249 1.045 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.952 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 89.8 t -134.68 108.96 11.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 174.369 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 312' ' ' ASN . . . . . 0.584 ' HA ' ' O ' ' A' ' 321' ' ' THR . 19.7 t30 -98.45 129.28 45.06 Favored 'General case' 0 CA--C 1.454 -2.749 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.006 177.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -119.93 121.42 38.95 Favored 'General case' 0 N--CA 1.384 -3.763 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.932 -178.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 22.1 t -84.75 105.81 15.82 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 174.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -73.69 -36.93 65.34 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.717 0.77 . . . . 0.0 110.481 -176.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -156.32 162.5 27.37 Favored Pre-proline 0 C--N 1.295 -1.802 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 -177.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.39 96.19 0.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 121.505 1.47 . . . . 0.0 111.56 -178.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 125.72 -24.93 5.7 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -100.08 116.22 31.59 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 122.244 -0.562 . . . . 0.0 109.638 -179.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -116.45 164.97 13.77 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.811 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 321' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 312' ' ' ASN . 90.8 m -152.68 108.9 3.38 Favored 'General case' 0 C--N 1.275 -2.665 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.455 -173.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 322' ' ' PHE . . . . . 0.49 ' HB3' HD11 ' A' ' 310' ' ' LEU . 81.2 m-85 -97.03 108.18 20.86 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.227 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 323' ' ' GLN . . . . . 0.557 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 37.0 tt0 -96.25 108.04 20.47 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -179.041 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.517 HG23 ' CE3' ' A' ' 308' ' ' TRP . 0.4 OUTLIER -101.86 105.25 17.63 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 CA-C-O 121.3 0.572 . . . . 0.0 110.951 179.385 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.93 157.57 36.44 Favored Pre-proline 0 N--CA 1.466 0.346 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.57 131.81 8.56 Favored 'Trans proline' 0 C--O 1.246 0.925 0 C-N-CA 121.988 1.792 . . . . 0.0 110.133 172.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 327' ' ' LYS . . . . . 0.485 ' HE3' ' O ' ' A' ' 308' ' ' TRP . 41.0 ttmt . . . . . 0 C--N 1.303 -1.447 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.587 -175.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 225' ' ' GLN . . . . . 0.446 ' C ' HD23 ' A' ' 245' ' ' LEU . 5.6 tp60 . . . . . 0 CA--C 1.555 1.159 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' THR . . . . . 0.701 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 7.0 m -59.11 114.89 2.82 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -168.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -142.44 168.45 19.7 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.343 -177.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' ILE . . . . . 0.617 HG12 ' HB2' ' A' ' 291' ' ' LEU . 2.2 pp -128.13 163.09 32.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.766 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -151.41 157.33 42.25 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.429 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 230' ' ' PHE . . . . . 0.55 ' CD2' HG11 ' A' ' 279' ' ' VAL . 87.7 t80 -129.7 135.47 48.53 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.31 177.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 -154.7 155.58 34.85 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 124.095 0.958 . . . . 0.0 108.993 177.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' LYS . . . . . 0.409 ' HE3' HG22 ' A' ' 284' ' ' THR . 53.5 mtpt -105.27 157.74 17.09 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 175.176 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -155.72 153.06 29.35 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 72.8 -114.31 4.77 Favored Glycine 0 N--CA 1.437 -1.28 0 C-N-CA 121.189 -0.529 . . . . 0.0 111.785 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -134.53 93.91 3.12 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 120.539 0.209 . . . . 0.0 110.869 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' ASN . . . . . 0.435 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 93.4 m-20 66.93 17.6 10.54 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 174.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -82.15 140.4 33.79 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -99.31 113.49 4.74 Favored Glycine 0 N--CA 1.432 -1.604 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.3 mp -105.13 111.53 34.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 121.618 0.723 . . . . 0.0 110.263 -178.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.6 mp -97.93 112.66 30.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 174.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -89.3 143.77 26.59 Favored 'General case' 0 N--CA 1.408 -2.548 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 176.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 12.2 tp -133.14 130.39 39.15 Favored 'General case' 0 C--N 1.263 -3.175 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.099 -176.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 243' ' ' ALA . . . . . 0.701 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -116.86 102.24 9.22 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 176.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -109.43 91.15 3.53 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' LEU . . . . . 0.446 HD23 ' C ' ' A' ' 225' ' ' GLN . 2.7 mm? -77.68 113.18 15.27 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.547 -175.012 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 114.79 -10.85 21.06 Favored Glycine 0 C--N 1.298 -1.531 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.319 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -100.73 124.31 46.17 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -178.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -103.82 -29.64 10.88 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -175.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -85.89 -161.51 35.18 Favored Glycine 0 CA--C 1.503 -0.68 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -103.48 143.02 25.79 Favored Pre-proline 0 C--N 1.303 -1.43 0 CA-C-N 117.847 0.824 . . . . 0.0 110.688 176.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.79 ' HB3' HD13 ' A' ' 264' ' ' LEU . 10.7 Cg_endo -64.6 172.03 7.4 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.108 2.539 . . . . 0.0 111.267 175.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -89.93 119.65 30.48 Favored 'General case' 0 C--N 1.274 -2.681 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 2.7 mp -102.46 127.65 55.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-O 121.57 0.7 . . . . 0.0 111.385 178.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 254' ' ' SER . . . . . 0.72 ' HB2' ' HB ' ' A' ' 261' ' ' ILE . 73.6 m -115.73 115.48 26.41 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 125.297 1.439 . . . . 0.0 108.217 175.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -101.15 113.85 27.26 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -175.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 256' ' ' GLN . . . . . 0.62 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 14.5 mm100 -116.92 166.03 12.64 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 174.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -77.07 -41.99 40.07 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.488 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -84.04 -14.75 49.79 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -174.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 259' ' ' HIS . . . . . 0.62 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 49.8 p-80 -171.77 162.31 6.17 Favored 'General case' 0 C--O 1.21 -0.995 0 CA-C-O 120.628 0.251 . . . . 0.0 111.041 175.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 260' ' ' ILE . . . . . 0.419 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 19.5 mt -106.9 145.2 14.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 177.602 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 261' ' ' ILE . . . . . 0.72 ' HB ' ' HB2' ' A' ' 254' ' ' SER . 3.6 mp -122.11 123.4 68.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 175.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.504 ' HB ' ' HB2' ' A' ' 300' ' ' LEU . 37.8 t -124.7 128.19 73.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 263' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 298' ' ' THR . 7.6 m -124.27 124.04 41.55 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-O 121.538 0.685 . . . . 0.0 111.503 -177.127 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.79 HD13 ' HB3' ' A' ' 251' ' ' PRO . 1.9 mm? -95.32 103.13 14.98 Favored 'General case' 0 CA--C 1.47 -2.119 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 173.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 265' ' ' LYS . . . . . 0.464 ' HA ' ' OD2' ' A' ' 297' ' ' ASP . 17.3 ttmm -76.38 137.95 40.11 Favored 'General case' 0 N--CA 1.383 -3.788 0 O-C-N 123.72 0.638 . . . . 0.0 110.779 -177.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 8.7 t30 70.44 27.71 3.87 Favored 'General case' 0 CA--C 1.548 0.881 0 O-C-N 124.864 1.352 . . . . 0.0 109.957 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 36.1 t60 -124.27 108.02 11.8 Favored 'General case' 0 C--O 1.206 -1.185 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -178.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 7.2 p -90.48 114.66 26.88 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -176.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 269' ' ' LEU . . . . . 0.492 HD12 ' HD2' ' A' ' 270' ' ' PRO . 19.7 tp -93.3 133.19 28.87 Favored Pre-proline 0 C--N 1.318 -0.8 0 C-N-CA 123.077 0.551 . . . . 0.0 110.468 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 270' ' ' PRO . . . . . 0.492 ' HD2' HD12 ' A' ' 269' ' ' LEU . 80.9 Cg_endo -78.98 157.03 26.94 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.218 1.945 . . . . 0.0 112.117 173.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 23.6 p -62.36 -35.04 77.89 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -177.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 13.7 m -65.85 -18.3 65.24 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 123.707 0.803 . . . . 0.0 111.709 -176.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 273' ' ' LEU . . . . . 0.426 HD13 ' O ' ' A' ' 226' ' ' THR . 95.0 mt -105.21 -13.91 15.54 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.446 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -83.78 114.38 21.58 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 275' ' ' ARG . . . . . 0.405 ' CG ' HD11 ' A' ' 228' ' ' ILE . 6.1 ptp180 -144.94 175.96 9.83 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -174.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 48.9 m -134.4 138.55 44.92 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-O 121.275 0.559 . . . . 0.0 110.177 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.533 ' O ' ' HG3' ' A' ' 288' ' ' LYS . 2.0 mm? -91.96 150.38 21.04 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 174.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -86.49 -60.69 1.92 Allowed 'General case' 0 C--N 1.274 -2.693 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 279' ' ' VAL . . . . . 0.55 HG11 ' CD2' ' A' ' 230' ' ' PHE 0.342 30.8 m 49.41 19.32 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 174.016 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -74.19 140.2 44.95 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 173.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 28.8 t70 73.77 16.92 3.71 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.935 1.294 . . . . 0.0 111.402 -178.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -80.61 -11.86 59.58 Favored 'General case' 0 CA--C 1.514 -0.414 0 O-C-N 121.351 -0.843 . . . . 0.0 111.016 173.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 60.98 61.26 1.66 Allowed 'General case' 0 CA--C 1.497 -1.062 0 C-N-CA 123.336 0.654 . . . . 0.0 111.361 -178.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 284' ' ' THR . . . . . 0.409 HG22 ' HE3' ' A' ' 232' ' ' LYS . 1.6 p -137.6 168.06 17.97 Favored Pre-proline 0 C--N 1.292 -1.911 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 177.431 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 285' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 18.4 Cg_exo -69.46 -23.35 32.27 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 121.467 1.445 . . . . 0.0 110.822 176.37 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.0 p -85.31 122.31 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 CA-C-O 122.254 1.026 . . . . 0.0 110.401 179.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -89.23 -37.93 14.61 Favored 'General case' 0 C--N 1.284 -2.252 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.465 -174.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 288' ' ' LYS . . . . . 0.533 ' HG3' ' O ' ' A' ' 277' ' ' LEU . 56.3 tttp -159.47 137.6 10.36 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.67 -178.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.416 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 42.8 t -103.47 128.86 56.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 290' ' ' THR . . . . . 0.46 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 90.6 m -135.14 121.26 20.04 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 120.743 0.306 . . . . 0.0 110.591 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 291' ' ' LEU . . . . . 0.617 ' HB2' HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -101.08 122.96 44.49 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 177.537 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -119.56 135.26 54.87 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -176.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -83.58 142.59 30.73 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 174.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 294' ' ' LEU . . . . . 0.436 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 12.9 tp -120.13 -174.17 2.72 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 176.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 295' ' ' ASN . . . . . 0.436 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 20.2 t-20 -72.35 -51.55 20.09 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 118.908 0.776 . . . . 0.0 111.565 -172.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -115.55 -3.94 12.3 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.611 -177.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 297' ' ' ASP . . . . . 0.464 ' OD2' ' HA ' ' A' ' 265' ' ' LYS . 3.7 m-20 -133.13 169.3 17.06 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.58 0.705 . . . . 0.0 110.671 -170.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 298' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 263' ' ' THR . 62.6 m -113.37 126.74 55.69 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 172.191 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -119.71 122.57 41.75 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-O 121.441 0.639 . . . . 0.0 110.099 -173.445 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.504 ' HB2' ' HB ' ' A' ' 262' ' ' VAL . 0.1 OUTLIER -97.63 135.87 38.82 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.149 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 301' ' ' ILE . . . . . 0.46 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 48.7 mt -124.83 109.73 23.1 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.433 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 302' ' ' ILE . . . . . 0.419 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 68.5 mt -114.65 101.24 12.11 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -178.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 21.0 m -68.91 134.14 49.17 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -177.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 10.6 p -136.98 167.32 21.72 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -177.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -148.87 151.16 34.21 Favored 'General case' 0 C--O 1.251 1.173 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.321 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 76.71 -157.18 47.13 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.087 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -99.98 141.99 32.06 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 176.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 308' ' ' TRP . . . . . 0.406 ' CE3' HG13 ' A' ' 324' ' ' VAL . 68.6 p-90 -154.84 167.58 29.79 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.756 -176.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -122.57 135.59 54.67 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 1.3 tt -104.69 113.99 27.92 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.715 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 311' ' ' VAL . . . . . 0.577 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 98.4 t -108.08 107.3 22.46 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 172.423 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.07 121.15 39.65 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.781 0.8 . . . . 0.0 110.429 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -122.91 148.62 45.23 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.777 -175.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 32.6 t -115.63 116.63 28.44 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 170.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -77.92 -34.83 51.14 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 122.152 0.977 . . . . 0.0 109.036 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -161.43 155.31 18.65 Favored Pre-proline 0 C--N 1.29 -2.016 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -60.73 94.93 0.11 Allowed 'Trans proline' 0 C--O 1.244 0.804 0 C-N-CA 122.239 1.96 . . . . 0.0 112.339 -176.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 136.16 -25.7 3.16 Favored Glycine 0 N--CA 1.433 -1.528 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.24 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -107.32 116.32 31.72 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -116.28 164.61 14.25 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-O 122.138 0.97 . . . . 0.0 111.037 -175.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 39.6 m -151.49 125.45 9.17 Favored 'General case' 0 C--N 1.269 -2.902 0 CA-C-N 114.394 -1.275 . . . . 0.0 108.893 -177.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -109.69 105.07 14.19 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 175.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 323' ' ' GLN . . . . . 0.577 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 41.4 tt0 -94.17 103.11 15.16 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -178.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 324' ' ' VAL . . . . . 0.406 HG13 ' CE3' ' A' ' 308' ' ' TRP . 86.7 t -94.71 99.37 9.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.9 151.41 45.29 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.031 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -77.97 132.84 11.99 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 121.546 1.497 . . . . 0.0 110.513 174.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt . . . . . 0 CA--C 1.484 -1.582 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 178.584 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 46.4 tpp . . . . . 0 C--O 1.237 0.438 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 154.39 -177.59 31.67 Favored Glycine 0 N--CA 1.432 -1.598 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 17.5 p -94.47 -82.94 0.35 Allowed 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 116.857 0.328 . . . . 0.0 111.491 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 13.2 t -116.47 -14.67 10.94 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.349 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 50.8 m80 63.68 -164.01 0.26 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.115 0.566 . . . . 0.0 110.174 -176.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' HIS . . . . . 0.435 ' HA ' ' O ' ' A' ' 200' ' ' HIS . 19.8 p-80 52.99 34.0 16.0 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.417 1.087 . . . . 0.0 112.138 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -80.2 -34.59 37.26 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.262 -1.336 . . . . 0.0 109.247 -177.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -139.01 4.94 2.3 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.899 0.856 . . . . 0.0 109.081 176.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' HIS . . . . . 0.435 ' O ' ' HA ' ' A' ' 197' ' ' HIS . 14.2 t60 -127.04 96.01 4.48 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -178.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -64.69 -54.77 26.36 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.815 0.34 . . . . 0.0 110.549 -177.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 133.42 44.31 0.13 Allowed Glycine 0 N--CA 1.437 -1.283 0 C-N-CA 119.747 -1.216 . . . . 0.0 112.919 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 6.1 tt -85.85 110.74 19.61 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 29.1 m -103.38 115.82 63.16 Favored Pre-proline 0 C--N 1.301 -1.54 0 CA-C-O 120.861 0.362 . . . . 0.0 111.207 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -75.93 162.97 34.04 Favored 'Trans proline' 0 C--O 1.249 1.032 0 C-N-CA 122.306 2.004 . . . . 0.0 111.167 176.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -143.74 34.84 1.27 Allowed 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.027 0.441 . . . . 0.0 111.467 -176.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 128.61 -166.83 20.99 Favored Glycine 0 C--N 1.301 -1.393 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 37.8 t -126.63 164.92 20.19 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 117.148 0.474 . . . . 0.0 110.521 -177.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 29.3 m-70 -115.46 0.47 13.38 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 175.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 84.2 mtp -89.09 114.44 25.69 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.861 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -177.07 -27.77 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 124.657 1.183 . . . . 0.0 108.133 -176.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 7.4 m -55.05 129.11 36.71 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.785 1.234 . . . . 0.0 110.958 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 61.8 mtt -100.06 95.93 7.17 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 28.4 m -74.33 97.13 2.96 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 157.01 152.44 6.31 Favored Glycine 0 N--CA 1.417 -2.595 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -152.28 -56.65 0.01 OUTLIER Glycine 0 N--CA 1.428 -1.836 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -93.7 175.1 6.86 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 176.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -75.97 -62.74 1.5 Allowed 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 50.6 ttm -179.07 -55.55 0.01 OUTLIER 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.148 0.979 . . . . 0.0 110.031 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -157.97 -147.95 4.99 Favored Glycine 0 N--CA 1.432 -1.612 0 N-CA-C 111.614 -0.594 . . . . 0.0 111.614 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -130.15 -46.1 1.12 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 120.938 0.399 . . . . 0.0 111.028 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -117.71 38.89 2.79 Favored Glycine 0 C--N 1.308 -1.016 0 N-CA-C 107.767 -2.133 . . . . 0.0 107.767 176.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.7 p -86.0 86.11 7.36 Favored 'General case' 0 N--CA 1.412 -2.355 0 CA-C-N 114.126 -1.037 . . . . 0.0 113.418 -174.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -128.15 -79.24 0.58 Allowed 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 170.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' GLN . . . . . 0.437 ' HB3' HD11 ' A' ' 273' ' ' LEU . 47.0 tp60 -155.21 176.17 12.91 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 177.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.636 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 5.6 m -56.04 126.49 26.17 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 124.384 1.074 . . . . 0.0 113.42 -171.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -152.95 168.17 26.72 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 116.345 -0.389 . . . . 0.0 109.979 -177.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.671 HG21 HD21 ' A' ' 300' ' ' LEU . 2.8 pp -134.35 165.53 31.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 123.114 0.565 . . . . 0.0 112.164 -178.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.514 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 9.4 t70 -149.89 156.36 41.63 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -133.88 134.63 42.93 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 176.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -152.32 171.61 17.73 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.437 ' HE3' HG22 ' A' ' 284' ' ' THR . 57.4 mtpt -118.98 148.57 42.84 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 175.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -144.68 143.23 30.63 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 123.436 0.46 . . . . 0.0 109.934 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 74.01 -98.81 1.0 Allowed Glycine 0 N--CA 1.435 -1.39 0 O-C-N 124.048 0.842 . . . . 0.0 111.89 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -146.15 98.6 3.12 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 120.761 0.315 . . . . 0.0 110.202 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 63.18 22.65 13.49 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 173.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -89.05 137.36 32.39 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -96.59 113.09 4.59 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 1.9 mp -106.42 121.36 58.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 117.237 0.519 . . . . 0.0 109.869 -177.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.5 mp -105.75 117.31 51.24 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 39.0 mt-10 -94.91 146.04 24.5 Favored 'General case' 0 C--N 1.284 -2.245 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.02 174.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 12.4 tp -134.36 128.87 34.53 Favored 'General case' 0 C--N 1.27 -2.88 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.133 -173.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ALA . . . . . 0.636 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -118.44 101.77 8.41 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -109.42 91.47 3.66 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.541 0.686 . . . . 0.0 109.493 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.94 111.41 13.77 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.562 -175.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 107.87 9.18 28.81 Favored Glycine 0 N--CA 1.431 -1.634 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.451 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -115.32 107.72 15.61 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 176.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -115.14 95.24 5.1 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.369 0.604 . . . . 0.0 109.784 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 165.55 -150.22 17.57 Favored Glycine 0 N--CA 1.425 -2.08 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -124.48 136.18 27.47 Favored Pre-proline 0 C--N 1.3 -1.572 0 CA-C-N 117.39 0.595 . . . . 0.0 110.339 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.657 ' HB3' HD23 ' A' ' 264' ' ' LEU . 10.6 Cg_endo -74.32 172.37 16.2 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 C-N-CA 122.505 2.137 . . . . 0.0 112.41 176.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.506 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 11.6 t70 -91.94 105.63 17.84 Favored 'General case' 0 C--N 1.284 -2.283 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 175.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.477 HD11 ' HG2' ' A' ' 251' ' ' PRO . 5.3 mp -103.43 124.14 57.44 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 C-N-CA 119.484 -0.887 . . . . 0.0 109.894 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' SER . . . . . 0.491 ' HB3' ' HB ' ' A' ' 261' ' ' ILE . 25.1 t -106.27 120.21 41.25 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -100.13 109.41 21.69 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.948 -178.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -124.42 162.5 23.75 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 174.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -73.57 -33.33 64.6 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 120.991 0.424 . . . . 0.0 110.124 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -70.78 -42.92 69.75 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.842 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' HIS . . . . . 0.459 ' CB ' ' HA ' ' A' ' 303' ' ' THR . 53.1 p-80 -169.42 167.55 9.91 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.472 0.177 . . . . 0.0 111.067 178.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 17.3 mt -106.21 139.5 27.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' ILE . . . . . 0.491 ' HB ' ' HB3' ' A' ' 254' ' ' SER . 3.4 mp -122.97 114.56 42.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 299' ' ' GLN . 0.8 OUTLIER -107.81 134.07 50.71 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 175.034 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 25.3 m -122.45 123.78 42.09 Favored 'General case' 0 C--N 1.267 -3.002 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.657 HD23 ' HB3' ' A' ' 251' ' ' PRO . 29.6 mt -100.17 93.73 5.86 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.441 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 63.1 mmtt -63.1 126.94 29.03 Favored 'General case' 0 CA--C 1.478 -1.814 0 O-C-N 124.29 0.994 . . . . 0.0 113.075 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 9.8 t30 69.77 32.53 3.19 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.432 -1.713 . . . . 0.0 109.909 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -125.69 100.54 6.47 Favored 'General case' 0 C--O 1.2 -1.525 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 6.4 m -88.26 112.2 22.53 Favored 'General case' 0 C--N 1.277 -2.57 0 C-N-CA 119.635 -0.826 . . . . 0.0 111.889 -173.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' LEU . . . . . 0.687 HD22 HD22 ' A' ' 291' ' ' LEU . 37.6 tp -81.83 125.81 76.89 Favored Pre-proline 0 N--CA 1.444 -0.77 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.275 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.408 ' HD2' HD12 ' A' ' 269' ' ' LEU . 31.3 Cg_exo -65.79 143.1 72.55 Favored 'Trans proline' 0 N--CA 1.44 -1.648 0 C-N-CA 122.105 1.87 . . . . 0.0 110.587 169.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 11.4 t -69.63 -12.71 61.86 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.388 0.613 . . . . 0.0 110.363 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 2.4 m -76.29 -16.57 59.76 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 123.961 0.904 . . . . 0.0 109.924 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.505 HD13 ' O ' ' A' ' 226' ' ' THR . 73.8 mt -110.88 -7.06 14.62 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.415 -177.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.521 ' HB2' ' O ' ' A' ' 291' ' ' LEU . 25.2 pt20 -81.35 115.64 20.81 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 119.101 -1.04 . . . . 0.0 109.61 -177.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 21.0 ptt180 -135.44 151.65 50.61 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 40.7 m -112.71 136.93 51.73 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.799 176.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.458 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 59.6 mt -105.67 116.47 32.0 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -61.02 -51.86 67.44 Favored 'General case' 0 C--N 1.311 -1.079 0 O-C-N 123.724 0.64 . . . . 0.0 110.419 -177.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . 0.263 26.9 m 46.19 25.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 116.856 2.169 . . . . 0.0 116.856 174.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -75.85 140.65 42.34 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 177.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 15.3 t70 73.02 20.99 3.31 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.701 1.2 . . . . 0.0 112.531 177.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -79.74 -4.98 54.3 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.574 -0.704 . . . . 0.0 110.22 172.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 mptt 65.77 50.94 1.49 Allowed 'General case' 0 CA--C 1.503 -0.85 0 C-N-CA 124.248 1.019 . . . . 0.0 109.924 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' THR . . . . . 0.437 HG22 ' HE3' ' A' ' 232' ' ' LYS . 1.2 p -133.34 165.03 39.74 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -74.78 -4.91 16.12 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.196 1.931 . . . . 0.0 111.752 177.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 49.8 t -87.59 129.54 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -99.86 -30.35 12.08 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.208 -176.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 20.6 ttmm -167.13 143.79 4.47 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.458 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 43.3 t -112.64 130.22 66.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 174.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.527 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 98.2 m -136.18 117.87 15.0 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-O 121.262 0.554 . . . . 0.0 110.762 -178.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.687 HD22 HD22 ' A' ' 269' ' ' LEU . 0.1 OUTLIER -91.47 114.13 26.58 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 104.244 -2.502 . . . . 0.0 104.244 174.861 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.407 ' HD3' ' OE1' ' A' ' 274' ' ' GLN . 17.0 tppt? -116.15 129.6 56.4 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -177.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -78.42 140.37 38.68 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 175.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.559 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 21.7 tp -111.23 -173.14 2.17 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 175.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.559 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 63.9 t30 -58.91 -66.66 0.47 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 119.172 0.896 . . . . 0.0 111.247 -177.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -115.86 -3.6 12.17 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 120.791 0.329 . . . . 0.0 111.147 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' ASP . . . . . 0.441 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 38.1 m-20 -115.23 172.69 6.92 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.397 0.618 . . . . 0.0 110.209 -177.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.515 ' HB ' ' HB2' ' A' ' 264' ' ' LEU . 92.8 m -116.98 132.11 56.79 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 176.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' GLN . . . . . 0.529 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 42.1 tt0 -120.17 127.78 52.79 Favored 'General case' 0 N--CA 1.421 -1.894 0 C-N-CA 120.529 -0.469 . . . . 0.0 110.35 -175.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.671 HD21 HG21 ' A' ' 228' ' ' ILE . 17.4 mt -100.08 127.7 46.27 Favored 'General case' 0 CA--C 1.443 -3.142 0 C-N-CA 120.127 -0.629 . . . . 0.0 111.462 172.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 301' ' ' ILE . . . . . 0.527 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 63.1 mt -115.19 109.23 27.65 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.373 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 302' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 50.9 mt -117.17 102.13 13.05 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.625 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.459 ' HA ' ' CB ' ' A' ' 259' ' ' HIS . 32.8 m -74.88 134.6 41.62 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.781 -175.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 19.0 p -133.74 179.72 6.06 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 123.189 0.595 . . . . 0.0 109.608 -177.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -159.59 148.47 17.86 Favored 'General case' 0 C--O 1.246 0.878 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 73.64 -142.4 31.05 Favored Glycine 0 C--O 1.243 0.675 0 O-C-N 123.613 0.571 . . . . 0.0 112.468 176.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 69.4 m-20 -105.26 130.23 53.44 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' TRP . . . . . 0.73 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 60.7 p-90 -145.79 171.27 15.03 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -177.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -129.98 135.06 47.88 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.73 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 25.8 tp -111.25 120.95 43.97 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.269 -177.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.554 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 54.3 t -116.2 107.55 22.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 173.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -94.75 134.97 36.78 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' LYS . . . . . 0.426 ' HB2' ' HB ' ' A' ' 321' ' ' THR . 67.6 mttm -130.58 145.01 51.8 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.619 -176.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 15.9 m -115.85 118.53 33.25 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 172.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -87.28 -24.83 24.22 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.605 0.716 . . . . 0.0 110.41 -177.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -170.24 162.59 6.34 Favored Pre-proline 0 C--N 1.307 -1.241 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -65.17 95.99 0.26 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.493 1.462 . . . . 0.0 110.504 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 133.52 -33.36 2.58 Favored Glycine 0 N--CA 1.421 -2.35 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.628 -177.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -99.89 116.44 31.96 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 122.036 -0.685 . . . . 0.0 109.87 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -119.3 163.94 16.4 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.932 -177.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.426 ' HB ' ' HB2' ' A' ' 313' ' ' LYS . 78.7 m -152.09 139.93 19.96 Favored 'General case' 0 C--N 1.269 -2.894 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.261 -178.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -126.43 112.4 15.57 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' GLN . . . . . 0.554 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 61.8 tt0 -97.37 109.7 22.4 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.598 HG13 ' CE3' ' A' ' 308' ' ' TRP . 91.7 t -98.38 99.31 8.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 C-N-CA 123.501 0.72 . . . . 0.0 109.687 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -88.43 152.86 50.36 Favored Pre-proline 0 C--N 1.309 -1.153 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -80.35 128.67 7.22 Favored 'Trans proline' 0 C--O 1.252 1.209 0 C-N-CA 121.27 1.314 . . . . 0.0 109.956 171.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -85.45 101.8 12.93 Favored 'General case' 0 CA--C 1.471 -2.06 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -88.54 122.87 32.47 Favored 'General case' 0 C--N 1.271 -2.82 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.994 -169.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 . . . . . 0 C--N 1.293 -1.88 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 176.056 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 N--CA 1.475 0.825 0 CA-C-O 120.654 0.264 . . . . 0.0 111.374 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 102.43 34.93 4.0 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 7.7 m -130.91 20.81 4.97 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -178.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 15.6 m -61.0 -24.46 66.18 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -173.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 42.7 m170 -104.24 5.66 34.91 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -142.45 -67.0 0.38 Allowed 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 61.9 m80 74.86 170.06 0.29 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.158 1.383 . . . . 0.0 109.614 -177.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -86.35 77.36 9.51 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 171.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -52.63 -46.41 67.08 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.853 -1.067 . . . . 0.0 113.759 -168.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -115.94 25.11 10.96 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.749 0.785 . . . . 0.0 109.147 176.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -124.75 51.89 0.81 Allowed Glycine 0 N--CA 1.437 -1.276 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.504 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 96.9 mt -94.62 0.74 55.38 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.083 0.468 . . . . 0.0 110.216 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 7.7 p -113.37 102.24 54.56 Favored Pre-proline 0 C--N 1.305 -1.327 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.604 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.31 96.7 1.08 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.421 2.081 . . . . 0.0 108.792 172.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -108.34 -14.64 14.64 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.829 -172.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 140.98 -134.41 6.36 Favored Glycine 0 N--CA 1.436 -1.305 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.119 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 16.4 m -70.27 126.93 31.07 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 122.903 0.481 . . . . 0.0 110.598 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -113.72 108.32 16.95 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.204 0.526 . . . . 0.0 110.652 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 53.5 ttp -92.67 155.29 17.82 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . 70.42 170.55 0.31 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 124.625 1.17 . . . . 0.0 111.415 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 15.3 m -92.92 129.49 38.82 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -71.43 128.97 37.62 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 176.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 17.9 m -47.89 120.12 3.25 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.586 0.755 . . . . 0.0 111.299 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -177.08 41.17 0.1 OUTLIER Glycine 0 N--CA 1.438 -1.189 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -169.36 39.66 0.21 Allowed Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -94.29 -23.17 17.95 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.272 0.558 . . . . 0.0 110.323 -177.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' GLN . . . . . 0.474 ' HB3' ' HD2' ' A' ' 221' ' ' ARG . 21.8 mm-40 -135.39 32.68 3.08 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 123.786 0.835 . . . . 0.0 110.116 -176.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -69.41 -46.36 67.02 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.934 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -101.83 102.01 2.28 Favored Glycine 0 N--CA 1.431 -1.663 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ARG . . . . . 0.474 ' HD2' ' HB3' ' A' ' 218' ' ' GLN . 66.2 mtp180 -124.21 98.89 5.97 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.029 0.442 . . . . 0.0 110.181 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -88.6 82.89 1.49 Allowed Glycine 0 C--N 1.3 -1.422 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 22.7 m -106.84 24.44 12.73 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 122.552 -0.381 . . . . 0.0 111.792 -175.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -64.73 -49.9 69.03 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' GLN . . . . . 0.409 ' C ' HD23 ' A' ' 245' ' ' LEU . 5.7 tp-100 -171.98 174.27 4.17 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 175.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.573 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 72.8 m -52.92 131.98 36.61 Favored 'General case' 0 C--O 1.208 -1.13 0 C-N-CA 124.178 0.991 . . . . 0.0 113.187 -172.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -162.54 175.59 11.29 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-O 121.023 0.44 . . . . 0.0 111.519 -174.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.439 HG21 HD21 ' A' ' 300' ' ' LEU . 1.8 pp -121.51 165.44 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.075 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.501 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 6.6 t70 -150.37 152.16 33.96 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -134.06 127.59 32.52 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.098 176.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.503 ' HD3' ' HB ' ' A' ' 239' ' ' ILE . 0.3 OUTLIER -150.91 157.39 42.85 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.633 179.063 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -104.67 162.44 13.29 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ASP . . . . . 0.453 ' O ' ' HB3' ' A' ' 237' ' ' ALA . 15.3 t70 -157.71 143.96 17.63 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 68.77 -118.89 9.36 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.486 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -135.35 111.89 9.93 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.97 0.385 . . . . 0.0 110.695 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 66.67 15.75 10.21 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.876 0.87 . . . . 0.0 112.403 174.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 233' ' ' ASP . . . -92.41 132.04 37.09 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -103.35 113.91 4.67 Favored Glycine 0 CA--C 1.491 -1.427 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.503 ' HB ' ' HD3' ' A' ' 231' ' ' ARG . 2.4 mp -106.77 117.12 51.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-O 121.512 0.672 . . . . 0.0 110.263 -177.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.4 mp -101.08 109.04 24.59 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.501 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 43.1 mt-10 -89.73 132.81 35.0 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 176.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 8.9 tp -117.59 122.27 43.16 Favored 'General case' 0 C--N 1.269 -2.934 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.131 -174.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ALA . . . . . 0.573 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -107.34 101.21 10.6 Favored 'General case' 0 N--CA 1.414 -2.259 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.452 ' HA ' HG23 ' A' ' 226' ' ' THR . . . -106.8 91.87 3.85 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.615 0.722 . . . . 0.0 109.076 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.409 HD23 ' C ' ' A' ' 225' ' ' GLN . 3.0 mm? -81.71 114.18 20.2 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.278 -175.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 103.42 22.75 8.86 Favored Glycine 0 C--N 1.297 -1.615 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.121 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' PHE . . . . . 0.403 ' HE1' ' O ' ' A' ' 265' ' ' LYS . 20.0 t80 -115.74 127.41 55.09 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -102.28 -21.05 14.41 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -174.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -104.18 -141.38 11.06 Favored Glycine 0 C--N 1.314 -0.685 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.841 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -127.59 142.5 44.32 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.7 ' HB3' HD13 ' A' ' 264' ' ' LEU . 18.0 Cg_endo -68.35 172.31 11.43 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.717 2.278 . . . . 0.0 112.853 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.525 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 20.3 t70 -96.02 119.86 35.28 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 175.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 4.6 mp -108.41 108.95 26.54 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-O 121.995 0.902 . . . . 0.0 111.232 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' SER . . . . . 0.651 ' HB2' ' HB ' ' A' ' 261' ' ' ILE . 47.4 m -96.47 104.83 16.83 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 114.163 -1.381 . . . . 0.0 109.198 177.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -88.1 118.25 27.54 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.865 -176.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 48.5 mt-30 -124.66 157.05 36.49 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 167.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 60.6 m80 -74.34 -29.79 61.74 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.926 -0.709 . . . . 0.0 111.202 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -69.65 -42.11 74.68 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.955 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' HIS . . . . . 0.403 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 49.9 p-80 -167.23 163.82 15.45 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.73 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 18.3 mt -105.48 142.02 19.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' ILE . . . . . 0.651 ' HB ' ' HB2' ' A' ' 254' ' ' SER . 3.8 mp -119.99 110.23 28.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.6 ' O ' ' HA ' ' A' ' 299' ' ' GLN . 0.8 OUTLIER -108.64 142.28 21.66 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.741 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 263' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 298' ' ' THR . 31.9 m -134.86 126.62 29.13 Favored 'General case' 0 C--N 1.275 -2.643 0 O-C-N 121.726 -0.609 . . . . 0.0 111.13 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.7 HD13 ' HB3' ' A' ' 251' ' ' PRO . 2.1 mm? -98.17 101.84 13.42 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 177.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.454 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 25.8 mmtm -67.65 130.94 44.58 Favored 'General case' 0 C--N 1.286 -2.178 0 O-C-N 124.033 0.833 . . . . 0.0 111.283 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 6.6 t30 73.84 21.59 2.67 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 124.678 1.236 . . . . 0.0 109.999 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -121.13 100.59 7.14 Favored 'General case' 0 CA--C 1.484 -1.581 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 3.7 m -90.2 121.03 31.86 Favored 'General case' 0 C--N 1.271 -2.828 0 C-N-CA 120.076 -0.649 . . . . 0.0 110.837 -175.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' LEU . . . . . 0.541 HD22 HD22 ' A' ' 291' ' ' LEU . 24.8 tp -92.76 127.3 48.47 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.242 -177.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.76 149.07 91.63 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.285 1.99 . . . . 0.0 110.989 170.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' THR . . . . . 0.609 ' O ' ' HG2' ' A' ' 274' ' ' GLN . 22.2 p -66.32 -25.35 66.79 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.336 -177.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 10.2 m -72.51 -18.52 61.65 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.508 0.67 . . . . 0.0 111.056 -177.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.511 HD13 ' O ' ' A' ' 226' ' ' THR . 82.1 mt -99.29 -19.12 17.23 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.497 -177.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.609 ' HG2' ' O ' ' A' ' 271' ' ' THR . 21.9 pt20 -76.82 137.69 39.38 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -173.42 169.48 4.39 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -174.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 3.1 p -123.99 132.86 53.76 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-O 121.478 0.656 . . . . 0.0 112.101 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 60.3 mt -100.58 113.06 25.56 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 104.34 -2.467 . . . . 0.0 104.34 175.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -63.41 -53.05 58.38 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -174.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 34.5 m 44.71 37.05 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 176.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -69.4 133.42 47.77 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 20.2 t70 61.9 36.15 16.0 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 125.005 1.322 . . . . 0.0 110.692 177.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.26 0.38 28.91 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.703 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt 69.01 59.03 0.35 Allowed 'General case' 0 CA--C 1.497 -1.095 0 C-N-CA 125.388 1.475 . . . . 0.0 111.478 177.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.35 152.66 11.02 Favored Pre-proline 0 C--N 1.295 -1.767 0 CA-C-N 113.851 -1.522 . . . . 0.0 108.675 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 285' ' ' PRO . . . . . 0.433 ' O ' ' HA ' ' A' ' 304' ' ' THR . 54.0 Cg_exo -50.14 -24.77 11.75 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.713 2.942 . . . . 0.0 113.55 175.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 46.9 t -74.06 118.33 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -94.64 -29.11 15.01 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.891 -178.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -170.21 135.23 1.29 Allowed 'General case' 0 N--CA 1.478 0.93 0 O-C-N 123.665 0.603 . . . . 0.0 110.863 -177.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 40.2 t -104.3 135.96 39.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.447 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 90.2 m -143.19 123.64 13.93 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 121.461 0.648 . . . . 0.0 111.09 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.541 HD22 HD22 ' A' ' 269' ' ' LEU . 0.1 OUTLIER -98.06 120.37 38.35 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 176.436 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.493 ' HD3' ' OE1' ' A' ' 274' ' ' GLN . 4.0 tppp? -128.76 135.88 49.8 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -79.99 145.01 32.78 Favored 'General case' 0 N--CA 1.426 -1.627 0 C-N-CA 118.858 -1.137 . . . . 0.0 109.273 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.548 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 18.0 tp -108.44 -174.08 2.43 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 177.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.548 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 5.8 t30 -56.65 -67.47 0.3 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.559 0.618 . . . . 0.0 111.688 -177.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -110.03 -4.28 15.97 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.825 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' ASP . . . . . 0.454 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 36.2 m-20 -119.81 176.4 5.42 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.599 0.714 . . . . 0.0 111.511 -169.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 263' ' ' THR . 90.1 m -113.73 133.4 55.37 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 176.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 299' ' ' GLN . . . . . 0.6 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 26.3 tt0 -124.08 132.07 53.62 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.13 -175.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.523 ' O ' ' HA ' ' A' ' 261' ' ' ILE . 25.4 mt -101.69 131.92 47.67 Favored 'General case' 0 CA--C 1.451 -2.86 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.967 173.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' ILE . . . . . 0.447 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 63.6 mt -116.26 108.63 25.6 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.697 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 175.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 65.2 mt -115.98 104.16 16.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 3.5 m -72.51 130.03 39.7 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 123.126 0.57 . . . . 0.0 109.641 -175.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 285' ' ' PRO . 8.7 p -136.02 176.71 8.44 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 122.319 0.248 . . . . 0.0 110.905 -178.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -147.73 148.94 31.52 Favored 'General case' 0 C--O 1.245 0.857 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 61.38 -148.61 46.61 Favored Glycine 0 N--CA 1.463 0.444 0 O-C-N 123.933 0.771 . . . . 0.0 113.089 177.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -97.72 144.4 27.39 Favored 'General case' 0 CA--C 1.47 -2.121 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' TRP . . . . . 0.718 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 65.9 p-90 -157.94 170.77 21.58 Favored 'General case' 0 C--N 1.27 -2.851 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -178.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.467 ' HG2' ' HE2' ' A' ' 327' ' ' LYS . 4.6 mt-10 -122.26 129.83 52.6 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -176.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.718 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 23.3 tp -105.65 117.81 34.96 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 120.996 0.427 . . . . 0.0 111.207 -176.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.5 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 48.8 t -114.63 107.36 22.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 174.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -94.18 126.61 39.52 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' LYS . . . . . 0.435 ' HB2' ' HB ' ' A' ' 321' ' ' THR . 95.3 mttt -119.83 149.45 42.04 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.964 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 23.9 t -115.97 114.59 24.83 Favored 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 172.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -80.18 -32.35 38.73 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.572 0.701 . . . . 0.0 109.561 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -168.76 162.18 8.25 Favored Pre-proline 0 C--N 1.305 -1.355 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.5 102.19 0.33 Allowed 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 121.532 1.488 . . . . 0.0 110.497 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 129.73 -32.43 3.18 Favored Glycine 0 N--CA 1.427 -1.954 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -177.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -102.77 116.59 32.88 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -119.16 161.79 19.74 Favored 'General case' 0 C--N 1.277 -2.546 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.292 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.435 ' HB ' ' HB2' ' A' ' 313' ' ' LYS . 89.4 m -151.62 124.93 8.79 Favored 'General case' 0 C--N 1.263 -3.16 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.74 -174.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' A' ' 239' ' ' ILE . 69.9 m-85 -112.4 109.98 19.92 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 323' ' ' GLN . . . . . 0.5 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 56.2 tt0 -96.73 105.72 17.89 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.617 HG13 ' CE3' ' A' ' 308' ' ' TRP . 94.0 t -95.01 100.41 11.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 C-N-CA 123.42 0.688 . . . . 0.0 110.228 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -92.42 153.33 42.74 Favored Pre-proline 0 C--N 1.313 -0.984 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -73.09 140.71 31.61 Favored 'Trans proline' 0 C--O 1.249 1.046 0 C-N-CA 121.765 1.643 . . . . 0.0 110.4 172.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.467 ' HE2' ' HG2' ' A' ' 309' ' ' GLU . 14.8 ttmm -100.54 125.72 46.91 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -176.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -93.53 98.92 11.49 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 173.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 329' ' ' GLN . . . . . 0.488 ' H ' ' NE2' ' A' ' 329' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.286 -2.176 0 CA-C-O 118.646 -0.692 . . . . 0.0 109.723 -177.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 69.3 mtm . . . . . 0 CA--C 1.519 -0.237 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 150.51 176.52 23.58 Favored Glycine 0 N--CA 1.439 -1.107 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -178.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 38.8 m -103.44 130.42 50.77 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 117.836 0.818 . . . . 0.0 110.052 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 36.4 t -174.46 -41.36 0.01 OUTLIER 'General case' 0 C--O 1.235 0.326 0 O-C-N 123.469 0.481 . . . . 0.0 110.25 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 71.8 5.09 5.26 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.376 1.07 . . . . 0.0 110.642 -177.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 28.4 t60 58.6 70.69 0.63 Allowed 'General case' 0 C--O 1.241 0.62 0 C-N-CA 125.081 1.352 . . . . 0.0 109.961 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -150.5 121.26 7.54 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -177.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 -68.88 132.24 46.41 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.134 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -92.67 -16.97 24.9 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.283 0.563 . . . . 0.0 111.396 -175.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -115.61 135.56 53.94 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 149.31 13.27 0.11 Allowed Glycine 0 C--N 1.312 -0.805 0 C-N-CA 119.678 -1.249 . . . . 0.0 113.255 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 79.3 mt -102.13 14.06 33.0 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.987 0.422 . . . . 0.0 111.012 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.415 ' O ' ' HD2' ' A' ' 206' ' ' ARG . 55.2 t -62.13 -44.84 90.41 Favored Pre-proline 0 CA--C 1.566 1.565 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.715 176.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -86.94 90.31 0.6 Allowed 'Trans proline' 0 N--CA 1.429 -2.269 0 CA-C-N 120.293 1.14 . . . . 0.0 110.517 170.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.47 ' H ' ' HD2' ' A' ' 206' ' ' ARG . 4.0 mpt_? -76.2 -37.12 58.22 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 162.39 65.82 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 8.4 t -114.39 10.84 17.12 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-O 121.361 0.601 . . . . 0.0 109.763 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -95.67 0.66 52.91 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.359 0.6 . . . . 0.0 110.382 173.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -154.59 118.55 4.67 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 105.842 -1.911 . . . . 0.0 105.842 177.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . 70.74 103.44 0.06 Allowed 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.701 1.201 . . . . 0.0 111.831 -177.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 18.8 m 67.68 86.79 0.13 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.24 -1.346 . . . . 0.0 112.646 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 65.2 mtm -87.31 89.78 8.12 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 6.7 m -151.68 9.31 0.53 Allowed 'General case' 0 CA--C 1.558 1.251 0 CA-C-O 121.828 0.823 . . . . 0.0 109.83 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 81.67 -62.9 4.45 Favored Glycine 0 C--O 1.242 0.608 0 O-C-N 121.685 -0.634 . . . . 0.0 111.92 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 140.28 25.38 0.25 Allowed Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.957 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -104.44 -70.52 0.77 Allowed 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 119.904 -0.719 . . . . 0.0 109.672 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -91.76 84.79 5.47 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 17.1 tpt -166.28 122.47 1.28 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.314 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -82.34 62.96 4.5 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 177.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 12.9 ttp180 -84.49 133.17 34.48 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 174.28 -87.88 0.08 OUTLIER Glycine 0 N--CA 1.422 -2.254 0 N-CA-C 108.425 -1.87 . . . . 0.0 108.425 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 15.6 m -77.24 103.23 7.05 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 174.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -125.57 -9.54 6.82 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.748 0.785 . . . . 0.0 109.656 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 8.1 pm0 -122.72 148.54 45.19 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.426 -175.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 28.7 m -59.93 128.62 37.78 Favored 'General case' 0 C--O 1.209 -1.028 0 O-C-N 124.121 0.888 . . . . 0.0 109.01 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -148.03 155.95 42.08 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.082 -170.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.657 HG12 ' HB2' ' A' ' 291' ' ' LEU . 2.7 pp -137.48 149.68 25.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 C-N-CA 124.134 0.974 . . . . 0.0 108.872 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -149.76 156.6 42.12 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 122.789 0.436 . . . . 0.0 111.038 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -127.0 139.18 53.21 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 120.97 0.414 . . . . 0.0 111.01 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 20.5 ptt85 -157.04 161.68 39.52 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 173.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.403 ' HE3' HG22 ' A' ' 284' ' ' THR . 53.2 mtpt -105.64 144.91 31.73 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 177.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ASP . . . . . 0.521 ' O ' ' HB3' ' A' ' 237' ' ' ALA . 21.7 t70 -159.76 117.38 2.66 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -176.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 104.12 -157.14 17.25 Favored Glycine 0 C--N 1.296 -1.694 0 C-N-CA 120.203 -0.998 . . . . 0.0 111.179 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -91.53 97.49 11.09 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 116.7 0.25 . . . . 0.0 110.391 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ASN . . . . . 0.538 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 3.4 m-20 60.92 23.26 13.36 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 124.197 0.936 . . . . 0.0 111.396 177.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 233' ' ' ASP . . . -87.11 136.91 32.75 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.491 -174.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -101.94 116.51 5.55 Favored Glycine 0 N--CA 1.427 -1.915 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.43 HG13 ' HG3' ' A' ' 323' ' ' GLN . 2.1 mp -106.52 114.87 46.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-O 121.34 0.591 . . . . 0.0 111.127 -175.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.3 mp -103.49 112.77 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 176.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -94.4 138.77 31.95 Favored 'General case' 0 C--N 1.277 -2.549 0 CA-C-O 121.363 0.601 . . . . 0.0 109.487 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 12.0 tp -127.49 131.04 50.2 Favored 'General case' 0 C--N 1.269 -2.924 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.392 -175.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -122.37 102.18 7.95 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.013 178.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -108.84 91.07 3.49 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -73.15 109.72 6.89 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -173.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 111.99 -4.64 27.23 Favored Glycine 0 C--N 1.304 -1.204 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.132 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -94.62 107.73 19.71 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -108.58 97.11 6.82 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 160.74 -147.78 15.02 Favored Glycine 0 C--N 1.297 -1.604 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -126.74 135.65 27.61 Favored Pre-proline 0 C--N 1.311 -1.095 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.822 ' HB3' HD13 ' A' ' 264' ' ' LEU . 13.7 Cg_endo -70.38 171.98 14.11 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.361 2.041 . . . . 0.0 109.901 176.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -91.13 110.26 21.53 Favored 'General case' 0 C--N 1.27 -2.878 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 175.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 3.8 mp -97.73 108.46 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.76 0 CA-C-O 121.605 0.717 . . . . 0.0 109.57 178.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' SER . . . . . 0.669 ' HB2' ' HB ' ' A' ' 261' ' ' ILE . 31.8 m -102.99 110.76 22.79 Favored 'General case' 0 C--N 1.282 -2.369 0 CA-C-N 114.473 -1.24 . . . . 0.0 108.274 175.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -100.18 117.36 34.26 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.48 -172.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -125.1 162.57 24.29 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 172.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' HIS . . . . . 0.402 ' HA ' ' HE1' ' A' ' 308' ' ' TRP . 13.1 m170 -76.53 -31.16 57.48 Favored 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 119.015 -1.074 . . . . 0.0 112.068 178.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -73.91 -30.94 62.86 Favored 'General case' 0 C--N 1.319 -0.744 0 O-C-N 123.661 0.6 . . . . 0.0 111.476 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' HIS . . . . . 0.447 ' CD2' HG23 ' A' ' 301' ' ' ILE . 39.4 p-80 -172.78 165.13 5.29 Favored 'General case' 0 CA--C 1.503 -0.864 0 O-C-N 122.252 -0.28 . . . . 0.0 110.623 175.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 18.4 mt -106.29 140.86 23.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' ILE . . . . . 0.669 ' HB ' ' HB2' ' A' ' 254' ' ' SER . 3.5 mp -116.64 108.69 25.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.442 ' HB ' ' HB2' ' A' ' 300' ' ' LEU . 49.1 t -105.66 131.54 54.82 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.492 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 177.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 298' ' ' THR . 26.6 m -134.46 126.17 28.92 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 121.289 0.566 . . . . 0.0 111.066 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.822 HD13 ' HB3' ' A' ' 251' ' ' PRO . 2.0 mm? -98.38 108.58 21.31 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.498 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 30.5 mmmt -67.75 131.58 45.83 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-O 121.526 0.679 . . . . 0.0 112.384 -178.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 65.1 t30 74.91 1.96 3.9 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 113.379 -1.737 . . . . 0.0 111.294 176.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -94.68 110.65 22.47 Favored 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -178.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 1.2 p -82.73 135.67 34.93 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-O 121.074 0.464 . . . . 0.0 111.405 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' LEU . . . . . 0.484 HD11 ' HB2' ' A' ' 273' ' ' LEU . 26.8 tp -112.88 124.11 32.36 Favored Pre-proline 0 N--CA 1.425 -1.698 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.125 176.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.42 ' O ' ' HG ' ' A' ' 269' ' ' LEU . 23.3 Cg_exo -70.77 160.08 50.58 Favored 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 122.619 2.213 . . . . 0.0 111.659 170.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 3.6 p -66.95 -26.19 66.71 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 123.803 0.841 . . . . 0.0 111.456 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 6.7 m -64.23 -23.6 67.37 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.01 1.324 . . . . 0.0 112.438 -177.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.484 ' HB2' HD11 ' A' ' 269' ' ' LEU . 3.2 mm? -99.47 -8.92 24.02 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-O 121.344 0.592 . . . . 0.0 111.707 -174.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -72.96 138.67 46.24 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.288 -0.869 . . . . 0.0 108.803 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -169.09 170.9 8.5 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 177.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 62.0 m -130.8 152.54 50.03 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-O 121.394 0.616 . . . . 0.0 110.302 176.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.468 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 1.8 mm? -111.98 108.91 18.41 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 105.998 -1.852 . . . . 0.0 105.998 177.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -80.72 85.52 6.07 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 122.444 1.116 . . . . 0.0 109.213 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' VAL . . . . . 0.641 ' HA ' ' CE1' ' A' ' 282' ' ' PHE . 87.8 t -89.63 36.69 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-N 113.364 -1.744 . . . . 0.0 111.619 -173.365 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -80.84 142.5 33.6 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.432 174.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 18.6 t70 72.51 20.49 3.89 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 122.673 1.225 . . . . 0.0 110.259 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.641 ' CE1' ' HA ' ' A' ' 279' ' ' VAL . 21.1 m-85 -90.3 -18.4 25.66 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.588 -0.695 . . . . 0.0 110.589 176.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 65.39 35.02 7.71 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.691 0.796 . . . . 0.0 111.841 176.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' THR . . . . . 0.403 HG22 ' HE3' ' A' ' 232' ' ' LYS . 2.3 p -115.58 174.91 2.13 Favored Pre-proline 0 C--N 1.3 -1.558 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 285' ' ' PRO . . . . . 0.538 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 9.2 Cg_exo -75.57 -15.2 19.66 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.764 1.643 . . . . 0.0 111.693 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.8 p -93.21 128.74 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-O 121.639 0.733 . . . . 0.0 109.87 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -94.51 -39.61 10.31 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.155 -174.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -160.14 134.52 7.49 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.541 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.468 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 40.6 t -99.39 123.77 52.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 87.5 m -130.11 122.91 29.17 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 120.852 0.358 . . . . 0.0 110.885 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.657 ' HB2' HG12 ' A' ' 228' ' ' ILE . 46.5 tp -99.74 125.06 45.57 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -124.4 139.12 54.2 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -175.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -83.66 148.54 27.05 Favored 'General case' 0 C--N 1.289 -2.061 0 C-N-CA 118.832 -1.147 . . . . 0.0 108.218 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.484 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 17.8 tp -115.73 -174.49 2.54 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 173.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.484 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 4.6 t30 -76.0 -55.23 5.8 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 120.07 1.305 . . . . 0.0 111.891 -173.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -107.36 -8.91 16.17 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.686 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' ASP . . . . . 0.498 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 29.3 m-20 -132.1 173.12 11.56 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.975 -171.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.609 ' O ' ' HA ' ' A' ' 263' ' ' THR . 79.1 m -110.7 132.96 53.74 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 299' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 32.7 tt0 -117.14 126.62 53.09 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.799 0.809 . . . . 0.0 110.112 -177.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.442 ' HB2' ' HB ' ' A' ' 262' ' ' VAL . 0.5 OUTLIER -110.89 122.82 48.83 Favored 'General case' 0 C--N 1.274 -2.689 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.211 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 301' ' ' ILE . . . . . 0.447 HG23 ' CD2' ' A' ' 259' ' ' HIS . 72.9 mt -109.12 109.22 27.56 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.368 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -177.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 59.9 mt -110.48 98.9 7.65 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 10.9 m -69.53 126.03 28.49 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 17.3 p -136.26 165.79 24.93 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 122.85 0.46 . . . . 0.0 110.98 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -149.63 138.68 21.19 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-O 120.631 0.253 . . . . 0.0 111.468 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 90.29 -168.28 33.53 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.242 176.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -84.12 127.81 34.15 Favored 'General case' 0 CA--C 1.482 -1.654 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' TRP . . . . . 0.708 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 68.4 p-90 -144.53 169.5 17.84 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -178.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -125.53 123.81 39.95 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -174.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.708 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 17.7 tp -100.19 122.36 42.89 Favored 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.137 -178.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.617 HG13 ' HB3' ' A' ' 323' ' ' GLN . 8.6 p -126.1 114.98 41.11 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-O 121.723 0.773 . . . . 0.0 109.558 171.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 312' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 321' ' ' THR . 11.4 t30 -102.51 129.9 49.18 Favored 'General case' 0 CA--C 1.437 -3.366 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.496 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -114.35 123.61 49.92 Favored 'General case' 1 N--CA 1.372 -4.334 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.874 -176.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 16.3 m -92.06 103.03 15.57 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 176.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -78.38 -34.15 48.4 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.88 -1.055 . . . . 0.0 112.539 -172.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.482 ' HB1' ' HD2' ' A' ' 317' ' ' PRO . . . -165.75 167.38 9.06 Favored Pre-proline 0 C--N 1.307 -1.273 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 -175.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 317' ' ' PRO . . . . . 0.482 ' HD2' ' HB1' ' A' ' 316' ' ' ALA . 25.2 Cg_endo -60.31 102.96 0.2 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.031 1.821 . . . . 0.0 112.088 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 105.83 -15.25 44.89 Favored Glycine 0 N--CA 1.436 -1.331 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.181 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -100.89 116.79 33.6 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 122.196 -0.59 . . . . 0.0 110.698 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' PHE . . . . . 0.497 ' CZ ' ' HD3' ' A' ' 251' ' ' PRO . 75.2 m-85 -122.49 163.65 19.5 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.975 -177.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 312' ' ' ASN . 88.4 m -152.8 110.66 3.62 Favored 'General case' 0 C--N 1.265 -3.076 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.194 -175.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -98.01 104.35 16.37 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' GLN . . . . . 0.617 ' HB3' HG13 ' A' ' 311' ' ' VAL . 42.6 tt0 -94.96 108.2 20.25 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.593 HG13 ' CE3' ' A' ' 308' ' ' TRP . 93.3 t -94.86 99.87 10.14 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.302 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.3 152.51 47.81 Favored Pre-proline 0 C--O 1.213 -0.836 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 326' ' ' PRO . . . . . 0.447 ' HG3' ' HB2' ' A' ' 236' ' ' ASN . 57.5 Cg_endo -77.33 137.39 16.78 Favored 'Trans proline' 0 C--O 1.249 1.069 0 C-N-CA 121.565 1.51 . . . . 0.0 110.18 172.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -84.31 126.29 33.06 Favored 'General case' 0 CA--C 1.468 -2.205 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.742 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 24.7 mtmm -95.19 26.93 3.47 Favored 'General case' 0 C--N 1.271 -2.836 0 CA-C-N 113.817 -1.538 . . . . 0.0 110.942 -170.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 . . . . . 0 C--N 1.294 -1.84 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.648 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 N--CA 1.467 0.39 0 CA-C-O 120.586 0.232 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -142.34 30.89 2.08 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.32 -178.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 14.5 t -123.19 11.51 9.45 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 176.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 15.0 m -78.78 93.55 4.98 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.43 -176.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.587 ' HA ' ' O ' ' A' ' 199' ' ' HIS . 12.1 p-80 -95.53 80.56 3.47 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.373 -0.83 . . . . 0.0 113.215 -174.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -92.13 -58.54 2.36 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 175.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -155.6 20.18 0.4 Allowed 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 174.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' HIS . . . . . 0.587 ' O ' ' HA ' ' A' ' 196' ' ' HIS . 93.7 m-70 -155.49 173.94 15.97 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 103.801 -2.666 . . . . 0.0 103.801 178.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -100.65 -36.82 9.01 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.789 0.804 . . . . 0.0 109.588 173.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -121.47 -53.85 1.99 Allowed 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 83.46 -152.42 29.17 Favored Glycine 0 N--CA 1.424 -2.12 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 -176.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.4 tt 61.35 42.88 11.2 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 8.9 p -164.4 130.5 2.2 Favored Pre-proline 0 C--N 1.313 -1.013 0 CA-C-N 114.196 -1.366 . . . . 0.0 107.575 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -70.16 94.96 0.57 Allowed 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 122.013 1.809 . . . . 0.0 112.491 -178.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 34.1 mmt180 -132.21 94.26 3.42 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.782 176.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -137.83 -156.44 7.19 Favored Glycine 0 N--CA 1.425 -2.054 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.9 p -113.33 160.56 18.23 Favored 'General case' 0 C--N 1.28 -2.437 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -73.74 106.86 5.67 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 174.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 23.5 ttt 74.39 148.28 0.09 Allowed 'General case' 0 C--O 1.251 1.184 0 O-C-N 124.448 1.093 . . . . 0.0 110.528 -174.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ALA . . . . . 0.446 ' HB1' ' HG2' ' A' ' 217' ' ' GLN . . . -77.57 92.98 4.11 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 173.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 22.4 t -108.43 40.09 1.85 Allowed 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.969 -172.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 57.4 mtm 65.49 22.7 11.86 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.041 0.924 . . . . 0.0 108.972 -176.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 1.4 p -91.35 31.28 1.16 Allowed 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 125.92 1.688 . . . . 0.0 110.499 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 152.81 -174.36 31.63 Favored Glycine 0 N--CA 1.411 -2.99 0 N-CA-C 108.456 -1.858 . . . . 0.0 108.456 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -76.7 118.65 5.26 Favored Glycine 0 N--CA 1.425 -2.074 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 176.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' GLN . . . . . 0.446 ' HG2' ' HB1' ' A' ' 211' ' ' ALA . 22.9 mt-30 -78.99 -30.84 44.58 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.007 0.432 . . . . 0.0 109.939 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -121.2 83.74 2.13 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 173.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 66.2 mtm -89.35 -51.69 5.43 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 175.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 72.7 157.87 4.0 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 114.357 -1.292 . . . . 0.0 114.011 176.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -162.24 3.0 0.05 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.321 -0.439 . . . . 0.0 111.096 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 77.88 18.52 76.89 Favored Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.941 -177.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.6 m -129.08 6.81 5.44 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.39 0.614 . . . . 0.0 110.388 -176.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -96.3 101.6 13.26 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 69.4 173.89 0.29 Allowed 'General case' 0 CA--C 1.555 1.167 0 O-C-N 125.02 1.45 . . . . 0.0 110.62 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 24.4 m -57.16 114.34 2.11 Favored 'General case' 0 C--O 1.198 -1.633 0 C-N-CA 123.679 0.792 . . . . 0.0 111.866 -171.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.412 ' HB3' ' HB3' ' A' ' 243' ' ' ALA . 48.2 t30 -130.96 160.21 35.19 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.812 -169.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.2 pp -128.97 151.74 36.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 124.286 1.034 . . . . 0.0 109.762 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.571 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 5.0 t70 -143.47 156.5 44.65 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -176.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 239' ' ' ILE . 77.3 t80 -137.91 139.32 39.75 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 110.27 -0.271 . . . . 0.0 110.27 178.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -165.1 175.01 9.75 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 123.952 0.901 . . . . 0.0 108.743 178.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.405 ' HE3' HG22 ' A' ' 284' ' ' THR . 54.5 mtpt -121.82 159.36 26.91 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 117.803 0.274 . . . . 0.0 110.552 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -164.38 148.23 9.46 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 82.43 -103.35 2.4 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 121.475 -0.393 . . . . 0.0 113.588 173.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -135.87 72.22 1.44 Allowed 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.14 0.495 . . . . 0.0 111.524 -176.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ASN . . . . . 0.465 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 86.0 m-20 67.16 27.52 8.48 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.131 179.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -82.88 143.15 30.95 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.824 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -98.13 117.74 5.92 Favored Glycine 0 N--CA 1.437 -1.264 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 230' ' ' PHE . 2.3 mp -105.59 118.64 53.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-N 117.318 0.559 . . . . 0.0 110.288 -177.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.89 111.61 36.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 175.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.571 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 49.6 mt-10 -92.76 138.8 31.18 Favored 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 177.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 13.9 tp -121.91 117.48 26.56 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.358 -176.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ALA . . . . . 0.579 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -106.19 94.4 5.14 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -102.7 91.34 4.14 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.813 0.816 . . . . 0.0 109.98 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -76.62 116.38 17.24 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.165 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 114.1 -7.55 23.29 Favored Glycine 0 N--CA 1.429 -1.831 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.762 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -102.48 145.79 29.06 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -136.09 -12.86 1.9 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.511 0.559 . . . . 0.0 112.511 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -92.5 -140.61 9.76 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.991 -178.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -122.72 134.25 24.88 Favored Pre-proline 0 C--N 1.311 -1.092 0 CA-C-O 120.517 0.199 . . . . 0.0 110.617 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.655 ' HB3' HD23 ' A' ' 264' ' ' LEU . 32.1 Cg_endo -77.79 172.43 15.7 Favored 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 122.66 2.24 . . . . 0.0 112.36 177.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.411 ' HB3' ' HB ' ' A' ' 263' ' ' THR . 34.3 t70 -95.87 111.26 23.29 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.462 177.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 3.8 mp -105.48 124.72 60.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 8.8 t -115.94 117.44 30.15 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 174.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -99.76 107.16 19.16 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 121.187 0.518 . . . . 0.0 111.923 -176.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.453 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 27.2 mt-30 -115.87 161.12 19.26 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 175.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' HIS . . . . . 0.443 ' HA ' ' HE1' ' A' ' 308' ' ' TRP . 30.6 m170 -73.91 -31.37 63.05 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.084 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -80.91 -26.54 36.72 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.707 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' HIS . . . . . 0.453 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 35.5 p-80 -174.03 161.48 3.66 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 120.878 0.37 . . . . 0.0 111.821 175.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.45 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 14.9 mt -106.67 142.75 18.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 177.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 3.1 mp -122.46 116.34 48.7 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' A' ' 300' ' ' LEU . 24.3 t -113.86 119.74 61.87 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 175.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' THR . . . . . 0.411 ' HB ' ' HB3' ' A' ' 252' ' ' ASP . 10.4 m -116.86 123.79 47.92 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 121.181 0.515 . . . . 0.0 110.168 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.655 HD23 ' HB3' ' A' ' 251' ' ' PRO . 21.2 mt -99.02 99.77 10.84 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.585 ' HD3' ' OD1' ' A' ' 297' ' ' ASP . 48.7 mmtt -61.28 129.34 40.77 Favored 'General case' 0 C--N 1.317 -0.815 0 O-C-N 124.147 0.904 . . . . 0.0 113.398 -177.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 63.4 t30 67.59 22.54 9.11 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.839 175.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 48.4 t60 -110.25 112.08 23.81 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 18.4 p -86.27 124.46 32.67 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-O 121.251 0.548 . . . . 0.0 111.451 -178.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 32.6 tp -99.01 127.63 34.49 Favored Pre-proline 0 N--CA 1.418 -2.064 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.699 177.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.87 147.31 55.43 Favored 'Trans proline' 0 N--CA 1.432 -2.092 0 C-N-CA 121.382 1.388 . . . . 0.0 110.692 170.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' THR . . . . . 0.422 ' O ' ' HG2' ' A' ' 274' ' ' GLN . 25.0 p -66.64 -15.06 63.2 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.424 0.63 . . . . 0.0 112.075 -177.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 12.2 m -74.58 -21.18 59.62 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.743 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 226' ' ' THR . 3.1 mm? -102.11 -13.97 17.27 Favored 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.077 -178.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 271' ' ' THR . 9.4 pt20 -77.11 129.78 36.48 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 119.563 -0.855 . . . . 0.0 108.996 -178.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -170.44 159.96 7.24 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -177.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 16.9 p -104.22 140.21 38.15 Favored 'General case' 0 N--CA 1.407 -2.613 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.735 173.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 82.4 mt -99.59 117.29 33.65 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 175.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -47.35 -68.97 0.14 Allowed 'General case' 0 C--N 1.316 -0.85 0 O-C-N 125.085 1.491 . . . . 0.0 110.594 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . 0.271 19.0 m 49.78 18.32 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 127.111 2.164 . . . . 0.0 116.697 173.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -73.75 132.79 43.01 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 22.2 t70 68.77 48.64 0.75 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 122.674 1.226 . . . . 0.0 112.327 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -98.08 -1.62 42.0 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 168.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? 61.86 59.94 1.65 Allowed 'General case' 0 CA--C 1.503 -0.86 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.825 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 236' ' ' ASN . 2.5 p -137.42 176.65 2.6 Favored Pre-proline 0 C--N 1.31 -1.14 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 285' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 3.3 Cg_exo -82.66 -7.1 11.6 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.077 1.852 . . . . 0.0 112.083 174.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.4 p -99.01 127.72 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 CA-C-O 121.623 0.725 . . . . 0.0 110.668 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -88.14 -44.65 10.76 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.441 -172.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -165.06 138.16 4.61 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.319 -176.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 30.7 t -104.39 140.58 22.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -178.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 276' ' ' SER . 75.4 m -142.42 116.35 9.34 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 122.031 -0.418 . . . . 0.0 111.177 177.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 56.2 tp -91.59 128.89 37.6 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 174.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -134.92 133.82 39.99 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 120.783 0.325 . . . . 0.0 110.971 -174.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 293' ' ' ARG . 23.3 ttt180 -71.05 125.11 26.0 Favored 'General case' 0 N--CA 1.4 -2.962 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 171.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.488 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 14.9 tp -102.88 -174.33 2.53 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 176.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.488 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 39.4 t30 -46.64 -74.54 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -120.61 -3.87 9.81 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 122.319 1.057 . . . . 0.0 108.745 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' ASP . . . . . 0.585 ' OD1' ' HD3' ' A' ' 265' ' ' LYS . 39.7 m-20 -111.67 164.12 13.37 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.236 -175.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.462 ' HB ' ' HB2' ' A' ' 264' ' ' LEU . 91.7 m -104.77 128.61 52.96 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 174.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -113.36 129.68 56.47 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -178.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.502 ' HB3' ' HB ' ' A' ' 262' ' ' VAL . 50.5 tp -114.16 119.02 35.65 Favored 'General case' 0 C--N 1.273 -2.758 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 176.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 51.6 mt -104.44 112.01 36.32 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.128 -177.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' ILE . . . . . 0.45 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 56.4 mt -112.6 103.83 16.06 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 3.7 m -77.8 130.38 36.62 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -174.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 15.5 p -135.56 -176.95 4.45 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 122.366 0.266 . . . . 0.0 111.286 -176.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -159.35 152.94 22.74 Favored 'General case' 0 C--O 1.247 0.946 0 C-N-CA 122.965 0.506 . . . . 0.0 110.169 175.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 74.85 -157.07 50.07 Favored Glycine 0 N--CA 1.444 -0.784 0 O-C-N 123.569 0.543 . . . . 0.0 112.955 175.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' ASN . . . . . 0.497 ' HB3' ' HB3' ' A' ' 327' ' ' LYS . 40.8 m-80 -92.39 131.28 37.69 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 177.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 308' ' ' TRP . . . . . 0.707 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 60.8 p-90 -148.77 166.3 28.84 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -178.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -124.76 135.99 53.46 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.707 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 27.0 tp -107.45 118.56 37.03 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.65 HG13 ' HB3' ' A' ' 323' ' ' GLN . 5.7 p -115.26 112.31 39.36 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.515 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 171.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -102.93 129.71 49.74 Favored 'General case' 0 N--CA 1.407 -2.586 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.075 -178.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -129.17 156.98 43.05 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.635 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 26.4 t -111.44 120.95 43.86 Favored 'General case' 0 N--CA 1.411 -2.417 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -88.91 -23.65 22.67 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.024 0.44 . . . . 0.0 110.726 -177.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -169.91 164.14 6.36 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.69 103.11 0.26 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 121.745 1.63 . . . . 0.0 111.238 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 115.01 -28.1 8.22 Favored Glycine 0 N--CA 1.436 -1.347 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -177.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -89.13 116.65 27.55 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.164 0.507 . . . . 0.0 110.339 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -116.28 165.74 12.84 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 115.377 -0.829 . . . . 0.0 108.865 177.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 89.6 m -152.05 130.18 11.91 Favored 'General case' 0 C--N 1.261 -3.278 0 C-N-CA 123.661 0.784 . . . . 0.0 108.894 -176.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -118.57 107.53 13.86 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' GLN . . . . . 0.65 ' HB3' HG13 ' A' ' 311' ' ' VAL . 35.9 tt0 -99.66 112.5 24.72 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 176.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.63 HG13 ' CE3' ' A' ' 308' ' ' TRP . 75.3 t -95.1 98.64 8.2 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.174 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -83.49 149.14 57.07 Favored Pre-proline 0 CA--C 1.512 -0.49 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -77.52 125.6 7.72 Favored 'Trans proline' 0 N--CA 1.44 -1.672 0 N-CA-C 108.498 -1.385 . . . . 0.0 108.498 170.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.497 ' HB3' ' HB3' ' A' ' 307' ' ' ASN . 40.1 ttmt -86.83 102.8 14.64 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -121.07 115.26 22.77 Favored 'General case' 0 N--CA 1.407 -2.583 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.502 -176.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 . . . . . 0 C--N 1.289 -2.039 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.973 -175.944 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 69.9 mtm . . . . . 0 N--CA 1.467 0.401 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 85.06 162.03 34.97 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.517 177.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 15.1 t -98.17 69.04 1.99 Allowed 'General case' 0 N--CA 1.413 -2.32 0 CA-C-O 122.076 0.941 . . . . 0.0 108.682 178.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 17.3 m -114.29 -45.98 3.01 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 114.533 -1.212 . . . . 0.0 108.61 176.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -141.18 114.91 9.0 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.587 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 -131.98 176.72 8.12 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 171.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 42.3 t-80 63.15 80.97 0.22 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 122.012 0.911 . . . . 0.0 109.921 -177.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -73.91 73.63 1.63 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.949 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 24.7 m80 64.18 -163.71 0.26 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.795 0.838 . . . . 0.0 110.158 -174.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -154.18 -72.76 0.13 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 175.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 66.47 -105.12 1.2 Allowed Glycine 0 N--CA 1.435 -1.413 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -176.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 29.8 tp -119.95 7.35 10.9 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.624 0.726 . . . . 0.0 109.766 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 46.8 t -122.45 128.25 25.53 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.918 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -66.02 132.84 31.3 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 121.968 1.779 . . . . 0.0 109.323 174.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.431 ' NE ' ' HA ' ' A' ' 206' ' ' ARG . 1.6 mmp_? -118.72 105.39 11.52 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.107 0.48 . . . . 0.0 110.221 -174.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 79.87 18.33 72.88 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.743 -176.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 32.0 m -137.35 4.34 2.65 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.413 -0.394 . . . . 0.0 112.001 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -104.56 100.29 9.96 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.961 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 23.1 ptt? -178.6 104.73 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.526 1.131 . . . . 0.0 109.974 175.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -84.87 -23.12 29.12 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 122.128 0.965 . . . . 0.0 108.966 177.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 20.2 t -154.09 162.36 41.25 Favored 'General case' 0 N--CA 1.414 -2.264 0 N-CA-C 104.705 -2.332 . . . . 0.0 104.705 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 16.4 tpt -121.29 134.82 55.16 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -177.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . 0.264 48.4 p 65.63 -60.72 0.27 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.968 1.707 . . . . 0.0 115.298 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -158.64 101.39 0.2 Allowed Glycine 0 N--CA 1.431 -1.657 0 C-N-CA 120.105 -1.045 . . . . 0.0 112.905 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -98.04 -45.88 2.34 Favored Glycine 0 C--N 1.3 -1.454 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 175.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -112.37 105.18 13.39 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -144.06 -55.97 0.37 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 65.9 mtt -106.28 -179.69 4.01 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.773 -178.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -118.33 -161.25 11.81 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 110.181 -1.167 . . . . 0.0 110.181 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -72.11 -35.66 69.22 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 117.274 0.537 . . . . 0.0 110.576 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -130.6 -89.86 0.53 Allowed Glycine 0 N--CA 1.436 -1.366 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 178.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.498 ' HB3' ' OH ' ' A' ' 319' ' ' TYR . 51.0 m 65.72 15.71 10.17 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 113.809 1.041 . . . . 0.0 113.809 176.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -125.69 1.11 7.49 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.547 0.689 . . . . 0.0 110.615 178.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' GLN . . . . . 0.427 ' O ' HD23 ' A' ' 245' ' ' LEU . 11.5 pm0 -140.9 156.87 46.01 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 56.9 m -67.44 116.39 8.13 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.407 ' ND2' ' HB3' ' A' ' 243' ' ' ALA . 10.0 p30 -144.51 173.02 12.17 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.308 -172.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.58 HD13 HD21 ' A' ' 277' ' ' LEU . 1.4 pp -136.06 158.65 38.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 CA-C-N 114.145 -1.389 . . . . 0.0 109.361 -178.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.463 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 12.8 t70 -150.23 151.32 32.85 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.51 ' CD2' HG11 ' A' ' 279' ' ' VAL . 86.4 t80 -129.84 133.75 47.12 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 173.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -153.39 152.81 31.48 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -104.15 153.19 21.23 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.442 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -151.61 162.61 40.7 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 64.7 -125.87 31.49 Favored Glycine 0 C--N 1.312 -0.751 0 O-C-N 123.454 0.471 . . . . 0.0 112.849 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -124.03 91.81 3.54 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ASN . . . . . 0.581 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 95.9 m-20 66.66 21.25 10.66 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 177.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -79.79 138.26 37.21 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -99.18 110.4 3.98 Favored Glycine 0 N--CA 1.436 -1.325 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.1 mp -102.7 115.09 44.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 117.483 0.641 . . . . 0.0 109.917 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.5 mp -102.57 113.68 39.86 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 35.1 mt-10 -93.11 145.08 24.66 Favored 'General case' 0 C--N 1.283 -2.284 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.965 173.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 12.0 tp -135.6 134.09 38.95 Favored 'General case' 0 C--N 1.264 -3.14 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.67 -174.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -126.93 106.6 9.42 Favored 'General case' 0 C--N 1.278 -2.514 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.464 ' O ' ' HA2' ' A' ' 318' ' ' GLY . . . -108.75 91.01 3.47 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.427 HD23 ' O ' ' A' ' 225' ' ' GLN . 3.3 mm? -84.4 114.0 21.58 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.678 0.752 . . . . 0.0 111.141 -175.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 116.51 3.91 18.18 Favored Glycine 0 N--CA 1.429 -1.767 0 CA-C-N 114.239 -1.346 . . . . 0.0 110.175 -177.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' PHE . . . . . 0.455 ' HB2' ' ND1' ' A' ' 267' ' ' HIS . 65.8 t80 -113.12 115.63 28.59 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 121.016 0.436 . . . . 0.0 110.25 -177.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -112.98 100.03 8.32 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 154.43 -158.37 28.17 Favored Glycine 0 N--CA 1.432 -1.597 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -114.43 140.89 25.72 Favored Pre-proline 0 C--N 1.301 -1.511 0 CA-C-N 116.853 0.327 . . . . 0.0 110.359 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.798 ' HB3' HD13 ' A' ' 264' ' ' LEU . 17.9 Cg_endo -72.57 171.85 16.32 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.56 2.173 . . . . 0.0 111.112 175.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 18.0 t70 -88.45 109.93 20.43 Favored 'General case' 0 C--N 1.277 -2.58 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 4.1 mp -97.99 108.18 21.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 121.84 0.828 . . . . 0.0 110.102 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' SER . . . . . 0.656 ' HB2' ' HB ' ' A' ' 261' ' ' ILE . 47.3 m -109.99 107.18 16.97 Favored 'General case' 0 C--N 1.278 -2.526 0 CA-C-N 114.482 -1.236 . . . . 0.0 108.43 177.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -99.18 126.73 45.02 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 122.126 -0.359 . . . . 0.0 110.865 -175.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -124.21 171.68 9.65 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 171.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -76.59 -40.12 50.51 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 120.871 0.367 . . . . 0.0 110.994 -177.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -82.79 -20.37 35.92 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.826 -175.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -171.99 160.83 5.5 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.905 0.384 . . . . 0.0 111.448 176.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.459 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 16.7 mt -106.71 143.78 16.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' ILE . . . . . 0.656 ' HB ' ' HB2' ' A' ' 254' ' ' SER . 3.9 mp -119.79 109.76 27.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 176.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.482 ' HB ' ' HB3' ' A' ' 300' ' ' LEU . 61.6 t -111.45 123.24 67.11 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.426 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 176.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 298' ' ' THR . 11.9 m -126.19 130.06 50.22 Favored 'General case' 0 C--N 1.285 -2.216 0 C-N-CA 120.096 -0.642 . . . . 0.0 111.029 -177.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.798 HD13 ' HB3' ' A' ' 251' ' ' PRO . 1.3 mm? -100.81 98.04 8.59 Favored 'General case' 0 N--CA 1.408 -2.574 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 177.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.493 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 58.6 mtpt -73.27 135.55 44.48 Favored 'General case' 0 C--N 1.267 -3.015 0 O-C-N 124.191 0.932 . . . . 0.0 110.81 -177.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 6.2 t30 72.85 20.65 3.55 Favored 'General case' 0 CA--C 1.55 0.961 0 O-C-N 124.539 1.15 . . . . 0.0 109.716 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' HIS . . . . . 0.455 ' ND1' ' HB2' ' A' ' 247' ' ' PHE . 54.5 t60 -114.85 100.1 7.97 Favored 'General case' 0 CA--C 1.495 -1.173 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 176.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.97 116.74 17.9 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-O 120.847 0.356 . . . . 0.0 110.436 -176.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 22.5 tp -99.29 123.08 49.86 Favored Pre-proline 0 N--CA 1.436 -1.175 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.769 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -67.73 158.0 59.2 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 122.429 2.086 . . . . 0.0 111.849 171.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' THR . . . . . 0.418 ' O ' ' HG2' ' A' ' 274' ' ' GLN . 24.6 p -68.34 -26.3 65.53 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 15.4 m -72.53 -19.74 61.46 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.353 -177.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -95.15 -22.31 17.94 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.492 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' A' ' 271' ' ' THR . 9.2 pt20 -77.47 140.03 39.75 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -177.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -177.96 175.46 1.29 Allowed 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -175.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 32.9 t -125.62 143.07 51.19 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-O 121.527 0.679 . . . . 0.0 110.453 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.58 HD21 HD13 ' A' ' 228' ' ' ILE . 1.3 mm? -91.84 103.14 15.72 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 102.917 -2.994 . . . . 0.0 102.917 174.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -59.2 -50.55 73.6 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 123.727 0.642 . . . . 0.0 112.089 -173.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' VAL . . . . . 0.51 HG11 ' CD2' ' A' ' 230' ' ' PHE . 25.8 m 44.9 30.1 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 173.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -72.52 134.32 45.2 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.646 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 73.59 19.62 3.26 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.069 1.348 . . . . 0.0 113.548 -174.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -79.35 -21.94 45.14 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.345 170.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? 57.8 61.86 2.27 Favored 'General case' 0 CA--C 1.493 -1.212 0 CA-C-O 122.253 1.025 . . . . 0.0 113.641 174.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 4.8 p -125.3 -178.67 0.73 Allowed Pre-proline 0 C--N 1.275 -2.641 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' PRO . . . . . 0.581 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 14.4 Cg_exo -71.1 -16.91 31.93 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 CA-C-N 121.281 1.493 . . . . 0.0 110.637 174.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.5 p -95.75 126.61 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-O 122.25 1.024 . . . . 0.0 110.562 177.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -84.16 -47.31 10.99 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 113.938 -1.483 . . . . 0.0 110.278 -175.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -162.09 148.84 13.67 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 -177.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.502 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 62.0 t -116.39 122.71 70.37 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.669 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 53.7 m -123.86 120.33 32.25 Favored 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.951 -0.468 . . . . 0.0 111.951 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 48.2 tp -94.53 122.8 37.48 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 175.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -129.84 141.89 50.76 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -176.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -82.41 138.97 34.28 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 118.501 -1.279 . . . . 0.0 108.843 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.481 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 17.0 tp -108.25 -175.32 2.74 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 176.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.481 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 26.0 t-20 -49.03 -67.45 0.26 Allowed 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 118.918 0.781 . . . . 0.0 113.0 -177.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -119.44 -2.21 10.6 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 122.13 0.967 . . . . 0.0 108.462 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' ASP . . . . . 0.493 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 5.5 m-20 -117.07 168.51 10.2 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.094 -169.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 263' ' ' THR . 58.8 m -111.73 124.21 51.86 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 176.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -113.13 124.61 52.97 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-O 121.582 0.706 . . . . 0.0 109.476 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.482 ' HB3' ' HB ' ' A' ' 262' ' ' VAL . 58.6 tp -110.97 120.34 42.07 Favored 'General case' 0 C--N 1.274 -2.689 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 54.9 mt -106.42 109.77 29.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.245 -176.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' ILE . . . . . 0.459 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 57.5 mt -107.96 103.18 15.08 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.496 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 8.4 m -77.1 131.1 38.17 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 -175.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 18.9 p -134.73 175.88 9.15 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 122.395 0.278 . . . . 0.0 111.719 -175.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -164.2 139.62 6.02 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.906 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 99.11 -151.87 19.52 Favored Glycine 0 N--CA 1.434 -1.479 0 C-N-CA 121.25 -0.5 . . . . 0.0 112.354 177.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' ASN . . . . . 0.45 ' HB3' ' HB3' ' A' ' 327' ' ' LYS . 64.4 m-20 -105.85 124.5 49.67 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 177.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 308' ' ' TRP . . . . . . . . . . . . . 69.1 p-90 -150.24 158.11 43.81 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.766 -176.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -115.62 137.88 51.63 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 1.4 tt -104.55 114.03 27.99 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 46.0 t -108.09 106.71 21.18 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 172.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -95.96 141.0 29.9 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' LYS . . . . . 0.429 ' HB2' ' HB ' ' A' ' 321' ' ' THR . 86.8 mttt -131.14 141.07 50.06 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -178.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 20.3 m -115.81 109.32 17.49 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -77.38 -33.41 55.17 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.586 0.707 . . . . 0.0 109.783 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -170.19 161.56 6.5 Favored Pre-proline 0 C--N 1.305 -1.364 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -65.24 96.97 0.29 Allowed 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 121.387 1.391 . . . . 0.0 110.245 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 244' ' ' ALA . . . 135.62 -16.81 4.02 Favored Glycine 0 N--CA 1.424 -2.107 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.74 -176.154 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 319' ' ' TYR . . . . . 0.498 ' OH ' ' HB3' ' A' ' 223' ' ' SER . 54.9 m-85 -122.29 118.39 28.39 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 122.344 -0.503 . . . . 0.0 110.171 178.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -126.87 161.79 27.42 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.507 -178.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.429 ' HB ' ' HB2' ' A' ' 313' ' ' LYS . 49.3 m -151.87 138.62 18.85 Favored 'General case' 0 C--N 1.267 -2.999 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -176.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -127.41 107.44 9.96 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' GLN . . . . . 0.618 HE21 HD21 ' A' ' 325' ' ' LEU . 45.9 tt0 -94.06 101.34 13.37 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 86.6 t -89.05 101.17 11.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.001 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.618 HD21 HE21 ' A' ' 323' ' ' GLN . 40.3 mt -95.59 145.39 29.45 Favored Pre-proline 0 C--N 1.299 -1.596 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.995 -176.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -72.25 123.61 9.32 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 121.102 1.201 . . . . 0.0 109.97 172.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 307' ' ' ASN . 41.0 ttmt -80.82 132.23 35.47 Favored 'General case' 0 CA--C 1.474 -1.962 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.713 -175.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -89.69 104.69 17.22 Favored 'General case' 0 N--CA 1.404 -2.736 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.582 -178.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 . . . . . 0 C--N 1.304 -1.396 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 -179.176 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 88.0 mtp . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 81.58 26.49 50.59 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.062 -1.066 . . . . 0.0 110.482 -177.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 18.7 m -71.1 -19.07 62.5 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 123.408 0.683 . . . . 0.0 112.232 -175.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 16.9 m -84.84 -9.45 58.13 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.488 0.661 . . . . 0.0 110.354 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -87.99 76.9 8.54 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.274 0.559 . . . . 0.0 112.083 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -151.25 88.71 1.46 Allowed 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 174.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -137.74 155.21 49.31 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -68.18 131.44 45.39 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.975 0.893 . . . . 0.0 111.602 -177.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -84.61 92.94 8.27 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 114.66 -1.154 . . . . 0.0 109.281 -176.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -97.58 23.66 7.51 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 114.348 -1.296 . . . . 0.0 110.489 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 117.2 125.86 3.69 Favored Glycine 0 N--CA 1.43 -1.713 0 N-CA-C 108.629 -1.789 . . . . 0.0 108.629 -174.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 72.49 159.37 0.21 Allowed 'General case' 0 C--O 1.247 0.961 0 C-N-CA 124.407 1.083 . . . . 0.0 111.53 -174.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 5.4 m -122.56 109.9 32.4 Favored Pre-proline 0 C--N 1.299 -1.594 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.678 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -51.16 111.43 0.56 Allowed 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.49 2.794 . . . . 0.0 112.902 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 78.15 -17.29 0.59 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.436 1.894 . . . . 0.0 112.017 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -68.88 -45.23 64.87 Favored Glycine 0 N--CA 1.451 -0.348 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 175.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 11.8 p -95.27 101.41 13.14 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 170.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -69.67 -49.54 52.62 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -170.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 64.2 mtm 70.81 107.13 0.06 Allowed 'General case' 0 N--CA 1.479 1.001 0 O-C-N 124.575 1.172 . . . . 0.0 108.314 -171.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -71.42 -34.86 70.69 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 18.0 p -153.95 112.18 3.58 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 120.567 0.222 . . . . 0.0 110.668 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 67.1 mtt -66.76 95.48 0.36 Allowed 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 51.2 m -87.54 107.04 18.39 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 121.361 0.6 . . . . 0.0 110.683 -177.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -139.28 -94.36 0.28 Allowed Glycine 0 N--CA 1.425 -2.05 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -80.02 87.82 1.27 Allowed Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -107.77 101.06 10.38 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -139.41 11.29 2.54 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.552 -176.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 27.9 ttt -133.16 16.26 4.14 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 121.82 0.819 . . . . 0.0 110.53 -176.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -160.32 77.96 0.17 Allowed Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 119.552 -1.309 . . . . 0.0 112.55 -178.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -100.19 -16.68 17.69 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 153.8 -62.16 0.37 Allowed Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.25 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 22.9 t -97.85 118.69 34.98 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.296 0.57 . . . . 0.0 110.524 -176.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -146.24 -48.14 0.2 Allowed 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.666 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' GLN . . . . . 0.485 ' CG ' HD21 ' A' ' 273' ' ' LEU . 1.1 tp60 -121.53 168.65 11.49 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -176.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.556 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 16.3 m -50.65 128.6 20.87 Favored 'General case' 0 CA--C 1.552 1.021 0 O-C-N 123.923 0.764 . . . . 0.0 110.73 177.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -146.07 156.6 43.57 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.048 0.452 . . . . 0.0 110.224 -174.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.566 HG12 ' HB2' ' A' ' 291' ' ' LEU . 2.1 pp -138.73 146.04 26.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 C-N-CA 124.882 1.273 . . . . 0.0 109.491 -177.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -150.58 157.16 42.67 Favored 'General case' 0 C--N 1.29 -1.991 0 O-C-N 123.34 0.4 . . . . 0.0 111.103 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -126.67 138.01 53.36 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-O 120.811 0.339 . . . . 0.0 111.153 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -146.92 168.11 22.28 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 173.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.423 ' HE3' HG22 ' A' ' 284' ' ' THR . 55.4 mtpt -116.01 155.52 27.94 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 122.402 -0.186 . . . . 0.0 110.677 178.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -138.55 145.47 40.71 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 123.366 0.416 . . . . 0.0 110.175 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 56.33 -104.7 0.38 Allowed Glycine 0 N--CA 1.441 -0.97 0 O-C-N 124.566 1.166 . . . . 0.0 114.796 172.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -119.15 83.86 2.1 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-O 121.212 0.53 . . . . 0.0 109.852 -176.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ASN . . . . . 0.452 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 94.9 m-20 61.37 23.05 13.35 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.646 -1.161 . . . . 0.0 114.075 172.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -78.32 136.63 37.75 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -99.45 114.57 5.06 Favored Glycine 0 N--CA 1.431 -1.697 0 N-CA-C 111.689 -0.564 . . . . 0.0 111.689 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.1 mp -107.49 115.84 49.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-O 121.35 0.595 . . . . 0.0 110.847 -177.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.3 mp -99.17 116.65 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.459 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 175.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -90.73 135.76 33.51 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 16.3 tp -130.86 131.85 44.81 Favored 'General case' 0 C--N 1.278 -2.514 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.057 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' ALA . . . . . 0.556 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -128.74 102.36 6.53 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -111.21 92.25 3.97 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.479 0.656 . . . . 0.0 109.697 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -76.42 114.59 15.29 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.224 -176.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 107.1 18.73 10.14 Favored Glycine 0 N--CA 1.431 -1.646 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.579 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -115.11 116.08 27.83 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -104.88 95.15 5.67 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.147 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 143.6 -166.17 26.97 Favored Glycine 0 C--N 1.299 -1.515 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 175.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -102.28 144.87 29.47 Favored Pre-proline 0 C--N 1.308 -1.205 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 177.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.625 ' HB3' HD23 ' A' ' 264' ' ' LEU . 21.5 Cg_endo -77.14 173.32 14.59 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.955 2.437 . . . . 0.0 112.38 178.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -97.76 118.0 33.33 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 3.2 mp -107.25 133.13 52.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-O 120.977 0.417 . . . . 0.0 111.18 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' SER . . . . . 0.495 ' HB3' ' HB ' ' A' ' 261' ' ' ILE . 23.2 t -115.81 111.35 20.37 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 173.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -90.86 105.05 17.56 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.342 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 74.8 mt-30 -125.14 152.52 44.32 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 176.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -60.1 -45.13 94.0 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -176.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -83.87 -20.14 33.61 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -174.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' HIS . . . . . 0.459 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 49.1 p-80 -171.8 158.75 5.0 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.083 0.468 . . . . 0.0 111.853 175.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.442 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 23.7 mt -106.72 144.14 16.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' ILE . . . . . 0.495 ' HB ' ' HB3' ' A' ' 254' ' ' SER . 3.5 mp -119.82 112.97 39.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 176.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.497 ' HB ' ' HB2' ' A' ' 300' ' ' LEU . 54.7 t -107.18 116.44 50.84 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 176.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 17.3 m -109.54 124.1 50.54 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-O 121.146 0.498 . . . . 0.0 110.19 -178.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.625 HD23 ' HB3' ' A' ' 251' ' ' PRO . 18.2 mt -102.96 89.84 3.57 Favored 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 178.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.605 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 61.2 mtpt -65.68 131.28 45.94 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.667 -175.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 71.23 21.08 4.85 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 124.601 1.188 . . . . 0.0 109.843 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -117.99 102.02 8.73 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 177.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 2.5 m -91.43 115.41 28.01 Favored 'General case' 0 C--N 1.28 -2.455 0 C-N-CA 119.829 -0.749 . . . . 0.0 111.208 -173.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 270' ' ' PRO . 21.2 tp -89.89 130.3 43.23 Favored Pre-proline 0 N--CA 1.43 -1.466 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.761 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.419 ' O ' ' HG ' ' A' ' 269' ' ' LEU . 6.7 Cg_exo -73.85 156.95 48.07 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 122.057 1.838 . . . . 0.0 110.603 170.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 271' ' ' THR . . . . . 0.508 ' HA ' ' HG2' ' A' ' 274' ' ' GLN . 7.1 p -73.55 -10.46 59.73 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.623 0.725 . . . . 0.0 112.186 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 15.4 m -73.59 -24.06 60.01 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.206 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.485 HD21 ' CG ' ' A' ' 225' ' ' GLN . 7.8 mp -101.95 -12.16 18.41 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.704 -174.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.508 ' HG2' ' HA ' ' A' ' 271' ' ' THR . 4.2 pt20 -81.12 127.37 32.57 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.0 -176.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -153.58 163.35 40.12 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 13.9 p -124.29 127.41 47.6 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-O 121.792 0.806 . . . . 0.0 111.714 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.565 HD21 HD13 ' A' ' 228' ' ' ILE . 2.1 mm? -81.25 118.45 22.61 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -84.39 92.89 8.15 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 118.66 -1.216 . . . . 0.0 108.543 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' VAL . . . . . 0.638 ' HA ' ' CD2' ' A' ' 282' ' ' PHE . 46.9 t -94.88 28.97 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 CA-C-O 123.328 1.537 . . . . 0.0 109.793 -175.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -79.74 149.92 30.99 Favored 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 175.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 28.1 t70 70.21 9.04 6.9 Favored 'General case' 0 CA--C 1.556 1.177 0 CA-C-O 122.156 0.979 . . . . 0.0 111.715 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.638 ' CD2' ' HA ' ' A' ' 279' ' ' VAL . 16.4 m-85 -83.38 -13.47 54.85 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 121.737 -0.602 . . . . 0.0 111.045 176.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 mptt 58.4 60.99 2.4 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.094 0.558 . . . . 0.0 111.132 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' THR . . . . . 0.423 HG22 ' HE3' ' A' ' 232' ' ' LYS . 1.5 p -136.64 174.74 4.12 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 285' ' ' PRO . . . . . 0.456 ' HB3' ' HB3' ' A' ' 308' ' ' TRP . 13.9 Cg_exo -71.47 -19.52 28.46 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 121.739 1.626 . . . . 0.0 111.601 175.243 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.3 p -94.85 132.76 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-O 121.517 0.675 . . . . 0.0 110.21 178.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -100.01 -32.27 11.04 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.9 -174.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 40.2 tttp -162.86 134.48 5.11 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 120.051 -0.659 . . . . 0.0 109.8 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.458 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 42.0 t -103.48 110.14 29.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 174.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.511 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 93.8 m -112.57 113.55 25.76 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-O 121.004 0.43 . . . . 0.0 111.375 -176.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.566 ' HB2' HG12 ' A' ' 228' ' ' ILE . 37.9 tp -94.93 122.71 37.86 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 173.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -140.84 144.4 35.33 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -79.02 149.9 32.08 Favored 'General case' 0 C--N 1.282 -2.339 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.468 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.554 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 15.8 tp -111.62 -173.98 2.36 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 176.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.554 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 64.0 t30 -51.78 -62.7 1.47 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.954 0.502 . . . . 0.0 112.091 -177.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -122.4 -3.21 8.91 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 121.154 0.502 . . . . 0.0 110.08 176.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' ASP . . . . . 0.605 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 11.8 m-20 -115.72 169.07 9.48 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.823 -170.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.527 ' HB ' ' HB2' ' A' ' 264' ' ' LEU . 86.7 m -106.28 135.32 47.96 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 176.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -122.68 127.71 49.64 Favored 'General case' 0 N--CA 1.417 -2.091 0 CA-C-O 121.522 0.677 . . . . 0.0 110.569 -176.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.497 ' HB2' ' HB ' ' A' ' 262' ' ' VAL . 1.8 mt -106.13 119.56 39.52 Favored 'General case' 0 C--N 1.273 -2.729 0 CA-C-N 115.32 -0.854 . . . . 0.0 108.902 175.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 301' ' ' ILE . . . . . 0.511 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 67.3 mt -108.0 109.26 27.59 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.796 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 302' ' ' ILE . . . . . 0.442 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 61.1 mt -108.94 101.06 12.02 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 24.9 m -69.51 132.3 46.06 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -178.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 11.4 p -137.41 169.76 17.23 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 122.896 0.479 . . . . 0.0 111.023 -177.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -159.11 144.72 16.25 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 92.2 -152.69 21.41 Favored Glycine 0 N--CA 1.436 -1.358 0 O-C-N 123.892 0.745 . . . . 0.0 112.623 176.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' ASN . . . . . 0.572 ' HB2' ' O ' ' A' ' 327' ' ' LYS . 6.6 m120 -101.17 129.19 47.05 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 308' ' ' TRP . . . . . 0.456 ' HB3' ' HB3' ' A' ' 285' ' ' PRO . 67.4 p-90 -153.59 162.9 40.82 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.011 -177.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.416 ' HG2' ' HE2' ' A' ' 327' ' ' LYS . 3.4 mt-10 -122.62 135.36 54.59 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -178.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 1.5 tt -102.74 122.87 45.34 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.683 HG13 ' HB3' ' A' ' 323' ' ' GLN . 7.6 p -125.53 111.97 29.26 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 CA-C-O 121.883 0.849 . . . . 0.0 109.794 170.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -98.79 135.97 39.49 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.259 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -128.2 139.74 52.29 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.098 -176.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 35.9 p -115.99 122.24 44.65 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 176.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -81.16 -38.03 27.8 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.698 0.761 . . . . 0.0 109.321 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.401 ' HB1' ' HD2' ' A' ' 317' ' ' PRO . . . -163.27 162.21 17.76 Favored Pre-proline 0 C--N 1.308 -1.21 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 317' ' ' PRO . . . . . 0.401 ' HD2' ' HB1' ' A' ' 316' ' ' ALA . 16.5 Cg_endo -58.29 110.43 0.65 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.038 1.826 . . . . 0.0 110.811 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 113.86 -36.13 4.17 Favored Glycine 0 N--CA 1.424 -2.104 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -93.29 115.59 28.18 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' PHE . . . . . 0.409 ' CZ ' ' HD3' ' A' ' 251' ' ' PRO . 74.4 m-85 -127.32 166.36 17.96 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-O 122.228 1.013 . . . . 0.0 111.407 -175.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 84.8 m -151.93 127.36 9.99 Favored 'General case' 0 C--N 1.278 -2.531 0 CA-C-N 113.988 -1.46 . . . . 0.0 108.604 -177.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -116.55 111.49 20.0 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' GLN . . . . . 0.683 ' HB3' HG13 ' A' ' 311' ' ' VAL . 61.6 tt0 -97.76 104.28 16.29 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.415 HG13 ' CE3' ' A' ' 308' ' ' TRP . 88.2 t -90.28 98.87 8.72 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 33.0 mt -87.05 148.61 45.62 Favored Pre-proline 0 C--N 1.292 -1.92 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.057 -178.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -77.43 143.46 21.92 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 121.62 1.547 . . . . 0.0 111.134 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.572 ' O ' ' HB2' ' A' ' 307' ' ' ASN . 19.7 ttmm -124.14 154.68 39.68 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 328' ' ' LYS . . . . . 0.429 ' HZ3' ' HB2' ' A' ' 328' ' ' LYS . 0.5 OUTLIER -152.16 122.45 7.22 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.71 -0.618 . . . . 0.0 110.511 173.536 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 . . . . . 0 N--CA 1.417 -2.121 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 177.308 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.469 0.477 0 CA-C-O 120.358 0.123 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 90.77 52.86 2.36 Favored Glycine 0 CA--C 1.489 -1.587 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 -175.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 11.3 m -70.43 90.27 0.71 Allowed 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.818 -0.691 . . . . 0.0 112.042 -174.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 7.5 t -121.95 131.64 54.12 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 174.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -52.45 -54.21 35.34 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 123.711 0.632 . . . . 0.0 112.169 -173.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -167.67 -37.6 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.842 0.353 . . . . 0.0 110.122 176.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -75.73 159.13 31.41 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.423 177.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -114.05 134.72 54.68 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 177.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 31.4 t-80 -66.05 -8.16 21.64 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.046 0.938 . . . . 0.0 111.815 -175.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 11.0 t60 71.36 108.34 0.06 Allowed 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 125.694 1.598 . . . . 0.0 111.195 176.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 145.33 -161.41 28.17 Favored Glycine 0 N--CA 1.416 -2.69 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 6.2 mp -97.92 -31.19 12.31 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 121.391 0.615 . . . . 0.0 109.442 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 21.9 t -133.61 126.84 19.28 Favored Pre-proline 0 C--N 1.313 -1.006 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.97 -50.34 6.46 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.58 2.187 . . . . 0.0 111.065 176.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -145.95 129.05 16.58 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 175.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -157.4 -163.27 12.37 Favored Glycine 0 N--CA 1.426 -1.973 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 20.6 m -84.95 -30.65 24.12 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 116.856 0.328 . . . . 0.0 110.313 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' HIS . . . . . 0.529 ' O ' ' HG3' ' A' ' 210' ' ' MET . 45.2 t-80 -86.97 73.4 9.92 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.689 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' MET . . . . . 0.529 ' HG3' ' O ' ' A' ' 209' ' ' HIS . 36.2 mtm 170.55 129.49 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 129.069 2.948 . . . . 0.0 106.271 176.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . 67.14 98.21 0.05 Allowed 'General case' 0 C--O 1.242 0.686 0 O-C-N 124.421 1.076 . . . . 0.0 111.485 -177.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 21.9 m -78.71 146.05 34.16 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.03 178.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 43.2 tpp -79.69 106.77 11.95 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 1.7 p -82.5 90.83 6.79 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -172.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 73.97 -38.85 0.95 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 116.413 1.325 . . . . 0.0 116.413 172.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -72.43 68.64 1.18 Allowed Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 116.03 1.172 . . . . 0.0 116.03 -173.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -135.75 76.79 1.63 Allowed 'General case' 0 C--O 1.246 0.905 0 CA-C-O 121.06 0.457 . . . . 0.0 110.513 174.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -120.69 -40.4 2.66 Favored 'General case' 0 C--O 1.207 -1.165 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.589 175.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 26.3 mmt 64.24 123.11 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 176.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 64.59 -92.12 0.12 Allowed Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.262 -0.881 . . . . 0.0 113.755 176.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -136.24 17.29 3.19 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.088 0.47 . . . . 0.0 110.667 -177.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 107.99 84.58 1.66 Allowed Glycine 0 CA--C 1.488 -1.63 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 -177.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.513 ' OG ' HD21 ' A' ' 245' ' ' LEU . 35.7 t -71.4 73.27 0.71 Allowed 'General case' 0 N--CA 1.428 -1.573 0 CA-C-O 122.323 1.059 . . . . 0.0 112.9 -174.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -128.22 5.7 5.84 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 169.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' GLN . . . . . 0.506 ' O ' HD23 ' A' ' 245' ' ' LEU . 3.6 pt20 -142.86 157.34 44.69 Favored 'General case' 0 N--CA 1.42 -1.945 0 CA-C-N 113.505 -1.679 . . . . 0.0 108.025 -174.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.594 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 43.3 m -78.43 127.61 32.43 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 121.118 0.485 . . . . 0.0 112.198 -175.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -151.89 166.35 31.72 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.372 -177.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.3 pp -121.43 165.45 17.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.321 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -150.25 156.46 41.62 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -133.39 130.6 38.96 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.234 0.54 . . . . 0.0 109.749 176.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.42 ' HD2' ' OE2' ' A' ' 241' ' ' GLU . 5.4 ptp180 -149.81 165.33 32.82 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.37 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -108.92 142.09 40.05 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ASP . . . . . 0.542 ' O ' ' HB3' ' A' ' 237' ' ' ALA . 18.8 t70 -156.77 117.99 3.75 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -178.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 102.13 -143.43 15.95 Favored Glycine 0 C--N 1.301 -1.412 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -178.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -114.46 101.5 9.19 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 117.468 0.634 . . . . 0.0 110.032 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 18.9 m120 65.39 27.25 11.91 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.621 1.168 . . . . 0.0 111.896 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 233' ' ' ASP . . . -97.94 134.74 40.64 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.304 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' GLY . . . . . 0.556 ' HA3' ' CG1' ' A' ' 286' ' ' VAL . . . -101.44 123.9 8.06 Favored Glycine 0 C--N 1.296 -1.671 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.414 HD12 ' C ' ' A' ' 238' ' ' GLY . 2.1 mp -116.78 120.11 64.03 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-N 118.045 0.923 . . . . 0.0 111.045 -176.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' ILE . . . . . 0.404 HD12 ' N ' ' A' ' 240' ' ' ILE . 3.2 mp -104.21 109.49 27.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 176.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.42 ' OE2' ' HD2' ' A' ' 231' ' ' ARG . 5.4 mt-10 -93.59 128.53 39.79 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-O 121.435 0.636 . . . . 0.0 109.742 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 13.0 tp -115.24 126.64 54.78 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 115.186 -0.916 . . . . 0.0 112.092 -171.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' ALA . . . . . 0.594 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -108.27 104.11 13.43 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 175.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -112.25 91.88 3.82 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.432 0.634 . . . . 0.0 109.477 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.513 HD21 ' OG ' ' A' ' 223' ' ' SER . 3.5 mm? -85.36 116.83 23.92 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.769 -175.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 108.68 13.33 18.85 Favored Glycine 0 N--CA 1.424 -2.113 0 CA-C-N 114.24 -1.346 . . . . 0.0 110.16 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -114.86 115.26 26.68 Favored 'General case' 0 N--CA 1.423 -1.812 0 C-N-CA 120.6 -0.44 . . . . 0.0 109.875 -177.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -112.93 95.15 5.25 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.05 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 152.47 -157.33 27.22 Favored Glycine 0 C--N 1.296 -1.672 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -114.56 141.55 26.81 Favored Pre-proline 0 C--N 1.303 -1.43 0 CA-C-N 116.991 0.396 . . . . 0.0 110.325 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.761 ' HB3' HD13 ' A' ' 264' ' ' LEU . 12.7 Cg_endo -68.97 172.19 12.29 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.403 2.069 . . . . 0.0 111.053 175.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.451 ' HB3' ' HB ' ' A' ' 263' ' ' THR . 34.1 t0 -97.48 107.84 20.43 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 3.1 mp -95.11 116.23 36.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 3.1 t -119.28 111.27 18.0 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -97.58 128.74 44.54 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -174.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 83.3 mt-30 -125.24 163.13 23.17 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 170.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -76.45 -29.85 57.12 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.29 174.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -68.24 -48.56 64.77 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.308 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' HIS . . . . . 0.506 ' CB ' ' HA ' ' A' ' 303' ' ' THR . 27.6 p-80 -163.37 167.62 21.49 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 116.704 -0.225 . . . . 0.0 110.451 177.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 19.8 mt -105.83 143.1 17.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 3.5 mp -120.93 109.1 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 176.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.511 ' HB ' ' HB3' ' A' ' 300' ' ' LEU . 51.4 t -106.54 117.76 52.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 177.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' THR . . . . . 0.57 ' HA ' ' O ' ' A' ' 298' ' ' THR . 25.3 m -116.79 123.96 48.41 Favored 'General case' 0 C--N 1.278 -2.52 0 CA-C-O 121.773 0.797 . . . . 0.0 111.27 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.761 HD13 ' HB3' ' A' ' 251' ' ' PRO . 1.7 mm? -93.47 98.03 10.93 Favored 'General case' 0 N--CA 1.399 -2.99 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 174.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.546 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 0.5 OUTLIER -67.79 129.81 41.06 Favored 'General case' 0 N--CA 1.388 -3.569 0 O-C-N 124.756 1.285 . . . . 0.0 108.921 -174.832 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 66.6 t30 71.05 27.38 3.34 Favored 'General case' 0 CA--C 1.549 0.924 0 O-C-N 124.483 1.115 . . . . 0.0 110.444 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -121.77 113.18 19.33 Favored 'General case' 0 C--O 1.203 -1.362 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 3.9 p -90.71 129.15 36.83 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' LEU . . . . . 0.575 HD22 HD22 ' A' ' 291' ' ' LEU . 23.8 tp -107.39 129.56 24.09 Favored Pre-proline 0 N--CA 1.446 -0.664 0 C-N-CA 123.624 0.77 . . . . 0.0 109.873 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -64.63 151.34 86.0 Favored 'Trans proline' 0 C--N 1.318 -1.052 0 C-N-CA 122.36 2.04 . . . . 0.0 111.584 172.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' THR . . . . . 0.499 ' HA ' ' HG2' ' A' ' 274' ' ' GLN . 16.3 p -74.96 -13.91 60.57 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.776 0.798 . . . . 0.0 112.176 -178.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 25.0 m -81.09 -17.91 48.39 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 122.018 0.913 . . . . 0.0 110.038 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.43 HD11 ' HB2' ' A' ' 225' ' ' GLN . 96.0 mt -101.19 -19.99 15.48 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.944 -178.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.499 ' HG2' ' HA ' ' A' ' 271' ' ' THR . 11.9 pt20 -74.5 136.15 42.21 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -164.87 178.59 7.05 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -173.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 39.9 m -134.78 123.82 24.19 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.346 0.593 . . . . 0.0 110.872 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.447 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 53.2 mt -91.09 120.25 31.89 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 103.977 -2.601 . . . . 0.0 103.977 174.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -68.2 -42.57 79.7 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.783 -172.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . 0.334 34.0 m 42.65 26.74 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 N-CA-C 117.353 2.353 . . . . 0.0 117.353 175.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -74.6 142.86 44.59 Favored 'General case' 0 N--CA 1.415 -2.209 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 176.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 30.0 t70 72.59 22.94 3.15 Favored 'General case' 0 CA--C 1.553 1.059 0 O-C-N 124.229 0.956 . . . . 0.0 111.521 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -86.78 1.94 50.55 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 176.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? 60.77 59.81 2.04 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 1.1 t -164.95 150.95 8.87 Favored Pre-proline 0 N--CA 1.423 -1.795 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.363 177.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' PRO . . . . . 0.416 ' O ' ' HA ' ' A' ' 304' ' ' THR . 18.4 Cg_exo -44.2 -35.81 8.33 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 124.556 3.504 . . . . 0.0 114.06 174.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.556 ' CG1' ' HA3' ' A' ' 238' ' ' GLY . 0.2 OUTLIER -73.57 115.53 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 CA-C-O 121.767 0.794 . . . . 0.0 109.442 177.32 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -94.7 -37.07 11.47 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.714 -174.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -154.62 146.51 23.48 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -176.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 55.1 t -120.04 125.59 74.4 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.499 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 96.1 m -126.49 127.17 44.93 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-O 121.056 0.455 . . . . 0.0 110.434 178.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.575 HD22 HD22 ' A' ' 269' ' ' LEU . 0.1 OUTLIER -100.88 120.1 39.66 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 174.902 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -123.75 134.3 53.69 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' ARG . . . . . 0.415 ' HG2' ' OE1' ' A' ' 274' ' ' GLN . 9.0 ptm180 -81.32 148.62 29.31 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 117.609 -1.636 . . . . 0.0 108.308 173.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.579 HD13 ' N ' ' A' ' 295' ' ' ASN . 2.8 tm? -122.96 166.9 14.3 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.579 ' N ' HD13 ' A' ' 294' ' ' LEU . 30.3 t-20 -24.02 -70.35 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 127.349 2.26 . . . . 0.0 112.149 177.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -124.7 -2.15 7.88 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' ASP . . . . . 0.546 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 12.3 m-20 -119.04 171.37 8.31 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.578 -168.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 263' ' ' THR . 70.5 m -114.3 128.16 56.22 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 176.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 40.7 tt0 -113.65 116.48 29.53 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -177.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.511 ' HB3' ' HB ' ' A' ' 262' ' ' VAL . 0.6 OUTLIER -101.52 120.25 40.01 Favored 'General case' 0 C--N 1.277 -2.587 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 177.87 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 301' ' ' ILE . . . . . 0.499 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 80.6 mt -110.76 115.19 49.19 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -176.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 45.8 mt -117.37 103.25 14.64 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.552 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.506 ' HA ' ' CB ' ' A' ' 259' ' ' HIS . 85.6 m -75.91 134.43 40.25 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 120.556 0.217 . . . . 0.0 110.416 -177.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 304' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 285' ' ' PRO . 9.1 p -132.76 -179.26 5.36 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 123.237 0.615 . . . . 0.0 110.932 -174.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -155.03 139.88 17.22 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 122.687 0.395 . . . . 0.0 110.162 177.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 77.15 -151.78 39.15 Favored Glycine 0 C--O 1.236 0.263 0 O-C-N 123.635 0.584 . . . . 0.0 112.384 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' ASN . . . . . 0.421 ' HB3' ' HB3' ' A' ' 327' ' ' LYS . 39.4 m-80 -96.59 137.11 36.17 Favored 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 176.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 308' ' ' TRP . . . . . . . . . . . . . 68.9 p-90 -154.13 165.43 36.25 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -175.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 324' ' ' VAL . 5.6 mt-10 -122.03 136.82 54.95 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -178.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.414 HD21 ' HB3' ' A' ' 322' ' ' PHE . 0.5 OUTLIER -107.25 124.21 49.43 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.961 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.57 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 58.3 t -115.88 107.34 22.38 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.637 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 173.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -92.84 124.92 37.18 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -123.46 149.95 44.46 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -177.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 12.9 p -115.69 122.27 45.03 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 177.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -89.81 -29.54 18.57 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.402 0.62 . . . . 0.0 110.494 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -164.29 163.12 15.36 Favored Pre-proline 0 C--N 1.309 -1.179 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -64.64 97.6 0.27 Allowed 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 121.537 1.491 . . . . 0.0 111.504 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 122.17 -20.63 7.97 Favored Glycine 0 C--O 1.218 -0.877 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.992 -177.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -103.17 116.34 32.29 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -121.45 168.27 11.89 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.674 0.749 . . . . 0.0 111.243 -175.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 60.6 m -151.2 129.23 11.79 Favored 'General case' 0 C--N 1.277 -2.569 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.37 -176.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 0.414 ' HB3' HD21 ' A' ' 310' ' ' LEU . 90.4 m-85 -117.53 108.76 15.89 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 177.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 323' ' ' GLN . . . . . 0.57 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 42.1 tt0 -98.9 105.33 17.46 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 309' ' ' GLU . 0.2 OUTLIER -100.97 105.83 18.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 CA-C-O 122.099 0.952 . . . . 0.0 110.102 178.039 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.7 mp -104.17 156.16 36.15 Favored Pre-proline 0 C--N 1.298 -1.637 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.803 -177.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -74.19 128.52 12.22 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 121.697 1.598 . . . . 0.0 112.082 177.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.421 ' HB3' ' HB3' ' A' ' 307' ' ' ASN . 23.1 ttmm -91.91 116.8 29.22 Favored 'General case' 0 CA--C 1.49 -1.342 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 177.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -146.64 157.57 43.74 Favored 'General case' 0 N--CA 1.414 -2.273 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.486 -173.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 . . . . . 0 C--N 1.302 -1.486 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 176.085 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 192' ' ' MET . . . . . 0.684 ' N ' ' HG ' ' A' ' 195' ' ' SER . 15.2 tpt . . . . . 0 N--CA 1.464 0.249 0 N-CA-C 111.131 0.048 . . . . 0.0 111.131 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -145.42 -60.38 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.586 0 C-N-CA 120.029 -1.082 . . . . 0.0 112.025 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 16.6 m -85.12 8.51 17.85 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.392 0.615 . . . . 0.0 110.428 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.684 ' HG ' ' N ' ' A' ' 192' ' ' MET . 7.5 m -65.05 120.8 13.32 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.097 178.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -85.63 -21.72 28.3 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.465 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -76.25 137.71 40.12 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 173.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -82.79 97.12 8.44 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -177.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -56.84 113.68 1.76 Allowed 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.102 -1.408 . . . . 0.0 111.566 -175.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 34.6 m-70 -65.15 126.66 28.79 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 175.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -63.36 -41.02 98.81 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 123.803 0.689 . . . . 0.0 112.613 -171.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -174.38 122.36 0.89 Allowed Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.452 HD12 HG13 ' A' ' 204' ' ' VAL . 4.6 pp -111.27 8.64 21.56 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.25 0.548 . . . . 0.0 111.044 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.452 HG13 HD12 ' A' ' 203' ' ' LEU . 5.8 m -119.8 105.85 42.53 Favored Pre-proline 0 C--N 1.312 -1.059 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.983 -178.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -62.54 127.77 21.71 Favored 'Trans proline' 0 C--O 1.246 0.902 0 C-N-CA 122.519 2.146 . . . . 0.0 110.616 176.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -136.04 165.04 26.62 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -175.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 154.4 156.09 7.54 Favored Glycine 0 N--CA 1.419 -2.461 0 C-N-CA 119.876 -1.154 . . . . 0.0 112.203 176.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 20.0 m -80.58 87.83 5.73 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-O 121.805 0.812 . . . . 0.0 109.205 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -79.68 129.52 34.55 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.865 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 56.4 ttp -104.68 88.03 2.83 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 175.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -84.17 -44.09 14.31 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 17.9 m -89.27 121.02 31.15 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 175.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 44.9 tpp -61.03 107.06 0.67 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.096 0.474 . . . . 0.0 111.599 -177.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 14.1 m -101.75 -12.8 18.06 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.724 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -94.3 127.38 9.06 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.937 -177.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 112.42 179.75 19.59 Favored Glycine 0 N--CA 1.437 -1.239 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.738 177.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 64.1 84.75 0.14 Allowed 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 124.851 1.26 . . . . 0.0 114.35 177.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -119.72 85.3 2.35 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 171.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 19.9 ptp -67.18 116.4 7.93 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.997 -173.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 87.3 -61.25 4.26 Favored Glycine 0 N--CA 1.437 -1.283 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.226 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ARG . . . . . 0.496 ' NE ' ' HA ' ' A' ' 221' ' ' ARG . 3.3 mmp_? -152.91 -161.99 1.4 Allowed 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -74.1 52.32 2.12 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-O 121.641 0.578 . . . . 0.0 111.729 176.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 9.0 m -98.85 105.82 18.01 Favored 'General case' 0 N--CA 1.417 -2.117 0 C-N-CA 124.393 1.077 . . . . 0.0 109.154 -177.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -144.78 11.5 1.42 Allowed 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' GLN . . . . . 0.442 ' O ' HD23 ' A' ' 245' ' ' LEU . 17.7 pt20 -124.27 130.52 52.66 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.492 -172.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.544 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 88.8 m -78.73 131.83 36.74 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.172 177.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -166.91 175.49 7.65 Favored 'General case' 0 CA--C 1.479 -1.788 0 CA-C-O 121.131 0.491 . . . . 0.0 110.289 -175.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.464 HG21 HD13 ' A' ' 300' ' ' LEU . 2.6 pp -128.04 162.72 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.53 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.696 177.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.528 ' HB2' ' HB2' ' A' ' 241' ' ' GLU . 4.8 m-20 -146.78 156.04 42.84 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -129.48 134.42 47.79 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.244 176.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 8.3 ptt-85 -144.15 169.33 18.07 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 175.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.453 ' HE3' HG22 ' A' ' 284' ' ' THR . 55.3 mtpt -114.93 150.2 36.07 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 175.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -152.56 152.06 31.41 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -177.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 73.57 -102.75 1.33 Allowed Glycine 0 C--N 1.314 -0.683 0 C-N-CA 121.285 -0.483 . . . . 0.0 113.748 176.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -152.98 104.26 2.82 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 123.2 0.6 . . . . 0.0 110.038 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ASN . . . . . 0.649 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 89.6 m-20 61.21 20.7 11.23 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.112 0.965 . . . . 0.0 111.762 176.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.34 137.84 33.02 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 120.822 0.344 . . . . 0.0 110.259 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -99.91 117.59 5.92 Favored Glycine 0 N--CA 1.425 -2.066 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.1 mp -108.47 117.79 54.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 117.194 0.497 . . . . 0.0 110.797 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' ILE . . . . . 0.408 HD12 ' N ' ' A' ' 240' ' ' ILE . 2.9 mp -103.68 110.12 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 176.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 229' ' ' ASP . 53.7 mt-10 -90.04 123.37 33.87 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 11.9 tp -112.14 124.23 51.98 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-O 120.981 0.42 . . . . 0.0 111.965 -174.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' ALA . . . . . 0.544 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -107.45 107.87 18.94 Favored 'General case' 0 C--O 1.206 -1.216 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 176.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.43 ' HA ' HG23 ' A' ' 226' ' ' THR . . . -118.15 92.35 3.8 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.24 0.543 . . . . 0.0 111.519 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 225' ' ' GLN . 3.6 mm? -86.56 116.25 24.57 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.246 0.546 . . . . 0.0 111.079 -177.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 111.64 -7.79 28.02 Favored Glycine 0 C--N 1.297 -1.603 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.146 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' PHE . . . . . 0.441 ' HB2' ' ND1' ' A' ' 267' ' ' HIS . 47.9 t80 -98.56 128.15 44.77 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -107.57 -34.98 6.86 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -174.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -86.3 -150.1 15.2 Favored Glycine 0 CA--C 1.506 -0.479 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.457 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -115.01 141.13 26.48 Favored Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.766 ' HB3' HD23 ' A' ' 264' ' ' LEU . 10.2 Cg_endo -69.44 172.27 12.62 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.957 1.771 . . . . 0.0 113.951 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.425 ' HB3' ' HB ' ' A' ' 263' ' ' THR . 11.5 t70 -97.49 105.37 17.51 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 176.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.473 HD11 ' HG2' ' A' ' 251' ' ' PRO . 4.8 mp -101.41 117.19 46.32 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 C-N-CA 119.122 -1.031 . . . . 0.0 109.738 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' SER . . . . . 0.498 ' HB3' ' HB ' ' A' ' 261' ' ' ILE . 24.6 t -97.79 112.32 24.27 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 176.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -97.67 101.98 13.63 Favored 'General case' 0 CA--C 1.497 -1.079 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.226 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -104.66 162.14 13.53 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 171.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -76.72 -33.48 58.17 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 120.624 0.249 . . . . 0.0 111.357 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -72.49 -39.3 67.77 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.889 -178.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' HIS . . . . . 0.42 ' CB ' ' HA ' ' A' ' 303' ' ' THR . 32.1 p-80 -166.7 165.96 16.18 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 301' ' ' ILE . 15.9 mt -106.83 142.73 18.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -177.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' ILE . . . . . 0.498 ' HB ' ' HB3' ' A' ' 254' ' ' SER . 3.6 mp -126.04 112.0 28.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 299' ' ' GLN . 0.8 OUTLIER -102.49 141.49 18.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 177.316 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 263' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 252' ' ' ASP . 6.2 m -129.05 118.88 23.25 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-O 121.2 0.524 . . . . 0.0 109.639 176.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.766 HD23 ' HB3' ' A' ' 251' ' ' PRO . 31.5 mt -96.76 95.36 7.85 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.428 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 31.6 mmtp -63.92 133.96 54.23 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.731 -1.122 . . . . 0.0 113.403 -174.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 65.9 t30 69.56 9.07 7.08 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 113.533 -1.667 . . . . 0.0 110.801 176.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' HIS . . . . . 0.441 ' ND1' ' HB2' ' A' ' 247' ' ' PHE . 46.4 t60 -100.25 114.39 27.8 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.938 -176.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.89 118.19 28.42 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 269' ' ' LEU . . . . . 0.409 HD22 HD22 ' A' ' 291' ' ' LEU . 31.4 tp -96.92 127.48 38.87 Favored Pre-proline 0 N--CA 1.439 -0.982 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.176 177.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -62.87 136.31 56.59 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.193 1.929 . . . . 0.0 111.26 170.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' THR . . . . . 0.497 ' HB ' ' HD2' ' A' ' 293' ' ' ARG . 8.5 t -66.21 -14.12 61.38 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 122.262 1.029 . . . . 0.0 110.756 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 2.8 m -78.14 -18.94 54.96 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.007 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 88.6 mt -106.9 -8.54 16.63 Favored 'General case' 0 C--O 1.246 0.912 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.844 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.483 ' HA ' HD13 ' A' ' 291' ' ' LEU . 10.5 pt20 -83.11 148.9 27.22 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.9 169.82 8.04 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 276' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 289' ' ' VAL . 15.8 m -119.62 117.02 27.2 Favored 'General case' 0 N--CA 1.406 -2.666 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 173.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 76.4 mt -81.53 117.9 22.31 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -79.3 89.5 4.94 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 122.224 1.011 . . . . 0.0 109.866 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' VAL . . . . . 0.623 ' HA ' ' CE1' ' A' ' 282' ' ' PHE . 47.3 t -98.74 27.34 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 CA-C-O 123.047 1.403 . . . . 0.0 109.658 -176.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -71.49 132.2 44.4 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.581 178.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 30.1 t70 68.53 28.49 5.88 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.461 1.504 . . . . 0.0 112.468 178.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.623 ' CE1' ' HA ' ' A' ' 279' ' ' VAL . 6.7 m-85 -84.25 -5.02 59.2 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.66 173.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? 60.97 50.36 5.18 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.691 0.758 . . . . 0.0 110.586 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' THR . . . . . 0.453 HG22 ' HE3' ' A' ' 232' ' ' LYS . 1.2 p -133.27 168.34 18.44 Favored Pre-proline 0 N--CA 1.433 -1.304 0 N-CA-C 104.314 -2.476 . . . . 0.0 104.314 177.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 285' ' ' PRO . . . . . 0.649 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 11.6 Cg_exo -75.05 -11.14 21.38 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 121.588 1.525 . . . . 0.0 110.889 176.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 57.9 t -86.04 129.9 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -92.36 -44.07 8.9 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.543 0.687 . . . . 0.0 109.175 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -164.21 134.54 4.16 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.814 -174.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 276' ' ' SER . 61.6 t -95.44 117.72 40.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 175.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.487 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 62.4 m -115.69 113.32 23.34 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-O 121.149 0.5 . . . . 0.0 110.359 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.483 HD13 ' HA ' ' A' ' 274' ' ' GLN . 0.0 OUTLIER -98.78 120.79 39.82 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 179.374 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -123.65 131.06 53.52 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -176.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' ARG . . . . . 0.497 ' HD2' ' HB ' ' A' ' 271' ' ' THR . 4.6 ptm180 -75.81 133.08 40.73 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 172.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.506 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 31.9 tp -110.39 -179.61 3.82 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -177.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.506 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 4.6 m-20 -35.31 -72.11 0.06 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.167 1.787 . . . . 0.0 112.881 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -123.7 -2.2 8.38 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' ASP . . . . . 0.428 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 12.9 m-20 -117.86 174.92 5.91 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.811 -170.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.559 ' HB ' ' HB2' ' A' ' 264' ' ' LEU . 83.5 m -117.4 126.97 53.56 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 175.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 299' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 36.3 tt0 -109.94 128.15 55.2 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -175.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.464 HD13 HG21 ' A' ' 228' ' ' ILE . 63.5 tp -116.38 117.39 29.82 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.644 177.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 301' ' ' ILE . . . . . 0.487 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 51.1 mt -107.14 115.26 48.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.391 -176.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 302' ' ' ILE . . . . . 0.401 ' HB ' HD12 ' A' ' 260' ' ' ILE . 56.0 mt -110.63 105.49 18.91 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.551 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.42 ' HA ' ' CB ' ' A' ' 259' ' ' HIS . 3.0 m -77.68 131.48 37.74 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -176.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 7.3 p -130.43 165.46 22.57 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -144.95 158.27 43.86 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 123.174 0.59 . . . . 0.0 109.89 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 74.54 -145.27 34.02 Favored Glycine 0 C--N 1.332 0.306 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 307' ' ' ASN . . . . . 0.421 ' HB3' ' HB3' ' A' ' 327' ' ' LYS . 31.9 m-80 -110.41 133.51 53.2 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 174.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 308' ' ' TRP . . . . . 0.724 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 57.0 p-90 -143.41 165.0 28.75 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 120.086 -0.646 . . . . 0.0 110.866 -175.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -126.18 134.85 51.15 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -177.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.724 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 18.5 tp -106.74 122.99 47.47 Favored 'General case' 0 CA--C 1.503 -0.841 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.788 -178.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.603 HG13 ' HB3' ' A' ' 323' ' ' GLN . 10.1 p -127.57 117.67 47.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-O 121.883 0.849 . . . . 0.0 109.461 171.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -106.11 136.18 46.26 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.466 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -129.58 151.28 50.37 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.374 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 43.2 t -116.05 112.79 22.28 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 177.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -70.13 -35.78 74.33 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.648 0.737 . . . . 0.0 109.105 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -164.83 157.61 14.19 Favored Pre-proline 0 N--CA 1.438 -1.054 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -63.17 100.48 0.26 Allowed 'Trans proline' 0 C--O 1.24 0.596 0 C-N-CA 121.778 1.652 . . . . 0.0 111.152 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 125.67 -9.99 7.61 Favored Glycine 0 N--CA 1.436 -1.329 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -176.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -127.01 116.18 20.35 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -121.54 168.53 11.63 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-O 121.573 0.701 . . . . 0.0 110.708 -174.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 91.8 m -151.48 123.56 8.17 Favored 'General case' 0 C--N 1.276 -2.602 0 C-N-CA 124.307 1.043 . . . . 0.0 108.817 -177.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -109.52 113.35 26.08 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' GLN . . . . . 0.603 ' HB3' HG13 ' A' ' 311' ' ' VAL . 8.0 tt0 -101.6 110.96 23.06 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.577 HG13 ' CE3' ' A' ' 308' ' ' TRP . 93.3 t -100.04 99.3 8.22 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.297 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -86.86 156.45 55.36 Favored Pre-proline 0 C--N 1.315 -0.92 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 326' ' ' PRO . . . . . 0.429 ' HG3' ' HB2' ' A' ' 236' ' ' ASN . 73.2 Cg_endo -81.33 138.63 11.17 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 121.713 1.609 . . . . 0.0 110.574 172.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.421 ' HB3' ' HB3' ' A' ' 307' ' ' ASN . 23.6 ttmm -108.99 154.97 21.43 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 27.4 tptp 82.31 101.41 0.05 Allowed 'General case' 0 C--N 1.307 -1.256 0 O-C-N 124.794 1.309 . . . . 0.0 113.179 172.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 . . . . . 0 N--CA 1.425 -1.707 0 CA-C-N 115.018 -0.992 . . . . 0.0 108.596 174.502 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 CA--C 1.523 -0.082 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -62.84 -18.55 59.76 Favored Glycine 0 C--O 1.217 -0.946 0 N-CA-C 114.82 0.688 . . . . 0.0 114.82 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 15.8 m -58.52 -36.58 74.04 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 117.563 0.682 . . . . 0.0 112.714 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 29.5 p -93.37 13.62 20.96 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-O 122.051 0.929 . . . . 0.0 110.6 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -135.88 25.86 3.33 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -79.0 111.04 14.8 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.567 -1.197 . . . . 0.0 111.211 -172.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -94.86 -176.37 3.84 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 177.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 70.85 27.33 3.54 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 122.188 0.994 . . . . 0.0 108.674 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -131.35 121.74 25.18 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -76.18 102.46 5.79 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -141.91 87.7 0.18 Allowed Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 119.913 -1.137 . . . . 0.0 112.973 -176.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 4.3 tt -88.81 105.39 17.69 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 105.005 -2.22 . . . . 0.0 105.005 175.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.433 ' HA ' ' HD3' ' A' ' 205' ' ' PRO . 30.5 m -120.73 134.53 24.28 Favored Pre-proline 0 C--N 1.301 -1.537 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -173.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 204' ' ' VAL . 17.6 Cg_exo -70.09 126.27 12.9 Favored 'Trans proline' 0 C--O 1.243 0.738 0 C-N-CA 122.401 2.067 . . . . 0.0 109.943 172.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -83.88 84.22 7.65 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.725 0.774 . . . . 0.0 112.772 -177.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -143.73 26.48 2.09 Favored Glycine 0 C--N 1.294 -1.795 0 N-CA-C 107.63 -2.188 . . . . 0.0 107.63 175.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 4.8 m -81.46 -39.72 24.39 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 113.692 -1.254 . . . . 0.0 111.608 -172.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 63.41 -153.08 0.33 Allowed 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 -170.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 27.7 ttt 68.52 -79.38 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.279 0.631 . . . . 0.0 111.361 176.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -94.21 74.16 3.98 Favored 'General case' 0 C--N 1.273 -2.757 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 39.7 m -150.68 105.94 3.35 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.399 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 26.3 ptm -75.36 4.55 7.04 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 121.286 0.565 . . . . 0.0 111.484 177.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 56.3 m -144.06 106.84 4.45 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -125.38 -131.27 3.59 Favored Glycine 0 CA--C 1.493 -1.304 0 N-CA-C 109.016 -1.633 . . . . 0.0 109.016 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -74.66 -32.34 57.48 Favored Glycine 0 C--N 1.311 -0.834 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 174.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 22.6 mp0 -107.22 139.02 42.33 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 114.37 -0.915 . . . . 0.0 108.994 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -115.87 -55.8 2.39 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 23.3 ptm -144.1 130.16 19.56 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 114.843 -1.072 . . . . 0.0 108.71 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -101.05 114.95 5.15 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -98.37 131.26 44.81 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 95.37 -77.13 0.85 Allowed Glycine 0 N--CA 1.427 -1.952 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 29.5 p 49.1 31.46 3.46 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.486 1.514 . . . . 0.0 114.34 172.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -132.39 6.66 4.15 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.409 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -133.73 128.8 35.67 Favored 'General case' 0 N--CA 1.432 -1.357 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.553 -177.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 91.1 m -65.61 121.51 15.12 Favored 'General case' 0 C--O 1.195 -1.783 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.354 -176.074 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -143.19 170.4 15.81 Favored 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.229 -173.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.518 HG21 HD13 ' A' ' 300' ' ' LEU . 2.8 pp -128.05 163.51 31.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.898 179.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -149.77 155.67 40.53 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -176.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -136.78 132.64 35.01 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.096 0.474 . . . . 0.0 110.701 176.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.605 ' HD3' ' OE2' ' A' ' 241' ' ' GLU . 0.3 OUTLIER -149.55 174.41 12.55 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.055 178.23 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -119.62 144.3 47.21 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -150.72 176.59 10.88 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 176.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 53.72 -138.73 37.19 Favored Glycine 0 C--N 1.309 -0.957 0 O-C-N 123.721 0.638 . . . . 0.0 113.682 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -115.1 100.24 8.02 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ASN . . . . . 0.413 ' HB2' ' HG3' ' A' ' 326' ' ' PRO . 5.1 m-20 60.53 29.08 18.74 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 121.792 0.806 . . . . 0.0 111.533 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.73 135.3 36.37 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.454 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' GLY . . . . . 0.563 ' HA3' ' CG1' ' A' ' 286' ' ' VAL . . . -102.25 123.47 7.88 Favored Glycine 0 C--N 1.299 -1.526 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -177.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.5 mp -113.67 120.27 63.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 117.423 0.612 . . . . 0.0 111.258 -176.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' ILE . . . . . 0.402 ' N ' HD12 ' A' ' 240' ' ' ILE . 3.1 mp -106.42 107.85 23.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.605 ' OE2' ' HD3' ' A' ' 231' ' ' ARG . 42.9 mt-10 -95.01 111.22 23.04 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 122.408 1.099 . . . . 0.0 111.783 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 12.8 tp -94.3 136.05 35.02 Favored 'General case' 0 C--N 1.278 -2.519 0 CA-C-N 114.097 -1.41 . . . . 0.0 110.756 -175.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' ALA . . . . . 0.517 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -121.56 98.72 6.1 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 176.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -103.16 91.34 4.06 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -79.37 112.8 16.96 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.314 -175.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 110.65 4.45 28.28 Favored Glycine 0 C--N 1.292 -1.875 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.138 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -111.98 108.71 18.14 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -104.51 100.45 10.13 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 159.78 -132.83 3.1 Favored Glycine 0 C--N 1.291 -1.922 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -153.69 132.65 6.95 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.661 ' HB3' HD13 ' A' ' 264' ' ' LEU . 14.0 Cg_endo -63.55 171.84 6.34 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.18 2.587 . . . . 0.0 113.111 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 29.5 t70 -96.01 105.88 17.97 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.009 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 4.4 mp -98.84 117.24 43.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-O 121.296 0.57 . . . . 0.0 111.034 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 13.5 t -102.49 116.84 33.42 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 176.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' GLN . . . . . 0.41 ' HG2' HD23 ' A' ' 310' ' ' LEU . 76.0 mt-30 -92.52 109.8 21.21 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-O 121.359 0.599 . . . . 0.0 111.909 -176.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 78.3 mt-30 -125.25 149.83 47.63 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 174.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -77.21 -28.58 53.87 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 -174.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -79.91 -24.6 41.01 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.271 -0.971 . . . . 0.0 110.107 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' HIS . . . . . 0.466 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 39.8 p-80 -171.68 159.25 5.3 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.955 173.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 25.2 mt -105.58 142.21 19.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 261' ' ' ILE . 2.9 mp -122.01 113.72 39.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 299' ' ' GLN . 1.9 m -110.99 135.69 49.33 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.496 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 298' ' ' THR . 29.2 m -129.58 125.07 35.35 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-O 121.589 0.709 . . . . 0.0 110.699 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.661 HD13 ' HB3' ' A' ' 251' ' ' PRO . 1.9 mm? -98.59 98.06 9.27 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 175.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.535 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 51.9 mtpt -71.55 131.52 43.38 Favored 'General case' 0 C--N 1.274 -2.7 0 O-C-N 124.005 0.816 . . . . 0.0 111.95 -178.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 9.4 t30 73.61 24.65 2.18 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 124.894 1.371 . . . . 0.0 109.931 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 54.6 t60 -117.16 117.8 30.59 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 121.45 -0.781 . . . . 0.0 109.179 178.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 10.9 p -88.5 130.02 35.31 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-O 120.975 0.417 . . . . 0.0 111.689 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 29.1 tp -115.97 124.95 29.11 Favored Pre-proline 0 N--CA 1.429 -1.496 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.086 177.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -68.6 156.72 64.59 Favored 'Trans proline' 0 C--N 1.321 -0.893 0 C-N-CA 122.66 2.24 . . . . 0.0 112.326 171.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' THR . . . . . 0.491 ' HA ' ' OE1' ' A' ' 274' ' ' GLN . 37.1 p -64.09 -31.48 72.68 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.351 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 2.2 m -64.21 -23.78 67.43 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.24 1.016 . . . . 0.0 112.606 -175.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -95.46 -10.13 30.7 Favored 'General case' 0 CA--C 1.498 -1.036 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.494 -176.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.504 HE21 ' HA ' ' A' ' 292' ' ' LYS . 50.9 mt-30 -72.73 111.94 8.33 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.962 178.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -142.09 150.44 41.18 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' SER . . . . . 0.568 ' HA ' ' O ' ' A' ' 289' ' ' VAL . 36.9 m -118.99 114.05 21.94 Favored 'General case' 0 N--CA 1.417 -2.09 0 O-C-N 123.594 0.559 . . . . 0.0 109.736 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 66.6 mt -85.8 112.85 21.48 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.221 -177.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -80.4 90.97 5.64 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 174.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 282' ' ' PHE . 17.2 m -109.97 25.76 2.96 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 CA-C-N 114.565 -1.198 . . . . 0.0 112.202 -173.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -70.02 150.76 46.31 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 174.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 24.6 t70 73.36 15.69 4.24 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 122.579 1.18 . . . . 0.0 110.955 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.457 ' HB2' ' O ' ' A' ' 279' ' ' VAL . 1.6 m-85 -85.52 -0.07 53.92 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.915 173.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? 62.37 61.17 1.3 Allowed 'General case' 0 CA--C 1.491 -1.326 0 CA-C-O 121.708 0.765 . . . . 0.0 112.649 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 1.8 t -164.21 148.7 8.39 Favored Pre-proline 0 N--CA 1.403 -2.823 0 CA-C-N 113.618 -1.628 . . . . 0.0 108.961 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' PRO . . . . . 0.424 ' O ' ' HA ' ' A' ' 304' ' ' THR . 14.7 Cg_exo -44.01 -35.48 7.45 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 124.68 3.587 . . . . 0.0 114.098 174.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.563 ' CG1' ' HA3' ' A' ' 238' ' ' GLY . 0.3 OUTLIER -75.87 117.74 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-O 121.989 0.9 . . . . 0.0 110.831 178.044 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -101.47 -37.98 8.19 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.152 -1.385 . . . . 0.0 111.857 -172.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -151.23 140.0 20.82 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.874 -0.516 . . . . 0.0 111.041 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 276' ' ' SER . 46.9 t -110.24 110.08 30.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 175.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.44 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 89.0 m -111.83 115.24 28.69 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 58.4 tp -95.87 118.65 32.91 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 176.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.504 ' HA ' HE21 ' A' ' 274' ' ' GLN . 40.8 ttmt -121.89 136.2 54.92 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 121.107 0.479 . . . . 0.0 110.484 -176.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -80.84 139.92 35.69 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 176.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.506 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 19.8 tp -113.0 -178.93 3.5 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 177.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.506 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 20.2 t-20 -53.39 -68.29 0.19 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.113 0.87 . . . . 0.0 112.5 -176.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -109.51 -3.79 16.73 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.032 0.444 . . . . 0.0 110.102 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 297' ' ' ASP . . . . . 0.535 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 13.1 m-20 -124.0 173.11 8.46 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.406 -168.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 263' ' ' THR . 31.8 m -114.92 130.72 56.97 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 175.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 299' ' ' GLN . . . . . 0.533 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 50.5 tt0 -118.66 124.2 46.81 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -177.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.518 HD13 HG21 ' A' ' 228' ' ' ILE . 67.3 tp -107.22 122.01 45.67 Favored 'General case' 0 N--CA 1.412 -2.371 0 C-N-CA 120.361 -0.535 . . . . 0.0 109.844 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 301' ' ' ILE . . . . . 0.441 HG23 ' CD2' ' A' ' 259' ' ' HIS . 64.0 mt -110.03 109.73 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.264 -176.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 61.6 mt -106.58 107.56 23.01 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.521 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 13.3 m -79.38 131.08 36.0 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -175.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 304' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 285' ' ' PRO . 8.9 p -135.64 175.96 9.12 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 122.721 0.408 . . . . 0.0 110.866 -176.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -161.18 141.66 11.09 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 89.52 -163.36 31.12 Favored Glycine 0 C--O 1.25 1.11 0 C-N-CA 121.459 -0.4 . . . . 0.0 113.179 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -91.37 125.38 36.1 Favored 'General case' 0 CA--C 1.486 -1.496 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 308' ' ' TRP . . . . . 0.694 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 59.8 p-90 -150.15 170.65 18.43 Favored 'General case' 0 N--CA 1.413 -2.29 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -177.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -128.91 131.39 47.57 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -176.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.694 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 24.7 tp -105.63 137.3 43.7 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 119.625 -0.83 . . . . 0.0 109.98 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.647 HG13 ' HB3' ' A' ' 323' ' ' GLN . 6.5 p -137.21 126.91 37.42 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.31 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 172.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -111.44 145.27 39.27 Favored 'General case' 0 N--CA 1.418 -2.032 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.421 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 313' ' ' LYS . . . . . 0.411 ' HB2' ' HB ' ' A' ' 321' ' ' THR . 65.1 mttm -139.62 158.01 44.84 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.986 -176.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 32.2 t -115.63 128.31 55.83 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 170.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -84.56 -43.34 14.59 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.706 0.765 . . . . 0.0 108.984 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -153.12 161.47 28.99 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -59.8 100.08 0.13 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.294 1.996 . . . . 0.0 112.336 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 121.38 -29.47 5.69 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -95.48 122.72 38.51 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -121.94 169.98 10.26 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 121.802 0.811 . . . . 0.0 110.907 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.411 ' HB ' ' HB2' ' A' ' 313' ' ' LYS . 72.8 m -152.1 128.72 10.78 Favored 'General case' 0 C--N 1.272 -2.787 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.376 -175.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -117.77 109.38 16.53 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 175.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' GLN . . . . . 0.647 ' HB3' HG13 ' A' ' 311' ' ' VAL . 60.4 tt0 -100.67 114.2 27.72 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 1.5 m -100.76 113.33 36.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 177.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -91.51 151.59 42.72 Favored Pre-proline 0 C--N 1.304 -1.378 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 326' ' ' PRO . . . . . 0.413 ' HG3' ' HB2' ' A' ' 236' ' ' ASN . 70.9 Cg_endo -81.68 134.01 8.42 Favored 'Trans proline' 0 N--CA 1.436 -1.887 0 C-N-CA 121.393 1.395 . . . . 0.0 109.948 173.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -92.9 100.02 12.56 Favored 'General case' 0 N--CA 1.413 -2.291 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 175.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . 0.285 26.9 tptp -81.94 102.67 11.07 Favored 'General case' 0 N--CA 1.413 -2.305 0 C-N-CA 118.309 -1.356 . . . . 0.0 114.554 -169.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 . . . . . 0 N--CA 1.393 -3.295 0 CA-C-N 112.217 -2.265 . . . . 0.0 105.11 170.936 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 94.0 mmm . . . . . 0 C--O 1.235 0.331 0 N-CA-C 111.276 0.102 . . . . 0.0 111.276 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -72.88 98.28 0.86 Allowed Glycine 0 C--O 1.247 0.935 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 176.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 41.5 t 73.74 166.59 0.3 Allowed 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.471 1.109 . . . . 0.0 108.912 -171.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 37.3 t -89.72 5.86 44.04 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 72.63 89.77 0.09 Allowed 'General case' 0 C--N 1.346 0.426 0 C-N-CA 124.249 1.019 . . . . 0.0 110.631 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -93.92 118.59 31.68 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.592 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -142.39 119.37 11.3 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -93.46 118.27 31.12 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 120.121 -0.631 . . . . 0.0 110.312 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -82.76 -18.56 40.27 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -113.73 117.23 30.94 Favored 'General case' 0 C--O 1.249 1.07 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 120.31 39.56 0.62 Allowed Glycine 0 C--N 1.298 -1.543 0 C-N-CA 119.384 -1.389 . . . . 0.0 113.461 175.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 60.0 tp -81.11 99.09 8.32 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 176.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.413 ' HA ' ' HD3' ' A' ' 205' ' ' PRO . 16.9 m -108.4 106.13 58.06 Favored Pre-proline 0 C--N 1.305 -1.363 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.536 -178.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 204' ' ' VAL . 12.7 Cg_endo -91.34 -162.87 0.11 Allowed 'Trans proline' 0 N--CA 1.445 -1.348 0 C-N-CA 122.642 2.228 . . . . 0.0 111.621 177.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -133.54 93.79 3.2 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.724 0.773 . . . . 0.0 110.811 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -139.33 64.28 0.54 Allowed Glycine 0 N--CA 1.432 -1.598 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.312 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 38.6 m -143.99 67.37 1.27 Allowed 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 177.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -75.99 90.9 3.03 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.403 -178.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 40.8 tpp -96.28 107.81 20.22 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.005 177.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -96.76 -28.04 14.46 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 3.5 t 55.14 62.2 2.6 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.326 178.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -96.87 106.21 18.48 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -178.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 19.7 m -84.78 115.42 22.7 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -104.52 39.31 2.87 Favored Glycine 0 C--N 1.307 -1.074 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -132.5 114.09 1.39 Allowed Glycine 0 N--CA 1.422 -2.3 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -86.69 81.98 8.03 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.704 0.764 . . . . 0.0 111.424 -178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -142.17 85.06 1.9 Allowed 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.346 176.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 24.3 ptp -83.07 -32.92 26.54 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 159.79 -155.69 26.82 Favored Glycine 0 N--CA 1.418 -2.55 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ARG . . . . . 0.445 ' H ' ' HB3' ' A' ' 245' ' ' LEU . 39.3 ptt180 -157.59 136.64 11.68 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 74.6 -74.54 1.3 Allowed Glycine 0 C--N 1.306 -1.1 0 C-N-CA 121.613 -0.327 . . . . 0.0 113.84 177.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.561 ' HB3' HD11 ' A' ' 245' ' ' LEU . 7.5 t -84.16 -170.66 3.2 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 123.648 0.779 . . . . 0.0 111.112 -176.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -84.49 82.79 8.25 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -171.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' GLN . . . . . 0.71 ' O ' HD23 ' A' ' 245' ' ' LEU . 12.8 pt20 44.08 -176.35 0.0 OUTLIER 'General case' 0 C--O 1.199 -1.571 0 C-N-CA 126.495 1.918 . . . . 0.0 115.017 172.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 16.6 m -75.23 110.94 9.98 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 166.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.416 ' HB3' ' HB3' ' A' ' 243' ' ' ALA . 38.9 t30 -139.52 151.72 46.36 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.8 -166.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.748 HG21 HD21 ' A' ' 300' ' ' LEU . 2.5 pp -133.94 144.54 35.3 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.388 0 CA-C-N 114.265 -1.334 . . . . 0.0 107.941 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' A' ' 240' ' ' ILE . 8.4 t0 -145.02 157.44 44.12 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -172.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.476 ' CD2' HG11 ' A' ' 279' ' ' VAL . 85.4 t80 -136.95 135.05 37.37 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ARG . . . . . 0.495 HH11 ' HB3' ' A' ' 231' ' ' ARG . 1.0 OUTLIER -156.77 174.29 15.7 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 176.869 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.447 ' HE3' HG22 ' A' ' 284' ' ' THR . 54.4 mtpt -118.07 153.92 32.93 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 120.462 0.172 . . . . 0.0 110.8 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -155.32 146.93 23.08 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 124.091 0.87 . . . . 0.0 109.019 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 69.96 -109.33 2.82 Favored Glycine 0 N--CA 1.447 -0.611 0 O-C-N 123.569 0.543 . . . . 0.0 113.735 174.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -123.76 83.49 2.14 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -177.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 61.03 24.15 14.28 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 176.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -80.46 140.56 35.87 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.16 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -100.17 109.54 3.73 Favored Glycine 0 N--CA 1.426 -1.998 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 230' ' ' PHE . 2.1 mp -98.6 114.51 36.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-N 117.144 0.472 . . . . 0.0 110.207 -176.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' ILE . . . . . 0.493 ' HA ' ' O ' ' A' ' 229' ' ' ASP . 3.7 mp -102.68 111.62 33.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 176.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 34.0 mt-10 -88.51 143.82 26.73 Favored 'General case' 0 N--CA 1.412 -2.334 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.629 175.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 13.5 tp -131.69 119.27 21.14 Favored 'General case' 0 C--N 1.27 -2.881 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.14 -177.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' ALA . . . . . 0.43 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -114.16 105.22 12.92 Favored 'General case' 0 C--N 1.276 -2.625 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -111.32 90.61 3.38 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.71 HD23 ' O ' ' A' ' 225' ' ' GLN . 4.0 mm? -81.92 118.25 22.8 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.257 -176.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 103.97 15.64 21.45 Favored Glycine 0 C--N 1.3 -1.471 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.361 178.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -115.15 116.23 28.05 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 121.067 0.46 . . . . 0.0 110.065 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -106.81 94.54 5.17 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.299 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 159.12 -161.98 32.38 Favored Glycine 0 N--CA 1.425 -2.087 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -118.36 140.76 28.58 Favored Pre-proline 0 C--N 1.298 -1.667 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.724 ' HB3' HD13 ' A' ' 264' ' ' LEU . 27.7 Cg_endo -73.67 165.42 32.37 Favored 'Trans proline' 0 N--CA 1.437 -1.796 0 C-N-CA 121.104 1.203 . . . . 0.0 110.17 176.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.582 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 11.9 t70 -87.63 106.56 18.1 Favored 'General case' 0 C--N 1.27 -2.866 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 177.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.431 HD11 ' HG2' ' A' ' 251' ' ' PRO . 5.3 mp -95.9 109.21 22.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 C-N-CA 119.354 -0.938 . . . . 0.0 109.669 175.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' SER . . . . . 0.655 ' HB2' ' HB ' ' A' ' 261' ' ' ILE . 26.5 m -99.61 117.6 34.33 Favored 'General case' 0 C--N 1.277 -2.546 0 C-N-CA 125.001 1.32 . . . . 0.0 108.48 177.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -100.02 124.89 45.89 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -175.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.494 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 14.5 mm100 -122.62 171.07 9.4 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 171.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 61.2 m-70 -76.89 -41.03 45.37 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.743 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -81.03 -24.83 37.62 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.618 -173.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' HIS . . . . . 0.494 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 45.7 p-80 -165.08 163.17 20.58 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.039 0.447 . . . . 0.0 111.151 177.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 21.3 mt -107.15 141.87 21.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' ILE . . . . . 0.655 ' HB ' ' HB2' ' A' ' 254' ' ' SER . 3.8 mp -119.21 117.26 53.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 299' ' ' GLN . 0.7 OUTLIER -114.95 142.48 27.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 C-N-CA 119.207 -0.997 . . . . 0.0 108.814 176.816 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 263' ' ' THR . . . . . 0.556 ' HA ' ' O ' ' A' ' 298' ' ' THR . 7.5 m -135.47 124.31 24.0 Favored 'General case' 0 C--N 1.291 -1.941 0 C-N-CA 119.825 -0.75 . . . . 0.0 112.064 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.724 HD13 ' HB3' ' A' ' 251' ' ' PRO . 1.9 mm? -97.2 100.24 11.71 Favored 'General case' 0 CA--C 1.467 -2.218 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 175.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.561 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 51.6 mtpt -68.39 126.67 30.34 Favored 'General case' 0 N--CA 1.405 -2.676 0 O-C-N 124.34 1.025 . . . . 0.0 113.235 -173.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 77.67 3.68 3.01 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 113.925 -1.489 . . . . 0.0 111.808 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -86.12 95.66 9.63 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 177.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.84 109.2 6.24 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.286 0.565 . . . . 0.0 111.592 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 23.8 tp -95.64 128.99 35.86 Favored Pre-proline 0 N--CA 1.433 -1.295 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.633 -178.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -71.69 154.87 59.33 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.157 2.571 . . . . 0.0 111.831 170.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 19.3 p -67.6 -29.45 68.79 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 123.206 0.602 . . . . 0.0 112.592 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 11.9 m -62.96 -22.03 66.51 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 123.714 0.806 . . . . 0.0 111.36 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 8.2 mp -96.94 -8.11 31.5 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.375 -175.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.585 HE21 ' HA ' ' A' ' 292' ' ' LYS . 47.7 mt-30 -77.78 136.35 38.11 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.755 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -161.13 165.72 29.1 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 176.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 16.9 m -134.46 138.26 44.61 Favored 'General case' 0 N--CA 1.414 -2.249 0 CA-C-O 121.351 0.596 . . . . 0.0 109.668 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.45 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 2.9 mm? -95.25 101.41 13.14 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -83.84 55.59 3.32 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.728 0.775 . . . . 0.0 109.567 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' VAL . . . . . 0.476 HG11 ' CD2' ' A' ' 230' ' ' PHE . 13.3 m -81.17 59.56 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.218 -1.355 . . . . 0.0 112.751 -174.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -74.44 121.54 21.61 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.597 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . 0.367 20.4 m-20 58.42 51.91 7.71 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 179.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -85.38 -2.08 57.71 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 165.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 25.7 mmmt 67.02 61.16 0.5 Allowed 'General case' 0 CA--C 1.485 -1.536 0 CA-C-N 113.222 -1.808 . . . . 0.0 109.996 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' THR . . . . . 0.447 HG22 ' HE3' ' A' ' 232' ' ' LYS . 0.7 OUTLIER -138.91 165.09 34.91 Favored Pre-proline 0 N--CA 1.42 -1.938 0 N-CA-C 103.565 -2.754 . . . . 0.0 103.565 179.243 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 285' ' ' PRO . . . . . 0.401 ' HB3' ' HB3' ' A' ' 308' ' ' TRP . 18.3 Cg_exo -69.12 -15.55 39.58 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.323 1.349 . . . . 0.0 111.405 177.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.408 HG21 HD11 ' A' ' 240' ' ' ILE . 42.5 t -84.04 129.55 37.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -96.92 -39.56 9.33 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.261 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -160.36 140.54 11.46 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.223 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.45 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 41.8 t -104.67 126.36 59.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 173.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.519 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 48.2 m -128.58 122.74 31.67 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 117.957 0.344 . . . . 0.0 110.69 -177.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.561 ' HB2' HG12 ' A' ' 228' ' ' ILE . 52.0 tp -103.41 108.27 19.44 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.585 ' HA ' HE21 ' A' ' 274' ' ' GLN . 24.5 ttmm -112.06 125.47 54.13 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.286 -177.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 293' ' ' ARG . . . . . 0.414 ' H ' ' NE2' ' A' ' 274' ' ' GLN . 1.9 ptm180 -68.72 137.94 54.5 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 174.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.585 HD13 ' N ' ' A' ' 295' ' ' ASN . 2.6 tm? -117.4 162.8 17.34 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 -174.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.585 ' N ' HD13 ' A' ' 294' ' ' LEU . 66.5 t30 -14.92 -70.98 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 127.541 2.336 . . . . 0.0 112.972 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -125.46 -2.28 7.44 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 175.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' ASP . . . . . 0.561 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 10.9 m-20 -118.09 178.61 4.36 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.485 -165.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' A' ' 263' ' ' THR . 42.3 m -114.93 125.53 53.74 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 173.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 299' ' ' GLN . . . . . 0.591 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 9.0 tt0 -115.16 129.89 56.78 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 120.949 0.404 . . . . 0.0 111.157 -176.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.748 HD21 HG21 ' A' ' 228' ' ' ILE . 12.6 mt -100.58 132.0 46.19 Favored 'General case' 0 CA--C 1.451 -2.862 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.043 172.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 301' ' ' ILE . . . . . 0.519 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 65.5 mt -118.24 108.1 23.51 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.238 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 174.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 66.0 mt -109.89 105.21 18.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.364 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 4.0 m -78.56 129.33 34.7 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -174.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 8.4 p -131.57 153.13 50.19 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -175.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -131.16 147.28 52.59 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.859 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 75.26 -160.21 52.2 Favored Glycine 0 N--CA 1.438 -1.187 0 O-C-N 123.994 0.809 . . . . 0.0 113.07 176.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' ASN . . . . . 0.41 ' HB3' ' HB3' ' A' ' 327' ' ' LYS . 31.0 m-80 -93.97 132.64 38.24 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 308' ' ' TRP . . . . . 0.435 ' CE3' HG13 ' A' ' 324' ' ' VAL . 62.0 p-90 -148.05 168.0 23.48 Favored 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.083 -175.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -130.14 127.91 40.71 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -178.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 1.4 tt -96.25 125.89 41.08 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.697 HG13 ' HB3' ' A' ' 323' ' ' GLN . 7.2 p -130.17 112.54 23.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 169.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 312' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 321' ' ' THR . 22.4 t30 -103.58 141.83 35.35 Favored 'General case' 0 CA--C 1.45 -2.89 0 C-N-CA 119.584 -0.847 . . . . 0.0 111.17 -176.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -119.36 121.43 39.53 Favored 'General case' 1 N--CA 1.369 -4.488 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.659 -178.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 16.8 m -95.83 106.47 18.61 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 173.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -84.96 -32.71 22.89 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.079 -175.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.416 ' HB1' ' HD2' ' A' ' 317' ' ' PRO . . . -165.42 164.69 12.13 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -177.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 317' ' ' PRO . . . . . 0.416 ' HD2' ' HB1' ' A' ' 316' ' ' ALA . 28.1 Cg_endo -62.68 94.98 0.15 Allowed 'Trans proline' 0 C--O 1.243 0.736 0 C-N-CA 122.058 1.839 . . . . 0.0 111.143 177.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 124.89 -23.55 6.2 Favored Glycine 0 N--CA 1.423 -2.171 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.417 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -101.71 116.19 32.19 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 122.048 -0.678 . . . . 0.0 110.685 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' PHE . . . . . 0.498 ' CZ ' ' HD3' ' A' ' 251' ' ' PRO . 68.7 m-85 -130.53 159.13 38.04 Favored 'General case' 0 N--CA 1.428 -1.547 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.412 -177.82 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 312' ' ' ASN . 61.6 m -152.67 111.93 3.85 Favored 'General case' 0 C--N 1.273 -2.726 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.354 -176.032 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -98.05 105.32 17.45 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' GLN . . . . . 0.697 ' HB3' HG13 ' A' ' 311' ' ' VAL . 46.3 tt0 -91.21 100.36 13.19 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.435 HG13 ' CE3' ' A' ' 308' ' ' TRP . 93.4 t -88.08 98.83 8.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.519 0.676 . . . . 0.0 109.456 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.505 HD21 HE21 ' A' ' 323' ' ' GLN . 20.9 mt -87.74 152.46 51.53 Favored Pre-proline 0 C--N 1.285 -2.208 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.197 -178.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -81.83 138.2 10.35 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 121.503 1.468 . . . . 0.0 109.812 172.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 307' ' ' ASN . 23.5 ttmm -96.72 118.06 32.35 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.587 -177.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 56.8 pttt -121.76 123.8 42.7 Favored 'General case' 0 C--N 1.288 -2.083 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.343 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 . . . . . 0 C--N 1.298 -1.643 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 177.714 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 67.1 mtt . . . . . 0 CA--C 1.504 -0.792 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 126.25 122.02 2.54 Favored Glycine 0 N--CA 1.431 -1.653 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 51.6 m -143.7 146.77 33.44 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 117.277 0.538 . . . . 0.0 111.4 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 24.2 m -106.84 78.18 1.23 Allowed 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 170.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -51.59 -25.2 6.44 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -172.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 46.7 t60 -123.57 83.3 2.12 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 36.1 p-80 -126.8 -0.67 6.68 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.652 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 6.7 t60 59.75 -88.76 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.437 1.095 . . . . 0.0 109.779 -176.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -149.06 13.95 0.89 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.792 0.806 . . . . 0.0 109.3 174.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 33.5 p80 -94.54 100.5 12.46 Favored 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.671 177.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 172.06 48.74 0.04 OUTLIER Glycine 0 N--CA 1.434 -1.494 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 3.7 tt -152.08 -66.43 0.17 Allowed 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.439 ' HB ' ' HD3' ' A' ' 205' ' ' PRO . 57.7 t -95.07 -59.5 0.19 Allowed Pre-proline 0 CA--C 1.551 1.014 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' PRO . . . . . 0.439 ' HD3' ' HB ' ' A' ' 204' ' ' VAL . 59.3 Cg_endo -75.4 125.31 8.97 Favored 'Trans proline' 0 C--N 1.364 1.365 0 C-N-CA 121.103 1.202 . . . . 0.0 110.218 171.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -134.1 -80.89 0.46 Allowed 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -87.37 -38.09 7.88 Favored Glycine 0 N--CA 1.436 -1.347 0 N-CA-C 108.331 -1.908 . . . . 0.0 108.331 174.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 4.1 m -83.43 137.38 33.94 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 174.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -135.5 138.54 43.21 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.992 -177.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 25.8 ttt -101.81 106.15 17.1 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 175.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -80.63 171.44 15.03 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 176.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 32.6 m 71.6 113.98 0.05 Allowed 'General case' 0 C--O 1.24 0.559 0 O-C-N 124.173 0.92 . . . . 0.0 109.856 -174.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 22.0 ptp -78.29 -23.82 47.0 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 21.8 m 59.45 77.92 0.29 Allowed 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.297 -176.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -91.55 112.98 4.25 Favored Glycine 0 N--CA 1.425 -2.096 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.48 -177.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -161.68 143.01 8.44 Favored Glycine 0 N--CA 1.423 -2.18 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' GLN . . . . . 0.44 ' HG3' ' HG3' ' A' ' 218' ' ' GLN . 6.6 tp60 -78.13 -61.75 1.9 Allowed 'General case' 0 C--N 1.306 -1.298 0 O-C-N 123.548 0.205 . . . . 0.0 110.651 -179.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' GLN . . . . . 0.44 ' HG3' ' HG3' ' A' ' 217' ' ' GLN . 76.8 mt-30 -121.25 77.07 1.28 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.648 0.737 . . . . 0.0 112.241 -178.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 62.6 mtm -87.34 -10.26 52.67 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 122.883 1.325 . . . . 0.0 107.609 174.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -132.76 148.65 19.33 Favored Glycine 0 N--CA 1.406 -3.305 0 N-CA-C 105.024 -3.23 . . . . 0.0 105.024 171.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 41.7 mtp-105 -74.44 -26.87 60.32 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 117.936 0.868 . . . . 0.0 111.687 -175.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -172.88 -36.45 0.03 OUTLIER Glycine 0 N--CA 1.436 -1.35 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 23.9 m -76.39 29.45 0.12 Allowed 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 123.766 0.826 . . . . 0.0 112.899 -177.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' LYS . . . . . 0.499 ' HD3' ' HB2' ' A' ' 225' ' ' GLN . 0.0 OUTLIER -97.8 -4.89 35.98 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 175.973 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 225' ' ' GLN . . . . . 0.499 ' HB2' ' HD3' ' A' ' 224' ' ' LYS . 1.8 tp60 -151.51 171.92 16.82 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 178.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 16.4 m -62.33 126.25 26.69 Favored 'General case' 0 C--N 1.314 -0.974 0 O-C-N 123.572 0.545 . . . . 0.0 110.791 -178.096 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -153.33 173.36 15.71 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.254 -178.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.506 HG21 HD13 ' A' ' 300' ' ' LEU . 2.1 pp -137.66 156.89 32.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 C-N-CA 124.731 1.212 . . . . 0.0 109.394 -178.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.458 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 1.1 t70 -150.59 156.99 42.46 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -127.79 137.2 52.32 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -153.31 161.98 41.78 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.441 ' HE3' HG22 ' A' ' 284' ' ' THR . 56.9 mtpt -110.65 158.01 19.07 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.597 178.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -155.12 168.22 27.75 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 55.92 -124.71 34.94 Favored Glycine 0 C--N 1.321 -0.29 0 O-C-N 123.704 0.628 . . . . 0.0 113.091 177.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -122.87 100.68 7.02 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 176.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' ASN . . . . . 0.617 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 94.0 m-20 63.02 24.55 14.59 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 124.16 0.912 . . . . 0.0 112.939 176.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -82.59 141.03 32.89 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -103.47 110.09 3.59 Favored Glycine 0 N--CA 1.429 -1.827 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.441 ' HA ' ' O ' ' A' ' 322' ' ' PHE . 2.0 mp -104.2 119.91 53.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 121.171 0.51 . . . . 0.0 110.223 -177.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.7 mp -104.14 114.08 42.78 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 175.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 49.2 mt-10 -89.43 142.97 27.19 Favored 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 175.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 15.3 tp -134.44 134.29 41.43 Favored 'General case' 0 C--N 1.276 -2.614 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.691 -175.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -127.25 110.33 12.74 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.174 178.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -115.05 91.6 3.67 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.417 0.627 . . . . 0.0 109.891 178.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -83.48 115.32 22.02 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.895 -177.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 111.62 13.81 12.33 Favored Glycine 0 C--N 1.299 -1.527 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.526 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -116.08 124.18 49.76 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -107.13 93.83 4.77 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 143.97 -157.81 27.21 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 177.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -113.88 148.85 40.8 Favored Pre-proline 0 C--N 1.314 -0.942 0 C-N-CA 123.06 0.544 . . . . 0.0 109.754 177.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.732 ' HB3' HD13 ' A' ' 264' ' ' LEU . 14.2 Cg_endo -74.24 172.14 16.62 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.698 2.265 . . . . 0.0 112.192 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.489 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 34.4 t70 -95.37 111.72 23.55 Favored 'General case' 0 C--N 1.286 -2.191 0 C-N-CA 124.275 1.03 . . . . 0.0 108.694 177.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 4.1 mp -104.91 128.03 58.96 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.329 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' SER . . . . . 0.433 ' HB3' ' HB ' ' A' ' 261' ' ' ILE . 14.1 t -111.43 124.58 52.55 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 174.059 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -102.63 102.55 12.77 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.14 0.495 . . . . 0.0 112.052 -173.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.5 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 78.8 mt-30 -109.8 158.47 18.11 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 172.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 50.9 m80 -73.42 -36.08 65.91 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -176.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -85.67 -16.1 40.19 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.405 -0.518 . . . . 0.0 112.241 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' HIS . . . . . 0.5 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 45.4 p-80 -170.69 156.03 5.07 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-O 121.044 0.449 . . . . 0.0 111.717 176.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.489 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 39.6 mt -106.95 141.73 21.44 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 261' ' ' ILE . . . . . 0.433 ' HB ' ' HB3' ' A' ' 254' ' ' SER . 3.1 mp -121.66 116.3 49.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 299' ' ' GLN . 1.9 m -112.5 139.31 37.99 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.526 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 177.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 263' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 298' ' ' THR . 19.3 m -135.0 127.82 31.2 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-O 121.3 0.572 . . . . 0.0 110.855 178.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.732 HD13 ' HB3' ' A' ' 251' ' ' PRO . 1.9 mm? -97.91 106.38 18.67 Favored 'General case' 0 CA--C 1.47 -2.107 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 176.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.564 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 31.8 mmmt -68.82 127.94 34.9 Favored 'General case' 0 N--CA 1.414 -2.247 0 O-C-N 124.309 1.006 . . . . 0.0 113.149 -174.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 62.8 t30 65.65 26.29 11.51 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 112.771 -2.013 . . . . 0.0 110.699 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 45.8 t60 -106.98 112.18 25.02 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.95 125.04 28.76 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 27.0 tp -111.14 125.32 30.82 Favored Pre-proline 0 N--CA 1.435 -1.216 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.251 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.485 ' HD2' HD22 ' A' ' 273' ' ' LEU . 24.1 Cg_exo -68.35 148.13 73.21 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.585 2.19 . . . . 0.0 111.399 170.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 271' ' ' THR . . . . . 0.55 ' HB ' ' HD2' ' A' ' 293' ' ' ARG . 6.1 t -71.47 -11.1 60.7 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.327 0.584 . . . . 0.0 112.112 -177.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 19.3 m -79.76 -21.15 44.77 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.521 0.677 . . . . 0.0 110.366 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.485 HD22 ' HD2' ' A' ' 270' ' ' PRO . 8.0 mp -96.59 -13.24 23.04 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.391 -174.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 271' ' ' THR . 18.7 pt20 -83.01 107.55 15.69 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-O 122.023 0.916 . . . . 0.0 109.135 -178.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -134.33 176.49 8.56 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 24.1 p -133.62 138.31 45.88 Favored 'General case' 0 N--CA 1.413 -2.289 0 CA-C-O 121.395 0.617 . . . . 0.0 111.06 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.491 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 2.1 mm? -87.19 122.34 30.86 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 103.823 -2.658 . . . . 0.0 103.823 173.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -67.65 -41.02 84.46 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 279' ' ' VAL . . . . . 0.486 ' HA ' ' CD1' ' A' ' 282' ' ' PHE . 14.8 p 41.65 27.25 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 127.489 2.316 . . . . 0.0 114.46 173.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -82.46 135.41 35.14 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.844 177.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 3.0 t70 72.59 25.76 2.59 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 125.269 1.428 . . . . 0.0 111.386 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.486 ' CD1' ' HA ' ' A' ' 279' ' ' VAL . 5.1 m-85 -88.43 -7.51 56.49 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.642 174.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? 55.09 60.64 3.33 Favored 'General case' 0 CA--C 1.509 -0.625 0 C-N-CA 124.56 1.144 . . . . 0.0 112.027 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 284' ' ' THR . . . . . 0.441 HG22 ' HE3' ' A' ' 232' ' ' LYS . 2.4 p -133.11 173.94 5.29 Favored Pre-proline 0 C--N 1.302 -1.47 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 178.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 285' ' ' PRO . . . . . 0.617 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 6.6 Cg_exo -77.65 -5.07 15.18 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 121.954 1.769 . . . . 0.0 110.796 176.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 54.4 t -90.72 137.94 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -99.44 -43.45 6.54 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.786 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 288' ' ' LYS . . . . . 0.425 ' HA ' HG12 ' A' ' 279' ' ' VAL . 22.6 ttmm -163.07 134.79 5.07 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -178.272 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.491 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 44.4 t -99.08 120.18 48.07 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.329 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 176.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 32.2 m -127.01 115.32 19.03 Favored 'General case' 0 C--N 1.284 -2.259 0 O-C-N 122.111 -0.368 . . . . 0.0 111.53 -176.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.499 ' HB2' HG12 ' A' ' 228' ' ' ILE . 49.1 tp -94.17 133.84 37.25 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -130.55 134.1 46.75 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -175.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' ARG . . . . . 0.55 ' HD2' ' HB ' ' A' ' 271' ' ' THR . 3.8 ptm180 -79.41 137.95 37.45 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 173.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.559 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 23.4 tp -111.57 178.98 4.15 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.559 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 63.0 t30 -49.68 -63.72 1.02 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 124.125 0.97 . . . . 0.0 112.517 -177.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -118.66 -2.91 10.89 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 120.673 0.273 . . . . 0.0 111.22 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 297' ' ' ASP . . . . . 0.564 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 20.6 m-20 -124.88 177.93 5.76 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.707 0.765 . . . . 0.0 110.9 -170.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.539 ' O ' ' HA ' ' A' ' 263' ' ' THR . 50.2 m -114.3 127.77 56.03 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 174.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 299' ' ' GLN . . . . . 0.508 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 37.0 tt0 -116.05 126.13 53.36 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -176.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.506 HD13 HG21 ' A' ' 228' ' ' ILE . 63.7 tp -110.77 120.24 41.76 Favored 'General case' 0 N--CA 1.417 -2.119 0 CA-C-O 121.164 0.507 . . . . 0.0 110.125 178.106 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 57.8 mt -106.65 109.84 29.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -177.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 302' ' ' ILE . . . . . 0.489 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 66.5 mt -108.01 107.78 23.65 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 18.1 m -77.77 133.46 38.25 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 12.5 p -135.18 173.85 11.26 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 122.831 0.452 . . . . 0.0 111.081 -175.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -156.28 147.08 21.93 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 120.526 0.203 . . . . 0.0 110.57 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 80.83 -159.23 41.75 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 115.701 -0.682 . . . . 0.0 113.651 174.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 307' ' ' ASN . . . . . 0.509 ' HB3' ' HB3' ' A' ' 327' ' ' LYS . 3.2 m-20 -90.34 123.29 33.97 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 176.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 308' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -149.12 162.79 39.27 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -177.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.565 ' HG2' ' HE2' ' A' ' 327' ' ' LYS . 8.6 mt-10 -119.04 137.52 53.49 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -178.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 1.1 tt -104.91 118.3 36.2 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.473 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 32.4 t -118.71 107.78 22.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 174.116 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -95.75 139.35 32.11 Favored 'General case' 0 C--N 1.311 -1.109 0 C-N-CA 119.093 -1.043 . . . . 0.0 109.207 177.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -125.86 134.93 51.47 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -177.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 28.6 t -115.74 111.88 21.2 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -80.03 -28.42 39.33 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.734 0.778 . . . . 0.0 109.82 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -166.75 160.15 11.5 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -64.71 101.13 0.36 Allowed 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 121.66 1.573 . . . . 0.0 109.837 176.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 127.81 -27.65 4.58 Favored Glycine 0 N--CA 1.426 -1.982 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.96 -176.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -108.36 118.43 36.75 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.864 -0.786 . . . . 0.0 110.818 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 320' ' ' PHE . . . . . 0.583 ' CZ ' ' HD3' ' A' ' 251' ' ' PRO . 48.2 m-85 -128.46 165.76 20.05 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-O 122.143 0.973 . . . . 0.0 110.902 -174.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 70.0 m -152.36 136.82 16.78 Favored 'General case' 0 C--N 1.269 -2.909 0 CA-C-N 114.518 -1.219 . . . . 0.0 107.848 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 0.441 ' O ' ' HA ' ' A' ' 239' ' ' ILE . 79.8 m-85 -119.88 117.69 28.79 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.061 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 323' ' ' GLN . . . . . 0.473 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 33.9 tt0 -101.55 100.26 10.66 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 91.3 t -88.79 102.03 12.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 50.8 mt -95.07 140.46 22.45 Favored Pre-proline 0 C--N 1.29 -1.988 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.161 -176.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -72.36 126.95 12.09 Favored 'Trans proline' 0 C--O 1.251 1.129 0 C-N-CA 121.431 1.421 . . . . 0.0 109.806 174.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.565 ' HE2' ' HG2' ' A' ' 309' ' ' GLU . 38.2 ttmt -95.06 105.84 17.79 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.08 147.7 23.45 Favored 'General case' 0 N--CA 1.412 -2.355 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.915 -175.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 . . . . . 0 C--N 1.292 -1.929 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.643 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 23.3 ptp . . . . . 0 CA--C 1.512 -0.498 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -146.39 -176.79 20.52 Favored Glycine 0 N--CA 1.431 -1.673 0 C-N-CA 119.915 -1.136 . . . . 0.0 112.304 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 35.0 t -122.15 107.46 12.19 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-O 121.141 0.496 . . . . 0.0 110.381 -178.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 28.9 p -134.15 151.4 51.34 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -73.06 -47.29 45.95 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -123.05 119.05 29.18 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 175.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -75.24 161.52 29.26 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.586 -175.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 56.87 27.85 13.62 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.232 1.413 . . . . 0.0 112.323 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -68.99 -50.22 50.91 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 26.7 m170 57.63 -169.34 0.11 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-N 114.835 -1.075 . . . . 0.0 113.129 178.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 113.59 -18.25 20.23 Favored Glycine 0 C--N 1.303 -1.254 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 6.0 mp -74.2 143.7 45.06 Favored 'General case' 0 C--O 1.251 1.182 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 33.8 m -79.94 143.24 57.29 Favored Pre-proline 0 C--N 1.301 -1.509 0 C-N-CA 120.351 -0.539 . . . . 0.0 109.991 -179.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' PRO . . . . . 0.423 ' HB2' ' O ' ' A' ' 208' ' ' SER . 74.5 Cg_endo -74.37 158.54 44.48 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 122.099 1.866 . . . . 0.0 111.236 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -82.91 78.62 9.47 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.39 -60.0 4.92 Favored Glycine 0 C--N 1.317 -0.513 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 -177.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 205' ' ' PRO . 30.9 t -129.71 169.34 15.22 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 177.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 -71.21 -66.06 0.67 Allowed 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -177.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 56.7 ttp -136.33 1.05 2.61 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 121.906 0.86 . . . . 0.0 109.677 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -83.78 166.7 17.78 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.96 -178.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 33.3 p -75.28 101.6 4.75 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -177.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' MET . . . . . 0.432 ' O ' ' HB ' ' A' ' 214' ' ' THR . 15.6 tpt -135.39 84.17 2.07 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 173.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.432 ' HB ' ' O ' ' A' ' 213' ' ' MET . 15.4 t 166.44 -13.29 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.199 1.4 . . . . 0.0 107.689 -176.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 100.73 -72.06 0.42 Allowed Glycine 0 N--CA 1.426 -2.003 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 151.14 90.97 0.08 OUTLIER Glycine 0 N--CA 1.426 -1.994 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -73.57 100.48 3.32 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.566 0.698 . . . . 0.0 110.372 -178.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -83.67 124.62 31.03 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.17 -174.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 94.7 mmm -80.61 -31.64 36.57 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 176.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 94.96 -143.56 16.67 Favored Glycine 0 N--CA 1.433 -1.518 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 -178.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -139.8 115.17 9.87 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.616 0.722 . . . . 0.0 109.314 174.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' GLY . . . . . 0.447 ' HA2' HD21 ' A' ' 227' ' ' ASN . . . 157.4 -162.75 32.12 Favored Glycine 0 N--CA 1.422 -2.238 0 N-CA-C 107.591 -2.204 . . . . 0.0 107.591 -174.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 23.3 t 69.72 -46.56 0.59 Allowed 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.231 1.012 . . . . 0.0 112.818 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -63.98 -62.09 1.86 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 123.453 0.701 . . . . 0.0 110.642 -178.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -162.62 168.6 21.48 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.526 HG23 ' HA ' ' A' ' 244' ' ' ALA . 59.5 m -61.39 129.72 42.59 Favored 'General case' 0 C--O 1.208 -1.125 0 C-N-CA 125.153 1.381 . . . . 0.0 111.632 -173.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.447 HD21 ' HA2' ' A' ' 222' ' ' GLY . 9.6 p30 -157.3 171.59 20.13 Favored 'General case' 0 CA--C 1.488 -1.43 0 CA-C-O 121.022 0.439 . . . . 0.0 110.462 -176.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.614 HG21 HD13 ' A' ' 300' ' ' LEU . 2.8 pp -130.27 155.65 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.199 179.022 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.487 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 18.8 t0 -144.64 156.27 44.03 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 -177.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.451 ' CE2' HG21 ' A' ' 279' ' ' VAL . 61.8 t80 -131.91 138.6 48.45 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 175.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -155.11 157.55 37.65 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -104.57 151.86 23.11 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.603 175.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -168.05 -174.87 2.47 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 61.81 -117.88 12.92 Favored Glycine 0 N--CA 1.445 -0.761 0 O-C-N 123.446 0.466 . . . . 0.0 113.03 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' LYS . . . . . 0.415 ' HE2' ' HB2' ' A' ' 235' ' ' LYS . 13.7 tppt? -126.96 79.91 1.91 Allowed 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -178.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 58.9 29.26 18.63 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.557 0.694 . . . . 0.0 111.249 -177.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.436 ' HB2' HD23 ' A' ' 325' ' ' LEU . . . -84.24 148.44 26.71 Favored 'General case' 0 N--CA 1.416 -2.168 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.305 -176.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -98.81 108.17 3.55 Favored Glycine 0 N--CA 1.418 -2.534 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.451 HG13 ' HG3' ' A' ' 323' ' ' GLN . 2.6 mp -101.49 118.84 48.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-N 117.391 0.596 . . . . 0.0 110.193 -177.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.8 mp -104.73 110.94 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.401 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 176.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.487 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 41.2 mt-10 -87.83 143.23 27.25 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 173.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 14.5 tp -132.12 125.97 32.59 Favored 'General case' 0 C--N 1.273 -2.719 0 CA-C-O 121.52 0.676 . . . . 0.0 111.044 -174.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' ALA . . . . . 0.48 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -113.73 105.73 13.65 Favored 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.526 ' HA ' HG23 ' A' ' 226' ' ' THR . . . -112.32 91.72 3.76 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.601 0.715 . . . . 0.0 109.119 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -81.73 112.52 18.97 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.398 -173.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 107.97 3.41 34.04 Favored Glycine 0 N--CA 1.427 -1.936 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.378 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' PHE . . . . . 0.457 ' CD2' HD12 ' A' ' 264' ' ' LEU . 37.8 t80 -115.82 107.96 15.7 Favored 'General case' 0 C--O 1.212 -0.908 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -102.22 3.28 38.13 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.006 0.431 . . . . 0.0 112.093 -177.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -95.35 -153.74 30.3 Favored Glycine 0 C--N 1.308 -1.012 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.638 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -116.16 137.64 23.6 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 177.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.774 ' HB3' HD13 ' A' ' 264' ' ' LEU . 17.4 Cg_endo -71.83 172.09 15.22 Favored 'Trans proline' 0 N--CA 1.439 -1.711 0 C-N-CA 122.029 1.819 . . . . 0.0 110.904 175.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -99.94 109.57 21.92 Favored 'General case' 0 C--N 1.275 -2.659 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 176.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 4.0 mp -100.11 124.19 53.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-O 121.079 0.466 . . . . 0.0 110.131 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 9.4 t -113.31 106.03 14.12 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 174.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -79.87 103.74 9.97 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.677 178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.512 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 77.8 mt-30 -124.16 152.06 43.28 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 175.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -71.07 -42.44 69.4 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -173.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -76.07 -24.63 55.1 Favored 'General case' 0 C--N 1.314 -0.978 0 O-C-N 123.442 0.464 . . . . 0.0 111.523 -176.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' HIS . . . . . 0.512 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 43.0 p-80 -170.19 158.38 6.82 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-O 120.549 0.214 . . . . 0.0 110.898 175.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 16.6 mt -105.94 141.45 21.23 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 261' ' ' ILE . . . . . 0.42 HD12 ' N ' ' A' ' 261' ' ' ILE . 3.1 mp -116.81 113.11 41.98 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.432 ' HB ' ' HB3' ' A' ' 300' ' ' LEU . 54.6 t -113.6 115.91 51.09 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 176.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 263' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' A' ' 298' ' ' THR . 41.6 m -121.65 126.24 48.55 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-O 121.48 0.657 . . . . 0.0 112.218 -177.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.774 HD13 ' HB3' ' A' ' 251' ' ' PRO . 1.6 mm? -94.38 104.09 16.08 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 177.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.588 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 30.1 mtpt -69.05 127.57 33.6 Favored 'General case' 0 N--CA 1.41 -2.446 0 O-C-N 124.204 0.94 . . . . 0.0 113.487 -173.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 64.4 t30 68.26 16.66 9.33 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 113.817 -1.538 . . . . 0.0 111.386 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 267' ' ' HIS . . . . . 0.44 ' ND1' ' HB2' ' A' ' 247' ' ' PHE . 54.6 t60 -95.46 107.74 19.91 Favored 'General case' 0 C--O 1.213 -0.821 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 174.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 1.2 p -82.92 109.79 17.34 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-O 120.889 0.376 . . . . 0.0 111.618 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 269' ' ' LEU . . . . . 0.413 HD22 HD22 ' A' ' 291' ' ' LEU . 23.4 tp -93.22 127.49 46.71 Favored Pre-proline 0 N--CA 1.436 -1.128 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.543 178.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -68.54 159.31 54.05 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 122.381 2.054 . . . . 0.0 111.544 171.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 19.6 p -66.69 -37.13 84.11 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.063 0.459 . . . . 0.0 111.544 -177.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 3.0 m -59.21 -19.35 44.7 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 124.66 1.184 . . . . 0.0 112.456 -178.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -95.96 -12.82 24.45 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 122.195 -0.316 . . . . 0.0 111.044 -176.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -72.31 142.11 48.85 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -163.86 155.38 16.52 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 175.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 16.6 m -122.84 123.7 41.6 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 64.4 mt -95.17 113.27 24.93 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -177.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -76.81 81.5 3.4 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.937 0.875 . . . . 0.0 108.95 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 279' ' ' VAL . . . . . 0.48 HG23 ' CG ' ' A' ' 282' ' ' PHE 0.282 1.5 p -98.37 69.75 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 CA-C-O 123.723 1.725 . . . . 0.0 111.642 -178.532 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -114.69 145.67 41.78 Favored 'General case' 0 N--CA 1.419 -1.993 0 CA-C-N 113.026 -1.897 . . . . 0.0 106.846 177.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 23.3 t70 68.19 18.22 9.3 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 122.494 1.14 . . . . 0.0 110.879 -178.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.48 ' CG ' HG23 ' A' ' 279' ' ' VAL . 31.2 m-85 -86.18 -13.84 45.79 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.599 -0.688 . . . . 0.0 109.344 174.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.79 60.62 1.55 Allowed 'General case' 0 CA--C 1.493 -1.22 0 C-N-CA 123.606 0.762 . . . . 0.0 110.822 -178.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -137.02 168.94 14.68 Favored Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 104.109 -2.552 . . . . 0.0 104.109 178.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -71.06 -13.19 31.24 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 121.482 1.455 . . . . 0.0 111.773 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 47.1 t -85.88 132.39 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 123.428 0.691 . . . . 0.0 109.343 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -101.57 -29.2 12.09 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.405 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -171.92 134.32 0.77 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.736 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 59.8 t -96.69 132.12 41.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 173.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.42 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 98.8 m -136.72 117.49 14.05 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.803 -0.56 . . . . 0.0 111.772 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.523 ' HB2' HG12 ' A' ' 228' ' ' ILE . 0.1 OUTLIER -97.41 116.77 30.24 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 179.385 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -126.21 136.45 52.84 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -78.74 144.44 35.22 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 176.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.583 HD13 ' N ' ' A' ' 295' ' ' ASN . 2.6 tm? -118.06 163.25 16.89 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 105.942 -1.874 . . . . 0.0 105.942 -178.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.583 ' N ' HD13 ' A' ' 294' ' ' LEU . 4.7 t-20 -29.39 -58.33 0.15 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.355 1.862 . . . . 0.0 113.754 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.58 -6.31 7.52 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 297' ' ' ASP . . . . . 0.588 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 6.0 m-20 -125.39 174.63 8.04 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.595 -160.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 263' ' ' THR . 56.1 m -115.34 120.09 38.45 Favored 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 175.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -110.92 117.31 33.03 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-O 121.696 0.76 . . . . 0.0 109.747 -176.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.614 HD13 HG21 ' A' ' 228' ' ' ILE . 46.1 tp -103.53 117.97 35.67 Favored 'General case' 0 C--N 1.263 -3.188 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 301' ' ' ILE . . . . . 0.42 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 63.3 mt -102.38 109.74 27.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 CA-C-N 114.566 -1.197 . . . . 0.0 107.88 -177.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 58.0 mt -108.71 100.3 10.47 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 27.7 m -72.52 132.17 43.48 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 7.4 p -138.49 174.82 10.14 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 123.482 0.713 . . . . 0.0 110.498 -176.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -158.55 137.43 11.27 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 117.514 0.143 . . . . 0.0 110.996 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 91.66 -157.68 24.7 Favored Glycine 0 N--CA 1.442 -0.908 0 O-C-N 123.508 0.505 . . . . 0.0 112.836 174.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 307' ' ' ASN . . . . . 0.414 ' HB3' ' HB3' ' A' ' 327' ' ' LYS . 76.5 m-20 -93.2 124.07 36.92 Favored 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 308' ' ' TRP . . . . . 0.465 ' CE3' HG13 ' A' ' 324' ' ' VAL . 70.3 p-90 -148.32 166.09 29.07 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -178.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -124.32 130.26 52.18 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -175.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 1.7 tt -100.73 122.67 43.75 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.598 HG13 ' HB3' ' A' ' 323' ' ' GLN . 7.6 p -123.34 114.77 43.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.612 171.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -98.32 144.82 27.31 Favored 'General case' 0 N--CA 1.424 -1.748 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.037 -178.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -131.58 141.06 49.59 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -178.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 78.0 p -111.64 115.43 29.11 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 173.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -76.16 -35.85 59.01 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -166.84 162.92 11.0 Favored Pre-proline 0 C--N 1.309 -1.19 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.77 97.06 0.32 Allowed 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.712 1.608 . . . . 0.0 110.177 176.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 129.37 -15.23 5.8 Favored Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -176.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -122.58 116.33 23.68 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 122.372 -0.487 . . . . 0.0 109.821 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -124.31 164.6 19.26 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.827 0.823 . . . . 0.0 110.661 -175.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 91.3 m -152.44 135.71 15.83 Favored 'General case' 0 C--N 1.267 -3.002 0 CA-C-N 114.871 -1.058 . . . . 0.0 108.846 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -124.06 117.86 25.66 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 323' ' ' GLN . . . . . 0.598 ' HB3' HG13 ' A' ' 311' ' ' VAL . 45.8 tt0 -102.26 103.43 13.91 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.465 HG13 ' CE3' ' A' ' 308' ' ' TRP . 92.7 t -87.13 98.94 7.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.054 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.507 HD21 HE21 ' A' ' 323' ' ' GLN . 32.1 mt -87.47 143.57 34.33 Favored Pre-proline 0 C--N 1.294 -1.813 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.667 -177.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -75.6 132.55 14.75 Favored 'Trans proline' 0 N--CA 1.458 -0.618 0 C-N-CA 121.93 1.753 . . . . 0.0 109.965 173.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.414 ' HB3' ' HB3' ' A' ' 307' ' ' ASN . 23.6 ttmm -97.09 101.26 12.79 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 120.056 -0.657 . . . . 0.0 110.417 -178.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 49.3 tptt -98.54 109.02 21.85 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 173.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 . . . . . 0 N--CA 1.419 -1.992 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 179.719 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 96.9 mmm . . . . . 0 CA--C 1.507 -0.693 0 CA-C-O 120.887 0.375 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -117.13 -20.64 4.75 Favored Glycine 0 N--CA 1.436 -1.318 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.608 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 18.5 p -77.05 -30.16 55.52 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.21 0.529 . . . . 0.0 110.952 178.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 42.8 t -146.71 133.26 19.79 Favored 'General case' 0 N--CA 1.419 -1.978 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.993 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -98.98 4.96 47.37 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 173.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 35.2 m-70 -69.29 -52.49 26.93 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 51.9 t60 -90.16 69.81 7.22 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 121.988 0.899 . . . . 0.0 108.933 178.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 -150.16 12.82 0.76 Allowed 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -178.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -115.8 159.42 21.49 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.201 -0.908 . . . . 0.0 108.679 -174.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -148.41 102.74 3.36 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 177.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 85.02 176.23 50.79 Favored Glycine 0 C--O 1.248 0.988 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -177.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 6.0 tt -84.97 -49.75 8.06 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 36.0 m -100.91 152.74 37.92 Favored Pre-proline 0 C--N 1.308 -1.198 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 176.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -69.53 95.07 0.52 Allowed 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 121.96 1.773 . . . . 0.0 111.745 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 32.2 tpt180 -80.91 94.92 6.59 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -178.39 71.99 0.07 OUTLIER Glycine 0 N--CA 1.419 -2.464 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 30.9 p -79.76 92.59 5.45 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.234 0.54 . . . . 0.0 109.854 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -134.47 -45.51 0.75 Allowed 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.68 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 58.1 ttp -147.56 107.88 4.08 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 120.406 -0.517 . . . . 0.0 111.214 -177.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -118.23 116.1 26.11 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 173.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 215' ' ' GLY . 49.2 m -85.75 109.53 18.7 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.081 0.467 . . . . 0.0 111.99 -176.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 16.6 tpt -171.66 -79.3 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 124.322 1.049 . . . . 0.0 109.303 175.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 13.5 t -85.19 -3.35 58.78 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 122.041 0.924 . . . . 0.0 109.522 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 212' ' ' SER . . . -172.67 -164.6 28.39 Favored Glycine 0 N--CA 1.405 -3.371 0 N-CA-C 107.003 -2.439 . . . . 0.0 107.003 179.024 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 128.2 -24.22 5.07 Favored Glycine 0 C--N 1.294 -1.773 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.806 178.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 65.21 80.28 0.23 Allowed 'General case' 0 C--O 1.25 1.126 0 C-N-CA 124.106 0.962 . . . . 0.0 111.107 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -79.64 171.48 15.08 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.943 176.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 63.0 mtt -80.13 74.11 6.93 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.535 0.683 . . . . 0.0 110.273 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -168.34 53.53 0.22 Allowed Glycine 0 C--N 1.292 -1.896 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -65.82 113.02 4.03 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-N 114.332 -0.934 . . . . 0.0 110.696 -175.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -79.37 58.94 4.39 Favored Glycine 0 C--O 1.219 -0.786 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 39.9 m -137.37 17.3 2.95 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.613 0.721 . . . . 0.0 109.961 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -126.53 17.86 7.52 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 122.943 1.354 . . . . 0.0 107.445 176.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' GLN . . . . . 0.421 ' O ' HD23 ' A' ' 245' ' ' LEU . 13.2 pt20 -152.5 152.56 32.07 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 -177.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.575 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 21.2 m -64.48 116.28 5.98 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 176.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -148.68 158.19 43.97 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.301 -170.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.624 HG21 HD21 ' A' ' 300' ' ' LEU . 2.7 pp -137.04 147.61 26.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -142.02 157.27 45.13 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 123.533 0.733 . . . . 0.0 109.991 -174.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.542 ' CD1' HG11 ' A' ' 279' ' ' VAL . 56.3 t80 -133.21 138.52 46.57 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.217 0.532 . . . . 0.0 111.254 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -155.94 164.53 38.37 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 172.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.423 ' HE3' HG22 ' A' ' 284' ' ' THR . 55.7 mtpt -104.48 162.58 13.12 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.929 178.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' ASP . . . . . 0.52 ' O ' ' HB3' ' A' ' 237' ' ' ALA . 15.8 t70 -157.97 125.62 5.21 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 81.53 -126.63 7.5 Favored Glycine 0 C--N 1.297 -1.586 0 C-N-CA 121.143 -0.551 . . . . 0.0 113.441 174.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -105.14 90.9 3.58 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -174.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' ASN . . . . . 0.539 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 17.6 m120 62.83 17.15 9.68 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.023 -0.99 . . . . 0.0 112.724 175.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 233' ' ' ASP . . . -83.51 140.93 31.99 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -176.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' GLY . . . . . 0.431 ' C ' HD12 ' A' ' 239' ' ' ILE . . . -101.64 130.27 10.18 Favored Glycine 0 N--CA 1.432 -1.596 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 178.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 230' ' ' PHE . 2.3 mp -118.45 117.28 54.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 117.651 0.725 . . . . 0.0 110.985 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.0 mp -104.16 109.43 27.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 176.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -91.39 118.23 30.35 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-O 121.558 0.694 . . . . 0.0 109.348 178.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 9.8 tp -108.7 117.06 33.19 Favored 'General case' 0 C--N 1.272 -2.775 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.754 -175.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' ALA . . . . . 0.575 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -103.19 94.4 5.5 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 176.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -101.92 90.93 4.15 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.69 0.757 . . . . 0.0 109.455 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.421 HD23 ' O ' ' A' ' 225' ' ' GLN . 3.6 mm? -88.09 115.29 25.46 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.672 0.749 . . . . 0.0 110.804 -177.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 123.21 -8.27 9.07 Favored Glycine 0 N--CA 1.423 -2.178 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.517 -176.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' PHE . . . . . 0.474 ' CD2' HD12 ' A' ' 264' ' ' LEU . 30.4 t80 -115.4 127.0 55.07 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -109.4 -19.15 13.37 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.901 -177.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -87.48 -140.99 6.8 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.921 -177.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -125.14 132.37 24.3 Favored Pre-proline 0 C--N 1.314 -0.943 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.718 ' HB3' HD13 ' A' ' 264' ' ' LEU . 14.1 Cg_endo -69.63 171.68 13.89 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.534 2.156 . . . . 0.0 111.679 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.619 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 33.3 t70 -91.32 105.88 18.1 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 176.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.544 HD11 ' HG2' ' A' ' 251' ' ' PRO . 5.2 mp -101.74 108.99 24.84 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.636 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 254' ' ' SER . . . . . 0.538 ' HB3' ' HB ' ' A' ' 261' ' ' ILE . 23.3 t -91.18 112.17 23.97 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.118 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -89.42 103.22 15.87 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.204 0.526 . . . . 0.0 111.241 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.634 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 13.9 mm100 -119.51 154.94 33.05 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 177.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' HIS . . . . . 0.426 ' HA ' ' HE1' ' A' ' 308' ' ' TRP . 37.4 m80 -76.67 -30.91 56.98 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.329 0.585 . . . . 0.0 109.662 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -68.3 -39.48 82.05 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.681 -1.145 . . . . 0.0 112.151 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' HIS . . . . . 0.634 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 39.5 p-80 -175.6 166.82 3.23 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.402 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 20.7 mt -105.87 133.21 50.89 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 106.552 -1.648 . . . . 0.0 106.552 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 261' ' ' ILE . . . . . 0.538 ' HB ' ' HB3' ' A' ' 254' ' ' SER . 3.4 mp -114.96 115.9 50.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 179.002 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.619 ' HA ' ' O ' ' A' ' 252' ' ' ASP . 0.8 OUTLIER -113.89 140.64 33.35 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.394 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 263' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 298' ' ' THR . 20.2 m -134.09 124.04 25.48 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.517 0.675 . . . . 0.0 111.887 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.718 HD13 ' HB3' ' A' ' 251' ' ' PRO . 1.8 mm? -98.14 108.12 20.75 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.482 ' HD3' ' OD1' ' A' ' 297' ' ' ASP . 59.4 mmtt -67.28 131.49 45.85 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 124.213 0.946 . . . . 0.0 113.549 -177.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 73.68 6.75 5.0 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.565 -1.652 . . . . 0.0 110.357 176.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -95.72 99.61 11.43 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.084 -174.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 19.3 p -77.56 108.96 11.11 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-O 121.224 0.535 . . . . 0.0 111.03 -178.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' LEU . . . . . 0.452 HD12 ' HD2' ' A' ' 270' ' ' PRO . 30.1 tp -89.92 128.38 50.27 Favored Pre-proline 0 N--CA 1.43 -1.438 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.12 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.452 ' HD2' HD12 ' A' ' 269' ' ' LEU . 16.0 Cg_exo -70.83 157.7 57.6 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.643 2.228 . . . . 0.0 111.905 171.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 271' ' ' THR . . . . . 0.474 ' HA ' ' OE1' ' A' ' 274' ' ' GLN . 6.7 p -66.87 -38.35 86.17 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.582 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 11.4 m -59.88 -26.3 65.77 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 124.656 1.182 . . . . 0.0 112.516 -178.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 8.5 mp -96.27 2.48 52.93 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.566 0.698 . . . . 0.0 110.814 -172.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.627 HE21 ' HA ' ' A' ' 292' ' ' LYS . 50.7 mt-30 -84.45 123.54 30.36 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.121 178.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 275' ' ' ARG . . . . . 0.534 ' HD2' ' O ' ' A' ' 228' ' ' ILE . 3.7 ptp180 -137.33 162.4 33.68 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 177.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 276' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 289' ' ' VAL . 24.5 t -139.86 126.77 20.79 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.528 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 1.1 mm? -98.16 111.43 23.76 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 124.925 1.29 . . . . 0.0 108.728 -176.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -86.62 92.68 8.99 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 279' ' ' VAL . . . . . 0.542 HG11 ' CD1' ' A' ' 230' ' ' PHE . 11.8 m -102.32 28.03 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 CA-C-N 114.404 -1.271 . . . . 0.0 112.187 -175.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -67.4 140.49 57.18 Favored 'General case' 0 N--CA 1.403 -2.82 0 CA-C-N 114.062 -1.427 . . . . 0.0 107.591 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 34.4 t70 73.71 4.02 4.62 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 124.892 1.277 . . . . 0.0 113.119 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -75.61 -3.32 33.76 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.475 -0.766 . . . . 0.0 111.492 174.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm 60.64 58.41 2.45 Favored 'General case' 0 CA--C 1.504 -0.81 0 C-N-CA 124.171 0.989 . . . . 0.0 111.007 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 284' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 236' ' ' ASN . 1.4 p -136.57 168.47 16.87 Favored Pre-proline 0 N--CA 1.428 -1.546 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 285' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 15.7 Cg_exo -71.58 -14.58 30.52 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 121.863 1.709 . . . . 0.0 110.892 176.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 21.4 t -84.18 139.75 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -103.18 -45.36 4.94 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.164 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 288' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 277' ' ' LEU . 7.3 ttpm? -163.22 137.61 6.18 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.437 -179.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.528 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 39.9 t -100.67 122.75 53.05 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.34 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 57.7 m -129.26 124.81 35.39 Favored 'General case' 0 C--N 1.28 -2.433 0 CA-C-O 121.217 0.532 . . . . 0.0 110.98 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.612 ' HB2' HG12 ' A' ' 228' ' ' ILE . 45.8 tp -100.04 113.38 25.94 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.627 ' HA ' HE21 ' A' ' 274' ' ' GLN . 40.8 ttmt -115.23 129.34 56.61 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -178.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 293' ' ' ARG . . . . . 0.455 ' H ' ' NE2' ' A' ' 274' ' ' GLN . 13.8 ptt180 -72.95 142.83 47.82 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 175.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.585 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 19.3 tp -108.38 -173.46 2.28 Favored 'General case' 0 C--N 1.274 -2.692 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.585 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 3.8 t-20 -52.57 -64.02 0.95 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.327 0.584 . . . . 0.0 112.079 -177.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -125.07 -3.49 7.57 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.817 0.818 . . . . 0.0 109.323 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 297' ' ' ASP . . . . . 0.482 ' OD1' ' HD3' ' A' ' 265' ' ' LYS . 49.6 m-20 -117.05 171.72 7.74 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.054 -175.163 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.572 ' O ' ' HA ' ' A' ' 263' ' ' THR . 27.2 m -108.05 133.7 51.98 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.045 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 299' ' ' GLN . . . . . 0.614 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 43.6 tt0 -121.44 131.71 54.32 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 118.462 0.574 . . . . 0.0 111.304 -177.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.624 HD21 HG21 ' A' ' 228' ' ' ILE . 9.1 mt -100.45 135.41 41.93 Favored 'General case' 0 CA--C 1.45 -2.902 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.39 170.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 62.6 mt -121.18 108.11 21.83 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 173.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 302' ' ' ILE . . . . . 0.402 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 56.0 mt -113.22 97.8 6.18 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.733 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.416 ' HA ' ' HB3' ' A' ' 259' ' ' HIS . 13.7 m -67.7 130.31 42.62 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -176.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 16.8 p -133.26 167.58 20.12 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 123.279 0.362 . . . . 0.0 110.671 -177.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -152.58 141.0 20.66 Favored 'General case' 0 C--O 1.248 0.976 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 87.24 -168.22 38.43 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 121.376 -0.44 . . . . 0.0 112.259 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -86.48 131.96 34.05 Favored 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 177.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 308' ' ' TRP . . . . . 0.711 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 63.4 p-90 -150.34 164.08 36.72 Favored 'General case' 0 N--CA 1.418 -2.036 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.119 -177.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 324' ' ' VAL . 10.2 mt-10 -122.21 135.45 54.77 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 -178.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.711 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 19.8 tp -107.28 115.26 29.86 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.406 -178.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 28.3 t -116.22 105.26 18.04 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 174.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 312' ' ' ASN . . . . . 0.405 ' HA ' ' O ' ' A' ' 321' ' ' THR . 25.6 t30 -98.45 134.39 41.5 Favored 'General case' 0 CA--C 1.432 -3.574 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 177.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 54.4 mttm -119.38 120.58 37.3 Favored 'General case' 1 N--CA 1.362 -4.826 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.541 -177.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 39.2 m -82.97 103.53 12.5 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 172.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -71.74 -31.71 66.96 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.992 -177.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.469 ' HB1' ' HD2' ' A' ' 317' ' ' PRO . . . -170.12 166.55 5.24 Favored Pre-proline 0 C--N 1.311 -1.09 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 -178.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 317' ' ' PRO . . . . . 0.469 ' HD2' ' HB1' ' A' ' 316' ' ' ALA . 23.2 Cg_endo -60.02 104.78 0.25 Allowed 'Trans proline' 0 C--O 1.246 0.913 0 C-N-CA 121.988 1.792 . . . . 0.0 112.137 178.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 107.77 -13.83 38.34 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.134 -178.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 319' ' ' TYR . . . . . 0.402 ' CD1' ' HB3' ' A' ' 316' ' ' ALA . 97.7 m-85 -108.56 116.19 31.51 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.991 -0.711 . . . . 0.0 109.136 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 320' ' ' PHE . . . . . 0.489 ' CZ ' ' HD3' ' A' ' 251' ' ' PRO . 83.5 m-85 -121.49 160.34 24.4 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.593 0.711 . . . . 0.0 110.137 -176.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 312' ' ' ASN . 94.8 m -152.96 105.88 2.98 Favored 'General case' 0 C--N 1.273 -2.738 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.335 -175.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -94.1 110.47 22.18 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 -178.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 323' ' ' GLN . . . . . 0.533 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 51.2 tt0 -97.63 99.98 11.37 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 176.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.41 HG23 ' CE3' ' A' ' 308' ' ' TRP . 0.1 OUTLIER -96.26 104.07 15.43 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.323 0 CA-C-O 122.642 1.21 . . . . 0.0 110.052 179.258 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 21.3 mt -95.22 149.54 36.35 Favored Pre-proline 0 C--N 1.296 -1.745 0 CA-C-N 113.238 -1.801 . . . . 0.0 109.555 -174.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -76.35 123.84 7.38 Favored 'Trans proline' 0 C--O 1.247 0.971 0 C-N-CA 121.78 1.653 . . . . 0.0 109.937 173.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -85.55 108.05 17.76 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.363 -176.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -133.01 4.31 3.78 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.897 174.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 . . . . . 0 C--N 1.287 -2.137 0 CA-C-N 113.646 -1.616 . . . . 0.0 107.01 -179.513 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 53.9 tpp . . . . . 0 N--CA 1.446 -0.651 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -89.2 -125.45 2.64 Favored Glycine 0 N--CA 1.429 -1.791 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 177.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 21.6 p -69.72 140.18 53.46 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 15.6 m -96.08 -169.53 1.94 Allowed 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.392 -177.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -74.1 126.08 29.76 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -175.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -101.51 135.8 42.43 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.98 -174.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -91.97 -38.91 11.98 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 175.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -83.39 90.74 7.22 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' HIS . . . . . 0.459 ' C ' ' HG2' ' A' ' 205' ' ' PRO . 24.5 t-80 -166.32 25.69 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.484 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -150.41 173.77 13.65 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 122.024 -0.423 . . . . 0.0 110.486 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 84.65 -61.09 4.74 Favored Glycine 0 C--O 1.226 -0.35 0 C-N-CA 121.641 -0.314 . . . . 0.0 113.249 175.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 4.6 mp -83.67 17.36 2.29 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 123.098 0.559 . . . . 0.0 111.458 -176.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . 0.293 33.8 m 43.18 68.85 2.63 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 124.977 1.311 . . . . 0.0 112.396 -173.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' PRO . . . . . 0.459 ' HG2' ' C ' ' A' ' 200' ' ' HIS . 2.7 Cg_exo -80.49 39.96 0.92 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.982 3.122 . . . . 0.0 113.519 -173.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -80.67 127.55 32.61 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 176.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -58.6 102.52 0.27 Allowed Glycine 0 N--CA 1.435 -1.394 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 178.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 19.4 m -80.74 16.28 1.47 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.844 0.831 . . . . 0.0 111.974 -173.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 72.7 m-70 -108.26 17.67 21.95 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 172.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 26.0 mmt 70.21 82.19 0.16 Allowed 'General case' 0 CA--C 1.503 -0.829 0 C-N-CA 125.881 1.672 . . . . 0.0 111.787 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -93.34 36.55 1.06 Allowed 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.513 -1.222 . . . . 0.0 110.055 -177.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 2.1 p -73.02 -40.75 64.91 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.558 0.694 . . . . 0.0 110.224 178.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 95.8 mmm -126.19 84.21 2.25 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 175.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 29.0 m -78.23 -45.74 22.17 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.767 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 139.19 171.56 12.26 Favored Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -74.52 -33.33 56.3 Favored Glycine 0 C--O 1.245 0.817 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -89.07 138.43 31.42 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -84.28 -38.88 19.89 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 174.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 42.4 ttm -109.24 87.24 2.45 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 176.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 132.66 166.7 11.57 Favored Glycine 0 C--N 1.294 -1.768 0 C-N-CA 120.167 -1.016 . . . . 0.0 111.434 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.9 mtp-105 -138.17 32.07 2.39 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -177.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 112.89 -25.17 11.93 Favored Glycine 0 CA--C 1.497 -1.068 0 N-CA-C 108.462 -1.855 . . . . 0.0 108.462 -175.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 19.8 m -135.89 163.11 31.0 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 174.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' LYS . . . . . 0.54 ' H ' ' HG ' ' A' ' 245' ' ' LEU . 4.7 tmmm? -159.83 -79.16 0.06 Allowed 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -177.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' GLN . . . . . 0.427 ' HG2' HD11 ' A' ' 273' ' ' LEU . 7.1 tt0 175.09 168.63 0.3 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 104.254 -2.499 . . . . 0.0 104.254 178.453 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.554 ' O ' HD13 ' A' ' 273' ' ' LEU . 11.0 m -64.88 147.72 52.78 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 118.454 0.57 . . . . 0.0 111.05 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -173.92 169.42 4.08 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 120.919 0.39 . . . . 0.0 110.323 173.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.443 HG21 HD13 ' A' ' 300' ' ' LEU . 2.8 pp -124.25 158.81 30.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.552 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 4.4 t70 -150.38 156.21 41.07 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -138.37 136.51 36.4 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 118.145 0.429 . . . . 0.0 111.368 177.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -149.43 166.38 29.25 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.573 173.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -103.92 139.72 38.69 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -151.39 169.57 21.69 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 59.3 -129.51 49.26 Favored Glycine 0 C--N 1.304 -1.233 0 N-CA-C 114.275 0.47 . . . . 0.0 114.275 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -118.33 89.44 3.12 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 123.889 0.876 . . . . 0.0 109.506 -176.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 54.08 33.8 18.52 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 122.221 1.01 . . . . 0.0 112.338 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.3 140.55 29.64 Favored 'General case' 0 N--CA 1.405 -2.685 0 CA-C-N 114.124 -1.398 . . . . 0.0 108.496 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' GLY . . . . . 0.407 ' O ' HG13 ' A' ' 324' ' ' VAL . . . -100.77 124.64 8.32 Favored Glycine 0 N--CA 1.422 -2.285 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.2 mp -112.62 118.34 57.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-N 117.602 0.701 . . . . 0.0 110.416 -177.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.0 mp -105.02 112.44 38.64 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 177.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 52.8 mt-10 -90.34 142.47 27.69 Favored 'General case' 0 C--N 1.279 -2.47 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 174.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 11.8 tp -129.99 117.82 20.65 Favored 'General case' 0 C--N 1.265 -3.074 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.275 -175.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' ALA . . . . . 0.55 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -103.89 106.24 16.68 Favored 'General case' 0 C--N 1.282 -2.345 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 177.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -117.88 90.36 3.32 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 121.603 0.716 . . . . 0.0 110.228 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.54 ' HG ' ' H ' ' A' ' 224' ' ' LYS . 3.9 mm? -87.0 113.91 23.16 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.4 -178.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 122.4 1.31 10.16 Favored Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -176.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -115.54 128.99 56.38 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -104.68 -30.82 9.69 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -176.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -94.26 -141.92 11.82 Favored Glycine 0 CA--C 1.493 -1.34 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.318 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -118.4 142.41 31.31 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -177.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.585 ' HB3' HD23 ' A' ' 264' ' ' LEU . 44.0 Cg_endo -79.58 172.34 14.51 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.812 2.341 . . . . 0.0 112.488 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -89.26 109.55 20.42 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.39 108.79 20.91 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 177.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' SER . . . . . 0.538 ' HB2' ' HB ' ' A' ' 261' ' ' ILE . 16.9 m -105.72 111.4 24.07 Favored 'General case' 0 N--CA 1.407 -2.619 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.6 176.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -94.34 112.51 24.3 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.496 -176.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.711 ' HB3' ' O ' ' A' ' 259' ' ' HIS . 6.8 tp60 -116.5 159.73 21.64 Favored 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -76.89 -37.19 55.93 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.145 -177.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -71.23 -34.41 70.76 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.697 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' HIS . . . . . 0.711 ' O ' ' HB3' ' A' ' 256' ' ' GLN . 26.8 p80 -168.08 171.22 9.74 Favored 'General case' 0 C--O 1.201 -1.451 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -178.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.424 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 21.7 mt -106.38 139.26 28.35 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 178.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 261' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' A' ' 254' ' ' SER . 3.6 mp -115.35 108.49 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.926 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.485 ' HB ' ' HB3' ' A' ' 300' ' ' LEU . 43.3 t -106.68 120.93 58.69 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.628 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 175.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 263' ' ' THR . . . . . 0.537 HG22 ' OD2' ' A' ' 297' ' ' ASP . 1.1 m -115.32 130.36 56.88 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.723 -177.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.585 HD23 ' HB3' ' A' ' 251' ' ' PRO . 25.5 mt -116.04 83.38 1.93 Allowed 'General case' 0 CA--C 1.474 -1.976 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -178.292 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.447 ' HA ' ' OD2' ' A' ' 297' ' ' ASP . 26.4 mmtm -61.65 140.88 58.11 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.6 -175.221 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 10.9 t30 66.68 15.05 10.02 Favored 'General case' 0 CA--C 1.552 1.027 0 O-C-N 124.792 1.307 . . . . 0.0 110.802 175.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 50.2 t60 -109.89 93.92 4.75 Favored 'General case' 0 C--O 1.187 -2.216 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 176.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 2.0 m -86.64 114.7 23.57 Favored 'General case' 0 C--N 1.28 -2.431 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.334 -173.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 19.6 tp -87.84 135.76 33.36 Favored Pre-proline 0 C--N 1.312 -1.037 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.47 -178.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -78.65 159.91 28.26 Favored 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 122.25 1.967 . . . . 0.0 111.413 171.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 271' ' ' THR . . . . . 0.479 ' HA ' ' OE1' ' A' ' 274' ' ' GLN . 23.5 p -64.0 -28.31 69.72 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.727 0.775 . . . . 0.0 111.081 -179.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 30.1 m -56.86 -26.29 58.29 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 125.693 1.597 . . . . 0.0 113.379 -177.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.554 HD13 ' O ' ' A' ' 226' ' ' THR . 64.7 mt -105.6 -2.27 23.69 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 121.965 -0.459 . . . . 0.0 111.537 -174.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.479 ' OE1' ' HA ' ' A' ' 271' ' ' THR . 55.3 mt-30 -77.9 108.31 11.06 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.971 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -138.26 153.34 49.08 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 20.2 m -117.77 131.99 56.52 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 63.9 mt -100.2 125.82 46.41 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -49.41 -69.11 0.13 Allowed 'General case' 0 N--CA 1.471 0.623 0 O-C-N 124.559 1.162 . . . . 0.0 111.642 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 279' ' ' VAL . . . . . 0.711 ' HA ' ' CD2' ' A' ' 282' ' ' PHE . 39.1 t 56.12 24.72 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.79 0 O-C-N 124.332 1.02 . . . . 0.0 112.247 176.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -79.5 138.27 37.49 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 120.637 -1.289 . . . . 0.0 109.991 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 60.21 38.68 19.93 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 123.92 0.762 . . . . 0.0 111.514 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.711 ' CD2' ' HA ' ' A' ' 279' ' ' VAL . 0.2 OUTLIER -88.59 -2.94 58.86 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.856 179.85 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 65.36 61.24 0.72 Allowed 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.894 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.9 153.45 10.82 Favored Pre-proline 0 C--N 1.298 -1.634 0 CA-C-N 114.127 -1.397 . . . . 0.0 108.966 179.018 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 285' ' ' PRO . . . . . 0.475 ' O ' ' HA ' ' A' ' 304' ' ' THR . 62.1 Cg_exo -50.31 -28.13 19.78 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.671 2.914 . . . . 0.0 112.948 173.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 42.4 t -69.57 124.39 25.37 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.946 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -98.71 -44.0 6.58 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.263 -177.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -161.64 139.17 8.85 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 47.0 t -100.89 130.89 49.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 176.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 62.6 m -139.72 117.0 11.24 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.119 0.485 . . . . 0.0 110.772 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 54.9 tp -97.47 115.58 28.04 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 292' ' ' LYS . . . . . 0.425 ' HA ' HE21 ' A' ' 274' ' ' GLN . 16.3 tppt? -114.63 129.01 56.62 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -176.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 293' ' ' ARG . . . . . 0.436 ' H ' ' NE2' ' A' ' 274' ' ' GLN . 5.7 ptm180 -79.46 140.18 37.41 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.166 -1.013 . . . . 0.0 108.572 176.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.621 ' HB3' ' HB3' ' A' ' 297' ' ' ASP . 2.7 tm? -120.29 158.48 26.97 Favored 'General case' 0 N--CA 1.416 -2.149 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.6 ' N ' HD13 ' A' ' 294' ' ' LEU . 21.3 t-20 -14.86 -71.43 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 127.583 2.353 . . . . 0.0 114.032 177.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -125.2 -3.47 7.49 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 297' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 294' ' ' LEU . 7.0 t70 -108.58 -177.65 3.38 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.242 1.017 . . . . 0.0 108.471 -169.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.501 ' HB ' ' HB2' ' A' ' 264' ' ' LEU . 58.3 m -134.18 109.55 8.97 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 174.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -103.23 119.17 38.37 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-O 121.708 0.766 . . . . 0.0 109.648 -175.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.485 ' HB3' ' HB ' ' A' ' 262' ' ' VAL . 59.9 tp -105.13 124.26 49.22 Favored 'General case' 0 C--N 1.271 -2.805 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.831 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 66.6 mt -107.16 109.85 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.641 -178.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 302' ' ' ILE . . . . . 0.424 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 61.6 mt -108.36 105.14 18.23 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.401 ' HA ' ' CB ' ' A' ' 259' ' ' HIS . 11.9 m -74.77 135.36 41.72 Favored 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.832 -174.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 304' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 285' ' ' PRO . 17.3 p -134.34 -177.04 4.41 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 123.051 0.54 . . . . 0.0 110.308 -177.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -166.75 149.9 6.76 Favored 'General case' 0 C--O 1.247 0.937 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 71.92 -161.05 54.22 Favored Glycine 0 C--O 1.243 0.659 0 O-C-N 123.672 0.608 . . . . 0.0 112.541 177.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 307' ' ' ASN . . . . . 0.413 ' HB3' ' HB3' ' A' ' 327' ' ' LYS . 83.6 m-20 -88.32 128.84 35.5 Favored 'General case' 0 CA--C 1.494 -1.197 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 308' ' ' TRP . . . . . 0.687 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 56.8 p-90 -147.83 167.59 24.36 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -177.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 324' ' ' VAL . 15.8 mt-10 -123.69 144.58 49.56 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -177.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.687 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 33.1 tp -120.83 117.52 27.61 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.916 0.389 . . . . 0.0 111.514 -176.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 58.8 t -110.87 108.27 25.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 174.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -98.46 129.64 45.07 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -135.08 158.71 43.65 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 120.807 0.337 . . . . 0.0 110.223 -178.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 12.0 p -116.5 138.88 51.04 Favored 'General case' 0 N--CA 1.414 -2.247 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.908 172.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -96.55 -22.97 16.75 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -172.39 163.3 4.11 Favored Pre-proline 0 C--N 1.313 -1.001 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -65.11 97.57 0.29 Allowed 'Trans proline' 0 C--O 1.247 0.948 0 C-N-CA 121.63 1.554 . . . . 0.0 111.172 177.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 120.9 -5.15 11.42 Favored Glycine 0 C--O 1.208 -1.521 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.433 -177.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -123.7 116.68 23.45 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.944 -0.739 . . . . 0.0 109.749 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -119.19 166.3 13.13 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.829 0.823 . . . . 0.0 110.749 -176.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 58.5 m -151.97 136.68 17.05 Favored 'General case' 0 C--N 1.281 -2.37 0 C-N-CA 124.259 1.024 . . . . 0.0 109.085 -177.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -123.03 116.26 23.22 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 323' ' ' GLN . . . . . 0.533 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 8.9 tt0 -103.53 105.87 16.23 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 309' ' ' GLU . 1.3 m -99.59 110.72 27.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-O 121.301 0.572 . . . . 0.0 109.8 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -92.1 156.89 41.73 Favored Pre-proline 0 C--N 1.313 -1.015 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.374 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -83.0 138.51 9.13 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 C-N-CA 121.814 1.676 . . . . 0.0 109.915 171.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 307' ' ' ASN . 34.6 ttmt -114.07 138.79 49.94 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -134.91 149.35 50.26 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 . . . . . 0 C--O 1.255 1.372 0 CA-C-O 118.088 -0.958 . . . . 0.0 110.921 -179.095 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 CA--C 1.51 -0.581 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 175.98 -68.85 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 177.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 20.0 m -96.51 134.65 39.44 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 28.1 m -81.76 -37.64 26.89 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 35.5 p-80 -133.82 107.47 7.89 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 176.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -96.45 -34.02 11.66 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 -175.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -71.45 144.04 49.86 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 121.546 0.688 . . . . 0.0 111.257 -177.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -134.33 106.43 7.1 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.522 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 47.8 t-80 -156.41 136.64 12.9 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -102.79 167.07 10.11 Favored 'General case' 0 C--N 1.29 -2.003 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.454 -177.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 87.87 -101.25 2.69 Favored Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 64.34 -171.47 0.18 Allowed 'General case' 0 C--O 1.25 1.125 0 C-N-CA 123.647 0.779 . . . . 0.0 110.731 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 9.2 p -145.71 127.62 7.78 Favored Pre-proline 0 N--CA 1.415 -2.207 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 176.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.55 -50.76 2.29 Favored 'Trans proline' 0 C--O 1.246 0.881 0 C-N-CA 121.711 1.608 . . . . 0.0 109.688 176.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 18.4 ttm-85 -166.45 -24.24 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.238 175.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 103.88 -96.7 1.33 Allowed Glycine 0 CA--C 1.489 -1.588 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 176.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 32.8 t -89.98 136.14 33.22 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 174.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -55.18 112.49 1.09 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.382 0.61 . . . . 0.0 112.185 -177.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 12.9 tpt 58.69 77.66 0.29 Allowed 'General case' 0 C--O 1.245 0.84 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.02 -173.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -139.83 18.25 2.49 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.218 -1.356 . . . . 0.0 108.865 176.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 29.8 t -163.78 129.82 3.11 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 58.1 ttp -152.14 -59.09 0.15 Allowed 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 4.5 m -85.04 -24.77 28.01 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -64.05 145.45 49.71 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.645 177.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 96.66 66.98 0.94 Allowed Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -177.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -103.93 174.15 6.0 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 120.604 0.24 . . . . 0.0 110.931 -178.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 11.5 tm0? -77.69 100.75 6.32 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 177.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 60.9 mtt -118.49 174.7 6.1 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.273 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 109.09 -16.46 32.75 Favored Glycine 0 N--CA 1.435 -1.402 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 -115.39 -48.91 2.78 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 122.549 -0.383 . . . . 0.0 110.446 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 81.41 -33.08 2.53 Favored Glycine 0 N--CA 1.461 0.305 0 C-N-CA 121.33 -0.462 . . . . 0.0 112.23 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.442 ' OG ' HD21 ' A' ' 245' ' ' LEU . 25.3 t -111.38 96.57 6.19 Favored 'General case' 0 N--CA 1.414 -2.225 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -103.81 -29.86 10.74 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' GLN . . . . . 0.496 ' HG2' ' H ' ' A' ' 226' ' ' THR . 42.1 tt0 -172.49 -163.79 0.24 Allowed 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 -176.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.635 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 24.7 m -63.83 125.64 25.02 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 123.403 0.681 . . . . 0.0 112.595 -170.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -152.55 171.81 17.55 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.18 -176.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.52 HG21 HD13 ' A' ' 300' ' ' LEU . 2.5 pp -133.7 158.85 42.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 C-N-CA 123.45 0.7 . . . . 0.0 110.868 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 1.8 t70 -149.85 156.63 42.11 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -175.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -138.08 138.28 38.59 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.153 0.501 . . . . 0.0 111.086 176.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 21.1 ptt85 -153.76 168.2 27.09 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 172.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.495 ' HE3' HG22 ' A' ' 284' ' ' THR . 54.4 mtpt -113.53 154.41 27.14 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -144.14 117.67 9.15 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 81.48 -117.23 4.37 Favored Glycine 0 C--N 1.294 -1.793 0 C-N-CA 121.186 -0.53 . . . . 0.0 113.956 175.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -101.33 80.22 2.07 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.332 0.587 . . . . 0.0 111.801 -173.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' ASN . . . . . 0.474 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 91.9 m-20 57.85 18.07 4.69 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 176.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -73.19 136.11 44.69 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' GLY . . . . . 0.474 ' HA3' ' CG1' ' A' ' 286' ' ' VAL . . . -91.59 123.86 7.37 Favored Glycine 0 N--CA 1.43 -1.752 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.15 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.6 mp -117.69 112.43 38.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 117.792 0.796 . . . . 0.0 110.77 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.1 mp -101.0 112.15 32.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.455 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 51.4 mt-10 -96.93 104.96 17.02 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 122.635 1.207 . . . . 0.0 110.558 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 11.5 tp -95.24 127.45 41.3 Favored 'General case' 0 C--N 1.27 -2.849 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.621 -175.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' ALA . . . . . 0.635 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -115.78 102.82 10.06 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -109.6 90.97 3.46 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.442 HD21 ' OG ' ' A' ' 223' ' ' SER . 2.9 mm? -78.62 115.82 18.58 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.725 -177.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 108.31 12.15 22.23 Favored Glycine 0 N--CA 1.425 -2.08 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.783 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' PHE . . . . . 0.435 ' HE1' ' O ' ' A' ' 265' ' ' LYS . 42.2 t80 -115.81 107.85 15.57 Favored 'General case' 0 N--CA 1.421 -1.905 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.803 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -103.76 94.71 5.58 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.409 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 156.76 -139.8 6.75 Favored Glycine 0 C--N 1.299 -1.473 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' GLN . . . . . 0.438 ' HA ' ' OE1' ' A' ' 250' ' ' GLN . 13.7 mm-40 -129.51 139.88 36.99 Favored Pre-proline 0 C--N 1.305 -1.357 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.721 ' HB3' HD13 ' A' ' 264' ' ' LEU . 9.1 Cg_endo -69.7 172.14 13.11 Favored 'Trans proline' 0 N--CA 1.434 -2.018 0 C-N-CA 121.212 1.275 . . . . 0.0 110.75 176.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -100.72 105.09 16.4 Favored 'General case' 0 C--N 1.267 -3.015 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 4.8 mp -102.37 138.66 25.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-O 121.043 0.449 . . . . 0.0 111.329 -176.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' SER . . . . . 0.496 ' HB3' ' HB ' ' A' ' 261' ' ' ILE . 33.3 t -127.57 124.98 39.44 Favored 'General case' 0 N--CA 1.425 -1.725 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 175.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -102.92 114.65 29.11 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.177 0.513 . . . . 0.0 111.932 -177.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -117.88 160.73 20.93 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 171.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -76.6 -30.89 57.15 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.658 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -68.56 -42.21 78.66 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.939 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' HIS . . . . . 0.541 ' CB ' ' HA ' ' A' ' 303' ' ' THR . 38.7 p-80 -168.73 168.69 10.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.665 178.181 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 20.2 mt -106.17 142.36 19.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 261' ' ' ILE . . . . . 0.496 ' HB ' ' HB3' ' A' ' 254' ' ' SER . 3.3 mp -122.64 122.89 67.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 299' ' ' GLN . 1.4 m -120.14 141.09 41.94 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 175.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 263' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 298' ' ' THR . 26.0 m -135.19 126.92 29.15 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-O 121.475 0.655 . . . . 0.0 110.86 177.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.721 HD13 ' HB3' ' A' ' 251' ' ' PRO . 1.5 mm? -94.17 99.3 11.59 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 177.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.586 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 13.2 mptt -59.7 125.4 23.5 Favored 'General case' 0 C--N 1.285 -2.225 0 O-C-N 124.838 1.336 . . . . 0.0 112.451 -178.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 66.4 t30 63.76 35.74 11.06 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.138 0.975 . . . . 0.0 110.402 178.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -121.26 119.09 31.25 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 2.8 p -87.27 144.79 26.64 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.031 0.443 . . . . 0.0 111.946 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 27.1 tp -130.26 129.98 22.97 Favored Pre-proline 0 N--CA 1.427 -1.608 0 C-N-CA 123.77 0.828 . . . . 0.0 109.301 178.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -72.86 152.34 52.18 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.021 1.814 . . . . 0.0 111.586 171.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 34.7 p -68.89 -19.56 64.22 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.942 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 13.6 m -74.97 -18.53 60.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.555 0.693 . . . . 0.0 109.686 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.4 HD11 ' HB3' ' A' ' 225' ' ' GLN . 89.9 mt -106.41 -7.11 17.78 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.065 -176.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -86.57 102.39 14.1 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.67 158.32 44.31 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.656 -177.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 33.9 p -114.59 145.87 41.46 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.566 -175.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.435 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 64.2 mt -112.44 119.36 37.95 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -85.88 94.24 9.12 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-O 121.889 0.852 . . . . 0.0 108.714 177.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 279' ' ' VAL . . . . . 0.59 ' HA ' ' CE1' ' A' ' 282' ' ' PHE . 17.6 t -105.83 30.18 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 CA-C-N 113.943 -1.48 . . . . 0.0 109.902 -173.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -82.0 144.96 30.51 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 35.8 t70 72.37 20.85 3.92 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 122.46 1.124 . . . . 0.0 110.789 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.59 ' CE1' ' HA ' ' A' ' 279' ' ' VAL . 19.5 m-85 -90.07 -1.73 58.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.858 173.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 73.23 13.45 4.71 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.539 1.136 . . . . 0.0 111.54 175.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 284' ' ' THR . . . . . 0.495 HG22 ' HE3' ' A' ' 232' ' ' LYS . 1.2 p -96.63 174.93 2.94 Favored Pre-proline 0 C--N 1.309 -1.157 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -175.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 285' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 7.9 Cg_exo -76.36 -15.26 17.94 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 121.854 1.703 . . . . 0.0 110.768 173.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.474 ' CG1' ' HA3' ' A' ' 238' ' ' GLY . 1.4 m -90.46 138.06 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 287' ' ' GLN . . . . . 0.477 ' OE1' ' HB2' ' A' ' 305' ' ' ALA . 11.3 mt-30 -104.82 -32.44 8.83 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.239 0.542 . . . . 0.0 110.814 -179.011 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 36.8 tttp -162.29 133.84 5.29 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.204 -174.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.435 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 45.3 t -99.46 132.93 43.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 172.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 97.2 m -142.8 118.92 10.73 Favored 'General case' 0 C--N 1.29 -2.009 0 O-C-N 121.631 -0.668 . . . . 0.0 111.087 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.466 ' HB2' HG12 ' A' ' 228' ' ' ILE . 42.7 tp -96.74 125.03 40.91 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -121.91 129.19 52.35 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.532 -174.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 41.9 ttt-85 -74.54 127.68 33.67 Favored 'General case' 0 N--CA 1.407 -2.584 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 173.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.51 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 19.4 tp -107.99 179.28 4.27 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 176.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.51 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 27.4 t-20 -46.54 -67.76 0.25 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.662 0.785 . . . . 0.0 112.883 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -123.83 -2.09 8.32 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.544 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 297' ' ' ASP . . . . . 0.586 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 15.9 m-20 -117.43 168.31 10.48 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -177.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 263' ' ' THR . 49.5 m -112.9 127.96 56.34 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 176.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 299' ' ' GLN . . . . . 0.477 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 41.4 tt0 -111.55 129.64 56.0 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -175.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.52 HD13 HG21 ' A' ' 228' ' ' ILE . 63.2 tp -111.15 124.61 52.53 Favored 'General case' 0 N--CA 1.415 -2.207 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 176.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 54.2 mt -112.5 121.01 64.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -177.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 53.7 mt -121.43 101.76 10.92 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 178.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.541 ' HA ' ' CB ' ' A' ' 259' ' ' HIS . 16.8 m -69.34 139.82 54.26 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.01 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 10.9 p -134.22 166.04 23.7 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -176.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 305' ' ' ALA . . . . . 0.477 ' HB2' ' OE1' ' A' ' 287' ' ' GLN . . . -144.66 143.91 30.98 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.315 0.646 . . . . 0.0 110.177 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 77.65 -159.62 48.23 Favored Glycine 0 C--O 1.245 0.801 0 O-C-N 123.897 0.748 . . . . 0.0 112.319 178.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 307' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 327' ' ' LYS . 28.9 m-80 -92.67 136.5 33.18 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 176.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 308' ' ' TRP . . . . . 0.732 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 59.3 p-90 -150.47 160.4 43.79 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.781 -0.767 . . . . 0.0 111.157 -175.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 324' ' ' VAL . 16.1 mt-10 -118.14 133.14 56.17 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -177.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.732 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 24.3 tp -108.35 120.92 43.77 Favored 'General case' 0 CA--C 1.498 -1.039 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.825 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.674 HG13 ' HB3' ' A' ' 323' ' ' GLN . 7.5 p -122.17 112.12 33.37 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-O 121.964 0.888 . . . . 0.0 109.395 172.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -94.94 139.58 31.13 Favored 'General case' 0 N--CA 1.414 -2.267 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.594 -177.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 313' ' ' LYS . . . . . 0.466 ' HB2' ' HB ' ' A' ' 321' ' ' THR . 67.0 mttm -130.92 151.32 51.47 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.342 -177.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 27.0 m -116.02 126.75 54.22 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 172.068 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -87.9 -34.62 18.1 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -167.41 163.77 9.7 Favored Pre-proline 0 C--N 1.307 -1.25 0 N-CA-C 104.74 -2.318 . . . . 0.0 104.74 -178.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.68 95.42 0.28 Allowed 'Trans proline' 0 C--O 1.244 0.813 0 C-N-CA 121.535 1.49 . . . . 0.0 111.266 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 131.79 -32.4 2.91 Favored Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -177.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -97.84 116.51 30.2 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 320' ' ' PHE . . . . . 0.444 ' CZ ' ' HD3' ' A' ' 251' ' ' PRO . 61.0 m-85 -119.2 165.03 14.73 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-O 122.188 0.994 . . . . 0.0 110.449 -175.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.466 ' HB ' ' HB2' ' A' ' 313' ' ' LYS . 59.3 m -151.72 128.72 11.05 Favored 'General case' 0 C--N 1.264 -3.135 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.619 -177.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -116.44 114.53 24.36 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 323' ' ' GLN . . . . . 0.674 ' HB3' HG13 ' A' ' 311' ' ' VAL . 34.9 tt0 -104.24 111.87 24.66 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 309' ' ' GLU . 0.2 OUTLIER -105.96 103.65 15.74 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.713 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.261 179.205 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.417 HD22 ' H ' ' A' ' 325' ' ' LEU . 1.0 OUTLIER -86.08 153.0 56.78 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.229 179.77 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -78.55 129.76 9.48 Favored 'Trans proline' 0 N--CA 1.447 -1.226 0 C-N-CA 121.669 1.58 . . . . 0.0 109.491 173.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 307' ' ' ASN . 41.1 ttmt -97.99 118.3 34.26 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -118.58 108.58 15.13 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 175.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 . . . . . 0 C--N 1.281 -2.386 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.423 -178.61 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 95.6 mmm . . . . . 0 CA--C 1.512 -0.481 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -99.08 59.36 0.84 Allowed Glycine 0 C--N 1.314 -0.674 0 N-CA-C 110.871 -0.891 . . . . 0.0 110.871 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 48.9 m 60.06 76.86 0.34 Allowed 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.209 1.004 . . . . 0.0 111.926 -177.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 31.4 t -100.8 -32.51 10.66 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.532 -178.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 68.17 115.53 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.409 1.084 . . . . 0.0 110.823 -176.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 42.0 t60 -77.11 116.74 18.01 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -119.25 105.13 11.04 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -97.07 87.05 4.11 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 174.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 33.0 m170 68.53 -177.93 0.21 Allowed 'General case' 0 C--O 1.241 0.619 0 C-N-CA 124.752 1.221 . . . . 0.0 108.795 -172.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -132.55 93.13 3.18 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 121.747 0.784 . . . . 0.0 110.466 176.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -134.29 163.53 24.6 Favored Glycine 0 N--CA 1.426 -1.981 0 N-CA-C 108.183 -1.967 . . . . 0.0 108.183 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -166.68 -31.49 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 117.798 0.799 . . . . 0.0 110.154 -175.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . 0.337 12.2 m 61.56 106.18 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.537 0 C-N-CA 126.376 1.871 . . . . 0.0 111.608 -173.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -31.04 -62.98 0.11 Allowed 'Trans proline' 0 C--N 1.372 1.798 1 C-N-CA 125.598 4.199 . . . . 0.0 116.003 -172.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -128.5 95.95 4.28 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.27 0.557 . . . . 0.0 110.224 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -162.25 38.29 0.37 Allowed Glycine 0 N--CA 1.436 -1.358 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 178.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 11.5 m -81.87 116.32 21.47 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' HIS . . . . . 0.465 ' HA ' ' OG ' ' A' ' 212' ' ' SER . 15.3 t-80 -84.62 -2.33 57.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.795 0.807 . . . . 0.0 110.272 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 27.9 ttt -82.28 89.69 6.57 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 170.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . 64.85 67.99 0.53 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.36 -175.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' SER . . . . . 0.465 ' OG ' ' HA ' ' A' ' 209' ' ' HIS . 61.0 m -65.66 -32.36 73.88 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.823 0.821 . . . . 0.0 108.865 175.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 10.8 tmm? -135.85 102.7 5.14 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 103.31 -2.848 . . . . 0.0 103.31 173.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 31.4 m -68.44 -61.22 1.93 Allowed 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.252 0.548 . . . . 0.0 110.256 -176.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 113.06 -64.92 0.27 Allowed Glycine 0 N--CA 1.416 -2.645 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -176.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 117.84 -68.29 0.32 Allowed Glycine 0 N--CA 1.421 -2.337 0 N-CA-C 111.324 -0.711 . . . . 0.0 111.324 177.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' GLN . . . . . 0.467 ' HA ' ' SD ' ' A' ' 219' ' ' MET . 1.9 mp0 -81.19 104.89 11.98 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.218 0.532 . . . . 0.0 110.349 -177.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -125.57 4.83 7.55 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' MET . . . . . 0.467 ' SD ' ' HA ' ' A' ' 217' ' ' GLN . 1.5 mpt? -55.37 133.59 49.78 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-N 114.469 -1.241 . . . . 0.0 113.472 -171.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 124.78 111.06 1.87 Allowed Glycine 0 N--CA 1.41 -3.049 0 N-CA-C 107.966 -2.054 . . . . 0.0 107.966 -173.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -70.84 -17.29 62.75 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.332 0.586 . . . . 0.0 110.697 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -178.49 86.87 0.07 OUTLIER Glycine 0 N--CA 1.423 -2.21 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 177.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 41.0 m -156.22 -29.89 0.09 Allowed 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 120.655 0.264 . . . . 0.0 111.207 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -81.18 -35.5 31.33 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.696 -176.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -142.57 177.62 8.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.559 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 31.1 m -61.5 133.47 55.76 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -167.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -162.17 170.99 18.12 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.177 -178.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.529 HG12 ' HB2' ' A' ' 291' ' ' LEU . 2.8 pp -136.56 157.34 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.183 178.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.414 ' HB2' ' HB2' ' A' ' 241' ' ' GLU . 5.1 m-20 -145.61 157.61 43.95 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 123.992 0.917 . . . . 0.0 110.147 -175.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.403 ' HZ ' HG21 ' A' ' 284' ' ' THR . 91.5 t80 -124.0 145.58 49.09 Favored 'General case' 0 C--N 1.31 -1.13 0 O-C-N 123.202 0.314 . . . . 0.0 110.549 177.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -155.52 165.22 37.25 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 170.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.501 ' CE ' ' HA ' ' A' ' 236' ' ' ASN . 55.2 mtpt -115.38 151.23 35.06 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 120.696 0.284 . . . . 0.0 110.586 176.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -136.68 140.51 42.75 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.96 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 66.14 -97.61 0.33 Allowed Glycine 0 N--CA 1.438 -1.188 0 O-C-N 124.3 1.0 . . . . 0.0 114.32 172.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -136.3 92.34 2.77 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-O 120.862 0.363 . . . . 0.0 110.074 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' ASN . . . . . 0.501 ' HA ' ' CE ' ' A' ' 232' ' ' LYS . 92.4 m-20 65.3 12.9 8.43 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 172.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -74.73 130.87 40.25 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -97.1 113.84 4.82 Favored Glycine 0 C--O 1.21 -1.385 0 O-C-N 123.696 0.623 . . . . 0.0 111.845 -177.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.422 HG13 ' HG3' ' A' ' 323' ' ' GLN . 2.7 mp -106.96 117.56 53.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 117.834 0.817 . . . . 0.0 111.015 -177.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.4 mp -103.66 112.57 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.919 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 175.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 229' ' ' ASP . 45.3 mt-10 -91.43 128.31 37.21 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 12.8 tp -116.08 123.69 48.52 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-O 121.054 0.454 . . . . 0.0 111.409 -175.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' ALA . . . . . 0.559 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -109.93 104.4 13.31 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -117.43 91.08 3.48 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.03 115.37 19.57 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.139 -174.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 113.08 2.24 25.04 Favored Glycine 0 N--CA 1.432 -1.612 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.718 178.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' PHE . . . . . 0.425 ' HB2' ' ND1' ' A' ' 267' ' ' HIS . 40.9 t80 -114.96 114.21 25.14 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -178.218 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -106.91 -10.05 16.11 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -84.1 -154.57 19.66 Favored Glycine 0 C--N 1.318 -0.435 0 C-N-CA 121.425 -0.417 . . . . 0.0 112.464 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 90.8 mm-40 -119.69 134.43 23.88 Favored Pre-proline 0 C--N 1.311 -1.082 0 O-C-N 122.485 -0.42 . . . . 0.0 109.872 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.624 ' HB3' HD23 ' A' ' 264' ' ' LEU . 32.9 Cg_endo -74.21 171.99 16.9 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.523 2.149 . . . . 0.0 113.042 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -94.71 113.24 25.0 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.104 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 2.2 mp -97.86 108.47 21.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 122.113 0.958 . . . . 0.0 110.191 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' SER . . . . . 0.623 ' HB2' ' HB ' ' A' ' 261' ' ' ILE . 36.6 m -108.98 111.67 23.46 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.37 -1.287 . . . . 0.0 108.856 176.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -104.87 124.18 49.01 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -174.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.44 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 14.3 mm-40 -124.77 167.86 14.01 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 173.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -76.95 -36.28 56.66 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 120.304 -0.558 . . . . 0.0 109.986 177.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -71.91 -37.75 70.03 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.942 -177.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' HIS . . . . . 0.44 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 55.0 p-80 -167.6 166.01 14.22 Favored 'General case' 0 C--N 1.318 -0.768 0 O-C-N 122.143 -0.348 . . . . 0.0 110.968 178.056 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.475 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 19.1 mt -106.43 143.75 16.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 261' ' ' ILE . . . . . 0.623 ' HB ' ' HB2' ' A' ' 254' ' ' SER . 4.2 mp -121.76 111.76 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 177.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' A' ' 300' ' ' LEU . 43.1 t -110.12 117.01 53.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 176.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 23.5 m -112.76 124.22 52.09 Favored 'General case' 0 C--N 1.285 -2.233 0 C-N-CA 119.951 -0.7 . . . . 0.0 110.943 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.624 HD23 ' HB3' ' A' ' 251' ' ' PRO . 17.1 mt -99.82 100.08 10.97 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.507 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 30.7 mmtp -65.7 129.43 39.73 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -174.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 6.4 t30 64.33 23.82 13.12 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 113.532 -1.667 . . . . 0.0 110.202 177.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 267' ' ' HIS . . . . . 0.425 ' ND1' ' HB2' ' A' ' 247' ' ' PHE . 54.9 t60 -112.05 107.69 16.73 Favored 'General case' 0 CA--C 1.476 -1.883 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 2.8 m -94.5 138.51 32.33 Favored 'General case' 0 C--N 1.263 -3.169 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.627 -175.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 29.7 tp -113.79 128.26 25.93 Favored Pre-proline 0 N--CA 1.431 -1.388 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.186 -176.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -62.21 135.7 55.92 Favored 'Trans proline' 0 C--O 1.248 0.98 0 C-N-CA 122.312 2.008 . . . . 0.0 110.705 169.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 271' ' ' THR . . . . . 0.452 ' O ' ' HG2' ' A' ' 274' ' ' GLN . 9.2 t -67.5 -13.11 61.75 Favored 'General case' 0 CA--C 1.56 1.36 0 CA-C-O 121.814 0.816 . . . . 0.0 111.223 -178.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 27.3 m -74.59 -23.99 58.83 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.81 178.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 96.7 mt -100.95 -9.27 21.67 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.128 -174.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.539 ' HB2' ' O ' ' A' ' 291' ' ' LEU . 25.4 pt20 -77.27 94.37 4.14 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-O 122.698 1.237 . . . . 0.0 109.647 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -100.72 166.53 10.83 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.094 -177.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 19.9 m -137.27 127.36 26.03 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.447 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 2.2 mm? -89.83 130.5 36.06 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 179.078 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -70.44 -42.1 71.98 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 279' ' ' VAL . . . . . 0.604 ' HA ' ' CD1' ' A' ' 282' ' ' PHE 0.257 10.4 p 40.35 34.3 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.548 0 C-N-CA 126.051 1.74 . . . . 0.0 112.609 177.969 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -89.61 137.66 32.14 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.1 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 14.2 t70 69.2 14.47 8.65 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 125.328 1.451 . . . . 0.0 109.887 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.604 ' CD1' ' HA ' ' A' ' 279' ' ' VAL . 7.9 m-85 -75.82 -20.45 58.17 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.39 174.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp 62.3 60.56 1.41 Allowed 'General case' 0 CA--C 1.5 -0.965 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.981 174.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 284' ' ' THR . . . . . 0.455 HG22 ' HE3' ' A' ' 232' ' ' LYS . 1.1 p -133.06 172.32 7.61 Favored Pre-proline 0 C--N 1.286 -2.163 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 177.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 285' ' ' PRO . . . . . 0.452 ' O ' ' HA ' ' A' ' 304' ' ' THR . 23.8 Cg_exo -65.9 -24.65 53.29 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.51 1.473 . . . . 0.0 110.958 175.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.2 p -87.64 120.22 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 CA-C-O 122.206 1.003 . . . . 0.0 110.077 176.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 -90.95 -37.76 13.3 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 114.111 -1.404 . . . . 0.0 111.062 -173.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 288' ' ' LYS . . . . . 0.463 ' HA ' ' CG1' ' A' ' 279' ' ' VAL . 86.6 tttt -154.29 134.79 13.46 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.013 178.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 35.8 t -102.03 116.56 45.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 175.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.465 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 27.2 m -124.37 121.28 34.51 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 120.729 0.299 . . . . 0.0 110.811 -176.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.539 ' O ' ' HB2' ' A' ' 274' ' ' GLN . 27.7 tp -96.9 126.79 42.3 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 175.172 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 21.5 tptp -125.59 121.98 35.16 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -172.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -77.9 128.25 33.65 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 118.579 -1.248 . . . . 0.0 108.607 177.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.501 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 15.1 tp -101.88 -173.91 2.46 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.501 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 51.1 t-20 -53.95 -67.05 0.29 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 118.311 0.505 . . . . 0.0 111.033 -177.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -120.43 -4.05 9.89 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.722 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 297' ' ' ASP . . . . . 0.507 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 30.3 m-20 -113.32 164.77 13.14 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.512 -175.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.502 ' HB ' ' HB2' ' A' ' 264' ' ' LEU . 98.9 m -108.09 124.86 50.86 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 174.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -112.97 128.33 56.46 Favored 'General case' 0 N--CA 1.416 -2.167 0 CA-C-O 121.59 0.71 . . . . 0.0 109.239 -176.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.419 ' HB2' ' HB ' ' A' ' 262' ' ' VAL . 0.5 OUTLIER -107.18 127.62 53.67 Favored 'General case' 0 C--N 1.271 -2.83 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 176.712 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 301' ' ' ILE . . . . . 0.465 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 58.1 mt -115.57 109.49 28.48 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 302' ' ' ILE . . . . . 0.475 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 63.3 mt -110.84 101.05 12.0 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 25.8 m -70.81 134.33 47.27 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 -177.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 304' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 285' ' ' PRO . 15.4 p -138.0 171.23 14.72 Favored 'General case' 0 C--N 1.31 -1.111 0 O-C-N 123.256 0.347 . . . . 0.0 111.322 -176.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -154.69 139.75 17.4 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 90.1 -153.41 22.91 Favored Glycine 0 C--N 1.314 -0.656 0 C-N-CA 121.256 -0.497 . . . . 0.0 111.866 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 307' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 327' ' ' LYS . 30.4 m-80 -104.3 139.99 38.51 Favored 'General case' 0 C--O 1.255 1.361 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 175.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 308' ' ' TRP . . . . . 0.416 ' HZ3' ' CB ' ' A' ' 310' ' ' LEU . 67.9 p-90 -155.63 166.3 33.93 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.356 -177.057 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.472 ' HG2' ' HE2' ' A' ' 327' ' ' LYS . 17.8 mt-10 -117.88 134.39 54.98 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.416 ' CB ' ' HZ3' ' A' ' 308' ' ' TRP . 1.1 tt -102.85 123.42 46.47 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 176.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.641 ' CG1' ' HB3' ' A' ' 323' ' ' GLN . 6.5 p -117.34 108.16 24.08 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 CA-C-O 122.065 0.936 . . . . 0.0 109.419 170.183 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -98.48 115.93 29.62 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.915 -175.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -116.14 149.77 38.49 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.926 -176.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 48.4 t -111.65 113.78 26.38 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 172.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -79.71 -35.98 38.16 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.533 0.682 . . . . 0.0 109.95 -177.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -168.16 161.59 9.24 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 -178.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -62.09 102.45 0.26 Allowed 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 121.574 1.516 . . . . 0.0 111.497 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 117.03 -9.4 15.73 Favored Glycine 0 N--CA 1.434 -1.45 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.629 -178.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -120.08 116.31 25.45 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 122.004 -0.703 . . . . 0.0 110.035 178.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -120.63 165.82 14.51 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.697 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 50.4 m -151.64 132.02 13.75 Favored 'General case' 0 C--N 1.274 -2.711 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.386 -176.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -120.29 107.33 12.84 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 177.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 323' ' ' GLN . . . . . 0.641 ' HB3' ' CG1' ' A' ' 311' ' ' VAL . 62.7 tt0 -98.67 115.89 29.69 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.41 HG13 ' CE3' ' A' ' 308' ' ' TRP . 92.0 t -100.05 99.16 7.95 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.803 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -88.04 144.8 35.1 Favored Pre-proline 0 C--N 1.318 -0.762 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -68.79 131.0 21.62 Favored 'Trans proline' 0 C--O 1.243 0.764 0 C-N-CA 121.443 1.429 . . . . 0.0 110.076 173.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.472 ' HE2' ' HG2' ' A' ' 309' ' ' GLU . 37.7 ttmt -102.02 115.7 31.1 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -179.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -102.46 144.65 30.64 Favored 'General case' 0 C--N 1.285 -2.207 0 C-N-CA 118.715 -1.194 . . . . 0.0 108.997 177.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 . . . . . 0 C--N 1.285 -2.199 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -177.7 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 64.9 mtt . . . . . 0 CA--C 1.509 -0.603 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 148.85 -32.22 1.19 Allowed Glycine 0 CA--C 1.493 -1.312 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 13.2 m -58.23 -41.21 83.65 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 123.635 0.774 . . . . 0.0 111.398 -179.329 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 22.2 p -85.05 -6.63 59.32 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -177.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -125.45 104.76 8.61 Favored 'General case' 0 CA--C 1.495 -1.139 0 O-C-N 121.829 -0.544 . . . . 0.0 110.438 -175.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 65.7 t60 -122.74 -40.16 2.46 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.646 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 71.03 99.87 0.06 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.311 1.044 . . . . 0.0 111.95 -179.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 29.7 t-80 -145.75 112.48 5.96 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.38 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -134.2 118.43 17.62 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 172.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -82.15 100.97 10.13 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 125.34 126.24 2.99 Favored Glycine 0 C--N 1.295 -1.701 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -178.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.501 ' H ' HD13 ' A' ' 203' ' ' LEU . 0.0 OUTLIER -115.84 -3.35 12.21 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 120.508 -0.477 . . . . 0.0 112.207 -178.947 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 8.7 p -127.85 123.25 22.75 Favored Pre-proline 0 C--N 1.307 -1.254 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.295 -178.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -72.89 131.97 17.75 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.343 2.029 . . . . 0.0 110.358 174.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -85.77 110.91 19.68 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 110.65 45.5 0.9 Allowed Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -177.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 21.3 m -65.95 24.03 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -172.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -101.19 -15.61 17.28 Favored 'General case' 0 C--N 1.308 -1.232 0 O-C-N 121.758 -0.589 . . . . 0.0 109.833 174.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -173.31 10.36 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 177.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -84.75 48.69 1.58 Allowed 'General case' 0 C--O 1.24 0.604 0 O-C-N 121.143 -0.973 . . . . 0.0 111.704 -176.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 8.0 t -65.21 -35.74 82.0 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 21.2 mmt -104.21 83.65 2.11 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 175.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 10.5 m -67.17 103.75 1.29 Allowed 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.017 -175.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 133.15 -16.13 4.7 Favored Glycine 0 N--CA 1.433 -1.522 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.731 -178.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -129.42 116.22 2.11 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 89.4 mm-40 -84.07 -33.62 24.37 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.948 0.404 . . . . 0.0 110.372 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -87.85 91.04 8.61 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 3.4 ppp? -100.03 -4.47 29.89 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.826 -176.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 147.08 146.13 4.31 Favored Glycine 0 N--CA 1.424 -2.114 0 C-N-CA 119.906 -1.14 . . . . 0.0 112.748 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -162.63 98.06 0.98 Allowed 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 177.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -155.9 64.89 0.32 Allowed Glycine 0 N--CA 1.418 -2.51 0 C-N-CA 119.151 -1.499 . . . . 0.0 113.145 -177.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 11.4 m -93.68 49.68 1.38 Allowed 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 174.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -107.59 8.16 29.05 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.907 -173.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' GLN . . . . . 0.466 ' O ' HD23 ' A' ' 245' ' ' LEU . 0.3 OUTLIER -155.63 166.29 33.95 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -177.301 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.567 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 10.5 m -69.79 117.18 11.06 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -151.23 173.02 14.93 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.265 -176.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.54 HD13 HD21 ' A' ' 277' ' ' LEU . 2.2 pp -133.48 159.37 42.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.33 -178.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -150.83 156.49 41.36 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -178.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -130.38 134.52 47.21 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.552 175.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -145.26 166.95 24.01 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 173.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.453 ' HE3' HG22 ' A' ' 284' ' ' THR . 55.2 mtpt -110.82 146.42 36.45 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 174.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' ASP . . . . . 0.428 ' O ' ' HB3' ' A' ' 237' ' ' ALA . 18.2 t70 -152.88 117.76 5.1 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -177.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 99.25 -131.32 10.52 Favored Glycine 0 N--CA 1.434 -1.467 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.263 178.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -101.39 85.59 2.82 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 122.686 0.395 . . . . 0.0 110.166 -177.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' ASN . . . . . 0.486 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 91.2 m-20 57.8 21.4 7.44 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 177.049 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 233' ' ' ASP . . . -79.18 138.4 37.84 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.907 -178.101 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -97.27 114.88 5.1 Favored Glycine 0 N--CA 1.421 -2.348 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.2 mp -107.19 111.96 37.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-O 121.505 0.669 . . . . 0.0 110.581 -177.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.5 mp -97.35 112.53 29.6 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 176.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -92.38 136.76 32.93 Favored 'General case' 0 C--N 1.277 -2.548 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 11.8 tp -127.98 127.78 43.86 Favored 'General case' 0 C--N 1.276 -2.598 0 C-N-CA 123.836 0.854 . . . . 0.0 110.359 -174.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' ALA . . . . . 0.567 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -113.25 101.19 9.18 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -108.28 90.78 3.4 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 225' ' ' GLN . 3.8 mm? -80.52 115.57 20.11 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.998 -174.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 105.87 14.22 21.67 Favored Glycine 0 N--CA 1.431 -1.675 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.597 178.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -114.98 118.21 32.79 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 -178.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -116.43 91.11 3.49 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.842 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 164.89 -148.51 14.33 Favored Glycine 0 N--CA 1.436 -1.305 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -126.42 138.6 32.69 Favored Pre-proline 0 C--N 1.31 -1.116 0 CA-C-N 117.277 0.539 . . . . 0.0 109.603 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.723 ' HB3' HD13 ' A' ' 264' ' ' LEU . 12.0 Cg_endo -71.5 172.1 14.93 Favored 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 121.683 1.589 . . . . 0.0 110.904 175.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 34.3 t70 -95.64 108.69 20.99 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.45 HD11 ' HG2' ' A' ' 251' ' ' PRO . 4.5 mp -105.84 116.25 49.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-O 121.302 0.572 . . . . 0.0 111.312 -178.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 19.3 t -95.51 111.8 23.64 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 175.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -88.76 95.68 10.37 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 121.468 0.651 . . . . 0.0 111.684 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.488 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 78.4 mt-30 -108.54 144.36 36.31 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 172.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -74.52 -19.98 60.14 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 119.769 -0.772 . . . . 0.0 112.109 -174.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -73.86 -47.24 39.64 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 123.875 0.734 . . . . 0.0 109.942 177.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' HIS . . . . . 0.488 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 44.3 p-80 -162.67 162.27 26.89 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.158 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 301' ' ' ILE . 29.5 mt -106.05 143.02 17.71 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -177.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 3.4 mp -125.51 114.7 40.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 178.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.548 ' HA ' ' O ' ' A' ' 252' ' ' ASP . 1.4 m -110.0 140.48 28.79 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.271 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 263' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 298' ' ' THR . 24.4 m -135.2 123.99 23.9 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-O 121.131 0.491 . . . . 0.0 111.14 177.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.723 HD13 ' HB3' ' A' ' 251' ' ' PRO . 1.7 mm? -93.98 107.75 19.63 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 176.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.43 ' HD3' ' OD1' ' A' ' 297' ' ' ASP . 30.3 mmtp -69.6 129.53 39.9 Favored 'General case' 0 C--N 1.29 -2.001 0 O-C-N 123.927 0.767 . . . . 0.0 112.689 -177.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 14.0 t30 70.1 22.62 5.57 Favored 'General case' 0 CA--C 1.554 1.113 0 O-C-N 124.952 1.407 . . . . 0.0 111.189 176.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 38.0 t60 -112.79 110.27 20.28 Favored 'General case' 0 C--O 1.213 -0.821 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 10.9 p -77.83 142.79 38.34 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.19 0.519 . . . . 0.0 112.158 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 35.9 tp -121.98 121.12 28.15 Favored Pre-proline 0 N--CA 1.431 -1.403 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.543 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -59.62 134.62 58.99 Favored 'Trans proline' 0 C--N 1.321 -0.91 0 C-N-CA 122.672 2.248 . . . . 0.0 111.276 170.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 271' ' ' THR . . . . . 0.571 ' HB ' ' HD3' ' A' ' 293' ' ' ARG . 6.5 t -66.3 -9.3 31.49 Favored 'General case' 0 CA--C 1.554 1.108 0 CA-C-O 121.823 0.82 . . . . 0.0 112.092 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 27.2 m -83.22 -14.95 52.21 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 121.642 0.734 . . . . 0.0 109.902 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.443 HD13 ' O ' ' A' ' 226' ' ' THR . 82.4 mt -106.23 -6.39 18.51 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.171 -176.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.492 ' OE1' ' HG2' ' A' ' 293' ' ' ARG . 8.5 pt20 -82.92 101.39 11.0 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 121.844 0.83 . . . . 0.0 109.637 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 275' ' ' ARG . . . . . 0.461 ' HG3' HD11 ' A' ' 228' ' ' ILE . 14.0 ptm180 -129.25 179.09 5.97 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 48.8 m -125.44 164.87 19.49 Favored 'General case' 0 N--CA 1.409 -2.476 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 176.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.54 HD21 HD13 ' A' ' 228' ' ' ILE . 2.9 mm? -122.29 115.91 23.17 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -77.98 92.37 4.32 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 174.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 279' ' ' VAL . . . . . 0.676 ' HA ' ' CD2' ' A' ' 282' ' ' PHE . 92.3 t -100.51 18.77 2.91 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 CA-C-O 123.124 1.44 . . . . 0.0 109.357 -176.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -70.19 137.07 50.63 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-N 114.583 -1.19 . . . . 0.0 107.967 176.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 72.94 19.27 3.81 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.961 0.904 . . . . 0.0 112.883 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.676 ' CD2' ' HA ' ' A' ' 279' ' ' VAL . 9.4 m-85 -85.69 -13.81 47.34 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.799 172.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.27 60.66 1.99 Allowed 'General case' 0 CA--C 1.492 -1.262 0 CA-C-O 121.838 0.828 . . . . 0.0 110.648 -177.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 284' ' ' THR . . . . . 0.453 HG22 ' HE3' ' A' ' 232' ' ' LYS . 2.9 p -136.12 173.3 5.79 Favored Pre-proline 0 N--CA 1.421 -1.924 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 178.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 285' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 2.8 Cg_exo -79.02 -5.98 14.78 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.404 1.402 . . . . 0.0 112.211 176.125 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.3 p -101.53 125.44 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-O 121.38 0.61 . . . . 0.0 110.446 178.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -86.93 -40.89 14.39 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.911 -175.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -159.16 134.26 8.27 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.939 -174.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.511 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 35.6 t -95.14 135.65 28.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 172.125 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 96.0 m -139.69 121.97 15.95 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 118.094 0.407 . . . . 0.0 110.531 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.523 ' HB2' HG12 ' A' ' 228' ' ' ILE . 45.7 tp -103.79 135.98 44.32 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 176.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -134.22 134.93 42.58 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -177.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 293' ' ' ARG . . . . . 0.571 ' HD3' ' HB ' ' A' ' 271' ' ' THR . 17.4 ptt180 -73.54 138.06 44.76 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 173.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.561 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 22.6 tp -115.29 -175.47 2.71 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.561 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 16.2 m120 -35.98 -75.94 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.944 1.698 . . . . 0.0 112.543 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -125.4 -1.27 7.55 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 174.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 297' ' ' ASP . . . . . 0.43 ' OD1' ' HD3' ' A' ' 265' ' ' LYS . 11.5 m-20 -108.49 171.79 7.21 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.594 -171.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.55 ' O ' ' HA ' ' A' ' 263' ' ' THR . 91.8 m -114.35 129.07 56.63 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 176.011 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 299' ' ' GLN . . . . . 0.544 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 36.3 tt0 -114.05 127.27 55.86 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -176.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.476 HD13 HG21 ' A' ' 228' ' ' ILE . 70.1 tp -114.94 123.08 48.21 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.503 178.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 301' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 260' ' ' ILE . 62.5 mt -111.24 118.9 58.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-O 121.429 0.633 . . . . 0.0 109.487 -177.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 302' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 65.7 mt -114.87 108.83 26.43 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.533 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 14.6 m -82.59 131.66 35.21 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -176.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 6.9 p -126.67 164.82 20.44 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -174.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -145.98 134.65 22.24 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 123.534 0.734 . . . . 0.0 109.894 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 88.74 -166.8 34.45 Favored Glycine 0 C--O 1.252 1.263 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.237 176.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 307' ' ' ASN . . . . . 0.405 ' HB3' ' HB3' ' A' ' 327' ' ' LYS . 69.5 m-20 -86.27 126.18 34.12 Favored 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 308' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -144.54 165.43 28.02 Favored 'General case' 0 C--N 1.286 -2.152 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.553 -175.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.441 ' HG2' ' HE2' ' A' ' 327' ' ' LYS . 15.2 mt-10 -125.39 145.36 50.08 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.88 122.7 48.51 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -178.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 21.7 t -122.07 106.23 17.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 169.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -100.39 113.02 25.43 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.789 0.804 . . . . 0.0 110.277 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -106.91 150.99 25.85 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.906 -174.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 36.0 t -115.53 102.91 10.22 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 175.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -69.17 -30.96 69.29 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.525 0.679 . . . . 0.0 110.063 -176.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -167.16 159.85 10.73 Favored Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -64.22 95.26 0.21 Allowed 'Trans proline' 0 C--O 1.247 0.953 0 C-N-CA 121.724 1.616 . . . . 0.0 110.858 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 135.38 -33.87 2.37 Favored Glycine 0 N--CA 1.427 -1.963 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.307 -177.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -100.44 117.09 33.89 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 122.188 -0.596 . . . . 0.0 110.171 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -117.14 160.59 20.79 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 121.751 0.786 . . . . 0.0 110.04 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 89.6 m -151.77 124.09 8.26 Favored 'General case' 0 C--N 1.268 -2.941 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.713 -176.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -109.82 109.49 20.17 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 323' ' ' GLN . . . . . 0.402 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 60.8 tt0 -97.62 107.84 20.42 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 309' ' ' GLU . 83.9 t -97.6 99.02 8.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.623 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -88.02 154.93 52.61 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -81.51 142.83 13.28 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 121.44 1.427 . . . . 0.0 109.343 171.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.441 ' HE2' ' HG2' ' A' ' 309' ' ' GLU . 37.3 ttmt -111.82 104.44 12.75 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -177.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 328' ' ' LYS . . . . . 0.403 ' HE3' ' HB3' ' A' ' 328' ' ' LYS . 13.7 ttpp -112.77 23.91 12.98 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 . . . . . 0 C--N 1.324 -0.538 0 CA-C-N 113.573 -1.649 . . . . 0.0 111.104 179.995 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 51.7 tpp . . . . . 0 C--O 1.236 0.369 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 142.73 -147.14 18.5 Favored Glycine 0 N--CA 1.434 -1.442 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -178.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 50.8 m -115.97 92.08 3.79 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 117.403 0.602 . . . . 0.0 109.923 177.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 49.3 m -82.75 90.39 6.88 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.059 -178.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 27.4 m80 -157.23 -166.62 2.1 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 125.559 1.543 . . . . 0.0 106.846 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 39.1 t60 -97.24 -11.15 24.53 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 119.729 -0.788 . . . . 0.0 111.429 -178.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 40.3 m80 75.04 107.54 0.07 Allowed 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 124.237 1.015 . . . . 0.0 113.675 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -87.76 -57.13 3.06 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 170.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' HIS . . . . . 0.415 ' HB2' ' HB2' ' A' ' 203' ' ' LEU . 1.6 p80 -76.9 99.0 5.07 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 173.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -79.18 -76.4 0.21 Allowed 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.201 -177.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -92.74 0.23 69.95 Favored Glycine 0 N--CA 1.435 -1.417 0 C-N-CA 120.118 -1.039 . . . . 0.0 112.079 -179.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' LEU . . . . . 0.415 ' HB2' ' HB2' ' A' ' 200' ' ' HIS . 3.3 mm? -82.13 83.87 7.21 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.631 0.729 . . . . 0.0 111.623 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 41.3 t -106.3 139.36 20.22 Favored Pre-proline 0 C--N 1.296 -1.76 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 175.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.62 -61.9 0.39 Allowed 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.015 1.81 . . . . 0.0 111.077 176.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -132.21 89.46 2.67 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.126 0.488 . . . . 0.0 110.232 176.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -110.79 104.6 1.79 Allowed Glycine 0 C--N 1.303 -1.265 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 177.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 20.1 m 63.6 -164.95 0.24 Allowed 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -174.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -158.92 -35.37 0.06 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.557 1.071 . . . . 0.0 113.703 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 15.6 tpt -88.83 -4.29 58.53 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 122.778 1.275 . . . . 0.0 109.398 -178.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -168.05 158.5 10.45 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 104.184 -2.524 . . . . 0.0 104.184 176.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 18.0 m -118.77 5.24 11.52 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 122.083 0.944 . . . . 0.0 108.777 177.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.64 160.46 43.11 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.322 -176.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 59.8 m -105.72 103.35 12.83 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 173.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -143.59 -152.37 5.64 Favored Glycine 0 N--CA 1.418 -2.544 0 C-N-CA 119.269 -1.443 . . . . 0.0 113.813 -174.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 124.72 -32.06 4.16 Favored Glycine 0 N--CA 1.428 -1.873 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -177.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' GLN . . . . . 0.522 ' O ' ' HB2' ' A' ' 221' ' ' ARG . 91.3 mt-30 -72.63 -24.16 61.02 Favored 'General case' 0 C--O 1.209 -1.076 0 CA-C-O 120.781 0.324 . . . . 0.0 111.071 -179.077 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -65.53 -32.02 73.4 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 176.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' MET . . . . . 0.489 ' O ' ' HA ' ' A' ' 224' ' ' LYS . 50.9 ttm -85.59 -56.23 3.61 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.726 -179.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -93.5 57.85 2.29 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 121.207 -0.521 . . . . 0.0 112.827 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' ARG . . . . . 0.522 ' HB2' ' O ' ' A' ' 217' ' ' GLN . 44.0 ttm180 -103.85 77.9 1.5 Allowed 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 82.08 -52.46 4.63 Favored Glycine 0 C--N 1.312 -0.788 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.129 -178.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 16.6 m -131.79 132.12 43.5 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 219' ' ' MET . 37.2 mtmm -86.05 -154.9 0.22 Allowed 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -111.05 173.81 6.16 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 176.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.698 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 52.5 m -63.47 112.61 2.84 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.679 0.752 . . . . 0.0 113.026 -174.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -145.49 165.69 27.86 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.85 -175.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.616 HD13 HD21 ' A' ' 277' ' ' LEU . 1.6 pp -115.5 161.97 13.87 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.076 178.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.52 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 7.1 t70 -151.26 155.91 39.75 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.404 ' HZ ' HG21 ' A' ' 284' ' ' THR . 75.4 t80 -132.87 135.57 45.68 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 173.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -149.45 168.84 22.33 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 174.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.526 ' HE3' HG22 ' A' ' 284' ' ' THR . 55.6 mtpt -117.19 139.91 50.19 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 174.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -149.0 117.78 6.64 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -175.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 99.55 -119.33 6.47 Favored Glycine 0 N--CA 1.428 -1.868 0 C-N-CA 120.608 -0.805 . . . . 0.0 113.127 177.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -113.34 85.35 2.17 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 122.88 -0.188 . . . . 0.0 110.833 -175.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' ASN . . . . . 0.564 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 5.9 m-20 56.2 21.8 5.57 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 124.705 1.202 . . . . 0.0 113.258 177.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.52 ' HB2' HD23 ' A' ' 325' ' ' LEU . . . -79.58 142.37 35.74 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.019 -176.117 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 238' ' ' GLY . . . . . 0.501 ' HA3' ' CG1' ' A' ' 286' ' ' VAL . . . -92.48 115.99 4.97 Favored Glycine 0 N--CA 1.418 -2.504 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 176.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.6 mp -110.0 109.7 29.39 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-N 118.065 0.932 . . . . 0.0 110.267 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.0 mp -98.96 109.61 24.54 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 N-CA-C 107.427 -1.324 . . . . 0.0 107.427 178.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.52 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 44.7 mt-10 -90.78 138.43 31.59 Favored 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 176.122 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 12.3 tp -128.47 131.48 48.36 Favored 'General case' 0 C--N 1.267 -3.022 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.561 -173.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' ALA . . . . . 0.698 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -116.41 106.25 13.41 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 244' ' ' ALA . . . . . 0.432 ' HA ' HG23 ' A' ' 226' ' ' THR . . . -118.19 90.91 3.43 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.093 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -83.25 113.87 20.98 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.538 0.685 . . . . 0.0 110.864 -174.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 122.99 -5.14 9.66 Favored Glycine 0 N--CA 1.428 -1.873 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.13 -175.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -115.99 113.09 22.76 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 176.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -114.96 16.77 17.13 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 120.852 0.358 . . . . 0.0 111.437 -175.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -116.68 -162.84 13.01 Favored Glycine 0 C--N 1.302 -1.352 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -101.28 132.51 21.79 Favored Pre-proline 0 C--N 1.301 -1.501 0 CA-C-N 117.798 0.799 . . . . 0.0 110.724 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.735 ' HB3' HD23 ' A' ' 264' ' ' LEU . 9.5 Cg_endo -71.73 172.52 14.27 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.429 2.086 . . . . 0.0 112.443 176.283 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 30.2 t70 -97.07 105.47 17.62 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.446 HD11 ' HG2' ' A' ' 251' ' ' PRO . 4.7 mp -104.86 118.09 51.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.566 -178.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 254' ' ' SER . . . . . 0.488 ' HB3' ' HB ' ' A' ' 261' ' ' ILE . 22.9 t -101.0 123.23 44.87 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 175.062 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -107.93 95.61 5.8 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -176.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -103.35 164.39 11.67 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -60.93 -48.16 83.07 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 117.851 0.296 . . . . 0.0 111.344 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -76.08 -33.17 59.53 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.255 -173.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' HIS . . . . . 0.421 ' CB ' ' HA ' ' A' ' 303' ' ' THR . 41.8 p-80 -164.64 166.47 20.1 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 119.908 -0.717 . . . . 0.0 112.677 176.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.467 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 18.6 mt -106.41 144.71 15.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 261' ' ' ILE . . . . . 0.488 ' HB ' ' HB3' ' A' ' 254' ' ' SER . 3.3 mp -128.94 114.13 31.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 299' ' ' GLN . 1.3 m -107.6 132.74 54.38 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.527 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 175.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 263' ' ' THR . . . . . 0.414 ' HB ' ' HB3' ' A' ' 252' ' ' ASP . 19.5 m -120.83 120.97 37.1 Favored 'General case' 0 C--N 1.281 -2.396 0 CA-C-O 121.211 0.529 . . . . 0.0 109.718 177.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.735 HD23 ' HB3' ' A' ' 251' ' ' PRO . 24.0 mt -100.91 94.74 6.18 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 179.189 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -57.8 126.57 27.97 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -175.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 4.5 t30 63.78 19.24 11.63 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 113.263 -1.789 . . . . 0.0 111.283 176.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 53.5 t60 -98.56 117.73 33.66 Favored 'General case' 0 C--O 1.21 -1.006 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 5.4 p -92.7 118.62 31.25 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -176.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 269' ' ' LEU . . . . . 0.513 HD12 ' HD2' ' A' ' 270' ' ' PRO . 21.5 tp -99.5 129.91 28.0 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.093 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.513 ' HD2' HD12 ' A' ' 269' ' ' LEU . 71.9 Cg_endo -75.96 160.0 37.38 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.28 1.987 . . . . 0.0 111.971 176.106 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 19.6 p -62.66 -41.24 98.97 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 123.548 0.739 . . . . 0.0 112.485 -174.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 32.2 m -63.15 -23.35 67.39 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 124.573 1.149 . . . . 0.0 113.094 -176.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.558 HD13 ' O ' ' A' ' 226' ' ' THR . 95.4 mt -95.96 -10.11 29.48 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.583 -174.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -74.3 133.39 42.58 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 175.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 275' ' ' ARG . . . . . 0.484 ' CG ' HD11 ' A' ' 228' ' ' ILE . 5.4 ptp180 -171.58 172.5 5.0 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 177.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 11.8 p -130.39 148.45 52.21 Favored 'General case' 0 N--CA 1.402 -2.845 0 CA-C-O 121.293 0.568 . . . . 0.0 111.008 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.616 HD21 HD13 ' A' ' 228' ' ' ILE . 1.3 mm? -95.79 117.31 30.31 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 103.058 -2.942 . . . . 0.0 103.058 174.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -63.54 -38.85 92.7 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 279' ' ' VAL . . . . . 0.479 ' HA ' ' CD1' ' A' ' 282' ' ' PHE 0.259 12.2 p 40.61 34.91 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.336 0 C-N-CA 127.139 2.176 . . . . 0.0 114.1 174.823 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -85.26 140.47 30.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 115.069 -0.968 . . . . 0.0 108.776 177.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 32.9 t70 72.52 7.65 5.62 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.285 1.034 . . . . 0.0 111.354 178.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.479 ' CD1' ' HA ' ' A' ' 279' ' ' VAL . 11.2 m-85 -73.22 -19.58 61.05 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.198 174.121 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm 61.85 60.7 1.52 Allowed 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 124.259 1.024 . . . . 0.0 112.032 174.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 284' ' ' THR . . . . . 0.526 HG22 ' HE3' ' A' ' 232' ' ' LYS . 4.9 p -128.26 178.25 1.73 Allowed Pre-proline 0 C--N 1.288 -2.108 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 285' ' ' PRO . . . . . 0.564 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 7.8 Cg_exo -75.36 -10.08 20.51 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 CA-C-N 121.172 1.454 . . . . 0.0 110.714 174.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 286' ' ' VAL . . . . . 0.501 ' CG1' ' HA3' ' A' ' 238' ' ' GLY . 0.8 OUTLIER -90.54 140.84 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.425 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 179.03 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -99.19 -51.02 3.95 Favored 'General case' 0 C--N 1.279 -2.459 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.425 -177.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 288' ' ' LYS . . . . . 0.45 ' HA ' ' CG1' ' A' ' 279' ' ' VAL . 86.8 tttt -155.45 135.49 12.94 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.454 ' HB ' HD23 ' A' ' 277' ' ' LEU . 42.9 t -102.44 126.18 56.59 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.927 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 60.8 m -132.49 125.72 31.3 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 121.001 0.429 . . . . 0.0 111.236 -177.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.423 ' HB2' HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -99.78 124.78 45.39 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 178.54 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -128.78 138.12 51.91 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.053 0.454 . . . . 0.0 110.112 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -80.82 144.72 31.85 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 174.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.507 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 32.4 tp -122.93 -179.76 4.37 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.507 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 88.2 m-20 -31.43 -71.92 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 126.514 1.926 . . . . 0.0 112.874 -178.124 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -126.26 -1.63 6.98 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 173.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -110.87 172.8 6.66 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 114.166 -1.379 . . . . 0.0 109.445 -169.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.498 ' HB ' HD12 ' A' ' 264' ' ' LEU . 88.8 m -116.71 134.97 54.16 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 174.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 299' ' ' GLN . . . . . 0.571 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 27.5 tt0 -122.17 125.29 45.8 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 120.975 0.416 . . . . 0.0 109.926 -175.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.467 ' HB3' HG13 ' A' ' 262' ' ' VAL . 62.5 tp -108.42 120.52 42.65 Favored 'General case' 0 C--N 1.284 -2.267 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.083 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 72.2 mt -106.95 114.8 46.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.795 -175.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 302' ' ' ILE . . . . . 0.467 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 52.0 mt -116.51 105.51 18.48 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.326 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 178.094 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 303' ' ' THR . . . . . 0.421 ' HA ' ' CB ' ' A' ' 259' ' ' HIS . 18.2 m -73.67 138.19 44.58 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -178.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 10.3 p -137.06 177.86 7.53 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 122.803 0.441 . . . . 0.0 111.691 -174.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -156.81 143.33 18.33 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 122.418 0.287 . . . . 0.0 111.168 178.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 77.72 -152.27 38.78 Favored Glycine 0 C--O 1.247 0.951 0 O-C-N 123.523 0.515 . . . . 0.0 113.819 173.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -93.22 129.01 39.41 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 177.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 308' ' ' TRP . . . . . 0.562 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 69.2 p-90 -157.56 160.29 38.01 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -177.218 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.461 ' HG2' ' HE2' ' A' ' 327' ' ' LYS . 6.7 mt-10 -119.67 130.88 55.26 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -176.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.562 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 1.6 tm? -97.76 136.53 37.96 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 57.3 t -135.42 111.79 13.27 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -101.16 131.52 47.08 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -130.65 143.78 50.98 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -178.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 13.8 m -111.23 116.38 30.95 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -80.35 -40.84 25.87 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.798 -176.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 316' ' ' ALA . . . . . 0.428 ' HB1' ' HD2' ' A' ' 317' ' ' PRO . . . -159.75 165.86 17.15 Favored Pre-proline 0 C--N 1.301 -1.517 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 -177.09 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 317' ' ' PRO . . . . . 0.428 ' HD2' ' HB1' ' A' ' 316' ' ' ALA . 29.7 Cg_endo -62.14 102.47 0.27 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 121.679 1.586 . . . . 0.0 111.018 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 116.39 -27.15 8.21 Favored Glycine 0 N--CA 1.426 -1.974 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.648 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -98.11 116.57 30.6 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.922 -0.752 . . . . 0.0 110.762 -178.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -118.63 166.68 12.44 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.474 -177.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 59.6 m -152.0 131.18 12.74 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.387 -176.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -118.56 114.14 22.36 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 176.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 323' ' ' GLN . . . . . 0.529 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 50.2 tt0 -101.18 102.94 13.95 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -98.11 101.97 12.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 CA-C-O 122.46 1.124 . . . . 0.0 109.736 177.204 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.52 HD23 ' HB2' ' A' ' 237' ' ' ALA . 28.0 mt -91.05 145.55 31.89 Favored Pre-proline 0 C--N 1.302 -1.473 0 CA-C-N 113.479 -1.692 . . . . 0.0 109.922 -175.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -72.6 144.4 39.88 Favored 'Trans proline' 0 C--O 1.245 0.856 0 C-N-CA 121.648 1.565 . . . . 0.0 109.442 174.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.461 ' HE2' ' HG2' ' A' ' 309' ' ' GLU . 36.3 ttmt -123.44 148.35 46.25 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -110.23 129.34 55.74 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 171.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 . . . . . 0 C--N 1.291 -1.967 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 179.467 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 49.8 tpp . . . . . 0 CA--C 1.516 -0.336 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -134.07 -50.31 0.08 OUTLIER Glycine 0 N--CA 1.433 -1.564 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 23.2 m -67.82 98.97 0.77 Allowed 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 120.938 0.399 . . . . 0.0 110.041 178.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 48.1 m -160.15 114.43 2.23 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 123.679 0.792 . . . . 0.0 109.122 -178.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -76.86 -40.48 47.48 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 174.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 81.8 t60 174.19 147.95 0.07 Allowed 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 124.459 1.104 . . . . 0.0 108.467 176.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -121.92 141.52 51.21 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 175.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 6.7 p-80 -130.48 -9.49 4.11 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 -144.52 71.99 1.33 Allowed 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.649 0.737 . . . . 0.0 109.287 -178.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -171.21 127.49 0.69 Allowed 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.669 -1.15 . . . . 0.0 108.236 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -95.77 92.09 1.4 Allowed Glycine 0 N--CA 1.424 -2.149 0 C-N-CA 119.894 -1.146 . . . . 0.0 112.055 178.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 59.7 tp -92.59 -49.57 6.04 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 175.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 64.7 t -88.35 -56.55 0.3 Allowed Pre-proline 0 CA--C 1.55 0.967 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.619 176.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -64.71 140.62 68.74 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 121.059 1.173 . . . . 0.0 109.794 176.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' ARG . . . . . 0.41 ' HD3' ' O ' ' A' ' 206' ' ' ARG . 0.0 OUTLIER -93.55 138.14 32.11 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 120.969 0.414 . . . . 0.0 112.044 -176.473 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 153.72 68.5 0.01 OUTLIER Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -177.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 43.2 t -113.98 -5.61 13.16 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -176.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -79.6 -70.93 0.48 Allowed 'General case' 0 CA--C 1.51 -0.596 0 CA-C-O 120.989 0.423 . . . . 0.0 111.095 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -111.51 136.69 50.34 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -65.47 89.73 0.1 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.48 0.657 . . . . 0.0 112.402 -177.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 22.6 m -137.07 127.78 27.1 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 23.7 ptp -156.04 171.72 19.63 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 24.3 p -92.56 80.11 4.84 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.397 0.618 . . . . 0.0 110.776 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -110.57 -45.92 0.88 Allowed Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.558 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 166.74 -137.96 4.93 Favored Glycine 0 C--N 1.292 -1.869 0 N-CA-C 108.159 -1.977 . . . . 0.0 108.159 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 63.42 21.77 12.93 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.312 0.645 . . . . 0.0 111.396 175.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -78.43 -4.54 48.86 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.068 -174.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 24.0 ptp -109.25 -6.74 15.43 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.246 -0.581 . . . . 0.0 109.86 173.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -108.4 74.57 0.21 Allowed Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 121.222 -0.513 . . . . 0.0 112.223 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.5 163.48 24.02 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 178.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 224' ' ' LYS . . . 75.89 -80.83 1.05 Allowed Glycine 0 C--N 1.312 -0.789 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 22.9 t -73.84 11.84 0.79 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.816 1.247 . . . . 0.0 110.237 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' LYS . . . . . 0.406 ' H ' ' C ' ' A' ' 222' ' ' GLY . 60.1 tttp -74.65 -27.38 60.41 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 172.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' GLN . . . . . 0.446 ' O ' HD23 ' A' ' 245' ' ' LEU . 5.7 tp-100 -131.54 -178.65 4.96 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 115.256 -0.883 . . . . 0.0 108.953 -176.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.646 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 28.3 m -74.1 123.86 25.22 Favored 'General case' 0 C--O 1.202 -1.41 0 C-N-CA 124.495 1.118 . . . . 0.0 113.696 -169.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -143.69 169.05 18.49 Favored 'General case' 0 CA--C 1.474 -1.976 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -175.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.64 HG12 ' HB2' ' A' ' 291' ' ' LEU . 2.8 pp -135.54 160.15 39.95 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 175.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 229' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 240' ' ' ILE . 24.0 t70 -148.3 156.49 42.6 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -173.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.422 ' CE2' HG21 ' A' ' 279' ' ' VAL . 76.7 t80 -125.82 139.06 53.81 Favored 'General case' 0 N--CA 1.427 -1.598 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.016 173.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -155.14 164.16 39.22 Favored 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 124.803 1.241 . . . . 0.0 108.076 177.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -115.94 144.74 43.64 Favored 'General case' 0 CA--C 1.486 -1.516 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 177.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 237' ' ' ALA . 32.7 t70 -149.71 124.83 10.05 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 123.716 0.635 . . . . 0.0 110.632 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 81.44 -133.12 11.75 Favored Glycine 0 C--N 1.3 -1.436 0 C-N-CA 120.966 -0.635 . . . . 0.0 114.258 175.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -86.34 76.2 9.7 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 122.843 0.457 . . . . 0.0 111.502 -171.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 58.22 20.04 6.76 Favored 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 124.128 0.971 . . . . 0.0 112.445 177.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.525 ' HB3' ' O ' ' A' ' 233' ' ' ASP . . . -78.58 140.43 38.48 Favored 'General case' 0 N--CA 1.421 -1.899 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.982 -175.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 238' ' ' GLY . . . . . 0.473 ' C ' HD12 ' A' ' 239' ' ' ILE . . . -95.81 131.35 10.63 Favored Glycine 0 N--CA 1.416 -2.634 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 177.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.473 HD12 ' C ' ' A' ' 238' ' ' GLY . 2.3 mp -120.52 115.74 47.98 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 CA-C-N 117.907 0.854 . . . . 0.0 110.403 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 240' ' ' ILE . . . . . 0.474 ' HB ' ' HB2' ' A' ' 322' ' ' PHE . 3.2 mp -100.1 106.92 19.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 176.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 241' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 30.9 mt-10 -86.88 141.72 28.56 Favored 'General case' 0 N--CA 1.417 -2.116 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.667 175.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 10.3 tp -128.78 125.34 37.62 Favored 'General case' 0 C--N 1.26 -3.308 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.208 -175.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' ALA . . . . . 0.646 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -112.46 97.61 6.72 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -107.15 91.56 3.71 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.62 0.724 . . . . 0.0 109.685 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 225' ' ' GLN . 3.0 mm? -80.58 115.48 20.11 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.377 -176.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 110.87 2.63 28.56 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.5 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -115.94 140.85 48.84 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -138.91 15.39 2.67 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 120.676 -0.409 . . . . 0.0 111.66 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -117.21 -163.18 12.91 Favored Glycine 0 CA--C 1.495 -1.207 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -105.64 133.11 20.35 Favored Pre-proline 0 C--N 1.3 -1.577 0 CA-C-N 117.538 0.669 . . . . 0.0 110.022 -177.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.734 ' HB3' HD23 ' A' ' 264' ' ' LEU . 25.6 Cg_endo -73.69 169.21 22.88 Favored 'Trans proline' 0 CA--C 1.506 -0.903 0 C-N-CA 122.322 2.015 . . . . 0.0 112.79 177.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.62 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 27.9 t70 -82.1 104.89 12.76 Favored 'General case' 0 CA--C 1.472 -2.023 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 174.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 253' ' ' ILE . . . . . 0.478 ' CG2' HE21 ' A' ' 255' ' ' GLN . 7.1 mt -102.89 116.65 47.01 Favored 'Isoleucine or valine' 0 C--N 1.245 -3.966 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 7.8 t -125.51 129.7 50.28 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' GLN . . . . . 0.666 HE22 HG23 ' A' ' 260' ' ' ILE . 70.4 mm-40 -110.36 131.73 54.8 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -175.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.521 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 28.3 mm-40 -119.74 163.48 17.38 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 171.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -73.19 -35.89 66.44 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -88.19 -17.14 31.53 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.674 -173.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' HIS . . . . . 0.521 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 51.2 p-80 -171.94 162.41 5.97 Favored 'General case' 0 C--O 1.213 -0.841 0 O-C-N 122.093 -0.379 . . . . 0.0 111.74 178.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.666 HG23 HE22 ' A' ' 255' ' ' GLN . 17.5 mt -107.52 144.72 15.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 261' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 300' ' ' LEU . 3.5 mp -124.79 125.86 70.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 176.143 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 252' ' ' ASP . 0.8 OUTLIER -122.16 139.8 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.717 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 172.686 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 263' ' ' THR . . . . . 0.48 ' HB ' ' HB3' ' A' ' 252' ' ' ASP . 24.7 m -131.05 123.54 28.92 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 118.527 0.603 . . . . 0.0 110.654 177.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.734 HD23 ' HB3' ' A' ' 251' ' ' PRO . 25.5 mt -100.54 96.48 7.41 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.318 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 24.1 mmtm -57.79 125.57 23.59 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -176.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 2.4 t30 62.6 26.87 15.92 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 126.064 1.746 . . . . 0.0 110.894 177.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -103.61 106.33 16.81 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 7.8 p -79.7 130.79 35.65 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.157 0.503 . . . . 0.0 112.226 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 269' ' ' LEU . . . . . 0.594 HD12 ' HD2' ' A' ' 270' ' ' PRO . 30.3 tp -116.92 136.28 23.23 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.115 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.594 ' HD2' HD12 ' A' ' 269' ' ' LEU . 84.5 Cg_endo -78.71 158.29 28.15 Favored 'Trans proline' 0 N--CA 1.438 -1.76 0 C-N-CA 121.204 1.269 . . . . 0.0 110.391 173.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 271' ' ' THR . . . . . 0.476 ' HA ' HE21 ' A' ' 274' ' ' GLN . 5.9 p -64.5 -29.02 70.06 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.476 0.655 . . . . 0.0 111.298 -177.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 7.1 m -61.84 -29.36 70.12 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 125.393 1.477 . . . . 0.0 112.255 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.546 HD13 ' HG2' ' A' ' 270' ' ' PRO . 10.4 mp -101.37 0.08 36.41 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.381 0.61 . . . . 0.0 111.913 -172.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 274' ' ' GLN . . . . . 0.476 HE21 ' HA ' ' A' ' 271' ' ' THR . 41.3 mt-30 -75.72 142.32 42.46 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 174.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -164.52 171.05 15.07 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -177.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 23.2 m -140.99 133.36 28.29 Favored 'General case' 0 N--CA 1.418 -2.052 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 176.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.516 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 1.5 mm? -100.14 111.26 23.55 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.4 79.61 9.4 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-O 123.501 1.619 . . . . 0.0 109.518 175.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 279' ' ' VAL . . . . . 0.422 HG21 ' CE2' ' A' ' 230' ' ' PHE 0.25 1.9 p -86.29 63.69 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.403 -2.815 0 CA-C-N 111.558 -2.565 . . . . 0.0 111.41 -175.555 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -105.97 144.93 32.0 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 113.07 -1.877 . . . . 0.0 106.911 177.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 31.7 t70 68.0 19.45 9.35 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 123.157 1.456 . . . . 0.0 110.538 -178.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 282' ' ' PHE . . . . . 0.405 ' CG ' HG23 ' A' ' 279' ' ' VAL . 41.1 m-85 -91.88 -13.1 31.84 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.101 173.005 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? 56.76 61.88 2.47 Favored 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 123.586 0.754 . . . . 0.0 112.569 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 1.5 p -136.24 170.62 10.48 Favored Pre-proline 0 N--CA 1.433 -1.32 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 178.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.46 -10.35 17.4 Favored 'Trans proline' 0 C--O 1.241 0.652 0 C-N-CA 122.018 1.812 . . . . 0.0 111.802 177.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.6 p -99.15 121.53 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.016 0 CA-C-O 121.991 0.9 . . . . 0.0 111.071 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 81.0 mm-40 -87.92 -41.57 13.08 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.199 -1.364 . . . . 0.0 112.522 -170.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -155.54 132.6 10.76 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -177.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 39.1 t -96.78 129.89 46.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 172.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 57.1 m -136.38 128.16 29.11 Favored 'General case' 0 C--N 1.293 -1.89 0 O-C-N 121.822 -0.549 . . . . 0.0 111.037 -178.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.64 ' HB2' HG12 ' A' ' 228' ' ' ILE . 53.5 tp -109.92 123.91 50.45 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -131.05 130.88 43.81 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 293' ' ' ARG . . . . . 0.466 ' HB3' HD23 ' A' ' 269' ' ' LEU . 17.7 ptt180 -79.51 137.18 37.1 Favored 'General case' 0 N--CA 1.415 -2.198 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.535 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 16.1 tp -99.96 -177.35 3.52 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.535 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 6.9 t30 -45.22 -66.26 0.42 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.217 1.007 . . . . 0.0 112.078 -177.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -118.67 -3.54 10.82 Favored 'General case' 0 CA--C 1.498 -1.02 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.062 174.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -110.22 173.17 6.45 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.308 -170.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.515 ' HB ' HD12 ' A' ' 264' ' ' LEU . 86.5 m -115.19 131.96 56.76 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 174.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 299' ' ' GLN . . . . . 0.577 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 20.4 tt0 -124.84 130.82 53.13 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.172 -174.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.581 HD11 HG21 ' A' ' 228' ' ' ILE . 1.2 mm? -94.71 142.27 27.65 Favored 'General case' 0 CA--C 1.467 -2.212 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.01 172.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 50.7 mt -129.01 108.51 17.19 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.568 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 172.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 302' ' ' ILE . . . . . 0.576 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 58.7 mt -114.14 103.38 15.27 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.813 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -177.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 5.5 m -75.79 129.93 37.81 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -174.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 15.4 p -128.38 172.18 11.34 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 122.587 0.355 . . . . 0.0 110.817 -177.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -156.22 137.53 13.86 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 90.69 -169.65 34.25 Favored Glycine 0 N--CA 1.436 -1.344 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -87.33 129.78 34.88 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 177.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 308' ' ' TRP . . . . . 0.704 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 57.4 p-90 -147.24 163.87 35.0 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.476 -174.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -125.63 142.64 51.41 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -178.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 310' ' ' LEU . . . . . 0.704 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 19.1 tp -116.87 139.35 50.73 Favored 'General case' 0 C--O 1.249 1.045 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.952 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 89.8 t -134.68 108.96 11.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 174.369 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 312' ' ' ASN . . . . . 0.584 ' HA ' ' O ' ' A' ' 321' ' ' THR . 19.7 t30 -98.45 129.28 45.06 Favored 'General case' 0 CA--C 1.454 -2.749 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.006 177.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -119.93 121.42 38.95 Favored 'General case' 0 N--CA 1.384 -3.763 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.932 -178.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 22.1 t -84.75 105.81 15.82 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 174.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -73.69 -36.93 65.34 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.717 0.77 . . . . 0.0 110.481 -176.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -156.32 162.5 27.37 Favored Pre-proline 0 C--N 1.295 -1.802 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 -177.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.39 96.19 0.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 121.505 1.47 . . . . 0.0 111.56 -178.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 125.72 -24.93 5.7 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -100.08 116.22 31.59 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 122.244 -0.562 . . . . 0.0 109.638 -179.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -116.45 164.97 13.77 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.811 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 321' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 312' ' ' ASN . 90.8 m -152.68 108.9 3.38 Favored 'General case' 0 C--N 1.275 -2.665 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.455 -173.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 322' ' ' PHE . . . . . 0.49 ' HB3' HD11 ' A' ' 310' ' ' LEU . 81.2 m-85 -97.03 108.18 20.86 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.227 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 323' ' ' GLN . . . . . 0.557 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 37.0 tt0 -96.25 108.04 20.47 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -179.041 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.517 HG23 ' CE3' ' A' ' 308' ' ' TRP . 0.4 OUTLIER -101.86 105.25 17.63 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 CA-C-O 121.3 0.572 . . . . 0.0 110.951 179.385 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.93 157.57 36.44 Favored Pre-proline 0 N--CA 1.466 0.346 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.57 131.81 8.56 Favored 'Trans proline' 0 C--O 1.246 0.925 0 C-N-CA 121.988 1.792 . . . . 0.0 110.133 172.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 327' ' ' LYS . . . . . 0.485 ' HE3' ' O ' ' A' ' 308' ' ' TRP . 41.0 ttmt -96.13 123.27 39.68 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.587 -175.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -121.72 18.61 11.12 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 122.121 0.962 . . . . 0.0 109.451 172.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 . . . . . 0 C--N 1.295 -1.771 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.809 -179.788 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 66.9 mtt . . . . . 0 N--CA 1.471 0.597 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -90.76 -29.67 12.94 Favored Glycine 0 C--N 1.307 -1.048 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.739 -178.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 18.1 t -99.91 159.52 15.01 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -177.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 16.6 m -81.19 127.56 32.8 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.616 -177.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -89.74 140.38 29.64 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 172.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 71.16 90.14 0.1 Allowed 'General case' 0 CA--C 1.5 -0.953 0 O-C-N 124.414 1.071 . . . . 0.0 108.285 -166.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 72.3 m-70 -81.24 -4.21 54.8 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.766 -175.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 61.6 m80 68.05 37.87 2.87 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.911 0.884 . . . . 0.0 111.041 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 73.9 m80 -129.03 149.13 50.98 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.784 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -132.02 110.47 10.76 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.84 177.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -93.92 -83.22 1.57 Allowed Glycine 0 C--N 1.303 -1.296 0 N-CA-C 108.241 -1.944 . . . . 0.0 108.241 171.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.49 -33.82 0.05 OUTLIER 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.53 -0.335 . . . . 0.0 110.865 172.083 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . 0.294 34.5 m 50.25 98.47 0.04 OUTLIER Pre-proline 0 N--CA 1.485 1.276 0 C-N-CA 124.974 1.31 . . . . 0.0 113.642 -177.274 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -58.42 -47.92 17.51 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.212 1.942 . . . . 0.0 110.689 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -141.71 130.78 23.28 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 176.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -112.92 148.6 18.52 Favored Glycine 0 C--N 1.297 -1.597 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 177.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 32.7 t -131.19 92.71 3.24 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-O 121.313 0.577 . . . . 0.0 110.856 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -124.85 -12.55 7.05 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.598 174.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 26.0 mmt 66.12 0.52 1.67 Allowed 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 125.593 1.557 . . . . 0.0 112.983 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -93.24 4.56 53.78 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-O 120.981 0.42 . . . . 0.0 111.314 -176.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 16.4 m -81.88 85.41 6.67 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 121.389 0.614 . . . . 0.0 109.484 178.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 48.6 ttp -75.99 -42.48 48.07 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.451 -177.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 33.2 m -82.71 120.61 25.81 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -66.75 -38.88 93.41 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.609 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 135.98 -20.58 3.6 Favored Glycine 0 C--N 1.307 -1.056 0 C-N-CA 120.142 -1.028 . . . . 0.0 112.27 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -94.67 111.9 23.66 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 176.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 68.84 103.78 0.06 Allowed 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 123.928 0.891 . . . . 0.0 112.827 -177.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 24.9 mmt -81.71 79.55 8.25 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 176.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -109.16 -132.78 6.61 Favored Glycine 0 N--CA 1.43 -1.725 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.123 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -169.77 137.07 1.65 Allowed 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 123.737 0.815 . . . . 0.0 110.593 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -95.75 112.7 4.47 Favored Glycine 0 N--CA 1.426 -2.033 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 27.3 t -100.97 95.22 6.45 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -178.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -100.72 6.65 44.01 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' GLN . . . . . 0.446 ' C ' HD23 ' A' ' 245' ' ' LEU . 5.6 tp60 69.04 170.73 0.3 Allowed 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 124.745 1.218 . . . . 0.0 109.399 -174.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' THR . . . . . 0.701 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 7.0 m -59.11 114.89 2.82 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -168.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -142.44 168.45 19.7 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.343 -177.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' ILE . . . . . 0.617 HG12 ' HB2' ' A' ' 291' ' ' LEU . 2.2 pp -128.13 163.09 32.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.766 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -151.41 157.33 42.25 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 230' ' ' PHE . . . . . 0.55 ' CD2' HG11 ' A' ' 279' ' ' VAL . 87.7 t80 -129.7 135.47 48.53 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.31 177.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 -154.7 155.58 34.85 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 124.095 0.958 . . . . 0.0 108.993 177.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.409 ' HE3' HG22 ' A' ' 284' ' ' THR . 53.5 mtpt -105.27 157.74 17.09 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 175.176 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -155.72 153.06 29.35 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 72.8 -114.31 4.77 Favored Glycine 0 N--CA 1.437 -1.28 0 C-N-CA 121.189 -0.529 . . . . 0.0 111.785 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -134.53 93.91 3.12 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 120.539 0.209 . . . . 0.0 110.869 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' ASN . . . . . 0.435 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 93.4 m-20 66.93 17.6 10.54 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 174.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -82.15 140.4 33.79 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -99.31 113.49 4.74 Favored Glycine 0 N--CA 1.432 -1.604 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.3 mp -105.13 111.53 34.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 121.618 0.723 . . . . 0.0 110.263 -178.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.6 mp -97.93 112.66 30.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 174.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -89.3 143.77 26.59 Favored 'General case' 0 N--CA 1.408 -2.548 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 176.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 12.2 tp -133.14 130.39 39.15 Favored 'General case' 0 C--N 1.263 -3.175 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.099 -176.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' ALA . . . . . 0.701 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -116.86 102.24 9.22 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 176.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -109.43 91.15 3.53 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' LEU . . . . . 0.446 HD23 ' C ' ' A' ' 225' ' ' GLN . 2.7 mm? -77.68 113.18 15.27 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.547 -175.012 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 114.79 -10.85 21.06 Favored Glycine 0 C--N 1.298 -1.531 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.319 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -100.73 124.31 46.17 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -178.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -103.82 -29.64 10.88 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -175.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -85.89 -161.51 35.18 Favored Glycine 0 CA--C 1.503 -0.68 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -103.48 143.02 25.79 Favored Pre-proline 0 C--N 1.303 -1.43 0 CA-C-N 117.847 0.824 . . . . 0.0 110.688 176.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.79 ' HB3' HD13 ' A' ' 264' ' ' LEU . 10.7 Cg_endo -64.6 172.03 7.4 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.108 2.539 . . . . 0.0 111.267 175.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -89.93 119.65 30.48 Favored 'General case' 0 C--N 1.274 -2.681 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 2.7 mp -102.46 127.65 55.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-O 121.57 0.7 . . . . 0.0 111.385 178.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' SER . . . . . 0.72 ' HB2' ' HB ' ' A' ' 261' ' ' ILE . 73.6 m -115.73 115.48 26.41 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 125.297 1.439 . . . . 0.0 108.217 175.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -101.15 113.85 27.26 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -175.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 256' ' ' GLN . . . . . 0.62 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 14.5 mm100 -116.92 166.03 12.64 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 174.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -77.07 -41.99 40.07 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.488 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -84.04 -14.75 49.79 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -174.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' HIS . . . . . 0.62 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 49.8 p-80 -171.77 162.31 6.17 Favored 'General case' 0 C--O 1.21 -0.995 0 CA-C-O 120.628 0.251 . . . . 0.0 111.041 175.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 260' ' ' ILE . . . . . 0.419 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 19.5 mt -106.9 145.2 14.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 177.602 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 261' ' ' ILE . . . . . 0.72 ' HB ' ' HB2' ' A' ' 254' ' ' SER . 3.6 mp -122.11 123.4 68.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 175.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.504 ' HB ' ' HB2' ' A' ' 300' ' ' LEU . 37.8 t -124.7 128.19 73.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 263' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 298' ' ' THR . 7.6 m -124.27 124.04 41.55 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-O 121.538 0.685 . . . . 0.0 111.503 -177.127 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.79 HD13 ' HB3' ' A' ' 251' ' ' PRO . 1.9 mm? -95.32 103.13 14.98 Favored 'General case' 0 CA--C 1.47 -2.119 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 173.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 265' ' ' LYS . . . . . 0.464 ' HA ' ' OD2' ' A' ' 297' ' ' ASP . 17.3 ttmm -76.38 137.95 40.11 Favored 'General case' 0 N--CA 1.383 -3.788 0 O-C-N 123.72 0.638 . . . . 0.0 110.779 -177.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 8.7 t30 70.44 27.71 3.87 Favored 'General case' 0 CA--C 1.548 0.881 0 O-C-N 124.864 1.352 . . . . 0.0 109.957 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 36.1 t60 -124.27 108.02 11.8 Favored 'General case' 0 C--O 1.206 -1.185 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -178.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 7.2 p -90.48 114.66 26.88 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -176.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 269' ' ' LEU . . . . . 0.492 HD12 ' HD2' ' A' ' 270' ' ' PRO . 19.7 tp -93.3 133.19 28.87 Favored Pre-proline 0 C--N 1.318 -0.8 0 C-N-CA 123.077 0.551 . . . . 0.0 110.468 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 270' ' ' PRO . . . . . 0.492 ' HD2' HD12 ' A' ' 269' ' ' LEU . 80.9 Cg_endo -78.98 157.03 26.94 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.218 1.945 . . . . 0.0 112.117 173.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 23.6 p -62.36 -35.04 77.89 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -177.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 13.7 m -65.85 -18.3 65.24 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 123.707 0.803 . . . . 0.0 111.709 -176.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 273' ' ' LEU . . . . . 0.426 HD13 ' O ' ' A' ' 226' ' ' THR . 95.0 mt -105.21 -13.91 15.54 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.446 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -83.78 114.38 21.58 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 275' ' ' ARG . . . . . 0.405 ' CG ' HD11 ' A' ' 228' ' ' ILE . 6.1 ptp180 -144.94 175.96 9.83 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -174.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 48.9 m -134.4 138.55 44.92 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-O 121.275 0.559 . . . . 0.0 110.177 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.533 ' O ' ' HG3' ' A' ' 288' ' ' LYS . 2.0 mm? -91.96 150.38 21.04 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 174.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -86.49 -60.69 1.92 Allowed 'General case' 0 C--N 1.274 -2.693 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 279' ' ' VAL . . . . . 0.55 HG11 ' CD2' ' A' ' 230' ' ' PHE 0.342 30.8 m 49.41 19.32 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 174.016 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -74.19 140.2 44.95 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 173.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 28.8 t70 73.77 16.92 3.71 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.935 1.294 . . . . 0.0 111.402 -178.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -80.61 -11.86 59.58 Favored 'General case' 0 CA--C 1.514 -0.414 0 O-C-N 121.351 -0.843 . . . . 0.0 111.016 173.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 60.98 61.26 1.66 Allowed 'General case' 0 CA--C 1.497 -1.062 0 C-N-CA 123.336 0.654 . . . . 0.0 111.361 -178.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 284' ' ' THR . . . . . 0.409 HG22 ' HE3' ' A' ' 232' ' ' LYS . 1.6 p -137.6 168.06 17.97 Favored Pre-proline 0 C--N 1.292 -1.911 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 177.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 285' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 18.4 Cg_exo -69.46 -23.35 32.27 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 121.467 1.445 . . . . 0.0 110.822 176.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.0 p -85.31 122.31 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 CA-C-O 122.254 1.026 . . . . 0.0 110.401 179.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -89.23 -37.93 14.61 Favored 'General case' 0 C--N 1.284 -2.252 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.465 -174.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 288' ' ' LYS . . . . . 0.533 ' HG3' ' O ' ' A' ' 277' ' ' LEU . 56.3 tttp -159.47 137.6 10.36 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.67 -178.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.416 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 42.8 t -103.47 128.86 56.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 290' ' ' THR . . . . . 0.46 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 90.6 m -135.14 121.26 20.04 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 120.743 0.306 . . . . 0.0 110.591 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 291' ' ' LEU . . . . . 0.617 ' HB2' HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -101.08 122.96 44.49 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 177.537 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -119.56 135.26 54.87 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -176.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -83.58 142.59 30.73 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 174.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 294' ' ' LEU . . . . . 0.436 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 12.9 tp -120.13 -174.17 2.72 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 176.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 295' ' ' ASN . . . . . 0.436 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 20.2 t-20 -72.35 -51.55 20.09 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 118.908 0.776 . . . . 0.0 111.565 -172.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -115.55 -3.94 12.3 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.611 -177.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 297' ' ' ASP . . . . . 0.464 ' OD2' ' HA ' ' A' ' 265' ' ' LYS . 3.7 m-20 -133.13 169.3 17.06 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.58 0.705 . . . . 0.0 110.671 -170.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 263' ' ' THR . 62.6 m -113.37 126.74 55.69 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 172.191 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -119.71 122.57 41.75 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-O 121.441 0.639 . . . . 0.0 110.099 -173.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.504 ' HB2' ' HB ' ' A' ' 262' ' ' VAL . 0.1 OUTLIER -97.63 135.87 38.82 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.149 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 301' ' ' ILE . . . . . 0.46 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 48.7 mt -124.83 109.73 23.1 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.433 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 302' ' ' ILE . . . . . 0.419 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 68.5 mt -114.65 101.24 12.11 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -178.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 21.0 m -68.91 134.14 49.17 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -177.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 10.6 p -136.98 167.32 21.72 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -177.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -148.87 151.16 34.21 Favored 'General case' 0 C--O 1.251 1.173 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.321 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 76.71 -157.18 47.13 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.087 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -99.98 141.99 32.06 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 176.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 308' ' ' TRP . . . . . 0.406 ' CE3' HG13 ' A' ' 324' ' ' VAL . 68.6 p-90 -154.84 167.58 29.79 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.756 -176.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -122.57 135.59 54.67 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 1.3 tt -104.69 113.99 27.92 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.715 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 311' ' ' VAL . . . . . 0.577 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 98.4 t -108.08 107.3 22.46 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 172.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.07 121.15 39.65 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.781 0.8 . . . . 0.0 110.429 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -122.91 148.62 45.23 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.777 -175.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 32.6 t -115.63 116.63 28.44 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 170.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -77.92 -34.83 51.14 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 122.152 0.977 . . . . 0.0 109.036 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -161.43 155.31 18.65 Favored Pre-proline 0 C--N 1.29 -2.016 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -60.73 94.93 0.11 Allowed 'Trans proline' 0 C--O 1.244 0.804 0 C-N-CA 122.239 1.96 . . . . 0.0 112.339 -176.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 136.16 -25.7 3.16 Favored Glycine 0 N--CA 1.433 -1.528 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.24 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -107.32 116.32 31.72 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -116.28 164.61 14.25 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-O 122.138 0.97 . . . . 0.0 111.037 -175.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 39.6 m -151.49 125.45 9.17 Favored 'General case' 0 C--N 1.269 -2.902 0 CA-C-N 114.394 -1.275 . . . . 0.0 108.893 -177.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -109.69 105.07 14.19 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 175.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 323' ' ' GLN . . . . . 0.577 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 41.4 tt0 -94.17 103.11 15.16 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -178.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 324' ' ' VAL . . . . . 0.406 HG13 ' CE3' ' A' ' 308' ' ' TRP . 86.7 t -94.71 99.37 9.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.9 151.41 45.29 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.031 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -77.97 132.84 11.99 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 121.546 1.497 . . . . 0.0 110.513 174.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -104.35 127.14 51.96 Favored 'General case' 0 CA--C 1.484 -1.582 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 178.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -96.5 165.9 11.94 Favored 'General case' 0 C--N 1.268 -2.958 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 20.7 mp0 . . . . . 0 C--N 1.313 -1.004 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -178.323 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . 0.437 ' HB3' HD11 ' A' ' 273' ' ' LEU . 8.0 tp-100 . . . . . 0 N--CA 1.426 -1.653 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.636 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 5.6 m -56.04 126.49 26.17 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 124.384 1.074 . . . . 0.0 113.42 -171.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -152.95 168.17 26.72 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 116.345 -0.389 . . . . 0.0 109.979 -177.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.671 HG21 HD21 ' A' ' 300' ' ' LEU . 2.8 pp -134.35 165.53 31.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 123.114 0.565 . . . . 0.0 112.164 -178.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . 0.514 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 9.4 t70 -149.89 156.36 41.63 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -133.88 134.63 42.93 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 176.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -152.32 171.61 17.73 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.437 ' HE3' HG22 ' A' ' 284' ' ' THR . 57.4 mtpt -118.98 148.57 42.84 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 175.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -144.68 143.23 30.63 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 123.436 0.46 . . . . 0.0 109.934 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 74.01 -98.81 1.0 Allowed Glycine 0 N--CA 1.435 -1.39 0 O-C-N 124.048 0.842 . . . . 0.0 111.89 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -146.15 98.6 3.12 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 120.761 0.315 . . . . 0.0 110.202 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 63.18 22.65 13.49 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 173.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -89.05 137.36 32.39 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -96.59 113.09 4.59 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 1.9 mp -106.42 121.36 58.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 117.237 0.519 . . . . 0.0 109.869 -177.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.5 mp -105.75 117.31 51.24 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 39.0 mt-10 -94.91 146.04 24.5 Favored 'General case' 0 C--N 1.284 -2.245 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.02 174.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 12.4 tp -134.36 128.87 34.53 Favored 'General case' 0 C--N 1.27 -2.88 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.133 -173.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . 0.636 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -118.44 101.77 8.41 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -109.42 91.47 3.66 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.541 0.686 . . . . 0.0 109.493 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.94 111.41 13.77 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.562 -175.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 107.87 9.18 28.81 Favored Glycine 0 N--CA 1.431 -1.634 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.451 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -115.32 107.72 15.61 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 176.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -115.14 95.24 5.1 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.369 0.604 . . . . 0.0 109.784 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 165.55 -150.22 17.57 Favored Glycine 0 N--CA 1.425 -2.08 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -124.48 136.18 27.47 Favored Pre-proline 0 C--N 1.3 -1.572 0 CA-C-N 117.39 0.595 . . . . 0.0 110.339 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.657 ' HB3' HD23 ' A' ' 264' ' ' LEU . 10.6 Cg_endo -74.32 172.37 16.2 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 C-N-CA 122.505 2.137 . . . . 0.0 112.41 176.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.506 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 11.6 t70 -91.94 105.63 17.84 Favored 'General case' 0 C--N 1.284 -2.283 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 175.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.477 HD11 ' HG2' ' A' ' 251' ' ' PRO . 5.3 mp -103.43 124.14 57.44 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 C-N-CA 119.484 -0.887 . . . . 0.0 109.894 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . 0.491 ' HB3' ' HB ' ' A' ' 261' ' ' ILE . 25.1 t -106.27 120.21 41.25 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -100.13 109.41 21.69 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.948 -178.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -124.42 162.5 23.75 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 174.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -73.57 -33.33 64.6 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 120.991 0.424 . . . . 0.0 110.124 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -70.78 -42.92 69.75 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.842 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . 0.459 ' CB ' ' HA ' ' A' ' 303' ' ' THR . 53.1 p-80 -169.42 167.55 9.91 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.472 0.177 . . . . 0.0 111.067 178.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 17.3 mt -106.21 139.5 27.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . 0.491 ' HB ' ' HB3' ' A' ' 254' ' ' SER . 3.4 mp -122.97 114.56 42.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 299' ' ' GLN . 0.8 OUTLIER -107.81 134.07 50.71 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 175.034 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 25.3 m -122.45 123.78 42.09 Favored 'General case' 0 C--N 1.267 -3.002 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.657 HD23 ' HB3' ' A' ' 251' ' ' PRO . 29.6 mt -100.17 93.73 5.86 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.441 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 63.1 mmtt -63.1 126.94 29.03 Favored 'General case' 0 CA--C 1.478 -1.814 0 O-C-N 124.29 0.994 . . . . 0.0 113.075 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 9.8 t30 69.77 32.53 3.19 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.432 -1.713 . . . . 0.0 109.909 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -125.69 100.54 6.47 Favored 'General case' 0 C--O 1.2 -1.525 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 6.4 m -88.26 112.2 22.53 Favored 'General case' 0 C--N 1.277 -2.57 0 C-N-CA 119.635 -0.826 . . . . 0.0 111.889 -173.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . 0.687 HD22 HD22 ' A' ' 291' ' ' LEU . 37.6 tp -81.83 125.81 76.89 Favored Pre-proline 0 N--CA 1.444 -0.77 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.275 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.408 ' HD2' HD12 ' A' ' 269' ' ' LEU . 31.3 Cg_exo -65.79 143.1 72.55 Favored 'Trans proline' 0 N--CA 1.44 -1.648 0 C-N-CA 122.105 1.87 . . . . 0.0 110.587 169.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 11.4 t -69.63 -12.71 61.86 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.388 0.613 . . . . 0.0 110.363 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 2.4 m -76.29 -16.57 59.76 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 123.961 0.904 . . . . 0.0 109.924 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.505 HD13 ' O ' ' A' ' 226' ' ' THR . 73.8 mt -110.88 -7.06 14.62 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.415 -177.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.521 ' HB2' ' O ' ' A' ' 291' ' ' LEU . 25.2 pt20 -81.35 115.64 20.81 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 119.101 -1.04 . . . . 0.0 109.61 -177.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 21.0 ptt180 -135.44 151.65 50.61 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 40.7 m -112.71 136.93 51.73 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.799 176.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.458 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 59.6 mt -105.67 116.47 32.0 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -61.02 -51.86 67.44 Favored 'General case' 0 C--N 1.311 -1.079 0 O-C-N 123.724 0.64 . . . . 0.0 110.419 -177.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . 0.263 26.9 m 46.19 25.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 116.856 2.169 . . . . 0.0 116.856 174.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -75.85 140.65 42.34 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 177.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 15.3 t70 73.02 20.99 3.31 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.701 1.2 . . . . 0.0 112.531 177.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -79.74 -4.98 54.3 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.574 -0.704 . . . . 0.0 110.22 172.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 mptt 65.77 50.94 1.49 Allowed 'General case' 0 CA--C 1.503 -0.85 0 C-N-CA 124.248 1.019 . . . . 0.0 109.924 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' THR . . . . . 0.437 HG22 ' HE3' ' A' ' 232' ' ' LYS . 1.2 p -133.34 165.03 39.74 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -74.78 -4.91 16.12 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.196 1.931 . . . . 0.0 111.752 177.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 49.8 t -87.59 129.54 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -99.86 -30.35 12.08 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.208 -176.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 20.6 ttmm -167.13 143.79 4.47 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.458 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 43.3 t -112.64 130.22 66.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 174.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.527 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 98.2 m -136.18 117.87 15.0 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-O 121.262 0.554 . . . . 0.0 110.762 -178.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.687 HD22 HD22 ' A' ' 269' ' ' LEU . 0.1 OUTLIER -91.47 114.13 26.58 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 104.244 -2.502 . . . . 0.0 104.244 174.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.407 ' HD3' ' OE1' ' A' ' 274' ' ' GLN . 17.0 tppt? -116.15 129.6 56.4 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -177.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -78.42 140.37 38.68 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 175.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.559 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 21.7 tp -111.23 -173.14 2.17 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 175.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.559 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 3.2 t-20 -58.91 -66.66 0.47 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 119.172 0.896 . . . . 0.0 111.247 -177.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -115.86 -3.6 12.17 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 120.791 0.329 . . . . 0.0 111.147 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . 0.441 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 38.1 m-20 -115.23 172.69 6.92 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.397 0.618 . . . . 0.0 110.209 -177.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.515 ' HB ' ' HB2' ' A' ' 264' ' ' LEU . 92.8 m -116.98 132.11 56.79 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 176.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . 0.529 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 42.1 tt0 -120.17 127.78 52.79 Favored 'General case' 0 N--CA 1.421 -1.894 0 C-N-CA 120.529 -0.469 . . . . 0.0 110.35 -175.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.671 HD21 HG21 ' A' ' 228' ' ' ILE . 17.4 mt -100.08 127.7 46.27 Favored 'General case' 0 CA--C 1.443 -3.142 0 C-N-CA 120.127 -0.629 . . . . 0.0 111.462 172.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' ILE . . . . . 0.527 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 63.1 mt -115.19 109.23 27.65 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.373 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 50.9 mt -117.17 102.13 13.05 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.625 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . 0.459 ' HA ' ' CB ' ' A' ' 259' ' ' HIS . 32.8 m -74.88 134.6 41.62 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.781 -175.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 19.0 p -133.74 179.72 6.06 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 123.189 0.595 . . . . 0.0 109.608 -177.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -159.59 148.47 17.86 Favored 'General case' 0 C--O 1.246 0.878 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 73.64 -142.4 31.05 Favored Glycine 0 C--O 1.243 0.675 0 O-C-N 123.613 0.571 . . . . 0.0 112.468 176.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -105.26 130.23 53.44 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' TRP . . . . . 0.73 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 60.7 p-90 -145.79 171.27 15.03 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -177.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -129.98 135.06 47.88 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.73 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 25.8 tp -111.25 120.95 43.97 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.269 -177.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.554 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 54.3 t -116.2 107.55 22.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 173.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -94.75 134.97 36.78 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . 0.426 ' HB2' ' HB ' ' A' ' 321' ' ' THR . 67.6 mttm -130.58 145.01 51.8 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.619 -176.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 15.9 m -115.85 118.53 33.25 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 172.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -87.28 -24.83 24.22 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.605 0.716 . . . . 0.0 110.41 -177.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -170.24 162.59 6.34 Favored Pre-proline 0 C--N 1.307 -1.241 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -65.17 95.99 0.26 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.493 1.462 . . . . 0.0 110.504 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 133.52 -33.36 2.58 Favored Glycine 0 N--CA 1.421 -2.35 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.628 -177.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -99.89 116.44 31.96 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 122.036 -0.685 . . . . 0.0 109.87 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -119.3 163.94 16.4 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.932 -177.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.426 ' HB ' ' HB2' ' A' ' 313' ' ' LYS . 78.7 m -152.09 139.93 19.96 Favored 'General case' 0 C--N 1.269 -2.894 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.261 -178.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -126.43 112.4 15.57 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . 0.554 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 61.8 tt0 -97.37 109.7 22.4 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.598 HG13 ' CE3' ' A' ' 308' ' ' TRP . 91.7 t -98.38 99.31 8.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 C-N-CA 123.501 0.72 . . . . 0.0 109.687 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -88.43 152.86 50.36 Favored Pre-proline 0 C--N 1.309 -1.153 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -80.35 128.67 7.22 Favored 'Trans proline' 0 C--O 1.252 1.209 0 C-N-CA 121.27 1.314 . . . . 0.0 109.956 171.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm . . . . . 0 CA--C 1.471 -2.06 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.686 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . 0.409 ' C ' HD23 ' A' ' 245' ' ' LEU . 5.7 tp-100 . . . . . 0 N--CA 1.436 -1.133 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.573 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 72.8 m -52.92 131.98 36.61 Favored 'General case' 0 C--O 1.208 -1.13 0 C-N-CA 124.178 0.991 . . . . 0.0 113.187 -172.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -162.54 175.59 11.29 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-O 121.023 0.44 . . . . 0.0 111.519 -174.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.439 HG21 HD21 ' A' ' 300' ' ' LEU . 1.8 pp -121.51 165.44 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.075 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . 0.501 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 6.6 t70 -150.37 152.16 33.96 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -134.06 127.59 32.52 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.098 176.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.503 ' HD3' ' HB ' ' A' ' 239' ' ' ILE . 0.3 OUTLIER -150.91 157.39 42.85 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.633 179.063 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -104.67 162.44 13.29 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . 0.453 ' O ' ' HB3' ' A' ' 237' ' ' ALA . 15.3 t70 -157.71 143.96 17.63 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 68.77 -118.89 9.36 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.486 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -135.35 111.89 9.93 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.97 0.385 . . . . 0.0 110.695 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 66.67 15.75 10.21 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.876 0.87 . . . . 0.0 112.403 174.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 233' ' ' ASP . . . -92.41 132.04 37.09 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -103.35 113.91 4.67 Favored Glycine 0 CA--C 1.491 -1.427 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.503 ' HB ' ' HD3' ' A' ' 231' ' ' ARG . 2.4 mp -106.77 117.12 51.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-O 121.512 0.672 . . . . 0.0 110.263 -177.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.4 mp -101.08 109.04 24.59 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.501 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 43.1 mt-10 -89.73 132.81 35.0 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 176.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 8.9 tp -117.59 122.27 43.16 Favored 'General case' 0 C--N 1.269 -2.934 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.131 -174.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . 0.573 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -107.34 101.21 10.6 Favored 'General case' 0 N--CA 1.414 -2.259 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.452 ' HA ' HG23 ' A' ' 226' ' ' THR . . . -106.8 91.87 3.85 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.615 0.722 . . . . 0.0 109.076 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.409 HD23 ' C ' ' A' ' 225' ' ' GLN . 3.0 mm? -81.71 114.18 20.2 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.278 -175.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 103.42 22.75 8.86 Favored Glycine 0 C--N 1.297 -1.615 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.121 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' PHE . . . . . 0.403 ' HE1' ' O ' ' A' ' 265' ' ' LYS . 20.0 t80 -115.74 127.41 55.09 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -102.28 -21.05 14.41 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -174.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -104.18 -141.38 11.06 Favored Glycine 0 C--N 1.314 -0.685 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.841 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -127.59 142.5 44.32 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.7 ' HB3' HD13 ' A' ' 264' ' ' LEU . 18.0 Cg_endo -68.35 172.31 11.43 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.717 2.278 . . . . 0.0 112.853 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.525 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 20.3 t70 -96.02 119.86 35.28 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 175.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 4.6 mp -108.41 108.95 26.54 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-O 121.995 0.902 . . . . 0.0 111.232 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . 0.651 ' HB2' ' HB ' ' A' ' 261' ' ' ILE . 47.4 m -96.47 104.83 16.83 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 114.163 -1.381 . . . . 0.0 109.198 177.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -88.1 118.25 27.54 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.865 -176.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 47.0 mt-30 -124.66 157.05 36.49 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 167.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 60.6 m80 -74.34 -29.79 61.74 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.926 -0.709 . . . . 0.0 111.202 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -69.65 -42.11 74.68 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.955 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . 0.403 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 49.9 p-80 -167.23 163.82 15.45 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.73 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 18.3 mt -105.48 142.02 19.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . 0.651 ' HB ' ' HB2' ' A' ' 254' ' ' SER . 3.8 mp -119.99 110.23 28.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.6 ' O ' ' HA ' ' A' ' 299' ' ' GLN . 0.8 OUTLIER -108.64 142.28 21.66 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 298' ' ' THR . 31.9 m -134.86 126.62 29.13 Favored 'General case' 0 C--N 1.275 -2.643 0 O-C-N 121.726 -0.609 . . . . 0.0 111.13 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.7 HD13 ' HB3' ' A' ' 251' ' ' PRO . 2.1 mm? -98.17 101.84 13.42 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 177.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.454 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 25.8 mmtm -67.65 130.94 44.58 Favored 'General case' 0 C--N 1.286 -2.178 0 O-C-N 124.033 0.833 . . . . 0.0 111.283 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 6.6 t30 73.84 21.59 2.67 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 124.678 1.236 . . . . 0.0 109.999 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -121.13 100.59 7.14 Favored 'General case' 0 CA--C 1.484 -1.581 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 3.7 m -90.2 121.03 31.86 Favored 'General case' 0 C--N 1.271 -2.828 0 C-N-CA 120.076 -0.649 . . . . 0.0 110.837 -175.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . 0.541 HD22 HD22 ' A' ' 291' ' ' LEU . 24.8 tp -92.76 127.3 48.47 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.242 -177.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.76 149.07 91.63 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.285 1.99 . . . . 0.0 110.989 170.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . 0.609 ' O ' ' HG2' ' A' ' 274' ' ' GLN . 22.2 p -66.32 -25.35 66.79 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.336 -177.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 10.2 m -72.51 -18.52 61.65 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.508 0.67 . . . . 0.0 111.056 -177.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.511 HD13 ' O ' ' A' ' 226' ' ' THR . 82.1 mt -99.29 -19.12 17.23 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.497 -177.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.609 ' HG2' ' O ' ' A' ' 271' ' ' THR . 21.9 pt20 -76.82 137.69 39.38 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -173.42 169.48 4.39 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -174.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 3.1 p -123.99 132.86 53.76 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-O 121.478 0.656 . . . . 0.0 112.101 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 60.3 mt -100.58 113.06 25.56 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 104.34 -2.467 . . . . 0.0 104.34 175.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -63.41 -53.05 58.38 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -174.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 34.5 m 44.71 37.05 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 176.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -69.4 133.42 47.77 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 20.2 t70 61.9 36.15 16.0 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 125.005 1.322 . . . . 0.0 110.692 177.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.26 0.38 28.91 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.703 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt 69.01 59.03 0.35 Allowed 'General case' 0 CA--C 1.497 -1.095 0 C-N-CA 125.388 1.475 . . . . 0.0 111.478 177.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.35 152.66 11.02 Favored Pre-proline 0 C--N 1.295 -1.767 0 CA-C-N 113.851 -1.522 . . . . 0.0 108.675 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . 0.433 ' O ' ' HA ' ' A' ' 304' ' ' THR . 54.0 Cg_exo -50.14 -24.77 11.75 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.713 2.942 . . . . 0.0 113.55 175.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 46.9 t -74.06 118.33 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -94.64 -29.11 15.01 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.891 -178.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -170.21 135.23 1.29 Allowed 'General case' 0 N--CA 1.478 0.93 0 O-C-N 123.665 0.603 . . . . 0.0 110.863 -177.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 40.2 t -104.3 135.96 39.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.447 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 90.2 m -143.19 123.64 13.93 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 121.461 0.648 . . . . 0.0 111.09 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.541 HD22 HD22 ' A' ' 269' ' ' LEU . 0.1 OUTLIER -98.06 120.37 38.35 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 176.436 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.493 ' HD3' ' OE1' ' A' ' 274' ' ' GLN . 4.0 tppp? -128.76 135.88 49.8 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -79.99 145.01 32.78 Favored 'General case' 0 N--CA 1.426 -1.627 0 C-N-CA 118.858 -1.137 . . . . 0.0 109.273 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.548 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 18.0 tp -108.44 -174.08 2.43 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 177.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.548 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 20.6 t-20 -56.65 -67.47 0.3 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.559 0.618 . . . . 0.0 111.688 -177.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -110.03 -4.28 15.97 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.825 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . 0.454 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 36.2 m-20 -119.81 176.4 5.42 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.599 0.714 . . . . 0.0 111.511 -169.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 263' ' ' THR . 90.1 m -113.73 133.4 55.37 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 176.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . 0.6 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 26.3 tt0 -124.08 132.07 53.62 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.13 -175.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.523 ' O ' ' HA ' ' A' ' 261' ' ' ILE . 25.4 mt -101.69 131.92 47.67 Favored 'General case' 0 CA--C 1.451 -2.86 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.967 173.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' ILE . . . . . 0.447 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 63.6 mt -116.26 108.63 25.6 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.697 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 175.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 65.2 mt -115.98 104.16 16.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 3.5 m -72.51 130.03 39.7 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 123.126 0.57 . . . . 0.0 109.641 -175.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 285' ' ' PRO . 8.7 p -136.02 176.71 8.44 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 122.319 0.248 . . . . 0.0 110.905 -178.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -147.73 148.94 31.52 Favored 'General case' 0 C--O 1.245 0.857 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 61.38 -148.61 46.61 Favored Glycine 0 N--CA 1.463 0.444 0 O-C-N 123.933 0.771 . . . . 0.0 113.089 177.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -97.72 144.4 27.39 Favored 'General case' 0 CA--C 1.47 -2.121 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' TRP . . . . . 0.718 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 65.9 p-90 -157.94 170.77 21.58 Favored 'General case' 0 C--N 1.27 -2.851 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -178.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . 0.467 ' HG2' ' HE2' ' A' ' 327' ' ' LYS . 4.6 mt-10 -122.26 129.83 52.6 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -176.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.718 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 23.3 tp -105.65 117.81 34.96 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 120.996 0.427 . . . . 0.0 111.207 -176.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.5 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 48.8 t -114.63 107.36 22.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 174.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -94.18 126.61 39.52 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . 0.435 ' HB2' ' HB ' ' A' ' 321' ' ' THR . 95.3 mttt -119.83 149.45 42.04 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.964 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 23.9 t -115.97 114.59 24.83 Favored 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 172.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -80.18 -32.35 38.73 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.572 0.701 . . . . 0.0 109.561 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -168.76 162.18 8.25 Favored Pre-proline 0 C--N 1.305 -1.355 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.5 102.19 0.33 Allowed 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 121.532 1.488 . . . . 0.0 110.497 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 129.73 -32.43 3.18 Favored Glycine 0 N--CA 1.427 -1.954 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -177.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -102.77 116.59 32.88 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -119.16 161.79 19.74 Favored 'General case' 0 C--N 1.277 -2.546 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.292 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.435 ' HB ' ' HB2' ' A' ' 313' ' ' LYS . 89.4 m -151.62 124.93 8.79 Favored 'General case' 0 C--N 1.263 -3.16 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.74 -174.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' A' ' 239' ' ' ILE . 69.9 m-85 -112.4 109.98 19.92 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . 0.5 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 8.8 tt0 -96.73 105.72 17.89 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.617 HG13 ' CE3' ' A' ' 308' ' ' TRP . 94.0 t -95.01 100.41 11.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 C-N-CA 123.42 0.688 . . . . 0.0 110.228 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -92.42 153.33 42.74 Favored Pre-proline 0 C--N 1.313 -0.984 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -73.09 140.71 31.61 Favored 'Trans proline' 0 C--O 1.249 1.046 0 C-N-CA 121.765 1.643 . . . . 0.0 110.4 172.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.467 ' HE2' ' HG2' ' A' ' 309' ' ' GLU . 14.8 ttmm . . . . . 0 CA--C 1.486 -1.511 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -176.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 8.1 pm0 . . . . . 0 N--CA 1.411 -2.376 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 28.7 m -59.93 128.62 37.78 Favored 'General case' 0 C--O 1.209 -1.028 0 O-C-N 124.121 0.888 . . . . 0.0 109.01 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -148.03 155.95 42.08 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.082 -170.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.657 HG12 ' HB2' ' A' ' 291' ' ' LEU . 2.7 pp -137.48 149.68 25.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 C-N-CA 124.134 0.974 . . . . 0.0 108.872 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -149.76 156.6 42.12 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 122.789 0.436 . . . . 0.0 111.038 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -127.0 139.18 53.21 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 120.97 0.414 . . . . 0.0 111.01 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 20.5 ptt85 -157.04 161.68 39.52 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 173.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.403 ' HE3' HG22 ' A' ' 284' ' ' THR . 53.2 mtpt -105.64 144.91 31.73 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 177.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . 0.521 ' O ' ' HB3' ' A' ' 237' ' ' ALA . 21.7 t70 -159.76 117.38 2.66 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -176.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 104.12 -157.14 17.25 Favored Glycine 0 C--N 1.296 -1.694 0 C-N-CA 120.203 -0.998 . . . . 0.0 111.179 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -91.53 97.49 11.09 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 116.7 0.25 . . . . 0.0 110.391 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . 0.538 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 3.4 m-20 60.92 23.26 13.36 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 124.197 0.936 . . . . 0.0 111.396 177.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 233' ' ' ASP . . . -87.11 136.91 32.75 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.491 -174.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -101.94 116.51 5.55 Favored Glycine 0 N--CA 1.427 -1.915 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.43 HG13 ' HG3' ' A' ' 323' ' ' GLN . 2.1 mp -106.52 114.87 46.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-O 121.34 0.591 . . . . 0.0 111.127 -175.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.3 mp -103.49 112.77 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 176.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -94.4 138.77 31.95 Favored 'General case' 0 C--N 1.277 -2.549 0 CA-C-O 121.363 0.601 . . . . 0.0 109.487 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 12.0 tp -127.49 131.04 50.2 Favored 'General case' 0 C--N 1.269 -2.924 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.392 -175.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -122.37 102.18 7.95 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.013 178.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -108.84 91.07 3.49 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -73.15 109.72 6.89 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -173.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 111.99 -4.64 27.23 Favored Glycine 0 C--N 1.304 -1.204 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.132 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -94.62 107.73 19.71 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -108.58 97.11 6.82 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 160.74 -147.78 15.02 Favored Glycine 0 C--N 1.297 -1.604 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -126.74 135.65 27.61 Favored Pre-proline 0 C--N 1.311 -1.095 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.822 ' HB3' HD13 ' A' ' 264' ' ' LEU . 13.7 Cg_endo -70.38 171.98 14.11 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.361 2.041 . . . . 0.0 109.901 176.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -91.13 110.26 21.53 Favored 'General case' 0 C--N 1.27 -2.878 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 175.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 3.8 mp -97.73 108.46 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.76 0 CA-C-O 121.605 0.717 . . . . 0.0 109.57 178.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . 0.669 ' HB2' ' HB ' ' A' ' 261' ' ' ILE . 31.8 m -102.99 110.76 22.79 Favored 'General case' 0 C--N 1.282 -2.369 0 CA-C-N 114.473 -1.24 . . . . 0.0 108.274 175.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . 0.503 HE21 HD23 ' A' ' 310' ' ' LEU . 70.4 mt-30 -100.18 117.36 34.26 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.48 -172.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -125.1 162.57 24.29 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 172.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . 0.402 ' HA ' ' HE1' ' A' ' 308' ' ' TRP . 13.1 m170 -76.53 -31.16 57.48 Favored 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 119.015 -1.074 . . . . 0.0 112.068 178.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -73.91 -30.94 62.86 Favored 'General case' 0 C--N 1.319 -0.744 0 O-C-N 123.661 0.6 . . . . 0.0 111.476 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . 0.447 ' CD2' HG23 ' A' ' 301' ' ' ILE . 39.4 p-80 -172.78 165.13 5.29 Favored 'General case' 0 CA--C 1.503 -0.864 0 O-C-N 122.252 -0.28 . . . . 0.0 110.623 175.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 18.4 mt -106.29 140.86 23.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . 0.669 ' HB ' ' HB2' ' A' ' 254' ' ' SER . 3.5 mp -116.64 108.69 25.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.442 ' HB ' ' HB2' ' A' ' 300' ' ' LEU . 49.1 t -105.66 131.54 54.82 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.492 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 177.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 298' ' ' THR . 26.6 m -134.46 126.17 28.92 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 121.289 0.566 . . . . 0.0 111.066 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.822 HD13 ' HB3' ' A' ' 251' ' ' PRO . 2.0 mm? -98.38 108.58 21.31 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.498 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 30.5 mmmt -67.75 131.58 45.83 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-O 121.526 0.679 . . . . 0.0 112.384 -178.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 74.91 1.96 3.9 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 113.379 -1.737 . . . . 0.0 111.294 176.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -94.68 110.65 22.47 Favored 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -178.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 1.2 p -82.73 135.67 34.93 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-O 121.074 0.464 . . . . 0.0 111.405 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . 0.484 HD11 ' HB2' ' A' ' 273' ' ' LEU . 26.8 tp -112.88 124.11 32.36 Favored Pre-proline 0 N--CA 1.425 -1.698 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.125 176.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.42 ' O ' ' HG ' ' A' ' 269' ' ' LEU . 23.3 Cg_exo -70.77 160.08 50.58 Favored 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 122.619 2.213 . . . . 0.0 111.659 170.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 3.6 p -66.95 -26.19 66.71 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 123.803 0.841 . . . . 0.0 111.456 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 6.7 m -64.23 -23.6 67.37 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.01 1.324 . . . . 0.0 112.438 -177.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.484 ' HB2' HD11 ' A' ' 269' ' ' LEU . 3.2 mm? -99.47 -8.92 24.02 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-O 121.344 0.592 . . . . 0.0 111.707 -174.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -72.96 138.67 46.24 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.288 -0.869 . . . . 0.0 108.803 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -169.09 170.9 8.5 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 177.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 62.0 m -130.8 152.54 50.03 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-O 121.394 0.616 . . . . 0.0 110.302 176.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.468 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 1.8 mm? -111.98 108.91 18.41 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 105.998 -1.852 . . . . 0.0 105.998 177.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -80.72 85.52 6.07 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 122.444 1.116 . . . . 0.0 109.213 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.641 ' HA ' ' CE1' ' A' ' 282' ' ' PHE . 87.8 t -89.63 36.69 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-N 113.364 -1.744 . . . . 0.0 111.619 -173.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -80.84 142.5 33.6 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.432 174.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 18.6 t70 72.51 20.49 3.89 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 122.673 1.225 . . . . 0.0 110.259 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.641 ' CE1' ' HA ' ' A' ' 279' ' ' VAL . 21.1 m-85 -90.3 -18.4 25.66 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.588 -0.695 . . . . 0.0 110.589 176.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 65.39 35.02 7.71 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.691 0.796 . . . . 0.0 111.841 176.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' THR . . . . . 0.403 HG22 ' HE3' ' A' ' 232' ' ' LYS . 2.3 p -115.58 174.91 2.13 Favored Pre-proline 0 C--N 1.3 -1.558 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . 0.538 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 9.2 Cg_exo -75.57 -15.2 19.66 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.764 1.643 . . . . 0.0 111.693 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.8 p -93.21 128.74 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-O 121.639 0.733 . . . . 0.0 109.87 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -94.51 -39.61 10.31 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.155 -174.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -160.14 134.52 7.49 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.541 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.468 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 40.6 t -99.39 123.77 52.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 87.5 m -130.11 122.91 29.17 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 120.852 0.358 . . . . 0.0 110.885 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.657 ' HB2' HG12 ' A' ' 228' ' ' ILE . 46.5 tp -99.74 125.06 45.57 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -124.4 139.12 54.2 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -175.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -83.66 148.54 27.05 Favored 'General case' 0 C--N 1.289 -2.061 0 C-N-CA 118.832 -1.147 . . . . 0.0 108.218 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.484 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 17.8 tp -115.73 -174.49 2.54 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 173.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.484 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 4.6 t30 -76.0 -55.23 5.8 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 120.07 1.305 . . . . 0.0 111.891 -173.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -107.36 -8.91 16.17 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.686 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . 0.498 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 29.3 m-20 -132.1 173.12 11.56 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.975 -171.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.609 ' O ' ' HA ' ' A' ' 263' ' ' THR . 79.1 m -110.7 132.96 53.74 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 32.7 tt0 -117.14 126.62 53.09 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.799 0.809 . . . . 0.0 110.112 -177.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.442 ' HB2' ' HB ' ' A' ' 262' ' ' VAL . 0.5 OUTLIER -110.89 122.82 48.83 Favored 'General case' 0 C--N 1.274 -2.689 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.211 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' ILE . . . . . 0.447 HG23 ' CD2' ' A' ' 259' ' ' HIS . 72.9 mt -109.12 109.22 27.56 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.368 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -177.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 59.9 mt -110.48 98.9 7.65 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 10.9 m -69.53 126.03 28.49 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 17.3 p -136.26 165.79 24.93 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 122.85 0.46 . . . . 0.0 110.98 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -149.63 138.68 21.19 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-O 120.631 0.253 . . . . 0.0 111.468 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 90.29 -168.28 33.53 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.242 176.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -84.12 127.81 34.15 Favored 'General case' 0 CA--C 1.482 -1.654 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' TRP . . . . . 0.708 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 68.4 p-90 -144.53 169.5 17.84 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -178.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -125.53 123.81 39.95 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -174.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.708 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 17.7 tp -100.19 122.36 42.89 Favored 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.137 -178.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.617 HG13 ' HB3' ' A' ' 323' ' ' GLN . 8.6 p -126.1 114.98 41.11 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-O 121.723 0.773 . . . . 0.0 109.558 171.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 321' ' ' THR . 11.4 t30 -102.51 129.9 49.18 Favored 'General case' 0 CA--C 1.437 -3.366 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.496 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -114.35 123.61 49.92 Favored 'General case' 1 N--CA 1.372 -4.334 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.874 -176.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 16.3 m -92.06 103.03 15.57 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 176.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -78.38 -34.15 48.4 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.88 -1.055 . . . . 0.0 112.539 -172.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.482 ' HB1' ' HD2' ' A' ' 317' ' ' PRO . . . -165.75 167.38 9.06 Favored Pre-proline 0 C--N 1.307 -1.273 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 -175.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' PRO . . . . . 0.482 ' HD2' ' HB1' ' A' ' 316' ' ' ALA . 25.2 Cg_endo -60.31 102.96 0.2 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.031 1.821 . . . . 0.0 112.088 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 105.83 -15.25 44.89 Favored Glycine 0 N--CA 1.436 -1.331 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.181 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -100.89 116.79 33.6 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 122.196 -0.59 . . . . 0.0 110.698 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' PHE . . . . . 0.497 ' CZ ' ' HD3' ' A' ' 251' ' ' PRO . 75.2 m-85 -122.49 163.65 19.5 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.975 -177.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 312' ' ' ASN . 88.4 m -152.8 110.66 3.62 Favored 'General case' 0 C--N 1.265 -3.076 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.194 -175.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -98.01 104.35 16.37 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . 0.617 ' HB3' HG13 ' A' ' 311' ' ' VAL . 42.6 tt0 -94.96 108.2 20.25 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.593 HG13 ' CE3' ' A' ' 308' ' ' TRP . 93.3 t -94.86 99.87 10.14 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.302 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.3 152.51 47.81 Favored Pre-proline 0 C--O 1.213 -0.836 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . 0.447 ' HG3' ' HB2' ' A' ' 236' ' ' ASN . 57.5 Cg_endo -77.33 137.39 16.78 Favored 'Trans proline' 0 C--O 1.249 1.069 0 C-N-CA 121.565 1.51 . . . . 0.0 110.18 172.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm . . . . . 0 CA--C 1.468 -2.205 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.742 -179.462 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 . . . . . 0 CA--C 1.555 1.167 0 N-CA-C 110.62 -0.141 . . . . 0.0 110.62 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 24.4 m -57.16 114.34 2.11 Favored 'General case' 0 C--O 1.198 -1.633 0 C-N-CA 123.679 0.792 . . . . 0.0 111.866 -171.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.412 ' HB3' ' HB3' ' A' ' 243' ' ' ALA . 48.2 t30 -130.96 160.21 35.19 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.812 -169.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.2 pp -128.97 151.74 36.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 124.286 1.034 . . . . 0.0 109.762 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . 0.571 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 5.0 t70 -143.47 156.5 44.65 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -176.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 239' ' ' ILE . 77.3 t80 -137.91 139.32 39.75 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 110.27 -0.271 . . . . 0.0 110.27 178.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -165.1 175.01 9.75 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 123.952 0.901 . . . . 0.0 108.743 178.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.405 ' HE3' HG22 ' A' ' 284' ' ' THR . 54.5 mtpt -121.82 159.36 26.91 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 117.803 0.274 . . . . 0.0 110.552 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -164.38 148.23 9.46 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 82.43 -103.35 2.4 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 121.475 -0.393 . . . . 0.0 113.588 173.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -135.87 72.22 1.44 Allowed 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.14 0.495 . . . . 0.0 111.524 -176.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . 0.465 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 86.0 m-20 67.16 27.52 8.48 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.131 179.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -82.88 143.15 30.95 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.824 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -98.13 117.74 5.92 Favored Glycine 0 N--CA 1.437 -1.264 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 230' ' ' PHE . 2.3 mp -105.59 118.64 53.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-N 117.318 0.559 . . . . 0.0 110.288 -177.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.89 111.61 36.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 175.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.571 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 49.6 mt-10 -92.76 138.8 31.18 Favored 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 177.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 13.9 tp -121.91 117.48 26.56 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.358 -176.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . 0.579 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -106.19 94.4 5.14 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -102.7 91.34 4.14 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.813 0.816 . . . . 0.0 109.98 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -76.62 116.38 17.24 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.165 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 114.1 -7.55 23.29 Favored Glycine 0 N--CA 1.429 -1.831 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.762 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -102.48 145.79 29.06 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -136.09 -12.86 1.9 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.511 0.559 . . . . 0.0 112.511 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -92.5 -140.61 9.76 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.991 -178.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -122.72 134.25 24.88 Favored Pre-proline 0 C--N 1.311 -1.092 0 CA-C-O 120.517 0.199 . . . . 0.0 110.617 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.655 ' HB3' HD23 ' A' ' 264' ' ' LEU . 32.1 Cg_endo -77.79 172.43 15.7 Favored 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 122.66 2.24 . . . . 0.0 112.36 177.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.411 ' HB3' ' HB ' ' A' ' 263' ' ' THR . 34.3 t70 -95.87 111.26 23.29 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.462 177.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 3.8 mp -105.48 124.72 60.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 8.8 t -115.94 117.44 30.15 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 174.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -99.76 107.16 19.16 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 121.187 0.518 . . . . 0.0 111.923 -176.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.453 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 27.2 mt-30 -115.87 161.12 19.26 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 175.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . 0.443 ' HA ' ' HE1' ' A' ' 308' ' ' TRP . 30.6 m170 -73.91 -31.37 63.05 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.084 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -80.91 -26.54 36.72 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.707 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . 0.453 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 35.5 p-80 -174.03 161.48 3.66 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 120.878 0.37 . . . . 0.0 111.821 175.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.45 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 14.9 mt -106.67 142.75 18.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 177.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 3.1 mp -122.46 116.34 48.7 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' A' ' 300' ' ' LEU . 24.3 t -113.86 119.74 61.87 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 175.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . 0.411 ' HB ' ' HB3' ' A' ' 252' ' ' ASP . 10.4 m -116.86 123.79 47.92 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 121.181 0.515 . . . . 0.0 110.168 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.655 HD23 ' HB3' ' A' ' 251' ' ' PRO . 21.2 mt -99.02 99.77 10.84 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.585 ' HD3' ' OD1' ' A' ' 297' ' ' ASP . 48.7 mmtt -61.28 129.34 40.77 Favored 'General case' 0 C--N 1.317 -0.815 0 O-C-N 124.147 0.904 . . . . 0.0 113.398 -177.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 63.4 t30 67.59 22.54 9.11 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.839 175.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 48.4 t60 -110.25 112.08 23.81 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 18.4 p -86.27 124.46 32.67 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-O 121.251 0.548 . . . . 0.0 111.451 -178.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 32.6 tp -99.01 127.63 34.49 Favored Pre-proline 0 N--CA 1.418 -2.064 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.699 177.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.87 147.31 55.43 Favored 'Trans proline' 0 N--CA 1.432 -2.092 0 C-N-CA 121.382 1.388 . . . . 0.0 110.692 170.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . 0.422 ' O ' ' HG2' ' A' ' 274' ' ' GLN . 25.0 p -66.64 -15.06 63.2 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.424 0.63 . . . . 0.0 112.075 -177.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 12.2 m -74.58 -21.18 59.62 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.743 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 226' ' ' THR . 3.1 mm? -102.11 -13.97 17.27 Favored 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.077 -178.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 271' ' ' THR . 9.4 pt20 -77.11 129.78 36.48 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 119.563 -0.855 . . . . 0.0 108.996 -178.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -170.44 159.96 7.24 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -177.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 16.9 p -104.22 140.21 38.15 Favored 'General case' 0 N--CA 1.407 -2.613 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.735 173.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 82.4 mt -99.59 117.29 33.65 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 175.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -47.35 -68.97 0.14 Allowed 'General case' 0 C--N 1.316 -0.85 0 O-C-N 125.085 1.491 . . . . 0.0 110.594 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . 0.271 19.0 m 49.78 18.32 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 127.111 2.164 . . . . 0.0 116.697 173.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -73.75 132.79 43.01 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 22.2 t70 68.77 48.64 0.75 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 122.674 1.226 . . . . 0.0 112.327 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -98.08 -1.62 42.0 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 168.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? 61.86 59.94 1.65 Allowed 'General case' 0 CA--C 1.503 -0.86 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.825 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 236' ' ' ASN . 2.5 p -137.42 176.65 2.6 Favored Pre-proline 0 C--N 1.31 -1.14 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 3.3 Cg_exo -82.66 -7.1 11.6 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.077 1.852 . . . . 0.0 112.083 174.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.4 p -99.01 127.72 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 CA-C-O 121.623 0.725 . . . . 0.0 110.668 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -88.14 -44.65 10.76 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.441 -172.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -165.06 138.16 4.61 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.319 -176.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 30.7 t -104.39 140.58 22.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -178.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 276' ' ' SER . 75.4 m -142.42 116.35 9.34 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 122.031 -0.418 . . . . 0.0 111.177 177.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 56.2 tp -91.59 128.89 37.6 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 174.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -134.92 133.82 39.99 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 120.783 0.325 . . . . 0.0 110.971 -174.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 293' ' ' ARG . 23.3 ttt180 -71.05 125.11 26.0 Favored 'General case' 0 N--CA 1.4 -2.962 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 171.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.488 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 14.9 tp -102.88 -174.33 2.53 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 176.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.488 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 39.4 t30 -46.64 -74.54 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -120.61 -3.87 9.81 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 122.319 1.057 . . . . 0.0 108.745 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . 0.585 ' OD1' ' HD3' ' A' ' 265' ' ' LYS . 39.7 m-20 -111.67 164.12 13.37 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.236 -175.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.462 ' HB ' ' HB2' ' A' ' 264' ' ' LEU . 91.7 m -104.77 128.61 52.96 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 174.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -113.36 129.68 56.47 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -178.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.502 ' HB3' ' HB ' ' A' ' 262' ' ' VAL . 50.5 tp -114.16 119.02 35.65 Favored 'General case' 0 C--N 1.273 -2.758 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 176.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 51.6 mt -104.44 112.01 36.32 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.128 -177.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . 0.45 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 56.4 mt -112.6 103.83 16.06 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 3.7 m -77.8 130.38 36.62 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -174.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 15.5 p -135.56 -176.95 4.45 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 122.366 0.266 . . . . 0.0 111.286 -176.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -159.35 152.94 22.74 Favored 'General case' 0 C--O 1.247 0.946 0 C-N-CA 122.965 0.506 . . . . 0.0 110.169 175.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 74.85 -157.07 50.07 Favored Glycine 0 N--CA 1.444 -0.784 0 O-C-N 123.569 0.543 . . . . 0.0 112.955 175.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' ASN . . . . . 0.497 ' HB3' ' HB3' ' A' ' 327' ' ' LYS . 40.8 m-80 -92.39 131.28 37.69 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 177.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' TRP . . . . . 0.707 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 60.8 p-90 -148.77 166.3 28.84 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -178.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -124.76 135.99 53.46 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.707 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 27.0 tp -107.45 118.56 37.03 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.65 HG13 ' HB3' ' A' ' 323' ' ' GLN . 5.7 p -115.26 112.31 39.36 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.515 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 171.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -102.93 129.71 49.74 Favored 'General case' 0 N--CA 1.407 -2.586 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.075 -178.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -129.17 156.98 43.05 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.635 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 26.4 t -111.44 120.95 43.86 Favored 'General case' 0 N--CA 1.411 -2.417 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -88.91 -23.65 22.67 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.024 0.44 . . . . 0.0 110.726 -177.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -169.91 164.14 6.36 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.69 103.11 0.26 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 121.745 1.63 . . . . 0.0 111.238 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 115.01 -28.1 8.22 Favored Glycine 0 N--CA 1.436 -1.347 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -177.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -89.13 116.65 27.55 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.164 0.507 . . . . 0.0 110.339 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -116.28 165.74 12.84 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 115.377 -0.829 . . . . 0.0 108.865 177.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 89.6 m -152.05 130.18 11.91 Favored 'General case' 0 C--N 1.261 -3.278 0 C-N-CA 123.661 0.784 . . . . 0.0 108.894 -176.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -118.57 107.53 13.86 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . 0.65 ' HB3' HG13 ' A' ' 311' ' ' VAL . 35.9 tt0 -99.66 112.5 24.72 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 176.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.63 HG13 ' CE3' ' A' ' 308' ' ' TRP . 75.3 t -95.1 98.64 8.2 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.174 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -83.49 149.14 57.07 Favored Pre-proline 0 CA--C 1.512 -0.49 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -77.52 125.6 7.72 Favored 'Trans proline' 0 N--CA 1.44 -1.672 0 N-CA-C 108.498 -1.385 . . . . 0.0 108.498 170.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.497 ' HB3' ' HB3' ' A' ' 307' ' ' ASN . 40.1 ttmt . . . . . 0 C--N 1.294 -1.808 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . 0.427 ' O ' HD23 ' A' ' 245' ' ' LEU . 11.5 pm0 . . . . . 0 N--CA 1.43 -1.429 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 56.9 m -67.44 116.39 8.13 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.407 ' ND2' ' HB3' ' A' ' 243' ' ' ALA . 10.0 p30 -144.51 173.02 12.17 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.308 -172.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.58 HD13 HD21 ' A' ' 277' ' ' LEU . 1.4 pp -136.06 158.65 38.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 CA-C-N 114.145 -1.389 . . . . 0.0 109.361 -178.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . 0.463 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 12.8 t70 -150.23 151.32 32.85 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.51 ' CD2' HG11 ' A' ' 279' ' ' VAL . 86.4 t80 -129.84 133.75 47.12 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 173.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -153.39 152.81 31.48 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -104.15 153.19 21.23 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.442 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -151.61 162.61 40.7 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 64.7 -125.87 31.49 Favored Glycine 0 C--N 1.312 -0.751 0 O-C-N 123.454 0.471 . . . . 0.0 112.849 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -124.03 91.81 3.54 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . 0.581 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 95.9 m-20 66.66 21.25 10.66 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 177.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -79.79 138.26 37.21 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -99.18 110.4 3.98 Favored Glycine 0 N--CA 1.436 -1.325 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.1 mp -102.7 115.09 44.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 117.483 0.641 . . . . 0.0 109.917 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.5 mp -102.57 113.68 39.86 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 35.1 mt-10 -93.11 145.08 24.66 Favored 'General case' 0 C--N 1.283 -2.284 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.965 173.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 12.0 tp -135.6 134.09 38.95 Favored 'General case' 0 C--N 1.264 -3.14 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.67 -174.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -126.93 106.6 9.42 Favored 'General case' 0 C--N 1.278 -2.514 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.464 ' O ' ' HA2' ' A' ' 318' ' ' GLY . . . -108.75 91.01 3.47 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.427 HD23 ' O ' ' A' ' 225' ' ' GLN . 3.3 mm? -84.4 114.0 21.58 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.678 0.752 . . . . 0.0 111.141 -175.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 116.51 3.91 18.18 Favored Glycine 0 N--CA 1.429 -1.767 0 CA-C-N 114.239 -1.346 . . . . 0.0 110.175 -177.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' PHE . . . . . 0.455 ' HB2' ' ND1' ' A' ' 267' ' ' HIS . 65.8 t80 -113.12 115.63 28.59 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 121.016 0.436 . . . . 0.0 110.25 -177.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -112.98 100.03 8.32 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 154.43 -158.37 28.17 Favored Glycine 0 N--CA 1.432 -1.597 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -114.43 140.89 25.72 Favored Pre-proline 0 C--N 1.301 -1.511 0 CA-C-N 116.853 0.327 . . . . 0.0 110.359 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.798 ' HB3' HD13 ' A' ' 264' ' ' LEU . 17.9 Cg_endo -72.57 171.85 16.32 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.56 2.173 . . . . 0.0 111.112 175.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 18.0 t70 -88.45 109.93 20.43 Favored 'General case' 0 C--N 1.277 -2.58 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 4.1 mp -97.99 108.18 21.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 121.84 0.828 . . . . 0.0 110.102 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . 0.656 ' HB2' ' HB ' ' A' ' 261' ' ' ILE . 47.3 m -109.99 107.18 16.97 Favored 'General case' 0 C--N 1.278 -2.526 0 CA-C-N 114.482 -1.236 . . . . 0.0 108.43 177.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -99.18 126.73 45.02 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 122.126 -0.359 . . . . 0.0 110.865 -175.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -124.21 171.68 9.65 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 171.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -76.59 -40.12 50.51 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 120.871 0.367 . . . . 0.0 110.994 -177.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -82.79 -20.37 35.92 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.826 -175.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -171.99 160.83 5.5 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.905 0.384 . . . . 0.0 111.448 176.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.459 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 16.7 mt -106.71 143.78 16.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . 0.656 ' HB ' ' HB2' ' A' ' 254' ' ' SER . 3.9 mp -119.79 109.76 27.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 176.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.482 ' HB ' ' HB3' ' A' ' 300' ' ' LEU . 61.6 t -111.45 123.24 67.11 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.426 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 176.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 298' ' ' THR . 11.9 m -126.19 130.06 50.22 Favored 'General case' 0 C--N 1.285 -2.216 0 C-N-CA 120.096 -0.642 . . . . 0.0 111.029 -177.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.798 HD13 ' HB3' ' A' ' 251' ' ' PRO . 1.3 mm? -100.81 98.04 8.59 Favored 'General case' 0 N--CA 1.408 -2.574 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 177.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.493 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 58.6 mtpt -73.27 135.55 44.48 Favored 'General case' 0 C--N 1.267 -3.015 0 O-C-N 124.191 0.932 . . . . 0.0 110.81 -177.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 6.2 t30 72.85 20.65 3.55 Favored 'General case' 0 CA--C 1.55 0.961 0 O-C-N 124.539 1.15 . . . . 0.0 109.716 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' HIS . . . . . 0.455 ' ND1' ' HB2' ' A' ' 247' ' ' PHE . 54.5 t60 -114.85 100.1 7.97 Favored 'General case' 0 CA--C 1.495 -1.173 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 176.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.97 116.74 17.9 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-O 120.847 0.356 . . . . 0.0 110.436 -176.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 22.5 tp -99.29 123.08 49.86 Favored Pre-proline 0 N--CA 1.436 -1.175 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.769 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -67.73 158.0 59.2 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 122.429 2.086 . . . . 0.0 111.849 171.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . 0.593 ' HA ' HE21 ' A' ' 274' ' ' GLN . 24.6 p -68.34 -26.3 65.53 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 15.4 m -72.53 -19.74 61.46 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.353 -177.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -95.15 -22.31 17.94 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.492 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.593 HE21 ' HA ' ' A' ' 271' ' ' THR . 5.4 pt20 -77.47 140.03 39.75 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -177.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -177.96 175.46 1.29 Allowed 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -175.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 32.9 t -125.62 143.07 51.19 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-O 121.527 0.679 . . . . 0.0 110.453 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.58 HD21 HD13 ' A' ' 228' ' ' ILE . 1.3 mm? -91.84 103.14 15.72 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 102.917 -2.994 . . . . 0.0 102.917 174.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -59.2 -50.55 73.6 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 123.727 0.642 . . . . 0.0 112.089 -173.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.51 HG11 ' CD2' ' A' ' 230' ' ' PHE . 25.8 m 44.9 30.1 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 173.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -72.52 134.32 45.2 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.646 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 73.59 19.62 3.26 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.069 1.348 . . . . 0.0 113.548 -174.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -79.35 -21.94 45.14 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.345 170.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? 57.8 61.86 2.27 Favored 'General case' 0 CA--C 1.493 -1.212 0 CA-C-O 122.253 1.025 . . . . 0.0 113.641 174.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 4.8 p -125.3 -178.67 0.73 Allowed Pre-proline 0 C--N 1.275 -2.641 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . 0.581 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 14.4 Cg_exo -71.1 -16.91 31.93 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 CA-C-N 121.281 1.493 . . . . 0.0 110.637 174.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.5 p -95.75 126.61 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-O 122.25 1.024 . . . . 0.0 110.562 177.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -84.16 -47.31 10.99 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 113.938 -1.483 . . . . 0.0 110.278 -175.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -162.09 148.84 13.67 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 -177.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.502 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 62.0 t -116.39 122.71 70.37 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.669 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 53.7 m -123.86 120.33 32.25 Favored 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.951 -0.468 . . . . 0.0 111.951 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 48.2 tp -94.53 122.8 37.48 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 175.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -129.84 141.89 50.76 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -176.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -82.41 138.97 34.28 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 118.501 -1.279 . . . . 0.0 108.843 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.481 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 17.0 tp -108.25 -175.32 2.74 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 176.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.481 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 26.0 t-20 -49.03 -67.45 0.26 Allowed 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 118.918 0.781 . . . . 0.0 113.0 -177.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -119.44 -2.21 10.6 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 122.13 0.967 . . . . 0.0 108.462 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . 0.493 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 5.5 m-20 -117.07 168.51 10.2 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.094 -169.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 263' ' ' THR . 58.8 m -111.73 124.21 51.86 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 176.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -113.13 124.61 52.97 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-O 121.582 0.706 . . . . 0.0 109.476 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.482 ' HB3' ' HB ' ' A' ' 262' ' ' VAL . 58.6 tp -110.97 120.34 42.07 Favored 'General case' 0 C--N 1.274 -2.689 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 54.9 mt -106.42 109.77 29.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.245 -176.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . 0.459 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 57.5 mt -107.96 103.18 15.08 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.496 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 8.4 m -77.1 131.1 38.17 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 -175.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 18.9 p -134.73 175.88 9.15 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 122.395 0.278 . . . . 0.0 111.719 -175.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -164.2 139.62 6.02 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.906 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 99.11 -151.87 19.52 Favored Glycine 0 N--CA 1.434 -1.479 0 C-N-CA 121.25 -0.5 . . . . 0.0 112.354 177.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' ASN . . . . . 0.45 ' HB3' ' HB3' ' A' ' 327' ' ' LYS . 64.4 m-20 -105.85 124.5 49.67 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 177.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' TRP . . . . . . . . . . . . . 69.1 p-90 -150.24 158.11 43.81 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.766 -176.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -115.62 137.88 51.63 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 1.4 tt -104.55 114.03 27.99 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 46.0 t -108.09 106.71 21.18 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 172.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -95.96 141.0 29.9 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . 0.429 ' HB2' ' HB ' ' A' ' 321' ' ' THR . 86.8 mttt -131.14 141.07 50.06 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -178.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 20.3 m -115.81 109.32 17.49 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -77.38 -33.41 55.17 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.586 0.707 . . . . 0.0 109.783 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -170.19 161.56 6.5 Favored Pre-proline 0 C--N 1.305 -1.364 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -65.24 96.97 0.29 Allowed 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 121.387 1.391 . . . . 0.0 110.245 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 244' ' ' ALA . . . 135.62 -16.81 4.02 Favored Glycine 0 N--CA 1.424 -2.107 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.74 -176.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -122.29 118.39 28.39 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 122.344 -0.503 . . . . 0.0 110.171 178.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -126.87 161.79 27.42 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.507 -178.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.429 ' HB ' ' HB2' ' A' ' 313' ' ' LYS . 49.3 m -151.87 138.62 18.85 Favored 'General case' 0 C--N 1.267 -2.999 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -176.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -127.41 107.44 9.96 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . 0.618 HE21 HD21 ' A' ' 325' ' ' LEU . 45.9 tt0 -94.06 101.34 13.37 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 86.6 t -89.05 101.17 11.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.001 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.618 HD21 HE21 ' A' ' 323' ' ' GLN . 40.3 mt -95.59 145.39 29.45 Favored Pre-proline 0 C--N 1.299 -1.596 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.995 -176.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -72.25 123.61 9.32 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 121.102 1.201 . . . . 0.0 109.97 172.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 307' ' ' ASN . 41.0 ttmt . . . . . 0 CA--C 1.474 -1.962 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.713 -175.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . 0.485 ' CG ' HD21 ' A' ' 273' ' ' LEU . 1.1 tp60 . . . . . 0 N--CA 1.431 -1.424 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.556 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 16.3 m -50.65 128.6 20.87 Favored 'General case' 0 CA--C 1.552 1.021 0 O-C-N 123.923 0.764 . . . . 0.0 110.73 177.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -146.07 156.6 43.57 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.048 0.452 . . . . 0.0 110.224 -174.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.566 HG12 ' HB2' ' A' ' 291' ' ' LEU . 2.1 pp -138.73 146.04 26.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 C-N-CA 124.882 1.273 . . . . 0.0 109.491 -177.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -150.58 157.16 42.67 Favored 'General case' 0 C--N 1.29 -1.991 0 O-C-N 123.34 0.4 . . . . 0.0 111.103 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -126.67 138.01 53.36 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-O 120.811 0.339 . . . . 0.0 111.153 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -146.92 168.11 22.28 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 173.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.423 ' HE3' HG22 ' A' ' 284' ' ' THR . 55.4 mtpt -116.01 155.52 27.94 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 122.402 -0.186 . . . . 0.0 110.677 178.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -138.55 145.47 40.71 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 123.366 0.416 . . . . 0.0 110.175 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 56.33 -104.7 0.38 Allowed Glycine 0 N--CA 1.441 -0.97 0 O-C-N 124.566 1.166 . . . . 0.0 114.796 172.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -119.15 83.86 2.1 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-O 121.212 0.53 . . . . 0.0 109.852 -176.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . 0.452 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 94.9 m-20 61.37 23.05 13.35 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.646 -1.161 . . . . 0.0 114.075 172.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -78.32 136.63 37.75 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -99.45 114.57 5.06 Favored Glycine 0 N--CA 1.431 -1.697 0 N-CA-C 111.689 -0.564 . . . . 0.0 111.689 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.1 mp -107.49 115.84 49.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-O 121.35 0.595 . . . . 0.0 110.847 -177.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.3 mp -99.17 116.65 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.459 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 175.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -90.73 135.76 33.51 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 16.3 tp -130.86 131.85 44.81 Favored 'General case' 0 C--N 1.278 -2.514 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.057 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . 0.556 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -128.74 102.36 6.53 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -111.21 92.25 3.97 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.479 0.656 . . . . 0.0 109.697 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -76.42 114.59 15.29 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.224 -176.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 107.1 18.73 10.14 Favored Glycine 0 N--CA 1.431 -1.646 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.579 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -115.11 116.08 27.83 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -104.88 95.15 5.67 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.147 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 143.6 -166.17 26.97 Favored Glycine 0 C--N 1.299 -1.515 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 175.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -102.28 144.87 29.47 Favored Pre-proline 0 C--N 1.308 -1.205 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 177.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.625 ' HB3' HD23 ' A' ' 264' ' ' LEU . 21.5 Cg_endo -77.14 173.32 14.59 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.955 2.437 . . . . 0.0 112.38 178.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -97.76 118.0 33.33 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 3.2 mp -107.25 133.13 52.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-O 120.977 0.417 . . . . 0.0 111.18 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . 0.495 ' HB3' ' HB ' ' A' ' 261' ' ' ILE . 23.2 t -115.81 111.35 20.37 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 173.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -90.86 105.05 17.56 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.342 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 74.8 mt-30 -125.14 152.52 44.32 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 176.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -60.1 -45.13 94.0 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -176.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -83.87 -20.14 33.61 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -174.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . 0.459 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 49.1 p-80 -171.8 158.75 5.0 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.083 0.468 . . . . 0.0 111.853 175.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.442 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 23.7 mt -106.72 144.14 16.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . 0.495 ' HB ' ' HB3' ' A' ' 254' ' ' SER . 3.5 mp -119.82 112.97 39.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 176.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.497 ' HB ' ' HB2' ' A' ' 300' ' ' LEU . 54.7 t -107.18 116.44 50.84 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 176.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 17.3 m -109.54 124.1 50.54 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-O 121.146 0.498 . . . . 0.0 110.19 -178.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.625 HD23 ' HB3' ' A' ' 251' ' ' PRO . 18.2 mt -102.96 89.84 3.57 Favored 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 178.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.605 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 61.2 mtpt -65.68 131.28 45.94 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.667 -175.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 71.23 21.08 4.85 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 124.601 1.188 . . . . 0.0 109.843 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -117.99 102.02 8.73 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 177.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 2.5 m -91.43 115.41 28.01 Favored 'General case' 0 C--N 1.28 -2.455 0 C-N-CA 119.829 -0.749 . . . . 0.0 111.208 -173.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 270' ' ' PRO . 21.2 tp -89.89 130.3 43.23 Favored Pre-proline 0 N--CA 1.43 -1.466 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.761 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.419 ' O ' ' HG ' ' A' ' 269' ' ' LEU . 6.7 Cg_exo -73.85 156.95 48.07 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 122.057 1.838 . . . . 0.0 110.603 170.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . 0.508 ' HA ' ' HG2' ' A' ' 274' ' ' GLN . 7.1 p -73.55 -10.46 59.73 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.623 0.725 . . . . 0.0 112.186 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 15.4 m -73.59 -24.06 60.01 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.206 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.485 HD21 ' CG ' ' A' ' 225' ' ' GLN . 7.8 mp -101.95 -12.16 18.41 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.704 -174.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.508 ' HG2' ' HA ' ' A' ' 271' ' ' THR . 0.0 OUTLIER -81.12 127.37 32.57 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.0 -176.723 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -153.58 163.35 40.12 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 13.9 p -124.29 127.41 47.6 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-O 121.792 0.806 . . . . 0.0 111.714 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.565 HD21 HD13 ' A' ' 228' ' ' ILE . 2.1 mm? -81.25 118.45 22.61 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -84.39 92.89 8.15 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 118.66 -1.216 . . . . 0.0 108.543 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.638 ' HA ' ' CD2' ' A' ' 282' ' ' PHE . 46.9 t -94.88 28.97 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 CA-C-O 123.328 1.537 . . . . 0.0 109.793 -175.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -79.74 149.92 30.99 Favored 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 175.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 28.1 t70 70.21 9.04 6.9 Favored 'General case' 0 CA--C 1.556 1.177 0 CA-C-O 122.156 0.979 . . . . 0.0 111.715 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.638 ' CD2' ' HA ' ' A' ' 279' ' ' VAL . 16.4 m-85 -83.38 -13.47 54.85 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 121.737 -0.602 . . . . 0.0 111.045 176.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 mptt 58.4 60.99 2.4 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.094 0.558 . . . . 0.0 111.132 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' THR . . . . . 0.423 HG22 ' HE3' ' A' ' 232' ' ' LYS . 1.5 p -136.64 174.74 4.12 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . 0.456 ' HB3' ' HB3' ' A' ' 308' ' ' TRP . 13.9 Cg_exo -71.47 -19.52 28.46 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 121.739 1.626 . . . . 0.0 111.601 175.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.3 p -94.85 132.76 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-O 121.517 0.675 . . . . 0.0 110.21 178.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' GLN . . . . . 0.413 HE21 HG22 ' A' ' 303' ' ' THR . 31.0 mt-30 -100.01 -32.27 11.04 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.9 -174.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 40.2 tttp -162.86 134.48 5.11 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 120.051 -0.659 . . . . 0.0 109.8 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.458 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 42.0 t -103.48 110.14 29.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 174.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.511 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 93.8 m -112.57 113.55 25.76 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-O 121.004 0.43 . . . . 0.0 111.375 -176.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.566 ' HB2' HG12 ' A' ' 228' ' ' ILE . 37.9 tp -94.93 122.71 37.86 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 173.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.401 ' HG3' HE22 ' A' ' 274' ' ' GLN . 25.3 ttpp -140.84 144.4 35.33 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -178.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -79.02 149.9 32.08 Favored 'General case' 0 C--N 1.282 -2.339 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.468 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.554 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 15.8 tp -111.62 -173.98 2.36 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 176.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.554 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 64.0 t30 -51.78 -62.7 1.47 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.954 0.502 . . . . 0.0 112.091 -177.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -122.4 -3.21 8.91 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 121.154 0.502 . . . . 0.0 110.08 176.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . 0.605 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 11.8 m-20 -115.72 169.07 9.48 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.823 -170.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.527 ' HB ' ' HB2' ' A' ' 264' ' ' LEU . 86.7 m -106.28 135.32 47.96 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 176.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -122.68 127.71 49.64 Favored 'General case' 0 N--CA 1.417 -2.091 0 CA-C-O 121.522 0.677 . . . . 0.0 110.569 -176.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.497 ' HB2' ' HB ' ' A' ' 262' ' ' VAL . 1.8 mt -106.13 119.56 39.52 Favored 'General case' 0 C--N 1.273 -2.729 0 CA-C-N 115.32 -0.854 . . . . 0.0 108.902 175.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' ILE . . . . . 0.511 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 67.3 mt -108.0 109.26 27.59 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.796 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . 0.442 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 61.1 mt -108.94 101.06 12.02 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . 0.413 HG22 HE21 ' A' ' 287' ' ' GLN . 24.9 m -69.51 132.3 46.06 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -178.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 11.4 p -137.41 169.76 17.23 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 122.896 0.479 . . . . 0.0 111.023 -177.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -159.11 144.72 16.25 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 92.2 -152.69 21.41 Favored Glycine 0 N--CA 1.436 -1.358 0 O-C-N 123.892 0.745 . . . . 0.0 112.623 176.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' ASN . . . . . 0.572 ' HB2' ' O ' ' A' ' 327' ' ' LYS . 6.6 m120 -101.17 129.19 47.05 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' TRP . . . . . 0.456 ' HB3' ' HB3' ' A' ' 285' ' ' PRO . 67.4 p-90 -153.59 162.9 40.82 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.011 -177.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . 0.416 ' HG2' ' HE2' ' A' ' 327' ' ' LYS . 3.4 mt-10 -122.62 135.36 54.59 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -178.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 1.5 tt -102.74 122.87 45.34 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.683 HG13 ' HB3' ' A' ' 323' ' ' GLN . 7.6 p -125.53 111.97 29.26 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 CA-C-O 121.883 0.849 . . . . 0.0 109.794 170.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -98.79 135.97 39.49 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.259 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -128.2 139.74 52.29 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.098 -176.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 35.9 p -115.99 122.24 44.65 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 176.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -81.16 -38.03 27.8 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.698 0.761 . . . . 0.0 109.321 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.401 ' HB1' ' HD2' ' A' ' 317' ' ' PRO . . . -163.27 162.21 17.76 Favored Pre-proline 0 C--N 1.308 -1.21 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' PRO . . . . . 0.401 ' HD2' ' HB1' ' A' ' 316' ' ' ALA . 16.5 Cg_endo -58.29 110.43 0.65 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.038 1.826 . . . . 0.0 110.811 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 113.86 -36.13 4.17 Favored Glycine 0 N--CA 1.424 -2.104 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -93.29 115.59 28.18 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' PHE . . . . . 0.409 ' CZ ' ' HD3' ' A' ' 251' ' ' PRO . 74.4 m-85 -127.32 166.36 17.96 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-O 122.228 1.013 . . . . 0.0 111.407 -175.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 84.8 m -151.93 127.36 9.99 Favored 'General case' 0 C--N 1.278 -2.531 0 CA-C-N 113.988 -1.46 . . . . 0.0 108.604 -177.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -116.55 111.49 20.0 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . 0.683 ' HB3' HG13 ' A' ' 311' ' ' VAL . 61.6 tt0 -97.76 104.28 16.29 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.415 HG13 ' CE3' ' A' ' 308' ' ' TRP . 88.2 t -90.28 98.87 8.72 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 33.0 mt -87.05 148.61 45.62 Favored Pre-proline 0 C--N 1.292 -1.92 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.057 -178.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -77.43 143.46 21.92 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 121.62 1.547 . . . . 0.0 111.134 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.572 ' O ' ' HB2' ' A' ' 307' ' ' ASN . 19.7 ttmm . . . . . 0 N--CA 1.434 -1.264 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . 0.506 ' O ' HD23 ' A' ' 245' ' ' LEU . 3.6 pt20 . . . . . 0 N--CA 1.42 -1.945 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.594 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 43.3 m -78.43 127.61 32.43 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 121.118 0.485 . . . . 0.0 112.198 -175.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -151.89 166.35 31.72 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.372 -177.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.3 pp -121.43 165.45 17.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.321 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -150.25 156.46 41.62 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -133.39 130.6 38.96 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.234 0.54 . . . . 0.0 109.749 176.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.42 ' HD2' ' OE2' ' A' ' 241' ' ' GLU . 5.4 ptp180 -149.81 165.33 32.82 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.37 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -108.92 142.09 40.05 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . 0.542 ' O ' ' HB3' ' A' ' 237' ' ' ALA . 18.8 t70 -156.77 117.99 3.75 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -178.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 102.13 -143.43 15.95 Favored Glycine 0 C--N 1.301 -1.412 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -178.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -114.46 101.5 9.19 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 117.468 0.634 . . . . 0.0 110.032 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 18.9 m120 65.39 27.25 11.91 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.621 1.168 . . . . 0.0 111.896 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 233' ' ' ASP . . . -97.94 134.74 40.64 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.304 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . 0.556 ' HA3' ' CG1' ' A' ' 286' ' ' VAL . . . -101.44 123.9 8.06 Favored Glycine 0 C--N 1.296 -1.671 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.414 HD12 ' C ' ' A' ' 238' ' ' GLY . 2.1 mp -116.78 120.11 64.03 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-N 118.045 0.923 . . . . 0.0 111.045 -176.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . 0.404 HD12 ' N ' ' A' ' 240' ' ' ILE . 3.2 mp -104.21 109.49 27.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 176.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.42 ' OE2' ' HD2' ' A' ' 231' ' ' ARG . 5.4 mt-10 -93.59 128.53 39.79 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-O 121.435 0.636 . . . . 0.0 109.742 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 13.0 tp -115.24 126.64 54.78 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 115.186 -0.916 . . . . 0.0 112.092 -171.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . 0.594 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -108.27 104.11 13.43 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 175.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -112.25 91.88 3.82 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.432 0.634 . . . . 0.0 109.477 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.506 HD23 ' O ' ' A' ' 225' ' ' GLN . 3.5 mm? -85.36 116.83 23.92 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.769 -175.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 108.68 13.33 18.85 Favored Glycine 0 N--CA 1.424 -2.113 0 CA-C-N 114.24 -1.346 . . . . 0.0 110.16 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -114.86 115.26 26.68 Favored 'General case' 0 N--CA 1.423 -1.812 0 C-N-CA 120.6 -0.44 . . . . 0.0 109.875 -177.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -112.93 95.15 5.25 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.05 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 152.47 -157.33 27.22 Favored Glycine 0 C--N 1.296 -1.672 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -114.56 141.55 26.81 Favored Pre-proline 0 C--N 1.303 -1.43 0 CA-C-N 116.991 0.396 . . . . 0.0 110.325 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.761 ' HB3' HD13 ' A' ' 264' ' ' LEU . 12.7 Cg_endo -68.97 172.19 12.29 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.403 2.069 . . . . 0.0 111.053 175.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.451 ' HB3' ' HB ' ' A' ' 263' ' ' THR . 34.1 t0 -97.48 107.84 20.43 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 3.1 mp -95.11 116.23 36.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 3.1 t -119.28 111.27 18.0 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -97.58 128.74 44.54 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -174.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 18.4 mt-30 -125.24 163.13 23.17 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 170.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -76.45 -29.85 57.12 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.29 174.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -68.24 -48.56 64.77 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.308 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . 0.506 ' CB ' ' HA ' ' A' ' 303' ' ' THR . 27.6 p-80 -163.37 167.62 21.49 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 116.704 -0.225 . . . . 0.0 110.451 177.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 19.8 mt -105.83 143.1 17.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 3.5 mp -120.93 109.1 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 176.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.511 ' HB ' ' HB3' ' A' ' 300' ' ' LEU . 51.4 t -106.54 117.76 52.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 177.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . 0.57 ' HA ' ' O ' ' A' ' 298' ' ' THR . 25.3 m -116.79 123.96 48.41 Favored 'General case' 0 C--N 1.278 -2.52 0 CA-C-O 121.773 0.797 . . . . 0.0 111.27 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.761 HD13 ' HB3' ' A' ' 251' ' ' PRO . 1.7 mm? -93.47 98.03 10.93 Favored 'General case' 0 N--CA 1.399 -2.99 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 174.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.546 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 0.5 OUTLIER -67.79 129.81 41.06 Favored 'General case' 0 N--CA 1.388 -3.569 0 O-C-N 124.756 1.285 . . . . 0.0 108.921 -174.832 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 66.6 t30 71.05 27.38 3.34 Favored 'General case' 0 CA--C 1.549 0.924 0 O-C-N 124.483 1.115 . . . . 0.0 110.444 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -121.77 113.18 19.33 Favored 'General case' 0 C--O 1.203 -1.362 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 3.9 p -90.71 129.15 36.83 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . 0.575 HD22 HD22 ' A' ' 291' ' ' LEU . 23.8 tp -107.39 129.56 24.09 Favored Pre-proline 0 N--CA 1.446 -0.664 0 C-N-CA 123.624 0.77 . . . . 0.0 109.873 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -64.63 151.34 86.0 Favored 'Trans proline' 0 C--N 1.318 -1.052 0 C-N-CA 122.36 2.04 . . . . 0.0 111.584 172.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . 0.499 ' HA ' ' HG2' ' A' ' 274' ' ' GLN . 16.3 p -74.96 -13.91 60.57 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.776 0.798 . . . . 0.0 112.176 -178.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 25.0 m -81.09 -17.91 48.39 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 122.018 0.913 . . . . 0.0 110.038 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.43 HD11 ' HB2' ' A' ' 225' ' ' GLN . 96.0 mt -101.19 -19.99 15.48 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.944 -178.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.499 ' HG2' ' HA ' ' A' ' 271' ' ' THR . 11.9 pt20 -74.5 136.15 42.21 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -164.87 178.59 7.05 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -173.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 39.9 m -134.78 123.82 24.19 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.346 0.593 . . . . 0.0 110.872 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.447 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 53.2 mt -91.09 120.25 31.89 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 103.977 -2.601 . . . . 0.0 103.977 174.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -68.2 -42.57 79.7 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.783 -172.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . . . . . . . . 0.334 34.0 m 42.65 26.74 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 N-CA-C 117.353 2.353 . . . . 0.0 117.353 175.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -74.6 142.86 44.59 Favored 'General case' 0 N--CA 1.415 -2.209 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 176.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 30.0 t70 72.59 22.94 3.15 Favored 'General case' 0 CA--C 1.553 1.059 0 O-C-N 124.229 0.956 . . . . 0.0 111.521 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -86.78 1.94 50.55 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 176.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? 60.77 59.81 2.04 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 1.1 t -164.95 150.95 8.87 Favored Pre-proline 0 N--CA 1.423 -1.795 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.363 177.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . 0.416 ' O ' ' HA ' ' A' ' 304' ' ' THR . 18.4 Cg_exo -44.2 -35.81 8.33 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 124.556 3.504 . . . . 0.0 114.06 174.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.556 ' CG1' ' HA3' ' A' ' 238' ' ' GLY . 0.2 OUTLIER -73.57 115.53 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 CA-C-O 121.767 0.794 . . . . 0.0 109.442 177.32 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -94.7 -37.07 11.47 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.714 -174.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -154.62 146.51 23.48 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -176.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 55.1 t -120.04 125.59 74.4 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.499 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 96.1 m -126.49 127.17 44.93 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-O 121.056 0.455 . . . . 0.0 110.434 178.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.575 HD22 HD22 ' A' ' 269' ' ' LEU . 0.1 OUTLIER -100.88 120.1 39.66 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 174.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -123.75 134.3 53.69 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . 0.415 ' HG2' ' OE1' ' A' ' 274' ' ' GLN . 9.0 ptm180 -81.32 148.62 29.31 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 117.609 -1.636 . . . . 0.0 108.308 173.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.579 HD13 ' N ' ' A' ' 295' ' ' ASN . 2.8 tm? -122.96 166.9 14.3 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.579 ' N ' HD13 ' A' ' 294' ' ' LEU . 0.2 OUTLIER -24.02 -70.35 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 127.349 2.26 . . . . 0.0 112.149 177.052 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -124.7 -2.15 7.88 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . 0.546 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 12.3 m-20 -119.04 171.37 8.31 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.578 -168.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 263' ' ' THR . 70.5 m -114.3 128.16 56.22 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 176.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -113.65 116.48 29.53 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -177.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.511 ' HB3' ' HB ' ' A' ' 262' ' ' VAL . 0.6 OUTLIER -101.52 120.25 40.01 Favored 'General case' 0 C--N 1.277 -2.587 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 177.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' ILE . . . . . 0.499 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 80.6 mt -110.76 115.19 49.19 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -176.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 45.8 mt -117.37 103.25 14.64 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.552 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . 0.506 ' HA ' ' CB ' ' A' ' 259' ' ' HIS . 85.6 m -75.91 134.43 40.25 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 120.556 0.217 . . . . 0.0 110.416 -177.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 285' ' ' PRO . 9.1 p -132.76 -179.26 5.36 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 123.237 0.615 . . . . 0.0 110.932 -174.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -155.03 139.88 17.22 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 122.687 0.395 . . . . 0.0 110.162 177.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 77.15 -151.78 39.15 Favored Glycine 0 C--O 1.236 0.263 0 O-C-N 123.635 0.584 . . . . 0.0 112.384 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' ASN . . . . . 0.421 ' HB3' ' HB3' ' A' ' 327' ' ' LYS . 39.4 m-80 -96.59 137.11 36.17 Favored 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 176.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' TRP . . . . . . . . . . . . . 68.9 p-90 -154.13 165.43 36.25 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -175.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 324' ' ' VAL . 5.6 mt-10 -122.03 136.82 54.95 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -178.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.414 HD21 ' HB3' ' A' ' 322' ' ' PHE . 0.5 OUTLIER -107.25 124.21 49.43 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.57 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 58.3 t -115.88 107.34 22.38 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.637 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 173.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -92.84 124.92 37.18 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -123.46 149.95 44.46 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -177.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 12.9 p -115.69 122.27 45.03 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 177.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -89.81 -29.54 18.57 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.402 0.62 . . . . 0.0 110.494 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -164.29 163.12 15.36 Favored Pre-proline 0 C--N 1.309 -1.179 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -64.64 97.6 0.27 Allowed 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 121.537 1.491 . . . . 0.0 111.504 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 122.17 -20.63 7.97 Favored Glycine 0 C--O 1.218 -0.877 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.992 -177.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -103.17 116.34 32.29 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -121.45 168.27 11.89 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.674 0.749 . . . . 0.0 111.243 -175.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 60.6 m -151.2 129.23 11.79 Favored 'General case' 0 C--N 1.277 -2.569 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.37 -176.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 0.414 ' HB3' HD21 ' A' ' 310' ' ' LEU . 90.4 m-85 -117.53 108.76 15.89 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 177.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . 0.57 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 42.1 tt0 -98.9 105.33 17.46 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 309' ' ' GLU . 0.2 OUTLIER -100.97 105.83 18.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 CA-C-O 122.099 0.952 . . . . 0.0 110.102 178.039 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.7 mp -104.17 156.16 36.15 Favored Pre-proline 0 C--N 1.298 -1.637 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.803 -177.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -74.19 128.52 12.22 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 121.697 1.598 . . . . 0.0 112.082 177.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.421 ' HB3' ' HB3' ' A' ' 307' ' ' ASN . 23.1 ttmm . . . . . 0 CA--C 1.49 -1.342 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . 0.442 ' O ' HD23 ' A' ' 245' ' ' LEU . 17.7 pt20 . . . . . 0 N--CA 1.436 -1.166 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.544 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 88.8 m -78.73 131.83 36.74 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.172 177.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -166.91 175.49 7.65 Favored 'General case' 0 CA--C 1.479 -1.788 0 CA-C-O 121.131 0.491 . . . . 0.0 110.289 -175.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.464 HG21 HD13 ' A' ' 300' ' ' LEU . 2.6 pp -128.04 162.72 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.53 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.696 177.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . 0.528 ' HB2' ' HB2' ' A' ' 241' ' ' GLU . 4.8 m-20 -146.78 156.04 42.84 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -129.48 134.42 47.79 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.244 176.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 8.3 ptt-85 -144.15 169.33 18.07 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 175.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.453 ' HE3' HG22 ' A' ' 284' ' ' THR . 55.3 mtpt -114.93 150.2 36.07 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 175.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -152.56 152.06 31.41 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -177.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 73.57 -102.75 1.33 Allowed Glycine 0 C--N 1.314 -0.683 0 C-N-CA 121.285 -0.483 . . . . 0.0 113.748 176.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -152.98 104.26 2.82 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 123.2 0.6 . . . . 0.0 110.038 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . 0.649 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 89.6 m-20 61.21 20.7 11.23 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.112 0.965 . . . . 0.0 111.762 176.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.34 137.84 33.02 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 120.822 0.344 . . . . 0.0 110.259 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -99.91 117.59 5.92 Favored Glycine 0 N--CA 1.425 -2.066 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.1 mp -108.47 117.79 54.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 117.194 0.497 . . . . 0.0 110.797 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . 0.408 HD12 ' N ' ' A' ' 240' ' ' ILE . 2.9 mp -103.68 110.12 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 176.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 229' ' ' ASP . 53.7 mt-10 -90.04 123.37 33.87 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 11.9 tp -112.14 124.23 51.98 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-O 120.981 0.42 . . . . 0.0 111.965 -174.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . 0.544 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -107.45 107.87 18.94 Favored 'General case' 0 C--O 1.206 -1.216 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 176.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.43 ' HA ' HG23 ' A' ' 226' ' ' THR . . . -118.15 92.35 3.8 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.24 0.543 . . . . 0.0 111.519 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 225' ' ' GLN . 3.6 mm? -86.56 116.25 24.57 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.246 0.546 . . . . 0.0 111.079 -177.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 111.64 -7.79 28.02 Favored Glycine 0 C--N 1.297 -1.603 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.146 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' PHE . . . . . 0.441 ' HB2' ' ND1' ' A' ' 267' ' ' HIS . 47.9 t80 -98.56 128.15 44.77 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -107.57 -34.98 6.86 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -174.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -86.3 -150.1 15.2 Favored Glycine 0 CA--C 1.506 -0.479 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.457 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -115.01 141.13 26.48 Favored Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.766 ' HB3' HD23 ' A' ' 264' ' ' LEU . 10.2 Cg_endo -69.44 172.27 12.62 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.957 1.771 . . . . 0.0 113.951 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.425 ' HB3' ' HB ' ' A' ' 263' ' ' THR . 11.5 t70 -97.49 105.37 17.51 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 176.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.473 HD11 ' HG2' ' A' ' 251' ' ' PRO . 4.8 mp -101.41 117.19 46.32 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 C-N-CA 119.122 -1.031 . . . . 0.0 109.738 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . 0.498 ' HB3' ' HB ' ' A' ' 261' ' ' ILE . 24.6 t -97.79 112.32 24.27 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 176.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -97.67 101.98 13.63 Favored 'General case' 0 CA--C 1.497 -1.079 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.226 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -104.66 162.14 13.53 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 171.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -76.72 -33.48 58.17 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 120.624 0.249 . . . . 0.0 111.357 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -72.49 -39.3 67.77 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.889 -178.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . 0.42 ' CB ' ' HA ' ' A' ' 303' ' ' THR . 32.1 p-80 -166.7 165.96 16.18 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 301' ' ' ILE . 15.9 mt -106.83 142.73 18.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -177.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . 0.498 ' HB ' ' HB3' ' A' ' 254' ' ' SER . 3.6 mp -126.04 112.0 28.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 299' ' ' GLN . 0.8 OUTLIER -102.49 141.49 18.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 177.316 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 252' ' ' ASP . 6.2 m -129.05 118.88 23.25 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-O 121.2 0.524 . . . . 0.0 109.639 176.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.766 HD23 ' HB3' ' A' ' 251' ' ' PRO . 31.5 mt -96.76 95.36 7.85 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.428 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 31.6 mmtp -63.92 133.96 54.23 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.731 -1.122 . . . . 0.0 113.403 -174.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 69.56 9.07 7.08 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 113.533 -1.667 . . . . 0.0 110.801 176.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' HIS . . . . . 0.441 ' ND1' ' HB2' ' A' ' 247' ' ' PHE . 46.4 t60 -100.25 114.39 27.8 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.938 -176.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.89 118.19 28.42 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . 0.409 HD22 HD22 ' A' ' 291' ' ' LEU . 31.4 tp -96.92 127.48 38.87 Favored Pre-proline 0 N--CA 1.439 -0.982 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.176 177.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -62.87 136.31 56.59 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.193 1.929 . . . . 0.0 111.26 170.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . 0.497 ' HB ' ' HD2' ' A' ' 293' ' ' ARG . 8.5 t -66.21 -14.12 61.38 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 122.262 1.029 . . . . 0.0 110.756 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 2.8 m -78.14 -18.94 54.96 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.007 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 88.6 mt -106.9 -8.54 16.63 Favored 'General case' 0 C--O 1.246 0.912 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.844 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.483 ' HA ' HD13 ' A' ' 291' ' ' LEU . 10.5 pt20 -83.11 148.9 27.22 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.9 169.82 8.04 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 289' ' ' VAL . 15.8 m -119.62 117.02 27.2 Favored 'General case' 0 N--CA 1.406 -2.666 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 173.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 76.4 mt -81.53 117.9 22.31 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -79.3 89.5 4.94 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 122.224 1.011 . . . . 0.0 109.866 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.623 ' HA ' ' CE1' ' A' ' 282' ' ' PHE . 47.3 t -98.74 27.34 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 CA-C-O 123.047 1.403 . . . . 0.0 109.658 -176.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -71.49 132.2 44.4 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.581 178.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 30.1 t70 68.53 28.49 5.88 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.461 1.504 . . . . 0.0 112.468 178.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.623 ' CE1' ' HA ' ' A' ' 279' ' ' VAL . 6.7 m-85 -84.25 -5.02 59.2 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.66 173.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? 60.97 50.36 5.18 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.691 0.758 . . . . 0.0 110.586 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' THR . . . . . 0.453 HG22 ' HE3' ' A' ' 232' ' ' LYS . 1.2 p -133.27 168.34 18.44 Favored Pre-proline 0 N--CA 1.433 -1.304 0 N-CA-C 104.314 -2.476 . . . . 0.0 104.314 177.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . 0.649 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 11.6 Cg_exo -75.05 -11.14 21.38 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 121.588 1.525 . . . . 0.0 110.889 176.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 57.9 t -86.04 129.9 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -92.36 -44.07 8.9 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.543 0.687 . . . . 0.0 109.175 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -164.21 134.54 4.16 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.814 -174.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 276' ' ' SER . 61.6 t -95.44 117.72 40.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 175.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.487 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 62.4 m -115.69 113.32 23.34 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-O 121.149 0.5 . . . . 0.0 110.359 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.483 HD13 ' HA ' ' A' ' 274' ' ' GLN . 0.0 OUTLIER -98.78 120.79 39.82 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 179.374 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -123.65 131.06 53.52 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -176.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . 0.497 ' HD2' ' HB ' ' A' ' 271' ' ' THR . 4.6 ptm180 -75.81 133.08 40.73 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 172.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.506 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 31.9 tp -110.39 -179.61 3.82 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -177.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.506 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 4.6 m-20 -35.31 -72.11 0.06 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.167 1.787 . . . . 0.0 112.881 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -123.7 -2.2 8.38 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . 0.428 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 12.9 m-20 -117.86 174.92 5.91 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.811 -170.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.559 ' HB ' ' HB2' ' A' ' 264' ' ' LEU . 83.5 m -117.4 126.97 53.56 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 175.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 36.3 tt0 -109.94 128.15 55.2 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -175.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.464 HD13 HG21 ' A' ' 228' ' ' ILE . 63.5 tp -116.38 117.39 29.82 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.644 177.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' ILE . . . . . 0.487 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 51.1 mt -107.14 115.26 48.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.391 -176.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . 0.401 ' HB ' HD12 ' A' ' 260' ' ' ILE . 56.0 mt -110.63 105.49 18.91 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.551 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . 0.42 ' HA ' ' CB ' ' A' ' 259' ' ' HIS . 3.0 m -77.68 131.48 37.74 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -176.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 7.3 p -130.43 165.46 22.57 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -144.95 158.27 43.86 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 123.174 0.59 . . . . 0.0 109.89 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 74.54 -145.27 34.02 Favored Glycine 0 C--N 1.332 0.306 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' ASN . . . . . 0.421 ' HB3' ' HB3' ' A' ' 327' ' ' LYS . 31.9 m-80 -110.41 133.51 53.2 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 174.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' TRP . . . . . 0.724 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 57.0 p-90 -143.41 165.0 28.75 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 120.086 -0.646 . . . . 0.0 110.866 -175.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -126.18 134.85 51.15 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -177.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.724 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 18.5 tp -106.74 122.99 47.47 Favored 'General case' 0 CA--C 1.503 -0.841 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.788 -178.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.603 HG13 ' HB3' ' A' ' 323' ' ' GLN . 10.1 p -127.57 117.67 47.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-O 121.883 0.849 . . . . 0.0 109.461 171.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -106.11 136.18 46.26 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.466 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -129.58 151.28 50.37 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.374 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 43.2 t -116.05 112.79 22.28 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 177.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -70.13 -35.78 74.33 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.648 0.737 . . . . 0.0 109.105 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -164.83 157.61 14.19 Favored Pre-proline 0 N--CA 1.438 -1.054 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -63.17 100.48 0.26 Allowed 'Trans proline' 0 C--O 1.24 0.596 0 C-N-CA 121.778 1.652 . . . . 0.0 111.152 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 125.67 -9.99 7.61 Favored Glycine 0 N--CA 1.436 -1.329 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -176.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -127.01 116.18 20.35 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -121.54 168.53 11.63 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-O 121.573 0.701 . . . . 0.0 110.708 -174.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 91.8 m -151.48 123.56 8.17 Favored 'General case' 0 C--N 1.276 -2.602 0 C-N-CA 124.307 1.043 . . . . 0.0 108.817 -177.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -109.52 113.35 26.08 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . 0.603 ' HB3' HG13 ' A' ' 311' ' ' VAL . 8.0 tt0 -101.6 110.96 23.06 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.577 HG13 ' CE3' ' A' ' 308' ' ' TRP . 93.3 t -100.04 99.3 8.22 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.297 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -86.86 156.45 55.36 Favored Pre-proline 0 C--N 1.315 -0.92 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . 0.429 ' HG3' ' HB2' ' A' ' 236' ' ' ASN . 73.2 Cg_endo -81.33 138.63 11.17 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 121.713 1.609 . . . . 0.0 110.574 172.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.421 ' HB3' ' HB3' ' A' ' 307' ' ' ASN . 23.6 ttmm . . . . . 0 C--N 1.296 -1.737 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 . . . . . 0 N--CA 1.432 -1.357 0 CA-C-O 121.015 0.436 . . . . 0.0 111.553 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 91.1 m -65.61 121.51 15.12 Favored 'General case' 0 C--O 1.195 -1.783 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.354 -176.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -143.19 170.4 15.81 Favored 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.229 -173.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.518 HG21 HD13 ' A' ' 300' ' ' LEU . 2.8 pp -128.05 163.51 31.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.898 179.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -149.77 155.67 40.53 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -176.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -136.78 132.64 35.01 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.096 0.474 . . . . 0.0 110.701 176.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.605 ' HD3' ' OE2' ' A' ' 241' ' ' GLU . 0.3 OUTLIER -149.55 174.41 12.55 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.055 178.23 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -119.62 144.3 47.21 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -150.72 176.59 10.88 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 176.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 53.72 -138.73 37.19 Favored Glycine 0 C--N 1.309 -0.957 0 O-C-N 123.721 0.638 . . . . 0.0 113.682 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -115.1 100.24 8.02 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . 0.413 ' HB2' ' HG3' ' A' ' 326' ' ' PRO . 5.1 m-20 60.53 29.08 18.74 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 121.792 0.806 . . . . 0.0 111.533 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.73 135.3 36.37 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.454 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . 0.563 ' HA3' ' CG1' ' A' ' 286' ' ' VAL . . . -102.25 123.47 7.88 Favored Glycine 0 C--N 1.299 -1.526 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -177.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.5 mp -113.67 120.27 63.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 117.423 0.612 . . . . 0.0 111.258 -176.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . 0.402 ' N ' HD12 ' A' ' 240' ' ' ILE . 3.1 mp -106.42 107.85 23.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.605 ' OE2' ' HD3' ' A' ' 231' ' ' ARG . 42.9 mt-10 -95.01 111.22 23.04 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 122.408 1.099 . . . . 0.0 111.783 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 12.8 tp -94.3 136.05 35.02 Favored 'General case' 0 C--N 1.278 -2.519 0 CA-C-N 114.097 -1.41 . . . . 0.0 110.756 -175.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . 0.517 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -121.56 98.72 6.1 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 176.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -103.16 91.34 4.06 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -79.37 112.8 16.96 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.314 -175.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 110.65 4.45 28.28 Favored Glycine 0 C--N 1.292 -1.875 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.138 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -111.98 108.71 18.14 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -104.51 100.45 10.13 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 159.78 -132.83 3.1 Favored Glycine 0 C--N 1.291 -1.922 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -153.69 132.65 6.95 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.661 ' HB3' HD13 ' A' ' 264' ' ' LEU . 14.0 Cg_endo -63.55 171.84 6.34 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.18 2.587 . . . . 0.0 113.111 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 29.5 t70 -96.01 105.88 17.97 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.009 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 4.4 mp -98.84 117.24 43.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-O 121.296 0.57 . . . . 0.0 111.034 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 13.5 t -102.49 116.84 33.42 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 176.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . 0.41 ' HG2' HD23 ' A' ' 310' ' ' LEU . 76.0 mt-30 -92.52 109.8 21.21 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-O 121.359 0.599 . . . . 0.0 111.909 -176.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 78.3 mt-30 -125.25 149.83 47.63 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 174.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -77.21 -28.58 53.87 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 -174.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -79.91 -24.6 41.01 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.271 -0.971 . . . . 0.0 110.107 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . 0.466 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 39.8 p-80 -171.68 159.25 5.3 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.955 173.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 25.2 mt -105.58 142.21 19.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 261' ' ' ILE . 2.9 mp -122.01 113.72 39.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 299' ' ' GLN . 1.9 m -110.99 135.69 49.33 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.496 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 298' ' ' THR . 29.2 m -129.58 125.07 35.35 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-O 121.589 0.709 . . . . 0.0 110.699 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.661 HD13 ' HB3' ' A' ' 251' ' ' PRO . 1.9 mm? -98.59 98.06 9.27 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 175.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.535 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 51.9 mtpt -71.55 131.52 43.38 Favored 'General case' 0 C--N 1.274 -2.7 0 O-C-N 124.005 0.816 . . . . 0.0 111.95 -178.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 9.4 t30 73.61 24.65 2.18 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 124.894 1.371 . . . . 0.0 109.931 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 54.6 t60 -117.16 117.8 30.59 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 121.45 -0.781 . . . . 0.0 109.179 178.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 10.9 p -88.5 130.02 35.31 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-O 120.975 0.417 . . . . 0.0 111.689 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 29.1 tp -115.97 124.95 29.11 Favored Pre-proline 0 N--CA 1.429 -1.496 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.086 177.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -68.6 156.72 64.59 Favored 'Trans proline' 0 C--N 1.321 -0.893 0 C-N-CA 122.66 2.24 . . . . 0.0 112.326 171.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . 0.491 ' HA ' ' OE1' ' A' ' 274' ' ' GLN . 37.1 p -64.09 -31.48 72.68 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.351 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 2.2 m -64.21 -23.78 67.43 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.24 1.016 . . . . 0.0 112.606 -175.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -95.46 -10.13 30.7 Favored 'General case' 0 CA--C 1.498 -1.036 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.494 -176.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.504 HE21 ' HA ' ' A' ' 292' ' ' LYS . 50.9 mt-30 -72.73 111.94 8.33 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.962 178.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -142.09 150.44 41.18 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . 0.568 ' HA ' ' O ' ' A' ' 289' ' ' VAL . 36.9 m -118.99 114.05 21.94 Favored 'General case' 0 N--CA 1.417 -2.09 0 O-C-N 123.594 0.559 . . . . 0.0 109.736 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 66.6 mt -85.8 112.85 21.48 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.221 -177.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -80.4 90.97 5.64 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 174.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 282' ' ' PHE . 17.2 m -109.97 25.76 2.96 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 CA-C-N 114.565 -1.198 . . . . 0.0 112.202 -173.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -70.02 150.76 46.31 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 174.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 24.6 t70 73.36 15.69 4.24 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 122.579 1.18 . . . . 0.0 110.955 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.457 ' HB2' ' O ' ' A' ' 279' ' ' VAL . 1.6 m-85 -85.52 -0.07 53.92 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.915 173.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? 62.37 61.17 1.3 Allowed 'General case' 0 CA--C 1.491 -1.326 0 CA-C-O 121.708 0.765 . . . . 0.0 112.649 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 1.8 t -164.21 148.7 8.39 Favored Pre-proline 0 N--CA 1.403 -2.823 0 CA-C-N 113.618 -1.628 . . . . 0.0 108.961 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . 0.424 ' O ' ' HA ' ' A' ' 304' ' ' THR . 14.7 Cg_exo -44.01 -35.48 7.45 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 124.68 3.587 . . . . 0.0 114.098 174.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.563 ' CG1' ' HA3' ' A' ' 238' ' ' GLY . 0.3 OUTLIER -75.87 117.74 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-O 121.989 0.9 . . . . 0.0 110.831 178.044 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -101.47 -37.98 8.19 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.152 -1.385 . . . . 0.0 111.857 -172.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -151.23 140.0 20.82 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.874 -0.516 . . . . 0.0 111.041 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 276' ' ' SER . 46.9 t -110.24 110.08 30.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 175.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.44 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 89.0 m -111.83 115.24 28.69 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 58.4 tp -95.87 118.65 32.91 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 176.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.504 ' HA ' HE21 ' A' ' 274' ' ' GLN . 40.8 ttmt -121.89 136.2 54.92 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 121.107 0.479 . . . . 0.0 110.484 -176.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -80.84 139.92 35.69 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 176.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.506 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 19.8 tp -113.0 -178.93 3.5 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 177.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.506 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 20.2 t-20 -53.39 -68.29 0.19 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.113 0.87 . . . . 0.0 112.5 -176.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -109.51 -3.79 16.73 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.032 0.444 . . . . 0.0 110.102 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . 0.535 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 13.1 m-20 -124.0 173.11 8.46 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.406 -168.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 263' ' ' THR . 31.8 m -114.92 130.72 56.97 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 175.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . 0.533 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 9.7 tt0 -118.66 124.2 46.81 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -177.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.518 HD13 HG21 ' A' ' 228' ' ' ILE . 67.3 tp -107.22 122.01 45.67 Favored 'General case' 0 N--CA 1.412 -2.371 0 C-N-CA 120.361 -0.535 . . . . 0.0 109.844 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' ILE . . . . . 0.441 HG23 ' CD2' ' A' ' 259' ' ' HIS . 64.0 mt -110.03 109.73 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.264 -176.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 61.6 mt -106.58 107.56 23.01 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.521 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 13.3 m -79.38 131.08 36.0 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -175.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 285' ' ' PRO . 8.9 p -135.64 175.96 9.12 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 122.721 0.408 . . . . 0.0 110.866 -176.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -161.18 141.66 11.09 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 89.52 -163.36 31.12 Favored Glycine 0 C--O 1.25 1.11 0 C-N-CA 121.459 -0.4 . . . . 0.0 113.179 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -91.37 125.38 36.1 Favored 'General case' 0 CA--C 1.486 -1.496 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' TRP . . . . . 0.694 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 59.8 p-90 -150.15 170.65 18.43 Favored 'General case' 0 N--CA 1.413 -2.29 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -177.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -128.91 131.39 47.57 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -176.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.694 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 24.7 tp -105.63 137.3 43.7 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 119.625 -0.83 . . . . 0.0 109.98 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.647 HG13 ' HB3' ' A' ' 323' ' ' GLN . 6.5 p -137.21 126.91 37.42 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.31 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 172.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -111.44 145.27 39.27 Favored 'General case' 0 N--CA 1.418 -2.032 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.421 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . 0.411 ' HB2' ' HB ' ' A' ' 321' ' ' THR . 65.1 mttm -139.62 158.01 44.84 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.986 -176.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 32.2 t -115.63 128.31 55.83 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 170.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -84.56 -43.34 14.59 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.706 0.765 . . . . 0.0 108.984 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -153.12 161.47 28.99 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -59.8 100.08 0.13 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.294 1.996 . . . . 0.0 112.336 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 121.38 -29.47 5.69 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -95.48 122.72 38.51 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -121.94 169.98 10.26 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 121.802 0.811 . . . . 0.0 110.907 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.411 ' HB ' ' HB2' ' A' ' 313' ' ' LYS . 72.8 m -152.1 128.72 10.78 Favored 'General case' 0 C--N 1.272 -2.787 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.376 -175.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -117.77 109.38 16.53 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 175.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . 0.647 ' HB3' HG13 ' A' ' 311' ' ' VAL . 9.3 tt0 -100.67 114.2 27.72 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 1.5 m -100.76 113.33 36.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 177.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -91.51 151.59 42.72 Favored Pre-proline 0 C--N 1.304 -1.378 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . 0.413 ' HG3' ' HB2' ' A' ' 236' ' ' ASN . 70.9 Cg_endo -81.68 134.01 8.42 Favored 'Trans proline' 0 N--CA 1.436 -1.887 0 C-N-CA 121.393 1.395 . . . . 0.0 109.948 173.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm . . . . . 0 N--CA 1.413 -2.291 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 175.99 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . 0.71 ' O ' HD23 ' A' ' 245' ' ' LEU . 12.8 pt20 . . . . . 0 C--O 1.199 -1.571 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 16.6 m -75.23 110.94 9.98 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 166.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.416 ' HB3' ' HB3' ' A' ' 243' ' ' ALA . 38.9 t30 -139.52 151.72 46.36 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.8 -166.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.748 HG21 HD21 ' A' ' 300' ' ' LEU . 2.5 pp -133.94 144.54 35.3 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.388 0 CA-C-N 114.265 -1.334 . . . . 0.0 107.941 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' A' ' 240' ' ' ILE . 8.4 t0 -145.02 157.44 44.12 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -172.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.476 ' CD2' HG11 ' A' ' 279' ' ' VAL . 85.4 t80 -136.95 135.05 37.37 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . 0.495 HH11 ' HB3' ' A' ' 231' ' ' ARG . 1.0 OUTLIER -156.77 174.29 15.7 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 176.869 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.447 ' HE3' HG22 ' A' ' 284' ' ' THR . 54.4 mtpt -118.07 153.92 32.93 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 120.462 0.172 . . . . 0.0 110.8 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -155.32 146.93 23.08 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 124.091 0.87 . . . . 0.0 109.019 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 69.96 -109.33 2.82 Favored Glycine 0 N--CA 1.447 -0.611 0 O-C-N 123.569 0.543 . . . . 0.0 113.735 174.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -123.76 83.49 2.14 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -177.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 61.03 24.15 14.28 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 176.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -80.46 140.56 35.87 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.16 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -100.17 109.54 3.73 Favored Glycine 0 N--CA 1.426 -1.998 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 230' ' ' PHE . 2.1 mp -98.6 114.51 36.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-N 117.144 0.472 . . . . 0.0 110.207 -176.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . 0.493 ' HA ' ' O ' ' A' ' 229' ' ' ASP . 3.7 mp -102.68 111.62 33.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 176.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 34.0 mt-10 -88.51 143.82 26.73 Favored 'General case' 0 N--CA 1.412 -2.334 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.629 175.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 13.5 tp -131.69 119.27 21.14 Favored 'General case' 0 C--N 1.27 -2.881 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.14 -177.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . 0.43 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -114.16 105.22 12.92 Favored 'General case' 0 C--N 1.276 -2.625 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -111.32 90.61 3.38 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.71 HD23 ' O ' ' A' ' 225' ' ' GLN . 4.0 mm? -81.92 118.25 22.8 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.257 -176.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 103.97 15.64 21.45 Favored Glycine 0 C--N 1.3 -1.471 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.361 178.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -115.15 116.23 28.05 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 121.067 0.46 . . . . 0.0 110.065 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -106.81 94.54 5.17 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.299 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 159.12 -161.98 32.38 Favored Glycine 0 N--CA 1.425 -2.087 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -118.36 140.76 28.58 Favored Pre-proline 0 C--N 1.298 -1.667 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.724 ' HB3' HD13 ' A' ' 264' ' ' LEU . 27.7 Cg_endo -73.67 165.42 32.37 Favored 'Trans proline' 0 N--CA 1.437 -1.796 0 C-N-CA 121.104 1.203 . . . . 0.0 110.17 176.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.582 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 11.9 t70 -87.63 106.56 18.1 Favored 'General case' 0 C--N 1.27 -2.866 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 177.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.431 HD11 ' HG2' ' A' ' 251' ' ' PRO . 5.3 mp -95.9 109.21 22.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 C-N-CA 119.354 -0.938 . . . . 0.0 109.669 175.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . 0.655 ' HB2' ' HB ' ' A' ' 261' ' ' ILE . 26.5 m -99.61 117.6 34.33 Favored 'General case' 0 C--N 1.277 -2.546 0 C-N-CA 125.001 1.32 . . . . 0.0 108.48 177.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -100.02 124.89 45.89 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -175.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.494 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 14.5 mm100 -122.62 171.07 9.4 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 171.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 61.2 m-70 -76.89 -41.03 45.37 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.743 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -81.03 -24.83 37.62 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.618 -173.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . 0.494 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 45.7 p-80 -165.08 163.17 20.58 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.039 0.447 . . . . 0.0 111.151 177.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 21.3 mt -107.15 141.87 21.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . 0.655 ' HB ' ' HB2' ' A' ' 254' ' ' SER . 3.8 mp -119.21 117.26 53.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 299' ' ' GLN . 0.7 OUTLIER -114.95 142.48 27.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 C-N-CA 119.207 -0.997 . . . . 0.0 108.814 176.816 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . 0.556 ' HA ' ' O ' ' A' ' 298' ' ' THR . 7.5 m -135.47 124.31 24.0 Favored 'General case' 0 C--N 1.291 -1.941 0 C-N-CA 119.825 -0.75 . . . . 0.0 112.064 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.724 HD13 ' HB3' ' A' ' 251' ' ' PRO . 1.9 mm? -97.2 100.24 11.71 Favored 'General case' 0 CA--C 1.467 -2.218 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 175.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.561 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 51.6 mtpt -68.39 126.67 30.34 Favored 'General case' 0 N--CA 1.405 -2.676 0 O-C-N 124.34 1.025 . . . . 0.0 113.235 -173.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 77.67 3.68 3.01 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 113.925 -1.489 . . . . 0.0 111.808 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -86.12 95.66 9.63 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 177.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.84 109.2 6.24 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.286 0.565 . . . . 0.0 111.592 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 23.8 tp -95.64 128.99 35.86 Favored Pre-proline 0 N--CA 1.433 -1.295 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.633 -178.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -71.69 154.87 59.33 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.157 2.571 . . . . 0.0 111.831 170.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 19.3 p -67.6 -29.45 68.79 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 123.206 0.602 . . . . 0.0 112.592 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 11.9 m -62.96 -22.03 66.51 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 123.714 0.806 . . . . 0.0 111.36 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 8.2 mp -96.94 -8.11 31.5 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.375 -175.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.585 HE21 ' HA ' ' A' ' 292' ' ' LYS . 47.7 mt-30 -77.78 136.35 38.11 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.755 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -161.13 165.72 29.1 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 176.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 16.9 m -134.46 138.26 44.61 Favored 'General case' 0 N--CA 1.414 -2.249 0 CA-C-O 121.351 0.596 . . . . 0.0 109.668 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.45 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 2.9 mm? -95.25 101.41 13.14 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -83.84 55.59 3.32 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.728 0.775 . . . . 0.0 109.567 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.476 HG11 ' CD2' ' A' ' 230' ' ' PHE . 13.3 m -81.17 59.56 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.218 -1.355 . . . . 0.0 112.751 -174.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -74.44 121.54 21.61 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.597 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . 0.367 20.4 m-20 58.42 51.91 7.71 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 179.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -85.38 -2.08 57.71 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 165.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 25.7 mmmt 67.02 61.16 0.5 Allowed 'General case' 0 CA--C 1.485 -1.536 0 CA-C-N 113.222 -1.808 . . . . 0.0 109.996 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' THR . . . . . 0.447 HG22 ' HE3' ' A' ' 232' ' ' LYS . 0.7 OUTLIER -138.91 165.09 34.91 Favored Pre-proline 0 N--CA 1.42 -1.938 0 N-CA-C 103.565 -2.754 . . . . 0.0 103.565 179.243 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . 0.401 ' HB3' ' HB3' ' A' ' 308' ' ' TRP . 18.3 Cg_exo -69.12 -15.55 39.58 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.323 1.349 . . . . 0.0 111.405 177.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.408 HG21 HD11 ' A' ' 240' ' ' ILE . 42.5 t -84.04 129.55 37.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -96.92 -39.56 9.33 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.261 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -160.36 140.54 11.46 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.223 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.45 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 41.8 t -104.67 126.36 59.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 173.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.519 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 48.2 m -128.58 122.74 31.67 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 117.957 0.344 . . . . 0.0 110.69 -177.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.561 ' HB2' HG12 ' A' ' 228' ' ' ILE . 52.0 tp -103.41 108.27 19.44 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.585 ' HA ' HE21 ' A' ' 274' ' ' GLN . 24.5 ttmm -112.06 125.47 54.13 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.286 -177.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . 0.414 ' H ' ' NE2' ' A' ' 274' ' ' GLN . 1.9 ptm180 -68.72 137.94 54.5 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 174.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.585 HD13 ' N ' ' A' ' 295' ' ' ASN . 2.6 tm? -117.4 162.8 17.34 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 -174.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.585 ' N ' HD13 ' A' ' 294' ' ' LEU . 66.5 t30 -14.92 -70.98 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 127.541 2.336 . . . . 0.0 112.972 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -125.46 -2.28 7.44 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 175.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . 0.561 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 10.9 m-20 -118.09 178.61 4.36 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.485 -165.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' A' ' 263' ' ' THR . 42.3 m -114.93 125.53 53.74 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 173.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . 0.591 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 9.0 tt0 -115.16 129.89 56.78 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 120.949 0.404 . . . . 0.0 111.157 -176.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.748 HD21 HG21 ' A' ' 228' ' ' ILE . 12.6 mt -100.58 132.0 46.19 Favored 'General case' 0 CA--C 1.451 -2.862 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.043 172.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' ILE . . . . . 0.519 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 65.5 mt -118.24 108.1 23.51 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.238 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 174.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 66.0 mt -109.89 105.21 18.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.364 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 4.0 m -78.56 129.33 34.7 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -174.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 8.4 p -131.57 153.13 50.19 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -175.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -131.16 147.28 52.59 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.859 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 75.26 -160.21 52.2 Favored Glycine 0 N--CA 1.438 -1.187 0 O-C-N 123.994 0.809 . . . . 0.0 113.07 176.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' ASN . . . . . 0.41 ' HB3' ' HB3' ' A' ' 327' ' ' LYS . 31.0 m-80 -93.97 132.64 38.24 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' TRP . . . . . 0.435 ' CE3' HG13 ' A' ' 324' ' ' VAL . 62.0 p-90 -148.05 168.0 23.48 Favored 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.083 -175.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -130.14 127.91 40.71 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -178.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 1.4 tt -96.25 125.89 41.08 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.697 HG13 ' HB3' ' A' ' 323' ' ' GLN . 7.2 p -130.17 112.54 23.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 169.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 321' ' ' THR . 22.4 t30 -103.58 141.83 35.35 Favored 'General case' 0 CA--C 1.45 -2.89 0 C-N-CA 119.584 -0.847 . . . . 0.0 111.17 -176.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -119.36 121.43 39.53 Favored 'General case' 1 N--CA 1.369 -4.488 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.659 -178.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 16.8 m -95.83 106.47 18.61 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 173.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -84.96 -32.71 22.89 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.079 -175.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.416 ' HB1' ' HD2' ' A' ' 317' ' ' PRO . . . -165.42 164.69 12.13 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -177.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' PRO . . . . . 0.416 ' HD2' ' HB1' ' A' ' 316' ' ' ALA . 28.1 Cg_endo -62.68 94.98 0.15 Allowed 'Trans proline' 0 C--O 1.243 0.736 0 C-N-CA 122.058 1.839 . . . . 0.0 111.143 177.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 124.89 -23.55 6.2 Favored Glycine 0 N--CA 1.423 -2.171 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.417 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -101.71 116.19 32.19 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 122.048 -0.678 . . . . 0.0 110.685 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' PHE . . . . . 0.498 ' CZ ' ' HD3' ' A' ' 251' ' ' PRO . 68.7 m-85 -130.53 159.13 38.04 Favored 'General case' 0 N--CA 1.428 -1.547 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.412 -177.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 312' ' ' ASN . 61.6 m -152.67 111.93 3.85 Favored 'General case' 0 C--N 1.273 -2.726 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.354 -176.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -98.05 105.32 17.45 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . 0.697 ' HB3' HG13 ' A' ' 311' ' ' VAL . 46.3 tt0 -91.21 100.36 13.19 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.435 HG13 ' CE3' ' A' ' 308' ' ' TRP . 93.4 t -88.08 98.83 8.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.519 0.676 . . . . 0.0 109.456 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.505 HD21 HE21 ' A' ' 323' ' ' GLN . 20.9 mt -87.74 152.46 51.53 Favored Pre-proline 0 C--N 1.285 -2.208 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.197 -178.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -81.83 138.2 10.35 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 121.503 1.468 . . . . 0.0 109.812 172.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 307' ' ' ASN . 23.5 ttmm . . . . . 0 CA--C 1.497 -1.078 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.587 -177.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . 0.484 ' CG ' HD21 ' A' ' 273' ' ' LEU . 1.8 tp60 . . . . . 0 N--CA 1.438 -1.036 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 16.4 m -62.33 126.25 26.69 Favored 'General case' 0 C--N 1.314 -0.974 0 O-C-N 123.572 0.545 . . . . 0.0 110.791 -178.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -153.33 173.36 15.71 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.254 -178.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.506 HG21 HD13 ' A' ' 300' ' ' LEU . 2.1 pp -137.66 156.89 32.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 C-N-CA 124.731 1.212 . . . . 0.0 109.394 -178.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . 0.458 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 1.1 t70 -150.59 156.99 42.46 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -127.79 137.2 52.32 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -153.31 161.98 41.78 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.441 ' HE3' HG22 ' A' ' 284' ' ' THR . 56.9 mtpt -110.65 158.01 19.07 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.597 178.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -155.12 168.22 27.75 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 55.92 -124.71 34.94 Favored Glycine 0 C--N 1.321 -0.29 0 O-C-N 123.704 0.628 . . . . 0.0 113.091 177.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -122.87 100.68 7.02 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 176.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . 0.617 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 94.0 m-20 63.02 24.55 14.59 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 124.16 0.912 . . . . 0.0 112.939 176.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -82.59 141.03 32.89 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -103.47 110.09 3.59 Favored Glycine 0 N--CA 1.429 -1.827 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.441 ' HA ' ' O ' ' A' ' 322' ' ' PHE . 2.0 mp -104.2 119.91 53.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 121.171 0.51 . . . . 0.0 110.223 -177.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.7 mp -104.14 114.08 42.78 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 175.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 49.2 mt-10 -89.43 142.97 27.19 Favored 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 175.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 15.3 tp -134.44 134.29 41.43 Favored 'General case' 0 C--N 1.276 -2.614 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.691 -175.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -127.25 110.33 12.74 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.174 178.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -115.05 91.6 3.67 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.417 0.627 . . . . 0.0 109.891 178.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -83.48 115.32 22.02 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.895 -177.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 111.62 13.81 12.33 Favored Glycine 0 C--N 1.299 -1.527 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.526 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -116.08 124.18 49.76 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -107.13 93.83 4.77 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 143.97 -157.81 27.21 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 177.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -113.88 148.85 40.8 Favored Pre-proline 0 C--N 1.314 -0.942 0 C-N-CA 123.06 0.544 . . . . 0.0 109.754 177.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.732 ' HB3' HD13 ' A' ' 264' ' ' LEU . 14.2 Cg_endo -74.24 172.14 16.62 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.698 2.265 . . . . 0.0 112.192 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.489 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 34.4 t70 -95.37 111.72 23.55 Favored 'General case' 0 C--N 1.286 -2.191 0 C-N-CA 124.275 1.03 . . . . 0.0 108.694 177.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 4.1 mp -104.91 128.03 58.96 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.329 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . 0.433 ' HB3' ' HB ' ' A' ' 261' ' ' ILE . 14.1 t -111.43 124.58 52.55 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 174.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -102.63 102.55 12.77 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.14 0.495 . . . . 0.0 112.052 -173.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.5 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 78.8 mt-30 -109.8 158.47 18.11 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 172.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 50.9 m80 -73.42 -36.08 65.91 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -176.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -85.67 -16.1 40.19 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.405 -0.518 . . . . 0.0 112.241 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . 0.5 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 45.4 p-80 -170.69 156.03 5.07 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-O 121.044 0.449 . . . . 0.0 111.717 176.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.489 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 39.6 mt -106.95 141.73 21.44 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . 0.433 ' HB ' ' HB3' ' A' ' 254' ' ' SER . 3.1 mp -121.66 116.3 49.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 299' ' ' GLN . 1.9 m -112.5 139.31 37.99 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.526 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 177.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 298' ' ' THR . 19.3 m -135.0 127.82 31.2 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-O 121.3 0.572 . . . . 0.0 110.855 178.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.732 HD13 ' HB3' ' A' ' 251' ' ' PRO . 1.9 mm? -97.91 106.38 18.67 Favored 'General case' 0 CA--C 1.47 -2.107 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 176.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.564 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 31.8 mmmt -68.82 127.94 34.9 Favored 'General case' 0 N--CA 1.414 -2.247 0 O-C-N 124.309 1.006 . . . . 0.0 113.149 -174.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 62.8 t30 65.65 26.29 11.51 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 112.771 -2.013 . . . . 0.0 110.699 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 45.8 t60 -106.98 112.18 25.02 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.95 125.04 28.76 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 27.0 tp -111.14 125.32 30.82 Favored Pre-proline 0 N--CA 1.435 -1.216 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.251 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.485 ' HD2' HD22 ' A' ' 273' ' ' LEU . 24.1 Cg_exo -68.35 148.13 73.21 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.585 2.19 . . . . 0.0 111.399 170.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . 0.55 ' HB ' ' HD2' ' A' ' 293' ' ' ARG . 6.1 t -71.47 -11.1 60.7 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.327 0.584 . . . . 0.0 112.112 -177.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 19.3 m -79.76 -21.15 44.77 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.521 0.677 . . . . 0.0 110.366 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.485 HD22 ' HD2' ' A' ' 270' ' ' PRO . 8.0 mp -96.59 -13.24 23.04 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.391 -174.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 271' ' ' THR . 18.7 pt20 -83.01 107.55 15.69 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-O 122.023 0.916 . . . . 0.0 109.135 -178.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -134.33 176.49 8.56 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 24.1 p -133.62 138.31 45.88 Favored 'General case' 0 N--CA 1.413 -2.289 0 CA-C-O 121.395 0.617 . . . . 0.0 111.06 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.491 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 2.1 mm? -87.19 122.34 30.86 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 103.823 -2.658 . . . . 0.0 103.823 173.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -67.65 -41.02 84.46 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.486 ' HA ' ' CD1' ' A' ' 282' ' ' PHE . 14.8 p 41.65 27.25 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 127.489 2.316 . . . . 0.0 114.46 173.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -82.46 135.41 35.14 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.844 177.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 3.0 t70 72.59 25.76 2.59 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 125.269 1.428 . . . . 0.0 111.386 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.486 ' CD1' ' HA ' ' A' ' 279' ' ' VAL . 5.1 m-85 -88.43 -7.51 56.49 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.642 174.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? 55.09 60.64 3.33 Favored 'General case' 0 CA--C 1.509 -0.625 0 C-N-CA 124.56 1.144 . . . . 0.0 112.027 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' THR . . . . . 0.441 HG22 ' HE3' ' A' ' 232' ' ' LYS . 2.4 p -133.11 173.94 5.29 Favored Pre-proline 0 C--N 1.302 -1.47 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 178.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . 0.617 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 6.6 Cg_exo -77.65 -5.07 15.18 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 121.954 1.769 . . . . 0.0 110.796 176.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 54.4 t -90.72 137.94 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -99.44 -43.45 6.54 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.786 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . 0.425 ' HA ' HG12 ' A' ' 279' ' ' VAL . 22.6 ttmm -163.07 134.79 5.07 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -178.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.491 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 44.4 t -99.08 120.18 48.07 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.329 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 176.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 32.2 m -127.01 115.32 19.03 Favored 'General case' 0 C--N 1.284 -2.259 0 O-C-N 122.111 -0.368 . . . . 0.0 111.53 -176.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.499 ' HB2' HG12 ' A' ' 228' ' ' ILE . 49.1 tp -94.17 133.84 37.25 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -130.55 134.1 46.75 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -175.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . 0.55 ' HD2' ' HB ' ' A' ' 271' ' ' THR . 3.8 ptm180 -79.41 137.95 37.45 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 173.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.559 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 23.4 tp -111.57 178.98 4.15 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.559 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 63.0 t30 -49.68 -63.72 1.02 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 124.125 0.97 . . . . 0.0 112.517 -177.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -118.66 -2.91 10.89 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 120.673 0.273 . . . . 0.0 111.22 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . 0.564 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 20.6 m-20 -124.88 177.93 5.76 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.707 0.765 . . . . 0.0 110.9 -170.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.539 ' O ' ' HA ' ' A' ' 263' ' ' THR . 50.2 m -114.3 127.77 56.03 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 174.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . 0.508 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 27.8 tt0 -116.05 126.13 53.36 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -176.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.506 HD13 HG21 ' A' ' 228' ' ' ILE . 63.7 tp -110.77 120.24 41.76 Favored 'General case' 0 N--CA 1.417 -2.119 0 CA-C-O 121.164 0.507 . . . . 0.0 110.125 178.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' ILE . . . . . 0.4 HD11 HE21 ' A' ' 299' ' ' GLN . 57.8 mt -106.65 109.84 29.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -177.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . 0.489 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 66.5 mt -108.01 107.78 23.65 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 18.1 m -77.77 133.46 38.25 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 12.5 p -135.18 173.85 11.26 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 122.831 0.452 . . . . 0.0 111.081 -175.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -156.28 147.08 21.93 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 120.526 0.203 . . . . 0.0 110.57 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 80.83 -159.23 41.75 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 115.701 -0.682 . . . . 0.0 113.651 174.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' ASN . . . . . 0.509 ' HB3' ' HB3' ' A' ' 327' ' ' LYS . 0.7 OUTLIER -90.34 123.29 33.97 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 176.141 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -149.12 162.79 39.27 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -177.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . 0.565 ' HG2' ' HE2' ' A' ' 327' ' ' LYS . 8.6 mt-10 -119.04 137.52 53.49 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -178.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 1.1 tt -104.91 118.3 36.2 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.473 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 32.4 t -118.71 107.78 22.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 174.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -95.75 139.35 32.11 Favored 'General case' 0 C--N 1.311 -1.109 0 C-N-CA 119.093 -1.043 . . . . 0.0 109.207 177.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -125.86 134.93 51.47 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -177.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 28.6 t -115.74 111.88 21.2 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -80.03 -28.42 39.33 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.734 0.778 . . . . 0.0 109.82 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -166.75 160.15 11.5 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -64.71 101.13 0.36 Allowed 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 121.66 1.573 . . . . 0.0 109.837 176.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 127.81 -27.65 4.58 Favored Glycine 0 N--CA 1.426 -1.982 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.96 -176.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -108.36 118.43 36.75 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.864 -0.786 . . . . 0.0 110.818 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' PHE . . . . . 0.583 ' CZ ' ' HD3' ' A' ' 251' ' ' PRO . 48.2 m-85 -128.46 165.76 20.05 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-O 122.143 0.973 . . . . 0.0 110.902 -174.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 70.0 m -152.36 136.82 16.78 Favored 'General case' 0 C--N 1.269 -2.909 0 CA-C-N 114.518 -1.219 . . . . 0.0 107.848 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 0.441 ' O ' ' HA ' ' A' ' 239' ' ' ILE . 79.8 m-85 -119.88 117.69 28.79 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . 0.473 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 33.9 tt0 -101.55 100.26 10.66 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 91.3 t -88.79 102.03 12.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 50.8 mt -95.07 140.46 22.45 Favored Pre-proline 0 C--N 1.29 -1.988 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.161 -176.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -72.36 126.95 12.09 Favored 'Trans proline' 0 C--O 1.251 1.129 0 C-N-CA 121.431 1.421 . . . . 0.0 109.806 174.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.565 ' HE2' ' HG2' ' A' ' 309' ' ' GLU . 38.2 ttmt . . . . . 0 C--N 1.305 -1.365 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 . . . . . 0 N--CA 1.444 -0.763 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.526 HG23 ' HA ' ' A' ' 244' ' ' ALA . 59.5 m -61.39 129.72 42.59 Favored 'General case' 0 C--O 1.208 -1.125 0 C-N-CA 125.153 1.381 . . . . 0.0 111.632 -173.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -157.3 171.59 20.13 Favored 'General case' 0 CA--C 1.488 -1.43 0 CA-C-O 121.022 0.439 . . . . 0.0 110.462 -176.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.614 HG21 HD13 ' A' ' 300' ' ' LEU . 2.8 pp -130.27 155.65 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.199 179.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . 0.487 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 18.8 t0 -144.64 156.27 44.03 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 -177.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.451 ' CE2' HG21 ' A' ' 279' ' ' VAL . 61.8 t80 -131.91 138.6 48.45 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 175.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -155.11 157.55 37.65 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -104.57 151.86 23.11 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.603 175.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -168.05 -174.87 2.47 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 61.81 -117.88 12.92 Favored Glycine 0 N--CA 1.445 -0.761 0 O-C-N 123.446 0.466 . . . . 0.0 113.03 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . 0.415 ' HE2' ' HB2' ' A' ' 235' ' ' LYS . 13.7 tppt? -126.96 79.91 1.91 Allowed 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -178.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 58.9 29.26 18.63 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.557 0.694 . . . . 0.0 111.249 -177.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.436 ' HB2' HD23 ' A' ' 325' ' ' LEU . . . -84.24 148.44 26.71 Favored 'General case' 0 N--CA 1.416 -2.168 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.305 -176.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -98.81 108.17 3.55 Favored Glycine 0 N--CA 1.418 -2.534 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.451 HG13 ' HG3' ' A' ' 323' ' ' GLN . 2.6 mp -101.49 118.84 48.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-N 117.391 0.596 . . . . 0.0 110.193 -177.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.8 mp -104.73 110.94 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.401 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 176.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.487 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 41.2 mt-10 -87.83 143.23 27.25 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 173.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 14.5 tp -132.12 125.97 32.59 Favored 'General case' 0 C--N 1.273 -2.719 0 CA-C-O 121.52 0.676 . . . . 0.0 111.044 -174.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . 0.48 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -113.73 105.73 13.65 Favored 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.526 ' HA ' HG23 ' A' ' 226' ' ' THR . . . -112.32 91.72 3.76 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.601 0.715 . . . . 0.0 109.119 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -81.73 112.52 18.97 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.398 -173.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 107.97 3.41 34.04 Favored Glycine 0 N--CA 1.427 -1.936 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.378 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' PHE . . . . . 0.457 ' CD2' HD12 ' A' ' 264' ' ' LEU . 37.8 t80 -115.82 107.96 15.7 Favored 'General case' 0 C--O 1.212 -0.908 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -102.22 3.28 38.13 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.006 0.431 . . . . 0.0 112.093 -177.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -95.35 -153.74 30.3 Favored Glycine 0 C--N 1.308 -1.012 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.638 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -116.16 137.64 23.6 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 177.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.774 ' HB3' HD13 ' A' ' 264' ' ' LEU . 17.4 Cg_endo -71.83 172.09 15.22 Favored 'Trans proline' 0 N--CA 1.439 -1.711 0 C-N-CA 122.029 1.819 . . . . 0.0 110.904 175.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -99.94 109.57 21.92 Favored 'General case' 0 C--N 1.275 -2.659 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 176.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 4.0 mp -100.11 124.19 53.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-O 121.079 0.466 . . . . 0.0 110.131 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 9.4 t -113.31 106.03 14.12 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 174.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -79.87 103.74 9.97 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.677 178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.512 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 77.8 mt-30 -124.16 152.06 43.28 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 175.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -71.07 -42.44 69.4 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -173.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -76.07 -24.63 55.1 Favored 'General case' 0 C--N 1.314 -0.978 0 O-C-N 123.442 0.464 . . . . 0.0 111.523 -176.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . 0.512 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 43.0 p-80 -170.19 158.38 6.82 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-O 120.549 0.214 . . . . 0.0 110.898 175.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 16.6 mt -105.94 141.45 21.23 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . 0.42 HD12 ' N ' ' A' ' 261' ' ' ILE . 3.1 mp -116.81 113.11 41.98 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.432 ' HB ' ' HB3' ' A' ' 300' ' ' LEU . 54.6 t -113.6 115.91 51.09 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 176.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' A' ' 298' ' ' THR . 41.6 m -121.65 126.24 48.55 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-O 121.48 0.657 . . . . 0.0 112.218 -177.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.774 HD13 ' HB3' ' A' ' 251' ' ' PRO . 1.6 mm? -94.38 104.09 16.08 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 177.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.588 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 30.1 mtpt -69.05 127.57 33.6 Favored 'General case' 0 N--CA 1.41 -2.446 0 O-C-N 124.204 0.94 . . . . 0.0 113.487 -173.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 64.4 t30 68.26 16.66 9.33 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 113.817 -1.538 . . . . 0.0 111.386 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' HIS . . . . . 0.44 ' ND1' ' HB2' ' A' ' 247' ' ' PHE . 54.6 t60 -95.46 107.74 19.91 Favored 'General case' 0 C--O 1.213 -0.821 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 174.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 1.2 p -82.92 109.79 17.34 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-O 120.889 0.376 . . . . 0.0 111.618 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . 0.413 HD22 HD22 ' A' ' 291' ' ' LEU . 23.4 tp -93.22 127.49 46.71 Favored Pre-proline 0 N--CA 1.436 -1.128 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.543 178.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -68.54 159.31 54.05 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 122.381 2.054 . . . . 0.0 111.544 171.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 19.6 p -66.69 -37.13 84.11 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.063 0.459 . . . . 0.0 111.544 -177.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 3.0 m -59.21 -19.35 44.7 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 124.66 1.184 . . . . 0.0 112.456 -178.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -95.96 -12.82 24.45 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 122.195 -0.316 . . . . 0.0 111.044 -176.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -72.31 142.11 48.85 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -163.86 155.38 16.52 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 175.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 16.6 m -122.84 123.7 41.6 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 64.4 mt -95.17 113.27 24.93 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -177.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -76.81 81.5 3.4 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.937 0.875 . . . . 0.0 108.95 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.48 HG23 ' CG ' ' A' ' 282' ' ' PHE 0.282 1.5 p -98.37 69.75 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 CA-C-O 123.723 1.725 . . . . 0.0 111.642 -178.532 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -114.69 145.67 41.78 Favored 'General case' 0 N--CA 1.419 -1.993 0 CA-C-N 113.026 -1.897 . . . . 0.0 106.846 177.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 23.3 t70 68.19 18.22 9.3 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 122.494 1.14 . . . . 0.0 110.879 -178.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.48 ' CG ' HG23 ' A' ' 279' ' ' VAL . 31.2 m-85 -86.18 -13.84 45.79 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.599 -0.688 . . . . 0.0 109.344 174.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.79 60.62 1.55 Allowed 'General case' 0 CA--C 1.493 -1.22 0 C-N-CA 123.606 0.762 . . . . 0.0 110.822 -178.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -137.02 168.94 14.68 Favored Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 104.109 -2.552 . . . . 0.0 104.109 178.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -71.06 -13.19 31.24 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 121.482 1.455 . . . . 0.0 111.773 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 47.1 t -85.88 132.39 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 123.428 0.691 . . . . 0.0 109.343 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -101.57 -29.2 12.09 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.405 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -171.92 134.32 0.77 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.736 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 59.8 t -96.69 132.12 41.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 173.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.42 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 98.8 m -136.72 117.49 14.05 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.803 -0.56 . . . . 0.0 111.772 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.523 ' HB2' HG12 ' A' ' 228' ' ' ILE . 0.1 OUTLIER -97.41 116.77 30.24 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 179.385 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -126.21 136.45 52.84 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -78.74 144.44 35.22 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 176.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.583 HD13 ' N ' ' A' ' 295' ' ' ASN . 2.6 tm? -118.06 163.25 16.89 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 105.942 -1.874 . . . . 0.0 105.942 -178.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.583 ' N ' HD13 ' A' ' 294' ' ' LEU . 4.5 t30 -29.39 -58.33 0.15 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.355 1.862 . . . . 0.0 113.754 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.58 -6.31 7.52 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . 0.588 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 6.0 m-20 -125.39 174.63 8.04 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.595 -160.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 263' ' ' THR . 56.1 m -115.34 120.09 38.45 Favored 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 175.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -110.92 117.31 33.03 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-O 121.696 0.76 . . . . 0.0 109.747 -176.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.614 HD13 HG21 ' A' ' 228' ' ' ILE . 46.1 tp -103.53 117.97 35.67 Favored 'General case' 0 C--N 1.263 -3.188 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' ILE . . . . . 0.42 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 63.3 mt -102.38 109.74 27.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 CA-C-N 114.566 -1.197 . . . . 0.0 107.88 -177.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 58.0 mt -108.71 100.3 10.47 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 27.7 m -72.52 132.17 43.48 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 7.4 p -138.49 174.82 10.14 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 123.482 0.713 . . . . 0.0 110.498 -176.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -158.55 137.43 11.27 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 117.514 0.143 . . . . 0.0 110.996 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 91.66 -157.68 24.7 Favored Glycine 0 N--CA 1.442 -0.908 0 O-C-N 123.508 0.505 . . . . 0.0 112.836 174.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' ASN . . . . . 0.414 ' HB3' ' HB3' ' A' ' 327' ' ' LYS . 76.5 m-20 -93.2 124.07 36.92 Favored 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' TRP . . . . . 0.465 ' CE3' HG13 ' A' ' 324' ' ' VAL . 70.3 p-90 -148.32 166.09 29.07 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -178.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -124.32 130.26 52.18 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -175.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 1.7 tt -100.73 122.67 43.75 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.598 HG13 ' HB3' ' A' ' 323' ' ' GLN . 7.6 p -123.34 114.77 43.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.612 171.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -98.32 144.82 27.31 Favored 'General case' 0 N--CA 1.424 -1.748 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.037 -178.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -131.58 141.06 49.59 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -178.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 78.0 p -111.64 115.43 29.11 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 173.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -76.16 -35.85 59.01 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -166.84 162.92 11.0 Favored Pre-proline 0 C--N 1.309 -1.19 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.77 97.06 0.32 Allowed 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.712 1.608 . . . . 0.0 110.177 176.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 129.37 -15.23 5.8 Favored Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -176.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -122.58 116.33 23.68 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 122.372 -0.487 . . . . 0.0 109.821 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -124.31 164.6 19.26 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.827 0.823 . . . . 0.0 110.661 -175.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 91.3 m -152.44 135.71 15.83 Favored 'General case' 0 C--N 1.267 -3.002 0 CA-C-N 114.871 -1.058 . . . . 0.0 108.846 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -124.06 117.86 25.66 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . 0.598 ' HB3' HG13 ' A' ' 311' ' ' VAL . 45.8 tt0 -102.26 103.43 13.91 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.465 HG13 ' CE3' ' A' ' 308' ' ' TRP . 92.7 t -87.13 98.94 7.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.507 HD21 HE21 ' A' ' 323' ' ' GLN . 32.1 mt -87.47 143.57 34.33 Favored Pre-proline 0 C--N 1.294 -1.813 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.667 -177.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -75.6 132.55 14.75 Favored 'Trans proline' 0 N--CA 1.458 -0.618 0 C-N-CA 121.93 1.753 . . . . 0.0 109.965 173.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.414 ' HB3' ' HB3' ' A' ' 307' ' ' ASN . 23.6 ttmm . . . . . 0 C--N 1.301 -1.525 0 C-N-CA 120.056 -0.657 . . . . 0.0 110.417 -178.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . 0.421 ' O ' HD23 ' A' ' 245' ' ' LEU . 3.9 pt20 . . . . . 0 N--CA 1.431 -1.424 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.575 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 21.2 m -64.48 116.28 5.98 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 176.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -148.68 158.19 43.97 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.301 -170.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.624 HG21 HD21 ' A' ' 300' ' ' LEU . 2.7 pp -137.04 147.61 26.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -142.02 157.27 45.13 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 123.533 0.733 . . . . 0.0 109.991 -174.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.542 ' CD1' HG11 ' A' ' 279' ' ' VAL . 56.3 t80 -133.21 138.52 46.57 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.217 0.532 . . . . 0.0 111.254 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -155.94 164.53 38.37 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 172.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.423 ' HE3' HG22 ' A' ' 284' ' ' THR . 55.7 mtpt -104.48 162.58 13.12 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.929 178.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . 0.52 ' O ' ' HB3' ' A' ' 237' ' ' ALA . 15.8 t70 -157.97 125.62 5.21 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 81.53 -126.63 7.5 Favored Glycine 0 C--N 1.297 -1.586 0 C-N-CA 121.143 -0.551 . . . . 0.0 113.441 174.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -105.14 90.9 3.58 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -174.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . 0.539 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 17.6 m120 62.83 17.15 9.68 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.023 -0.99 . . . . 0.0 112.724 175.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 233' ' ' ASP . . . -83.51 140.93 31.99 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -176.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . 0.431 ' C ' HD12 ' A' ' 239' ' ' ILE . . . -101.64 130.27 10.18 Favored Glycine 0 N--CA 1.432 -1.596 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 178.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 230' ' ' PHE . 2.3 mp -118.45 117.28 54.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 117.651 0.725 . . . . 0.0 110.985 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.0 mp -104.16 109.43 27.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 176.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -91.39 118.23 30.35 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-O 121.558 0.694 . . . . 0.0 109.348 178.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 9.8 tp -108.7 117.06 33.19 Favored 'General case' 0 C--N 1.272 -2.775 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.754 -175.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . 0.575 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -103.19 94.4 5.5 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 176.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -101.92 90.93 4.15 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.69 0.757 . . . . 0.0 109.455 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.421 HD23 ' O ' ' A' ' 225' ' ' GLN . 3.6 mm? -88.09 115.29 25.46 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.672 0.749 . . . . 0.0 110.804 -177.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 123.21 -8.27 9.07 Favored Glycine 0 N--CA 1.423 -2.178 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.517 -176.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' PHE . . . . . 0.474 ' CD2' HD12 ' A' ' 264' ' ' LEU . 30.4 t80 -115.4 127.0 55.07 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -109.4 -19.15 13.37 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.901 -177.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -87.48 -140.99 6.8 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.921 -177.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -125.14 132.37 24.3 Favored Pre-proline 0 C--N 1.314 -0.943 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.718 ' HB3' HD13 ' A' ' 264' ' ' LEU . 14.1 Cg_endo -69.63 171.68 13.89 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.534 2.156 . . . . 0.0 111.679 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.619 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 33.3 t70 -91.32 105.88 18.1 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 176.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.544 HD11 ' HG2' ' A' ' 251' ' ' PRO . 5.2 mp -101.74 108.99 24.84 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.636 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . 0.538 ' HB3' ' HB ' ' A' ' 261' ' ' ILE . 23.3 t -91.18 112.17 23.97 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -89.42 103.22 15.87 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.204 0.526 . . . . 0.0 111.241 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.634 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 13.9 mm100 -119.51 154.94 33.05 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 177.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . 0.426 ' HA ' ' HE1' ' A' ' 308' ' ' TRP . 37.4 m80 -76.67 -30.91 56.98 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.329 0.585 . . . . 0.0 109.662 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -68.3 -39.48 82.05 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.681 -1.145 . . . . 0.0 112.151 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . 0.634 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 39.5 p-80 -175.6 166.82 3.23 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.402 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 20.7 mt -105.87 133.21 50.89 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 106.552 -1.648 . . . . 0.0 106.552 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . 0.538 ' HB ' ' HB3' ' A' ' 254' ' ' SER . 3.4 mp -114.96 115.9 50.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 179.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.619 ' HA ' ' O ' ' A' ' 252' ' ' ASP . 0.8 OUTLIER -113.89 140.64 33.35 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.394 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 298' ' ' THR . 20.2 m -134.09 124.04 25.48 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.517 0.675 . . . . 0.0 111.887 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.718 HD13 ' HB3' ' A' ' 251' ' ' PRO . 1.8 mm? -98.14 108.12 20.75 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.482 ' HD3' ' OD1' ' A' ' 297' ' ' ASP . 59.4 mmtt -67.28 131.49 45.85 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 124.213 0.946 . . . . 0.0 113.549 -177.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 73.68 6.75 5.0 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.565 -1.652 . . . . 0.0 110.357 176.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -95.72 99.61 11.43 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.084 -174.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 19.3 p -77.56 108.96 11.11 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-O 121.224 0.535 . . . . 0.0 111.03 -178.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . 0.452 HD12 ' HD2' ' A' ' 270' ' ' PRO . 30.1 tp -89.92 128.38 50.27 Favored Pre-proline 0 N--CA 1.43 -1.438 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.12 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.452 ' HD2' HD12 ' A' ' 269' ' ' LEU . 16.0 Cg_exo -70.83 157.7 57.6 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.643 2.228 . . . . 0.0 111.905 171.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . 0.474 ' HA ' ' OE1' ' A' ' 274' ' ' GLN . 6.7 p -66.87 -38.35 86.17 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.582 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 11.4 m -59.88 -26.3 65.77 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 124.656 1.182 . . . . 0.0 112.516 -178.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 8.5 mp -96.27 2.48 52.93 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.566 0.698 . . . . 0.0 110.814 -172.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.627 HE21 ' HA ' ' A' ' 292' ' ' LYS . 50.7 mt-30 -84.45 123.54 30.36 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.121 178.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . 0.534 ' HD2' ' O ' ' A' ' 228' ' ' ILE . 3.7 ptp180 -137.33 162.4 33.68 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 177.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 289' ' ' VAL . 24.5 t -139.86 126.77 20.79 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.528 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 1.1 mm? -98.16 111.43 23.76 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 124.925 1.29 . . . . 0.0 108.728 -176.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -86.62 92.68 8.99 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.542 HG11 ' CD1' ' A' ' 230' ' ' PHE . 11.8 m -102.32 28.03 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 CA-C-N 114.404 -1.271 . . . . 0.0 112.187 -175.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -67.4 140.49 57.18 Favored 'General case' 0 N--CA 1.403 -2.82 0 CA-C-N 114.062 -1.427 . . . . 0.0 107.591 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 34.4 t70 73.71 4.02 4.62 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 124.892 1.277 . . . . 0.0 113.119 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -75.61 -3.32 33.76 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.475 -0.766 . . . . 0.0 111.492 174.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm 60.64 58.41 2.45 Favored 'General case' 0 CA--C 1.504 -0.81 0 C-N-CA 124.171 0.989 . . . . 0.0 111.007 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 236' ' ' ASN . 1.4 p -136.57 168.47 16.87 Favored Pre-proline 0 N--CA 1.428 -1.546 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 15.7 Cg_exo -71.58 -14.58 30.52 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 121.863 1.709 . . . . 0.0 110.892 176.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 21.4 t -84.18 139.75 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -103.18 -45.36 4.94 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.164 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 277' ' ' LEU . 7.3 ttpm? -163.22 137.61 6.18 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.437 -179.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.528 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 39.9 t -100.67 122.75 53.05 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.34 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 57.7 m -129.26 124.81 35.39 Favored 'General case' 0 C--N 1.28 -2.433 0 CA-C-O 121.217 0.532 . . . . 0.0 110.98 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.612 ' HB2' HG12 ' A' ' 228' ' ' ILE . 45.8 tp -100.04 113.38 25.94 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.627 ' HA ' HE21 ' A' ' 274' ' ' GLN . 40.8 ttmt -115.23 129.34 56.61 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -178.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . 0.455 ' H ' ' NE2' ' A' ' 274' ' ' GLN . 13.8 ptt180 -72.95 142.83 47.82 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 175.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.585 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 19.3 tp -108.38 -173.46 2.28 Favored 'General case' 0 C--N 1.274 -2.692 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.585 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 3.8 t-20 -52.57 -64.02 0.95 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.327 0.584 . . . . 0.0 112.079 -177.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -125.07 -3.49 7.57 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.817 0.818 . . . . 0.0 109.323 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . 0.482 ' OD1' ' HD3' ' A' ' 265' ' ' LYS . 49.6 m-20 -117.05 171.72 7.74 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.054 -175.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.572 ' O ' ' HA ' ' A' ' 263' ' ' THR . 27.2 m -108.05 133.7 51.98 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . 0.614 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 8.2 tt0 -121.44 131.71 54.32 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 118.462 0.574 . . . . 0.0 111.304 -177.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.624 HD21 HG21 ' A' ' 228' ' ' ILE . 9.1 mt -100.45 135.41 41.93 Favored 'General case' 0 CA--C 1.45 -2.902 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.39 170.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 62.6 mt -121.18 108.11 21.83 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 173.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . 0.402 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 56.0 mt -113.22 97.8 6.18 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.733 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . 0.416 ' HA ' ' HB3' ' A' ' 259' ' ' HIS . 13.7 m -67.7 130.31 42.62 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -176.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 16.8 p -133.26 167.58 20.12 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 123.279 0.362 . . . . 0.0 110.671 -177.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -152.58 141.0 20.66 Favored 'General case' 0 C--O 1.248 0.976 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 87.24 -168.22 38.43 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 121.376 -0.44 . . . . 0.0 112.259 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -86.48 131.96 34.05 Favored 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 177.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' TRP . . . . . 0.711 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 63.4 p-90 -150.34 164.08 36.72 Favored 'General case' 0 N--CA 1.418 -2.036 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.119 -177.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 324' ' ' VAL . 10.2 mt-10 -122.21 135.45 54.77 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 -178.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.711 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 19.8 tp -107.28 115.26 29.86 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.406 -178.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 28.3 t -116.22 105.26 18.04 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 174.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . 0.405 ' HA ' ' O ' ' A' ' 321' ' ' THR . 25.6 t30 -98.45 134.39 41.5 Favored 'General case' 0 CA--C 1.432 -3.574 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 177.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 54.4 mttm -119.38 120.58 37.3 Favored 'General case' 1 N--CA 1.362 -4.826 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.541 -177.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 39.2 m -82.97 103.53 12.5 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 172.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -71.74 -31.71 66.96 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.992 -177.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.469 ' HB1' ' HD2' ' A' ' 317' ' ' PRO . . . -170.12 166.55 5.24 Favored Pre-proline 0 C--N 1.311 -1.09 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 -178.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' PRO . . . . . 0.469 ' HD2' ' HB1' ' A' ' 316' ' ' ALA . 23.2 Cg_endo -60.02 104.78 0.25 Allowed 'Trans proline' 0 C--O 1.246 0.913 0 C-N-CA 121.988 1.792 . . . . 0.0 112.137 178.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 107.77 -13.83 38.34 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.134 -178.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 319' ' ' TYR . . . . . 0.402 ' CD1' ' HB3' ' A' ' 316' ' ' ALA . 97.7 m-85 -108.56 116.19 31.51 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.991 -0.711 . . . . 0.0 109.136 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' PHE . . . . . 0.489 ' CZ ' ' HD3' ' A' ' 251' ' ' PRO . 83.5 m-85 -121.49 160.34 24.4 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.593 0.711 . . . . 0.0 110.137 -176.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 312' ' ' ASN . 94.8 m -152.96 105.88 2.98 Favored 'General case' 0 C--N 1.273 -2.738 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.335 -175.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -94.1 110.47 22.18 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 -178.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . 0.533 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 51.2 tt0 -97.63 99.98 11.37 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 176.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.41 HG23 ' CE3' ' A' ' 308' ' ' TRP . 0.1 OUTLIER -96.26 104.07 15.43 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.323 0 CA-C-O 122.642 1.21 . . . . 0.0 110.052 179.258 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 21.3 mt -95.22 149.54 36.35 Favored Pre-proline 0 C--N 1.296 -1.745 0 CA-C-N 113.238 -1.801 . . . . 0.0 109.555 -174.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -76.35 123.84 7.38 Favored 'Trans proline' 0 C--O 1.247 0.971 0 C-N-CA 121.78 1.653 . . . . 0.0 109.937 173.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm . . . . . 0 C--N 1.306 -1.312 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.363 -176.584 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . 0.427 ' HG2' HD11 ' A' ' 273' ' ' LEU . 7.1 tt0 . . . . . 0 N--CA 1.451 -0.419 0 N-CA-C 104.254 -2.499 . . . . 0.0 104.254 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.554 ' O ' HD13 ' A' ' 273' ' ' LEU . 11.0 m -64.88 147.72 52.78 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 118.454 0.57 . . . . 0.0 111.05 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -173.92 169.42 4.08 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 120.919 0.39 . . . . 0.0 110.323 173.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.443 HG21 HD13 ' A' ' 300' ' ' LEU . 2.8 pp -124.25 158.81 30.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . 0.552 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 4.4 t70 -150.38 156.21 41.07 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -138.37 136.51 36.4 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 118.145 0.429 . . . . 0.0 111.368 177.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -149.43 166.38 29.25 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.573 173.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -103.92 139.72 38.69 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -151.39 169.57 21.69 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 59.3 -129.51 49.26 Favored Glycine 0 C--N 1.304 -1.233 0 N-CA-C 114.275 0.47 . . . . 0.0 114.275 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -118.33 89.44 3.12 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 123.889 0.876 . . . . 0.0 109.506 -176.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 54.08 33.8 18.52 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 122.221 1.01 . . . . 0.0 112.338 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.3 140.55 29.64 Favored 'General case' 0 N--CA 1.405 -2.685 0 CA-C-N 114.124 -1.398 . . . . 0.0 108.496 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . 0.407 ' O ' HG13 ' A' ' 324' ' ' VAL . . . -100.77 124.64 8.32 Favored Glycine 0 N--CA 1.422 -2.285 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.2 mp -112.62 118.34 57.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-N 117.602 0.701 . . . . 0.0 110.416 -177.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.0 mp -105.02 112.44 38.64 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 177.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 52.8 mt-10 -90.34 142.47 27.69 Favored 'General case' 0 C--N 1.279 -2.47 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 174.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 11.8 tp -129.99 117.82 20.65 Favored 'General case' 0 C--N 1.265 -3.074 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.275 -175.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . 0.55 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -103.89 106.24 16.68 Favored 'General case' 0 C--N 1.282 -2.345 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 177.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -117.88 90.36 3.32 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 121.603 0.716 . . . . 0.0 110.228 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -87.0 113.91 23.16 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.4 -178.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 122.4 1.31 10.16 Favored Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -176.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -115.54 128.99 56.38 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -104.68 -30.82 9.69 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -176.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -94.26 -141.92 11.82 Favored Glycine 0 CA--C 1.493 -1.34 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.318 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -118.4 142.41 31.31 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -177.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.585 ' HB3' HD23 ' A' ' 264' ' ' LEU . 44.0 Cg_endo -79.58 172.34 14.51 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.812 2.341 . . . . 0.0 112.488 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -89.26 109.55 20.42 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.39 108.79 20.91 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 177.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . 0.538 ' HB2' ' HB ' ' A' ' 261' ' ' ILE . 16.9 m -105.72 111.4 24.07 Favored 'General case' 0 N--CA 1.407 -2.619 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.6 176.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -94.34 112.51 24.3 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.496 -176.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.711 ' HB3' ' O ' ' A' ' 259' ' ' HIS . 6.8 tp60 -116.5 159.73 21.64 Favored 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -76.89 -37.19 55.93 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.145 -177.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -71.23 -34.41 70.76 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.697 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . 0.711 ' O ' ' HB3' ' A' ' 256' ' ' GLN . 35.0 p-80 -168.08 171.22 9.74 Favored 'General case' 0 C--O 1.201 -1.451 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -178.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.424 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 21.7 mt -106.38 139.26 28.35 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 178.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' A' ' 254' ' ' SER . 3.6 mp -115.35 108.49 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.926 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.485 ' HB ' ' HB3' ' A' ' 300' ' ' LEU . 43.3 t -106.68 120.93 58.69 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.628 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 175.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . 0.537 HG22 ' OD2' ' A' ' 297' ' ' ASP . 1.1 m -115.32 130.36 56.88 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.723 -177.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.585 HD23 ' HB3' ' A' ' 251' ' ' PRO . 25.5 mt -116.04 83.38 1.93 Allowed 'General case' 0 CA--C 1.474 -1.976 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -178.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.447 ' HA ' ' OD2' ' A' ' 297' ' ' ASP . 26.4 mmtm -61.65 140.88 58.11 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.6 -175.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 10.9 t30 66.68 15.05 10.02 Favored 'General case' 0 CA--C 1.552 1.027 0 O-C-N 124.792 1.307 . . . . 0.0 110.802 175.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 50.2 t60 -109.89 93.92 4.75 Favored 'General case' 0 C--O 1.187 -2.216 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 176.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 2.0 m -86.64 114.7 23.57 Favored 'General case' 0 C--N 1.28 -2.431 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.334 -173.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 19.6 tp -87.84 135.76 33.36 Favored Pre-proline 0 C--N 1.312 -1.037 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.47 -178.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -78.65 159.91 28.26 Favored 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 122.25 1.967 . . . . 0.0 111.413 171.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . 0.479 ' HA ' ' OE1' ' A' ' 274' ' ' GLN . 23.5 p -64.0 -28.31 69.72 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.727 0.775 . . . . 0.0 111.081 -179.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 30.1 m -56.86 -26.29 58.29 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 125.693 1.597 . . . . 0.0 113.379 -177.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.554 HD13 ' O ' ' A' ' 226' ' ' THR . 64.7 mt -105.6 -2.27 23.69 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 121.965 -0.459 . . . . 0.0 111.537 -174.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.479 ' OE1' ' HA ' ' A' ' 271' ' ' THR . 55.3 mt-30 -77.9 108.31 11.06 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.971 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -138.26 153.34 49.08 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 20.2 m -117.77 131.99 56.52 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 63.9 mt -100.2 125.82 46.41 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -49.41 -69.11 0.13 Allowed 'General case' 0 N--CA 1.471 0.623 0 O-C-N 124.559 1.162 . . . . 0.0 111.642 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.711 ' HA ' ' CD2' ' A' ' 282' ' ' PHE . 39.1 t 56.12 24.72 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.79 0 O-C-N 124.332 1.02 . . . . 0.0 112.247 176.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -79.5 138.27 37.49 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 120.637 -1.289 . . . . 0.0 109.991 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 60.21 38.68 19.93 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 123.92 0.762 . . . . 0.0 111.514 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.711 ' CD2' ' HA ' ' A' ' 279' ' ' VAL . 0.2 OUTLIER -88.59 -2.94 58.86 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.856 179.85 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 65.36 61.24 0.72 Allowed 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.894 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.9 153.45 10.82 Favored Pre-proline 0 C--N 1.298 -1.634 0 CA-C-N 114.127 -1.397 . . . . 0.0 108.966 179.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . 0.475 ' O ' ' HA ' ' A' ' 304' ' ' THR . 62.1 Cg_exo -50.31 -28.13 19.78 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.671 2.914 . . . . 0.0 112.948 173.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 42.4 t -69.57 124.39 25.37 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.946 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -98.71 -44.0 6.58 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.263 -177.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -161.64 139.17 8.85 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 47.0 t -100.89 130.89 49.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 176.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 62.6 m -139.72 117.0 11.24 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.119 0.485 . . . . 0.0 110.772 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 54.9 tp -97.47 115.58 28.04 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.425 ' HA ' HE21 ' A' ' 274' ' ' GLN . 16.3 tppt? -114.63 129.01 56.62 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -176.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . 0.436 ' H ' ' NE2' ' A' ' 274' ' ' GLN . 5.7 ptm180 -79.46 140.18 37.41 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.166 -1.013 . . . . 0.0 108.572 176.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.621 ' HB3' ' HB3' ' A' ' 297' ' ' ASP . 2.7 tm? -120.29 158.48 26.97 Favored 'General case' 0 N--CA 1.416 -2.149 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.6 ' N ' HD13 ' A' ' 294' ' ' LEU . 21.3 t-20 -14.86 -71.43 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 127.583 2.353 . . . . 0.0 114.032 177.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -125.2 -3.47 7.49 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 294' ' ' LEU . 7.0 t70 -108.58 -177.65 3.38 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.242 1.017 . . . . 0.0 108.471 -169.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.501 ' HB ' ' HB2' ' A' ' 264' ' ' LEU . 58.3 m -134.18 109.55 8.97 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 174.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -103.23 119.17 38.37 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-O 121.708 0.766 . . . . 0.0 109.648 -175.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.485 ' HB3' ' HB ' ' A' ' 262' ' ' VAL . 59.9 tp -105.13 124.26 49.22 Favored 'General case' 0 C--N 1.271 -2.805 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.831 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 66.6 mt -107.16 109.85 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.641 -178.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . 0.424 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 61.6 mt -108.36 105.14 18.23 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . 0.401 ' HA ' ' CB ' ' A' ' 259' ' ' HIS . 11.9 m -74.77 135.36 41.72 Favored 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.832 -174.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 285' ' ' PRO . 17.3 p -134.34 -177.04 4.41 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 123.051 0.54 . . . . 0.0 110.308 -177.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -166.75 149.9 6.76 Favored 'General case' 0 C--O 1.247 0.937 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 71.92 -161.05 54.22 Favored Glycine 0 C--O 1.243 0.659 0 O-C-N 123.672 0.608 . . . . 0.0 112.541 177.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' ASN . . . . . 0.413 ' HB3' ' HB3' ' A' ' 327' ' ' LYS . 83.6 m-20 -88.32 128.84 35.5 Favored 'General case' 0 CA--C 1.494 -1.197 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' TRP . . . . . 0.687 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 56.8 p-90 -147.83 167.59 24.36 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -177.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 324' ' ' VAL . 15.8 mt-10 -123.69 144.58 49.56 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -177.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.687 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 33.1 tp -120.83 117.52 27.61 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.916 0.389 . . . . 0.0 111.514 -176.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 58.8 t -110.87 108.27 25.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 174.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -98.46 129.64 45.07 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -135.08 158.71 43.65 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 120.807 0.337 . . . . 0.0 110.223 -178.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 12.0 p -116.5 138.88 51.04 Favored 'General case' 0 N--CA 1.414 -2.247 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.908 172.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -96.55 -22.97 16.75 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -172.39 163.3 4.11 Favored Pre-proline 0 C--N 1.313 -1.001 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -65.11 97.57 0.29 Allowed 'Trans proline' 0 C--O 1.247 0.948 0 C-N-CA 121.63 1.554 . . . . 0.0 111.172 177.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 120.9 -5.15 11.42 Favored Glycine 0 C--O 1.208 -1.521 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.433 -177.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -123.7 116.68 23.45 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.944 -0.739 . . . . 0.0 109.749 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -119.19 166.3 13.13 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.829 0.823 . . . . 0.0 110.749 -176.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 58.5 m -151.97 136.68 17.05 Favored 'General case' 0 C--N 1.281 -2.37 0 C-N-CA 124.259 1.024 . . . . 0.0 109.085 -177.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -123.03 116.26 23.22 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . 0.533 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 8.9 tt0 -103.53 105.87 16.23 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 309' ' ' GLU . 1.3 m -99.59 110.72 27.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-O 121.301 0.572 . . . . 0.0 109.8 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -92.1 156.89 41.73 Favored Pre-proline 0 C--N 1.313 -1.015 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.374 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -83.0 138.51 9.13 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 C-N-CA 121.814 1.676 . . . . 0.0 109.915 171.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 307' ' ' ASN . 34.6 ttmt . . . . . 0 C--N 1.295 -1.768 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . 0.496 ' HG2' ' H ' ' A' ' 226' ' ' THR . 42.1 tt0 . . . . . 0 N--CA 1.424 -1.769 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.635 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 24.7 m -63.83 125.64 25.02 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 123.403 0.681 . . . . 0.0 112.595 -170.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -152.55 171.81 17.55 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.18 -176.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.52 HG21 HD13 ' A' ' 300' ' ' LEU . 2.5 pp -133.7 158.85 42.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 C-N-CA 123.45 0.7 . . . . 0.0 110.868 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 1.8 t70 -149.85 156.63 42.11 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -175.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -138.08 138.28 38.59 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.153 0.501 . . . . 0.0 111.086 176.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 21.1 ptt85 -153.76 168.2 27.09 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 172.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.495 ' HE3' HG22 ' A' ' 284' ' ' THR . 54.4 mtpt -113.53 154.41 27.14 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -144.14 117.67 9.15 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 81.48 -117.23 4.37 Favored Glycine 0 C--N 1.294 -1.793 0 C-N-CA 121.186 -0.53 . . . . 0.0 113.956 175.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -101.33 80.22 2.07 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.332 0.587 . . . . 0.0 111.801 -173.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . 0.474 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 91.9 m-20 57.85 18.07 4.69 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 176.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -73.19 136.11 44.69 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . 0.474 ' HA3' ' CG1' ' A' ' 286' ' ' VAL . . . -91.59 123.86 7.37 Favored Glycine 0 N--CA 1.43 -1.752 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.6 mp -117.69 112.43 38.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 117.792 0.796 . . . . 0.0 110.77 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.1 mp -101.0 112.15 32.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.455 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 51.4 mt-10 -96.93 104.96 17.02 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 122.635 1.207 . . . . 0.0 110.558 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 11.5 tp -95.24 127.45 41.3 Favored 'General case' 0 C--N 1.27 -2.849 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.621 -175.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . 0.635 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -115.78 102.82 10.06 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -109.6 90.97 3.46 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.434 HD23 ' C ' ' A' ' 225' ' ' GLN . 2.9 mm? -78.62 115.82 18.58 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.725 -177.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 108.31 12.15 22.23 Favored Glycine 0 N--CA 1.425 -2.08 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.783 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' PHE . . . . . 0.435 ' HE1' ' O ' ' A' ' 265' ' ' LYS . 42.2 t80 -115.81 107.85 15.57 Favored 'General case' 0 N--CA 1.421 -1.905 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.803 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -103.76 94.71 5.58 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.409 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 156.76 -139.8 6.75 Favored Glycine 0 C--N 1.299 -1.473 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . 0.438 ' HA ' ' OE1' ' A' ' 250' ' ' GLN . 13.7 mm-40 -129.51 139.88 36.99 Favored Pre-proline 0 C--N 1.305 -1.357 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.721 ' HB3' HD13 ' A' ' 264' ' ' LEU . 9.1 Cg_endo -69.7 172.14 13.11 Favored 'Trans proline' 0 N--CA 1.434 -2.018 0 C-N-CA 121.212 1.275 . . . . 0.0 110.75 176.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -100.72 105.09 16.4 Favored 'General case' 0 C--N 1.267 -3.015 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 4.8 mp -102.37 138.66 25.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-O 121.043 0.449 . . . . 0.0 111.329 -176.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . 0.496 ' HB3' ' HB ' ' A' ' 261' ' ' ILE . 33.3 t -127.57 124.98 39.44 Favored 'General case' 0 N--CA 1.425 -1.725 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 175.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -102.92 114.65 29.11 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.177 0.513 . . . . 0.0 111.932 -177.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -117.88 160.73 20.93 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 171.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -76.6 -30.89 57.15 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.658 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -68.56 -42.21 78.66 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.939 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . 0.541 ' CB ' ' HA ' ' A' ' 303' ' ' THR . 38.7 p-80 -168.73 168.69 10.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.665 178.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 20.2 mt -106.17 142.36 19.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . 0.496 ' HB ' ' HB3' ' A' ' 254' ' ' SER . 3.3 mp -122.64 122.89 67.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 299' ' ' GLN . 1.4 m -120.14 141.09 41.94 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 175.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 298' ' ' THR . 26.0 m -135.19 126.92 29.15 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-O 121.475 0.655 . . . . 0.0 110.86 177.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.721 HD13 ' HB3' ' A' ' 251' ' ' PRO . 1.5 mm? -94.17 99.3 11.59 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 177.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.586 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 13.2 mptt -59.7 125.4 23.5 Favored 'General case' 0 C--N 1.285 -2.225 0 O-C-N 124.838 1.336 . . . . 0.0 112.451 -178.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 66.4 t30 63.76 35.74 11.06 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.138 0.975 . . . . 0.0 110.402 178.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -121.26 119.09 31.25 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 2.8 p -87.27 144.79 26.64 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.031 0.443 . . . . 0.0 111.946 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 27.1 tp -130.26 129.98 22.97 Favored Pre-proline 0 N--CA 1.427 -1.608 0 C-N-CA 123.77 0.828 . . . . 0.0 109.301 178.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -72.86 152.34 52.18 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.021 1.814 . . . . 0.0 111.586 171.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 34.7 p -68.89 -19.56 64.22 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.942 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 13.6 m -74.97 -18.53 60.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.555 0.693 . . . . 0.0 109.686 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.4 HD11 ' HB3' ' A' ' 225' ' ' GLN . 89.9 mt -106.41 -7.11 17.78 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.065 -176.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -86.57 102.39 14.1 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.67 158.32 44.31 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.656 -177.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 33.9 p -114.59 145.87 41.46 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.566 -175.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.435 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 64.2 mt -112.44 119.36 37.95 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -85.88 94.24 9.12 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-O 121.889 0.852 . . . . 0.0 108.714 177.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.59 ' HA ' ' CE1' ' A' ' 282' ' ' PHE . 17.6 t -105.83 30.18 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 CA-C-N 113.943 -1.48 . . . . 0.0 109.902 -173.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -82.0 144.96 30.51 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 35.8 t70 72.37 20.85 3.92 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 122.46 1.124 . . . . 0.0 110.789 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.59 ' CE1' ' HA ' ' A' ' 279' ' ' VAL . 19.5 m-85 -90.07 -1.73 58.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.858 173.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 73.23 13.45 4.71 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.539 1.136 . . . . 0.0 111.54 175.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' THR . . . . . 0.495 HG22 ' HE3' ' A' ' 232' ' ' LYS . 1.2 p -96.63 174.93 2.94 Favored Pre-proline 0 C--N 1.309 -1.157 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -175.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 7.9 Cg_exo -76.36 -15.26 17.94 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 121.854 1.703 . . . . 0.0 110.768 173.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.474 ' CG1' ' HA3' ' A' ' 238' ' ' GLY . 1.4 m -90.46 138.06 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' GLN . . . . . 0.477 ' OE1' ' HB2' ' A' ' 305' ' ' ALA . 11.3 mt-30 -104.82 -32.44 8.83 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.239 0.542 . . . . 0.0 110.814 -179.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 36.8 tttp -162.29 133.84 5.29 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.204 -174.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.435 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 45.3 t -99.46 132.93 43.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 172.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 97.2 m -142.8 118.92 10.73 Favored 'General case' 0 C--N 1.29 -2.009 0 O-C-N 121.631 -0.668 . . . . 0.0 111.087 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.466 ' HB2' HG12 ' A' ' 228' ' ' ILE . 42.7 tp -96.74 125.03 40.91 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -121.91 129.19 52.35 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.532 -174.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 41.9 ttt-85 -74.54 127.68 33.67 Favored 'General case' 0 N--CA 1.407 -2.584 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 173.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.51 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 19.4 tp -107.99 179.28 4.27 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 176.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.51 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 27.4 t-20 -46.54 -67.76 0.25 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.662 0.785 . . . . 0.0 112.883 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -123.83 -2.09 8.32 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.544 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . 0.586 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 15.9 m-20 -117.43 168.31 10.48 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -177.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 263' ' ' THR . 49.5 m -112.9 127.96 56.34 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 176.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . 0.477 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 41.4 tt0 -111.55 129.64 56.0 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -175.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.52 HD13 HG21 ' A' ' 228' ' ' ILE . 63.2 tp -111.15 124.61 52.53 Favored 'General case' 0 N--CA 1.415 -2.207 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 176.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 54.2 mt -112.5 121.01 64.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -177.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 53.7 mt -121.43 101.76 10.92 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 178.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . 0.541 ' HA ' ' CB ' ' A' ' 259' ' ' HIS . 16.8 m -69.34 139.82 54.26 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 10.9 p -134.22 166.04 23.7 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -176.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . 0.477 ' HB2' ' OE1' ' A' ' 287' ' ' GLN . . . -144.66 143.91 30.98 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.315 0.646 . . . . 0.0 110.177 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 77.65 -159.62 48.23 Favored Glycine 0 C--O 1.245 0.801 0 O-C-N 123.897 0.748 . . . . 0.0 112.319 178.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 327' ' ' LYS . 28.9 m-80 -92.67 136.5 33.18 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 176.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' TRP . . . . . 0.732 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 59.3 p-90 -150.47 160.4 43.79 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.781 -0.767 . . . . 0.0 111.157 -175.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 324' ' ' VAL . 16.1 mt-10 -118.14 133.14 56.17 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -177.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.732 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 24.3 tp -108.35 120.92 43.77 Favored 'General case' 0 CA--C 1.498 -1.039 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.825 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.674 HG13 ' HB3' ' A' ' 323' ' ' GLN . 7.5 p -122.17 112.12 33.37 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-O 121.964 0.888 . . . . 0.0 109.395 172.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -94.94 139.58 31.13 Favored 'General case' 0 N--CA 1.414 -2.267 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.594 -177.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . 0.466 ' HB2' ' HB ' ' A' ' 321' ' ' THR . 67.0 mttm -130.92 151.32 51.47 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.342 -177.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 27.0 m -116.02 126.75 54.22 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 172.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -87.9 -34.62 18.1 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -167.41 163.77 9.7 Favored Pre-proline 0 C--N 1.307 -1.25 0 N-CA-C 104.74 -2.318 . . . . 0.0 104.74 -178.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.68 95.42 0.28 Allowed 'Trans proline' 0 C--O 1.244 0.813 0 C-N-CA 121.535 1.49 . . . . 0.0 111.266 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 131.79 -32.4 2.91 Favored Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -177.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -97.84 116.51 30.2 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' PHE . . . . . 0.444 ' CZ ' ' HD3' ' A' ' 251' ' ' PRO . 61.0 m-85 -119.2 165.03 14.73 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-O 122.188 0.994 . . . . 0.0 110.449 -175.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.466 ' HB ' ' HB2' ' A' ' 313' ' ' LYS . 59.3 m -151.72 128.72 11.05 Favored 'General case' 0 C--N 1.264 -3.135 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.619 -177.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -116.44 114.53 24.36 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . 0.674 ' HB3' HG13 ' A' ' 311' ' ' VAL . 34.9 tt0 -104.24 111.87 24.66 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 309' ' ' GLU . 0.2 OUTLIER -105.96 103.65 15.74 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.713 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.261 179.205 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.417 HD22 ' H ' ' A' ' 325' ' ' LEU . 1.0 OUTLIER -86.08 153.0 56.78 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.229 179.77 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -78.55 129.76 9.48 Favored 'Trans proline' 0 N--CA 1.447 -1.226 0 C-N-CA 121.669 1.58 . . . . 0.0 109.491 173.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 307' ' ' ASN . 41.1 ttmt . . . . . 0 C--N 1.295 -1.795 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 . . . . . 0 N--CA 1.436 -1.141 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.559 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 31.1 m -61.5 133.47 55.76 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -167.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -162.17 170.99 18.12 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.177 -178.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.529 HG12 ' HB2' ' A' ' 291' ' ' LEU . 2.8 pp -136.56 157.34 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.183 178.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . 0.414 ' HB2' ' HB2' ' A' ' 241' ' ' GLU . 5.1 m-20 -145.61 157.61 43.95 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 123.992 0.917 . . . . 0.0 110.147 -175.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.403 ' HZ ' HG21 ' A' ' 284' ' ' THR . 91.5 t80 -124.0 145.58 49.09 Favored 'General case' 0 C--N 1.31 -1.13 0 O-C-N 123.202 0.314 . . . . 0.0 110.549 177.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -155.52 165.22 37.25 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 170.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.501 ' CE ' ' HA ' ' A' ' 236' ' ' ASN . 55.2 mtpt -115.38 151.23 35.06 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 120.696 0.284 . . . . 0.0 110.586 176.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -136.68 140.51 42.75 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.96 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 66.14 -97.61 0.33 Allowed Glycine 0 N--CA 1.438 -1.188 0 O-C-N 124.3 1.0 . . . . 0.0 114.32 172.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -136.3 92.34 2.77 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-O 120.862 0.363 . . . . 0.0 110.074 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . 0.501 ' HA ' ' CE ' ' A' ' 232' ' ' LYS . 92.4 m-20 65.3 12.9 8.43 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 172.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -74.73 130.87 40.25 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -97.1 113.84 4.82 Favored Glycine 0 C--O 1.21 -1.385 0 O-C-N 123.696 0.623 . . . . 0.0 111.845 -177.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.422 HG13 ' HG3' ' A' ' 323' ' ' GLN . 2.7 mp -106.96 117.56 53.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 117.834 0.817 . . . . 0.0 111.015 -177.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.4 mp -103.66 112.57 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.919 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 175.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 229' ' ' ASP . 45.3 mt-10 -91.43 128.31 37.21 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 12.8 tp -116.08 123.69 48.52 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-O 121.054 0.454 . . . . 0.0 111.409 -175.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . 0.559 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -109.93 104.4 13.31 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -117.43 91.08 3.48 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.03 115.37 19.57 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.139 -174.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 113.08 2.24 25.04 Favored Glycine 0 N--CA 1.432 -1.612 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.718 178.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' PHE . . . . . 0.425 ' HB2' ' ND1' ' A' ' 267' ' ' HIS . 40.9 t80 -114.96 114.21 25.14 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -178.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -106.91 -10.05 16.11 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -84.1 -154.57 19.66 Favored Glycine 0 C--N 1.318 -0.435 0 C-N-CA 121.425 -0.417 . . . . 0.0 112.464 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -119.69 134.43 23.88 Favored Pre-proline 0 C--N 1.311 -1.082 0 O-C-N 122.485 -0.42 . . . . 0.0 109.872 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.624 ' HB3' HD23 ' A' ' 264' ' ' LEU . 32.9 Cg_endo -74.21 171.99 16.9 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.523 2.149 . . . . 0.0 113.042 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -94.71 113.24 25.0 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.104 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 2.2 mp -97.86 108.47 21.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 122.113 0.958 . . . . 0.0 110.191 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . 0.623 ' HB2' ' HB ' ' A' ' 261' ' ' ILE . 36.6 m -108.98 111.67 23.46 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.37 -1.287 . . . . 0.0 108.856 176.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -104.87 124.18 49.01 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -174.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.44 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 14.3 mm-40 -124.77 167.86 14.01 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 173.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -76.95 -36.28 56.66 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 120.304 -0.558 . . . . 0.0 109.986 177.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -71.91 -37.75 70.03 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.942 -177.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . 0.44 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 55.0 p-80 -167.6 166.01 14.22 Favored 'General case' 0 C--N 1.318 -0.768 0 O-C-N 122.143 -0.348 . . . . 0.0 110.968 178.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.475 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 19.1 mt -106.43 143.75 16.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . 0.623 ' HB ' ' HB2' ' A' ' 254' ' ' SER . 4.2 mp -121.76 111.76 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 177.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' A' ' 300' ' ' LEU . 43.1 t -110.12 117.01 53.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 176.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 23.5 m -112.76 124.22 52.09 Favored 'General case' 0 C--N 1.285 -2.233 0 C-N-CA 119.951 -0.7 . . . . 0.0 110.943 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.624 HD23 ' HB3' ' A' ' 251' ' ' PRO . 17.1 mt -99.82 100.08 10.97 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.507 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 30.7 mmtp -65.7 129.43 39.73 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -174.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 6.4 t30 64.33 23.82 13.12 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 113.532 -1.667 . . . . 0.0 110.202 177.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' HIS . . . . . 0.425 ' ND1' ' HB2' ' A' ' 247' ' ' PHE . 54.9 t60 -112.05 107.69 16.73 Favored 'General case' 0 CA--C 1.476 -1.883 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 2.8 m -94.5 138.51 32.33 Favored 'General case' 0 C--N 1.263 -3.169 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.627 -175.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 29.7 tp -113.79 128.26 25.93 Favored Pre-proline 0 N--CA 1.431 -1.388 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.186 -176.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -62.21 135.7 55.92 Favored 'Trans proline' 0 C--O 1.248 0.98 0 C-N-CA 122.312 2.008 . . . . 0.0 110.705 169.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . 0.452 ' O ' ' HG2' ' A' ' 274' ' ' GLN . 9.2 t -67.5 -13.11 61.75 Favored 'General case' 0 CA--C 1.56 1.36 0 CA-C-O 121.814 0.816 . . . . 0.0 111.223 -178.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 27.3 m -74.59 -23.99 58.83 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.81 178.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 96.7 mt -100.95 -9.27 21.67 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.128 -174.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.539 ' HB2' ' O ' ' A' ' 291' ' ' LEU . 3.2 pt20 -77.27 94.37 4.14 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-O 122.698 1.237 . . . . 0.0 109.647 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -100.72 166.53 10.83 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.094 -177.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 19.9 m -137.27 127.36 26.03 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.447 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 2.2 mm? -89.83 130.5 36.06 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 179.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -70.44 -42.1 71.98 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.604 ' HA ' ' CD1' ' A' ' 282' ' ' PHE 0.257 10.4 p 40.35 34.3 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.548 0 C-N-CA 126.051 1.74 . . . . 0.0 112.609 177.969 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -89.61 137.66 32.14 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.1 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 14.2 t70 69.2 14.47 8.65 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 125.328 1.451 . . . . 0.0 109.887 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.604 ' CD1' ' HA ' ' A' ' 279' ' ' VAL . 7.9 m-85 -75.82 -20.45 58.17 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.39 174.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp 62.3 60.56 1.41 Allowed 'General case' 0 CA--C 1.5 -0.965 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.981 174.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' THR . . . . . 0.455 HG22 ' HE3' ' A' ' 232' ' ' LYS . 1.1 p -133.06 172.32 7.61 Favored Pre-proline 0 C--N 1.286 -2.163 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 177.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . 0.452 ' O ' ' HA ' ' A' ' 304' ' ' THR . 23.8 Cg_exo -65.9 -24.65 53.29 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.51 1.473 . . . . 0.0 110.958 175.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.2 p -87.64 120.22 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 CA-C-O 122.206 1.003 . . . . 0.0 110.077 176.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -90.95 -37.76 13.3 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 114.111 -1.404 . . . . 0.0 111.062 -173.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . 0.463 ' HA ' ' CG1' ' A' ' 279' ' ' VAL . 86.6 tttt -154.29 134.79 13.46 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.013 178.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 35.8 t -102.03 116.56 45.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 175.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.465 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 27.2 m -124.37 121.28 34.51 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 120.729 0.299 . . . . 0.0 110.811 -176.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.539 ' O ' ' HB2' ' A' ' 274' ' ' GLN . 27.7 tp -96.9 126.79 42.3 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 175.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . 0.525 ' HA ' ' NE2' ' A' ' 274' ' ' GLN . 21.5 tptp -125.59 121.98 35.16 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -172.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -77.9 128.25 33.65 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 118.579 -1.248 . . . . 0.0 108.607 177.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.501 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 15.1 tp -101.88 -173.91 2.46 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.501 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 51.1 t-20 -53.95 -67.05 0.29 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 118.311 0.505 . . . . 0.0 111.033 -177.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' ASN . . . . . 0.408 ' H ' HD22 ' A' ' 296' ' ' ASN . 0.1 OUTLIER -120.43 -4.05 9.89 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.722 178.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . 0.507 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 30.3 m-20 -113.32 164.77 13.14 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.512 -175.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.502 ' HB ' ' HB2' ' A' ' 264' ' ' LEU . 98.9 m -108.09 124.86 50.86 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 174.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -112.97 128.33 56.46 Favored 'General case' 0 N--CA 1.416 -2.167 0 CA-C-O 121.59 0.71 . . . . 0.0 109.239 -176.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.419 ' HB2' ' HB ' ' A' ' 262' ' ' VAL . 0.5 OUTLIER -107.18 127.62 53.67 Favored 'General case' 0 C--N 1.271 -2.83 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 176.712 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 301' ' ' ILE . . . . . 0.465 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 58.1 mt -115.57 109.49 28.48 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . 0.475 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 63.3 mt -110.84 101.05 12.0 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 25.8 m -70.81 134.33 47.27 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 -177.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 285' ' ' PRO . 15.4 p -138.0 171.23 14.72 Favored 'General case' 0 C--N 1.31 -1.111 0 O-C-N 123.256 0.347 . . . . 0.0 111.322 -176.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -154.69 139.75 17.4 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 90.1 -153.41 22.91 Favored Glycine 0 C--N 1.314 -0.656 0 C-N-CA 121.256 -0.497 . . . . 0.0 111.866 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 327' ' ' LYS . 30.4 m-80 -104.3 139.99 38.51 Favored 'General case' 0 C--O 1.255 1.361 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 175.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' TRP . . . . . 0.416 ' HZ3' ' CB ' ' A' ' 310' ' ' LEU . 67.9 p-90 -155.63 166.3 33.93 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.356 -177.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . 0.472 ' HG2' ' HE2' ' A' ' 327' ' ' LYS . 17.8 mt-10 -117.88 134.39 54.98 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.416 ' CB ' ' HZ3' ' A' ' 308' ' ' TRP . 1.1 tt -102.85 123.42 46.47 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 176.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.641 ' CG1' ' HB3' ' A' ' 323' ' ' GLN . 6.5 p -117.34 108.16 24.08 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 CA-C-O 122.065 0.936 . . . . 0.0 109.419 170.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -98.48 115.93 29.62 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.915 -175.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -116.14 149.77 38.49 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.926 -176.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 48.4 t -111.65 113.78 26.38 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 172.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -79.71 -35.98 38.16 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.533 0.682 . . . . 0.0 109.95 -177.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -168.16 161.59 9.24 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 -178.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -62.09 102.45 0.26 Allowed 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 121.574 1.516 . . . . 0.0 111.497 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 117.03 -9.4 15.73 Favored Glycine 0 N--CA 1.434 -1.45 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.629 -178.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -120.08 116.31 25.45 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 122.004 -0.703 . . . . 0.0 110.035 178.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -120.63 165.82 14.51 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.697 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 50.4 m -151.64 132.02 13.75 Favored 'General case' 0 C--N 1.274 -2.711 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.386 -176.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -120.29 107.33 12.84 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 177.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . 0.641 ' HB3' ' CG1' ' A' ' 311' ' ' VAL . 62.7 tt0 -98.67 115.89 29.69 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.41 HG13 ' CE3' ' A' ' 308' ' ' TRP . 92.0 t -100.05 99.16 7.95 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.803 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -88.04 144.8 35.1 Favored Pre-proline 0 C--N 1.318 -0.762 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -68.79 131.0 21.62 Favored 'Trans proline' 0 C--O 1.243 0.764 0 C-N-CA 121.443 1.429 . . . . 0.0 110.076 173.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.472 ' HE2' ' HG2' ' A' ' 309' ' ' GLU . 37.7 ttmt . . . . . 0 CA--C 1.495 -1.157 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . 0.466 ' O ' HD23 ' A' ' 245' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.439 -0.983 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.567 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 10.5 m -69.79 117.18 11.06 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -151.23 173.02 14.93 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.265 -176.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.54 HD13 HD21 ' A' ' 277' ' ' LEU . 2.2 pp -133.48 159.37 42.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.33 -178.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -150.83 156.49 41.36 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -178.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -130.38 134.52 47.21 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.552 175.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -145.26 166.95 24.01 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 173.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.453 ' HE3' HG22 ' A' ' 284' ' ' THR . 55.2 mtpt -110.82 146.42 36.45 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 174.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . 0.428 ' O ' ' HB3' ' A' ' 237' ' ' ALA . 18.2 t70 -152.88 117.76 5.1 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -177.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 99.25 -131.32 10.52 Favored Glycine 0 N--CA 1.434 -1.467 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.263 178.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -101.39 85.59 2.82 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 122.686 0.395 . . . . 0.0 110.166 -177.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . 0.486 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 91.2 m-20 57.8 21.4 7.44 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 177.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 233' ' ' ASP . . . -79.18 138.4 37.84 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.907 -178.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -97.27 114.88 5.1 Favored Glycine 0 N--CA 1.421 -2.348 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.2 mp -107.19 111.96 37.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-O 121.505 0.669 . . . . 0.0 110.581 -177.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.5 mp -97.35 112.53 29.6 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 176.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -92.38 136.76 32.93 Favored 'General case' 0 C--N 1.277 -2.548 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 11.8 tp -127.98 127.78 43.86 Favored 'General case' 0 C--N 1.276 -2.598 0 C-N-CA 123.836 0.854 . . . . 0.0 110.359 -174.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . 0.567 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -113.25 101.19 9.18 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -108.28 90.78 3.4 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 225' ' ' GLN . 3.8 mm? -80.52 115.57 20.11 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.998 -174.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 105.87 14.22 21.67 Favored Glycine 0 N--CA 1.431 -1.675 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.597 178.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -114.98 118.21 32.79 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 -178.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -116.43 91.11 3.49 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.842 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 164.89 -148.51 14.33 Favored Glycine 0 N--CA 1.436 -1.305 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -126.42 138.6 32.69 Favored Pre-proline 0 C--N 1.31 -1.116 0 CA-C-N 117.277 0.539 . . . . 0.0 109.603 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.723 ' HB3' HD13 ' A' ' 264' ' ' LEU . 12.0 Cg_endo -71.5 172.1 14.93 Favored 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 121.683 1.589 . . . . 0.0 110.904 175.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 34.3 t70 -95.64 108.69 20.99 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.45 HD11 ' HG2' ' A' ' 251' ' ' PRO . 4.5 mp -105.84 116.25 49.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-O 121.302 0.572 . . . . 0.0 111.312 -178.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 19.3 t -95.51 111.8 23.64 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 175.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -88.76 95.68 10.37 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 121.468 0.651 . . . . 0.0 111.684 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.488 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 78.4 mt-30 -108.54 144.36 36.31 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 172.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -74.52 -19.98 60.14 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 119.769 -0.772 . . . . 0.0 112.109 -174.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -73.86 -47.24 39.64 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 123.875 0.734 . . . . 0.0 109.942 177.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . 0.488 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 44.3 p-80 -162.67 162.27 26.89 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.158 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 301' ' ' ILE . 29.5 mt -106.05 143.02 17.71 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -177.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 3.4 mp -125.51 114.7 40.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 178.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.548 ' HA ' ' O ' ' A' ' 252' ' ' ASP . 1.4 m -110.0 140.48 28.79 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.271 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 298' ' ' THR . 24.4 m -135.2 123.99 23.9 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-O 121.131 0.491 . . . . 0.0 111.14 177.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.723 HD13 ' HB3' ' A' ' 251' ' ' PRO . 1.7 mm? -93.98 107.75 19.63 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 176.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.43 ' HD3' ' OD1' ' A' ' 297' ' ' ASP . 30.3 mmtp -69.6 129.53 39.9 Favored 'General case' 0 C--N 1.29 -2.001 0 O-C-N 123.927 0.767 . . . . 0.0 112.689 -177.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 14.0 t30 70.1 22.62 5.57 Favored 'General case' 0 CA--C 1.554 1.113 0 O-C-N 124.952 1.407 . . . . 0.0 111.189 176.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 38.0 t60 -112.79 110.27 20.28 Favored 'General case' 0 C--O 1.213 -0.821 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 10.9 p -77.83 142.79 38.34 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.19 0.519 . . . . 0.0 112.158 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 35.9 tp -121.98 121.12 28.15 Favored Pre-proline 0 N--CA 1.431 -1.403 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.543 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -59.62 134.62 58.99 Favored 'Trans proline' 0 C--N 1.321 -0.91 0 C-N-CA 122.672 2.248 . . . . 0.0 111.276 170.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . 0.571 ' HB ' ' HD3' ' A' ' 293' ' ' ARG . 6.5 t -66.3 -9.3 31.49 Favored 'General case' 0 CA--C 1.554 1.108 0 CA-C-O 121.823 0.82 . . . . 0.0 112.092 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 27.2 m -83.22 -14.95 52.21 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 121.642 0.734 . . . . 0.0 109.902 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.443 HD13 ' O ' ' A' ' 226' ' ' THR . 82.4 mt -106.23 -6.39 18.51 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.171 -176.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.492 ' OE1' ' HG2' ' A' ' 293' ' ' ARG . 8.5 pt20 -82.92 101.39 11.0 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 121.844 0.83 . . . . 0.0 109.637 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . 0.461 ' HG3' HD11 ' A' ' 228' ' ' ILE . 14.0 ptm180 -129.25 179.09 5.97 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 48.8 m -125.44 164.87 19.49 Favored 'General case' 0 N--CA 1.409 -2.476 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 176.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.54 HD21 HD13 ' A' ' 228' ' ' ILE . 2.9 mm? -122.29 115.91 23.17 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -77.98 92.37 4.32 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 174.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.676 ' HA ' ' CD2' ' A' ' 282' ' ' PHE . 92.3 t -100.51 18.77 2.91 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 CA-C-O 123.124 1.44 . . . . 0.0 109.357 -176.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -70.19 137.07 50.63 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-N 114.583 -1.19 . . . . 0.0 107.967 176.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 72.94 19.27 3.81 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.961 0.904 . . . . 0.0 112.883 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.676 ' CD2' ' HA ' ' A' ' 279' ' ' VAL . 9.4 m-85 -85.69 -13.81 47.34 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.799 172.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.27 60.66 1.99 Allowed 'General case' 0 CA--C 1.492 -1.262 0 CA-C-O 121.838 0.828 . . . . 0.0 110.648 -177.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' THR . . . . . 0.453 HG22 ' HE3' ' A' ' 232' ' ' LYS . 2.9 p -136.12 173.3 5.79 Favored Pre-proline 0 N--CA 1.421 -1.924 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 178.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 2.8 Cg_exo -79.02 -5.98 14.78 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.404 1.402 . . . . 0.0 112.211 176.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.3 p -101.53 125.44 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-O 121.38 0.61 . . . . 0.0 110.446 178.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -86.93 -40.89 14.39 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.911 -175.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -159.16 134.26 8.27 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.939 -174.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.511 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 35.6 t -95.14 135.65 28.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 172.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 96.0 m -139.69 121.97 15.95 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 118.094 0.407 . . . . 0.0 110.531 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.523 ' HB2' HG12 ' A' ' 228' ' ' ILE . 45.7 tp -103.79 135.98 44.32 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 176.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -134.22 134.93 42.58 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -177.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . 0.571 ' HD3' ' HB ' ' A' ' 271' ' ' THR . 17.4 ptt180 -73.54 138.06 44.76 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 173.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.561 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 22.6 tp -115.29 -175.47 2.71 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.561 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 16.2 m120 -35.98 -75.94 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.944 1.698 . . . . 0.0 112.543 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' ASN . . . . . 0.401 ' H ' HD22 ' A' ' 296' ' ' ASN . 0.0 OUTLIER -125.4 -1.27 7.55 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 174.519 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . 0.43 ' OD1' ' HD3' ' A' ' 265' ' ' LYS . 11.5 m-20 -108.49 171.79 7.21 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.594 -171.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.55 ' O ' ' HA ' ' A' ' 263' ' ' THR . 91.8 m -114.35 129.07 56.63 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 176.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . 0.544 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 36.3 tt0 -114.05 127.27 55.86 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -176.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.476 HD13 HG21 ' A' ' 228' ' ' ILE . 70.1 tp -114.94 123.08 48.21 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.503 178.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 301' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 260' ' ' ILE . 62.5 mt -111.24 118.9 58.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-O 121.429 0.633 . . . . 0.0 109.487 -177.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 65.7 mt -114.87 108.83 26.43 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.533 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 14.6 m -82.59 131.66 35.21 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -176.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 6.9 p -126.67 164.82 20.44 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -174.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -145.98 134.65 22.24 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 123.534 0.734 . . . . 0.0 109.894 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 88.74 -166.8 34.45 Favored Glycine 0 C--O 1.252 1.263 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.237 176.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' ASN . . . . . 0.405 ' HB3' ' HB3' ' A' ' 327' ' ' LYS . 69.5 m-20 -86.27 126.18 34.12 Favored 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -144.54 165.43 28.02 Favored 'General case' 0 C--N 1.286 -2.152 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.553 -175.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . 0.441 ' HG2' ' HE2' ' A' ' 327' ' ' LYS . 15.2 mt-10 -125.39 145.36 50.08 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.88 122.7 48.51 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -178.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 21.7 t -122.07 106.23 17.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 169.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -100.39 113.02 25.43 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.789 0.804 . . . . 0.0 110.277 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -106.91 150.99 25.85 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.906 -174.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 36.0 t -115.53 102.91 10.22 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 175.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -69.17 -30.96 69.29 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.525 0.679 . . . . 0.0 110.063 -176.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -167.16 159.85 10.73 Favored Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -64.22 95.26 0.21 Allowed 'Trans proline' 0 C--O 1.247 0.953 0 C-N-CA 121.724 1.616 . . . . 0.0 110.858 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 135.38 -33.87 2.37 Favored Glycine 0 N--CA 1.427 -1.963 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.307 -177.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -100.44 117.09 33.89 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 122.188 -0.596 . . . . 0.0 110.171 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -117.14 160.59 20.79 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 121.751 0.786 . . . . 0.0 110.04 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 89.6 m -151.77 124.09 8.26 Favored 'General case' 0 C--N 1.268 -2.941 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.713 -176.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -109.82 109.49 20.17 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . 0.402 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 60.8 tt0 -97.62 107.84 20.42 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 309' ' ' GLU . 83.9 t -97.6 99.02 8.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.623 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -88.02 154.93 52.61 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -81.51 142.83 13.28 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 121.44 1.427 . . . . 0.0 109.343 171.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.441 ' HE2' ' HG2' ' A' ' 309' ' ' GLU . 37.3 ttmt . . . . . 0 C--N 1.303 -1.434 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -177.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 . . . . . 0 N--CA 1.421 -1.896 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.698 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 52.5 m -63.47 112.61 2.84 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.679 0.752 . . . . 0.0 113.026 -174.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.419 ' C ' HD22 ' A' ' 227' ' ' ASN . 0.2 OUTLIER -145.49 165.69 27.86 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.85 -175.283 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.616 HD13 HD21 ' A' ' 277' ' ' LEU . 1.6 pp -115.5 161.97 13.87 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.076 178.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . 0.52 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 7.1 t70 -151.26 155.91 39.75 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.404 ' HZ ' HG21 ' A' ' 284' ' ' THR . 75.4 t80 -132.87 135.57 45.68 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 173.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -149.45 168.84 22.33 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 174.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.526 ' HE3' HG22 ' A' ' 284' ' ' THR . 55.6 mtpt -117.19 139.91 50.19 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 174.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -149.0 117.78 6.64 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -175.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 99.55 -119.33 6.47 Favored Glycine 0 N--CA 1.428 -1.868 0 C-N-CA 120.608 -0.805 . . . . 0.0 113.127 177.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -113.34 85.35 2.17 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 122.88 -0.188 . . . . 0.0 110.833 -175.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . 0.564 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 5.9 m-20 56.2 21.8 5.57 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 124.705 1.202 . . . . 0.0 113.258 177.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.52 ' HB2' HD23 ' A' ' 325' ' ' LEU . . . -79.58 142.37 35.74 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.019 -176.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . 0.501 ' HA3' ' CG1' ' A' ' 286' ' ' VAL . . . -92.48 115.99 4.97 Favored Glycine 0 N--CA 1.418 -2.504 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 176.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.6 mp -110.0 109.7 29.39 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-N 118.065 0.932 . . . . 0.0 110.267 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.0 mp -98.96 109.61 24.54 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 N-CA-C 107.427 -1.324 . . . . 0.0 107.427 178.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.52 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 44.7 mt-10 -90.78 138.43 31.59 Favored 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 176.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 12.3 tp -128.47 131.48 48.36 Favored 'General case' 0 C--N 1.267 -3.022 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.561 -173.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . 0.698 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -116.41 106.25 13.41 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . 0.432 ' HA ' HG23 ' A' ' 226' ' ' THR . . . -118.19 90.91 3.43 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -83.25 113.87 20.98 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.538 0.685 . . . . 0.0 110.864 -174.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 122.99 -5.14 9.66 Favored Glycine 0 N--CA 1.428 -1.873 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.13 -175.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -115.99 113.09 22.76 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 176.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -114.96 16.77 17.13 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 120.852 0.358 . . . . 0.0 111.437 -175.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -116.68 -162.84 13.01 Favored Glycine 0 C--N 1.302 -1.352 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -101.28 132.51 21.79 Favored Pre-proline 0 C--N 1.301 -1.501 0 CA-C-N 117.798 0.799 . . . . 0.0 110.724 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.735 ' HB3' HD23 ' A' ' 264' ' ' LEU . 9.5 Cg_endo -71.73 172.52 14.27 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.429 2.086 . . . . 0.0 112.443 176.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 30.2 t70 -97.07 105.47 17.62 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.446 HD11 ' HG2' ' A' ' 251' ' ' PRO . 4.7 mp -104.86 118.09 51.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.566 -178.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . 0.488 ' HB3' ' HB ' ' A' ' 261' ' ' ILE . 22.9 t -101.0 123.23 44.87 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 175.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -107.93 95.61 5.8 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -176.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -103.35 164.39 11.67 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -60.93 -48.16 83.07 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 117.851 0.296 . . . . 0.0 111.344 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -76.08 -33.17 59.53 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.255 -173.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . 0.421 ' CB ' ' HA ' ' A' ' 303' ' ' THR . 41.8 p-80 -164.64 166.47 20.1 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 119.908 -0.717 . . . . 0.0 112.677 176.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.467 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 18.6 mt -106.41 144.71 15.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . 0.488 ' HB ' ' HB3' ' A' ' 254' ' ' SER . 3.3 mp -128.94 114.13 31.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 299' ' ' GLN . 1.3 m -107.6 132.74 54.38 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.527 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 175.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . 0.414 ' HB ' ' HB3' ' A' ' 252' ' ' ASP . 19.5 m -120.83 120.97 37.1 Favored 'General case' 0 C--N 1.281 -2.396 0 CA-C-O 121.211 0.529 . . . . 0.0 109.718 177.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.735 HD23 ' HB3' ' A' ' 251' ' ' PRO . 24.0 mt -100.91 94.74 6.18 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 179.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -57.8 126.57 27.97 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -175.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 63.78 19.24 11.63 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 113.263 -1.789 . . . . 0.0 111.283 176.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 53.5 t60 -98.56 117.73 33.66 Favored 'General case' 0 C--O 1.21 -1.006 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 5.4 p -92.7 118.62 31.25 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -176.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . 0.513 HD12 ' HD2' ' A' ' 270' ' ' PRO . 21.5 tp -99.5 129.91 28.0 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.093 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.513 ' HD2' HD12 ' A' ' 269' ' ' LEU . 71.9 Cg_endo -75.96 160.0 37.38 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.28 1.987 . . . . 0.0 111.971 176.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 19.6 p -62.66 -41.24 98.97 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 123.548 0.739 . . . . 0.0 112.485 -174.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 32.2 m -63.15 -23.35 67.39 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 124.573 1.149 . . . . 0.0 113.094 -176.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.558 HD13 ' O ' ' A' ' 226' ' ' THR . 95.4 mt -95.96 -10.11 29.48 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.583 -174.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -74.3 133.39 42.58 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 175.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . 0.484 ' CG ' HD11 ' A' ' 228' ' ' ILE . 5.4 ptp180 -171.58 172.5 5.0 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 177.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 11.8 p -130.39 148.45 52.21 Favored 'General case' 0 N--CA 1.402 -2.845 0 CA-C-O 121.293 0.568 . . . . 0.0 111.008 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.616 HD21 HD13 ' A' ' 228' ' ' ILE . 1.3 mm? -95.79 117.31 30.31 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 103.058 -2.942 . . . . 0.0 103.058 174.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -63.54 -38.85 92.7 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.479 ' HA ' ' CD1' ' A' ' 282' ' ' PHE 0.259 12.2 p 40.61 34.91 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.336 0 C-N-CA 127.139 2.176 . . . . 0.0 114.1 174.823 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -85.26 140.47 30.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 115.069 -0.968 . . . . 0.0 108.776 177.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 32.9 t70 72.52 7.65 5.62 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.285 1.034 . . . . 0.0 111.354 178.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.479 ' CD1' ' HA ' ' A' ' 279' ' ' VAL . 11.2 m-85 -73.22 -19.58 61.05 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.198 174.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm 61.85 60.7 1.52 Allowed 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 124.259 1.024 . . . . 0.0 112.032 174.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' THR . . . . . 0.526 HG22 ' HE3' ' A' ' 232' ' ' LYS . 4.9 p -128.26 178.25 1.73 Allowed Pre-proline 0 C--N 1.288 -2.108 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . 0.564 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 7.8 Cg_exo -75.36 -10.08 20.51 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 CA-C-N 121.172 1.454 . . . . 0.0 110.714 174.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . 0.501 ' CG1' ' HA3' ' A' ' 238' ' ' GLY . 0.8 OUTLIER -90.54 140.84 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.425 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 179.03 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -99.19 -51.02 3.95 Favored 'General case' 0 C--N 1.279 -2.459 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.425 -177.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . 0.45 ' HA ' ' CG1' ' A' ' 279' ' ' VAL . 86.8 tttt -155.45 135.49 12.94 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.454 ' HB ' HD23 ' A' ' 277' ' ' LEU . 42.9 t -102.44 126.18 56.59 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.927 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 60.8 m -132.49 125.72 31.3 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 121.001 0.429 . . . . 0.0 111.236 -177.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.423 ' HB2' HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -99.78 124.78 45.39 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 178.54 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -128.78 138.12 51.91 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.053 0.454 . . . . 0.0 110.112 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -80.82 144.72 31.85 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 174.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.507 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 32.4 tp -122.93 -179.76 4.37 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.507 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 88.2 m-20 -31.43 -71.92 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 126.514 1.926 . . . . 0.0 112.874 -178.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' ASN . . . . . 0.424 ' H ' HD22 ' A' ' 296' ' ' ASN . 0.0 OUTLIER -126.26 -1.63 6.98 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 173.329 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -110.87 172.8 6.66 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 114.166 -1.379 . . . . 0.0 109.445 -169.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.498 ' HB ' HD12 ' A' ' 264' ' ' LEU . 88.8 m -116.71 134.97 54.16 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 174.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . 0.571 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 27.5 tt0 -122.17 125.29 45.8 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 120.975 0.416 . . . . 0.0 109.926 -175.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.467 ' HB3' HG13 ' A' ' 262' ' ' VAL . 62.5 tp -108.42 120.52 42.65 Favored 'General case' 0 C--N 1.284 -2.267 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.083 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 72.2 mt -106.95 114.8 46.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.795 -175.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . 0.467 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 52.0 mt -116.51 105.51 18.48 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.326 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 178.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . 0.421 ' HA ' ' CB ' ' A' ' 259' ' ' HIS . 18.2 m -73.67 138.19 44.58 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -178.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 10.3 p -137.06 177.86 7.53 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 122.803 0.441 . . . . 0.0 111.691 -174.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -156.81 143.33 18.33 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 122.418 0.287 . . . . 0.0 111.168 178.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 77.72 -152.27 38.78 Favored Glycine 0 C--O 1.247 0.951 0 O-C-N 123.523 0.515 . . . . 0.0 113.819 173.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -93.22 129.01 39.41 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 177.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' TRP . . . . . 0.562 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 69.2 p-90 -157.56 160.29 38.01 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -177.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . 0.461 ' HG2' ' HE2' ' A' ' 327' ' ' LYS . 6.7 mt-10 -119.67 130.88 55.26 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -176.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.562 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 1.6 tm? -97.76 136.53 37.96 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 57.3 t -135.42 111.79 13.27 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -101.16 131.52 47.08 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -130.65 143.78 50.98 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -178.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 13.8 m -111.23 116.38 30.95 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -80.35 -40.84 25.87 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.798 -176.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . 0.428 ' HB1' ' HD2' ' A' ' 317' ' ' PRO . . . -159.75 165.86 17.15 Favored Pre-proline 0 C--N 1.301 -1.517 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 -177.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 317' ' ' PRO . . . . . 0.428 ' HD2' ' HB1' ' A' ' 316' ' ' ALA . 29.7 Cg_endo -62.14 102.47 0.27 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 121.679 1.586 . . . . 0.0 111.018 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 116.39 -27.15 8.21 Favored Glycine 0 N--CA 1.426 -1.974 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.648 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -98.11 116.57 30.6 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.922 -0.752 . . . . 0.0 110.762 -178.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -118.63 166.68 12.44 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.474 -177.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 59.6 m -152.0 131.18 12.74 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.387 -176.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -118.56 114.14 22.36 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 176.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . 0.529 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 7.2 tt0 -101.18 102.94 13.95 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -98.11 101.97 12.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 CA-C-O 122.46 1.124 . . . . 0.0 109.736 177.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.52 HD23 ' HB2' ' A' ' 237' ' ' ALA . 28.0 mt -91.05 145.55 31.89 Favored Pre-proline 0 C--N 1.302 -1.473 0 CA-C-N 113.479 -1.692 . . . . 0.0 109.922 -175.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -72.6 144.4 39.88 Favored 'Trans proline' 0 C--O 1.245 0.856 0 C-N-CA 121.648 1.565 . . . . 0.0 109.442 174.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.461 ' HE2' ' HG2' ' A' ' 309' ' ' GLU . 36.3 ttmt . . . . . 0 C--N 1.307 -1.276 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . 0.446 ' O ' HD23 ' A' ' 245' ' ' LEU . 5.7 tp-100 . . . . . 0 N--CA 1.421 -1.89 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.646 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 28.3 m -74.1 123.86 25.22 Favored 'General case' 0 C--O 1.202 -1.41 0 C-N-CA 124.495 1.118 . . . . 0.0 113.696 -169.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -143.69 169.05 18.49 Favored 'General case' 0 CA--C 1.474 -1.976 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -175.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.64 HG12 ' HB2' ' A' ' 291' ' ' LEU . 2.8 pp -135.54 160.15 39.95 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 175.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 240' ' ' ILE . 24.0 t70 -148.3 156.49 42.6 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -173.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.422 ' CE2' HG21 ' A' ' 279' ' ' VAL . 76.7 t80 -125.82 139.06 53.81 Favored 'General case' 0 N--CA 1.427 -1.598 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.016 173.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -155.14 164.16 39.22 Favored 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 124.803 1.241 . . . . 0.0 108.076 177.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -115.94 144.74 43.64 Favored 'General case' 0 CA--C 1.486 -1.516 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 177.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 237' ' ' ALA . 32.7 t70 -149.71 124.83 10.05 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 123.716 0.635 . . . . 0.0 110.632 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 81.44 -133.12 11.75 Favored Glycine 0 C--N 1.3 -1.436 0 C-N-CA 120.966 -0.635 . . . . 0.0 114.258 175.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -86.34 76.2 9.7 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 122.843 0.457 . . . . 0.0 111.502 -171.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 58.22 20.04 6.76 Favored 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 124.128 0.971 . . . . 0.0 112.445 177.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.525 ' HB3' ' O ' ' A' ' 233' ' ' ASP . . . -78.58 140.43 38.48 Favored 'General case' 0 N--CA 1.421 -1.899 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.982 -175.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . 0.473 ' C ' HD12 ' A' ' 239' ' ' ILE . . . -95.81 131.35 10.63 Favored Glycine 0 N--CA 1.416 -2.634 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 177.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . 0.473 HD12 ' C ' ' A' ' 238' ' ' GLY . 2.3 mp -120.52 115.74 47.98 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 CA-C-N 117.907 0.854 . . . . 0.0 110.403 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . 0.474 ' HB ' ' HB2' ' A' ' 322' ' ' PHE . 3.2 mp -100.1 106.92 19.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 176.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 30.9 mt-10 -86.88 141.72 28.56 Favored 'General case' 0 N--CA 1.417 -2.116 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.667 175.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 10.3 tp -128.78 125.34 37.62 Favored 'General case' 0 C--N 1.26 -3.308 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.208 -175.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . 0.646 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -112.46 97.61 6.72 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -107.15 91.56 3.71 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.62 0.724 . . . . 0.0 109.685 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 225' ' ' GLN . 3.0 mm? -80.58 115.48 20.11 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.377 -176.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 110.87 2.63 28.56 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.5 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -115.94 140.85 48.84 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -138.91 15.39 2.67 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 120.676 -0.409 . . . . 0.0 111.66 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -117.21 -163.18 12.91 Favored Glycine 0 CA--C 1.495 -1.207 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -105.64 133.11 20.35 Favored Pre-proline 0 C--N 1.3 -1.577 0 CA-C-N 117.538 0.669 . . . . 0.0 110.022 -177.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.734 ' HB3' HD23 ' A' ' 264' ' ' LEU . 25.6 Cg_endo -73.69 169.21 22.88 Favored 'Trans proline' 0 CA--C 1.506 -0.903 0 C-N-CA 122.322 2.015 . . . . 0.0 112.79 177.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.62 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 27.9 t70 -82.1 104.89 12.76 Favored 'General case' 0 CA--C 1.472 -2.023 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 174.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.478 ' CG2' HE21 ' A' ' 255' ' ' GLN . 7.1 mt -102.89 116.65 47.01 Favored 'Isoleucine or valine' 0 C--N 1.245 -3.966 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 7.8 t -125.51 129.7 50.28 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . 0.666 HE22 HG23 ' A' ' 260' ' ' ILE . 70.4 mm-40 -110.36 131.73 54.8 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -175.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.521 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 28.3 mm-40 -119.74 163.48 17.38 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 171.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -73.19 -35.89 66.44 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -88.19 -17.14 31.53 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.674 -173.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . 0.521 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 51.2 p-80 -171.94 162.41 5.97 Favored 'General case' 0 C--O 1.213 -0.841 0 O-C-N 122.093 -0.379 . . . . 0.0 111.74 178.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.666 HG23 HE22 ' A' ' 255' ' ' GLN . 17.5 mt -107.52 144.72 15.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 300' ' ' LEU . 3.5 mp -124.79 125.86 70.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 176.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 252' ' ' ASP . 0.8 OUTLIER -122.16 139.8 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.717 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 172.686 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . 0.48 ' HB ' ' HB3' ' A' ' 252' ' ' ASP . 24.7 m -131.05 123.54 28.92 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 118.527 0.603 . . . . 0.0 110.654 177.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.734 HD23 ' HB3' ' A' ' 251' ' ' PRO . 25.5 mt -100.54 96.48 7.41 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 24.1 mmtm -57.79 125.57 23.59 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -176.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 2.4 t30 62.6 26.87 15.92 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 126.064 1.746 . . . . 0.0 110.894 177.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -103.61 106.33 16.81 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 7.8 p -79.7 130.79 35.65 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.157 0.503 . . . . 0.0 112.226 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . 0.594 HD12 ' HD2' ' A' ' 270' ' ' PRO . 30.3 tp -116.92 136.28 23.23 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.594 ' HD2' HD12 ' A' ' 269' ' ' LEU . 84.5 Cg_endo -78.71 158.29 28.15 Favored 'Trans proline' 0 N--CA 1.438 -1.76 0 C-N-CA 121.204 1.269 . . . . 0.0 110.391 173.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . 0.476 ' HA ' HE21 ' A' ' 274' ' ' GLN . 5.9 p -64.5 -29.02 70.06 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.476 0.655 . . . . 0.0 111.298 -177.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 7.1 m -61.84 -29.36 70.12 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 125.393 1.477 . . . . 0.0 112.255 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.546 HD13 ' HG2' ' A' ' 270' ' ' PRO . 10.4 mp -101.37 0.08 36.41 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.381 0.61 . . . . 0.0 111.913 -172.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . 0.476 HE21 ' HA ' ' A' ' 271' ' ' THR . 41.3 mt-30 -75.72 142.32 42.46 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 174.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -164.52 171.05 15.07 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -177.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 23.2 m -140.99 133.36 28.29 Favored 'General case' 0 N--CA 1.418 -2.052 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 176.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.516 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 1.5 mm? -100.14 111.26 23.55 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.4 79.61 9.4 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-O 123.501 1.619 . . . . 0.0 109.518 175.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.422 HG21 ' CE2' ' A' ' 230' ' ' PHE 0.25 1.9 p -86.29 63.69 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.403 -2.815 0 CA-C-N 111.558 -2.565 . . . . 0.0 111.41 -175.555 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -105.97 144.93 32.0 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 113.07 -1.877 . . . . 0.0 106.911 177.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 31.7 t70 68.0 19.45 9.35 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 123.157 1.456 . . . . 0.0 110.538 -178.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . 0.405 ' CG ' HG23 ' A' ' 279' ' ' VAL . 41.1 m-85 -91.88 -13.1 31.84 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.101 173.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? 56.76 61.88 2.47 Favored 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 123.586 0.754 . . . . 0.0 112.569 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 1.5 p -136.24 170.62 10.48 Favored Pre-proline 0 N--CA 1.433 -1.32 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 178.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.46 -10.35 17.4 Favored 'Trans proline' 0 C--O 1.241 0.652 0 C-N-CA 122.018 1.812 . . . . 0.0 111.802 177.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.6 p -99.15 121.53 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.016 0 CA-C-O 121.991 0.9 . . . . 0.0 111.071 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -87.92 -41.57 13.08 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.199 -1.364 . . . . 0.0 112.522 -170.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -155.54 132.6 10.76 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -177.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 39.1 t -96.78 129.89 46.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 172.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 57.1 m -136.38 128.16 29.11 Favored 'General case' 0 C--N 1.293 -1.89 0 O-C-N 121.822 -0.549 . . . . 0.0 111.037 -178.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.64 ' HB2' HG12 ' A' ' 228' ' ' ILE . 53.5 tp -109.92 123.91 50.45 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -131.05 130.88 43.81 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . 0.466 ' HB3' HD23 ' A' ' 269' ' ' LEU . 17.7 ptt180 -79.51 137.18 37.1 Favored 'General case' 0 N--CA 1.415 -2.198 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.535 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 16.1 tp -99.96 -177.35 3.52 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.535 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 17.7 t-20 -45.22 -66.26 0.42 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.217 1.007 . . . . 0.0 112.078 -177.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -118.67 -3.54 10.82 Favored 'General case' 0 CA--C 1.498 -1.02 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.062 174.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -110.22 173.17 6.45 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.308 -170.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.515 ' HB ' HD12 ' A' ' 264' ' ' LEU . 86.5 m -115.19 131.96 56.76 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 174.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . 0.577 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 20.4 tt0 -124.84 130.82 53.13 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.172 -174.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.581 HD11 HG21 ' A' ' 228' ' ' ILE . 1.2 mm? -94.71 142.27 27.65 Favored 'General case' 0 CA--C 1.467 -2.212 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.01 172.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 50.7 mt -129.01 108.51 17.19 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.568 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 172.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . 0.576 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 58.7 mt -114.14 103.38 15.27 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.813 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -177.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 5.5 m -75.79 129.93 37.81 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -174.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 15.4 p -128.38 172.18 11.34 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 122.587 0.355 . . . . 0.0 110.817 -177.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -156.22 137.53 13.86 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 90.69 -169.65 34.25 Favored Glycine 0 N--CA 1.436 -1.344 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -87.33 129.78 34.88 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 177.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' TRP . . . . . 0.704 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 57.4 p-90 -147.24 163.87 35.0 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.476 -174.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -125.63 142.64 51.41 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -178.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . 0.704 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 19.1 tp -116.87 139.35 50.73 Favored 'General case' 0 C--O 1.249 1.045 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.952 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 89.8 t -134.68 108.96 11.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 174.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . 0.584 ' HA ' ' O ' ' A' ' 321' ' ' THR . 19.7 t30 -98.45 129.28 45.06 Favored 'General case' 0 CA--C 1.454 -2.749 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.006 177.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -119.93 121.42 38.95 Favored 'General case' 0 N--CA 1.384 -3.763 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.932 -178.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 22.1 t -84.75 105.81 15.82 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 174.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -73.69 -36.93 65.34 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.717 0.77 . . . . 0.0 110.481 -176.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -156.32 162.5 27.37 Favored Pre-proline 0 C--N 1.295 -1.802 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 -177.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.39 96.19 0.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 121.505 1.47 . . . . 0.0 111.56 -178.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 125.72 -24.93 5.7 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -100.08 116.22 31.59 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 122.244 -0.562 . . . . 0.0 109.638 -179.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -116.45 164.97 13.77 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.811 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 312' ' ' ASN . 90.8 m -152.68 108.9 3.38 Favored 'General case' 0 C--N 1.275 -2.665 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.455 -173.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . 0.49 ' HB3' HD11 ' A' ' 310' ' ' LEU . 81.2 m-85 -97.03 108.18 20.86 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . 0.557 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 37.0 tt0 -96.25 108.04 20.47 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -179.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.517 HG23 ' CE3' ' A' ' 308' ' ' TRP . 0.4 OUTLIER -101.86 105.25 17.63 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 CA-C-O 121.3 0.572 . . . . 0.0 110.951 179.385 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.93 157.57 36.44 Favored Pre-proline 0 N--CA 1.466 0.346 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.57 131.81 8.56 Favored 'Trans proline' 0 C--O 1.246 0.925 0 C-N-CA 121.988 1.792 . . . . 0.0 110.133 172.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . 0.485 ' HE3' ' O ' ' A' ' 308' ' ' TRP . 41.0 ttmt . . . . . 0 C--N 1.303 -1.447 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.587 -175.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' GLN . . . . . 0.446 ' C ' HD23 ' A' ' 245' ' ' LEU . 5.6 tp60 . . . . . 0 CA--C 1.555 1.159 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' THR . . . . . 0.701 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 7.0 m -59.11 114.89 2.82 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -168.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -142.44 168.45 19.7 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.343 -177.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' ILE . . . . . 0.617 HG12 ' HB2' ' A' ' 291' ' ' LEU . 2.2 pp -128.13 163.09 32.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.766 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -151.41 157.33 42.25 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' PHE . . . . . 0.55 ' CD2' HG11 ' A' ' 279' ' ' VAL . 87.7 t80 -129.7 135.47 48.53 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.31 177.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 -154.7 155.58 34.85 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 124.095 0.958 . . . . 0.0 108.993 177.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . 0.409 ' HE3' HG22 ' A' ' 284' ' ' THR . 53.5 mtpt -105.27 157.74 17.09 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 175.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -155.72 153.06 29.35 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 72.8 -114.31 4.77 Favored Glycine 0 N--CA 1.437 -1.28 0 C-N-CA 121.189 -0.529 . . . . 0.0 111.785 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -134.53 93.91 3.12 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 120.539 0.209 . . . . 0.0 110.869 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' ASN . . . . . 0.435 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 93.4 m-20 66.93 17.6 10.54 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 174.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -82.15 140.4 33.79 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -99.31 113.49 4.74 Favored Glycine 0 N--CA 1.432 -1.604 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.3 mp -105.13 111.53 34.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 121.618 0.723 . . . . 0.0 110.263 -178.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.6 mp -97.93 112.66 30.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 174.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -89.3 143.77 26.59 Favored 'General case' 0 N--CA 1.408 -2.548 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 176.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 12.2 tp -133.14 130.39 39.15 Favored 'General case' 0 C--N 1.263 -3.175 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.099 -176.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' ALA . . . . . 0.701 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -116.86 102.24 9.22 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 176.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -109.43 91.15 3.53 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' LEU . . . . . 0.446 HD23 ' C ' ' A' ' 225' ' ' GLN . 2.7 mm? -77.68 113.18 15.27 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.547 -175.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 114.79 -10.85 21.06 Favored Glycine 0 C--N 1.298 -1.531 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.319 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -100.73 124.31 46.17 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -178.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -103.82 -29.64 10.88 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -175.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -85.89 -161.51 35.18 Favored Glycine 0 CA--C 1.503 -0.68 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -103.48 143.02 25.79 Favored Pre-proline 0 C--N 1.303 -1.43 0 CA-C-N 117.847 0.824 . . . . 0.0 110.688 176.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.79 ' HB3' HD13 ' A' ' 264' ' ' LEU . 10.7 Cg_endo -64.6 172.03 7.4 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.108 2.539 . . . . 0.0 111.267 175.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -89.93 119.65 30.48 Favored 'General case' 0 C--N 1.274 -2.681 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' ILE . . . . . 0.402 HG12 HD22 ' A' ' 312' ' ' ASN . 2.7 mp -102.46 127.65 55.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-O 121.57 0.7 . . . . 0.0 111.385 178.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' SER . . . . . 0.72 ' HB2' ' HB ' ' A' ' 261' ' ' ILE . 73.6 m -115.73 115.48 26.41 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 125.297 1.439 . . . . 0.0 108.217 175.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -101.15 113.85 27.26 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -175.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' GLN . . . . . 0.62 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 14.5 mm100 -116.92 166.03 12.64 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 174.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -77.07 -41.99 40.07 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.488 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -84.04 -14.75 49.79 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -174.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . 0.62 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 49.8 p-80 -171.77 162.31 6.17 Favored 'General case' 0 C--O 1.21 -0.995 0 CA-C-O 120.628 0.251 . . . . 0.0 111.041 175.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' ILE . . . . . 0.419 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 19.5 mt -106.9 145.2 14.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 177.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' ILE . . . . . 0.72 ' HB ' ' HB2' ' A' ' 254' ' ' SER . 3.6 mp -122.11 123.4 68.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 175.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.504 ' HB ' ' HB2' ' A' ' 300' ' ' LEU . 37.8 t -124.7 128.19 73.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 298' ' ' THR . 7.6 m -124.27 124.04 41.55 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-O 121.538 0.685 . . . . 0.0 111.503 -177.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.79 HD13 ' HB3' ' A' ' 251' ' ' PRO . 1.9 mm? -95.32 103.13 14.98 Favored 'General case' 0 CA--C 1.47 -2.119 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 173.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' LYS . . . . . 0.464 ' HA ' ' OD2' ' A' ' 297' ' ' ASP . 17.3 ttmm -76.38 137.95 40.11 Favored 'General case' 0 N--CA 1.383 -3.788 0 O-C-N 123.72 0.638 . . . . 0.0 110.779 -177.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 8.7 t30 70.44 27.71 3.87 Favored 'General case' 0 CA--C 1.548 0.881 0 O-C-N 124.864 1.352 . . . . 0.0 109.957 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 36.1 t60 -124.27 108.02 11.8 Favored 'General case' 0 C--O 1.206 -1.185 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -178.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 7.2 p -90.48 114.66 26.88 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -176.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' LEU . . . . . 0.492 HD12 ' HD2' ' A' ' 270' ' ' PRO . 19.7 tp -93.3 133.19 28.87 Favored Pre-proline 0 C--N 1.318 -0.8 0 C-N-CA 123.077 0.551 . . . . 0.0 110.468 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' PRO . . . . . 0.492 ' HD2' HD12 ' A' ' 269' ' ' LEU . 80.9 Cg_endo -78.98 157.03 26.94 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.218 1.945 . . . . 0.0 112.117 173.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 23.6 p -62.36 -35.04 77.89 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -177.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 13.7 m -65.85 -18.3 65.24 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 123.707 0.803 . . . . 0.0 111.709 -176.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' LEU . . . . . 0.426 HD13 ' O ' ' A' ' 226' ' ' THR . 95.0 mt -105.21 -13.91 15.54 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.446 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -83.78 114.38 21.58 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' ARG . . . . . 0.405 ' CG ' HD11 ' A' ' 228' ' ' ILE . 6.1 ptp180 -144.94 175.96 9.83 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -174.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 48.9 m -134.4 138.55 44.92 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-O 121.275 0.559 . . . . 0.0 110.177 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.533 ' O ' ' HG3' ' A' ' 288' ' ' LYS . 2.0 mm? -91.96 150.38 21.04 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 174.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -86.49 -60.69 1.92 Allowed 'General case' 0 C--N 1.274 -2.693 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' VAL . . . . . 0.55 HG11 ' CD2' ' A' ' 230' ' ' PHE 0.342 30.8 m 49.41 19.32 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 174.016 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -74.19 140.2 44.95 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 173.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 28.8 t70 73.77 16.92 3.71 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.935 1.294 . . . . 0.0 111.402 -178.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -80.61 -11.86 59.58 Favored 'General case' 0 CA--C 1.514 -0.414 0 O-C-N 121.351 -0.843 . . . . 0.0 111.016 173.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 60.98 61.26 1.66 Allowed 'General case' 0 CA--C 1.497 -1.062 0 C-N-CA 123.336 0.654 . . . . 0.0 111.361 -178.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' THR . . . . . 0.409 HG22 ' HE3' ' A' ' 232' ' ' LYS . 1.6 p -137.6 168.06 17.97 Favored Pre-proline 0 C--N 1.292 -1.911 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 177.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 18.4 Cg_exo -69.46 -23.35 32.27 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 121.467 1.445 . . . . 0.0 110.822 176.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.0 p -85.31 122.31 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 CA-C-O 122.254 1.026 . . . . 0.0 110.401 179.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -89.23 -37.93 14.61 Favored 'General case' 0 C--N 1.284 -2.252 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.465 -174.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . 0.533 ' HG3' ' O ' ' A' ' 277' ' ' LEU . 56.3 tttp -159.47 137.6 10.36 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.67 -178.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.416 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 42.8 t -103.47 128.86 56.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' THR . . . . . 0.46 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 90.6 m -135.14 121.26 20.04 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 120.743 0.306 . . . . 0.0 110.591 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' LEU . . . . . 0.617 ' HB2' HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -101.08 122.96 44.49 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 177.537 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -119.56 135.26 54.87 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -176.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -83.58 142.59 30.73 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 174.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' LEU . . . . . 0.436 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 12.9 tp -120.13 -174.17 2.72 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 176.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' ASN . . . . . 0.436 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 20.2 t-20 -72.35 -51.55 20.09 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 118.908 0.776 . . . . 0.0 111.565 -172.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -115.55 -3.94 12.3 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.611 -177.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' ASP . . . . . 0.464 ' OD2' ' HA ' ' A' ' 265' ' ' LYS . 3.7 m-20 -133.13 169.3 17.06 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.58 0.705 . . . . 0.0 110.671 -170.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 263' ' ' THR . 62.6 m -113.37 126.74 55.69 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 172.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -119.71 122.57 41.75 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-O 121.441 0.639 . . . . 0.0 110.099 -173.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.504 ' HB2' ' HB ' ' A' ' 262' ' ' VAL . 0.1 OUTLIER -97.63 135.87 38.82 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.149 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 301' ' ' ILE . . . . . 0.46 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 48.7 mt -124.83 109.73 23.1 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 302' ' ' ILE . . . . . 0.419 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 68.5 mt -114.65 101.24 12.11 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -178.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 21.0 m -68.91 134.14 49.17 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -177.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 10.6 p -136.98 167.32 21.72 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -177.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -148.87 151.16 34.21 Favored 'General case' 0 C--O 1.251 1.173 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.321 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 76.71 -157.18 47.13 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.087 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -99.98 141.99 32.06 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 176.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 308' ' ' TRP . . . . . 0.406 ' CE3' HG13 ' A' ' 324' ' ' VAL . 68.6 p-90 -154.84 167.58 29.79 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.756 -176.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -122.57 135.59 54.67 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 1.3 tt -104.69 113.99 27.92 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.715 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' VAL . . . . . 0.577 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 98.4 t -108.08 107.3 22.46 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 172.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' ASN . . . . . 0.402 HD22 HG12 ' A' ' 253' ' ' ILE . 20.2 p30 -98.07 121.15 39.65 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.781 0.8 . . . . 0.0 110.429 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -122.91 148.62 45.23 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.777 -175.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 32.6 t -115.63 116.63 28.44 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 170.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -77.92 -34.83 51.14 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 122.152 0.977 . . . . 0.0 109.036 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -161.43 155.31 18.65 Favored Pre-proline 0 C--N 1.29 -2.016 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -60.73 94.93 0.11 Allowed 'Trans proline' 0 C--O 1.244 0.804 0 C-N-CA 122.239 1.96 . . . . 0.0 112.339 -176.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 136.16 -25.7 3.16 Favored Glycine 0 N--CA 1.433 -1.528 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.24 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -107.32 116.32 31.72 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -116.28 164.61 14.25 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-O 122.138 0.97 . . . . 0.0 111.037 -175.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 39.6 m -151.49 125.45 9.17 Favored 'General case' 0 C--N 1.269 -2.902 0 CA-C-N 114.394 -1.275 . . . . 0.0 108.893 -177.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -109.69 105.07 14.19 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 175.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 323' ' ' GLN . . . . . 0.577 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 7.3 tt0 -94.17 103.11 15.16 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -178.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 324' ' ' VAL . . . . . 0.406 HG13 ' CE3' ' A' ' 308' ' ' TRP . 86.7 t -94.71 99.37 9.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.9 151.41 45.29 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -77.97 132.84 11.99 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 121.546 1.497 . . . . 0.0 110.513 174.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt . . . . . 0 CA--C 1.484 -1.582 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 178.584 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 46.4 tpp . . . . . 0 C--O 1.237 0.438 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 154.39 -177.59 31.67 Favored Glycine 0 N--CA 1.432 -1.598 0 N-CA-C 110.931 -0.868 . . . . 0.0 110.931 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 17.5 p -94.47 -82.94 0.35 Allowed 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 116.857 0.328 . . . . 0.0 111.491 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 13.2 t -116.47 -14.67 10.94 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.349 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 50.8 m80 63.68 -164.01 0.26 Allowed 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.115 0.566 . . . . 0.0 110.174 -176.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . 0.435 ' HA ' ' O ' ' A' ' 200' ' ' HIS . 19.8 p-80 52.99 34.0 16.0 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.417 1.087 . . . . 0.0 112.138 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -80.2 -34.59 37.26 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 114.262 -1.336 . . . . 0.0 109.247 -177.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 45.2 t-80 -139.01 4.94 2.3 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.899 0.856 . . . . 0.0 109.081 176.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . 0.435 ' O ' ' HA ' ' A' ' 197' ' ' HIS . 14.2 t60 -127.04 96.01 4.48 Favored 'General case' 0 C--N 1.31 -1.118 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -178.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -64.69 -54.77 26.36 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.815 0.34 . . . . 0.0 110.549 -177.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 133.42 44.31 0.13 Allowed Glycine 0 N--CA 1.437 -1.283 0 C-N-CA 119.747 -1.216 . . . . 0.0 112.919 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 6.1 tt -85.85 110.74 19.61 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 176.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 29.1 m -103.38 115.82 63.16 Favored Pre-proline 0 C--N 1.301 -1.54 0 CA-C-O 120.861 0.362 . . . . 0.0 111.207 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -75.93 162.97 34.04 Favored 'Trans proline' 0 C--O 1.249 1.032 0 C-N-CA 122.306 2.004 . . . . 0.0 111.167 176.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -143.74 34.84 1.27 Allowed 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.027 0.441 . . . . 0.0 111.467 -176.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 128.61 -166.83 20.99 Favored Glycine 0 C--N 1.301 -1.393 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 37.8 t -126.63 164.92 20.19 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 117.148 0.474 . . . . 0.0 110.521 -177.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 29.3 m-70 -115.46 0.47 13.38 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 175.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 84.2 mtp -89.09 114.44 25.69 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.861 -176.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -177.07 -27.77 0.01 OUTLIER 'General case' 0 C--N 1.314 -0.978 0 C-N-CA 124.657 1.183 . . . . 0.0 108.133 -176.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 7.4 m -55.05 129.11 36.71 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 124.785 1.234 . . . . 0.0 110.958 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 61.8 mtt -100.06 95.93 7.17 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 28.4 m -74.33 97.13 2.96 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 178.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 157.01 152.44 6.31 Favored Glycine 0 N--CA 1.417 -2.595 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -152.28 -56.65 0.01 OUTLIER Glycine 0 N--CA 1.428 -1.836 0 N-CA-C 109.094 -1.602 . . . . 0.0 109.094 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -93.7 175.1 6.86 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 176.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -75.97 -62.74 1.5 Allowed 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 -178.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 50.6 ttm -179.07 -55.55 0.01 OUTLIER 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.148 0.979 . . . . 0.0 110.031 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -157.97 -147.95 4.99 Favored Glycine 0 N--CA 1.432 -1.612 0 N-CA-C 111.614 -0.594 . . . . 0.0 111.614 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 11.5 ptm180 -130.15 -46.1 1.12 Allowed 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 120.938 0.399 . . . . 0.0 111.028 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -117.71 38.89 2.79 Favored Glycine 0 C--N 1.308 -1.016 0 N-CA-C 107.767 -2.133 . . . . 0.0 107.767 176.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.7 p -86.0 86.11 7.36 Favored 'General case' 0 N--CA 1.412 -2.355 0 CA-C-N 114.126 -1.037 . . . . 0.0 113.418 -174.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -128.15 -79.24 0.58 Allowed 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 170.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . 0.437 ' HB3' HD11 ' A' ' 273' ' ' LEU . 8.0 tp-100 -155.21 176.17 12.91 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 177.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.636 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 5.6 m -56.04 126.49 26.17 Favored 'General case' 0 C--N 1.31 -1.134 0 C-N-CA 124.384 1.074 . . . . 0.0 113.42 -171.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -152.95 168.17 26.72 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 116.345 -0.389 . . . . 0.0 109.979 -177.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.671 HG21 HD21 ' A' ' 300' ' ' LEU . 2.8 pp -134.35 165.53 31.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 C-N-CA 123.114 0.565 . . . . 0.0 112.164 -178.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.514 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 9.4 t70 -149.89 156.36 41.63 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -133.88 134.63 42.93 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 176.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 -152.32 171.61 17.73 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.437 ' HE3' HG22 ' A' ' 284' ' ' THR . 57.4 mtpt -118.98 148.57 42.84 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 175.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -144.68 143.23 30.63 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 123.436 0.46 . . . . 0.0 109.934 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 74.01 -98.81 1.0 Allowed Glycine 0 N--CA 1.435 -1.39 0 O-C-N 124.048 0.842 . . . . 0.0 111.89 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -146.15 98.6 3.12 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 120.761 0.315 . . . . 0.0 110.202 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 63.18 22.65 13.49 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 173.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -89.05 137.36 32.39 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -96.59 113.09 4.59 Favored Glycine 0 N--CA 1.432 -1.601 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 1.9 mp -106.42 121.36 58.9 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 CA-C-N 117.237 0.519 . . . . 0.0 109.869 -177.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.5 mp -105.75 117.31 51.24 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.223 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 39.0 mt-10 -94.91 146.04 24.5 Favored 'General case' 0 C--N 1.284 -2.245 0 C-N-CA 119.822 -0.751 . . . . 0.0 109.02 174.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 12.4 tp -134.36 128.87 34.53 Favored 'General case' 0 C--N 1.27 -2.88 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.133 -173.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . 0.636 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -118.44 101.77 8.41 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -109.42 91.47 3.66 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.541 0.686 . . . . 0.0 109.493 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -77.94 111.41 13.77 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.562 -175.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 107.87 9.18 28.81 Favored Glycine 0 N--CA 1.431 -1.634 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.451 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -115.32 107.72 15.61 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 176.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -115.14 95.24 5.1 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.369 0.604 . . . . 0.0 109.784 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 165.55 -150.22 17.57 Favored Glycine 0 N--CA 1.425 -2.08 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 -178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -124.48 136.18 27.47 Favored Pre-proline 0 C--N 1.3 -1.572 0 CA-C-N 117.39 0.595 . . . . 0.0 110.339 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.657 ' HB3' HD23 ' A' ' 264' ' ' LEU . 10.6 Cg_endo -74.32 172.37 16.2 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 C-N-CA 122.505 2.137 . . . . 0.0 112.41 176.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.506 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 11.6 t70 -91.94 105.63 17.84 Favored 'General case' 0 C--N 1.284 -2.283 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 175.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.477 HD11 ' HG2' ' A' ' 251' ' ' PRO . 5.3 mp -103.43 124.14 57.44 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 C-N-CA 119.484 -0.887 . . . . 0.0 109.894 178.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . 0.491 ' HB3' ' HB ' ' A' ' 261' ' ' ILE . 25.1 t -106.27 120.21 41.25 Favored 'General case' 0 C--N 1.287 -2.126 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 176.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -100.13 109.41 21.69 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.948 -178.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -124.42 162.5 23.75 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 174.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 39.2 m80 -73.57 -33.33 64.6 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 120.991 0.424 . . . . 0.0 110.124 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -70.78 -42.92 69.75 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.842 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . 0.459 ' CB ' ' HA ' ' A' ' 303' ' ' THR . 53.1 p-80 -169.42 167.55 9.91 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.472 0.177 . . . . 0.0 111.067 178.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 17.3 mt -106.21 139.5 27.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 106.084 -1.821 . . . . 0.0 106.084 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . 0.491 ' HB ' ' HB3' ' A' ' 254' ' ' SER . 3.4 mp -122.97 114.56 42.66 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 299' ' ' GLN . 0.8 OUTLIER -107.81 134.07 50.71 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 175.034 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 25.3 m -122.45 123.78 42.09 Favored 'General case' 0 C--N 1.267 -3.002 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 176.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.657 HD23 ' HB3' ' A' ' 251' ' ' PRO . 29.6 mt -100.17 93.73 5.86 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.441 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 63.1 mmtt -63.1 126.94 29.03 Favored 'General case' 0 CA--C 1.478 -1.814 0 O-C-N 124.29 0.994 . . . . 0.0 113.075 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 9.8 t30 69.77 32.53 3.19 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.432 -1.713 . . . . 0.0 109.909 177.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 61.5 t60 -125.69 100.54 6.47 Favored 'General case' 0 C--O 1.2 -1.525 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 6.4 m -88.26 112.2 22.53 Favored 'General case' 0 C--N 1.277 -2.57 0 C-N-CA 119.635 -0.826 . . . . 0.0 111.889 -173.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . 0.687 HD22 HD22 ' A' ' 291' ' ' LEU . 37.6 tp -81.83 125.81 76.89 Favored Pre-proline 0 N--CA 1.444 -0.77 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.275 178.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.408 ' HD2' HD12 ' A' ' 269' ' ' LEU . 31.3 Cg_exo -65.79 143.1 72.55 Favored 'Trans proline' 0 N--CA 1.44 -1.648 0 C-N-CA 122.105 1.87 . . . . 0.0 110.587 169.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 11.4 t -69.63 -12.71 61.86 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.388 0.613 . . . . 0.0 110.363 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 2.4 m -76.29 -16.57 59.76 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 123.961 0.904 . . . . 0.0 109.924 179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.505 HD13 ' O ' ' A' ' 226' ' ' THR . 73.8 mt -110.88 -7.06 14.62 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.415 -177.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.521 ' HB2' ' O ' ' A' ' 291' ' ' LEU . 25.2 pt20 -81.35 115.64 20.81 Favored 'General case' 0 N--CA 1.43 -1.427 0 C-N-CA 119.101 -1.04 . . . . 0.0 109.61 -177.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 21.0 ptt180 -135.44 151.65 50.61 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 40.7 m -112.71 136.93 51.73 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.799 176.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.458 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 59.6 mt -105.67 116.47 32.0 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -61.02 -51.86 67.44 Favored 'General case' 0 C--N 1.311 -1.079 0 O-C-N 123.724 0.64 . . . . 0.0 110.419 -177.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . 0.263 26.9 m 46.19 25.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 116.856 2.169 . . . . 0.0 116.856 174.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -75.85 140.65 42.34 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 177.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 15.3 t70 73.02 20.99 3.31 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 124.701 1.2 . . . . 0.0 112.531 177.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -79.74 -4.98 54.3 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.574 -0.704 . . . . 0.0 110.22 172.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 mptt 65.77 50.94 1.49 Allowed 'General case' 0 CA--C 1.503 -0.85 0 C-N-CA 124.248 1.019 . . . . 0.0 109.924 -178.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' THR . . . . . 0.437 HG22 ' HE3' ' A' ' 232' ' ' LYS . 1.2 p -133.34 165.03 39.74 Favored Pre-proline 0 C--N 1.302 -1.461 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 179.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -74.78 -4.91 16.12 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.196 1.931 . . . . 0.0 111.752 177.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 49.8 t -87.59 129.54 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.357 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -99.86 -30.35 12.08 Favored 'General case' 0 C--N 1.283 -2.286 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.208 -176.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 20.6 ttmm -167.13 143.79 4.47 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.458 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 43.3 t -112.64 130.22 66.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 174.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.527 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 98.2 m -136.18 117.87 15.0 Favored 'General case' 0 C--N 1.283 -2.307 0 CA-C-O 121.262 0.554 . . . . 0.0 110.762 -178.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.687 HD22 HD22 ' A' ' 269' ' ' LEU . 0.1 OUTLIER -91.47 114.13 26.58 Favored 'General case' 0 N--CA 1.428 -1.555 0 N-CA-C 104.244 -2.502 . . . . 0.0 104.244 174.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.407 ' HD3' ' OE1' ' A' ' 274' ' ' GLN . 17.0 tppt? -116.15 129.6 56.4 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -177.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -78.42 140.37 38.68 Favored 'General case' 0 N--CA 1.42 -1.956 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 175.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.559 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 21.7 tp -111.23 -173.14 2.17 Favored 'General case' 0 C--N 1.276 -2.617 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 175.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.559 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 3.2 t-20 -58.91 -66.66 0.47 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 119.172 0.896 . . . . 0.0 111.247 -177.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -115.86 -3.6 12.17 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 120.791 0.329 . . . . 0.0 111.147 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . 0.441 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 38.1 m-20 -115.23 172.69 6.92 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.397 0.618 . . . . 0.0 110.209 -177.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.515 ' HB ' ' HB2' ' A' ' 264' ' ' LEU . 92.8 m -116.98 132.11 56.79 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 176.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . 0.529 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 42.1 tt0 -120.17 127.78 52.79 Favored 'General case' 0 N--CA 1.421 -1.894 0 C-N-CA 120.529 -0.469 . . . . 0.0 110.35 -175.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.671 HD21 HG21 ' A' ' 228' ' ' ILE . 17.4 mt -100.08 127.7 46.27 Favored 'General case' 0 CA--C 1.443 -3.142 0 C-N-CA 120.127 -0.629 . . . . 0.0 111.462 172.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' ILE . . . . . 0.527 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 63.1 mt -115.19 109.23 27.65 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.373 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 176.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 50.9 mt -117.17 102.13 13.05 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.625 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.459 ' HA ' ' CB ' ' A' ' 259' ' ' HIS . 32.8 m -74.88 134.6 41.62 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.781 -175.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 19.0 p -133.74 179.72 6.06 Favored 'General case' 0 C--N 1.303 -1.414 0 C-N-CA 123.189 0.595 . . . . 0.0 109.608 -177.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -159.59 148.47 17.86 Favored 'General case' 0 C--O 1.246 0.878 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 73.64 -142.4 31.05 Favored Glycine 0 C--O 1.243 0.675 0 O-C-N 123.613 0.571 . . . . 0.0 112.468 176.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -105.26 130.23 53.44 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' TRP . . . . . 0.73 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 60.7 p-90 -145.79 171.27 15.03 Favored 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -177.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -129.98 135.06 47.88 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -177.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.73 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 25.8 tp -111.25 120.95 43.97 Favored 'General case' 0 C--O 1.244 0.764 0 C-N-CA 120.614 -0.435 . . . . 0.0 111.269 -177.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.554 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 54.3 t -116.2 107.55 22.85 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 173.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 21.3 p-10 -94.75 134.97 36.78 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . 0.426 ' HB2' ' HB ' ' A' ' 321' ' ' THR . 67.6 mttm -130.58 145.01 51.8 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.619 -176.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 15.9 m -115.85 118.53 33.25 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 172.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -87.28 -24.83 24.22 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.605 0.716 . . . . 0.0 110.41 -177.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -170.24 162.59 6.34 Favored Pre-proline 0 C--N 1.307 -1.241 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -65.17 95.99 0.26 Allowed 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 121.493 1.462 . . . . 0.0 110.504 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 133.52 -33.36 2.58 Favored Glycine 0 N--CA 1.421 -2.35 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.628 -177.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -99.89 116.44 31.96 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 122.036 -0.685 . . . . 0.0 109.87 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -119.3 163.94 16.4 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.932 -177.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.426 ' HB ' ' HB2' ' A' ' 313' ' ' LYS . 78.7 m -152.09 139.93 19.96 Favored 'General case' 0 C--N 1.269 -2.894 0 CA-C-N 115.3 -0.863 . . . . 0.0 109.261 -178.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -126.43 112.4 15.57 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 177.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . 0.554 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 61.8 tt0 -97.37 109.7 22.4 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.598 HG13 ' CE3' ' A' ' 308' ' ' TRP . 91.7 t -98.38 99.31 8.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.587 0 C-N-CA 123.501 0.72 . . . . 0.0 109.687 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -88.43 152.86 50.36 Favored Pre-proline 0 C--N 1.309 -1.153 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -80.35 128.67 7.22 Favored 'Trans proline' 0 C--O 1.252 1.209 0 C-N-CA 121.27 1.314 . . . . 0.0 109.956 171.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -85.45 101.8 12.93 Favored 'General case' 0 CA--C 1.471 -2.06 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 30.3 mtmm -88.54 122.87 32.47 Favored 'General case' 0 C--N 1.271 -2.82 0 CA-C-N 114.519 -1.219 . . . . 0.0 111.994 -169.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 . . . . . 0 C--N 1.293 -1.88 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 176.056 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 4.3 mpp? . . . . . 0 N--CA 1.475 0.825 0 CA-C-O 120.654 0.264 . . . . 0.0 111.374 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 102.43 34.93 4.0 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -177.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 7.7 m -130.91 20.81 4.97 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -178.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 15.6 m -61.0 -24.46 66.18 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -173.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 42.7 m170 -104.24 5.66 34.91 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -142.45 -67.0 0.38 Allowed 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 -179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 61.9 m80 74.86 170.06 0.29 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.158 1.383 . . . . 0.0 109.614 -177.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -86.35 77.36 9.51 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 104.46 -2.422 . . . . 0.0 104.46 171.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -52.63 -46.41 67.08 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.853 -1.067 . . . . 0.0 113.759 -168.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -115.94 25.11 10.96 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.749 0.785 . . . . 0.0 109.147 176.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -124.75 51.89 0.81 Allowed Glycine 0 N--CA 1.437 -1.276 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.504 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 96.9 mt -94.62 0.74 55.38 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.083 0.468 . . . . 0.0 110.216 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 7.7 p -113.37 102.24 54.56 Favored Pre-proline 0 C--N 1.305 -1.327 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.604 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.31 96.7 1.08 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.421 2.081 . . . . 0.0 108.792 172.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 36.3 ttp180 -108.34 -14.64 14.64 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.829 -172.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 140.98 -134.41 6.36 Favored Glycine 0 N--CA 1.436 -1.305 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.119 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 16.4 m -70.27 126.93 31.07 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 122.903 0.481 . . . . 0.0 110.598 -178.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -113.72 108.32 16.95 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.204 0.526 . . . . 0.0 110.652 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 53.5 ttp -92.67 155.29 17.82 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . 70.42 170.55 0.31 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 124.625 1.17 . . . . 0.0 111.415 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 15.3 m -92.92 129.49 38.82 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 25.3 ptt? -71.43 128.97 37.62 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 176.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 17.9 m -47.89 120.12 3.25 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 123.586 0.755 . . . . 0.0 111.299 -179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -177.08 41.17 0.1 OUTLIER Glycine 0 N--CA 1.438 -1.189 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 178.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -169.36 39.66 0.21 Allowed Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -94.29 -23.17 17.95 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 121.272 0.558 . . . . 0.0 110.323 -177.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . 0.474 ' HB3' ' HD2' ' A' ' 221' ' ' ARG . 21.8 mm-40 -135.39 32.68 3.08 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 123.786 0.835 . . . . 0.0 110.116 -176.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -69.41 -46.36 67.02 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.07 -0.968 . . . . 0.0 108.934 -178.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -101.83 102.01 2.28 Favored Glycine 0 N--CA 1.431 -1.663 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . 0.474 ' HD2' ' HB3' ' A' ' 218' ' ' GLN . 66.2 mtp180 -124.21 98.89 5.97 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.029 0.442 . . . . 0.0 110.181 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -88.6 82.89 1.49 Allowed Glycine 0 C--N 1.3 -1.422 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 178.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 22.7 m -106.84 24.44 12.73 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 122.552 -0.381 . . . . 0.0 111.792 -175.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -64.73 -49.9 69.03 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . 0.409 ' C ' HD23 ' A' ' 245' ' ' LEU . 5.7 tp-100 -171.98 174.27 4.17 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 105.716 -1.957 . . . . 0.0 105.716 175.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.573 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 72.8 m -52.92 131.98 36.61 Favored 'General case' 0 C--O 1.208 -1.13 0 C-N-CA 124.178 0.991 . . . . 0.0 113.187 -172.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -162.54 175.59 11.29 Favored 'General case' 0 CA--C 1.501 -0.914 0 CA-C-O 121.023 0.44 . . . . 0.0 111.519 -174.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.439 HG21 HD21 ' A' ' 300' ' ' LEU . 1.8 pp -121.51 165.44 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.484 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.075 178.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.501 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 6.6 t70 -150.37 152.16 33.96 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 178.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -134.06 127.59 32.52 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.098 176.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.503 ' HD3' ' HB ' ' A' ' 239' ' ' ILE . 0.3 OUTLIER -150.91 157.39 42.85 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.633 179.063 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -104.67 162.44 13.29 Favored 'General case' 0 C--N 1.28 -2.444 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . 0.453 ' O ' ' HB3' ' A' ' 237' ' ' ALA . 15.3 t70 -157.71 143.96 17.63 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 68.77 -118.89 9.36 Favored Glycine 0 N--CA 1.441 -1.014 0 C-N-CA 120.577 -0.821 . . . . 0.0 111.486 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -135.35 111.89 9.93 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.97 0.385 . . . . 0.0 110.695 -178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 66.67 15.75 10.21 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.876 0.87 . . . . 0.0 112.403 174.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 233' ' ' ASP . . . -92.41 132.04 37.09 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -103.35 113.91 4.67 Favored Glycine 0 CA--C 1.491 -1.427 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.503 ' HB ' ' HD3' ' A' ' 231' ' ' ARG . 2.4 mp -106.77 117.12 51.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.857 0 CA-C-O 121.512 0.672 . . . . 0.0 110.263 -177.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.4 mp -101.08 109.04 24.59 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.207 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 176.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.501 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 43.1 mt-10 -89.73 132.81 35.0 Favored 'General case' 0 C--N 1.286 -2.164 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 176.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 8.9 tp -117.59 122.27 43.16 Favored 'General case' 0 C--N 1.269 -2.934 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.131 -174.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . 0.573 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -107.34 101.21 10.6 Favored 'General case' 0 N--CA 1.414 -2.259 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 177.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.452 ' HA ' HG23 ' A' ' 226' ' ' THR . . . -106.8 91.87 3.85 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-O 121.615 0.722 . . . . 0.0 109.076 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.409 HD23 ' C ' ' A' ' 225' ' ' GLN . 3.0 mm? -81.71 114.18 20.2 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.278 -175.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 103.42 22.75 8.86 Favored Glycine 0 C--N 1.297 -1.615 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.121 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . 0.403 ' HE1' ' O ' ' A' ' 265' ' ' LYS . 20.0 t80 -115.74 127.41 55.09 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -102.28 -21.05 14.41 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -174.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -104.18 -141.38 11.06 Favored Glycine 0 C--N 1.314 -0.685 0 C-N-CA 120.396 -0.907 . . . . 0.0 112.841 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -127.59 142.5 44.32 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.7 ' HB3' HD13 ' A' ' 264' ' ' LEU . 18.0 Cg_endo -68.35 172.31 11.43 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.717 2.278 . . . . 0.0 112.853 179.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.525 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 20.3 t70 -96.02 119.86 35.28 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 175.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 4.6 mp -108.41 108.95 26.54 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.009 0 CA-C-O 121.995 0.902 . . . . 0.0 111.232 178.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . 0.651 ' HB2' ' HB ' ' A' ' 261' ' ' ILE . 47.4 m -96.47 104.83 16.83 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-N 114.163 -1.381 . . . . 0.0 109.198 177.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -88.1 118.25 27.54 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.865 -176.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 47.0 mt-30 -124.66 157.05 36.49 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 106.495 -1.669 . . . . 0.0 106.495 167.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 60.6 m80 -74.34 -29.79 61.74 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.926 -0.709 . . . . 0.0 111.202 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -69.65 -42.11 74.68 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.955 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . 0.403 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 49.9 p-80 -167.23 163.82 15.45 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.73 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 18.3 mt -105.48 142.02 19.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . 0.651 ' HB ' ' HB2' ' A' ' 254' ' ' SER . 3.8 mp -119.99 110.23 28.42 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 178.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.6 ' O ' ' HA ' ' A' ' 299' ' ' GLN . 0.8 OUTLIER -108.64 142.28 21.66 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.441 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 176.741 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 298' ' ' THR . 31.9 m -134.86 126.62 29.13 Favored 'General case' 0 C--N 1.275 -2.643 0 O-C-N 121.726 -0.609 . . . . 0.0 111.13 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.7 HD13 ' HB3' ' A' ' 251' ' ' PRO . 2.1 mm? -98.17 101.84 13.42 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 177.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.454 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 25.8 mmtm -67.65 130.94 44.58 Favored 'General case' 0 C--N 1.286 -2.178 0 O-C-N 124.033 0.833 . . . . 0.0 111.283 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 6.6 t30 73.84 21.59 2.67 Favored 'General case' 0 N--CA 1.478 0.943 0 O-C-N 124.678 1.236 . . . . 0.0 109.999 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -121.13 100.59 7.14 Favored 'General case' 0 CA--C 1.484 -1.581 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 -179.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 3.7 m -90.2 121.03 31.86 Favored 'General case' 0 C--N 1.271 -2.828 0 C-N-CA 120.076 -0.649 . . . . 0.0 110.837 -175.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . 0.541 HD22 HD22 ' A' ' 291' ' ' LEU . 24.8 tp -92.76 127.3 48.47 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.242 -177.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.76 149.07 91.63 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.285 1.99 . . . . 0.0 110.989 170.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . 0.609 ' O ' ' HG2' ' A' ' 274' ' ' GLN . 22.2 p -66.32 -25.35 66.79 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 115.866 -0.606 . . . . 0.0 112.336 -177.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 10.2 m -72.51 -18.52 61.65 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 121.508 0.67 . . . . 0.0 111.056 -177.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.511 HD13 ' O ' ' A' ' 226' ' ' THR . 82.1 mt -99.29 -19.12 17.23 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.497 -177.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.609 ' HG2' ' O ' ' A' ' 271' ' ' THR . 21.9 pt20 -76.82 137.69 39.38 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 9.7 ptp180 -173.42 169.48 4.39 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -174.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 3.1 p -123.99 132.86 53.76 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-O 121.478 0.656 . . . . 0.0 112.101 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 60.3 mt -100.58 113.06 25.56 Favored 'General case' 0 N--CA 1.429 -1.505 0 N-CA-C 104.34 -2.467 . . . . 0.0 104.34 175.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -63.41 -53.05 58.38 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -174.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . . 34.5 m 44.71 37.05 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 115.899 1.814 . . . . 0.0 115.899 176.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -69.4 133.42 47.77 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 20.2 t70 61.9 36.15 16.0 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 125.005 1.322 . . . . 0.0 110.692 177.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -79.26 0.38 28.91 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.703 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt 69.01 59.03 0.35 Allowed 'General case' 0 CA--C 1.497 -1.095 0 C-N-CA 125.388 1.475 . . . . 0.0 111.478 177.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.35 152.66 11.02 Favored Pre-proline 0 C--N 1.295 -1.767 0 CA-C-N 113.851 -1.522 . . . . 0.0 108.675 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . 0.433 ' O ' ' HA ' ' A' ' 304' ' ' THR . 54.0 Cg_exo -50.14 -24.77 11.75 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.713 2.942 . . . . 0.0 113.55 175.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 46.9 t -74.06 118.33 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -94.64 -29.11 15.01 Favored 'General case' 0 C--N 1.294 -1.808 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.891 -178.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -170.21 135.23 1.29 Allowed 'General case' 0 N--CA 1.478 0.93 0 O-C-N 123.665 0.603 . . . . 0.0 110.863 -177.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 40.2 t -104.3 135.96 39.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.447 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 90.2 m -143.19 123.64 13.93 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 121.461 0.648 . . . . 0.0 111.09 -179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.541 HD22 HD22 ' A' ' 269' ' ' LEU . 0.1 OUTLIER -98.06 120.37 38.35 Favored 'General case' 0 N--CA 1.429 -1.49 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 176.436 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.493 ' HD3' ' OE1' ' A' ' 274' ' ' GLN . 4.0 tppp? -128.76 135.88 49.8 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -79.99 145.01 32.78 Favored 'General case' 0 N--CA 1.426 -1.627 0 C-N-CA 118.858 -1.137 . . . . 0.0 109.273 178.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.548 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 18.0 tp -108.44 -174.08 2.43 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 177.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.548 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 20.6 t-20 -56.65 -67.47 0.3 Allowed 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 118.559 0.618 . . . . 0.0 111.688 -177.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -110.03 -4.28 15.97 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.289 -0.564 . . . . 0.0 109.825 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . 0.454 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 36.2 m-20 -119.81 176.4 5.42 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.599 0.714 . . . . 0.0 111.511 -169.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 263' ' ' THR . 90.1 m -113.73 133.4 55.37 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 176.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . 0.6 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 26.3 tt0 -124.08 132.07 53.62 Favored 'General case' 0 N--CA 1.43 -1.425 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.13 -175.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.523 ' O ' ' HA ' ' A' ' 261' ' ' ILE . 25.4 mt -101.69 131.92 47.67 Favored 'General case' 0 CA--C 1.451 -2.86 0 C-N-CA 120.426 -0.51 . . . . 0.0 111.967 173.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' ILE . . . . . 0.447 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 63.6 mt -116.26 108.63 25.6 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.697 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 175.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 65.2 mt -115.98 104.16 16.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.201 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 3.5 m -72.51 130.03 39.7 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 123.126 0.57 . . . . 0.0 109.641 -175.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . 0.433 ' HA ' ' O ' ' A' ' 285' ' ' PRO . 8.7 p -136.02 176.71 8.44 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 122.319 0.248 . . . . 0.0 110.905 -178.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -147.73 148.94 31.52 Favored 'General case' 0 C--O 1.245 0.857 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 61.38 -148.61 46.61 Favored Glycine 0 N--CA 1.463 0.444 0 O-C-N 123.933 0.771 . . . . 0.0 113.089 177.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -97.72 144.4 27.39 Favored 'General case' 0 CA--C 1.47 -2.121 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' TRP . . . . . 0.718 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 65.9 p-90 -157.94 170.77 21.58 Favored 'General case' 0 C--N 1.27 -2.851 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -178.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.467 ' HG2' ' HE2' ' A' ' 327' ' ' LYS . 4.6 mt-10 -122.26 129.83 52.6 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -176.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.718 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 23.3 tp -105.65 117.81 34.96 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-O 120.996 0.427 . . . . 0.0 111.207 -176.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.5 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 48.8 t -114.63 107.36 22.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 174.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -94.18 126.61 39.52 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 177.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . 0.435 ' HB2' ' HB ' ' A' ' 321' ' ' THR . 95.3 mttt -119.83 149.45 42.04 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.964 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 23.9 t -115.97 114.59 24.83 Favored 'General case' 0 N--CA 1.416 -2.141 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 172.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -80.18 -32.35 38.73 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 121.572 0.701 . . . . 0.0 109.561 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -168.76 162.18 8.25 Favored Pre-proline 0 C--N 1.305 -1.355 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.5 102.19 0.33 Allowed 'Trans proline' 0 N--CA 1.452 -0.912 0 C-N-CA 121.532 1.488 . . . . 0.0 110.497 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 129.73 -32.43 3.18 Favored Glycine 0 N--CA 1.427 -1.954 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -177.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -102.77 116.59 32.88 Favored 'General case' 0 CA--C 1.494 -1.177 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -119.16 161.79 19.74 Favored 'General case' 0 C--N 1.277 -2.546 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.292 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.435 ' HB ' ' HB2' ' A' ' 313' ' ' LYS . 89.4 m -151.62 124.93 8.79 Favored 'General case' 0 C--N 1.263 -3.16 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.74 -174.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 0.4 ' O ' ' HA ' ' A' ' 239' ' ' ILE . 69.9 m-85 -112.4 109.98 19.92 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . 0.5 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 8.8 tt0 -96.73 105.72 17.89 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.617 HG13 ' CE3' ' A' ' 308' ' ' TRP . 94.0 t -95.01 100.41 11.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 C-N-CA 123.42 0.688 . . . . 0.0 110.228 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -92.42 153.33 42.74 Favored Pre-proline 0 C--N 1.313 -0.984 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_endo -73.09 140.71 31.61 Favored 'Trans proline' 0 C--O 1.249 1.046 0 C-N-CA 121.765 1.643 . . . . 0.0 110.4 172.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.467 ' HE2' ' HG2' ' A' ' 309' ' ' GLU . 14.8 ttmm -100.54 125.72 46.91 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -176.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -93.53 98.92 11.49 Favored 'General case' 0 N--CA 1.419 -1.978 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 173.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' GLN . . . . . 0.488 ' H ' ' NE2' ' A' ' 329' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.286 -2.176 0 CA-C-O 118.646 -0.692 . . . . 0.0 109.723 -177.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 69.3 mtm . . . . . 0 CA--C 1.519 -0.237 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 150.51 176.52 23.58 Favored Glycine 0 N--CA 1.439 -1.107 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -178.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 38.8 m -103.44 130.42 50.77 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 117.836 0.818 . . . . 0.0 110.052 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 36.4 t -174.46 -41.36 0.01 OUTLIER 'General case' 0 C--O 1.235 0.326 0 O-C-N 123.469 0.481 . . . . 0.0 110.25 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 71.8 5.09 5.26 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.376 1.07 . . . . 0.0 110.642 -177.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 28.4 t60 58.6 70.69 0.63 Allowed 'General case' 0 C--O 1.241 0.62 0 C-N-CA 125.081 1.352 . . . . 0.0 109.961 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -150.5 121.26 7.54 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 -177.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 -68.88 132.24 46.41 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.134 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -92.67 -16.97 24.9 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-O 121.283 0.563 . . . . 0.0 111.396 -175.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -115.61 135.56 53.94 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 149.31 13.27 0.11 Allowed Glycine 0 C--N 1.312 -0.805 0 C-N-CA 119.678 -1.249 . . . . 0.0 113.255 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 79.3 mt -102.13 14.06 33.0 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.987 0.422 . . . . 0.0 111.012 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.415 ' O ' ' HD2' ' A' ' 206' ' ' ARG . 55.2 t -62.13 -44.84 90.41 Favored Pre-proline 0 CA--C 1.566 1.565 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.715 176.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -86.94 90.31 0.6 Allowed 'Trans proline' 0 N--CA 1.429 -2.269 0 CA-C-N 120.293 1.14 . . . . 0.0 110.517 170.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.47 ' H ' ' HD2' ' A' ' 206' ' ' ARG . 4.0 mpt_? -76.2 -37.12 58.22 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 162.39 65.82 0.02 OUTLIER Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 8.4 t -114.39 10.84 17.12 Favored 'General case' 0 N--CA 1.436 -1.139 0 CA-C-O 121.361 0.601 . . . . 0.0 109.763 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -95.67 0.66 52.91 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-O 121.359 0.6 . . . . 0.0 110.382 173.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -154.59 118.55 4.67 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 105.842 -1.911 . . . . 0.0 105.842 177.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . 70.74 103.44 0.06 Allowed 'General case' 0 C--O 1.238 0.485 0 C-N-CA 124.701 1.201 . . . . 0.0 111.831 -177.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 18.8 m 67.68 86.79 0.13 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.24 -1.346 . . . . 0.0 112.646 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 65.2 mtm -87.31 89.78 8.12 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 6.7 m -151.68 9.31 0.53 Allowed 'General case' 0 CA--C 1.558 1.251 0 CA-C-O 121.828 0.823 . . . . 0.0 109.83 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 81.67 -62.9 4.45 Favored Glycine 0 C--O 1.242 0.608 0 O-C-N 121.685 -0.634 . . . . 0.0 111.92 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 140.28 25.38 0.25 Allowed Glycine 0 N--CA 1.44 -1.1 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.957 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -104.44 -70.52 0.77 Allowed 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 119.904 -0.719 . . . . 0.0 109.672 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -91.76 84.79 5.47 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 17.1 tpt -166.28 122.47 1.28 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.314 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -82.34 62.96 4.5 Favored Glycine 0 N--CA 1.443 -0.836 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 177.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 12.9 ttp180 -84.49 133.17 34.48 Favored 'General case' 0 N--CA 1.429 -1.488 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 174.28 -87.88 0.08 OUTLIER Glycine 0 N--CA 1.422 -2.254 0 N-CA-C 108.425 -1.87 . . . . 0.0 108.425 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 15.6 m -77.24 103.23 7.05 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 174.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -125.57 -9.54 6.82 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.748 0.785 . . . . 0.0 109.656 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 8.1 pm0 -122.72 148.54 45.19 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.426 -175.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 28.7 m -59.93 128.62 37.78 Favored 'General case' 0 C--O 1.209 -1.028 0 O-C-N 124.121 0.888 . . . . 0.0 109.01 -179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -148.03 155.95 42.08 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.625 -0.83 . . . . 0.0 111.082 -170.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.657 HG12 ' HB2' ' A' ' 291' ' ' LEU . 2.7 pp -137.48 149.68 25.66 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 C-N-CA 124.134 0.974 . . . . 0.0 108.872 179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -149.76 156.6 42.12 Favored 'General case' 0 C--N 1.302 -1.479 0 C-N-CA 122.789 0.436 . . . . 0.0 111.038 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -127.0 139.18 53.21 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 120.97 0.414 . . . . 0.0 111.01 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 20.5 ptt85 -157.04 161.68 39.52 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 173.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.403 ' HE3' HG22 ' A' ' 284' ' ' THR . 53.2 mtpt -105.64 144.91 31.73 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 177.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . 0.521 ' O ' ' HB3' ' A' ' 237' ' ' ALA . 21.7 t70 -159.76 117.38 2.66 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -176.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 104.12 -157.14 17.25 Favored Glycine 0 C--N 1.296 -1.694 0 C-N-CA 120.203 -0.998 . . . . 0.0 111.179 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -91.53 97.49 11.09 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 116.7 0.25 . . . . 0.0 110.391 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.538 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 3.4 m-20 60.92 23.26 13.36 Favored 'General case' 0 N--CA 1.485 1.302 0 O-C-N 124.197 0.936 . . . . 0.0 111.396 177.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.521 ' HB3' ' O ' ' A' ' 233' ' ' ASP . . . -87.11 136.91 32.75 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.491 -174.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -101.94 116.51 5.55 Favored Glycine 0 N--CA 1.427 -1.915 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.43 HG13 ' HG3' ' A' ' 323' ' ' GLN . 2.1 mp -106.52 114.87 46.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-O 121.34 0.591 . . . . 0.0 111.127 -175.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.3 mp -103.49 112.77 38.24 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 176.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -94.4 138.77 31.95 Favored 'General case' 0 C--N 1.277 -2.549 0 CA-C-O 121.363 0.601 . . . . 0.0 109.487 177.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 12.0 tp -127.49 131.04 50.2 Favored 'General case' 0 C--N 1.269 -2.924 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.392 -175.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . 0.417 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -122.37 102.18 7.95 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.013 178.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -108.84 91.07 3.49 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -73.15 109.72 6.89 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -173.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 111.99 -4.64 27.23 Favored Glycine 0 C--N 1.304 -1.204 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.132 178.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -94.62 107.73 19.71 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -108.58 97.11 6.82 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 178.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 160.74 -147.78 15.02 Favored Glycine 0 C--N 1.297 -1.604 0 N-CA-C 110.011 -1.235 . . . . 0.0 110.011 -179.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -126.74 135.65 27.61 Favored Pre-proline 0 C--N 1.311 -1.095 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.822 ' HB3' HD13 ' A' ' 264' ' ' LEU . 13.7 Cg_endo -70.38 171.98 14.11 Favored 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.361 2.041 . . . . 0.0 109.901 176.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -91.13 110.26 21.53 Favored 'General case' 0 C--N 1.27 -2.878 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 175.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 3.8 mp -97.73 108.46 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.76 0 CA-C-O 121.605 0.717 . . . . 0.0 109.57 178.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . 0.669 ' HB2' ' HB ' ' A' ' 261' ' ' ILE . 31.8 m -102.99 110.76 22.79 Favored 'General case' 0 C--N 1.282 -2.369 0 CA-C-N 114.473 -1.24 . . . . 0.0 108.274 175.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . 0.503 HE21 HD23 ' A' ' 310' ' ' LEU . 70.4 mt-30 -100.18 117.36 34.26 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.48 -172.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -125.1 162.57 24.29 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 172.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . 0.402 ' HA ' ' HE1' ' A' ' 308' ' ' TRP . 13.1 m170 -76.53 -31.16 57.48 Favored 'General case' 0 CA--C 1.499 -1.012 0 C-N-CA 119.015 -1.074 . . . . 0.0 112.068 178.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -73.91 -30.94 62.86 Favored 'General case' 0 C--N 1.319 -0.744 0 O-C-N 123.661 0.6 . . . . 0.0 111.476 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . 0.447 ' CD2' HG23 ' A' ' 301' ' ' ILE . 39.4 p-80 -172.78 165.13 5.29 Favored 'General case' 0 CA--C 1.503 -0.864 0 O-C-N 122.252 -0.28 . . . . 0.0 110.623 175.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 18.4 mt -106.29 140.86 23.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . 0.669 ' HB ' ' HB2' ' A' ' 254' ' ' SER . 3.5 mp -116.64 108.69 25.66 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.701 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.442 ' HB ' ' HB2' ' A' ' 300' ' ' LEU . 49.1 t -105.66 131.54 54.82 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.492 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 177.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 298' ' ' THR . 26.6 m -134.46 126.17 28.92 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 121.289 0.566 . . . . 0.0 111.066 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.822 HD13 ' HB3' ' A' ' 251' ' ' PRO . 2.0 mm? -98.38 108.58 21.31 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.498 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 30.5 mmmt -67.75 131.58 45.83 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-O 121.526 0.679 . . . . 0.0 112.384 -178.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 74.91 1.96 3.9 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 113.379 -1.737 . . . . 0.0 111.294 176.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -94.68 110.65 22.47 Favored 'General case' 0 C--O 1.211 -0.958 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -178.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 1.2 p -82.73 135.67 34.93 Favored 'General case' 0 C--N 1.29 -1.997 0 CA-C-O 121.074 0.464 . . . . 0.0 111.405 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . 0.484 HD11 ' HB2' ' A' ' 273' ' ' LEU . 26.8 tp -112.88 124.11 32.36 Favored Pre-proline 0 N--CA 1.425 -1.698 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.125 176.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.42 ' O ' ' HG ' ' A' ' 269' ' ' LEU . 23.3 Cg_exo -70.77 160.08 50.58 Favored 'Trans proline' 0 C--N 1.317 -1.11 0 C-N-CA 122.619 2.213 . . . . 0.0 111.659 170.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 3.6 p -66.95 -26.19 66.71 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 123.803 0.841 . . . . 0.0 111.456 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 6.7 m -64.23 -23.6 67.37 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.01 1.324 . . . . 0.0 112.438 -177.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.484 ' HB2' HD11 ' A' ' 269' ' ' LEU . 3.2 mm? -99.47 -8.92 24.02 Favored 'General case' 0 CA--C 1.496 -1.11 0 CA-C-O 121.344 0.592 . . . . 0.0 111.707 -174.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -72.96 138.67 46.24 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.288 -0.869 . . . . 0.0 108.803 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -169.09 170.9 8.5 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 177.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 62.0 m -130.8 152.54 50.03 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-O 121.394 0.616 . . . . 0.0 110.302 176.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.468 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 1.8 mm? -111.98 108.91 18.41 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 105.998 -1.852 . . . . 0.0 105.998 177.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -80.72 85.52 6.07 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 122.444 1.116 . . . . 0.0 109.213 177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.641 ' HA ' ' CE1' ' A' ' 282' ' ' PHE . 87.8 t -89.63 36.69 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-N 113.364 -1.744 . . . . 0.0 111.619 -173.365 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -80.84 142.5 33.6 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 115.026 -0.988 . . . . 0.0 108.432 174.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 18.6 t70 72.51 20.49 3.89 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 122.673 1.225 . . . . 0.0 110.259 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.641 ' CE1' ' HA ' ' A' ' 279' ' ' VAL . 21.1 m-85 -90.3 -18.4 25.66 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.588 -0.695 . . . . 0.0 110.589 176.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER 65.39 35.02 7.71 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.691 0.796 . . . . 0.0 111.841 176.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' THR . . . . . 0.403 HG22 ' HE3' ' A' ' 232' ' ' LYS . 2.3 p -115.58 174.91 2.13 Favored Pre-proline 0 C--N 1.3 -1.558 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . 0.538 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 9.2 Cg_exo -75.57 -15.2 19.66 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.764 1.643 . . . . 0.0 111.693 176.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.8 p -93.21 128.74 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.541 0 CA-C-O 121.639 0.733 . . . . 0.0 109.87 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -94.51 -39.61 10.31 Favored 'General case' 0 C--N 1.293 -1.88 0 CA-C-N 114.915 -1.038 . . . . 0.0 110.155 -174.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 25.4 ttpp -160.14 134.52 7.49 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.541 -176.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.468 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 40.6 t -99.39 123.77 52.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 174.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 87.5 m -130.11 122.91 29.17 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-O 120.852 0.358 . . . . 0.0 110.885 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.657 ' HB2' HG12 ' A' ' 228' ' ' ILE . 46.5 tp -99.74 125.06 45.57 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -124.4 139.12 54.2 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -175.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -83.66 148.54 27.05 Favored 'General case' 0 C--N 1.289 -2.061 0 C-N-CA 118.832 -1.147 . . . . 0.0 108.218 176.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.484 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 17.8 tp -115.73 -174.49 2.54 Favored 'General case' 0 C--N 1.288 -2.073 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 173.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.484 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 4.6 t30 -76.0 -55.23 5.8 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 120.07 1.305 . . . . 0.0 111.891 -173.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -107.36 -8.91 16.17 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.686 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . 0.498 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 29.3 m-20 -132.1 173.12 11.56 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.975 -171.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.609 ' O ' ' HA ' ' A' ' 263' ' ' THR . 79.1 m -110.7 132.96 53.74 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . 0.422 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 32.7 tt0 -117.14 126.62 53.09 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 121.799 0.809 . . . . 0.0 110.112 -177.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.442 ' HB2' ' HB ' ' A' ' 262' ' ' VAL . 0.5 OUTLIER -110.89 122.82 48.83 Favored 'General case' 0 C--N 1.274 -2.689 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 178.211 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' ILE . . . . . 0.447 HG23 ' CD2' ' A' ' 259' ' ' HIS . 72.9 mt -109.12 109.22 27.56 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.368 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -177.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 59.9 mt -110.48 98.9 7.65 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 10.9 m -69.53 126.03 28.49 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -177.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 17.3 p -136.26 165.79 24.93 Favored 'General case' 0 C--N 1.308 -1.231 0 C-N-CA 122.85 0.46 . . . . 0.0 110.98 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -149.63 138.68 21.19 Favored 'General case' 0 C--O 1.244 0.815 0 CA-C-O 120.631 0.253 . . . . 0.0 111.468 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 90.29 -168.28 33.53 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.242 176.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -84.12 127.81 34.15 Favored 'General case' 0 CA--C 1.482 -1.654 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' TRP . . . . . 0.708 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 68.4 p-90 -144.53 169.5 17.84 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -178.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -125.53 123.81 39.95 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -174.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.708 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 17.7 tp -100.19 122.36 42.89 Favored 'General case' 0 CA--C 1.501 -0.914 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.137 -178.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.617 HG13 ' HB3' ' A' ' 323' ' ' GLN . 8.6 p -126.1 114.98 41.11 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.966 0 CA-C-O 121.723 0.773 . . . . 0.0 109.558 171.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 321' ' ' THR . 11.4 t30 -102.51 129.9 49.18 Favored 'General case' 0 CA--C 1.437 -3.366 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.496 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 45.8 mtmt -114.35 123.61 49.92 Favored 'General case' 1 N--CA 1.372 -4.334 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.874 -176.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 16.3 m -92.06 103.03 15.57 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 176.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -78.38 -34.15 48.4 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.88 -1.055 . . . . 0.0 112.539 -172.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.482 ' HB1' ' HD2' ' A' ' 317' ' ' PRO . . . -165.75 167.38 9.06 Favored Pre-proline 0 C--N 1.307 -1.273 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 -175.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . 0.482 ' HD2' ' HB1' ' A' ' 316' ' ' ALA . 25.2 Cg_endo -60.31 102.96 0.2 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.031 1.821 . . . . 0.0 112.088 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 105.83 -15.25 44.89 Favored Glycine 0 N--CA 1.436 -1.331 0 CA-C-N 115.177 -0.92 . . . . 0.0 112.181 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -100.89 116.79 33.6 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 122.196 -0.59 . . . . 0.0 110.698 -178.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . 0.497 ' CZ ' ' HD3' ' A' ' 251' ' ' PRO . 75.2 m-85 -122.49 163.65 19.5 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.975 -177.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 312' ' ' ASN . 88.4 m -152.8 110.66 3.62 Favored 'General case' 0 C--N 1.265 -3.076 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.194 -175.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -98.01 104.35 16.37 Favored 'General case' 0 C--N 1.284 -2.257 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . 0.617 ' HB3' HG13 ' A' ' 311' ' ' VAL . 42.6 tt0 -94.96 108.2 20.25 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.502 -1.295 . . . . 0.0 107.502 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.593 HG13 ' CE3' ' A' ' 308' ' ' TRP . 93.3 t -94.86 99.87 10.14 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.302 -178.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.3 152.51 47.81 Favored Pre-proline 0 C--O 1.213 -0.836 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 177.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . 0.447 ' HG3' ' HB2' ' A' ' 236' ' ' ASN . 57.5 Cg_endo -77.33 137.39 16.78 Favored 'Trans proline' 0 C--O 1.249 1.069 0 C-N-CA 121.565 1.51 . . . . 0.0 110.18 172.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 22.8 ttmm -84.31 126.29 33.06 Favored 'General case' 0 CA--C 1.468 -2.205 0 C-N-CA 119.048 -1.061 . . . . 0.0 109.742 -179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 24.7 mtmm -95.19 26.93 3.47 Favored 'General case' 0 C--N 1.271 -2.836 0 CA-C-N 113.817 -1.538 . . . . 0.0 110.942 -170.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 . . . . . 0 C--N 1.294 -1.84 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.648 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 26.8 ttt . . . . . 0 N--CA 1.467 0.39 0 CA-C-O 120.586 0.232 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -142.34 30.89 2.08 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.32 -178.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 14.5 t -123.19 11.51 9.45 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 176.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 15.0 m -78.78 93.55 4.98 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.43 -176.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.587 ' HA ' ' O ' ' A' ' 199' ' ' HIS . 12.1 p-80 -95.53 80.56 3.47 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 115.373 -0.83 . . . . 0.0 113.215 -174.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -92.13 -58.54 2.36 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 175.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -155.6 20.18 0.4 Allowed 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 174.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . 0.587 ' O ' ' HA ' ' A' ' 196' ' ' HIS . 93.7 m-70 -155.49 173.94 15.97 Favored 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 103.801 -2.666 . . . . 0.0 103.801 178.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -100.65 -36.82 9.01 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.789 0.804 . . . . 0.0 109.588 173.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -121.47 -53.85 1.99 Allowed 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 83.46 -152.42 29.17 Favored Glycine 0 N--CA 1.424 -2.12 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 -176.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 1.4 tt 61.35 42.88 11.2 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 8.9 p -164.4 130.5 2.2 Favored Pre-proline 0 C--N 1.313 -1.013 0 CA-C-N 114.196 -1.366 . . . . 0.0 107.575 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -70.16 94.96 0.57 Allowed 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 122.013 1.809 . . . . 0.0 112.491 -178.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 34.1 mmt180 -132.21 94.26 3.42 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.782 176.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -137.83 -156.44 7.19 Favored Glycine 0 N--CA 1.425 -2.054 0 N-CA-C 110.895 -0.882 . . . . 0.0 110.895 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 50.9 p -113.33 160.56 18.23 Favored 'General case' 0 C--N 1.28 -2.437 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -73.74 106.86 5.67 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 174.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 23.5 ttt 74.39 148.28 0.09 Allowed 'General case' 0 C--O 1.251 1.184 0 O-C-N 124.448 1.093 . . . . 0.0 110.528 -174.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . 0.446 ' HB1' ' HG2' ' A' ' 217' ' ' GLN . . . -77.57 92.98 4.11 Favored 'General case' 0 N--CA 1.428 -1.531 0 N-CA-C 107.17 -1.418 . . . . 0.0 107.17 173.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 22.4 t -108.43 40.09 1.85 Allowed 'General case' 0 C--N 1.304 -1.37 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.969 -172.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 57.4 mtm 65.49 22.7 11.86 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 122.041 0.924 . . . . 0.0 108.972 -176.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 1.4 p -91.35 31.28 1.16 Allowed 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 125.92 1.688 . . . . 0.0 110.499 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 152.81 -174.36 31.63 Favored Glycine 0 N--CA 1.411 -2.99 0 N-CA-C 108.456 -1.858 . . . . 0.0 108.456 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -76.7 118.65 5.26 Favored Glycine 0 N--CA 1.425 -2.074 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 176.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . 0.446 ' HG2' ' HB1' ' A' ' 211' ' ' ALA . 22.9 mt-30 -78.99 -30.84 44.58 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.007 0.432 . . . . 0.0 109.939 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -121.2 83.74 2.13 Favored 'General case' 0 N--CA 1.43 -1.473 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 173.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 66.2 mtm -89.35 -51.69 5.43 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 175.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 72.7 157.87 4.0 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-N 114.357 -1.292 . . . . 0.0 114.011 176.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -162.24 3.0 0.05 Allowed 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.321 -0.439 . . . . 0.0 111.096 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 77.88 18.52 76.89 Favored Glycine 0 N--CA 1.439 -1.138 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.941 -177.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 2.6 m -129.08 6.81 5.44 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.39 0.614 . . . . 0.0 110.388 -176.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 22.8 tptm -96.3 101.6 13.26 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 69.4 173.89 0.29 Allowed 'General case' 0 CA--C 1.555 1.167 0 O-C-N 125.02 1.45 . . . . 0.0 110.62 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 24.4 m -57.16 114.34 2.11 Favored 'General case' 0 C--O 1.198 -1.633 0 C-N-CA 123.679 0.792 . . . . 0.0 111.866 -171.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.412 ' HB3' ' HB3' ' A' ' 243' ' ' ALA . 48.2 t30 -130.96 160.21 35.19 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.812 -169.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.2 pp -128.97 151.74 36.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 124.286 1.034 . . . . 0.0 109.762 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.571 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 5.0 t70 -143.47 156.5 44.65 Favored 'General case' 0 C--N 1.29 -1.998 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -176.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.418 ' HA ' ' O ' ' A' ' 239' ' ' ILE . 77.3 t80 -137.91 139.32 39.75 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 110.27 -0.271 . . . . 0.0 110.27 178.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -165.1 175.01 9.75 Favored 'General case' 0 C--N 1.313 -1.011 0 C-N-CA 123.952 0.901 . . . . 0.0 108.743 178.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.405 ' HE3' HG22 ' A' ' 284' ' ' THR . 54.5 mtpt -121.82 159.36 26.91 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 117.803 0.274 . . . . 0.0 110.552 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -164.38 148.23 9.46 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 82.43 -103.35 2.4 Favored Glycine 0 N--CA 1.439 -1.128 0 C-N-CA 121.475 -0.393 . . . . 0.0 113.588 173.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -135.87 72.22 1.44 Allowed 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.14 0.495 . . . . 0.0 111.524 -176.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.465 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 86.0 m-20 67.16 27.52 8.48 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 115.785 -0.643 . . . . 0.0 112.131 179.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -82.88 143.15 30.95 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.824 179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -98.13 117.74 5.92 Favored Glycine 0 N--CA 1.437 -1.264 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 230' ' ' PHE . 2.3 mp -105.59 118.64 53.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 CA-C-N 117.318 0.559 . . . . 0.0 110.288 -177.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.3 mp -108.89 111.61 36.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 175.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.571 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 49.6 mt-10 -92.76 138.8 31.18 Favored 'General case' 0 C--N 1.278 -2.539 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 177.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 13.9 tp -121.91 117.48 26.56 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.358 -176.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . 0.579 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -106.19 94.4 5.14 Favored 'General case' 0 C--N 1.28 -2.414 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -102.7 91.34 4.14 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-O 121.813 0.816 . . . . 0.0 109.98 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -76.62 116.38 17.24 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.165 -176.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 114.1 -7.55 23.29 Favored Glycine 0 N--CA 1.429 -1.831 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.762 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -102.48 145.79 29.06 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -136.09 -12.86 1.9 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 112.511 0.559 . . . . 0.0 112.511 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -92.5 -140.61 9.76 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.434 -0.889 . . . . 0.0 112.991 -178.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -122.72 134.25 24.88 Favored Pre-proline 0 C--N 1.311 -1.092 0 CA-C-O 120.517 0.199 . . . . 0.0 110.617 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.655 ' HB3' HD23 ' A' ' 264' ' ' LEU . 32.1 Cg_endo -77.79 172.43 15.7 Favored 'Trans proline' 0 N--CA 1.443 -1.447 0 C-N-CA 122.66 2.24 . . . . 0.0 112.36 177.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.411 ' HB3' ' HB ' ' A' ' 263' ' ' THR . 34.3 t70 -95.87 111.26 23.29 Favored 'General case' 0 C--N 1.29 -1.984 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.462 177.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 3.8 mp -105.48 124.72 60.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 8.8 t -115.94 117.44 30.15 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 174.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -99.76 107.16 19.16 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 121.187 0.518 . . . . 0.0 111.923 -176.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.453 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 27.2 mt-30 -115.87 161.12 19.26 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 175.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . 0.443 ' HA ' ' HE1' ' A' ' 308' ' ' TRP . 30.6 m170 -73.91 -31.37 63.05 Favored 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 120.154 -0.618 . . . . 0.0 110.084 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -80.91 -26.54 36.72 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.707 -177.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . 0.453 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 35.5 p-80 -174.03 161.48 3.66 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 120.878 0.37 . . . . 0.0 111.821 175.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.45 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 14.9 mt -106.67 142.75 18.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 177.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 3.1 mp -122.46 116.34 48.7 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' A' ' 300' ' ' LEU . 24.3 t -113.86 119.74 61.87 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.093 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 175.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . 0.411 ' HB ' ' HB3' ' A' ' 252' ' ' ASP . 10.4 m -116.86 123.79 47.92 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 121.181 0.515 . . . . 0.0 110.168 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.655 HD23 ' HB3' ' A' ' 251' ' ' PRO . 21.2 mt -99.02 99.77 10.84 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.585 ' HD3' ' OD1' ' A' ' 297' ' ' ASP . 48.7 mmtt -61.28 129.34 40.77 Favored 'General case' 0 C--N 1.317 -0.815 0 O-C-N 124.147 0.904 . . . . 0.0 113.398 -177.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 63.4 t30 67.59 22.54 9.11 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-N 114.274 -1.33 . . . . 0.0 110.839 175.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 48.4 t60 -110.25 112.08 23.81 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 18.4 p -86.27 124.46 32.67 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-O 121.251 0.548 . . . . 0.0 111.451 -178.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 32.6 tp -99.01 127.63 34.49 Favored Pre-proline 0 N--CA 1.418 -2.064 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.699 177.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.87 147.31 55.43 Favored 'Trans proline' 0 N--CA 1.432 -2.092 0 C-N-CA 121.382 1.388 . . . . 0.0 110.692 170.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . 0.422 ' O ' ' HG2' ' A' ' 274' ' ' GLN . 25.0 p -66.64 -15.06 63.2 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.424 0.63 . . . . 0.0 112.075 -177.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 12.2 m -74.58 -21.18 59.62 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.743 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' A' ' 226' ' ' THR . 3.1 mm? -102.11 -13.97 17.27 Favored 'General case' 0 CA--C 1.499 -0.985 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.077 -178.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 271' ' ' THR . 9.4 pt20 -77.11 129.78 36.48 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 119.563 -0.855 . . . . 0.0 108.996 -178.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -170.44 159.96 7.24 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -177.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 290' ' ' THR . 16.9 p -104.22 140.21 38.15 Favored 'General case' 0 N--CA 1.407 -2.613 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.735 173.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 82.4 mt -99.59 117.29 33.65 Favored 'General case' 0 C--N 1.292 -1.901 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 175.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -47.35 -68.97 0.14 Allowed 'General case' 0 C--N 1.316 -0.85 0 O-C-N 125.085 1.491 . . . . 0.0 110.594 -177.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . 0.271 19.0 m 49.78 18.32 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 C-N-CA 127.111 2.164 . . . . 0.0 116.697 173.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -73.75 132.79 43.01 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 177.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 22.2 t70 68.77 48.64 0.75 Allowed 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 122.674 1.226 . . . . 0.0 112.327 -178.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -98.08 -1.62 42.0 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 168.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? 61.86 59.94 1.65 Allowed 'General case' 0 CA--C 1.503 -0.86 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.825 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 236' ' ' ASN . 2.5 p -137.42 176.65 2.6 Favored Pre-proline 0 C--N 1.31 -1.14 0 N-CA-C 105.389 -2.078 . . . . 0.0 105.389 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 3.3 Cg_exo -82.66 -7.1 11.6 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.077 1.852 . . . . 0.0 112.083 174.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.4 p -99.01 127.72 51.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 CA-C-O 121.623 0.725 . . . . 0.0 110.668 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -88.14 -44.65 10.76 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.441 -172.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 38.0 ttmt -165.06 138.16 4.61 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.319 -176.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 30.7 t -104.39 140.58 22.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -178.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.434 ' HA ' ' HA ' ' A' ' 276' ' ' SER . 75.4 m -142.42 116.35 9.34 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 122.031 -0.418 . . . . 0.0 111.177 177.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 56.2 tp -91.59 128.89 37.6 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 174.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -134.92 133.82 39.99 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-O 120.783 0.325 . . . . 0.0 110.971 -174.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 293' ' ' ARG . 23.3 ttt180 -71.05 125.11 26.0 Favored 'General case' 0 N--CA 1.4 -2.962 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 171.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.488 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 14.9 tp -102.88 -174.33 2.53 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 105.502 -2.036 . . . . 0.0 105.502 176.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.488 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 39.4 t30 -46.64 -74.54 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 113.379 0.881 . . . . 0.0 113.379 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -120.61 -3.87 9.81 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 122.319 1.057 . . . . 0.0 108.745 178.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . 0.585 ' OD1' ' HD3' ' A' ' 265' ' ' LYS . 39.7 m-20 -111.67 164.12 13.37 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.475 -1.239 . . . . 0.0 109.236 -175.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.462 ' HB ' ' HB2' ' A' ' 264' ' ' LEU . 91.7 m -104.77 128.61 52.96 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 174.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -113.36 129.68 56.47 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -178.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.502 ' HB3' ' HB ' ' A' ' 262' ' ' VAL . 50.5 tp -114.16 119.02 35.65 Favored 'General case' 0 C--N 1.273 -2.758 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 176.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 51.6 mt -104.44 112.01 36.32 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.9 0 CA-C-N 114.718 -1.128 . . . . 0.0 108.128 -177.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . 0.45 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 56.4 mt -112.6 103.83 16.06 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.304 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 3.7 m -77.8 130.38 36.62 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 -174.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 15.5 p -135.56 -176.95 4.45 Favored 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 122.366 0.266 . . . . 0.0 111.286 -176.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -159.35 152.94 22.74 Favored 'General case' 0 C--O 1.247 0.946 0 C-N-CA 122.965 0.506 . . . . 0.0 110.169 175.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 74.85 -157.07 50.07 Favored Glycine 0 N--CA 1.444 -0.784 0 O-C-N 123.569 0.543 . . . . 0.0 112.955 175.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' ASN . . . . . 0.497 ' HB3' ' HB3' ' A' ' 327' ' ' LYS . 40.8 m-80 -92.39 131.28 37.69 Favored 'General case' 0 CA--C 1.485 -1.53 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 177.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' TRP . . . . . 0.707 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 60.8 p-90 -148.77 166.3 28.84 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -178.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -124.76 135.99 53.46 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.707 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 27.0 tp -107.45 118.56 37.03 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.65 HG13 ' HB3' ' A' ' 323' ' ' GLN . 5.7 p -115.26 112.31 39.36 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.515 0 N-CA-C 108.677 -0.861 . . . . 0.0 108.677 171.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 25.0 p-10 -102.93 129.71 49.74 Favored 'General case' 0 N--CA 1.407 -2.586 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.075 -178.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -129.17 156.98 43.05 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.635 -177.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 26.4 t -111.44 120.95 43.86 Favored 'General case' 0 N--CA 1.411 -2.417 0 N-CA-C 106.192 -1.781 . . . . 0.0 106.192 173.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -88.91 -23.65 22.67 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-O 121.024 0.44 . . . . 0.0 110.726 -177.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -169.91 164.14 6.36 Favored Pre-proline 0 C--N 1.307 -1.245 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -61.69 103.11 0.26 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 121.745 1.63 . . . . 0.0 111.238 178.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 115.01 -28.1 8.22 Favored Glycine 0 N--CA 1.436 -1.347 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -177.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -89.13 116.65 27.55 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.164 0.507 . . . . 0.0 110.339 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -116.28 165.74 12.84 Favored 'General case' 0 C--N 1.28 -2.443 0 CA-C-N 115.377 -0.829 . . . . 0.0 108.865 177.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 89.6 m -152.05 130.18 11.91 Favored 'General case' 0 C--N 1.261 -3.278 0 C-N-CA 123.661 0.784 . . . . 0.0 108.894 -176.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -118.57 107.53 13.86 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . 0.65 ' HB3' HG13 ' A' ' 311' ' ' VAL . 35.9 tt0 -99.66 112.5 24.72 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 176.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.63 HG13 ' CE3' ' A' ' 308' ' ' TRP . 75.3 t -95.1 98.64 8.2 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.174 -178.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -83.49 149.14 57.07 Favored Pre-proline 0 CA--C 1.512 -0.49 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -77.52 125.6 7.72 Favored 'Trans proline' 0 N--CA 1.44 -1.672 0 N-CA-C 108.498 -1.385 . . . . 0.0 108.498 170.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.497 ' HB3' ' HB3' ' A' ' 307' ' ' ASN . 40.1 ttmt -86.83 102.8 14.64 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.275 -1.38 . . . . 0.0 107.275 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -121.07 115.26 22.77 Favored 'General case' 0 N--CA 1.407 -2.583 0 C-N-CA 119.876 -0.73 . . . . 0.0 109.502 -176.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 . . . . . 0 C--N 1.289 -2.039 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.973 -175.944 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 69.9 mtm . . . . . 0 N--CA 1.467 0.401 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 85.06 162.03 34.97 Favored Glycine 0 N--CA 1.439 -1.152 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.517 177.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 15.1 t -98.17 69.04 1.99 Allowed 'General case' 0 N--CA 1.413 -2.32 0 CA-C-O 122.076 0.941 . . . . 0.0 108.682 178.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 17.3 m -114.29 -45.98 3.01 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 114.533 -1.212 . . . . 0.0 108.61 176.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 49.3 t-80 -141.18 114.91 9.0 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.587 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 44.6 m-70 -131.98 176.72 8.12 Favored 'General case' 0 C--N 1.284 -2.255 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 171.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 69.8 t60 63.15 80.97 0.22 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 122.012 0.911 . . . . 0.0 109.921 -177.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -73.91 73.63 1.63 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.949 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 24.7 m80 64.18 -163.71 0.26 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.795 0.838 . . . . 0.0 110.158 -174.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -154.18 -72.76 0.13 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 175.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 66.47 -105.12 1.2 Allowed Glycine 0 N--CA 1.435 -1.413 0 N-CA-C 109.893 -1.283 . . . . 0.0 109.893 -176.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 29.8 tp -119.95 7.35 10.9 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.624 0.726 . . . . 0.0 109.766 179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 46.8 t -122.45 128.25 25.53 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 116.002 -0.544 . . . . 0.0 109.918 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -66.02 132.84 31.3 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 121.968 1.779 . . . . 0.0 109.323 174.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.431 ' NE ' ' HA ' ' A' ' 206' ' ' ARG . 1.6 mmp_? -118.72 105.39 11.52 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.107 0.48 . . . . 0.0 110.221 -174.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 79.87 18.33 72.88 Favored Glycine 0 N--CA 1.441 -0.97 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.743 -176.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 32.0 m -137.35 4.34 2.65 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.413 -0.394 . . . . 0.0 112.001 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -104.56 100.29 9.96 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.278 -0.569 . . . . 0.0 111.961 -177.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 23.1 ptt? -178.6 104.73 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 124.526 1.131 . . . . 0.0 109.974 175.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -84.87 -23.12 29.12 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 122.128 0.965 . . . . 0.0 108.966 177.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 20.2 t -154.09 162.36 41.25 Favored 'General case' 0 N--CA 1.414 -2.264 0 N-CA-C 104.705 -2.332 . . . . 0.0 104.705 177.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 16.4 tpt -121.29 134.82 55.16 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -177.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . 0.264 48.4 p 65.63 -60.72 0.27 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 125.968 1.707 . . . . 0.0 115.298 179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -158.64 101.39 0.2 Allowed Glycine 0 N--CA 1.431 -1.657 0 C-N-CA 120.105 -1.045 . . . . 0.0 112.905 -177.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -98.04 -45.88 2.34 Favored Glycine 0 C--N 1.3 -1.454 0 N-CA-C 110.434 -1.066 . . . . 0.0 110.434 175.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 53.5 mt-30 -112.37 105.18 13.39 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -144.06 -55.97 0.37 Allowed 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 65.9 mtt -106.28 -179.69 4.01 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.773 -178.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -118.33 -161.25 11.81 Favored Glycine 0 N--CA 1.434 -1.463 0 N-CA-C 110.181 -1.167 . . . . 0.0 110.181 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 67.6 ttt180 -72.11 -35.66 69.22 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 117.274 0.537 . . . . 0.0 110.576 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -130.6 -89.86 0.53 Allowed Glycine 0 N--CA 1.436 -1.366 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 178.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.498 ' HB3' ' OH ' ' A' ' 319' ' ' TYR . 51.0 m 65.72 15.71 10.17 Favored 'General case' 0 CA--C 1.548 0.87 0 N-CA-C 113.809 1.041 . . . . 0.0 113.809 176.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -125.69 1.11 7.49 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.547 0.689 . . . . 0.0 110.615 178.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . 0.427 ' O ' HD23 ' A' ' 245' ' ' LEU . 11.5 pm0 -140.9 156.87 46.01 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 -179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 56.9 m -67.44 116.39 8.13 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.407 ' ND2' ' HB3' ' A' ' 243' ' ' ALA . 10.0 p30 -144.51 173.02 12.17 Favored 'General case' 0 C--N 1.295 -1.803 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.308 -172.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.58 HD13 HD21 ' A' ' 277' ' ' LEU . 1.4 pp -136.06 158.65 38.88 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 CA-C-N 114.145 -1.389 . . . . 0.0 109.361 -178.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.463 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 12.8 t70 -150.23 151.32 32.85 Favored 'General case' 0 C--N 1.285 -2.235 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.51 ' CD2' HG11 ' A' ' 279' ' ' VAL . 86.4 t80 -129.84 133.75 47.12 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 173.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 18.8 ptp180 -153.39 152.81 31.48 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 178.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -104.15 153.19 21.23 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 121.087 -0.245 . . . . 0.0 110.442 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -151.61 162.61 40.7 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 64.7 -125.87 31.49 Favored Glycine 0 C--N 1.312 -0.751 0 O-C-N 123.454 0.471 . . . . 0.0 112.849 178.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -124.03 91.81 3.54 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.581 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 95.9 m-20 66.66 21.25 10.66 Favored 'General case' 0 C--N 1.312 -1.027 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 177.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -79.79 138.26 37.21 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 178.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -99.18 110.4 3.98 Favored Glycine 0 N--CA 1.436 -1.325 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.1 mp -102.7 115.09 44.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 117.483 0.641 . . . . 0.0 109.917 -178.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.5 mp -102.57 113.68 39.86 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.123 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 35.1 mt-10 -93.11 145.08 24.66 Favored 'General case' 0 C--N 1.283 -2.284 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.965 173.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 12.0 tp -135.6 134.09 38.95 Favored 'General case' 0 C--N 1.264 -3.14 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.67 -174.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . 0.542 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -126.93 106.6 9.42 Favored 'General case' 0 C--N 1.278 -2.514 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 177.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.464 ' O ' ' HA2' ' A' ' 318' ' ' GLY . . . -108.75 91.01 3.47 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.427 HD23 ' O ' ' A' ' 225' ' ' GLN . 3.3 mm? -84.4 114.0 21.58 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-O 121.678 0.752 . . . . 0.0 111.141 -175.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 116.51 3.91 18.18 Favored Glycine 0 N--CA 1.429 -1.767 0 CA-C-N 114.239 -1.346 . . . . 0.0 110.175 -177.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . 0.455 ' HB2' ' ND1' ' A' ' 267' ' ' HIS . 65.8 t80 -113.12 115.63 28.59 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 121.016 0.436 . . . . 0.0 110.25 -177.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -112.98 100.03 8.32 Favored 'General case' 0 N--CA 1.427 -1.618 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 154.43 -158.37 28.17 Favored Glycine 0 N--CA 1.432 -1.597 0 N-CA-C 109.831 -1.308 . . . . 0.0 109.831 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -114.43 140.89 25.72 Favored Pre-proline 0 C--N 1.301 -1.511 0 CA-C-N 116.853 0.327 . . . . 0.0 110.359 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.798 ' HB3' HD13 ' A' ' 264' ' ' LEU . 17.9 Cg_endo -72.57 171.85 16.32 Favored 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.56 2.173 . . . . 0.0 111.112 175.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.445 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 18.0 t70 -88.45 109.93 20.43 Favored 'General case' 0 C--N 1.277 -2.58 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 175.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 4.1 mp -97.99 108.18 21.44 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 121.84 0.828 . . . . 0.0 110.102 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . 0.656 ' HB2' ' HB ' ' A' ' 261' ' ' ILE . 47.3 m -109.99 107.18 16.97 Favored 'General case' 0 C--N 1.278 -2.526 0 CA-C-N 114.482 -1.236 . . . . 0.0 108.43 177.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -99.18 126.73 45.02 Favored 'General case' 0 C--N 1.316 -0.866 0 O-C-N 122.126 -0.359 . . . . 0.0 110.865 -175.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -124.21 171.68 9.65 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 171.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -76.59 -40.12 50.51 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 120.871 0.367 . . . . 0.0 110.994 -177.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -82.79 -20.37 35.92 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.826 -175.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 49.9 p-80 -171.99 160.83 5.5 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.905 0.384 . . . . 0.0 111.448 176.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.459 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 16.7 mt -106.71 143.78 16.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 178.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . 0.656 ' HB ' ' HB2' ' A' ' 254' ' ' SER . 3.9 mp -119.79 109.76 27.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.901 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 176.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.482 ' HB ' ' HB3' ' A' ' 300' ' ' LEU . 61.6 t -111.45 123.24 67.11 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.426 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 176.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . 0.486 ' HA ' ' O ' ' A' ' 298' ' ' THR . 11.9 m -126.19 130.06 50.22 Favored 'General case' 0 C--N 1.285 -2.216 0 C-N-CA 120.096 -0.642 . . . . 0.0 111.029 -177.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.798 HD13 ' HB3' ' A' ' 251' ' ' PRO . 1.3 mm? -100.81 98.04 8.59 Favored 'General case' 0 N--CA 1.408 -2.574 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 177.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.493 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 58.6 mtpt -73.27 135.55 44.48 Favored 'General case' 0 C--N 1.267 -3.015 0 O-C-N 124.191 0.932 . . . . 0.0 110.81 -177.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 6.2 t30 72.85 20.65 3.55 Favored 'General case' 0 CA--C 1.55 0.961 0 O-C-N 124.539 1.15 . . . . 0.0 109.716 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' HIS . . . . . 0.455 ' ND1' ' HB2' ' A' ' 247' ' ' PHE . 54.5 t60 -114.85 100.1 7.97 Favored 'General case' 0 CA--C 1.495 -1.173 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 176.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.97 116.74 17.9 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-O 120.847 0.356 . . . . 0.0 110.436 -176.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 22.5 tp -99.29 123.08 49.86 Favored Pre-proline 0 N--CA 1.436 -1.175 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.769 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -67.73 158.0 59.2 Favored 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 122.429 2.086 . . . . 0.0 111.849 171.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . 0.593 ' HA ' HE21 ' A' ' 274' ' ' GLN . 24.6 p -68.34 -26.3 65.53 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 112.681 0.623 . . . . 0.0 112.681 -177.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 15.4 m -72.53 -19.74 61.46 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.353 -177.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -95.15 -22.31 17.94 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 120.369 -0.532 . . . . 0.0 110.492 -177.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.593 HE21 ' HA ' ' A' ' 271' ' ' THR . 5.4 pt20 -77.47 140.03 39.75 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 -177.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -177.96 175.46 1.29 Allowed 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -175.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 32.9 t -125.62 143.07 51.19 Favored 'General case' 0 N--CA 1.422 -1.831 0 CA-C-O 121.527 0.679 . . . . 0.0 110.453 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.58 HD21 HD13 ' A' ' 228' ' ' ILE . 1.3 mm? -91.84 103.14 15.72 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 102.917 -2.994 . . . . 0.0 102.917 174.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -59.2 -50.55 73.6 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 123.727 0.642 . . . . 0.0 112.089 -173.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.51 HG11 ' CD2' ' A' ' 230' ' ' PHE . 25.8 m 44.9 30.1 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 173.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -72.52 134.32 45.2 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.646 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 73.59 19.62 3.26 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.069 1.348 . . . . 0.0 113.548 -174.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -79.35 -21.94 45.14 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 119.853 -0.739 . . . . 0.0 110.345 170.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 1.2 mptm? 57.8 61.86 2.27 Favored 'General case' 0 CA--C 1.493 -1.212 0 CA-C-O 122.253 1.025 . . . . 0.0 113.641 174.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 4.8 p -125.3 -178.67 0.73 Allowed Pre-proline 0 C--N 1.275 -2.641 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . 0.581 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 14.4 Cg_exo -71.1 -16.91 31.93 Favored 'Trans proline' 0 N--CA 1.453 -0.891 0 CA-C-N 121.281 1.493 . . . . 0.0 110.637 174.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.5 p -95.75 126.61 48.26 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.502 0 CA-C-O 122.25 1.024 . . . . 0.0 110.562 177.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 16.3 mm-40 -84.16 -47.31 10.99 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 113.938 -1.483 . . . . 0.0 110.278 -175.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -162.09 148.84 13.67 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 -177.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.502 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 62.0 t -116.39 122.71 70.37 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.669 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 53.7 m -123.86 120.33 32.25 Favored 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.951 -0.468 . . . . 0.0 111.951 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 48.2 tp -94.53 122.8 37.48 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 106.9 -1.519 . . . . 0.0 106.9 175.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -129.84 141.89 50.76 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 -176.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 6.3 ptm180 -82.41 138.97 34.28 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 118.501 -1.279 . . . . 0.0 108.843 178.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.481 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 17.0 tp -108.25 -175.32 2.74 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 176.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.481 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 26.0 t-20 -49.03 -67.45 0.26 Allowed 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 118.918 0.781 . . . . 0.0 113.0 -177.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -119.44 -2.21 10.6 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 122.13 0.967 . . . . 0.0 108.462 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . 0.493 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 5.5 m-20 -117.07 168.51 10.2 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.094 -169.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 263' ' ' THR . 58.8 m -111.73 124.21 51.86 Favored 'General case' 0 C--N 1.288 -2.066 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 176.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -113.13 124.61 52.97 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-O 121.582 0.706 . . . . 0.0 109.476 -178.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.482 ' HB3' ' HB ' ' A' ' 262' ' ' VAL . 58.6 tp -110.97 120.34 42.07 Favored 'General case' 0 C--N 1.274 -2.689 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 54.9 mt -106.42 109.77 29.17 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.245 -176.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . 0.459 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 57.5 mt -107.96 103.18 15.08 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.496 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 8.4 m -77.1 131.1 38.17 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 -175.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 18.9 p -134.73 175.88 9.15 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 122.395 0.278 . . . . 0.0 111.719 -175.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -164.2 139.62 6.02 Favored 'General case' 0 C--O 1.242 0.705 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.906 176.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 99.11 -151.87 19.52 Favored Glycine 0 N--CA 1.434 -1.479 0 C-N-CA 121.25 -0.5 . . . . 0.0 112.354 177.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' ASN . . . . . 0.45 ' HB3' ' HB3' ' A' ' 327' ' ' LYS . 64.4 m-20 -105.85 124.5 49.67 Favored 'General case' 0 CA--C 1.489 -1.403 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 177.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' TRP . . . . . . . . . . . . . 69.1 p-90 -150.24 158.11 43.81 Favored 'General case' 0 C--N 1.289 -2.058 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.766 -176.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -115.62 137.88 51.63 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -178.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 1.4 tt -104.55 114.03 27.99 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 46.0 t -108.09 106.71 21.18 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 172.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -95.96 141.0 29.9 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . 0.429 ' HB2' ' HB ' ' A' ' 321' ' ' THR . 86.8 mttt -131.14 141.07 50.06 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -178.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 20.3 m -115.81 109.32 17.49 Favored 'General case' 0 C--N 1.285 -2.202 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -77.38 -33.41 55.17 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.586 0.707 . . . . 0.0 109.783 -178.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -170.19 161.56 6.5 Favored Pre-proline 0 C--N 1.305 -1.364 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 -179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -65.24 96.97 0.29 Allowed 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 121.387 1.391 . . . . 0.0 110.245 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 244' ' ' ALA . . . 135.62 -16.81 4.02 Favored Glycine 0 N--CA 1.424 -2.107 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.74 -176.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . 0.498 ' OH ' ' HB3' ' A' ' 223' ' ' SER . 54.9 m-85 -122.29 118.39 28.39 Favored 'General case' 0 CA--C 1.495 -1.169 0 O-C-N 122.344 -0.503 . . . . 0.0 110.171 178.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -126.87 161.79 27.42 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.507 -178.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.429 ' HB ' ' HB2' ' A' ' 313' ' ' LYS . 49.3 m -151.87 138.62 18.85 Favored 'General case' 0 C--N 1.267 -2.999 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -176.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -127.41 107.44 9.96 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . 0.618 HE21 HD21 ' A' ' 325' ' ' LEU . 45.9 tt0 -94.06 101.34 13.37 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 179.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 86.6 t -89.05 101.17 11.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.001 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.618 HD21 HE21 ' A' ' 323' ' ' GLN . 40.3 mt -95.59 145.39 29.45 Favored Pre-proline 0 C--N 1.299 -1.596 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.995 -176.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -72.25 123.61 9.32 Favored 'Trans proline' 0 N--CA 1.45 -1.076 0 C-N-CA 121.102 1.201 . . . . 0.0 109.97 172.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 307' ' ' ASN . 41.0 ttmt -80.82 132.23 35.47 Favored 'General case' 0 CA--C 1.474 -1.962 0 CA-C-N 116.139 -0.482 . . . . 0.0 109.713 -175.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -89.69 104.69 17.22 Favored 'General case' 0 N--CA 1.404 -2.736 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.582 -178.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 . . . . . 0 C--N 1.304 -1.396 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 -179.176 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 88.0 mtp . . . . . 0 N--CA 1.474 0.748 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 81.58 26.49 50.59 Favored Glycine 0 N--CA 1.442 -0.924 0 C-N-CA 120.062 -1.066 . . . . 0.0 110.482 -177.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 18.7 m -71.1 -19.07 62.5 Favored 'General case' 0 C--N 1.32 -0.683 0 C-N-CA 123.408 0.683 . . . . 0.0 112.232 -175.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 16.9 m -84.84 -9.45 58.13 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.488 0.661 . . . . 0.0 110.354 178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 12.2 m-70 -87.99 76.9 8.54 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.274 0.559 . . . . 0.0 112.083 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 5.9 p80 -151.25 88.71 1.46 Allowed 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 174.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 44.6 m80 -137.74 155.21 49.31 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -68.18 131.44 45.39 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.975 0.893 . . . . 0.0 111.602 -177.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 67.4 m80 -84.61 92.94 8.27 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 114.66 -1.154 . . . . 0.0 109.281 -176.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -97.58 23.66 7.51 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 114.348 -1.296 . . . . 0.0 110.489 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 117.2 125.86 3.69 Favored Glycine 0 N--CA 1.43 -1.713 0 N-CA-C 108.629 -1.789 . . . . 0.0 108.629 -174.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 3.8 mm? 72.49 159.37 0.21 Allowed 'General case' 0 C--O 1.247 0.961 0 C-N-CA 124.407 1.083 . . . . 0.0 111.53 -174.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 5.4 m -122.56 109.9 32.4 Favored Pre-proline 0 C--N 1.299 -1.594 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.678 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -51.16 111.43 0.56 Allowed 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 123.49 2.794 . . . . 0.0 112.902 -178.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 64.2 ttt180 78.15 -17.29 0.59 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 126.436 1.894 . . . . 0.0 112.017 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -68.88 -45.23 64.87 Favored Glycine 0 N--CA 1.451 -0.348 0 N-CA-C 108.91 -1.676 . . . . 0.0 108.91 175.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 11.8 p -95.27 101.41 13.14 Favored 'General case' 0 N--CA 1.425 -1.72 0 N-CA-C 105.668 -1.975 . . . . 0.0 105.668 170.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -69.67 -49.54 52.62 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -170.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 64.2 mtm 70.81 107.13 0.06 Allowed 'General case' 0 N--CA 1.479 1.001 0 O-C-N 124.575 1.172 . . . . 0.0 108.314 -171.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -71.42 -34.86 70.69 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -175.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 18.0 p -153.95 112.18 3.58 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 120.567 0.222 . . . . 0.0 110.668 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 67.1 mtt -66.76 95.48 0.36 Allowed 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 177.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 51.2 m -87.54 107.04 18.39 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 121.361 0.6 . . . . 0.0 110.683 -177.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -139.28 -94.36 0.28 Allowed Glycine 0 N--CA 1.425 -2.05 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -80.02 87.82 1.27 Allowed Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 178.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -107.77 101.06 10.38 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -178.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -139.41 11.29 2.54 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.552 -176.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 27.9 ttt -133.16 16.26 4.14 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 121.82 0.819 . . . . 0.0 110.53 -176.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -160.32 77.96 0.17 Allowed Glycine 0 N--CA 1.439 -1.121 0 C-N-CA 119.552 -1.309 . . . . 0.0 112.55 -178.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -100.19 -16.68 17.69 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 153.8 -62.16 0.37 Allowed Glycine 0 N--CA 1.435 -1.403 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.25 179.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 22.9 t -97.85 118.69 34.98 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.296 0.57 . . . . 0.0 110.524 -176.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 20.1 tptm -146.24 -48.14 0.2 Allowed 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.666 178.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . 0.485 ' CG ' HD21 ' A' ' 273' ' ' LEU . 1.1 tp60 -121.53 168.65 11.49 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -176.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.556 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 16.3 m -50.65 128.6 20.87 Favored 'General case' 0 CA--C 1.552 1.021 0 O-C-N 123.923 0.764 . . . . 0.0 110.73 177.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -146.07 156.6 43.57 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 121.048 0.452 . . . . 0.0 110.224 -174.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.566 HG12 ' HB2' ' A' ' 291' ' ' LEU . 2.1 pp -138.73 146.04 26.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.693 0 C-N-CA 124.882 1.273 . . . . 0.0 109.491 -177.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -150.58 157.16 42.67 Favored 'General case' 0 C--N 1.29 -1.991 0 O-C-N 123.34 0.4 . . . . 0.0 111.103 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -126.67 138.01 53.36 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-O 120.811 0.339 . . . . 0.0 111.153 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -146.92 168.11 22.28 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 173.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.423 ' HE3' HG22 ' A' ' 284' ' ' THR . 55.4 mtpt -116.01 155.52 27.94 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 122.402 -0.186 . . . . 0.0 110.677 178.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -138.55 145.47 40.71 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 123.366 0.416 . . . . 0.0 110.175 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 56.33 -104.7 0.38 Allowed Glycine 0 N--CA 1.441 -0.97 0 O-C-N 124.566 1.166 . . . . 0.0 114.796 172.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -119.15 83.86 2.1 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-O 121.212 0.53 . . . . 0.0 109.852 -176.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.452 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 94.9 m-20 61.37 23.05 13.35 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.646 -1.161 . . . . 0.0 114.075 172.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -78.32 136.63 37.75 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -99.45 114.57 5.06 Favored Glycine 0 N--CA 1.431 -1.697 0 N-CA-C 111.689 -0.564 . . . . 0.0 111.689 -177.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.1 mp -107.49 115.84 49.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 CA-C-O 121.35 0.595 . . . . 0.0 110.847 -177.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.3 mp -99.17 116.65 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.459 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 175.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -90.73 135.76 33.51 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 16.3 tp -130.86 131.85 44.81 Favored 'General case' 0 C--N 1.278 -2.514 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.057 -177.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . 0.556 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -128.74 102.36 6.53 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 178.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -111.21 92.25 3.97 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.479 0.656 . . . . 0.0 109.697 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -76.42 114.59 15.29 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.224 -176.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 107.1 18.73 10.14 Favored Glycine 0 N--CA 1.431 -1.646 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.579 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -115.11 116.08 27.83 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -104.88 95.15 5.67 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.147 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 143.6 -166.17 26.97 Favored Glycine 0 C--N 1.299 -1.515 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 175.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 85.0 mm-40 -102.28 144.87 29.47 Favored Pre-proline 0 C--N 1.308 -1.205 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 177.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.625 ' HB3' HD23 ' A' ' 264' ' ' LEU . 21.5 Cg_endo -77.14 173.32 14.59 Favored 'Trans proline' 0 N--CA 1.45 -1.038 0 C-N-CA 122.955 2.437 . . . . 0.0 112.38 178.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -97.76 118.0 33.33 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 3.2 mp -107.25 133.13 52.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-O 120.977 0.417 . . . . 0.0 111.18 -177.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . 0.495 ' HB3' ' HB ' ' A' ' 261' ' ' ILE . 23.2 t -115.81 111.35 20.37 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 173.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -90.86 105.05 17.56 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.342 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 74.8 mt-30 -125.14 152.52 44.32 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 176.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 31.9 m80 -60.1 -45.13 94.0 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 -176.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -83.87 -20.14 33.61 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 -174.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . 0.459 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 49.1 p-80 -171.8 158.75 5.0 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.083 0.468 . . . . 0.0 111.853 175.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.442 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 23.7 mt -106.72 144.14 16.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . 0.495 ' HB ' ' HB3' ' A' ' 254' ' ' SER . 3.5 mp -119.82 112.97 39.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 176.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.497 ' HB ' ' HB2' ' A' ' 300' ' ' LEU . 54.7 t -107.18 116.44 50.84 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.111 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 176.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 17.3 m -109.54 124.1 50.54 Favored 'General case' 0 C--N 1.288 -2.101 0 CA-C-O 121.146 0.498 . . . . 0.0 110.19 -178.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.625 HD23 ' HB3' ' A' ' 251' ' ' PRO . 18.2 mt -102.96 89.84 3.57 Favored 'General case' 0 CA--C 1.479 -1.752 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 178.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.605 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 61.2 mtpt -65.68 131.28 45.94 Favored 'General case' 0 N--CA 1.42 -1.961 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.667 -175.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 13.0 t-20 71.23 21.08 4.85 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 124.601 1.188 . . . . 0.0 109.843 179.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -117.99 102.02 8.73 Favored 'General case' 0 CA--C 1.489 -1.377 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 177.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 2.5 m -91.43 115.41 28.01 Favored 'General case' 0 C--N 1.28 -2.455 0 C-N-CA 119.829 -0.749 . . . . 0.0 111.208 -173.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . 0.419 ' HG ' ' O ' ' A' ' 270' ' ' PRO . 21.2 tp -89.89 130.3 43.23 Favored Pre-proline 0 N--CA 1.43 -1.466 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.761 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.419 ' O ' ' HG ' ' A' ' 269' ' ' LEU . 6.7 Cg_exo -73.85 156.95 48.07 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 122.057 1.838 . . . . 0.0 110.603 170.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . 0.508 ' HA ' ' HG2' ' A' ' 274' ' ' GLN . 7.1 p -73.55 -10.46 59.73 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.623 0.725 . . . . 0.0 112.186 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 15.4 m -73.59 -24.06 60.01 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.206 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.485 HD21 ' CG ' ' A' ' 225' ' ' GLN . 7.8 mp -101.95 -12.16 18.41 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.704 -174.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.508 ' HG2' ' HA ' ' A' ' 271' ' ' THR . 0.0 OUTLIER -81.12 127.37 32.57 Favored 'General case' 0 N--CA 1.419 -1.982 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.0 -176.723 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -153.58 163.35 40.12 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 13.9 p -124.29 127.41 47.6 Favored 'General case' 0 N--CA 1.422 -1.834 0 CA-C-O 121.792 0.806 . . . . 0.0 111.714 179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.565 HD21 HD13 ' A' ' 228' ' ' ILE . 2.1 mm? -81.25 118.45 22.61 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -84.39 92.89 8.15 Favored 'General case' 0 C--N 1.294 -1.813 0 C-N-CA 118.66 -1.216 . . . . 0.0 108.543 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.638 ' HA ' ' CD2' ' A' ' 282' ' ' PHE . 46.9 t -94.88 28.97 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 CA-C-O 123.328 1.537 . . . . 0.0 109.793 -175.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -79.74 149.92 30.99 Favored 'General case' 0 N--CA 1.414 -2.274 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 175.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 28.1 t70 70.21 9.04 6.9 Favored 'General case' 0 CA--C 1.556 1.177 0 CA-C-O 122.156 0.979 . . . . 0.0 111.715 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.638 ' CD2' ' HA ' ' A' ' 279' ' ' VAL . 16.4 m-85 -83.38 -13.47 54.85 Favored 'General case' 0 C--N 1.317 -0.839 0 O-C-N 121.737 -0.602 . . . . 0.0 111.045 176.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 mptt 58.4 60.99 2.4 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.094 0.558 . . . . 0.0 111.132 -177.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' THR . . . . . 0.423 HG22 ' HE3' ' A' ' 232' ' ' LYS . 1.5 p -136.64 174.74 4.12 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . 0.456 ' HB3' ' HB3' ' A' ' 308' ' ' TRP . 13.9 Cg_exo -71.47 -19.52 28.46 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 121.739 1.626 . . . . 0.0 111.601 175.243 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.3 p -94.85 132.76 37.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-O 121.517 0.675 . . . . 0.0 110.21 178.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . 0.413 HE21 HG22 ' A' ' 303' ' ' THR . 31.0 mt-30 -100.01 -32.27 11.04 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.9 -174.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 40.2 tttp -162.86 134.48 5.11 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 120.051 -0.659 . . . . 0.0 109.8 -174.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.458 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 42.0 t -103.48 110.14 29.05 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 174.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.511 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 93.8 m -112.57 113.55 25.76 Favored 'General case' 0 C--N 1.281 -2.409 0 CA-C-O 121.004 0.43 . . . . 0.0 111.375 -176.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.566 ' HB2' HG12 ' A' ' 228' ' ' ILE . 37.9 tp -94.93 122.71 37.86 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 106.53 -1.655 . . . . 0.0 106.53 173.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.401 ' HG3' HE22 ' A' ' 274' ' ' GLN . 25.3 ttpp -140.84 144.4 35.33 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -178.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -79.02 149.9 32.08 Favored 'General case' 0 C--N 1.282 -2.339 0 C-N-CA 120.1 -0.64 . . . . 0.0 110.468 -179.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.554 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 15.8 tp -111.62 -173.98 2.36 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 176.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.554 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 64.0 t30 -51.78 -62.7 1.47 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 122.954 0.502 . . . . 0.0 112.091 -177.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 41.8 m-80 -122.4 -3.21 8.91 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 121.154 0.502 . . . . 0.0 110.08 176.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . 0.605 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 11.8 m-20 -115.72 169.07 9.48 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 115.155 -0.93 . . . . 0.0 109.823 -170.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.527 ' HB ' ' HB2' ' A' ' 264' ' ' LEU . 86.7 m -106.28 135.32 47.96 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 176.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -122.68 127.71 49.64 Favored 'General case' 0 N--CA 1.417 -2.091 0 CA-C-O 121.522 0.677 . . . . 0.0 110.569 -176.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.497 ' HB2' ' HB ' ' A' ' 262' ' ' VAL . 1.8 mt -106.13 119.56 39.52 Favored 'General case' 0 C--N 1.273 -2.729 0 CA-C-N 115.32 -0.854 . . . . 0.0 108.902 175.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' ILE . . . . . 0.511 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 67.3 mt -108.0 109.26 27.59 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.796 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 -179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . 0.442 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 61.1 mt -108.94 101.06 12.02 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 -178.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.413 HG22 HE21 ' A' ' 287' ' ' GLN . 24.9 m -69.51 132.3 46.06 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -178.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 11.4 p -137.41 169.76 17.23 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 122.896 0.479 . . . . 0.0 111.023 -177.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -159.11 144.72 16.25 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 92.2 -152.69 21.41 Favored Glycine 0 N--CA 1.436 -1.358 0 O-C-N 123.892 0.745 . . . . 0.0 112.623 176.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' ASN . . . . . 0.572 ' HB2' ' O ' ' A' ' 327' ' ' LYS . 6.6 m120 -101.17 129.19 47.05 Favored 'General case' 0 CA--C 1.497 -1.095 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 178.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' TRP . . . . . 0.456 ' HB3' ' HB3' ' A' ' 285' ' ' PRO . 67.4 p-90 -153.59 162.9 40.82 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.011 -177.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.416 ' HG2' ' HE2' ' A' ' 327' ' ' LYS . 3.4 mt-10 -122.62 135.36 54.59 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -178.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 1.5 tt -102.74 122.87 45.34 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.077 -1.082 . . . . 0.0 108.077 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.683 HG13 ' HB3' ' A' ' 323' ' ' GLN . 7.6 p -125.53 111.97 29.26 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 CA-C-O 121.883 0.849 . . . . 0.0 109.794 170.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 18.6 p-10 -98.79 135.97 39.49 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.259 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -128.2 139.74 52.29 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.098 -176.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 35.9 p -115.99 122.24 44.65 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 176.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -81.16 -38.03 27.8 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-O 121.698 0.761 . . . . 0.0 109.321 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.401 ' HB1' ' HD2' ' A' ' 317' ' ' PRO . . . -163.27 162.21 17.76 Favored Pre-proline 0 C--N 1.308 -1.21 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . 0.401 ' HD2' ' HB1' ' A' ' 316' ' ' ALA . 16.5 Cg_endo -58.29 110.43 0.65 Allowed 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.038 1.826 . . . . 0.0 110.811 178.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 113.86 -36.13 4.17 Favored Glycine 0 N--CA 1.424 -2.104 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -93.29 115.59 28.18 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . 0.409 ' CZ ' ' HD3' ' A' ' 251' ' ' PRO . 74.4 m-85 -127.32 166.36 17.96 Favored 'General case' 0 N--CA 1.425 -1.712 0 CA-C-O 122.228 1.013 . . . . 0.0 111.407 -175.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 84.8 m -151.93 127.36 9.99 Favored 'General case' 0 C--N 1.278 -2.531 0 CA-C-N 113.988 -1.46 . . . . 0.0 108.604 -177.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -116.55 111.49 20.0 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 177.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . 0.683 ' HB3' HG13 ' A' ' 311' ' ' VAL . 61.6 tt0 -97.76 104.28 16.29 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.415 HG13 ' CE3' ' A' ' 308' ' ' TRP . 88.2 t -90.28 98.87 8.72 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 33.0 mt -87.05 148.61 45.62 Favored Pre-proline 0 C--N 1.292 -1.92 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.057 -178.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -77.43 143.46 21.92 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 121.62 1.547 . . . . 0.0 111.134 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.572 ' O ' ' HB2' ' A' ' 307' ' ' ASN . 19.7 ttmm -124.14 154.68 39.68 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . 0.429 ' HZ3' ' HB2' ' A' ' 328' ' ' LYS . 0.5 OUTLIER -152.16 122.45 7.22 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.71 -0.618 . . . . 0.0 110.511 173.536 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 . . . . . 0 N--CA 1.417 -2.121 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 177.308 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 28.1 ttt . . . . . 0 N--CA 1.469 0.477 0 CA-C-O 120.358 0.123 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 90.77 52.86 2.36 Favored Glycine 0 CA--C 1.489 -1.587 0 N-CA-C 108.597 -1.801 . . . . 0.0 108.597 -175.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 11.3 m -70.43 90.27 0.71 Allowed 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 114.818 -0.691 . . . . 0.0 112.042 -174.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 7.5 t -121.95 131.64 54.12 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 104.295 -2.483 . . . . 0.0 104.295 174.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -52.45 -54.21 35.34 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 123.711 0.632 . . . . 0.0 112.169 -173.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -167.67 -37.6 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.842 0.353 . . . . 0.0 110.122 176.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -75.73 159.13 31.41 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.423 177.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 61.9 m80 -114.05 134.72 54.68 Favored 'General case' 0 C--N 1.28 -2.417 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 177.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 31.4 t-80 -66.05 -8.16 21.64 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.046 0.938 . . . . 0.0 111.815 -175.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 11.0 t60 71.36 108.34 0.06 Allowed 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 125.694 1.598 . . . . 0.0 111.195 176.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 145.33 -161.41 28.17 Favored Glycine 0 N--CA 1.416 -2.69 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 6.2 mp -97.92 -31.19 12.31 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 121.391 0.615 . . . . 0.0 109.442 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 21.9 t -133.61 126.84 19.28 Favored Pre-proline 0 C--N 1.313 -1.006 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.97 -50.34 6.46 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 122.58 2.187 . . . . 0.0 111.065 176.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 74.8 ttt180 -145.95 129.05 16.58 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 175.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -157.4 -163.27 12.37 Favored Glycine 0 N--CA 1.426 -1.973 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 20.6 m -84.95 -30.65 24.12 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 116.856 0.328 . . . . 0.0 110.313 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . 0.529 ' O ' ' HG3' ' A' ' 210' ' ' MET . 45.2 t-80 -86.97 73.4 9.92 Favored 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.689 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . 0.529 ' HG3' ' O ' ' A' ' 209' ' ' HIS . 36.2 mtm 170.55 129.49 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 129.069 2.948 . . . . 0.0 106.271 176.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . 67.14 98.21 0.05 Allowed 'General case' 0 C--O 1.242 0.686 0 O-C-N 124.421 1.076 . . . . 0.0 111.485 -177.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 21.9 m -78.71 146.05 34.16 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.03 178.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 43.2 tpp -79.69 106.77 11.95 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 1.7 p -82.5 90.83 6.79 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 114.144 1.164 . . . . 0.0 114.144 -172.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 73.97 -38.85 0.95 Allowed Glycine 0 CA--C 1.527 0.808 0 N-CA-C 116.413 1.325 . . . . 0.0 116.413 172.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -72.43 68.64 1.18 Allowed Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 116.03 1.172 . . . . 0.0 116.03 -173.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -135.75 76.79 1.63 Allowed 'General case' 0 C--O 1.246 0.905 0 CA-C-O 121.06 0.457 . . . . 0.0 110.513 174.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -120.69 -40.4 2.66 Favored 'General case' 0 C--O 1.207 -1.165 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.589 175.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 26.3 mmt 64.24 123.11 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 176.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 64.59 -92.12 0.12 Allowed Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.262 -0.881 . . . . 0.0 113.755 176.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -136.24 17.29 3.19 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.088 0.47 . . . . 0.0 110.667 -177.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 107.99 84.58 1.66 Allowed Glycine 0 CA--C 1.488 -1.63 0 N-CA-C 109.051 -1.62 . . . . 0.0 109.051 -177.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.513 ' OG ' HD21 ' A' ' 245' ' ' LEU . 35.7 t -71.4 73.27 0.71 Allowed 'General case' 0 N--CA 1.428 -1.573 0 CA-C-O 122.323 1.059 . . . . 0.0 112.9 -174.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -128.22 5.7 5.84 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 169.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . 0.506 ' O ' HD23 ' A' ' 245' ' ' LEU . 3.6 pt20 -142.86 157.34 44.69 Favored 'General case' 0 N--CA 1.42 -1.945 0 CA-C-N 113.505 -1.679 . . . . 0.0 108.025 -174.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.594 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 43.3 m -78.43 127.61 32.43 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 121.118 0.485 . . . . 0.0 112.198 -175.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -151.89 166.35 31.72 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.372 -177.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . . . . . . . . . 2.3 pp -121.43 165.45 17.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.321 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -150.25 156.46 41.62 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -133.39 130.6 38.96 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.234 0.54 . . . . 0.0 109.749 176.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.42 ' HD2' ' OE2' ' A' ' 241' ' ' GLU . 5.4 ptp180 -149.81 165.33 32.82 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.37 179.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 13.0 mmmm -108.92 142.09 40.05 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . 0.542 ' O ' ' HB3' ' A' ' 237' ' ' ALA . 18.8 t70 -156.77 117.99 3.75 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 -178.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 102.13 -143.43 15.95 Favored Glycine 0 C--N 1.301 -1.412 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 -178.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -114.46 101.5 9.19 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 117.468 0.634 . . . . 0.0 110.032 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 18.9 m120 65.39 27.25 11.91 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 124.621 1.168 . . . . 0.0 111.896 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.542 ' HB3' ' O ' ' A' ' 233' ' ' ASP . . . -97.94 134.74 40.64 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.304 -178.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . 0.556 ' HA3' ' CG1' ' A' ' 286' ' ' VAL . . . -101.44 123.9 8.06 Favored Glycine 0 C--N 1.296 -1.671 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.414 HD12 ' C ' ' A' ' 238' ' ' GLY . 2.1 mp -116.78 120.11 64.03 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-N 118.045 0.923 . . . . 0.0 111.045 -176.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . 0.404 HD12 ' N ' ' A' ' 240' ' ' ILE . 3.2 mp -104.21 109.49 27.48 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 176.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.42 ' OE2' ' HD2' ' A' ' 231' ' ' ARG . 5.4 mt-10 -93.59 128.53 39.79 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-O 121.435 0.636 . . . . 0.0 109.742 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 13.0 tp -115.24 126.64 54.78 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 115.186 -0.916 . . . . 0.0 112.092 -171.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . 0.594 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -108.27 104.11 13.43 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 175.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -112.25 91.88 3.82 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.432 0.634 . . . . 0.0 109.477 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.513 HD21 ' OG ' ' A' ' 223' ' ' SER . 3.5 mm? -85.36 116.83 23.92 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.769 -175.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 108.68 13.33 18.85 Favored Glycine 0 N--CA 1.424 -2.113 0 CA-C-N 114.24 -1.346 . . . . 0.0 110.16 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -114.86 115.26 26.68 Favored 'General case' 0 N--CA 1.423 -1.812 0 C-N-CA 120.6 -0.44 . . . . 0.0 109.875 -177.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -112.93 95.15 5.25 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.05 177.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 152.47 -157.33 27.22 Favored Glycine 0 C--N 1.296 -1.672 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -114.56 141.55 26.81 Favored Pre-proline 0 C--N 1.303 -1.43 0 CA-C-N 116.991 0.396 . . . . 0.0 110.325 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.761 ' HB3' HD13 ' A' ' 264' ' ' LEU . 12.7 Cg_endo -68.97 172.19 12.29 Favored 'Trans proline' 0 N--CA 1.449 -1.113 0 C-N-CA 122.403 2.069 . . . . 0.0 111.053 175.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.451 ' HB3' ' HB ' ' A' ' 263' ' ' THR . 34.1 t0 -97.48 107.84 20.43 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 178.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 3.1 mp -95.11 116.23 36.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 3.1 t -119.28 111.27 18.0 Favored 'General case' 0 N--CA 1.426 -1.669 0 N-CA-C 107.14 -1.429 . . . . 0.0 107.14 176.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -97.58 128.74 44.54 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -174.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.437 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 18.4 mt-30 -125.24 163.13 23.17 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 105.44 -2.059 . . . . 0.0 105.44 170.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -76.45 -29.85 57.12 Favored 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 119.941 -0.704 . . . . 0.0 110.29 174.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -68.24 -48.56 64.77 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.308 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . 0.506 ' CB ' ' HA ' ' A' ' 303' ' ' THR . 27.6 p-80 -163.37 167.62 21.49 Favored 'General case' 0 CA--C 1.508 -0.662 0 CA-C-N 116.704 -0.225 . . . . 0.0 110.451 177.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 19.8 mt -105.83 143.1 17.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 3.5 mp -120.93 109.1 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.509 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 176.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.511 ' HB ' ' HB3' ' A' ' 300' ' ' LEU . 51.4 t -106.54 117.76 52.94 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.059 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 177.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . 0.57 ' HA ' ' O ' ' A' ' 298' ' ' THR . 25.3 m -116.79 123.96 48.41 Favored 'General case' 0 C--N 1.278 -2.52 0 CA-C-O 121.773 0.797 . . . . 0.0 111.27 -178.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.761 HD13 ' HB3' ' A' ' 251' ' ' PRO . 1.7 mm? -93.47 98.03 10.93 Favored 'General case' 0 N--CA 1.399 -2.99 0 N-CA-C 104.454 -2.424 . . . . 0.0 104.454 174.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.546 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 0.5 OUTLIER -67.79 129.81 41.06 Favored 'General case' 0 N--CA 1.388 -3.569 0 O-C-N 124.756 1.285 . . . . 0.0 108.921 -174.832 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 66.6 t30 71.05 27.38 3.34 Favored 'General case' 0 CA--C 1.549 0.924 0 O-C-N 124.483 1.115 . . . . 0.0 110.444 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -121.77 113.18 19.33 Favored 'General case' 0 C--O 1.203 -1.362 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 3.9 p -90.71 129.15 36.83 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . 0.575 HD22 HD22 ' A' ' 291' ' ' LEU . 23.8 tp -107.39 129.56 24.09 Favored Pre-proline 0 N--CA 1.446 -0.664 0 C-N-CA 123.624 0.77 . . . . 0.0 109.873 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -64.63 151.34 86.0 Favored 'Trans proline' 0 C--N 1.318 -1.052 0 C-N-CA 122.36 2.04 . . . . 0.0 111.584 172.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . 0.499 ' HA ' ' HG2' ' A' ' 274' ' ' GLN . 16.3 p -74.96 -13.91 60.57 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 121.776 0.798 . . . . 0.0 112.176 -178.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 25.0 m -81.09 -17.91 48.39 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 122.018 0.913 . . . . 0.0 110.038 178.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.43 HD11 ' HB2' ' A' ' 225' ' ' GLN . 96.0 mt -101.19 -19.99 15.48 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 115.96 -0.563 . . . . 0.0 109.944 -178.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.499 ' HG2' ' HA ' ' A' ' 271' ' ' THR . 11.9 pt20 -74.5 136.15 42.21 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 178.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -164.87 178.59 7.05 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -173.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 39.9 m -134.78 123.82 24.19 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 121.346 0.593 . . . . 0.0 110.872 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.447 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 53.2 mt -91.09 120.25 31.89 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 103.977 -2.601 . . . . 0.0 103.977 174.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -68.2 -42.57 79.7 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 120.464 -0.494 . . . . 0.0 110.783 -172.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . . . . . . . . 0.334 34.0 m 42.65 26.74 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 N-CA-C 117.353 2.353 . . . . 0.0 117.353 175.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -74.6 142.86 44.59 Favored 'General case' 0 N--CA 1.415 -2.209 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 176.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 30.0 t70 72.59 22.94 3.15 Favored 'General case' 0 CA--C 1.553 1.059 0 O-C-N 124.229 0.956 . . . . 0.0 111.521 178.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -86.78 1.94 50.55 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 176.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? 60.77 59.81 2.04 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 1.1 t -164.95 150.95 8.87 Favored Pre-proline 0 N--CA 1.423 -1.795 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.363 177.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . 0.416 ' O ' ' HA ' ' A' ' 304' ' ' THR . 18.4 Cg_exo -44.2 -35.81 8.33 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 124.556 3.504 . . . . 0.0 114.06 174.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.556 ' CG1' ' HA3' ' A' ' 238' ' ' GLY . 0.2 OUTLIER -73.57 115.53 14.67 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.273 0 CA-C-O 121.767 0.794 . . . . 0.0 109.442 177.32 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -94.7 -37.07 11.47 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-N 114.422 -1.263 . . . . 0.0 111.714 -174.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -154.62 146.51 23.48 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -176.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 55.1 t -120.04 125.59 74.4 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.725 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.499 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 96.1 m -126.49 127.17 44.93 Favored 'General case' 0 C--N 1.285 -2.215 0 CA-C-O 121.056 0.455 . . . . 0.0 110.434 178.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.575 HD22 HD22 ' A' ' 269' ' ' LEU . 0.1 OUTLIER -100.88 120.1 39.66 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 104.677 -2.342 . . . . 0.0 104.677 174.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -123.75 134.3 53.69 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . 0.415 ' HG2' ' OE1' ' A' ' 274' ' ' GLN . 9.0 ptm180 -81.32 148.62 29.31 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 117.609 -1.636 . . . . 0.0 108.308 173.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.579 HD13 ' N ' ' A' ' 295' ' ' ASN . 2.8 tm? -122.96 166.9 14.3 Favored 'General case' 0 C--N 1.284 -2.245 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.579 ' N ' HD13 ' A' ' 294' ' ' LEU . 0.2 OUTLIER -24.02 -70.35 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 127.349 2.26 . . . . 0.0 112.149 177.052 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -124.7 -2.15 7.88 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . 0.546 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 12.3 m-20 -119.04 171.37 8.31 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.578 -168.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 263' ' ' THR . 70.5 m -114.3 128.16 56.22 Favored 'General case' 0 C--N 1.289 -2.032 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 176.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -113.65 116.48 29.53 Favored 'General case' 0 N--CA 1.431 -1.409 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -177.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.511 ' HB3' ' HB ' ' A' ' 262' ' ' VAL . 0.6 OUTLIER -101.52 120.25 40.01 Favored 'General case' 0 C--N 1.277 -2.587 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 177.87 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' ILE . . . . . 0.499 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 80.6 mt -110.76 115.19 49.19 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.467 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 -176.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 45.8 mt -117.37 103.25 14.64 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.552 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.506 ' HA ' ' CB ' ' A' ' 259' ' ' HIS . 85.6 m -75.91 134.43 40.25 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 120.556 0.217 . . . . 0.0 110.416 -177.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 285' ' ' PRO . 9.1 p -132.76 -179.26 5.36 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 123.237 0.615 . . . . 0.0 110.932 -174.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -155.03 139.88 17.22 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 122.687 0.395 . . . . 0.0 110.162 177.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 77.15 -151.78 39.15 Favored Glycine 0 C--O 1.236 0.263 0 O-C-N 123.635 0.584 . . . . 0.0 112.384 176.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' ASN . . . . . 0.421 ' HB3' ' HB3' ' A' ' 327' ' ' LYS . 39.4 m-80 -96.59 137.11 36.17 Favored 'General case' 0 CA--C 1.486 -1.495 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 176.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' TRP . . . . . . . . . . . . . 68.9 p-90 -154.13 165.43 36.25 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -175.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.55 ' O ' ' HA ' ' A' ' 324' ' ' VAL . 5.6 mt-10 -122.03 136.82 54.95 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -178.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.414 HD21 ' HB3' ' A' ' 322' ' ' PHE . 0.5 OUTLIER -107.25 124.21 49.43 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.57 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 58.3 t -115.88 107.34 22.38 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.637 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 173.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -92.84 124.92 37.18 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 51.3 mtmt -123.46 149.95 44.46 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -177.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 12.9 p -115.69 122.27 45.03 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 177.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -89.81 -29.54 18.57 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.402 0.62 . . . . 0.0 110.494 -178.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -164.29 163.12 15.36 Favored Pre-proline 0 C--N 1.309 -1.179 0 N-CA-C 105.793 -1.928 . . . . 0.0 105.793 -179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_endo -64.64 97.6 0.27 Allowed 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 121.537 1.491 . . . . 0.0 111.504 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 122.17 -20.63 7.97 Favored Glycine 0 C--O 1.218 -0.877 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.992 -177.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -103.17 116.34 32.29 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -121.45 168.27 11.89 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-O 121.674 0.749 . . . . 0.0 111.243 -175.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 60.6 m -151.2 129.23 11.79 Favored 'General case' 0 C--N 1.277 -2.569 0 CA-C-N 114.477 -1.238 . . . . 0.0 108.37 -176.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 0.414 ' HB3' HD21 ' A' ' 310' ' ' LEU . 90.4 m-85 -117.53 108.76 15.89 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 177.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . 0.57 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 42.1 tt0 -98.9 105.33 17.46 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -179.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 309' ' ' GLU . 0.2 OUTLIER -100.97 105.83 18.41 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 CA-C-O 122.099 0.952 . . . . 0.0 110.102 178.039 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.7 mp -104.17 156.16 36.15 Favored Pre-proline 0 C--N 1.298 -1.637 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.803 -177.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -74.19 128.52 12.22 Favored 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 121.697 1.598 . . . . 0.0 112.082 177.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.421 ' HB3' ' HB3' ' A' ' 307' ' ' ASN . 23.1 ttmm -91.91 116.8 29.22 Favored 'General case' 0 CA--C 1.49 -1.342 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 177.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -146.64 157.57 43.74 Favored 'General case' 0 N--CA 1.414 -2.273 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.486 -173.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 78.4 mm-40 . . . . . 0 C--N 1.302 -1.486 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 176.085 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' MET . . . . . 0.684 ' N ' ' HG ' ' A' ' 195' ' ' SER . 15.2 tpt . . . . . 0 N--CA 1.464 0.249 0 N-CA-C 111.131 0.048 . . . . 0.0 111.131 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -145.42 -60.38 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.586 0 C-N-CA 120.029 -1.082 . . . . 0.0 112.025 -179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 16.6 m -85.12 8.51 17.85 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 121.392 0.615 . . . . 0.0 110.428 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.684 ' HG ' ' N ' ' A' ' 192' ' ' MET . 7.5 m -65.05 120.8 13.32 Favored 'General case' 0 N--CA 1.427 -1.624 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.097 178.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 71.3 m-70 -85.63 -21.72 28.3 Favored 'General case' 0 CA--C 1.493 -1.226 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.465 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -76.25 137.71 40.12 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 173.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -82.79 97.12 8.44 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -177.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 63.4 t60 -56.84 113.68 1.76 Allowed 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 114.102 -1.408 . . . . 0.0 111.566 -175.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 34.6 m-70 -65.15 126.66 28.79 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 175.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -63.36 -41.02 98.81 Favored 'General case' 0 C--N 1.312 -1.052 0 O-C-N 123.803 0.689 . . . . 0.0 112.613 -171.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -174.38 122.36 0.89 Allowed Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.452 HD12 HG13 ' A' ' 204' ' ' VAL . 4.6 pp -111.27 8.64 21.56 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.25 0.548 . . . . 0.0 111.044 -178.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.452 HG13 HD12 ' A' ' 203' ' ' LEU . 5.8 m -119.8 105.85 42.53 Favored Pre-proline 0 C--N 1.312 -1.059 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.983 -178.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -62.54 127.77 21.71 Favored 'Trans proline' 0 C--O 1.246 0.902 0 C-N-CA 122.519 2.146 . . . . 0.0 110.616 176.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -136.04 165.04 26.62 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 -175.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 154.4 156.09 7.54 Favored Glycine 0 N--CA 1.419 -2.461 0 C-N-CA 119.876 -1.154 . . . . 0.0 112.203 176.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 20.0 m -80.58 87.83 5.73 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-O 121.805 0.812 . . . . 0.0 109.205 178.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 21.2 m-70 -79.68 129.52 34.55 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.865 -179.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 56.4 ttp -104.68 88.03 2.83 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 175.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -84.17 -44.09 14.31 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 17.9 m -89.27 121.02 31.15 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 175.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 44.9 tpp -61.03 107.06 0.67 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.096 0.474 . . . . 0.0 111.599 -177.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 14.1 m -101.75 -12.8 18.06 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.724 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -94.3 127.38 9.06 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.586 -0.816 . . . . 0.0 111.937 -177.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 112.42 179.75 19.59 Favored Glycine 0 N--CA 1.437 -1.239 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.738 177.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 64.1 84.75 0.14 Allowed 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 124.851 1.26 . . . . 0.0 114.35 177.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 26.5 mp0 -119.72 85.3 2.35 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 171.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 19.9 ptp -67.18 116.4 7.93 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.997 -173.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 87.3 -61.25 4.26 Favored Glycine 0 N--CA 1.437 -1.283 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.226 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . 0.496 ' NE ' ' HA ' ' A' ' 221' ' ' ARG . 3.3 mmp_? -152.91 -161.99 1.4 Allowed 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -74.1 52.32 2.12 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-O 121.641 0.578 . . . . 0.0 111.729 176.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 9.0 m -98.85 105.82 18.01 Favored 'General case' 0 N--CA 1.417 -2.117 0 C-N-CA 124.393 1.077 . . . . 0.0 109.154 -177.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -144.78 11.5 1.42 Allowed 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . 0.442 ' O ' HD23 ' A' ' 245' ' ' LEU . 17.7 pt20 -124.27 130.52 52.66 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.492 -172.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.544 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 88.8 m -78.73 131.83 36.74 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.172 177.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -166.91 175.49 7.65 Favored 'General case' 0 CA--C 1.479 -1.788 0 CA-C-O 121.131 0.491 . . . . 0.0 110.289 -175.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.464 HG21 HD13 ' A' ' 300' ' ' LEU . 2.6 pp -128.04 162.72 33.56 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.53 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.696 177.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.528 ' HB2' ' HB2' ' A' ' 241' ' ' GLU . 4.8 m-20 -146.78 156.04 42.84 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 178.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -129.48 134.42 47.79 Favored 'General case' 0 C--N 1.309 -1.167 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.244 176.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 8.3 ptt-85 -144.15 169.33 18.07 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 175.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.453 ' HE3' HG22 ' A' ' 284' ' ' THR . 55.3 mtpt -114.93 150.2 36.07 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 175.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -152.56 152.06 31.41 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -177.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 73.57 -102.75 1.33 Allowed Glycine 0 C--N 1.314 -0.683 0 C-N-CA 121.285 -0.483 . . . . 0.0 113.748 176.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -152.98 104.26 2.82 Favored 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 123.2 0.6 . . . . 0.0 110.038 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.649 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 89.6 m-20 61.21 20.7 11.23 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.112 0.965 . . . . 0.0 111.762 176.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.34 137.84 33.02 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 120.822 0.344 . . . . 0.0 110.259 -176.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -99.91 117.59 5.92 Favored Glycine 0 N--CA 1.425 -2.066 0 N-CA-C 110.679 -0.968 . . . . 0.0 110.679 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.1 mp -108.47 117.79 54.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 CA-C-N 117.194 0.497 . . . . 0.0 110.797 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . 0.408 HD12 ' N ' ' A' ' 240' ' ' ILE . 2.9 mp -103.68 110.12 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.728 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 176.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 229' ' ' ASP . 53.7 mt-10 -90.04 123.37 33.87 Favored 'General case' 0 C--N 1.281 -2.39 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 11.9 tp -112.14 124.23 51.98 Favored 'General case' 0 C--N 1.284 -2.258 0 CA-C-O 120.981 0.42 . . . . 0.0 111.965 -174.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . 0.544 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -107.45 107.87 18.94 Favored 'General case' 0 C--O 1.206 -1.216 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 176.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.43 ' HA ' HG23 ' A' ' 226' ' ' THR . . . -118.15 92.35 3.8 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.24 0.543 . . . . 0.0 111.519 179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.442 HD23 ' O ' ' A' ' 225' ' ' GLN . 3.6 mm? -86.56 116.25 24.57 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.246 0.546 . . . . 0.0 111.079 -177.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 111.64 -7.79 28.02 Favored Glycine 0 C--N 1.297 -1.603 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.146 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . 0.441 ' HB2' ' ND1' ' A' ' 267' ' ' HIS . 47.9 t80 -98.56 128.15 44.77 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -107.57 -34.98 6.86 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -174.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -86.3 -150.1 15.2 Favored Glycine 0 CA--C 1.506 -0.479 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.457 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -115.01 141.13 26.48 Favored Pre-proline 0 C--N 1.308 -1.215 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.766 ' HB3' HD23 ' A' ' 264' ' ' LEU . 10.2 Cg_endo -69.44 172.27 12.62 Favored 'Trans proline' 0 N--CA 1.452 -0.965 0 C-N-CA 121.957 1.771 . . . . 0.0 113.951 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.425 ' HB3' ' HB ' ' A' ' 263' ' ' THR . 11.5 t70 -97.49 105.37 17.51 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 176.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.473 HD11 ' HG2' ' A' ' 251' ' ' PRO . 4.8 mp -101.41 117.19 46.32 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.121 0 C-N-CA 119.122 -1.031 . . . . 0.0 109.738 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . 0.498 ' HB3' ' HB ' ' A' ' 261' ' ' ILE . 24.6 t -97.79 112.32 24.27 Favored 'General case' 0 C--N 1.28 -2.433 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 176.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 71.7 mt-30 -97.67 101.98 13.63 Favored 'General case' 0 CA--C 1.497 -1.079 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.226 -177.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 17.6 mp0 -104.66 162.14 13.53 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 171.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -76.72 -33.48 58.17 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 120.624 0.249 . . . . 0.0 111.357 -179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -72.49 -39.3 67.77 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.889 -178.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . 0.42 ' CB ' ' HA ' ' A' ' 303' ' ' THR . 32.1 p-80 -166.7 165.96 16.18 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.403 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 301' ' ' ILE . 15.9 mt -106.83 142.73 18.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -177.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . 0.498 ' HB ' ' HB3' ' A' ' 254' ' ' SER . 3.6 mp -126.04 112.0 28.7 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 299' ' ' GLN . 0.8 OUTLIER -102.49 141.49 18.49 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.221 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 177.316 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . 0.425 ' HB ' ' HB3' ' A' ' 252' ' ' ASP . 6.2 m -129.05 118.88 23.25 Favored 'General case' 0 C--N 1.281 -2.373 0 CA-C-O 121.2 0.524 . . . . 0.0 109.639 176.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.766 HD23 ' HB3' ' A' ' 251' ' ' PRO . 31.5 mt -96.76 95.36 7.85 Favored 'General case' 0 N--CA 1.423 -1.811 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.428 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 31.6 mmtp -63.92 133.96 54.23 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 114.731 -1.122 . . . . 0.0 113.403 -174.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 69.56 9.07 7.08 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-N 113.533 -1.667 . . . . 0.0 110.801 176.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' HIS . . . . . 0.441 ' ND1' ' HB2' ' A' ' 247' ' ' PHE . 46.4 t60 -100.25 114.39 27.8 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.938 -176.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.89 118.19 28.42 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . 0.409 HD22 HD22 ' A' ' 291' ' ' LEU . 31.4 tp -96.92 127.48 38.87 Favored Pre-proline 0 N--CA 1.439 -0.982 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.176 177.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -62.87 136.31 56.59 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.193 1.929 . . . . 0.0 111.26 170.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . 0.497 ' HB ' ' HD2' ' A' ' 293' ' ' ARG . 8.5 t -66.21 -14.12 61.38 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 122.262 1.029 . . . . 0.0 110.756 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 2.8 m -78.14 -18.94 54.96 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.007 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 88.6 mt -106.9 -8.54 16.63 Favored 'General case' 0 C--O 1.246 0.912 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.844 -176.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.483 ' HA ' HD13 ' A' ' 291' ' ' LEU . 10.5 pt20 -83.11 148.9 27.22 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.9 169.82 8.04 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 289' ' ' VAL . 15.8 m -119.62 117.02 27.2 Favored 'General case' 0 N--CA 1.406 -2.666 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 173.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 76.4 mt -81.53 117.9 22.31 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -79.3 89.5 4.94 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 122.224 1.011 . . . . 0.0 109.866 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.623 ' HA ' ' CE1' ' A' ' 282' ' ' PHE . 47.3 t -98.74 27.34 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.124 0 CA-C-O 123.047 1.403 . . . . 0.0 109.658 -176.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -71.49 132.2 44.4 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.581 178.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 30.1 t70 68.53 28.49 5.88 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.461 1.504 . . . . 0.0 112.468 178.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.623 ' CE1' ' HA ' ' A' ' 279' ' ' VAL . 6.7 m-85 -84.25 -5.02 59.2 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.66 173.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? 60.97 50.36 5.18 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.691 0.758 . . . . 0.0 110.586 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' THR . . . . . 0.453 HG22 ' HE3' ' A' ' 232' ' ' LYS . 1.2 p -133.27 168.34 18.44 Favored Pre-proline 0 N--CA 1.433 -1.304 0 N-CA-C 104.314 -2.476 . . . . 0.0 104.314 177.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . 0.649 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 11.6 Cg_exo -75.05 -11.14 21.38 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 121.588 1.525 . . . . 0.0 110.889 176.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 57.9 t -86.04 129.9 37.39 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -92.36 -44.07 8.9 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-O 121.543 0.687 . . . . 0.0 109.175 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -164.21 134.54 4.16 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.814 -174.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 276' ' ' SER . 61.6 t -95.44 117.72 40.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 175.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.487 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 62.4 m -115.69 113.32 23.34 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-O 121.149 0.5 . . . . 0.0 110.359 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.483 HD13 ' HA ' ' A' ' 274' ' ' GLN . 0.0 OUTLIER -98.78 120.79 39.82 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 179.374 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -123.65 131.06 53.52 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -176.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . 0.497 ' HD2' ' HB ' ' A' ' 271' ' ' THR . 4.6 ptm180 -75.81 133.08 40.73 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 172.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.506 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 31.9 tp -110.39 -179.61 3.82 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -177.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.506 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 4.6 m-20 -35.31 -72.11 0.06 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 126.167 1.787 . . . . 0.0 112.881 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -123.7 -2.2 8.38 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 177.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . 0.428 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 12.9 m-20 -117.86 174.92 5.91 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.811 -170.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.559 ' HB ' ' HB2' ' A' ' 264' ' ' LEU . 83.5 m -117.4 126.97 53.56 Favored 'General case' 0 C--N 1.282 -2.34 0 N-CA-C 107.343 -1.354 . . . . 0.0 107.343 175.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 36.3 tt0 -109.94 128.15 55.2 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -175.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.464 HD13 HG21 ' A' ' 228' ' ' ILE . 63.5 tp -116.38 117.39 29.82 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 119.744 -0.782 . . . . 0.0 110.644 177.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' ILE . . . . . 0.487 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 51.1 mt -107.14 115.26 48.16 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.391 -176.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . 0.401 ' HB ' HD12 ' A' ' 260' ' ' ILE . 56.0 mt -110.63 105.49 18.91 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.551 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.42 ' HA ' ' CB ' ' A' ' 259' ' ' HIS . 3.0 m -77.68 131.48 37.74 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -176.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 7.3 p -130.43 165.46 22.57 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 112.69 0.626 . . . . 0.0 112.69 -177.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -144.95 158.27 43.86 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 123.174 0.59 . . . . 0.0 109.89 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 74.54 -145.27 34.02 Favored Glycine 0 C--N 1.332 0.306 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' ASN . . . . . 0.421 ' HB3' ' HB3' ' A' ' 327' ' ' LYS . 31.9 m-80 -110.41 133.51 53.2 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 174.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' TRP . . . . . 0.724 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 57.0 p-90 -143.41 165.0 28.75 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 120.086 -0.646 . . . . 0.0 110.866 -175.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -126.18 134.85 51.15 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -177.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.724 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 18.5 tp -106.74 122.99 47.47 Favored 'General case' 0 CA--C 1.503 -0.841 0 C-N-CA 120.14 -0.624 . . . . 0.0 110.788 -178.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.603 HG13 ' HB3' ' A' ' 323' ' ' GLN . 10.1 p -127.57 117.67 47.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-O 121.883 0.849 . . . . 0.0 109.461 171.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -106.11 136.18 46.26 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.466 -176.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -129.58 151.28 50.37 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.374 -178.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 43.2 t -116.05 112.79 22.28 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 177.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -70.13 -35.78 74.33 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.648 0.737 . . . . 0.0 109.105 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -164.83 157.61 14.19 Favored Pre-proline 0 N--CA 1.438 -1.054 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -63.17 100.48 0.26 Allowed 'Trans proline' 0 C--O 1.24 0.596 0 C-N-CA 121.778 1.652 . . . . 0.0 111.152 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 125.67 -9.99 7.61 Favored Glycine 0 N--CA 1.436 -1.329 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -176.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -127.01 116.18 20.35 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -121.54 168.53 11.63 Favored 'General case' 0 C--N 1.289 -2.022 0 CA-C-O 121.573 0.701 . . . . 0.0 110.708 -174.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 91.8 m -151.48 123.56 8.17 Favored 'General case' 0 C--N 1.276 -2.602 0 C-N-CA 124.307 1.043 . . . . 0.0 108.817 -177.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -109.52 113.35 26.08 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 177.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . 0.603 ' HB3' HG13 ' A' ' 311' ' ' VAL . 8.0 tt0 -101.6 110.96 23.06 Favored 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.577 HG13 ' CE3' ' A' ' 308' ' ' TRP . 93.3 t -100.04 99.3 8.22 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.297 -179.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -86.86 156.45 55.36 Favored Pre-proline 0 C--N 1.315 -0.92 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . 0.429 ' HG3' ' HB2' ' A' ' 236' ' ' ASN . 73.2 Cg_endo -81.33 138.63 11.17 Favored 'Trans proline' 0 N--CA 1.447 -1.237 0 C-N-CA 121.713 1.609 . . . . 0.0 110.574 172.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.421 ' HB3' ' HB3' ' A' ' 307' ' ' ASN . 23.6 ttmm -108.99 154.97 21.43 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 27.4 tptp 82.31 101.41 0.05 Allowed 'General case' 0 C--N 1.307 -1.256 0 O-C-N 124.794 1.309 . . . . 0.0 113.179 172.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 . . . . . 0 N--CA 1.425 -1.707 0 CA-C-N 115.018 -0.992 . . . . 0.0 108.596 174.502 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 CA--C 1.523 -0.082 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -62.84 -18.55 59.76 Favored Glycine 0 C--O 1.217 -0.946 0 N-CA-C 114.82 0.688 . . . . 0.0 114.82 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 15.8 m -58.52 -36.58 74.04 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 117.563 0.682 . . . . 0.0 112.714 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 29.5 p -93.37 13.62 20.96 Favored 'General case' 0 C--O 1.245 0.861 0 CA-C-O 122.051 0.929 . . . . 0.0 110.6 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -135.88 25.86 3.33 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 26.1 t60 -79.0 111.04 14.8 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.567 -1.197 . . . . 0.0 111.211 -172.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 82.6 m-70 -94.86 -176.37 3.84 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 177.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 70.85 27.33 3.54 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 122.188 0.994 . . . . 0.0 108.674 -179.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -131.35 121.74 25.18 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -76.18 102.46 5.79 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -141.91 87.7 0.18 Allowed Glycine 0 N--CA 1.43 -1.761 0 C-N-CA 119.913 -1.137 . . . . 0.0 112.973 -176.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 4.3 tt -88.81 105.39 17.69 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 105.005 -2.22 . . . . 0.0 105.005 175.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.433 ' HA ' ' HD3' ' A' ' 205' ' ' PRO . 30.5 m -120.73 134.53 24.28 Favored Pre-proline 0 C--N 1.301 -1.537 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -173.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 204' ' ' VAL . 17.6 Cg_exo -70.09 126.27 12.9 Favored 'Trans proline' 0 C--O 1.243 0.738 0 C-N-CA 122.401 2.067 . . . . 0.0 109.943 172.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -83.88 84.22 7.65 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-O 121.725 0.774 . . . . 0.0 112.772 -177.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -143.73 26.48 2.09 Favored Glycine 0 C--N 1.294 -1.795 0 N-CA-C 107.63 -2.188 . . . . 0.0 107.63 175.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 4.8 m -81.46 -39.72 24.39 Favored 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 113.692 -1.254 . . . . 0.0 111.608 -172.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 63.41 -153.08 0.33 Allowed 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 -170.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 27.7 ttt 68.52 -79.38 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.279 0.631 . . . . 0.0 111.361 176.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -94.21 74.16 3.98 Favored 'General case' 0 C--N 1.273 -2.757 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 39.7 m -150.68 105.94 3.35 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.399 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 26.3 ptm -75.36 4.55 7.04 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-O 121.286 0.565 . . . . 0.0 111.484 177.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 56.3 m -144.06 106.84 4.45 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 177.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -125.38 -131.27 3.59 Favored Glycine 0 CA--C 1.493 -1.304 0 N-CA-C 109.016 -1.633 . . . . 0.0 109.016 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -74.66 -32.34 57.48 Favored Glycine 0 C--N 1.311 -0.834 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 174.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 22.6 mp0 -107.22 139.02 42.33 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 114.37 -0.915 . . . . 0.0 108.994 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -115.87 -55.8 2.39 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 23.3 ptm -144.1 130.16 19.56 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-N 114.843 -1.072 . . . . 0.0 108.71 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -101.05 114.95 5.15 Favored Glycine 0 N--CA 1.431 -1.673 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -98.37 131.26 44.81 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 177.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 95.37 -77.13 0.85 Allowed Glycine 0 N--CA 1.427 -1.952 0 N-CA-C 108.975 -1.65 . . . . 0.0 108.975 -177.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 29.5 p 49.1 31.46 3.46 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.486 1.514 . . . . 0.0 114.34 172.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -132.39 6.66 4.15 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.409 -179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -133.73 128.8 35.67 Favored 'General case' 0 N--CA 1.432 -1.357 0 C-N-CA 120.353 -0.539 . . . . 0.0 111.553 -177.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 91.1 m -65.61 121.51 15.12 Favored 'General case' 0 C--O 1.195 -1.783 0 CA-C-N 114.596 -1.184 . . . . 0.0 110.354 -176.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -143.19 170.4 15.81 Favored 'General case' 0 C--N 1.288 -2.094 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.229 -173.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.518 HG21 HD13 ' A' ' 300' ' ' LEU . 2.8 pp -128.05 163.51 31.8 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-N 115.084 -0.962 . . . . 0.0 108.898 179.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -149.77 155.67 40.53 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 -176.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -136.78 132.64 35.01 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.096 0.474 . . . . 0.0 110.701 176.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.605 ' HD3' ' OE2' ' A' ' 241' ' ' GLU . 0.3 OUTLIER -149.55 174.41 12.55 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.055 178.23 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -119.62 144.3 47.21 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 26.8 t0 -150.72 176.59 10.88 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 105.333 -2.099 . . . . 0.0 105.333 176.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 53.72 -138.73 37.19 Favored Glycine 0 C--N 1.309 -0.957 0 O-C-N 123.721 0.638 . . . . 0.0 113.682 178.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -115.1 100.24 8.02 Favored 'General case' 0 N--CA 1.429 -1.502 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.413 ' HB2' ' HG3' ' A' ' 326' ' ' PRO . 5.1 m-20 60.53 29.08 18.74 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-O 121.792 0.806 . . . . 0.0 111.533 179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.73 135.3 36.37 Favored 'General case' 0 N--CA 1.428 -1.57 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.454 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . 0.563 ' HA3' ' CG1' ' A' ' 286' ' ' VAL . . . -102.25 123.47 7.88 Favored Glycine 0 C--N 1.299 -1.526 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -177.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.5 mp -113.67 120.27 63.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 117.423 0.612 . . . . 0.0 111.258 -176.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . 0.402 ' N ' HD12 ' A' ' 240' ' ' ILE . 3.1 mp -106.42 107.85 23.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.605 ' OE2' ' HD3' ' A' ' 231' ' ' ARG . 42.9 mt-10 -95.01 111.22 23.04 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 122.408 1.099 . . . . 0.0 111.783 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 12.8 tp -94.3 136.05 35.02 Favored 'General case' 0 C--N 1.278 -2.519 0 CA-C-N 114.097 -1.41 . . . . 0.0 110.756 -175.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . 0.517 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -121.56 98.72 6.1 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 176.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -103.16 91.34 4.06 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -79.37 112.8 16.96 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.314 -175.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 110.65 4.45 28.28 Favored Glycine 0 C--N 1.292 -1.875 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.138 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -111.98 108.71 18.14 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -104.51 100.45 10.13 Favored 'General case' 0 C--N 1.291 -1.961 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 177.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 159.78 -132.83 3.1 Favored Glycine 0 C--N 1.291 -1.922 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -153.69 132.65 6.95 Favored Pre-proline 0 C--N 1.309 -1.188 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.661 ' HB3' HD13 ' A' ' 264' ' ' LEU . 14.0 Cg_endo -63.55 171.84 6.34 Favored 'Trans proline' 0 C--N 1.355 0.915 0 C-N-CA 123.18 2.587 . . . . 0.0 113.111 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 29.5 t70 -96.01 105.88 17.97 Favored 'General case' 0 C--N 1.29 -2.001 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.009 178.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 4.4 mp -98.84 117.24 43.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-O 121.296 0.57 . . . . 0.0 111.034 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 13.5 t -102.49 116.84 33.42 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 176.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . 0.41 ' HG2' HD23 ' A' ' 310' ' ' LEU . 76.0 mt-30 -92.52 109.8 21.21 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-O 121.359 0.599 . . . . 0.0 111.909 -176.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 78.3 mt-30 -125.25 149.83 47.63 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 174.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -77.21 -28.58 53.87 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 -174.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -79.91 -24.6 41.01 Favored 'General case' 0 C--N 1.309 -1.189 0 C-N-CA 119.271 -0.971 . . . . 0.0 110.107 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . 0.466 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 39.8 p-80 -171.68 159.25 5.3 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.955 173.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 25.2 mt -105.58 142.21 19.19 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 261' ' ' ILE . 2.9 mp -122.01 113.72 39.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 299' ' ' GLN . 1.9 m -110.99 135.69 49.33 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.496 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 178.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 298' ' ' THR . 29.2 m -129.58 125.07 35.35 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-O 121.589 0.709 . . . . 0.0 110.699 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.661 HD13 ' HB3' ' A' ' 251' ' ' PRO . 1.9 mm? -98.59 98.06 9.27 Favored 'General case' 0 N--CA 1.416 -2.142 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 175.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.535 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 51.9 mtpt -71.55 131.52 43.38 Favored 'General case' 0 C--N 1.274 -2.7 0 O-C-N 124.005 0.816 . . . . 0.0 111.95 -178.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 9.4 t30 73.61 24.65 2.18 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 124.894 1.371 . . . . 0.0 109.931 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 54.6 t60 -117.16 117.8 30.59 Favored 'General case' 0 C--N 1.321 -0.665 0 O-C-N 121.45 -0.781 . . . . 0.0 109.179 178.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 10.9 p -88.5 130.02 35.31 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-O 120.975 0.417 . . . . 0.0 111.689 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 29.1 tp -115.97 124.95 29.11 Favored Pre-proline 0 N--CA 1.429 -1.496 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.086 177.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -68.6 156.72 64.59 Favored 'Trans proline' 0 C--N 1.321 -0.893 0 C-N-CA 122.66 2.24 . . . . 0.0 112.326 171.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . 0.491 ' HA ' ' OE1' ' A' ' 274' ' ' GLN . 37.1 p -64.09 -31.48 72.68 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.351 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 2.2 m -64.21 -23.78 67.43 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.24 1.016 . . . . 0.0 112.606 -175.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -95.46 -10.13 30.7 Favored 'General case' 0 CA--C 1.498 -1.036 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.494 -176.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.504 HE21 ' HA ' ' A' ' 292' ' ' LYS . 50.9 mt-30 -72.73 111.94 8.33 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.146 -0.933 . . . . 0.0 109.962 178.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -142.09 150.44 41.18 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . 0.568 ' HA ' ' O ' ' A' ' 289' ' ' VAL . 36.9 m -118.99 114.05 21.94 Favored 'General case' 0 N--CA 1.417 -2.09 0 O-C-N 123.594 0.559 . . . . 0.0 109.736 179.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 66.6 mt -85.8 112.85 21.48 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.221 -177.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -80.4 90.97 5.64 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 174.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.457 ' O ' ' HB2' ' A' ' 282' ' ' PHE . 17.2 m -109.97 25.76 2.96 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.311 0 CA-C-N 114.565 -1.198 . . . . 0.0 112.202 -173.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -70.02 150.76 46.31 Favored 'General case' 0 N--CA 1.422 -1.862 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 174.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 24.6 t70 73.36 15.69 4.24 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 122.579 1.18 . . . . 0.0 110.955 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.457 ' HB2' ' O ' ' A' ' 279' ' ' VAL . 1.6 m-85 -85.52 -0.07 53.92 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.915 173.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? 62.37 61.17 1.3 Allowed 'General case' 0 CA--C 1.491 -1.326 0 CA-C-O 121.708 0.765 . . . . 0.0 112.649 179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 1.8 t -164.21 148.7 8.39 Favored Pre-proline 0 N--CA 1.403 -2.823 0 CA-C-N 113.618 -1.628 . . . . 0.0 108.961 176.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . 0.424 ' O ' ' HA ' ' A' ' 304' ' ' THR . 14.7 Cg_exo -44.01 -35.48 7.45 Favored 'Trans proline' 0 CA--C 1.536 0.62 0 C-N-CA 124.68 3.587 . . . . 0.0 114.098 174.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.563 ' CG1' ' HA3' ' A' ' 238' ' ' GLY . 0.3 OUTLIER -75.87 117.74 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 CA-C-O 121.989 0.9 . . . . 0.0 110.831 178.044 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 9.3 mm-40 -101.47 -37.98 8.19 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 114.152 -1.385 . . . . 0.0 111.857 -172.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -151.23 140.0 20.82 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.874 -0.516 . . . . 0.0 111.041 -178.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 276' ' ' SER . 46.9 t -110.24 110.08 30.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.18 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 175.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.44 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 89.0 m -111.83 115.24 28.69 Favored 'General case' 0 C--N 1.277 -2.555 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 58.4 tp -95.87 118.65 32.91 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 176.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.504 ' HA ' HE21 ' A' ' 274' ' ' GLN . 40.8 ttmt -121.89 136.2 54.92 Favored 'General case' 0 N--CA 1.431 -1.419 0 CA-C-O 121.107 0.479 . . . . 0.0 110.484 -176.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 16.3 ptt180 -80.84 139.92 35.69 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 176.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.506 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 19.8 tp -113.0 -178.93 3.5 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 177.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.506 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 20.2 t-20 -53.39 -68.29 0.19 Allowed 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 119.113 0.87 . . . . 0.0 112.5 -176.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -109.51 -3.79 16.73 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.032 0.444 . . . . 0.0 110.102 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . 0.535 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 13.1 m-20 -124.0 173.11 8.46 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.406 -168.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 263' ' ' THR . 31.8 m -114.92 130.72 56.97 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 175.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . 0.533 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 9.7 tt0 -118.66 124.2 46.81 Favored 'General case' 0 N--CA 1.432 -1.329 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -177.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.518 HD13 HG21 ' A' ' 228' ' ' ILE . 67.3 tp -107.22 122.01 45.67 Favored 'General case' 0 N--CA 1.412 -2.371 0 C-N-CA 120.361 -0.535 . . . . 0.0 109.844 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' ILE . . . . . 0.441 HG23 ' CD2' ' A' ' 259' ' ' HIS . 64.0 mt -110.03 109.73 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.264 -176.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 61.6 mt -106.58 107.56 23.01 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.521 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 13.3 m -79.38 131.08 36.0 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -175.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 285' ' ' PRO . 8.9 p -135.64 175.96 9.12 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 122.721 0.408 . . . . 0.0 110.866 -176.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -161.18 141.66 11.09 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 177.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 89.52 -163.36 31.12 Favored Glycine 0 C--O 1.25 1.11 0 C-N-CA 121.459 -0.4 . . . . 0.0 113.179 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -91.37 125.38 36.1 Favored 'General case' 0 CA--C 1.486 -1.496 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' TRP . . . . . 0.694 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 59.8 p-90 -150.15 170.65 18.43 Favored 'General case' 0 N--CA 1.413 -2.29 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -177.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -128.91 131.39 47.57 Favored 'General case' 0 C--N 1.311 -1.075 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -176.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.694 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 24.7 tp -105.63 137.3 43.7 Favored 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 119.625 -0.83 . . . . 0.0 109.98 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.647 HG13 ' HB3' ' A' ' 323' ' ' GLN . 6.5 p -137.21 126.91 37.42 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.31 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 172.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -111.44 145.27 39.27 Favored 'General case' 0 N--CA 1.418 -2.032 0 C-N-CA 119.237 -0.985 . . . . 0.0 110.421 -177.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . 0.411 ' HB2' ' HB ' ' A' ' 321' ' ' THR . 65.1 mttm -139.62 158.01 44.84 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.986 -176.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 32.2 t -115.63 128.31 55.83 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 170.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -84.56 -43.34 14.59 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-O 121.706 0.765 . . . . 0.0 108.984 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -153.12 161.47 28.99 Favored Pre-proline 0 C--N 1.303 -1.44 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -59.8 100.08 0.13 Allowed 'Trans proline' 0 CA--C 1.537 0.655 0 C-N-CA 122.294 1.996 . . . . 0.0 112.336 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 121.38 -29.47 5.69 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -177.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -95.48 122.72 38.51 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -121.94 169.98 10.26 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 121.802 0.811 . . . . 0.0 110.907 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.411 ' HB ' ' HB2' ' A' ' 313' ' ' LYS . 72.8 m -152.1 128.72 10.78 Favored 'General case' 0 C--N 1.272 -2.787 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.376 -175.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -117.77 109.38 16.53 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 175.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . 0.647 ' HB3' HG13 ' A' ' 311' ' ' VAL . 9.3 tt0 -100.67 114.2 27.72 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 1.5 m -100.76 113.33 36.34 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 177.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -91.51 151.59 42.72 Favored Pre-proline 0 C--N 1.304 -1.378 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 176.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . 0.413 ' HG3' ' HB2' ' A' ' 236' ' ' ASN . 70.9 Cg_endo -81.68 134.01 8.42 Favored 'Trans proline' 0 N--CA 1.436 -1.887 0 C-N-CA 121.393 1.395 . . . . 0.0 109.948 173.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 20.2 ttmm -92.9 100.02 12.56 Favored 'General case' 0 N--CA 1.413 -2.291 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 175.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . 0.285 26.9 tptp -81.94 102.67 11.07 Favored 'General case' 0 N--CA 1.413 -2.305 0 C-N-CA 118.309 -1.356 . . . . 0.0 114.554 -169.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 . . . . . 0 N--CA 1.393 -3.295 0 CA-C-N 112.217 -2.265 . . . . 0.0 105.11 170.936 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 94.0 mmm . . . . . 0 C--O 1.235 0.331 0 N-CA-C 111.276 0.102 . . . . 0.0 111.276 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -72.88 98.28 0.86 Allowed Glycine 0 C--O 1.247 0.935 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 176.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 41.5 t 73.74 166.59 0.3 Allowed 'General case' 0 C--O 1.239 0.547 0 C-N-CA 124.471 1.109 . . . . 0.0 108.912 -171.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 37.3 t -89.72 5.86 44.04 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 72.63 89.77 0.09 Allowed 'General case' 0 C--N 1.346 0.426 0 C-N-CA 124.249 1.019 . . . . 0.0 110.631 178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -93.92 118.59 31.68 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.592 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -142.39 119.37 11.3 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 32.4 m170 -93.46 118.27 31.12 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 120.121 -0.631 . . . . 0.0 110.312 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 42.1 t-80 -82.76 -18.56 40.27 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 34.8 m-70 -113.73 117.23 30.94 Favored 'General case' 0 C--O 1.249 1.07 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 176.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 120.31 39.56 0.62 Allowed Glycine 0 C--N 1.298 -1.543 0 C-N-CA 119.384 -1.389 . . . . 0.0 113.461 175.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 60.0 tp -81.11 99.09 8.32 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 176.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.413 ' HA ' ' HD3' ' A' ' 205' ' ' PRO . 16.9 m -108.4 106.13 58.06 Favored Pre-proline 0 C--N 1.305 -1.363 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.536 -178.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 204' ' ' VAL . 12.7 Cg_endo -91.34 -162.87 0.11 Allowed 'Trans proline' 0 N--CA 1.445 -1.348 0 C-N-CA 122.642 2.228 . . . . 0.0 111.621 177.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 16.5 ptp180 -133.54 93.79 3.2 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-O 121.724 0.773 . . . . 0.0 110.811 178.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -139.33 64.28 0.54 Allowed Glycine 0 N--CA 1.432 -1.598 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.312 -178.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 38.6 m -143.99 67.37 1.27 Allowed 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 177.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 30.9 t60 -75.99 90.9 3.03 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.403 -178.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 40.8 tpp -96.28 107.81 20.22 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.005 177.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -96.76 -28.04 14.46 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 3.5 t 55.14 62.2 2.6 Favored 'General case' 0 C--O 1.244 0.765 0 CA-C-N 114.395 -1.275 . . . . 0.0 109.326 178.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -96.87 106.21 18.48 Favored 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -178.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 19.7 m -84.78 115.42 22.7 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -104.52 39.31 2.87 Favored Glycine 0 C--N 1.307 -1.074 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -132.5 114.09 1.39 Allowed Glycine 0 N--CA 1.422 -2.3 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -86.69 81.98 8.03 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-O 121.704 0.764 . . . . 0.0 111.424 -178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -142.17 85.06 1.9 Allowed 'General case' 0 C--N 1.299 -1.622 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.346 176.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 24.3 ptp -83.07 -32.92 26.54 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 159.79 -155.69 26.82 Favored Glycine 0 N--CA 1.418 -2.55 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . 0.445 ' H ' ' HB3' ' A' ' 245' ' ' LEU . 39.3 ptt180 -157.59 136.64 11.68 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 74.6 -74.54 1.3 Allowed Glycine 0 C--N 1.306 -1.1 0 C-N-CA 121.613 -0.327 . . . . 0.0 113.84 177.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.561 ' HB3' HD11 ' A' ' 245' ' ' LEU . 7.5 t -84.16 -170.66 3.2 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 123.648 0.779 . . . . 0.0 111.112 -176.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 66.6 mttm -84.49 82.79 8.25 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 113.627 0.973 . . . . 0.0 113.627 -171.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . 0.71 ' O ' HD23 ' A' ' 245' ' ' LEU . 12.8 pt20 44.08 -176.35 0.0 OUTLIER 'General case' 0 C--O 1.199 -1.571 0 C-N-CA 126.495 1.918 . . . . 0.0 115.017 172.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 16.6 m -75.23 110.94 9.98 Favored 'General case' 0 C--N 1.281 -2.393 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 166.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.416 ' HB3' ' HB3' ' A' ' 243' ' ' ALA . 38.9 t30 -139.52 151.72 46.36 Favored 'General case' 0 C--N 1.284 -2.264 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.8 -166.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.748 HG21 HD21 ' A' ' 300' ' ' LEU . 2.5 pp -133.94 144.54 35.3 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.388 0 CA-C-N 114.265 -1.334 . . . . 0.0 107.941 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.493 ' O ' ' HA ' ' A' ' 240' ' ' ILE . 8.4 t0 -145.02 157.44 44.12 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -172.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.476 ' CD2' HG11 ' A' ' 279' ' ' VAL . 85.4 t80 -136.95 135.05 37.37 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . 0.495 HH11 ' HB3' ' A' ' 231' ' ' ARG . 1.0 OUTLIER -156.77 174.29 15.7 Favored 'General case' 0 N--CA 1.434 -1.262 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 176.869 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.447 ' HE3' HG22 ' A' ' 284' ' ' THR . 54.4 mtpt -118.07 153.92 32.93 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 120.462 0.172 . . . . 0.0 110.8 178.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -155.32 146.93 23.08 Favored 'General case' 0 C--N 1.308 -1.225 0 O-C-N 124.091 0.87 . . . . 0.0 109.019 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 69.96 -109.33 2.82 Favored Glycine 0 N--CA 1.447 -0.611 0 O-C-N 123.569 0.543 . . . . 0.0 113.735 174.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -123.76 83.49 2.14 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -177.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 61.03 24.15 14.28 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 176.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -80.46 140.56 35.87 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.16 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -100.17 109.54 3.73 Favored Glycine 0 N--CA 1.426 -1.998 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 230' ' ' PHE . 2.1 mp -98.6 114.51 36.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-N 117.144 0.472 . . . . 0.0 110.207 -176.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . 0.493 ' HA ' ' O ' ' A' ' 229' ' ' ASP . 3.7 mp -102.68 111.62 33.1 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 176.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.413 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 34.0 mt-10 -88.51 143.82 26.73 Favored 'General case' 0 N--CA 1.412 -2.334 0 C-N-CA 119.387 -0.925 . . . . 0.0 109.629 175.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 13.5 tp -131.69 119.27 21.14 Favored 'General case' 0 C--N 1.27 -2.881 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.14 -177.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . 0.43 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -114.16 105.22 12.92 Favored 'General case' 0 C--N 1.276 -2.625 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -111.32 90.61 3.38 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.71 HD23 ' O ' ' A' ' 225' ' ' GLN . 4.0 mm? -81.92 118.25 22.8 Favored 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.257 -176.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 103.97 15.64 21.45 Favored Glycine 0 C--N 1.3 -1.471 0 CA-C-N 114.792 -1.095 . . . . 0.0 111.361 178.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -115.15 116.23 28.05 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-O 121.067 0.46 . . . . 0.0 110.065 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -106.81 94.54 5.17 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.299 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 159.12 -161.98 32.38 Favored Glycine 0 N--CA 1.425 -2.087 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -118.36 140.76 28.58 Favored Pre-proline 0 C--N 1.298 -1.667 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.724 ' HB3' HD13 ' A' ' 264' ' ' LEU . 27.7 Cg_endo -73.67 165.42 32.37 Favored 'Trans proline' 0 N--CA 1.437 -1.796 0 C-N-CA 121.104 1.203 . . . . 0.0 110.17 176.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.582 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 11.9 t70 -87.63 106.56 18.1 Favored 'General case' 0 C--N 1.27 -2.866 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 177.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.431 HD11 ' HG2' ' A' ' 251' ' ' PRO . 5.3 mp -95.9 109.21 22.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 C-N-CA 119.354 -0.938 . . . . 0.0 109.669 175.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . 0.655 ' HB2' ' HB ' ' A' ' 261' ' ' ILE . 26.5 m -99.61 117.6 34.33 Favored 'General case' 0 C--N 1.277 -2.546 0 C-N-CA 125.001 1.32 . . . . 0.0 108.48 177.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -100.02 124.89 45.89 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -175.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.494 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 14.5 mm100 -122.62 171.07 9.4 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 104.979 -2.23 . . . . 0.0 104.979 171.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 61.2 m-70 -76.89 -41.03 45.37 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 120.079 -0.648 . . . . 0.0 110.743 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -81.03 -24.83 37.62 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.618 -173.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . 0.494 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 45.7 p-80 -165.08 163.17 20.58 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.039 0.447 . . . . 0.0 111.151 177.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 21.3 mt -107.15 141.87 21.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 106.465 -1.68 . . . . 0.0 106.465 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . 0.655 ' HB ' ' HB2' ' A' ' 254' ' ' SER . 3.8 mp -119.21 117.26 53.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 177.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 299' ' ' GLN . 0.7 OUTLIER -114.95 142.48 27.62 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 C-N-CA 119.207 -0.997 . . . . 0.0 108.814 176.816 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . 0.556 ' HA ' ' O ' ' A' ' 298' ' ' THR . 7.5 m -135.47 124.31 24.0 Favored 'General case' 0 C--N 1.291 -1.941 0 C-N-CA 119.825 -0.75 . . . . 0.0 112.064 179.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.724 HD13 ' HB3' ' A' ' 251' ' ' PRO . 1.9 mm? -97.2 100.24 11.71 Favored 'General case' 0 CA--C 1.467 -2.218 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 175.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.561 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 51.6 mtpt -68.39 126.67 30.34 Favored 'General case' 0 N--CA 1.405 -2.676 0 O-C-N 124.34 1.025 . . . . 0.0 113.235 -173.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 77.67 3.68 3.01 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 113.925 -1.489 . . . . 0.0 111.808 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -86.12 95.66 9.63 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 177.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.84 109.2 6.24 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.286 0.565 . . . . 0.0 111.592 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 23.8 tp -95.64 128.99 35.86 Favored Pre-proline 0 N--CA 1.433 -1.295 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.633 -178.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -71.69 154.87 59.33 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.157 2.571 . . . . 0.0 111.831 170.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 19.3 p -67.6 -29.45 68.79 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 123.206 0.602 . . . . 0.0 112.592 -177.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 11.9 m -62.96 -22.03 66.51 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 123.714 0.806 . . . . 0.0 111.36 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 8.2 mp -96.94 -8.11 31.5 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.375 -175.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.585 HE21 ' HA ' ' A' ' 292' ' ' LYS . 47.7 mt-30 -77.78 136.35 38.11 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.755 178.256 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -161.13 165.72 29.1 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 176.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 16.9 m -134.46 138.26 44.61 Favored 'General case' 0 N--CA 1.414 -2.249 0 CA-C-O 121.351 0.596 . . . . 0.0 109.668 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.45 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 2.9 mm? -95.25 101.41 13.14 Favored 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 178.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -83.84 55.59 3.32 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.728 0.775 . . . . 0.0 109.567 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.476 HG11 ' CD2' ' A' ' 230' ' ' PHE . 13.3 m -81.17 59.56 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 114.218 -1.355 . . . . 0.0 112.751 -174.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -74.44 121.54 21.61 Favored 'General case' 0 N--CA 1.415 -2.211 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.597 -178.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . 0.367 20.4 m-20 58.42 51.91 7.71 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 179.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 5.9 m-85 -85.38 -2.08 57.71 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 165.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 25.7 mmmt 67.02 61.16 0.5 Allowed 'General case' 0 CA--C 1.485 -1.536 0 CA-C-N 113.222 -1.808 . . . . 0.0 109.996 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' THR . . . . . 0.447 HG22 ' HE3' ' A' ' 232' ' ' LYS . 0.7 OUTLIER -138.91 165.09 34.91 Favored Pre-proline 0 N--CA 1.42 -1.938 0 N-CA-C 103.565 -2.754 . . . . 0.0 103.565 179.243 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . 0.401 ' HB3' ' HB3' ' A' ' 308' ' ' TRP . 18.3 Cg_exo -69.12 -15.55 39.58 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 121.323 1.349 . . . . 0.0 111.405 177.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.408 HG21 HD11 ' A' ' 240' ' ' ILE . 42.5 t -84.04 129.55 37.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -96.92 -39.56 9.33 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.261 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 21.4 ttmm -160.36 140.54 11.46 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.223 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.45 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 41.8 t -104.67 126.36 59.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 173.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.519 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 48.2 m -128.58 122.74 31.67 Favored 'General case' 0 C--N 1.281 -2.378 0 CA-C-N 117.957 0.344 . . . . 0.0 110.69 -177.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.561 ' HB2' HG12 ' A' ' 228' ' ' ILE . 52.0 tp -103.41 108.27 19.44 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.585 ' HA ' HE21 ' A' ' 274' ' ' GLN . 24.5 ttmm -112.06 125.47 54.13 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.286 -177.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . 0.414 ' H ' ' NE2' ' A' ' 274' ' ' GLN . 1.9 ptm180 -68.72 137.94 54.5 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 174.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.585 HD13 ' N ' ' A' ' 295' ' ' ASN . 2.6 tm? -117.4 162.8 17.34 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 -174.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.585 ' N ' HD13 ' A' ' 294' ' ' LEU . 66.5 t30 -14.92 -70.98 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 127.541 2.336 . . . . 0.0 112.972 177.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -125.46 -2.28 7.44 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 175.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . 0.561 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 10.9 m-20 -118.09 178.61 4.36 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.485 -165.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' A' ' 263' ' ' THR . 42.3 m -114.93 125.53 53.74 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 173.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . 0.591 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 9.0 tt0 -115.16 129.89 56.78 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 120.949 0.404 . . . . 0.0 111.157 -176.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.748 HD21 HG21 ' A' ' 228' ' ' ILE . 12.6 mt -100.58 132.0 46.19 Favored 'General case' 0 CA--C 1.451 -2.862 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.043 172.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' ILE . . . . . 0.519 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 65.5 mt -118.24 108.1 23.51 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.238 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 174.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 66.0 mt -109.89 105.21 18.37 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.364 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 4.0 m -78.56 129.33 34.7 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -174.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 8.4 p -131.57 153.13 50.19 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 -175.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -131.16 147.28 52.59 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.859 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 75.26 -160.21 52.2 Favored Glycine 0 N--CA 1.438 -1.187 0 O-C-N 123.994 0.809 . . . . 0.0 113.07 176.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' ASN . . . . . 0.41 ' HB3' ' HB3' ' A' ' 327' ' ' LYS . 31.0 m-80 -93.97 132.64 38.24 Favored 'General case' 0 CA--C 1.497 -1.093 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' TRP . . . . . 0.435 ' CE3' HG13 ' A' ' 324' ' ' VAL . 62.0 p-90 -148.05 168.0 23.48 Favored 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 120.977 -0.289 . . . . 0.0 111.083 -175.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -130.14 127.91 40.71 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -178.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 1.4 tt -96.25 125.89 41.08 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.697 HG13 ' HB3' ' A' ' 323' ' ' GLN . 7.2 p -130.17 112.54 23.73 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 169.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 321' ' ' THR . 22.4 t30 -103.58 141.83 35.35 Favored 'General case' 0 CA--C 1.45 -2.89 0 C-N-CA 119.584 -0.847 . . . . 0.0 111.17 -176.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -119.36 121.43 39.53 Favored 'General case' 1 N--CA 1.369 -4.488 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.659 -178.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 16.8 m -95.83 106.47 18.61 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 173.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -84.96 -32.71 22.89 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.079 -175.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.416 ' HB1' ' HD2' ' A' ' 317' ' ' PRO . . . -165.42 164.69 12.13 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 -177.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . 0.416 ' HD2' ' HB1' ' A' ' 316' ' ' ALA . 28.1 Cg_endo -62.68 94.98 0.15 Allowed 'Trans proline' 0 C--O 1.243 0.736 0 C-N-CA 122.058 1.839 . . . . 0.0 111.143 177.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 124.89 -23.55 6.2 Favored Glycine 0 N--CA 1.423 -2.171 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.417 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -101.71 116.19 32.19 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 122.048 -0.678 . . . . 0.0 110.685 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . 0.498 ' CZ ' ' HD3' ' A' ' 251' ' ' PRO . 68.7 m-85 -130.53 159.13 38.04 Favored 'General case' 0 N--CA 1.428 -1.547 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.412 -177.82 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 312' ' ' ASN . 61.6 m -152.67 111.93 3.85 Favored 'General case' 0 C--N 1.273 -2.726 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.354 -176.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -98.05 105.32 17.45 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . 0.697 ' HB3' HG13 ' A' ' 311' ' ' VAL . 46.3 tt0 -91.21 100.36 13.19 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.435 HG13 ' CE3' ' A' ' 308' ' ' TRP . 93.4 t -88.08 98.83 8.05 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 CA-C-O 121.519 0.676 . . . . 0.0 109.456 -178.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.505 HD21 HE21 ' A' ' 323' ' ' GLN . 20.9 mt -87.74 152.46 51.53 Favored Pre-proline 0 C--N 1.285 -2.208 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.197 -178.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -81.83 138.2 10.35 Favored 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 121.503 1.468 . . . . 0.0 109.812 172.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 307' ' ' ASN . 23.5 ttmm -96.72 118.06 32.35 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 120.439 -0.504 . . . . 0.0 110.587 -177.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 56.8 pttt -121.76 123.8 42.7 Favored 'General case' 0 C--N 1.288 -2.083 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.343 176.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 . . . . . 0 C--N 1.298 -1.643 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 177.714 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 67.1 mtt . . . . . 0 CA--C 1.504 -0.792 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 126.25 122.02 2.54 Favored Glycine 0 N--CA 1.431 -1.653 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 51.6 m -143.7 146.77 33.44 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 117.277 0.538 . . . . 0.0 111.4 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 24.2 m -106.84 78.18 1.23 Allowed 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 170.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -51.59 -25.2 6.44 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -172.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 46.7 t60 -123.57 83.3 2.12 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 36.1 p-80 -126.8 -0.67 6.68 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.652 -178.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 6.7 t60 59.75 -88.76 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.437 1.095 . . . . 0.0 109.779 -176.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -149.06 13.95 0.89 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 121.792 0.806 . . . . 0.0 109.3 174.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 33.5 p80 -94.54 100.5 12.46 Favored 'General case' 0 C--N 1.317 -0.848 0 C-N-CA 119.348 -0.941 . . . . 0.0 109.671 177.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 172.06 48.74 0.04 OUTLIER Glycine 0 N--CA 1.434 -1.494 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 3.7 tt -152.08 -66.43 0.17 Allowed 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.439 ' HB ' ' HD3' ' A' ' 205' ' ' PRO . 57.7 t -95.07 -59.5 0.19 Allowed Pre-proline 0 CA--C 1.551 1.014 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . 0.439 ' HD3' ' HB ' ' A' ' 204' ' ' VAL . 59.3 Cg_endo -75.4 125.31 8.97 Favored 'Trans proline' 0 C--N 1.364 1.365 0 C-N-CA 121.103 1.202 . . . . 0.0 110.218 171.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -134.1 -80.89 0.46 Allowed 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -87.37 -38.09 7.88 Favored Glycine 0 N--CA 1.436 -1.347 0 N-CA-C 108.331 -1.908 . . . . 0.0 108.331 174.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 4.1 m -83.43 137.38 33.94 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 174.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 10.4 p-80 -135.5 138.54 43.21 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 120.496 -0.482 . . . . 0.0 110.992 -177.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 25.8 ttt -101.81 106.15 17.1 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 175.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -80.63 171.44 15.03 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 176.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 32.6 m 71.6 113.98 0.05 Allowed 'General case' 0 C--O 1.24 0.559 0 O-C-N 124.173 0.92 . . . . 0.0 109.856 -174.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 22.0 ptp -78.29 -23.82 47.0 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 21.8 m 59.45 77.92 0.29 Allowed 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 114.453 -1.249 . . . . 0.0 110.297 -176.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -91.55 112.98 4.25 Favored Glycine 0 N--CA 1.425 -2.096 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.48 -177.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -161.68 143.01 8.44 Favored Glycine 0 N--CA 1.423 -2.18 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . 0.44 ' HG3' ' HG3' ' A' ' 218' ' ' GLN . 6.6 tp60 -78.13 -61.75 1.9 Allowed 'General case' 0 C--N 1.306 -1.298 0 O-C-N 123.548 0.205 . . . . 0.0 110.651 -179.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . 0.44 ' HG3' ' HG3' ' A' ' 217' ' ' GLN . 24.6 mt-30 -121.25 77.07 1.28 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-O 121.648 0.737 . . . . 0.0 112.241 -178.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 62.6 mtm -87.34 -10.26 52.67 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 122.883 1.325 . . . . 0.0 107.609 174.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -132.76 148.65 19.33 Favored Glycine 0 N--CA 1.406 -3.305 0 N-CA-C 105.024 -3.23 . . . . 0.0 105.024 171.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 41.7 mtp-105 -74.44 -26.87 60.32 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 117.936 0.868 . . . . 0.0 111.687 -175.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -172.88 -36.45 0.03 OUTLIER Glycine 0 N--CA 1.436 -1.35 0 N-CA-C 111.046 -0.822 . . . . 0.0 111.046 179.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 23.9 m -76.39 29.45 0.12 Allowed 'General case' 0 C--N 1.31 -1.123 0 C-N-CA 123.766 0.826 . . . . 0.0 112.899 -177.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . 0.499 ' HD3' ' HB2' ' A' ' 225' ' ' GLN . 0.0 OUTLIER -97.8 -4.89 35.98 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 175.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . 0.499 ' HB2' ' HD3' ' A' ' 224' ' ' LYS . 1.8 tp60 -151.51 171.92 16.82 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 178.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 16.4 m -62.33 126.25 26.69 Favored 'General case' 0 C--N 1.314 -0.974 0 O-C-N 123.572 0.545 . . . . 0.0 110.791 -178.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -153.33 173.36 15.71 Favored 'General case' 0 C--N 1.312 -1.045 0 C-N-CA 120.451 -0.5 . . . . 0.0 111.254 -178.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.506 HG21 HD13 ' A' ' 300' ' ' LEU . 2.1 pp -137.66 156.89 32.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 C-N-CA 124.731 1.212 . . . . 0.0 109.394 -178.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.458 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 1.1 t70 -150.59 156.99 42.46 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 60.0 t80 -127.79 137.2 52.32 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 176.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -153.31 161.98 41.78 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 176.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.441 ' HE3' HG22 ' A' ' 284' ' ' THR . 56.9 mtpt -110.65 158.01 19.07 Favored 'General case' 0 C--N 1.296 -1.738 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.597 178.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -155.12 168.22 27.75 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 55.92 -124.71 34.94 Favored Glycine 0 C--N 1.321 -0.29 0 O-C-N 123.704 0.628 . . . . 0.0 113.091 177.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -122.87 100.68 7.02 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 176.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.617 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 94.0 m-20 63.02 24.55 14.59 Favored 'General case' 0 N--CA 1.476 0.834 0 O-C-N 124.16 0.912 . . . . 0.0 112.939 176.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -82.59 141.03 32.89 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 110.156 -0.313 . . . . 0.0 110.156 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -103.47 110.09 3.59 Favored Glycine 0 N--CA 1.429 -1.827 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.441 ' HA ' ' O ' ' A' ' 322' ' ' PHE . 2.0 mp -104.2 119.91 53.68 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-O 121.171 0.51 . . . . 0.0 110.223 -177.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.7 mp -104.14 114.08 42.78 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 175.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 49.2 mt-10 -89.43 142.97 27.19 Favored 'General case' 0 C--N 1.283 -2.304 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 175.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 15.3 tp -134.44 134.29 41.43 Favored 'General case' 0 C--N 1.276 -2.614 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.691 -175.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . 0.545 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -127.25 110.33 12.74 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.174 178.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -115.05 91.6 3.67 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-O 121.417 0.627 . . . . 0.0 109.891 178.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -83.48 115.32 22.02 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.895 -177.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 111.62 13.81 12.33 Favored Glycine 0 C--N 1.299 -1.527 0 CA-C-N 114.918 -1.037 . . . . 0.0 110.526 -179.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 52.8 t80 -116.08 124.18 49.76 Favored 'General case' 0 N--CA 1.431 -1.391 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -107.13 93.83 4.77 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 143.97 -157.81 27.21 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 110.843 -0.903 . . . . 0.0 110.843 177.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -113.88 148.85 40.8 Favored Pre-proline 0 C--N 1.314 -0.942 0 C-N-CA 123.06 0.544 . . . . 0.0 109.754 177.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.732 ' HB3' HD13 ' A' ' 264' ' ' LEU . 14.2 Cg_endo -74.24 172.14 16.62 Favored 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.698 2.265 . . . . 0.0 112.192 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.489 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 34.4 t70 -95.37 111.72 23.55 Favored 'General case' 0 C--N 1.286 -2.191 0 C-N-CA 124.275 1.03 . . . . 0.0 108.694 177.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 4.1 mp -104.91 128.03 58.96 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.003 0 C-N-CA 120.456 -0.498 . . . . 0.0 110.329 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . 0.433 ' HB3' ' HB ' ' A' ' 261' ' ' ILE . 14.1 t -111.43 124.58 52.55 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 174.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -102.63 102.55 12.77 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 121.14 0.495 . . . . 0.0 112.052 -173.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.5 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 78.8 mt-30 -109.8 158.47 18.11 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 172.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 50.9 m80 -73.42 -36.08 65.91 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -176.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -85.67 -16.1 40.19 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.405 -0.518 . . . . 0.0 112.241 -178.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . 0.5 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 45.4 p-80 -170.69 156.03 5.07 Favored 'General case' 0 C--O 1.221 -0.432 0 CA-C-O 121.044 0.449 . . . . 0.0 111.717 176.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.489 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 39.6 mt -106.95 141.73 21.44 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . 0.433 ' HB ' ' HB3' ' A' ' 254' ' ' SER . 3.1 mp -121.66 116.3 49.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 299' ' ' GLN . 1.9 m -112.5 139.31 37.99 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.526 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 177.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . 0.539 ' HA ' ' O ' ' A' ' 298' ' ' THR . 19.3 m -135.0 127.82 31.2 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-O 121.3 0.572 . . . . 0.0 110.855 178.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.732 HD13 ' HB3' ' A' ' 251' ' ' PRO . 1.9 mm? -97.91 106.38 18.67 Favored 'General case' 0 CA--C 1.47 -2.107 0 N-CA-C 105.862 -1.903 . . . . 0.0 105.862 176.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.564 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 31.8 mmmt -68.82 127.94 34.9 Favored 'General case' 0 N--CA 1.414 -2.247 0 O-C-N 124.309 1.006 . . . . 0.0 113.149 -174.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 62.8 t30 65.65 26.29 11.51 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 112.771 -2.013 . . . . 0.0 110.699 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 45.8 t60 -106.98 112.18 25.02 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.95 125.04 28.76 Favored 'General case' 0 C--N 1.282 -2.342 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 27.0 tp -111.14 125.32 30.82 Favored Pre-proline 0 N--CA 1.435 -1.216 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.251 176.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.485 ' HD2' HD22 ' A' ' 273' ' ' LEU . 24.1 Cg_exo -68.35 148.13 73.21 Favored 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 122.585 2.19 . . . . 0.0 111.399 170.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . 0.55 ' HB ' ' HD2' ' A' ' 293' ' ' ARG . 6.1 t -71.47 -11.1 60.7 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 121.327 0.584 . . . . 0.0 112.112 -177.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 19.3 m -79.76 -21.15 44.77 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.521 0.677 . . . . 0.0 110.366 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.485 HD22 ' HD2' ' A' ' 270' ' ' PRO . 8.0 mp -96.59 -13.24 23.04 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.391 -174.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 271' ' ' THR . 18.7 pt20 -83.01 107.55 15.69 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-O 122.023 0.916 . . . . 0.0 109.135 -178.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -134.33 176.49 8.56 Favored 'General case' 0 C--N 1.293 -1.879 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 24.1 p -133.62 138.31 45.88 Favored 'General case' 0 N--CA 1.413 -2.289 0 CA-C-O 121.395 0.617 . . . . 0.0 111.06 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.491 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 2.1 mm? -87.19 122.34 30.86 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 103.823 -2.658 . . . . 0.0 103.823 173.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -67.65 -41.02 84.46 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.486 ' HA ' ' CD1' ' A' ' 282' ' ' PHE . 14.8 p 41.65 27.25 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 C-N-CA 127.489 2.316 . . . . 0.0 114.46 173.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -82.46 135.41 35.14 Favored 'General case' 0 N--CA 1.419 -2.012 0 CA-C-N 115.325 -0.852 . . . . 0.0 108.844 177.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 3.0 t70 72.59 25.76 2.59 Favored 'General case' 0 C--N 1.312 -1.054 0 C-N-CA 125.269 1.428 . . . . 0.0 111.386 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.486 ' CD1' ' HA ' ' A' ' 279' ' ' VAL . 5.1 m-85 -88.43 -7.51 56.49 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 114.811 -1.086 . . . . 0.0 109.642 174.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? 55.09 60.64 3.33 Favored 'General case' 0 CA--C 1.509 -0.625 0 C-N-CA 124.56 1.144 . . . . 0.0 112.027 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' THR . . . . . 0.441 HG22 ' HE3' ' A' ' 232' ' ' LYS . 2.4 p -133.11 173.94 5.29 Favored Pre-proline 0 C--N 1.302 -1.47 0 N-CA-C 105.299 -2.111 . . . . 0.0 105.299 178.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . 0.617 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 6.6 Cg_exo -77.65 -5.07 15.18 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 121.954 1.769 . . . . 0.0 110.796 176.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 54.4 t -90.72 137.94 20.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.399 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -99.44 -43.45 6.54 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.786 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . 0.425 ' HA ' HG12 ' A' ' 279' ' ' VAL . 22.6 ttmm -163.07 134.79 5.07 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -178.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.491 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 44.4 t -99.08 120.18 48.07 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.329 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 176.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 32.2 m -127.01 115.32 19.03 Favored 'General case' 0 C--N 1.284 -2.259 0 O-C-N 122.111 -0.368 . . . . 0.0 111.53 -176.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.499 ' HB2' HG12 ' A' ' 228' ' ' ILE . 49.1 tp -94.17 133.84 37.25 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 176.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -130.55 134.1 46.75 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -175.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . 0.55 ' HD2' ' HB ' ' A' ' 271' ' ' THR . 3.8 ptm180 -79.41 137.95 37.45 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 173.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.559 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 23.4 tp -111.57 178.98 4.15 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.559 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 63.0 t30 -49.68 -63.72 1.02 Allowed 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 124.125 0.97 . . . . 0.0 112.517 -177.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -118.66 -2.91 10.89 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 120.673 0.273 . . . . 0.0 111.22 177.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . 0.564 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 20.6 m-20 -124.88 177.93 5.76 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.707 0.765 . . . . 0.0 110.9 -170.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.539 ' O ' ' HA ' ' A' ' 263' ' ' THR . 50.2 m -114.3 127.77 56.03 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 174.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . 0.508 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 27.8 tt0 -116.05 126.13 53.36 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -176.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.506 HD13 HG21 ' A' ' 228' ' ' ILE . 63.7 tp -110.77 120.24 41.76 Favored 'General case' 0 N--CA 1.417 -2.119 0 CA-C-O 121.164 0.507 . . . . 0.0 110.125 178.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' ILE . . . . . 0.4 HD11 HE21 ' A' ' 299' ' ' GLN . 57.8 mt -106.65 109.84 29.49 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 -177.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . 0.489 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 66.5 mt -108.01 107.78 23.65 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 178.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 18.1 m -77.77 133.46 38.25 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -178.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 12.5 p -135.18 173.85 11.26 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 122.831 0.452 . . . . 0.0 111.081 -175.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -156.28 147.08 21.93 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-O 120.526 0.203 . . . . 0.0 110.57 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 80.83 -159.23 41.75 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 115.701 -0.682 . . . . 0.0 113.651 174.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' ASN . . . . . 0.509 ' HB3' ' HB3' ' A' ' 327' ' ' LYS . 0.7 OUTLIER -90.34 123.29 33.97 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 176.141 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' TRP . . . . . . . . . . . . . 69.6 p-90 -149.12 162.79 39.27 Favored 'General case' 0 C--N 1.281 -2.381 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 -177.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.565 ' HG2' ' HE2' ' A' ' 327' ' ' LYS . 8.6 mt-10 -119.04 137.52 53.49 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -178.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 1.1 tt -104.91 118.3 36.2 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.473 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 32.4 t -118.71 107.78 22.51 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 174.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -95.75 139.35 32.11 Favored 'General case' 0 C--N 1.311 -1.109 0 C-N-CA 119.093 -1.043 . . . . 0.0 109.207 177.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -125.86 134.93 51.47 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 -177.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 28.6 t -115.74 111.88 21.2 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -80.03 -28.42 39.33 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.734 0.778 . . . . 0.0 109.82 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -166.75 160.15 11.5 Favored Pre-proline 0 C--N 1.303 -1.431 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -64.71 101.13 0.36 Allowed 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 121.66 1.573 . . . . 0.0 109.837 176.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 127.81 -27.65 4.58 Favored Glycine 0 N--CA 1.426 -1.982 0 CA-C-N 115.033 -0.985 . . . . 0.0 110.96 -176.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -108.36 118.43 36.75 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.864 -0.786 . . . . 0.0 110.818 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . 0.583 ' CZ ' ' HD3' ' A' ' 251' ' ' PRO . 48.2 m-85 -128.46 165.76 20.05 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-O 122.143 0.973 . . . . 0.0 110.902 -174.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 70.0 m -152.36 136.82 16.78 Favored 'General case' 0 C--N 1.269 -2.909 0 CA-C-N 114.518 -1.219 . . . . 0.0 107.848 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 0.441 ' O ' ' HA ' ' A' ' 239' ' ' ILE . 79.8 m-85 -119.88 117.69 28.79 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . 0.473 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 33.9 tt0 -101.55 100.26 10.66 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 91.3 t -88.79 102.03 12.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 50.8 mt -95.07 140.46 22.45 Favored Pre-proline 0 C--N 1.29 -1.988 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.161 -176.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -72.36 126.95 12.09 Favored 'Trans proline' 0 C--O 1.251 1.129 0 C-N-CA 121.431 1.421 . . . . 0.0 109.806 174.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.565 ' HE2' ' HG2' ' A' ' 309' ' ' GLU . 38.2 ttmt -95.06 105.84 17.79 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.08 147.7 23.45 Favored 'General case' 0 N--CA 1.412 -2.355 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.915 -175.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 . . . . . 0 C--N 1.292 -1.929 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.643 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 23.3 ptp . . . . . 0 CA--C 1.512 -0.498 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -146.39 -176.79 20.52 Favored Glycine 0 N--CA 1.431 -1.673 0 C-N-CA 119.915 -1.136 . . . . 0.0 112.304 -179.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 35.0 t -122.15 107.46 12.19 Favored 'General case' 0 N--CA 1.428 -1.552 0 CA-C-O 121.141 0.496 . . . . 0.0 110.381 -178.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 28.9 p -134.15 151.4 51.34 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 40.9 t60 -73.06 -47.29 45.95 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -123.05 119.05 29.18 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.784 -1.562 . . . . 0.0 106.784 175.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 -75.24 161.52 29.26 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.586 -175.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 56.87 27.85 13.62 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 125.232 1.413 . . . . 0.0 112.323 -177.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -68.99 -50.22 50.91 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 26.7 m170 57.63 -169.34 0.11 Allowed 'General case' 0 C--O 1.236 0.393 0 CA-C-N 114.835 -1.075 . . . . 0.0 113.129 178.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 113.59 -18.25 20.23 Favored Glycine 0 C--N 1.303 -1.254 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 6.0 mp -74.2 143.7 45.06 Favored 'General case' 0 C--O 1.251 1.182 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 33.8 m -79.94 143.24 57.29 Favored Pre-proline 0 C--N 1.301 -1.509 0 C-N-CA 120.351 -0.539 . . . . 0.0 109.991 -179.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . 0.423 ' HB2' ' O ' ' A' ' 208' ' ' SER . 74.5 Cg_endo -74.37 158.54 44.48 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 122.099 1.866 . . . . 0.0 111.236 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -82.91 78.62 9.47 Favored 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 83.39 -60.0 4.92 Favored Glycine 0 C--N 1.317 -0.513 0 N-CA-C 110.524 -1.03 . . . . 0.0 110.524 -177.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 205' ' ' PRO . 30.9 t -129.71 169.34 15.22 Favored 'General case' 0 N--CA 1.427 -1.622 0 N-CA-C 105.554 -2.017 . . . . 0.0 105.554 177.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 -71.21 -66.06 0.67 Allowed 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -177.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 56.7 ttp -136.33 1.05 2.61 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 121.906 0.86 . . . . 0.0 109.677 178.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -83.78 166.7 17.78 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.96 -178.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 33.3 p -75.28 101.6 4.75 Favored 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -177.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . 0.432 ' O ' ' HB ' ' A' ' 214' ' ' THR . 15.6 tpt -135.39 84.17 2.07 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 173.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.432 ' HB ' ' O ' ' A' ' 213' ' ' MET . 15.4 t 166.44 -13.29 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.199 1.4 . . . . 0.0 107.689 -176.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 100.73 -72.06 0.42 Allowed Glycine 0 N--CA 1.426 -2.003 0 N-CA-C 110.546 -1.022 . . . . 0.0 110.546 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 151.14 90.97 0.08 OUTLIER Glycine 0 N--CA 1.426 -1.994 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -178.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 78.6 mt-30 -73.57 100.48 3.32 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.566 0.698 . . . . 0.0 110.372 -178.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -83.67 124.62 31.03 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.17 -174.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 94.7 mmm -80.61 -31.64 36.57 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 176.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 94.96 -143.56 16.67 Favored Glycine 0 N--CA 1.433 -1.518 0 N-CA-C 109.596 -1.401 . . . . 0.0 109.596 -178.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -139.8 115.17 9.87 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-O 121.616 0.722 . . . . 0.0 109.314 174.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . 0.447 ' HA2' HD21 ' A' ' 227' ' ' ASN . . . 157.4 -162.75 32.12 Favored Glycine 0 N--CA 1.422 -2.238 0 N-CA-C 107.591 -2.204 . . . . 0.0 107.591 -174.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 23.3 t 69.72 -46.56 0.59 Allowed 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.231 1.012 . . . . 0.0 112.818 179.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -63.98 -62.09 1.86 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 123.453 0.701 . . . . 0.0 110.642 -178.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -162.62 168.6 21.48 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.526 HG23 ' HA ' ' A' ' 244' ' ' ALA . 59.5 m -61.39 129.72 42.59 Favored 'General case' 0 C--O 1.208 -1.125 0 C-N-CA 125.153 1.381 . . . . 0.0 111.632 -173.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.447 HD21 ' HA2' ' A' ' 222' ' ' GLY . 9.6 p30 -157.3 171.59 20.13 Favored 'General case' 0 CA--C 1.488 -1.43 0 CA-C-O 121.022 0.439 . . . . 0.0 110.462 -176.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.614 HG21 HD13 ' A' ' 300' ' ' LEU . 2.8 pp -130.27 155.65 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.199 179.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.487 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 18.8 t0 -144.64 156.27 44.03 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 -177.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.451 ' CE2' HG21 ' A' ' 279' ' ' VAL . 61.8 t80 -131.91 138.6 48.45 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 175.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 17.0 ptm180 -155.11 157.55 37.65 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -104.57 151.86 23.11 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.603 175.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -168.05 -174.87 2.47 Favored 'General case' 0 C--N 1.305 -1.326 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 61.81 -117.88 12.92 Favored Glycine 0 N--CA 1.445 -0.761 0 O-C-N 123.446 0.466 . . . . 0.0 113.03 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . 0.415 ' HE2' ' HB2' ' A' ' 235' ' ' LYS . 13.7 tppt? -126.96 79.91 1.91 Allowed 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 -178.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 66.4 m-20 58.9 29.26 18.63 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.557 0.694 . . . . 0.0 111.249 -177.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.436 ' HB2' HD23 ' A' ' 325' ' ' LEU . . . -84.24 148.44 26.71 Favored 'General case' 0 N--CA 1.416 -2.168 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.305 -176.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -98.81 108.17 3.55 Favored Glycine 0 N--CA 1.418 -2.534 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.451 HG13 ' HG3' ' A' ' 323' ' ' GLN . 2.6 mp -101.49 118.84 48.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-N 117.391 0.596 . . . . 0.0 110.193 -177.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.8 mp -104.73 110.94 32.3 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.401 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 176.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.487 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 41.2 mt-10 -87.83 143.23 27.25 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 173.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 14.5 tp -132.12 125.97 32.59 Favored 'General case' 0 C--N 1.273 -2.719 0 CA-C-O 121.52 0.676 . . . . 0.0 111.044 -174.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . 0.48 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -113.73 105.73 13.65 Favored 'General case' 0 N--CA 1.418 -2.074 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.526 ' HA ' HG23 ' A' ' 226' ' ' THR . . . -112.32 91.72 3.76 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 121.601 0.715 . . . . 0.0 109.119 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -81.73 112.52 18.97 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.398 -173.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 107.97 3.41 34.04 Favored Glycine 0 N--CA 1.427 -1.936 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.378 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . 0.457 ' CD2' HD12 ' A' ' 264' ' ' LEU . 37.8 t80 -115.82 107.96 15.7 Favored 'General case' 0 C--O 1.212 -0.908 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -102.22 3.28 38.13 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.006 0.431 . . . . 0.0 112.093 -177.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -95.35 -153.74 30.3 Favored Glycine 0 C--N 1.308 -1.012 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.638 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 82.3 mm-40 -116.16 137.64 23.6 Favored Pre-proline 0 C--N 1.303 -1.435 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 177.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.774 ' HB3' HD13 ' A' ' 264' ' ' LEU . 17.4 Cg_endo -71.83 172.09 15.22 Favored 'Trans proline' 0 N--CA 1.439 -1.711 0 C-N-CA 122.029 1.819 . . . . 0.0 110.904 175.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -99.94 109.57 21.92 Favored 'General case' 0 C--N 1.275 -2.659 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 176.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 4.0 mp -100.11 124.19 53.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 CA-C-O 121.079 0.466 . . . . 0.0 110.131 -179.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 9.4 t -113.31 106.03 14.12 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 174.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 78.9 mt-30 -79.87 103.74 9.97 Favored 'General case' 0 CA--C 1.503 -0.862 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.677 178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.512 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 77.8 mt-30 -124.16 152.06 43.28 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 175.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 37.5 m80 -71.07 -42.44 69.4 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -173.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -76.07 -24.63 55.1 Favored 'General case' 0 C--N 1.314 -0.978 0 O-C-N 123.442 0.464 . . . . 0.0 111.523 -176.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . 0.512 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 43.0 p-80 -170.19 158.38 6.82 Favored 'General case' 0 CA--C 1.501 -0.918 0 CA-C-O 120.549 0.214 . . . . 0.0 110.898 175.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 16.6 mt -105.94 141.45 21.23 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.934 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . 0.42 HD12 ' N ' ' A' ' 261' ' ' ILE . 3.1 mp -116.81 113.11 41.98 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 177.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.432 ' HB ' ' HB3' ' A' ' 300' ' ' LEU . 54.6 t -113.6 115.91 51.09 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 176.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . 0.584 ' HA ' ' O ' ' A' ' 298' ' ' THR . 41.6 m -121.65 126.24 48.55 Favored 'General case' 0 C--N 1.285 -2.196 0 CA-C-O 121.48 0.657 . . . . 0.0 112.218 -177.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.774 HD13 ' HB3' ' A' ' 251' ' ' PRO . 1.6 mm? -94.38 104.09 16.08 Favored 'General case' 0 N--CA 1.414 -2.232 0 N-CA-C 105.744 -1.947 . . . . 0.0 105.744 177.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.588 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 30.1 mtpt -69.05 127.57 33.6 Favored 'General case' 0 N--CA 1.41 -2.446 0 O-C-N 124.204 0.94 . . . . 0.0 113.487 -173.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 64.4 t30 68.26 16.66 9.33 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 113.817 -1.538 . . . . 0.0 111.386 179.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' HIS . . . . . 0.44 ' ND1' ' HB2' ' A' ' 247' ' ' PHE . 54.6 t60 -95.46 107.74 19.91 Favored 'General case' 0 C--O 1.213 -0.821 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 174.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 1.2 p -82.92 109.79 17.34 Favored 'General case' 0 C--N 1.277 -2.563 0 CA-C-O 120.889 0.376 . . . . 0.0 111.618 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . 0.413 HD22 HD22 ' A' ' 291' ' ' LEU . 23.4 tp -93.22 127.49 46.71 Favored Pre-proline 0 N--CA 1.436 -1.128 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.543 178.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -68.54 159.31 54.05 Favored 'Trans proline' 0 C--N 1.315 -1.223 0 C-N-CA 122.381 2.054 . . . . 0.0 111.544 171.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 19.6 p -66.69 -37.13 84.11 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.063 0.459 . . . . 0.0 111.544 -177.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 3.0 m -59.21 -19.35 44.7 Favored 'General case' 0 CA--C 1.557 1.24 0 C-N-CA 124.66 1.184 . . . . 0.0 112.456 -178.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -95.96 -12.82 24.45 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 122.195 -0.316 . . . . 0.0 111.044 -176.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -72.31 142.11 48.85 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -163.86 155.38 16.52 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 175.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 16.6 m -122.84 123.7 41.6 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 178.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 64.4 mt -95.17 113.27 24.93 Favored 'General case' 0 C--N 1.287 -2.116 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -177.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -76.81 81.5 3.4 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-O 121.937 0.875 . . . . 0.0 108.95 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.48 HG23 ' CG ' ' A' ' 282' ' ' PHE 0.282 1.5 p -98.37 69.75 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 CA-C-O 123.723 1.725 . . . . 0.0 111.642 -178.532 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -114.69 145.67 41.78 Favored 'General case' 0 N--CA 1.419 -1.993 0 CA-C-N 113.026 -1.897 . . . . 0.0 106.846 177.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 23.3 t70 68.19 18.22 9.3 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 122.494 1.14 . . . . 0.0 110.879 -178.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.48 ' CG ' HG23 ' A' ' 279' ' ' VAL . 31.2 m-85 -86.18 -13.84 45.79 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.599 -0.688 . . . . 0.0 109.344 174.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.79 60.62 1.55 Allowed 'General case' 0 CA--C 1.493 -1.22 0 C-N-CA 123.606 0.762 . . . . 0.0 110.822 -178.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -137.02 168.94 14.68 Favored Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 104.109 -2.552 . . . . 0.0 104.109 178.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -71.06 -13.19 31.24 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 121.482 1.455 . . . . 0.0 111.773 176.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 47.1 t -85.88 132.39 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 123.428 0.691 . . . . 0.0 109.343 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -101.57 -29.2 12.09 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.405 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -171.92 134.32 0.77 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.736 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 59.8 t -96.69 132.12 41.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 173.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.42 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 98.8 m -136.72 117.49 14.05 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.803 -0.56 . . . . 0.0 111.772 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.523 ' HB2' HG12 ' A' ' 228' ' ' ILE . 0.1 OUTLIER -97.41 116.77 30.24 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 179.385 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 17.7 tppt? -126.21 136.45 52.84 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -78.74 144.44 35.22 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 176.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.583 HD13 ' N ' ' A' ' 295' ' ' ASN . 2.6 tm? -118.06 163.25 16.89 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 105.942 -1.874 . . . . 0.0 105.942 -178.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.583 ' N ' HD13 ' A' ' 294' ' ' LEU . 4.5 t30 -29.39 -58.33 0.15 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 126.355 1.862 . . . . 0.0 113.754 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -124.58 -6.31 7.52 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . 0.588 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 6.0 m-20 -125.39 174.63 8.04 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-N 115.042 -0.981 . . . . 0.0 110.595 -160.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 263' ' ' THR . 56.1 m -115.34 120.09 38.45 Favored 'General case' 0 C--N 1.283 -2.297 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 175.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -110.92 117.31 33.03 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-O 121.696 0.76 . . . . 0.0 109.747 -176.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.614 HD13 HG21 ' A' ' 228' ' ' ILE . 46.1 tp -103.53 117.97 35.67 Favored 'General case' 0 C--N 1.263 -3.188 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' ILE . . . . . 0.42 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 63.3 mt -102.38 109.74 27.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.345 0 CA-C-N 114.566 -1.197 . . . . 0.0 107.88 -177.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 58.0 mt -108.71 100.3 10.47 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 27.7 m -72.52 132.17 43.48 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -178.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 7.4 p -138.49 174.82 10.14 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 123.482 0.713 . . . . 0.0 110.498 -176.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -158.55 137.43 11.27 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-N 117.514 0.143 . . . . 0.0 110.996 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 91.66 -157.68 24.7 Favored Glycine 0 N--CA 1.442 -0.908 0 O-C-N 123.508 0.505 . . . . 0.0 112.836 174.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' ASN . . . . . 0.414 ' HB3' ' HB3' ' A' ' 327' ' ' LYS . 76.5 m-20 -93.2 124.07 36.92 Favored 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 178.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' TRP . . . . . 0.465 ' CE3' HG13 ' A' ' 324' ' ' VAL . 70.3 p-90 -148.32 166.09 29.07 Favored 'General case' 0 C--N 1.282 -2.361 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -178.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -124.32 130.26 52.18 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -175.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 1.7 tt -100.73 122.67 43.75 Favored 'General case' 0 C--N 1.311 -1.09 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -179.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.598 HG13 ' HB3' ' A' ' 323' ' ' GLN . 7.6 p -123.34 114.77 43.22 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.612 171.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -98.32 144.82 27.31 Favored 'General case' 0 N--CA 1.424 -1.748 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.037 -178.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -131.58 141.06 49.59 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -178.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 78.0 p -111.64 115.43 29.11 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 173.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -76.16 -35.85 59.01 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 178.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -166.84 162.92 11.0 Favored Pre-proline 0 C--N 1.309 -1.19 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -65.77 97.06 0.32 Allowed 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.712 1.608 . . . . 0.0 110.177 176.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 129.37 -15.23 5.8 Favored Glycine 0 N--CA 1.439 -1.116 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -176.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 84.2 m-85 -122.58 116.33 23.68 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 122.372 -0.487 . . . . 0.0 109.821 178.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -124.31 164.6 19.26 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 121.827 0.823 . . . . 0.0 110.661 -175.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 91.3 m -152.44 135.71 15.83 Favored 'General case' 0 C--N 1.267 -3.002 0 CA-C-N 114.871 -1.058 . . . . 0.0 108.846 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -124.06 117.86 25.66 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . 0.598 ' HB3' HG13 ' A' ' 311' ' ' VAL . 45.8 tt0 -102.26 103.43 13.91 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.465 HG13 ' CE3' ' A' ' 308' ' ' TRP . 92.7 t -87.13 98.94 7.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.507 HD21 HE21 ' A' ' 323' ' ' GLN . 32.1 mt -87.47 143.57 34.33 Favored Pre-proline 0 C--N 1.294 -1.813 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.667 -177.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -75.6 132.55 14.75 Favored 'Trans proline' 0 N--CA 1.458 -0.618 0 C-N-CA 121.93 1.753 . . . . 0.0 109.965 173.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.414 ' HB3' ' HB3' ' A' ' 307' ' ' ASN . 23.6 ttmm -97.09 101.26 12.79 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 120.056 -0.657 . . . . 0.0 110.417 -178.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 49.3 tptt -98.54 109.02 21.85 Favored 'General case' 0 C--N 1.28 -2.429 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 173.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 . . . . . 0 N--CA 1.419 -1.992 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 179.719 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 96.9 mmm . . . . . 0 CA--C 1.507 -0.693 0 CA-C-O 120.887 0.375 . . . . 0.0 110.107 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -117.13 -20.64 4.75 Favored Glycine 0 N--CA 1.436 -1.318 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.608 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 18.5 p -77.05 -30.16 55.52 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.21 0.529 . . . . 0.0 110.952 178.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 42.8 t -146.71 133.26 19.79 Favored 'General case' 0 N--CA 1.419 -1.978 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.993 -178.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -98.98 4.96 47.37 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 173.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 35.2 m-70 -69.29 -52.49 26.93 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 51.9 t60 -90.16 69.81 7.22 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-O 121.988 0.899 . . . . 0.0 108.933 178.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 21.2 t-160 -150.16 12.82 0.76 Allowed 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -178.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -115.8 159.42 21.49 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.201 -0.908 . . . . 0.0 108.679 -174.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -148.41 102.74 3.36 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 177.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 85.02 176.23 50.79 Favored Glycine 0 C--O 1.248 0.988 0 N-CA-C 110.988 -0.845 . . . . 0.0 110.988 -177.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 6.0 tt -84.97 -49.75 8.06 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 36.0 m -100.91 152.74 37.92 Favored Pre-proline 0 C--N 1.308 -1.198 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 176.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -69.53 95.07 0.52 Allowed 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 121.96 1.773 . . . . 0.0 111.745 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 32.2 tpt180 -80.91 94.92 6.59 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -178.39 71.99 0.07 OUTLIER Glycine 0 N--CA 1.419 -2.464 0 N-CA-C 110.377 -1.089 . . . . 0.0 110.377 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 30.9 p -79.76 92.59 5.45 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.234 0.54 . . . . 0.0 109.854 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -134.47 -45.51 0.75 Allowed 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.68 -177.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 58.1 ttp -147.56 107.88 4.08 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 120.406 -0.517 . . . . 0.0 111.214 -177.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -118.23 116.1 26.11 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 173.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 215' ' ' GLY . 49.2 m -85.75 109.53 18.7 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-O 121.081 0.467 . . . . 0.0 111.99 -176.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 16.6 tpt -171.66 -79.3 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 124.322 1.049 . . . . 0.0 109.303 175.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 13.5 t -85.19 -3.35 58.78 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 122.041 0.924 . . . . 0.0 109.522 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 212' ' ' SER . . . -172.67 -164.6 28.39 Favored Glycine 0 N--CA 1.405 -3.371 0 N-CA-C 107.003 -2.439 . . . . 0.0 107.003 179.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 128.2 -24.22 5.07 Favored Glycine 0 C--N 1.294 -1.773 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.806 178.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 65.21 80.28 0.23 Allowed 'General case' 0 C--O 1.25 1.126 0 C-N-CA 124.106 0.962 . . . . 0.0 111.107 178.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -79.64 171.48 15.08 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.008 -0.996 . . . . 0.0 108.943 176.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 63.0 mtt -80.13 74.11 6.93 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.535 0.683 . . . . 0.0 110.273 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -168.34 53.53 0.22 Allowed Glycine 0 C--N 1.292 -1.896 0 N-CA-C 108.16 -1.976 . . . . 0.0 108.16 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -65.82 113.02 4.03 Favored 'General case' 0 C--O 1.247 0.966 0 CA-C-N 114.332 -0.934 . . . . 0.0 110.696 -175.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -79.37 58.94 4.39 Favored Glycine 0 C--O 1.219 -0.786 0 N-CA-C 111.65 -0.58 . . . . 0.0 111.65 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 39.9 m -137.37 17.3 2.95 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.613 0.721 . . . . 0.0 109.961 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -126.53 17.86 7.52 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 122.943 1.354 . . . . 0.0 107.445 176.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . 0.421 ' O ' HD23 ' A' ' 245' ' ' LEU . 3.9 pt20 -152.5 152.56 32.07 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 -177.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.575 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 21.2 m -64.48 116.28 5.98 Favored 'General case' 0 C--N 1.313 -0.993 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 176.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -148.68 158.19 43.97 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.301 -170.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.624 HG21 HD21 ' A' ' 300' ' ' LEU . 2.7 pp -137.04 147.61 26.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -142.02 157.27 45.13 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 123.533 0.733 . . . . 0.0 109.991 -174.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.542 ' CD1' HG11 ' A' ' 279' ' ' VAL . 56.3 t80 -133.21 138.52 46.57 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.217 0.532 . . . . 0.0 111.254 179.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -155.94 164.53 38.37 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 172.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.423 ' HE3' HG22 ' A' ' 284' ' ' THR . 55.7 mtpt -104.48 162.58 13.12 Favored 'General case' 0 C--N 1.294 -1.814 0 C-N-CA 121.11 -0.236 . . . . 0.0 110.929 178.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . 0.52 ' O ' ' HB3' ' A' ' 237' ' ' ALA . 15.8 t70 -157.97 125.62 5.21 Favored 'General case' 0 CA--C 1.507 -0.701 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 81.53 -126.63 7.5 Favored Glycine 0 C--N 1.297 -1.586 0 C-N-CA 121.143 -0.551 . . . . 0.0 113.441 174.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -105.14 90.9 3.58 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -174.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.539 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 17.6 m120 62.83 17.15 9.68 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.023 -0.99 . . . . 0.0 112.724 175.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.52 ' HB3' ' O ' ' A' ' 233' ' ' ASP . . . -83.51 140.93 31.99 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -176.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . 0.431 ' C ' HD12 ' A' ' 239' ' ' ILE . . . -101.64 130.27 10.18 Favored Glycine 0 N--CA 1.432 -1.596 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 178.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.449 ' O ' ' HA ' ' A' ' 230' ' ' PHE . 2.3 mp -118.45 117.28 54.07 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 CA-C-N 117.651 0.725 . . . . 0.0 110.985 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.0 mp -104.16 109.43 27.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 176.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -91.39 118.23 30.35 Favored 'General case' 0 C--N 1.285 -2.225 0 CA-C-O 121.558 0.694 . . . . 0.0 109.348 178.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 9.8 tp -108.7 117.06 33.19 Favored 'General case' 0 C--N 1.272 -2.775 0 CA-C-N 114.737 -1.12 . . . . 0.0 110.754 -175.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . 0.575 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -103.19 94.4 5.5 Favored 'General case' 0 C--N 1.281 -2.401 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 176.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -101.92 90.93 4.15 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-O 121.69 0.757 . . . . 0.0 109.455 -178.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.421 HD23 ' O ' ' A' ' 225' ' ' GLN . 3.6 mm? -88.09 115.29 25.46 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.672 0.749 . . . . 0.0 110.804 -177.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 123.21 -8.27 9.07 Favored Glycine 0 N--CA 1.423 -2.178 0 CA-C-N 114.465 -1.243 . . . . 0.0 110.517 -176.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . 0.474 ' CD2' HD12 ' A' ' 264' ' ' LEU . 30.4 t80 -115.4 127.0 55.07 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -109.4 -19.15 13.37 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 120.763 -0.375 . . . . 0.0 111.901 -177.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -87.48 -140.99 6.8 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.921 -177.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -125.14 132.37 24.3 Favored Pre-proline 0 C--N 1.314 -0.943 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.718 ' HB3' HD13 ' A' ' 264' ' ' LEU . 14.1 Cg_endo -69.63 171.68 13.89 Favored 'Trans proline' 0 C--N 1.354 0.848 0 C-N-CA 122.534 2.156 . . . . 0.0 111.679 179.36 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.619 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 33.3 t70 -91.32 105.88 18.1 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 176.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.544 HD11 ' HG2' ' A' ' 251' ' ' PRO . 5.2 mp -101.74 108.99 24.84 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.636 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . 0.538 ' HB3' ' HB ' ' A' ' 261' ' ' ILE . 23.3 t -91.18 112.17 23.97 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -89.42 103.22 15.87 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.204 0.526 . . . . 0.0 111.241 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.634 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 13.9 mm100 -119.51 154.94 33.05 Favored 'General case' 0 C--N 1.294 -1.843 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 177.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . 0.426 ' HA ' ' HE1' ' A' ' 308' ' ' TRP . 37.4 m80 -76.67 -30.91 56.98 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-O 121.329 0.585 . . . . 0.0 109.662 179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -68.3 -39.48 82.05 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.681 -1.145 . . . . 0.0 112.151 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . 0.634 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 39.5 p-80 -175.6 166.82 3.23 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.402 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 20.7 mt -105.87 133.21 50.89 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 106.552 -1.648 . . . . 0.0 106.552 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . 0.538 ' HB ' ' HB3' ' A' ' 254' ' ' SER . 3.4 mp -114.96 115.9 50.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 179.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.619 ' HA ' ' O ' ' A' ' 252' ' ' ASP . 0.8 OUTLIER -113.89 140.64 33.35 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 177.394 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . 0.572 ' HA ' ' O ' ' A' ' 298' ' ' THR . 20.2 m -134.09 124.04 25.48 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-O 121.517 0.675 . . . . 0.0 111.887 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.718 HD13 ' HB3' ' A' ' 251' ' ' PRO . 1.8 mm? -98.14 108.12 20.75 Favored 'General case' 0 N--CA 1.422 -1.836 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.482 ' HD3' ' OD1' ' A' ' 297' ' ' ASP . 59.4 mmtt -67.28 131.49 45.85 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 124.213 0.946 . . . . 0.0 113.549 -177.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 19.4 t-20 73.68 6.75 5.0 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 113.565 -1.652 . . . . 0.0 110.357 176.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -95.72 99.61 11.43 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.084 -174.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 19.3 p -77.56 108.96 11.11 Favored 'General case' 0 N--CA 1.42 -1.959 0 CA-C-O 121.224 0.535 . . . . 0.0 111.03 -178.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . 0.452 HD12 ' HD2' ' A' ' 270' ' ' PRO . 30.1 tp -89.92 128.38 50.27 Favored Pre-proline 0 N--CA 1.43 -1.438 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.12 179.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.452 ' HD2' HD12 ' A' ' 269' ' ' LEU . 16.0 Cg_exo -70.83 157.7 57.6 Favored 'Trans proline' 0 N--CA 1.447 -1.208 0 C-N-CA 122.643 2.228 . . . . 0.0 111.905 171.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . 0.474 ' HA ' ' OE1' ' A' ' 274' ' ' GLN . 6.7 p -66.87 -38.35 86.17 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.582 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 11.4 m -59.88 -26.3 65.77 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 124.656 1.182 . . . . 0.0 112.516 -178.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 8.5 mp -96.27 2.48 52.93 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.566 0.698 . . . . 0.0 110.814 -172.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.627 HE21 ' HA ' ' A' ' 292' ' ' LYS . 50.7 mt-30 -84.45 123.54 30.36 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.121 178.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . 0.534 ' HD2' ' O ' ' A' ' 228' ' ' ILE . 3.7 ptp180 -137.33 162.4 33.68 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 177.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 289' ' ' VAL . 24.5 t -139.86 126.77 20.79 Favored 'General case' 0 N--CA 1.425 -1.682 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.528 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 1.1 mm? -98.16 111.43 23.76 Favored 'General case' 0 C--N 1.309 -1.166 0 C-N-CA 124.925 1.29 . . . . 0.0 108.728 -176.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -86.62 92.68 8.99 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.542 HG11 ' CD1' ' A' ' 230' ' ' PHE . 11.8 m -102.32 28.03 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 CA-C-N 114.404 -1.271 . . . . 0.0 112.187 -175.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -67.4 140.49 57.18 Favored 'General case' 0 N--CA 1.403 -2.82 0 CA-C-N 114.062 -1.427 . . . . 0.0 107.591 174.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 34.4 t70 73.71 4.02 4.62 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 124.892 1.277 . . . . 0.0 113.119 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -75.61 -3.32 33.76 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.475 -0.766 . . . . 0.0 111.492 174.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm 60.64 58.41 2.45 Favored 'General case' 0 CA--C 1.504 -0.81 0 C-N-CA 124.171 0.989 . . . . 0.0 111.007 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 236' ' ' ASN . 1.4 p -136.57 168.47 16.87 Favored Pre-proline 0 N--CA 1.428 -1.546 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 15.7 Cg_exo -71.58 -14.58 30.52 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 121.863 1.709 . . . . 0.0 110.892 176.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 21.4 t -84.18 139.75 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 25.7 mm-40 -103.18 -45.36 4.94 Favored 'General case' 0 C--N 1.275 -2.66 0 CA-C-N 115.257 -0.883 . . . . 0.0 109.164 -179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 277' ' ' LEU . 7.3 ttpm? -163.22 137.61 6.18 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.437 -179.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.528 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 39.9 t -100.67 122.75 53.05 Favored 'Isoleucine or valine' 0 C--O 1.204 -1.34 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 57.7 m -129.26 124.81 35.39 Favored 'General case' 0 C--N 1.28 -2.433 0 CA-C-O 121.217 0.532 . . . . 0.0 110.98 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.612 ' HB2' HG12 ' A' ' 228' ' ' ILE . 45.8 tp -100.04 113.38 25.94 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 176.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.627 ' HA ' HE21 ' A' ' 274' ' ' GLN . 40.8 ttmt -115.23 129.34 56.61 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 -178.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . 0.455 ' H ' ' NE2' ' A' ' 274' ' ' GLN . 13.8 ptt180 -72.95 142.83 47.82 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 175.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.585 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 19.3 tp -108.38 -173.46 2.28 Favored 'General case' 0 C--N 1.274 -2.692 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.585 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 3.8 t-20 -52.57 -64.02 0.95 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.327 0.584 . . . . 0.0 112.079 -177.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -125.07 -3.49 7.57 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.817 0.818 . . . . 0.0 109.323 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . 0.482 ' OD1' ' HD3' ' A' ' 265' ' ' LYS . 49.6 m-20 -117.05 171.72 7.74 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.34 -0.846 . . . . 0.0 110.054 -175.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.572 ' O ' ' HA ' ' A' ' 263' ' ' THR . 27.2 m -108.05 133.7 51.98 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . 0.614 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 8.2 tt0 -121.44 131.71 54.32 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 118.462 0.574 . . . . 0.0 111.304 -177.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.624 HD21 HG21 ' A' ' 228' ' ' ILE . 9.1 mt -100.45 135.41 41.93 Favored 'General case' 0 CA--C 1.45 -2.902 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.39 170.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 62.6 mt -121.18 108.11 21.83 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 173.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . 0.402 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 56.0 mt -113.22 97.8 6.18 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.733 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.416 ' HA ' ' HB3' ' A' ' 259' ' ' HIS . 13.7 m -67.7 130.31 42.62 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -176.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 16.8 p -133.26 167.58 20.12 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 123.279 0.362 . . . . 0.0 110.671 -177.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -152.58 141.0 20.66 Favored 'General case' 0 C--O 1.248 0.976 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 177.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 87.24 -168.22 38.43 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 121.376 -0.44 . . . . 0.0 112.259 178.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -86.48 131.96 34.05 Favored 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 177.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' TRP . . . . . 0.711 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 63.4 p-90 -150.34 164.08 36.72 Favored 'General case' 0 N--CA 1.418 -2.036 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.119 -177.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.404 ' O ' ' HA ' ' A' ' 324' ' ' VAL . 10.2 mt-10 -122.21 135.45 54.77 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 -178.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.711 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 19.8 tp -107.28 115.26 29.86 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.406 -178.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 28.3 t -116.22 105.26 18.04 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 174.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . 0.405 ' HA ' ' O ' ' A' ' 321' ' ' THR . 25.6 t30 -98.45 134.39 41.5 Favored 'General case' 0 CA--C 1.432 -3.574 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 177.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 54.4 mttm -119.38 120.58 37.3 Favored 'General case' 1 N--CA 1.362 -4.826 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.541 -177.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 39.2 m -82.97 103.53 12.5 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 172.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -71.74 -31.71 66.96 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.992 -177.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.469 ' HB1' ' HD2' ' A' ' 317' ' ' PRO . . . -170.12 166.55 5.24 Favored Pre-proline 0 C--N 1.311 -1.09 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 -178.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . 0.469 ' HD2' ' HB1' ' A' ' 316' ' ' ALA . 23.2 Cg_endo -60.02 104.78 0.25 Allowed 'Trans proline' 0 C--O 1.246 0.913 0 C-N-CA 121.988 1.792 . . . . 0.0 112.137 178.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 107.77 -13.83 38.34 Favored Glycine 0 N--CA 1.44 -1.092 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.134 -178.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . 0.402 ' CD1' ' HB3' ' A' ' 316' ' ' ALA . 97.7 m-85 -108.56 116.19 31.51 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.991 -0.711 . . . . 0.0 109.136 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . 0.489 ' CZ ' ' HD3' ' A' ' 251' ' ' PRO . 83.5 m-85 -121.49 160.34 24.4 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.593 0.711 . . . . 0.0 110.137 -176.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.405 ' O ' ' HA ' ' A' ' 312' ' ' ASN . 94.8 m -152.96 105.88 2.98 Favored 'General case' 0 C--N 1.273 -2.738 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.335 -175.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -94.1 110.47 22.18 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 -178.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . 0.533 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 51.2 tt0 -97.63 99.98 11.37 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 176.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.41 HG23 ' CE3' ' A' ' 308' ' ' TRP . 0.1 OUTLIER -96.26 104.07 15.43 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.323 0 CA-C-O 122.642 1.21 . . . . 0.0 110.052 179.258 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 21.3 mt -95.22 149.54 36.35 Favored Pre-proline 0 C--N 1.296 -1.745 0 CA-C-N 113.238 -1.801 . . . . 0.0 109.555 -174.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -76.35 123.84 7.38 Favored 'Trans proline' 0 C--O 1.247 0.971 0 C-N-CA 121.78 1.653 . . . . 0.0 109.937 173.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -85.55 108.05 17.76 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.363 -176.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -133.01 4.31 3.78 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.715 -0.794 . . . . 0.0 110.897 174.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 . . . . . 0 C--N 1.287 -2.137 0 CA-C-N 113.646 -1.616 . . . . 0.0 107.01 -179.513 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 53.9 tpp . . . . . 0 N--CA 1.446 -0.651 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -89.2 -125.45 2.64 Favored Glycine 0 N--CA 1.429 -1.791 0 N-CA-C 110.398 -1.081 . . . . 0.0 110.398 177.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 21.6 p -69.72 140.18 53.46 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 15.6 m -96.08 -169.53 1.94 Allowed 'General case' 0 N--CA 1.426 -1.628 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.392 -177.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -74.1 126.08 29.76 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 -175.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -101.51 135.8 42.43 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.98 -174.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 11.3 t60 -91.97 -38.91 11.98 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 175.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -83.39 90.74 7.22 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . 0.459 ' C ' ' HG2' ' A' ' 205' ' ' PRO . 24.5 t-80 -166.32 25.69 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.484 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 16.7 p80 -150.41 173.77 13.65 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 122.024 -0.423 . . . . 0.0 110.486 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 84.65 -61.09 4.74 Favored Glycine 0 C--O 1.226 -0.35 0 C-N-CA 121.641 -0.314 . . . . 0.0 113.249 175.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 4.6 mp -83.67 17.36 2.29 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 123.098 0.559 . . . . 0.0 111.458 -176.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . 0.293 33.8 m 43.18 68.85 2.63 Favored Pre-proline 0 N--CA 1.476 0.835 0 C-N-CA 124.977 1.311 . . . . 0.0 112.396 -173.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . 0.459 ' HG2' ' C ' ' A' ' 200' ' ' HIS . 2.7 Cg_exo -80.49 39.96 0.92 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 123.982 3.122 . . . . 0.0 113.519 -173.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -80.67 127.55 32.61 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 176.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -58.6 102.52 0.27 Allowed Glycine 0 N--CA 1.435 -1.394 0 N-CA-C 110.501 -1.04 . . . . 0.0 110.501 178.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 19.4 m -80.74 16.28 1.47 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.844 0.831 . . . . 0.0 111.974 -173.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 72.7 m-70 -108.26 17.67 21.95 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 172.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 26.0 mmt 70.21 82.19 0.16 Allowed 'General case' 0 CA--C 1.503 -0.829 0 C-N-CA 125.881 1.672 . . . . 0.0 111.787 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -93.34 36.55 1.06 Allowed 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.513 -1.222 . . . . 0.0 110.055 -177.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 2.1 p -73.02 -40.75 64.91 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.558 0.694 . . . . 0.0 110.224 178.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 95.8 mmm -126.19 84.21 2.25 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 175.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 29.0 m -78.23 -45.74 22.17 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.767 -178.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 139.19 171.56 12.26 Favored Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 -179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -74.52 -33.33 56.3 Favored Glycine 0 C--O 1.245 0.817 0 N-CA-C 111.758 -0.537 . . . . 0.0 111.758 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -89.07 138.43 31.42 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -84.28 -38.88 19.89 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.448 -1.315 . . . . 0.0 107.448 174.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 42.4 ttm -109.24 87.24 2.45 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 176.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 132.66 166.7 11.57 Favored Glycine 0 C--N 1.294 -1.768 0 C-N-CA 120.167 -1.016 . . . . 0.0 111.434 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 42.9 mtp-105 -138.17 32.07 2.39 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.558 -0.904 . . . . 0.0 108.558 -177.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 112.89 -25.17 11.93 Favored Glycine 0 CA--C 1.497 -1.068 0 N-CA-C 108.462 -1.855 . . . . 0.0 108.462 -175.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 19.8 m -135.89 163.11 31.0 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 174.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . 0.54 ' H ' ' HG ' ' A' ' 245' ' ' LEU . 4.7 tmmm? -159.83 -79.16 0.06 Allowed 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -177.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . 0.427 ' HG2' HD11 ' A' ' 273' ' ' LEU . 7.1 tt0 175.09 168.63 0.3 Allowed 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 104.254 -2.499 . . . . 0.0 104.254 178.453 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.554 ' O ' HD13 ' A' ' 273' ' ' LEU . 11.0 m -64.88 147.72 52.78 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 118.454 0.57 . . . . 0.0 111.05 -179.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -173.92 169.42 4.08 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 120.919 0.39 . . . . 0.0 110.323 173.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.443 HG21 HD13 ' A' ' 300' ' ' LEU . 2.8 pp -124.25 158.81 30.61 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.721 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.552 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 4.4 t70 -150.38 156.21 41.07 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -178.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -138.37 136.51 36.4 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 118.145 0.429 . . . . 0.0 111.368 177.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 13.0 ptt180 -149.43 166.38 29.25 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.573 173.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 11.7 mmmm -103.92 139.72 38.69 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 177.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -151.39 169.57 21.69 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 59.3 -129.51 49.26 Favored Glycine 0 C--N 1.304 -1.233 0 N-CA-C 114.275 0.47 . . . . 0.0 114.275 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -118.33 89.44 3.12 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 123.889 0.876 . . . . 0.0 109.506 -176.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 54.08 33.8 18.52 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 122.221 1.01 . . . . 0.0 112.338 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -94.3 140.55 29.64 Favored 'General case' 0 N--CA 1.405 -2.685 0 CA-C-N 114.124 -1.398 . . . . 0.0 108.496 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . 0.407 ' O ' HG13 ' A' ' 324' ' ' VAL . . . -100.77 124.64 8.32 Favored Glycine 0 N--CA 1.422 -2.285 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.2 mp -112.62 118.34 57.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-N 117.602 0.701 . . . . 0.0 110.416 -177.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.0 mp -105.02 112.44 38.64 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.195 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 177.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.552 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 52.8 mt-10 -90.34 142.47 27.69 Favored 'General case' 0 C--N 1.279 -2.47 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 174.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 11.8 tp -129.99 117.82 20.65 Favored 'General case' 0 C--N 1.265 -3.074 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.275 -175.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . 0.55 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -103.89 106.24 16.68 Favored 'General case' 0 C--N 1.282 -2.345 0 N-CA-C 107.362 -1.348 . . . . 0.0 107.362 177.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -117.88 90.36 3.32 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 121.603 0.716 . . . . 0.0 110.228 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.54 ' HG ' ' H ' ' A' ' 224' ' ' LYS . 3.9 mm? -87.0 113.91 23.16 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.4 -178.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 122.4 1.31 10.16 Favored Glycine 0 N--CA 1.43 -1.733 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -176.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -115.54 128.99 56.38 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -104.68 -30.82 9.69 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -176.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -94.26 -141.92 11.82 Favored Glycine 0 CA--C 1.493 -1.34 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.318 -177.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -118.4 142.41 31.31 Favored Pre-proline 0 C--N 1.303 -1.442 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -177.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.585 ' HB3' HD23 ' A' ' 264' ' ' LEU . 44.0 Cg_endo -79.58 172.34 14.51 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.812 2.341 . . . . 0.0 112.488 179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -89.26 109.55 20.42 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.39 108.79 20.91 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 177.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . 0.538 ' HB2' ' HB ' ' A' ' 261' ' ' ILE . 16.9 m -105.72 111.4 24.07 Favored 'General case' 0 N--CA 1.407 -2.619 0 CA-C-N 114.743 -1.117 . . . . 0.0 109.6 176.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -94.34 112.51 24.3 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.496 -176.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.711 ' HB3' ' O ' ' A' ' 259' ' ' HIS . 6.8 tp60 -116.5 159.73 21.64 Favored 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -76.89 -37.19 55.93 Favored 'General case' 0 C--N 1.307 -1.277 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.145 -177.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -71.23 -34.41 70.76 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.697 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . 0.711 ' O ' ' HB3' ' A' ' 256' ' ' GLN . 35.0 p-80 -168.08 171.22 9.74 Favored 'General case' 0 C--O 1.201 -1.451 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 -178.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.424 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 21.7 mt -106.38 139.26 28.35 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.242 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 178.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' A' ' 254' ' ' SER . 3.6 mp -115.35 108.49 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.926 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.485 ' HB ' ' HB3' ' A' ' 300' ' ' LEU . 43.3 t -106.68 120.93 58.69 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.628 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 175.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . 0.537 HG22 ' OD2' ' A' ' 297' ' ' ASP . 1.1 m -115.32 130.36 56.88 Favored 'General case' 0 C--N 1.29 -1.981 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.723 -177.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.585 HD23 ' HB3' ' A' ' 251' ' ' PRO . 25.5 mt -116.04 83.38 1.93 Allowed 'General case' 0 CA--C 1.474 -1.976 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -178.292 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.447 ' HA ' ' OD2' ' A' ' 297' ' ' ASP . 26.4 mmtm -61.65 140.88 58.11 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.6 -175.221 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 10.9 t30 66.68 15.05 10.02 Favored 'General case' 0 CA--C 1.552 1.027 0 O-C-N 124.792 1.307 . . . . 0.0 110.802 175.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 50.2 t60 -109.89 93.92 4.75 Favored 'General case' 0 C--O 1.187 -2.216 0 N-CA-C 104.637 -2.357 . . . . 0.0 104.637 176.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 2.0 m -86.64 114.7 23.57 Favored 'General case' 0 C--N 1.28 -2.431 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.334 -173.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 19.6 tp -87.84 135.76 33.36 Favored Pre-proline 0 C--N 1.312 -1.037 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.47 -178.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -78.65 159.91 28.26 Favored 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 122.25 1.967 . . . . 0.0 111.413 171.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . 0.479 ' HA ' ' OE1' ' A' ' 274' ' ' GLN . 23.5 p -64.0 -28.31 69.72 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.727 0.775 . . . . 0.0 111.081 -179.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 30.1 m -56.86 -26.29 58.29 Favored 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 125.693 1.597 . . . . 0.0 113.379 -177.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.554 HD13 ' O ' ' A' ' 226' ' ' THR . 64.7 mt -105.6 -2.27 23.69 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 121.965 -0.459 . . . . 0.0 111.537 -174.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.479 ' OE1' ' HA ' ' A' ' 271' ' ' THR . 55.3 mt-30 -77.9 108.31 11.06 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.949 -0.568 . . . . 0.0 109.971 -179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -138.26 153.34 49.08 Favored 'General case' 0 C--N 1.283 -2.293 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 20.2 m -117.77 131.99 56.52 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 63.9 mt -100.2 125.82 46.41 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -49.41 -69.11 0.13 Allowed 'General case' 0 N--CA 1.471 0.623 0 O-C-N 124.559 1.162 . . . . 0.0 111.642 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.711 ' HA ' ' CD2' ' A' ' 282' ' ' PHE . 39.1 t 56.12 24.72 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.79 0 O-C-N 124.332 1.02 . . . . 0.0 112.247 176.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -79.5 138.27 37.49 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 120.637 -1.289 . . . . 0.0 109.991 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 60.21 38.68 19.93 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 123.92 0.762 . . . . 0.0 111.514 179.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.711 ' CD2' ' HA ' ' A' ' 279' ' ' VAL . 0.2 OUTLIER -88.59 -2.94 58.86 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.856 179.85 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 65.36 61.24 0.72 Allowed 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.894 -179.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.9 153.45 10.82 Favored Pre-proline 0 C--N 1.298 -1.634 0 CA-C-N 114.127 -1.397 . . . . 0.0 108.966 179.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . 0.475 ' O ' ' HA ' ' A' ' 304' ' ' THR . 62.1 Cg_exo -50.31 -28.13 19.78 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 123.671 2.914 . . . . 0.0 112.948 173.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 42.4 t -69.57 124.39 25.37 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.946 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -98.71 -44.0 6.58 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.263 -177.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 28.5 ttpp -161.64 139.17 8.85 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -177.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 47.0 t -100.89 130.89 49.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 176.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 62.6 m -139.72 117.0 11.24 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.119 0.485 . . . . 0.0 110.772 -178.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . . . . . . . . . 54.9 tp -97.47 115.58 28.04 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.425 ' HA ' HE21 ' A' ' 274' ' ' GLN . 16.3 tppt? -114.63 129.01 56.62 Favored 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -176.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . 0.436 ' H ' ' NE2' ' A' ' 274' ' ' GLN . 5.7 ptm180 -79.46 140.18 37.41 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 119.166 -1.013 . . . . 0.0 108.572 176.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.621 ' HB3' ' HB3' ' A' ' 297' ' ' ASP . 2.7 tm? -120.29 158.48 26.97 Favored 'General case' 0 N--CA 1.416 -2.149 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.6 ' N ' HD13 ' A' ' 294' ' ' LEU . 21.3 t-20 -14.86 -71.43 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 127.583 2.353 . . . . 0.0 114.032 177.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -125.2 -3.47 7.49 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . 0.621 ' HB3' ' HB3' ' A' ' 294' ' ' LEU . 7.0 t70 -108.58 -177.65 3.38 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.242 1.017 . . . . 0.0 108.471 -169.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.501 ' HB ' ' HB2' ' A' ' 264' ' ' LEU . 58.3 m -134.18 109.55 8.97 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 174.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -103.23 119.17 38.37 Favored 'General case' 0 N--CA 1.421 -1.901 0 CA-C-O 121.708 0.766 . . . . 0.0 109.648 -175.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.485 ' HB3' ' HB ' ' A' ' 262' ' ' VAL . 59.9 tp -105.13 124.26 49.22 Favored 'General case' 0 C--N 1.271 -2.805 0 CA-C-N 115.505 -0.771 . . . . 0.0 109.831 -179.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 66.6 mt -107.16 109.85 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.662 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.641 -178.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . 0.424 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 61.6 mt -108.36 105.14 18.23 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 177.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.401 ' HA ' ' CB ' ' A' ' 259' ' ' HIS . 11.9 m -74.77 135.36 41.72 Favored 'General case' 0 C--N 1.293 -1.866 0 C-N-CA 120.843 -0.343 . . . . 0.0 110.832 -174.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . 0.475 ' HA ' ' O ' ' A' ' 285' ' ' PRO . 17.3 p -134.34 -177.04 4.41 Favored 'General case' 0 C--N 1.312 -1.035 0 C-N-CA 123.051 0.54 . . . . 0.0 110.308 -177.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -166.75 149.9 6.76 Favored 'General case' 0 C--O 1.247 0.937 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 71.92 -161.05 54.22 Favored Glycine 0 C--O 1.243 0.659 0 O-C-N 123.672 0.608 . . . . 0.0 112.541 177.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' ASN . . . . . 0.413 ' HB3' ' HB3' ' A' ' 327' ' ' LYS . 83.6 m-20 -88.32 128.84 35.5 Favored 'General case' 0 CA--C 1.494 -1.197 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 176.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' TRP . . . . . 0.687 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 56.8 p-90 -147.83 167.59 24.36 Favored 'General case' 0 C--N 1.289 -2.05 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -177.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 324' ' ' VAL . 15.8 mt-10 -123.69 144.58 49.56 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -177.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.687 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 33.1 tp -120.83 117.52 27.61 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.916 0.389 . . . . 0.0 111.514 -176.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.533 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 58.8 t -110.87 108.27 25.04 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 174.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -98.46 129.64 45.07 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 9.8 mtmp? -135.08 158.71 43.65 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 120.807 0.337 . . . . 0.0 110.223 -178.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 12.0 p -116.5 138.88 51.04 Favored 'General case' 0 N--CA 1.414 -2.247 0 CA-C-N 115.284 -0.871 . . . . 0.0 108.908 172.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -96.55 -22.97 16.75 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -172.39 163.3 4.11 Favored Pre-proline 0 C--N 1.313 -1.001 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -65.11 97.57 0.29 Allowed 'Trans proline' 0 C--O 1.247 0.948 0 C-N-CA 121.63 1.554 . . . . 0.0 111.172 177.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 120.9 -5.15 11.42 Favored Glycine 0 C--O 1.208 -1.521 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.433 -177.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -123.7 116.68 23.45 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 121.944 -0.739 . . . . 0.0 109.749 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -119.19 166.3 13.13 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-O 121.829 0.823 . . . . 0.0 110.749 -176.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 58.5 m -151.97 136.68 17.05 Favored 'General case' 0 C--N 1.281 -2.37 0 C-N-CA 124.259 1.024 . . . . 0.0 109.085 -177.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -123.03 116.26 23.22 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . 0.533 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 8.9 tt0 -103.53 105.87 16.23 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 309' ' ' GLU . 1.3 m -99.59 110.72 27.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 CA-C-O 121.301 0.572 . . . . 0.0 109.8 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -92.1 156.89 41.73 Favored Pre-proline 0 C--N 1.313 -1.015 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.374 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -83.0 138.51 9.13 Favored 'Trans proline' 0 N--CA 1.444 -1.388 0 C-N-CA 121.814 1.676 . . . . 0.0 109.915 171.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 307' ' ' ASN . 34.6 ttmt -114.07 138.79 49.94 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -134.91 149.35 50.26 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 . . . . . 0 C--O 1.255 1.372 0 CA-C-O 118.088 -0.958 . . . . 0.0 110.921 -179.095 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 1.6 mpt? . . . . . 0 CA--C 1.51 -0.581 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 175.98 -68.85 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 177.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 20.0 m -96.51 134.65 39.44 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 28.1 m -81.76 -37.64 26.89 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 35.5 p-80 -133.82 107.47 7.89 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 176.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -96.45 -34.02 11.66 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 -175.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 26.6 m170 -71.45 144.04 49.86 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 121.546 0.688 . . . . 0.0 111.257 -177.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -134.33 106.43 7.1 Favored 'General case' 0 C--N 1.293 -1.868 0 CA-C-N 114.988 -1.005 . . . . 0.0 108.522 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 47.8 t-80 -156.41 136.64 12.9 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 33.0 p-80 -102.79 167.07 10.11 Favored 'General case' 0 C--N 1.29 -2.003 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.454 -177.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 87.87 -101.25 2.69 Favored Glycine 0 N--CA 1.43 -1.737 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 64.34 -171.47 0.18 Allowed 'General case' 0 C--O 1.25 1.125 0 C-N-CA 123.647 0.779 . . . . 0.0 110.731 -178.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 9.2 p -145.71 127.62 7.78 Favored Pre-proline 0 N--CA 1.415 -2.207 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 176.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -64.55 -50.76 2.29 Favored 'Trans proline' 0 C--O 1.246 0.881 0 C-N-CA 121.711 1.608 . . . . 0.0 109.688 176.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 18.4 ttm-85 -166.45 -24.24 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.238 175.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 103.88 -96.7 1.33 Allowed Glycine 0 CA--C 1.489 -1.588 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 176.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 32.8 t -89.98 136.14 33.22 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 174.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -55.18 112.49 1.09 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.382 0.61 . . . . 0.0 112.185 -177.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 12.9 tpt 58.69 77.66 0.29 Allowed 'General case' 0 C--O 1.245 0.84 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.02 -173.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -139.83 18.25 2.49 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-N 114.218 -1.356 . . . . 0.0 108.865 176.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 29.8 t -163.78 129.82 3.11 Favored 'General case' 0 N--CA 1.434 -1.234 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 58.1 ttp -152.14 -59.09 0.15 Allowed 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 178.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 4.5 m -85.04 -24.77 28.01 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -64.05 145.45 49.71 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.465 -0.788 . . . . 0.0 111.645 177.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 96.66 66.98 0.94 Allowed Glycine 0 N--CA 1.43 -1.756 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -177.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -103.93 174.15 6.0 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 120.604 0.24 . . . . 0.0 110.931 -178.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 11.5 tm0? -77.69 100.75 6.32 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 177.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 60.9 mtt -118.49 174.7 6.1 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.273 -178.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 109.09 -16.46 32.75 Favored Glycine 0 N--CA 1.435 -1.402 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 -115.39 -48.91 2.78 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 122.549 -0.383 . . . . 0.0 110.446 179.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 81.41 -33.08 2.53 Favored Glycine 0 N--CA 1.461 0.305 0 C-N-CA 121.33 -0.462 . . . . 0.0 112.23 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.442 ' OG ' HD21 ' A' ' 245' ' ' LEU . 25.3 t -111.38 96.57 6.19 Favored 'General case' 0 N--CA 1.414 -2.225 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 18.1 ptpt -103.81 -29.86 10.74 Favored 'General case' 0 C--O 1.243 0.717 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . 0.496 ' HG2' ' H ' ' A' ' 226' ' ' THR . 42.1 tt0 -172.49 -163.79 0.24 Allowed 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 -176.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.635 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 24.7 m -63.83 125.64 25.02 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 123.403 0.681 . . . . 0.0 112.595 -170.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -152.55 171.81 17.55 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.18 -176.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.52 HG21 HD13 ' A' ' 300' ' ' LEU . 2.5 pp -133.7 158.85 42.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 C-N-CA 123.45 0.7 . . . . 0.0 110.868 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 1.8 t70 -149.85 156.63 42.11 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -175.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -138.08 138.28 38.59 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 121.153 0.501 . . . . 0.0 111.086 176.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 21.1 ptt85 -153.76 168.2 27.09 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 172.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.495 ' HE3' HG22 ' A' ' 284' ' ' THR . 54.4 mtpt -113.53 154.41 27.14 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -144.14 117.67 9.15 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 -179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 81.48 -117.23 4.37 Favored Glycine 0 C--N 1.294 -1.793 0 C-N-CA 121.186 -0.53 . . . . 0.0 113.956 175.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 58.2 pttt -101.33 80.22 2.07 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.332 0.587 . . . . 0.0 111.801 -173.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.474 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 91.9 m-20 57.85 18.07 4.69 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.792 1.034 . . . . 0.0 113.792 176.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -73.19 136.11 44.69 Favored 'General case' 0 N--CA 1.428 -1.54 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . 0.474 ' HA3' ' CG1' ' A' ' 286' ' ' VAL . . . -91.59 123.86 7.37 Favored Glycine 0 N--CA 1.43 -1.752 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -179.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.6 mp -117.69 112.43 38.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 117.792 0.796 . . . . 0.0 110.77 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.1 mp -101.0 112.15 32.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.455 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 51.4 mt-10 -96.93 104.96 17.02 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 122.635 1.207 . . . . 0.0 110.558 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 11.5 tp -95.24 127.45 41.3 Favored 'General case' 0 C--N 1.27 -2.849 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.621 -175.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . 0.635 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -115.78 102.82 10.06 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -109.6 90.97 3.46 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.442 HD21 ' OG ' ' A' ' 223' ' ' SER . 2.9 mm? -78.62 115.82 18.58 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.725 -177.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 108.31 12.15 22.23 Favored Glycine 0 N--CA 1.425 -2.08 0 CA-C-N 114.862 -1.063 . . . . 0.0 110.783 -179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . 0.435 ' HE1' ' O ' ' A' ' 265' ' ' LYS . 42.2 t80 -115.81 107.85 15.57 Favored 'General case' 0 N--CA 1.421 -1.905 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.803 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -103.76 94.71 5.58 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.409 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 156.76 -139.8 6.75 Favored Glycine 0 C--N 1.299 -1.473 0 N-CA-C 110.571 -1.011 . . . . 0.0 110.571 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . 0.438 ' HA ' ' OE1' ' A' ' 250' ' ' GLN . 13.7 mm-40 -129.51 139.88 36.99 Favored Pre-proline 0 C--N 1.305 -1.357 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 178.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.721 ' HB3' HD13 ' A' ' 264' ' ' LEU . 9.1 Cg_endo -69.7 172.14 13.11 Favored 'Trans proline' 0 N--CA 1.434 -2.018 0 C-N-CA 121.212 1.275 . . . . 0.0 110.75 176.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -100.72 105.09 16.4 Favored 'General case' 0 C--N 1.267 -3.015 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 4.8 mp -102.37 138.66 25.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 CA-C-O 121.043 0.449 . . . . 0.0 111.329 -176.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . 0.496 ' HB3' ' HB ' ' A' ' 261' ' ' ILE . 33.3 t -127.57 124.98 39.44 Favored 'General case' 0 N--CA 1.425 -1.725 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 175.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -102.92 114.65 29.11 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.177 0.513 . . . . 0.0 111.932 -177.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -117.88 160.73 20.93 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 171.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 34.4 m170 -76.6 -30.89 57.15 Favored 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.658 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -68.56 -42.21 78.66 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.939 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . 0.541 ' CB ' ' HA ' ' A' ' 303' ' ' THR . 38.7 p-80 -168.73 168.69 10.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.665 178.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 20.2 mt -106.17 142.36 19.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . 0.496 ' HB ' ' HB3' ' A' ' 254' ' ' SER . 3.3 mp -122.64 122.89 67.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 178.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 299' ' ' GLN . 1.4 m -120.14 141.09 41.94 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 175.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 298' ' ' THR . 26.0 m -135.19 126.92 29.15 Favored 'General case' 0 C--N 1.275 -2.641 0 CA-C-O 121.475 0.655 . . . . 0.0 110.86 177.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.721 HD13 ' HB3' ' A' ' 251' ' ' PRO . 1.5 mm? -94.17 99.3 11.59 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 177.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.586 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 13.2 mptt -59.7 125.4 23.5 Favored 'General case' 0 C--N 1.285 -2.225 0 O-C-N 124.838 1.336 . . . . 0.0 112.451 -178.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 66.4 t30 63.76 35.74 11.06 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.138 0.975 . . . . 0.0 110.402 178.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -121.26 119.09 31.25 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 2.8 p -87.27 144.79 26.64 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.031 0.443 . . . . 0.0 111.946 178.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 27.1 tp -130.26 129.98 22.97 Favored Pre-proline 0 N--CA 1.427 -1.608 0 C-N-CA 123.77 0.828 . . . . 0.0 109.301 178.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -72.86 152.34 52.18 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.021 1.814 . . . . 0.0 111.586 171.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 34.7 p -68.89 -19.56 64.22 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.942 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 13.6 m -74.97 -18.53 60.37 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.555 0.693 . . . . 0.0 109.686 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.4 HD11 ' HB3' ' A' ' 225' ' ' GLN . 89.9 mt -106.41 -7.11 17.78 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.065 -176.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -86.57 102.39 14.1 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 178.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.67 158.32 44.31 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.656 -177.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 33.9 p -114.59 145.87 41.46 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.566 -175.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.435 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 64.2 mt -112.44 119.36 37.95 Favored 'General case' 0 N--CA 1.426 -1.66 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -85.88 94.24 9.12 Favored 'General case' 0 C--N 1.279 -2.478 0 CA-C-O 121.889 0.852 . . . . 0.0 108.714 177.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.59 ' HA ' ' CE1' ' A' ' 282' ' ' PHE . 17.6 t -105.83 30.18 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 CA-C-N 113.943 -1.48 . . . . 0.0 109.902 -173.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -82.0 144.96 30.51 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 176.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 35.8 t70 72.37 20.85 3.92 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-O 122.46 1.124 . . . . 0.0 110.789 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.59 ' CE1' ' HA ' ' A' ' 279' ' ' VAL . 19.5 m-85 -90.07 -1.73 58.0 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.858 173.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 73.23 13.45 4.71 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.539 1.136 . . . . 0.0 111.54 175.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' THR . . . . . 0.495 HG22 ' HE3' ' A' ' 232' ' ' LYS . 1.2 p -96.63 174.93 2.94 Favored Pre-proline 0 C--N 1.309 -1.157 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -175.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 7.9 Cg_exo -76.36 -15.26 17.94 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 121.854 1.703 . . . . 0.0 110.768 173.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.474 ' CG1' ' HA3' ' A' ' 238' ' ' GLY . 1.4 m -90.46 138.06 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.75 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . 0.477 ' OE1' ' HB2' ' A' ' 305' ' ' ALA . 11.3 mt-30 -104.82 -32.44 8.83 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.239 0.542 . . . . 0.0 110.814 -179.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 36.8 tttp -162.29 133.84 5.29 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.204 -174.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.435 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 45.3 t -99.46 132.93 43.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 172.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 97.2 m -142.8 118.92 10.73 Favored 'General case' 0 C--N 1.29 -2.009 0 O-C-N 121.631 -0.668 . . . . 0.0 111.087 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.466 ' HB2' HG12 ' A' ' 228' ' ' ILE . 42.7 tp -96.74 125.03 40.91 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? -121.91 129.19 52.35 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.532 -174.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 41.9 ttt-85 -74.54 127.68 33.67 Favored 'General case' 0 N--CA 1.407 -2.584 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 173.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.51 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 19.4 tp -107.99 179.28 4.27 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 176.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.51 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 27.4 t-20 -46.54 -67.76 0.25 Allowed 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.662 0.785 . . . . 0.0 112.883 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -123.83 -2.09 8.32 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.544 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . 0.586 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 15.9 m-20 -117.43 168.31 10.48 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -177.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 263' ' ' THR . 49.5 m -112.9 127.96 56.34 Favored 'General case' 0 C--N 1.286 -2.176 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 176.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . 0.477 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 41.4 tt0 -111.55 129.64 56.0 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -175.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.52 HD13 HG21 ' A' ' 228' ' ' ILE . 63.2 tp -111.15 124.61 52.53 Favored 'General case' 0 N--CA 1.415 -2.207 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 176.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 54.2 mt -112.5 121.01 64.04 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -177.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . . . . . . . . . 53.7 mt -121.43 101.76 10.92 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.011 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 178.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.541 ' HA ' ' CB ' ' A' ' 259' ' ' HIS . 16.8 m -69.34 139.82 54.26 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -178.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 10.9 p -134.22 166.04 23.7 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -176.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . 0.477 ' HB2' ' OE1' ' A' ' 287' ' ' GLN . . . -144.66 143.91 30.98 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 123.315 0.646 . . . . 0.0 110.177 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 77.65 -159.62 48.23 Favored Glycine 0 C--O 1.245 0.801 0 O-C-N 123.897 0.748 . . . . 0.0 112.319 178.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 327' ' ' LYS . 28.9 m-80 -92.67 136.5 33.18 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 176.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' TRP . . . . . 0.732 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 59.3 p-90 -150.47 160.4 43.79 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.781 -0.767 . . . . 0.0 111.157 -175.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.429 ' O ' ' HA ' ' A' ' 324' ' ' VAL . 16.1 mt-10 -118.14 133.14 56.17 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -177.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.732 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 24.3 tp -108.35 120.92 43.77 Favored 'General case' 0 CA--C 1.498 -1.039 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.825 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.674 HG13 ' HB3' ' A' ' 323' ' ' GLN . 7.5 p -122.17 112.12 33.37 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-O 121.964 0.888 . . . . 0.0 109.395 172.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -94.94 139.58 31.13 Favored 'General case' 0 N--CA 1.414 -2.267 0 CA-C-N 115.069 -0.968 . . . . 0.0 110.594 -177.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . 0.466 ' HB2' ' HB ' ' A' ' 321' ' ' THR . 67.0 mttm -130.92 151.32 51.47 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.342 -177.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 27.0 m -116.02 126.75 54.22 Favored 'General case' 0 C--N 1.288 -2.075 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 172.068 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -87.9 -34.62 18.1 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -167.41 163.77 9.7 Favored Pre-proline 0 C--N 1.307 -1.25 0 N-CA-C 104.74 -2.318 . . . . 0.0 104.74 -178.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -65.68 95.42 0.28 Allowed 'Trans proline' 0 C--O 1.244 0.813 0 C-N-CA 121.535 1.49 . . . . 0.0 111.266 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 131.79 -32.4 2.91 Favored Glycine 0 N--CA 1.433 -1.556 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 -177.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -97.84 116.51 30.2 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . 0.444 ' CZ ' ' HD3' ' A' ' 251' ' ' PRO . 61.0 m-85 -119.2 165.03 14.73 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-O 122.188 0.994 . . . . 0.0 110.449 -175.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.466 ' HB ' ' HB2' ' A' ' 313' ' ' LYS . 59.3 m -151.72 128.72 11.05 Favored 'General case' 0 C--N 1.264 -3.135 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.619 -177.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -116.44 114.53 24.36 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 177.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . 0.674 ' HB3' HG13 ' A' ' 311' ' ' VAL . 34.9 tt0 -104.24 111.87 24.66 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 309' ' ' GLU . 0.2 OUTLIER -105.96 103.65 15.74 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.713 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.261 179.205 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.417 HD22 ' H ' ' A' ' 325' ' ' LEU . 1.0 OUTLIER -86.08 153.0 56.78 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.229 179.77 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -78.55 129.76 9.48 Favored 'Trans proline' 0 N--CA 1.447 -1.226 0 C-N-CA 121.669 1.58 . . . . 0.0 109.491 173.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 307' ' ' ASN . 41.1 ttmt -97.99 118.3 34.26 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 -178.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -118.58 108.58 15.13 Favored 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 175.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 . . . . . 0 C--N 1.281 -2.386 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.423 -178.61 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 95.6 mmm . . . . . 0 CA--C 1.512 -0.481 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -99.08 59.36 0.84 Allowed Glycine 0 C--N 1.314 -0.674 0 N-CA-C 110.871 -0.891 . . . . 0.0 110.871 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 48.9 m 60.06 76.86 0.34 Allowed 'General case' 0 C--O 1.24 0.579 0 C-N-CA 124.209 1.004 . . . . 0.0 111.926 -177.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 31.4 t -100.8 -32.51 10.66 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.532 -178.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 54.6 m-70 68.17 115.53 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 124.409 1.084 . . . . 0.0 110.823 -176.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 42.0 t60 -77.11 116.74 18.01 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 -179.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -119.25 105.13 11.04 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 7.7 t60 -97.07 87.05 4.11 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 174.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 33.0 m170 68.53 -177.93 0.21 Allowed 'General case' 0 C--O 1.241 0.619 0 C-N-CA 124.752 1.221 . . . . 0.0 108.795 -172.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 8.0 p80 -132.55 93.13 3.18 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-O 121.747 0.784 . . . . 0.0 110.466 176.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -134.29 163.53 24.6 Favored Glycine 0 N--CA 1.426 -1.981 0 N-CA-C 108.183 -1.967 . . . . 0.0 108.183 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -166.68 -31.49 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 117.798 0.799 . . . . 0.0 110.154 -175.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . 0.337 12.2 m 61.56 106.18 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.537 0 C-N-CA 126.376 1.871 . . . . 0.0 111.608 -173.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -31.04 -62.98 0.11 Allowed 'Trans proline' 0 C--N 1.372 1.798 1 C-N-CA 125.598 4.199 . . . . 0.0 116.003 -172.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -128.5 95.95 4.28 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 121.27 0.557 . . . . 0.0 110.224 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -162.25 38.29 0.37 Allowed Glycine 0 N--CA 1.436 -1.358 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 178.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 11.5 m -81.87 116.32 21.47 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . 0.465 ' HA ' ' OG ' ' A' ' 212' ' ' SER . 15.3 t-80 -84.62 -2.33 57.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.795 0.807 . . . . 0.0 110.272 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 27.9 ttt -82.28 89.69 6.57 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 170.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . 64.85 67.99 0.53 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.643 -1.162 . . . . 0.0 111.36 -175.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . 0.465 ' OG ' ' HA ' ' A' ' 209' ' ' HIS . 61.0 m -65.66 -32.36 73.88 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.823 0.821 . . . . 0.0 108.865 175.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 10.8 tmm? -135.85 102.7 5.14 Favored 'General case' 0 N--CA 1.417 -2.095 0 N-CA-C 103.31 -2.848 . . . . 0.0 103.31 173.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 31.4 m -68.44 -61.22 1.93 Allowed 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 121.252 0.548 . . . . 0.0 110.256 -176.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 113.06 -64.92 0.27 Allowed Glycine 0 N--CA 1.416 -2.645 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -176.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 117.84 -68.29 0.32 Allowed Glycine 0 N--CA 1.421 -2.337 0 N-CA-C 111.324 -0.711 . . . . 0.0 111.324 177.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . 0.467 ' HA ' ' SD ' ' A' ' 219' ' ' MET . 1.9 mp0 -81.19 104.89 11.98 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.218 0.532 . . . . 0.0 110.349 -177.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -125.57 4.83 7.55 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 177.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . 0.467 ' SD ' ' HA ' ' A' ' 217' ' ' GLN . 1.5 mpt? -55.37 133.59 49.78 Favored 'General case' 0 C--O 1.248 0.989 0 CA-C-N 114.469 -1.241 . . . . 0.0 113.472 -171.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 124.78 111.06 1.87 Allowed Glycine 0 N--CA 1.41 -3.049 0 N-CA-C 107.966 -2.054 . . . . 0.0 107.966 -173.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 32.1 ptt180 -70.84 -17.29 62.75 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.332 0.586 . . . . 0.0 110.697 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -178.49 86.87 0.07 OUTLIER Glycine 0 N--CA 1.423 -2.21 0 N-CA-C 110.572 -1.011 . . . . 0.0 110.572 177.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 41.0 m -156.22 -29.89 0.09 Allowed 'General case' 0 C--N 1.31 -1.116 0 CA-C-O 120.655 0.264 . . . . 0.0 111.207 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -81.18 -35.5 31.33 Favored 'General case' 0 C--N 1.317 -0.83 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.696 -176.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -142.57 177.62 8.17 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.559 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 31.1 m -61.5 133.47 55.76 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 114.353 1.242 . . . . 0.0 114.353 -167.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -162.17 170.99 18.12 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.177 -178.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.529 HG12 ' HB2' ' A' ' 291' ' ' LEU . 2.8 pp -136.56 157.34 36.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.183 178.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.414 ' HB2' ' HB2' ' A' ' 241' ' ' GLU . 5.1 m-20 -145.61 157.61 43.95 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 123.992 0.917 . . . . 0.0 110.147 -175.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.403 ' HZ ' HG21 ' A' ' 284' ' ' THR . 91.5 t80 -124.0 145.58 49.09 Favored 'General case' 0 C--N 1.31 -1.13 0 O-C-N 123.202 0.314 . . . . 0.0 110.549 177.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -155.52 165.22 37.25 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 170.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.501 ' CE ' ' HA ' ' A' ' 236' ' ' ASN . 55.2 mtpt -115.38 151.23 35.06 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 120.696 0.284 . . . . 0.0 110.586 176.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -136.68 140.51 42.75 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 116.302 -0.408 . . . . 0.0 109.96 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 66.14 -97.61 0.33 Allowed Glycine 0 N--CA 1.438 -1.188 0 O-C-N 124.3 1.0 . . . . 0.0 114.32 172.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -136.3 92.34 2.77 Favored 'General case' 0 N--CA 1.422 -1.853 0 CA-C-O 120.862 0.363 . . . . 0.0 110.074 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.501 ' HA ' ' CE ' ' A' ' 232' ' ' LYS . 92.4 m-20 65.3 12.9 8.43 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 172.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -74.73 130.87 40.25 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -97.1 113.84 4.82 Favored Glycine 0 C--O 1.21 -1.385 0 O-C-N 123.696 0.623 . . . . 0.0 111.845 -177.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.422 HG13 ' HG3' ' A' ' 323' ' ' GLN . 2.7 mp -106.96 117.56 53.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 117.834 0.817 . . . . 0.0 111.015 -177.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.4 mp -103.66 112.57 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.919 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 175.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 229' ' ' ASP . 45.3 mt-10 -91.43 128.31 37.21 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 12.8 tp -116.08 123.69 48.52 Favored 'General case' 0 C--N 1.284 -2.249 0 CA-C-O 121.054 0.454 . . . . 0.0 111.409 -175.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . 0.559 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -109.93 104.4 13.31 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -117.43 91.08 3.48 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -80.03 115.37 19.57 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.139 -174.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 113.08 2.24 25.04 Favored Glycine 0 N--CA 1.432 -1.612 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.718 178.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . 0.425 ' HB2' ' ND1' ' A' ' 267' ' ' HIS . 40.9 t80 -114.96 114.21 25.14 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -178.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -106.91 -10.05 16.11 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -84.1 -154.57 19.66 Favored Glycine 0 C--N 1.318 -0.435 0 C-N-CA 121.425 -0.417 . . . . 0.0 112.464 -179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -119.69 134.43 23.88 Favored Pre-proline 0 C--N 1.311 -1.082 0 O-C-N 122.485 -0.42 . . . . 0.0 109.872 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.624 ' HB3' HD23 ' A' ' 264' ' ' LEU . 32.9 Cg_endo -74.21 171.99 16.9 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.523 2.149 . . . . 0.0 113.042 178.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -94.71 113.24 25.0 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.104 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . . . . . . . . . 2.2 mp -97.86 108.47 21.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 CA-C-O 122.113 0.958 . . . . 0.0 110.191 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . 0.623 ' HB2' ' HB ' ' A' ' 261' ' ' ILE . 36.6 m -108.98 111.67 23.46 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.37 -1.287 . . . . 0.0 108.856 176.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -104.87 124.18 49.01 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 112.392 0.516 . . . . 0.0 112.392 -174.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.44 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 14.3 mm-40 -124.77 167.86 14.01 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 173.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 53.5 m80 -76.95 -36.28 56.66 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 120.304 -0.558 . . . . 0.0 109.986 177.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -71.91 -37.75 70.03 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.876 -1.056 . . . . 0.0 111.942 -177.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . 0.44 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 55.0 p-80 -167.6 166.01 14.22 Favored 'General case' 0 C--N 1.318 -0.768 0 O-C-N 122.143 -0.348 . . . . 0.0 110.968 178.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.475 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 19.1 mt -106.43 143.75 16.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . 0.623 ' HB ' ' HB2' ' A' ' 254' ' ' SER . 4.2 mp -121.76 111.76 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.701 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 177.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.419 ' HB ' ' HB2' ' A' ' 300' ' ' LEU . 43.1 t -110.12 117.01 53.75 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 176.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 23.5 m -112.76 124.22 52.09 Favored 'General case' 0 C--N 1.285 -2.233 0 C-N-CA 119.951 -0.7 . . . . 0.0 110.943 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.624 HD23 ' HB3' ' A' ' 251' ' ' PRO . 17.1 mt -99.82 100.08 10.97 Favored 'General case' 0 N--CA 1.43 -1.45 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.507 ' HA ' ' OD1' ' A' ' 297' ' ' ASP . 30.7 mmtp -65.7 129.43 39.73 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 113.717 1.006 . . . . 0.0 113.717 -174.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 6.4 t30 64.33 23.82 13.12 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 113.532 -1.667 . . . . 0.0 110.202 177.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' HIS . . . . . 0.425 ' ND1' ' HB2' ' A' ' 247' ' ' PHE . 54.9 t60 -112.05 107.69 16.73 Favored 'General case' 0 CA--C 1.476 -1.883 0 N-CA-C 105.163 -2.162 . . . . 0.0 105.163 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 2.8 m -94.5 138.51 32.33 Favored 'General case' 0 C--N 1.263 -3.169 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.627 -175.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 29.7 tp -113.79 128.26 25.93 Favored Pre-proline 0 N--CA 1.431 -1.388 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.186 -176.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -62.21 135.7 55.92 Favored 'Trans proline' 0 C--O 1.248 0.98 0 C-N-CA 122.312 2.008 . . . . 0.0 110.705 169.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . 0.452 ' O ' ' HG2' ' A' ' 274' ' ' GLN . 9.2 t -67.5 -13.11 61.75 Favored 'General case' 0 CA--C 1.56 1.36 0 CA-C-O 121.814 0.816 . . . . 0.0 111.223 -178.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 27.3 m -74.59 -23.99 58.83 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.81 178.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . . . . . . . . . 96.7 mt -100.95 -9.27 21.67 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.128 -174.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.539 ' HB2' ' O ' ' A' ' 291' ' ' LEU . 3.2 pt20 -77.27 94.37 4.14 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-O 122.698 1.237 . . . . 0.0 109.647 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 8.3 ptp180 -100.72 166.53 10.83 Favored 'General case' 0 C--N 1.284 -2.242 0 CA-C-N 114.759 -1.11 . . . . 0.0 110.094 -177.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 19.9 m -137.27 127.36 26.03 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.447 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 2.2 mm? -89.83 130.5 36.06 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 105.99 -1.856 . . . . 0.0 105.99 179.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -70.44 -42.1 71.98 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.604 ' HA ' ' CD1' ' A' ' 282' ' ' PHE 0.257 10.4 p 40.35 34.3 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.548 0 C-N-CA 126.051 1.74 . . . . 0.0 112.609 177.969 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -89.61 137.66 32.14 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.1 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 14.2 t70 69.2 14.47 8.65 Favored 'General case' 0 C--N 1.32 -0.699 0 C-N-CA 125.328 1.451 . . . . 0.0 109.887 -177.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.604 ' CD1' ' HA ' ' A' ' 279' ' ' VAL . 7.9 m-85 -75.82 -20.45 58.17 Favored 'General case' 0 CA--C 1.503 -0.851 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.39 174.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp 62.3 60.56 1.41 Allowed 'General case' 0 CA--C 1.5 -0.965 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.981 174.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' THR . . . . . 0.455 HG22 ' HE3' ' A' ' 232' ' ' LYS . 1.1 p -133.06 172.32 7.61 Favored Pre-proline 0 C--N 1.286 -2.163 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 177.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . 0.452 ' O ' ' HA ' ' A' ' 304' ' ' THR . 23.8 Cg_exo -65.9 -24.65 53.29 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 121.51 1.473 . . . . 0.0 110.958 175.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.2 p -87.64 120.22 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 CA-C-O 122.206 1.003 . . . . 0.0 110.077 176.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -90.95 -37.76 13.3 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 114.111 -1.404 . . . . 0.0 111.062 -173.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . 0.463 ' HA ' ' CG1' ' A' ' 279' ' ' VAL . 86.6 tttt -154.29 134.79 13.46 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.013 178.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.447 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 35.8 t -102.03 116.56 45.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.463 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 175.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.465 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 27.2 m -124.37 121.28 34.51 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 120.729 0.299 . . . . 0.0 110.811 -176.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.539 ' O ' ' HB2' ' A' ' 274' ' ' GLN . 27.7 tp -96.9 126.79 42.3 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.224 -1.398 . . . . 0.0 107.224 175.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . 0.525 ' HA ' ' NE2' ' A' ' 274' ' ' GLN . 21.5 tptp -125.59 121.98 35.16 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -172.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -77.9 128.25 33.65 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 118.579 -1.248 . . . . 0.0 108.607 177.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.501 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 15.1 tp -101.88 -173.91 2.46 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.501 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 51.1 t-20 -53.95 -67.05 0.29 Allowed 'General case' 0 N--CA 1.482 1.169 0 CA-C-N 118.311 0.505 . . . . 0.0 111.033 -177.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . 0.408 ' H ' HD22 ' A' ' 296' ' ' ASN . 0.1 OUTLIER -120.43 -4.05 9.89 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.722 178.928 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . 0.507 ' OD1' ' HA ' ' A' ' 265' ' ' LYS . 30.3 m-20 -113.32 164.77 13.14 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.512 -175.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.502 ' HB ' ' HB2' ' A' ' 264' ' ' LEU . 98.9 m -108.09 124.86 50.86 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 174.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -112.97 128.33 56.46 Favored 'General case' 0 N--CA 1.416 -2.167 0 CA-C-O 121.59 0.71 . . . . 0.0 109.239 -176.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.419 ' HB2' ' HB ' ' A' ' 262' ' ' VAL . 0.5 OUTLIER -107.18 127.62 53.67 Favored 'General case' 0 C--N 1.271 -2.83 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 176.712 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' ILE . . . . . 0.465 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 58.1 mt -115.57 109.49 28.48 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . 0.475 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 63.3 mt -110.84 101.05 12.0 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 25.8 m -70.81 134.33 47.27 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 -177.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 285' ' ' PRO . 15.4 p -138.0 171.23 14.72 Favored 'General case' 0 C--N 1.31 -1.111 0 O-C-N 123.256 0.347 . . . . 0.0 111.322 -176.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -154.69 139.75 17.4 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 177.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 90.1 -153.41 22.91 Favored Glycine 0 C--N 1.314 -0.656 0 C-N-CA 121.256 -0.497 . . . . 0.0 111.866 178.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 327' ' ' LYS . 30.4 m-80 -104.3 139.99 38.51 Favored 'General case' 0 C--O 1.255 1.361 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 175.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' TRP . . . . . 0.416 ' HZ3' ' CB ' ' A' ' 310' ' ' LEU . 67.9 p-90 -155.63 166.3 33.93 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.356 -177.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.472 ' HG2' ' HE2' ' A' ' 327' ' ' LYS . 17.8 mt-10 -117.88 134.39 54.98 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.416 ' CB ' ' HZ3' ' A' ' 308' ' ' TRP . 1.1 tt -102.85 123.42 46.47 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 176.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.641 ' CG1' ' HB3' ' A' ' 323' ' ' GLN . 6.5 p -117.34 108.16 24.08 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 CA-C-O 122.065 0.936 . . . . 0.0 109.419 170.183 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 16.5 p-10 -98.48 115.93 29.62 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 114.365 -1.289 . . . . 0.0 111.915 -175.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 49.6 mtmt -116.14 149.77 38.49 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.926 -176.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 48.4 t -111.65 113.78 26.38 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 172.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -79.71 -35.98 38.16 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.533 0.682 . . . . 0.0 109.95 -177.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -168.16 161.59 9.24 Favored Pre-proline 0 C--N 1.303 -1.434 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 -178.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -62.09 102.45 0.26 Allowed 'Trans proline' 0 C--O 1.247 0.926 0 C-N-CA 121.574 1.516 . . . . 0.0 111.497 -179.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 117.03 -9.4 15.73 Favored Glycine 0 N--CA 1.434 -1.45 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.629 -178.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -120.08 116.31 25.45 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 122.004 -0.703 . . . . 0.0 110.035 178.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -120.63 165.82 14.51 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.697 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 50.4 m -151.64 132.02 13.75 Favored 'General case' 0 C--N 1.274 -2.711 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.386 -176.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -120.29 107.33 12.84 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 177.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . 0.641 ' HB3' ' CG1' ' A' ' 311' ' ' VAL . 62.7 tt0 -98.67 115.89 29.69 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 107.78 -1.192 . . . . 0.0 107.78 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.41 HG13 ' CE3' ' A' ' 308' ' ' TRP . 92.0 t -100.05 99.16 7.95 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.296 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.803 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -88.04 144.8 35.1 Favored Pre-proline 0 C--N 1.318 -0.762 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 177.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -68.79 131.0 21.62 Favored 'Trans proline' 0 C--O 1.243 0.764 0 C-N-CA 121.443 1.429 . . . . 0.0 110.076 173.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.472 ' HE2' ' HG2' ' A' ' 309' ' ' GLU . 37.7 ttmt -102.02 115.7 31.1 Favored 'General case' 0 CA--C 1.495 -1.157 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 -179.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -102.46 144.65 30.64 Favored 'General case' 0 C--N 1.285 -2.207 0 C-N-CA 118.715 -1.194 . . . . 0.0 108.997 177.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 . . . . . 0 C--N 1.285 -2.199 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -177.7 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 64.9 mtt . . . . . 0 CA--C 1.509 -0.603 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 148.85 -32.22 1.19 Allowed Glycine 0 CA--C 1.493 -1.312 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 13.2 m -58.23 -41.21 83.65 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 123.635 0.774 . . . . 0.0 111.398 -179.329 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 22.2 p -85.05 -6.63 59.32 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -177.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -125.45 104.76 8.61 Favored 'General case' 0 CA--C 1.495 -1.139 0 O-C-N 121.829 -0.544 . . . . 0.0 110.438 -175.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 65.7 t60 -122.74 -40.16 2.46 Favored 'General case' 0 C--N 1.293 -1.86 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.646 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 71.03 99.87 0.06 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.311 1.044 . . . . 0.0 111.95 -179.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 29.7 t-80 -145.75 112.48 5.96 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.38 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -134.2 118.43 17.62 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 172.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -82.15 100.97 10.13 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . 125.34 126.24 2.99 Favored Glycine 0 C--N 1.295 -1.701 0 N-CA-C 110.582 -1.007 . . . . 0.0 110.582 -178.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.501 ' H ' HD13 ' A' ' 203' ' ' LEU . 0.0 OUTLIER -115.84 -3.35 12.21 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 120.508 -0.477 . . . . 0.0 112.207 -178.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 8.7 p -127.85 123.25 22.75 Favored Pre-proline 0 C--N 1.307 -1.254 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.295 -178.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -72.89 131.97 17.75 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.343 2.029 . . . . 0.0 110.358 174.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -85.77 110.91 19.68 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 110.65 45.5 0.9 Allowed Glycine 0 N--CA 1.446 -0.656 0 N-CA-C 110.562 -1.015 . . . . 0.0 110.562 -177.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 21.3 m -65.95 24.03 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.002 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -172.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -101.19 -15.61 17.28 Favored 'General case' 0 C--N 1.308 -1.232 0 O-C-N 121.758 -0.589 . . . . 0.0 109.833 174.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -173.31 10.36 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 112.613 0.597 . . . . 0.0 112.613 177.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -84.75 48.69 1.58 Allowed 'General case' 0 C--O 1.24 0.604 0 O-C-N 121.143 -0.973 . . . . 0.0 111.704 -176.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 8.0 t -65.21 -35.74 82.0 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 21.2 mmt -104.21 83.65 2.11 Favored 'General case' 0 N--CA 1.428 -1.574 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 175.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 10.5 m -67.17 103.75 1.29 Allowed 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.017 -175.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 133.15 -16.13 4.7 Favored Glycine 0 N--CA 1.433 -1.522 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.731 -178.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . -129.42 116.22 2.11 Favored Glycine 0 N--CA 1.432 -1.609 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -84.07 -33.62 24.37 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 120.948 0.404 . . . . 0.0 110.372 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -87.85 91.04 8.61 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 174.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 3.4 ppp? -100.03 -4.47 29.89 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.826 -176.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 147.08 146.13 4.31 Favored Glycine 0 N--CA 1.424 -2.114 0 C-N-CA 119.906 -1.14 . . . . 0.0 112.748 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 32.0 ttp180 -162.63 98.06 0.98 Allowed 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 177.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -155.9 64.89 0.32 Allowed Glycine 0 N--CA 1.418 -2.51 0 C-N-CA 119.151 -1.499 . . . . 0.0 113.145 -177.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 11.4 m -93.68 49.68 1.38 Allowed 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 174.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -107.59 8.16 29.05 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.907 -173.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . 0.466 ' O ' HD23 ' A' ' 245' ' ' LEU . 0.3 OUTLIER -155.63 166.29 33.95 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -177.301 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.567 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 10.5 m -69.79 117.18 11.06 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -151.23 173.02 14.93 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.741 -0.784 . . . . 0.0 111.265 -176.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.54 HD13 HD21 ' A' ' 277' ' ' LEU . 2.2 pp -133.48 159.37 42.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.33 -178.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -150.83 156.49 41.36 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -178.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -130.38 134.52 47.21 Favored 'General case' 0 C--N 1.316 -0.873 0 C-N-CA 120.031 -0.668 . . . . 0.0 111.552 175.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 13.3 ptp180 -145.26 166.95 24.01 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 173.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.453 ' HE3' HG22 ' A' ' 284' ' ' THR . 55.2 mtpt -110.82 146.42 36.45 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 174.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . 0.428 ' O ' ' HB3' ' A' ' 237' ' ' ALA . 18.2 t70 -152.88 117.76 5.1 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 -177.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 99.25 -131.32 10.52 Favored Glycine 0 N--CA 1.434 -1.467 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.263 178.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 34.3 ttmt -101.39 85.59 2.82 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 122.686 0.395 . . . . 0.0 110.166 -177.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.486 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 91.2 m-20 57.8 21.4 7.44 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 177.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.428 ' HB3' ' O ' ' A' ' 233' ' ' ASP . . . -79.18 138.4 37.84 Favored 'General case' 0 N--CA 1.424 -1.729 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.907 -178.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -97.27 114.88 5.1 Favored Glycine 0 N--CA 1.421 -2.348 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.2 mp -107.19 111.96 37.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-O 121.505 0.669 . . . . 0.0 110.581 -177.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.5 mp -97.35 112.53 29.6 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.187 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 176.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -92.38 136.76 32.93 Favored 'General case' 0 C--N 1.277 -2.548 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 11.8 tp -127.98 127.78 43.86 Favored 'General case' 0 C--N 1.276 -2.598 0 C-N-CA 123.836 0.854 . . . . 0.0 110.359 -174.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . 0.567 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -113.25 101.19 9.18 Favored 'General case' 0 N--CA 1.417 -2.088 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -108.28 90.78 3.4 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 225' ' ' GLN . 3.8 mm? -80.52 115.57 20.11 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.998 -174.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 105.87 14.22 21.67 Favored Glycine 0 N--CA 1.431 -1.675 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.597 178.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -114.98 118.21 32.79 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 -178.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -116.43 91.11 3.49 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.842 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . 164.89 -148.51 14.33 Favored Glycine 0 N--CA 1.436 -1.305 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -126.42 138.6 32.69 Favored Pre-proline 0 C--N 1.31 -1.116 0 CA-C-N 117.277 0.539 . . . . 0.0 109.603 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.723 ' HB3' HD13 ' A' ' 264' ' ' LEU . 12.0 Cg_endo -71.5 172.1 14.93 Favored 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 121.683 1.589 . . . . 0.0 110.904 175.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 34.3 t70 -95.64 108.69 20.99 Favored 'General case' 0 C--N 1.28 -2.426 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.45 HD11 ' HG2' ' A' ' 251' ' ' PRO . 4.5 mp -105.84 116.25 49.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-O 121.302 0.572 . . . . 0.0 111.312 -178.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 19.3 t -95.51 111.8 23.64 Favored 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 175.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -88.76 95.68 10.37 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-O 121.468 0.651 . . . . 0.0 111.684 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.488 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 78.4 mt-30 -108.54 144.36 36.31 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 172.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -74.52 -19.98 60.14 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 119.769 -0.772 . . . . 0.0 112.109 -174.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -73.86 -47.24 39.64 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 123.875 0.734 . . . . 0.0 109.942 177.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . 0.488 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 44.3 p-80 -162.67 162.27 26.89 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.158 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 301' ' ' ILE . 29.5 mt -106.05 143.02 17.71 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 -177.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . . . . . . . . . 3.4 mp -125.51 114.7 40.75 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 178.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.548 ' HA ' ' O ' ' A' ' 252' ' ' ASP . 1.4 m -110.0 140.48 28.79 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.271 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 178.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . 0.55 ' HA ' ' O ' ' A' ' 298' ' ' THR . 24.4 m -135.2 123.99 23.9 Favored 'General case' 0 C--N 1.286 -2.193 0 CA-C-O 121.131 0.491 . . . . 0.0 111.14 177.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.723 HD13 ' HB3' ' A' ' 251' ' ' PRO . 1.7 mm? -93.98 107.75 19.63 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 176.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.43 ' HD3' ' OD1' ' A' ' 297' ' ' ASP . 30.3 mmtp -69.6 129.53 39.9 Favored 'General case' 0 C--N 1.29 -2.001 0 O-C-N 123.927 0.767 . . . . 0.0 112.689 -177.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 14.0 t30 70.1 22.62 5.57 Favored 'General case' 0 CA--C 1.554 1.113 0 O-C-N 124.952 1.407 . . . . 0.0 111.189 176.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 38.0 t60 -112.79 110.27 20.28 Favored 'General case' 0 C--O 1.213 -0.821 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 10.9 p -77.83 142.79 38.34 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.19 0.519 . . . . 0.0 112.158 -179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . . . . . . . . . 35.9 tp -121.98 121.12 28.15 Favored Pre-proline 0 N--CA 1.431 -1.403 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.543 177.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -59.62 134.62 58.99 Favored 'Trans proline' 0 C--N 1.321 -0.91 0 C-N-CA 122.672 2.248 . . . . 0.0 111.276 170.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . 0.571 ' HB ' ' HD3' ' A' ' 293' ' ' ARG . 6.5 t -66.3 -9.3 31.49 Favored 'General case' 0 CA--C 1.554 1.108 0 CA-C-O 121.823 0.82 . . . . 0.0 112.092 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 27.2 m -83.22 -14.95 52.21 Favored 'General case' 0 C--N 1.295 -1.766 0 CA-C-O 121.642 0.734 . . . . 0.0 109.902 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.443 HD13 ' O ' ' A' ' 226' ' ' THR . 82.4 mt -106.23 -6.39 18.51 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.171 -176.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.492 ' OE1' ' HG2' ' A' ' 293' ' ' ARG . 8.5 pt20 -82.92 101.39 11.0 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-O 121.844 0.83 . . . . 0.0 109.637 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . 0.461 ' HG3' HD11 ' A' ' 228' ' ' ILE . 14.0 ptm180 -129.25 179.09 5.97 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 48.8 m -125.44 164.87 19.49 Favored 'General case' 0 N--CA 1.409 -2.476 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 176.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.54 HD21 HD13 ' A' ' 228' ' ' ILE . 2.9 mm? -122.29 115.91 23.17 Favored 'General case' 0 C--N 1.286 -2.165 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -77.98 92.37 4.32 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 174.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.676 ' HA ' ' CD2' ' A' ' 282' ' ' PHE . 92.3 t -100.51 18.77 2.91 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.216 0 CA-C-O 123.124 1.44 . . . . 0.0 109.357 -176.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -70.19 137.07 50.63 Favored 'General case' 0 N--CA 1.421 -1.876 0 CA-C-N 114.583 -1.19 . . . . 0.0 107.967 176.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 72.94 19.27 3.81 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.961 0.904 . . . . 0.0 112.883 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.676 ' CD2' ' HA ' ' A' ' 279' ' ' VAL . 9.4 m-85 -85.69 -13.81 47.34 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.799 172.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.27 60.66 1.99 Allowed 'General case' 0 CA--C 1.492 -1.262 0 CA-C-O 121.838 0.828 . . . . 0.0 110.648 -177.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' THR . . . . . 0.453 HG22 ' HE3' ' A' ' 232' ' ' LYS . 2.9 p -136.12 173.3 5.79 Favored Pre-proline 0 N--CA 1.421 -1.924 0 N-CA-C 104.445 -2.428 . . . . 0.0 104.445 178.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 2.8 Cg_exo -79.02 -5.98 14.78 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.404 1.402 . . . . 0.0 112.211 176.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.3 p -101.53 125.44 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-O 121.38 0.61 . . . . 0.0 110.446 178.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -86.93 -40.89 14.39 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.911 -175.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -159.16 134.26 8.27 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.939 -174.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.511 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 35.6 t -95.14 135.65 28.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 172.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 96.0 m -139.69 121.97 15.95 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 118.094 0.407 . . . . 0.0 110.531 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.523 ' HB2' HG12 ' A' ' 228' ' ' ILE . 45.7 tp -103.79 135.98 44.32 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 176.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -134.22 134.93 42.58 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -177.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . 0.571 ' HD3' ' HB ' ' A' ' 271' ' ' THR . 17.4 ptt180 -73.54 138.06 44.76 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 173.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.561 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 22.6 tp -115.29 -175.47 2.71 Favored 'General case' 0 C--N 1.284 -2.246 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.561 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 16.2 m120 -35.98 -75.94 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.944 1.698 . . . . 0.0 112.543 179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . 0.401 ' H ' HD22 ' A' ' 296' ' ' ASN . 0.0 OUTLIER -125.4 -1.27 7.55 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 174.519 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . 0.43 ' OD1' ' HD3' ' A' ' 265' ' ' LYS . 11.5 m-20 -108.49 171.79 7.21 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 113.869 -1.514 . . . . 0.0 109.594 -171.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.55 ' O ' ' HA ' ' A' ' 263' ' ' THR . 91.8 m -114.35 129.07 56.63 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 176.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . 0.544 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 36.3 tt0 -114.05 127.27 55.86 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -176.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.476 HD13 HG21 ' A' ' 228' ' ' ILE . 70.1 tp -114.94 123.08 48.21 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 120.606 -0.438 . . . . 0.0 110.503 178.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 260' ' ' ILE . 62.5 mt -111.24 118.9 58.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-O 121.429 0.633 . . . . 0.0 109.487 -177.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 65.7 mt -114.87 108.83 26.43 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.533 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 14.6 m -82.59 131.66 35.21 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -176.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 6.9 p -126.67 164.82 20.44 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -174.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -145.98 134.65 22.24 Favored 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 123.534 0.734 . . . . 0.0 109.894 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 88.74 -166.8 34.45 Favored Glycine 0 C--O 1.252 1.263 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.237 176.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' ASN . . . . . 0.405 ' HB3' ' HB3' ' A' ' 327' ' ' LYS . 69.5 m-20 -86.27 126.18 34.12 Favored 'General case' 0 CA--C 1.489 -1.39 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 177.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -144.54 165.43 28.02 Favored 'General case' 0 C--N 1.286 -2.152 0 C-N-CA 120.118 -0.633 . . . . 0.0 110.553 -175.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.441 ' HG2' ' HE2' ' A' ' 327' ' ' LYS . 15.2 mt-10 -125.39 145.36 50.08 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.88 122.7 48.51 Favored 'General case' 0 N--CA 1.437 -1.076 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 -178.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 21.7 t -122.07 106.23 17.62 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 169.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -100.39 113.02 25.43 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-O 121.789 0.804 . . . . 0.0 110.277 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -106.91 150.99 25.85 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 114.474 -1.239 . . . . 0.0 109.906 -174.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 36.0 t -115.53 102.91 10.22 Favored 'General case' 0 C--N 1.288 -2.076 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 175.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -69.17 -30.96 69.29 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.525 0.679 . . . . 0.0 110.063 -176.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -167.16 159.85 10.73 Favored Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 178.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -64.22 95.26 0.21 Allowed 'Trans proline' 0 C--O 1.247 0.953 0 C-N-CA 121.724 1.616 . . . . 0.0 110.858 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 135.38 -33.87 2.37 Favored Glycine 0 N--CA 1.427 -1.963 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.307 -177.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -100.44 117.09 33.89 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 122.188 -0.596 . . . . 0.0 110.171 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -117.14 160.59 20.79 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 121.751 0.786 . . . . 0.0 110.04 -179.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 89.6 m -151.77 124.09 8.26 Favored 'General case' 0 C--N 1.268 -2.941 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.713 -176.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -109.82 109.49 20.17 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . 0.402 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 60.8 tt0 -97.62 107.84 20.42 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 309' ' ' GLU . 83.9 t -97.6 99.02 8.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.875 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.623 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -88.02 154.93 52.61 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -81.51 142.83 13.28 Favored 'Trans proline' 0 N--CA 1.444 -1.42 0 C-N-CA 121.44 1.427 . . . . 0.0 109.343 171.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.441 ' HE2' ' HG2' ' A' ' 309' ' ' GLU . 37.3 ttmt -111.82 104.44 12.75 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -177.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . 0.403 ' HE3' ' HB3' ' A' ' 328' ' ' LYS . 13.7 ttpp -112.77 23.91 12.98 Favored 'General case' 0 C--N 1.28 -2.418 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 . . . . . 0 C--N 1.324 -0.538 0 CA-C-N 113.573 -1.649 . . . . 0.0 111.104 179.995 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 51.7 tpp . . . . . 0 C--O 1.236 0.369 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 142.73 -147.14 18.5 Favored Glycine 0 N--CA 1.434 -1.442 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -178.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 50.8 m -115.97 92.08 3.79 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 117.403 0.602 . . . . 0.0 109.923 177.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 49.3 m -82.75 90.39 6.88 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.059 -178.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 27.4 m80 -157.23 -166.62 2.1 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 125.559 1.543 . . . . 0.0 106.846 179.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 39.1 t60 -97.24 -11.15 24.53 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 119.729 -0.788 . . . . 0.0 111.429 -178.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 40.3 m80 75.04 107.54 0.07 Allowed 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 124.237 1.015 . . . . 0.0 113.675 178.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -87.76 -57.13 3.06 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 170.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . 0.415 ' HB2' ' HB2' ' A' ' 203' ' ' LEU . 1.6 p80 -76.9 99.0 5.07 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 173.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 70.8 m80 -79.18 -76.4 0.21 Allowed 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.201 -177.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -92.74 0.23 69.95 Favored Glycine 0 N--CA 1.435 -1.417 0 C-N-CA 120.118 -1.039 . . . . 0.0 112.079 -179.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . 0.415 ' HB2' ' HB2' ' A' ' 200' ' ' HIS . 3.3 mm? -82.13 83.87 7.21 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.631 0.729 . . . . 0.0 111.623 -179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 41.3 t -106.3 139.36 20.22 Favored Pre-proline 0 C--N 1.296 -1.76 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 175.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -53.62 -61.9 0.39 Allowed 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.015 1.81 . . . . 0.0 111.077 176.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 -132.21 89.46 2.67 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.126 0.488 . . . . 0.0 110.232 176.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -110.79 104.6 1.79 Allowed Glycine 0 C--N 1.303 -1.265 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 177.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 20.1 m 63.6 -164.95 0.24 Allowed 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -174.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -158.92 -35.37 0.06 Allowed 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 119.557 1.071 . . . . 0.0 113.703 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 15.6 tpt -88.83 -4.29 58.53 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 122.778 1.275 . . . . 0.0 109.398 -178.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -168.05 158.5 10.45 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 104.184 -2.524 . . . . 0.0 104.184 176.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 18.0 m -118.77 5.24 11.52 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 122.083 0.944 . . . . 0.0 108.777 177.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.64 160.46 43.11 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 114.402 -1.272 . . . . 0.0 108.322 -176.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 59.8 m -105.72 103.35 12.83 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 173.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -143.59 -152.37 5.64 Favored Glycine 0 N--CA 1.418 -2.544 0 C-N-CA 119.269 -1.443 . . . . 0.0 113.813 -174.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 124.72 -32.06 4.16 Favored Glycine 0 N--CA 1.428 -1.873 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -177.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . 0.522 ' O ' ' HB2' ' A' ' 221' ' ' ARG . 26.7 mt-30 -72.63 -24.16 61.02 Favored 'General case' 0 C--O 1.209 -1.076 0 CA-C-O 120.781 0.324 . . . . 0.0 111.071 -179.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -65.53 -32.02 73.4 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 176.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . 0.489 ' O ' ' HA ' ' A' ' 224' ' ' LYS . 50.9 ttm -85.59 -56.23 3.61 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-N 114.999 -1.001 . . . . 0.0 109.726 -179.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -93.5 57.85 2.29 Favored Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 121.207 -0.521 . . . . 0.0 112.827 -177.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . 0.522 ' HB2' ' O ' ' A' ' 217' ' ' GLN . 44.0 ttm180 -103.85 77.9 1.5 Allowed 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 177.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 82.08 -52.46 4.63 Favored Glycine 0 C--N 1.312 -0.788 0 CA-C-N 115.587 -0.733 . . . . 0.0 112.129 -178.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 16.6 m -131.79 132.12 43.5 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 219' ' ' MET . 37.2 mtmm -86.05 -154.9 0.22 Allowed 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 178.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -111.05 173.81 6.16 Favored 'General case' 0 N--CA 1.421 -1.896 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 176.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.698 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 52.5 m -63.47 112.61 2.84 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.679 0.752 . . . . 0.0 113.026 -174.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.419 ' C ' HD22 ' A' ' 227' ' ' ASN . 0.2 OUTLIER -145.49 165.69 27.86 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.85 -175.283 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.616 HD13 HD21 ' A' ' 277' ' ' LEU . 1.6 pp -115.5 161.97 13.87 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.428 0 CA-C-N 114.931 -1.031 . . . . 0.0 111.076 178.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.52 ' HB3' ' HB2' ' A' ' 241' ' ' GLU . 7.1 t70 -151.26 155.91 39.75 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.404 ' HZ ' HG21 ' A' ' 284' ' ' THR . 75.4 t80 -132.87 135.57 45.68 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 173.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -149.45 168.84 22.33 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 174.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.526 ' HE3' HG22 ' A' ' 284' ' ' THR . 55.6 mtpt -117.19 139.91 50.19 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 174.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -149.0 117.78 6.64 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -175.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 99.55 -119.33 6.47 Favored Glycine 0 N--CA 1.428 -1.868 0 C-N-CA 120.608 -0.805 . . . . 0.0 113.127 177.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -113.34 85.35 2.17 Favored 'General case' 0 C--N 1.305 -1.341 0 O-C-N 122.88 -0.188 . . . . 0.0 110.833 -175.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.564 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 5.9 m-20 56.2 21.8 5.57 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 124.705 1.202 . . . . 0.0 113.258 177.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.52 ' HB2' HD23 ' A' ' 325' ' ' LEU . . . -79.58 142.37 35.74 Favored 'General case' 0 N--CA 1.42 -1.971 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.019 -176.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . 0.501 ' HA3' ' CG1' ' A' ' 286' ' ' VAL . . . -92.48 115.99 4.97 Favored Glycine 0 N--CA 1.418 -2.504 0 N-CA-C 108.798 -1.721 . . . . 0.0 108.798 176.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.6 mp -110.0 109.7 29.39 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-N 118.065 0.932 . . . . 0.0 110.267 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.0 mp -98.96 109.61 24.54 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.165 0 N-CA-C 107.427 -1.324 . . . . 0.0 107.427 178.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.52 ' HB2' ' HB3' ' A' ' 229' ' ' ASP . 44.7 mt-10 -90.78 138.43 31.59 Favored 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 176.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 12.3 tp -128.47 131.48 48.36 Favored 'General case' 0 C--N 1.267 -3.022 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.561 -173.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . 0.698 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -116.41 106.25 13.41 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . 0.432 ' HA ' HG23 ' A' ' 226' ' ' THR . . . -118.19 90.91 3.43 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 175.093 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -83.25 113.87 20.98 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-O 121.538 0.685 . . . . 0.0 110.864 -174.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 122.99 -5.14 9.66 Favored Glycine 0 N--CA 1.428 -1.873 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.13 -175.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -115.99 113.09 22.76 Favored 'General case' 0 N--CA 1.431 -1.387 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 176.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -114.96 16.77 17.13 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 120.852 0.358 . . . . 0.0 111.437 -175.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -116.68 -162.84 13.01 Favored Glycine 0 C--N 1.302 -1.352 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -101.28 132.51 21.79 Favored Pre-proline 0 C--N 1.301 -1.501 0 CA-C-N 117.798 0.799 . . . . 0.0 110.724 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.735 ' HB3' HD23 ' A' ' 264' ' ' LEU . 9.5 Cg_endo -71.73 172.52 14.27 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.429 2.086 . . . . 0.0 112.443 176.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 30.2 t70 -97.07 105.47 17.62 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 178.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.446 HD11 ' HG2' ' A' ' 251' ' ' PRO . 4.7 mp -104.86 118.09 51.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.566 -178.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . 0.488 ' HB3' ' HB ' ' A' ' 261' ' ' ILE . 22.9 t -101.0 123.23 44.87 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 175.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -107.93 95.61 5.8 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -176.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -103.35 164.39 11.67 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -60.93 -48.16 83.07 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 117.851 0.296 . . . . 0.0 111.344 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -76.08 -33.17 59.53 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.255 -173.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . 0.421 ' CB ' ' HA ' ' A' ' 303' ' ' THR . 41.8 p-80 -164.64 166.47 20.1 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 119.908 -0.717 . . . . 0.0 112.677 176.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.467 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 18.6 mt -106.41 144.71 15.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 179.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . 0.488 ' HB ' ' HB3' ' A' ' 254' ' ' SER . 3.3 mp -128.94 114.13 31.56 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 299' ' ' GLN . 1.3 m -107.6 132.74 54.38 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.527 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 175.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . 0.414 ' HB ' ' HB3' ' A' ' 252' ' ' ASP . 19.5 m -120.83 120.97 37.1 Favored 'General case' 0 C--N 1.281 -2.396 0 CA-C-O 121.211 0.529 . . . . 0.0 109.718 177.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.735 HD23 ' HB3' ' A' ' 251' ' ' PRO . 24.0 mt -100.91 94.74 6.18 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 179.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -57.8 126.57 27.97 Favored 'General case' 0 N--CA 1.432 -1.374 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 -175.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 63.78 19.24 11.63 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 113.263 -1.789 . . . . 0.0 111.283 176.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 53.5 t60 -98.56 117.73 33.66 Favored 'General case' 0 C--O 1.21 -1.006 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 178.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 5.4 p -92.7 118.62 31.25 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -176.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . 0.513 HD12 ' HD2' ' A' ' 270' ' ' PRO . 21.5 tp -99.5 129.91 28.0 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.093 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.513 ' HD2' HD12 ' A' ' 269' ' ' LEU . 71.9 Cg_endo -75.96 160.0 37.38 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.28 1.987 . . . . 0.0 111.971 176.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 19.6 p -62.66 -41.24 98.97 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 123.548 0.739 . . . . 0.0 112.485 -174.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 32.2 m -63.15 -23.35 67.39 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 124.573 1.149 . . . . 0.0 113.094 -176.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.558 HD13 ' O ' ' A' ' 226' ' ' THR . 95.4 mt -95.96 -10.11 29.48 Favored 'General case' 0 N--CA 1.438 -1.045 0 C-N-CA 120.21 -0.596 . . . . 0.0 110.583 -174.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -74.3 133.39 42.58 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 175.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . 0.484 ' CG ' HD11 ' A' ' 228' ' ' ILE . 5.4 ptp180 -171.58 172.5 5.0 Favored 'General case' 0 C--N 1.285 -2.237 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 177.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 11.8 p -130.39 148.45 52.21 Favored 'General case' 0 N--CA 1.402 -2.845 0 CA-C-O 121.293 0.568 . . . . 0.0 111.008 177.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.616 HD21 HD13 ' A' ' 228' ' ' ILE . 1.3 mm? -95.79 117.31 30.31 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 103.058 -2.942 . . . . 0.0 103.058 174.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -63.54 -38.85 92.7 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.479 ' HA ' ' CD1' ' A' ' 282' ' ' PHE 0.259 12.2 p 40.61 34.91 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.336 0 C-N-CA 127.139 2.176 . . . . 0.0 114.1 174.823 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -85.26 140.47 30.82 Favored 'General case' 0 N--CA 1.43 -1.467 0 CA-C-N 115.069 -0.968 . . . . 0.0 108.776 177.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 32.9 t70 72.52 7.65 5.62 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.285 1.034 . . . . 0.0 111.354 178.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.479 ' CD1' ' HA ' ' A' ' 279' ' ' VAL . 11.2 m-85 -73.22 -19.58 61.05 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.198 174.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm 61.85 60.7 1.52 Allowed 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 124.259 1.024 . . . . 0.0 112.032 174.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' THR . . . . . 0.526 HG22 ' HE3' ' A' ' 232' ' ' LYS . 4.9 p -128.26 178.25 1.73 Allowed Pre-proline 0 C--N 1.288 -2.108 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . 0.564 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 7.8 Cg_exo -75.36 -10.08 20.51 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 CA-C-N 121.172 1.454 . . . . 0.0 110.714 174.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . 0.501 ' CG1' ' HA3' ' A' ' 238' ' ' GLY . 0.8 OUTLIER -90.54 140.84 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.425 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 179.03 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -99.19 -51.02 3.95 Favored 'General case' 0 C--N 1.279 -2.459 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.425 -177.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . 0.45 ' HA ' ' CG1' ' A' ' 279' ' ' VAL . 86.8 tttt -155.45 135.49 12.94 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.454 ' HB ' HD23 ' A' ' 277' ' ' LEU . 42.9 t -102.44 126.18 56.59 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.927 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 60.8 m -132.49 125.72 31.3 Favored 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 121.001 0.429 . . . . 0.0 111.236 -177.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.423 ' HB2' HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -99.78 124.78 45.39 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 178.54 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -128.78 138.12 51.91 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.053 0.454 . . . . 0.0 110.112 -177.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 23.7 ptt180 -80.82 144.72 31.85 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 174.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.507 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 32.4 tp -122.93 -179.76 4.37 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -178.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.507 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 88.2 m-20 -31.43 -71.92 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 126.514 1.926 . . . . 0.0 112.874 -178.124 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . 0.424 ' H ' HD22 ' A' ' 296' ' ' ASN . 0.0 OUTLIER -126.26 -1.63 6.98 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 173.329 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -110.87 172.8 6.66 Favored 'General case' 0 CA--C 1.498 -1.035 0 CA-C-N 114.166 -1.379 . . . . 0.0 109.445 -169.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.498 ' HB ' HD12 ' A' ' 264' ' ' LEU . 88.8 m -116.71 134.97 54.16 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 174.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . 0.571 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 27.5 tt0 -122.17 125.29 45.8 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 120.975 0.416 . . . . 0.0 109.926 -175.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.467 ' HB3' HG13 ' A' ' 262' ' ' VAL . 62.5 tp -108.42 120.52 42.65 Favored 'General case' 0 C--N 1.284 -2.267 0 C-N-CA 119.966 -0.694 . . . . 0.0 110.083 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 72.2 mt -106.95 114.8 46.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.795 -175.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . 0.467 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 52.0 mt -116.51 105.51 18.48 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.326 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 178.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . 0.421 ' HA ' ' CB ' ' A' ' 259' ' ' HIS . 18.2 m -73.67 138.19 44.58 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -178.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 10.3 p -137.06 177.86 7.53 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 122.803 0.441 . . . . 0.0 111.691 -174.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -156.81 143.33 18.33 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 122.418 0.287 . . . . 0.0 111.168 178.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 77.72 -152.27 38.78 Favored Glycine 0 C--O 1.247 0.951 0 O-C-N 123.523 0.515 . . . . 0.0 113.819 173.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -93.22 129.01 39.41 Favored 'General case' 0 CA--C 1.491 -1.322 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 177.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' TRP . . . . . 0.562 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 69.2 p-90 -157.56 160.29 38.01 Favored 'General case' 0 C--N 1.283 -2.319 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -177.218 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.461 ' HG2' ' HE2' ' A' ' 327' ' ' LYS . 6.7 mt-10 -119.67 130.88 55.26 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -176.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.562 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 1.6 tm? -97.76 136.53 37.96 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.529 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 57.3 t -135.42 111.79 13.27 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -101.16 131.52 47.08 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -130.65 143.78 50.98 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -178.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 13.8 m -111.23 116.38 30.95 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -80.35 -40.84 25.87 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.798 -176.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . 0.428 ' HB1' ' HD2' ' A' ' 317' ' ' PRO . . . -159.75 165.86 17.15 Favored Pre-proline 0 C--N 1.301 -1.517 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 -177.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . 0.428 ' HD2' ' HB1' ' A' ' 316' ' ' ALA . 29.7 Cg_endo -62.14 102.47 0.27 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 121.679 1.586 . . . . 0.0 111.018 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 116.39 -27.15 8.21 Favored Glycine 0 N--CA 1.426 -1.974 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.648 -178.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -98.11 116.57 30.6 Favored 'General case' 0 C--N 1.296 -1.758 0 O-C-N 121.922 -0.752 . . . . 0.0 110.762 -178.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -118.63 166.68 12.44 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.065 -0.971 . . . . 0.0 110.474 -177.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 59.6 m -152.0 131.18 12.74 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.387 -176.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -118.56 114.14 22.36 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 176.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . 0.529 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 7.2 tt0 -101.18 102.94 13.95 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -98.11 101.97 12.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.043 0 CA-C-O 122.46 1.124 . . . . 0.0 109.736 177.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.52 HD23 ' HB2' ' A' ' 237' ' ' ALA . 28.0 mt -91.05 145.55 31.89 Favored Pre-proline 0 C--N 1.302 -1.473 0 CA-C-N 113.479 -1.692 . . . . 0.0 109.922 -175.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -72.6 144.4 39.88 Favored 'Trans proline' 0 C--O 1.245 0.856 0 C-N-CA 121.648 1.565 . . . . 0.0 109.442 174.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.461 ' HE2' ' HG2' ' A' ' 309' ' ' GLU . 36.3 ttmt -123.44 148.35 46.25 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 -178.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 65.0 tttp -110.23 129.34 55.74 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 171.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 . . . . . 0 C--N 1.291 -1.967 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 179.467 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 49.8 tpp . . . . . 0 CA--C 1.516 -0.336 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -134.07 -50.31 0.08 OUTLIER Glycine 0 N--CA 1.433 -1.564 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 -179.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 23.2 m -67.82 98.97 0.77 Allowed 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 120.938 0.399 . . . . 0.0 110.041 178.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 48.1 m -160.15 114.43 2.23 Favored 'General case' 0 C--N 1.312 -1.046 0 C-N-CA 123.679 0.792 . . . . 0.0 109.122 -178.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -76.86 -40.48 47.48 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 174.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 81.8 t60 174.19 147.95 0.07 Allowed 'General case' 0 CA--C 1.52 -0.193 0 C-N-CA 124.459 1.104 . . . . 0.0 108.467 176.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . . . . . . . . . 36.1 m170 -121.92 141.52 51.21 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 175.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 6.7 p-80 -130.48 -9.49 4.11 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 112.311 0.485 . . . . 0.0 112.311 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 -144.52 71.99 1.33 Allowed 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.649 0.737 . . . . 0.0 109.287 -178.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -171.21 127.49 0.69 Allowed 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 114.669 -1.15 . . . . 0.0 108.236 -179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -95.77 92.09 1.4 Allowed Glycine 0 N--CA 1.424 -2.149 0 C-N-CA 119.894 -1.146 . . . . 0.0 112.055 178.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 59.7 tp -92.59 -49.57 6.04 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 175.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 64.7 t -88.35 -56.55 0.3 Allowed Pre-proline 0 CA--C 1.55 0.967 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.619 176.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -64.71 140.62 68.74 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 121.059 1.173 . . . . 0.0 109.794 176.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . 0.41 ' HD3' ' O ' ' A' ' 206' ' ' ARG . 0.0 OUTLIER -93.55 138.14 32.11 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 120.969 0.414 . . . . 0.0 112.044 -176.473 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . 153.72 68.5 0.01 OUTLIER Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -177.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 43.2 t -113.98 -5.61 13.16 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -176.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -79.6 -70.93 0.48 Allowed 'General case' 0 CA--C 1.51 -0.596 0 CA-C-O 120.989 0.423 . . . . 0.0 111.095 179.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -111.51 136.69 50.34 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -65.47 89.73 0.1 Allowed 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 121.48 0.657 . . . . 0.0 112.402 -177.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 22.6 m -137.07 127.78 27.1 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 23.7 ptp -156.04 171.72 19.63 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 -179.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 24.3 p -92.56 80.11 4.84 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.397 0.618 . . . . 0.0 110.776 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -110.57 -45.92 0.88 Allowed Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 120.629 -0.796 . . . . 0.0 111.558 -179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 166.74 -137.96 4.93 Favored Glycine 0 C--N 1.292 -1.869 0 N-CA-C 108.159 -1.977 . . . . 0.0 108.159 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 63.42 21.77 12.93 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.312 0.645 . . . . 0.0 111.396 175.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -78.43 -4.54 48.86 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.068 -174.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 24.0 ptp -109.25 -6.74 15.43 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 120.246 -0.581 . . . . 0.0 109.86 173.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -108.4 74.57 0.21 Allowed Glycine 0 N--CA 1.437 -1.265 0 C-N-CA 121.222 -0.513 . . . . 0.0 112.223 -178.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.5 163.48 24.02 Favored 'General case' 0 CA--C 1.504 -0.809 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 178.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 224' ' ' LYS . . . 75.89 -80.83 1.05 Allowed Glycine 0 C--N 1.312 -0.789 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 22.9 t -73.84 11.84 0.79 Allowed 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.816 1.247 . . . . 0.0 110.237 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . 0.406 ' H ' ' C ' ' A' ' 222' ' ' GLY . 60.1 tttp -74.65 -27.38 60.41 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 172.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . 0.446 ' O ' HD23 ' A' ' 245' ' ' LEU . 5.7 tp-100 -131.54 -178.65 4.96 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-N 115.256 -0.883 . . . . 0.0 108.953 -176.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.646 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 28.3 m -74.1 123.86 25.22 Favored 'General case' 0 C--O 1.202 -1.41 0 C-N-CA 124.495 1.118 . . . . 0.0 113.696 -169.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 40.3 m-80 -143.69 169.05 18.49 Favored 'General case' 0 CA--C 1.474 -1.976 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -175.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.64 HG12 ' HB2' ' A' ' 291' ' ' LEU . 2.8 pp -135.54 160.15 39.95 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 175.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 240' ' ' ILE . 24.0 t70 -148.3 156.49 42.6 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -173.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.422 ' CE2' HG21 ' A' ' 279' ' ' VAL . 76.7 t80 -125.82 139.06 53.81 Favored 'General case' 0 N--CA 1.427 -1.598 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.016 173.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 10.5 ptm180 -155.14 164.16 39.22 Favored 'General case' 0 C--N 1.311 -1.096 0 C-N-CA 124.803 1.241 . . . . 0.0 108.076 177.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 53.7 mtpt -115.94 144.74 43.64 Favored 'General case' 0 CA--C 1.486 -1.516 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 177.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 237' ' ' ALA . 32.7 t70 -149.71 124.83 10.05 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 123.716 0.635 . . . . 0.0 110.632 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 81.44 -133.12 11.75 Favored Glycine 0 C--N 1.3 -1.436 0 C-N-CA 120.966 -0.635 . . . . 0.0 114.258 175.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -86.34 76.2 9.7 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 122.843 0.457 . . . . 0.0 111.502 -171.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 58.22 20.04 6.76 Favored 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 124.128 0.971 . . . . 0.0 112.445 177.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.525 ' HB3' ' O ' ' A' ' 233' ' ' ASP . . . -78.58 140.43 38.48 Favored 'General case' 0 N--CA 1.421 -1.899 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.982 -175.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . 0.473 ' C ' HD12 ' A' ' 239' ' ' ILE . . . -95.81 131.35 10.63 Favored Glycine 0 N--CA 1.416 -2.634 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 177.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.473 HD12 ' C ' ' A' ' 238' ' ' GLY . 2.3 mp -120.52 115.74 47.98 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.301 0 CA-C-N 117.907 0.854 . . . . 0.0 110.403 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . 0.474 ' HB ' ' HB2' ' A' ' 322' ' ' PHE . 3.2 mp -100.1 106.92 19.96 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 176.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . 0.411 ' O ' ' HA ' ' A' ' 228' ' ' ILE . 30.9 mt-10 -86.88 141.72 28.56 Favored 'General case' 0 N--CA 1.417 -2.116 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.667 175.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 10.3 tp -128.78 125.34 37.62 Favored 'General case' 0 C--N 1.26 -3.308 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.208 -175.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . 0.646 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -112.46 97.61 6.72 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -107.15 91.56 3.71 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.62 0.724 . . . . 0.0 109.685 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.446 HD23 ' O ' ' A' ' 225' ' ' GLN . 3.0 mm? -80.58 115.48 20.11 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.377 -176.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 110.87 2.63 28.56 Favored Glycine 0 N--CA 1.43 -1.746 0 CA-C-N 114.938 -1.028 . . . . 0.0 111.5 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -115.94 140.85 48.84 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -138.91 15.39 2.67 Favored 'General case' 0 C--N 1.312 -1.059 0 C-N-CA 120.676 -0.409 . . . . 0.0 111.66 -178.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -117.21 -163.18 12.91 Favored Glycine 0 CA--C 1.495 -1.207 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -105.64 133.11 20.35 Favored Pre-proline 0 C--N 1.3 -1.577 0 CA-C-N 117.538 0.669 . . . . 0.0 110.022 -177.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.734 ' HB3' HD23 ' A' ' 264' ' ' LEU . 25.6 Cg_endo -73.69 169.21 22.88 Favored 'Trans proline' 0 CA--C 1.506 -0.903 0 C-N-CA 122.322 2.015 . . . . 0.0 112.79 177.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.62 ' O ' ' HA ' ' A' ' 262' ' ' VAL . 27.9 t70 -82.1 104.89 12.76 Favored 'General case' 0 CA--C 1.472 -2.023 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 174.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.478 ' CG2' HE21 ' A' ' 255' ' ' GLN . 7.1 mt -102.89 116.65 47.01 Favored 'Isoleucine or valine' 0 C--N 1.245 -3.966 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . . . . . . . . . 7.8 t -125.51 129.7 50.28 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 107.637 -1.245 . . . . 0.0 107.637 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . 0.666 HE22 HG23 ' A' ' 260' ' ' ILE . 70.4 mm-40 -110.36 131.73 54.8 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -175.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.521 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 28.3 mm-40 -119.74 163.48 17.38 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 104.703 -2.332 . . . . 0.0 104.703 171.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 36.8 m80 -73.19 -35.89 66.44 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -88.19 -17.14 31.53 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.518 -1.219 . . . . 0.0 112.674 -173.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . 0.521 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 51.2 p-80 -171.94 162.41 5.97 Favored 'General case' 0 C--O 1.213 -0.841 0 O-C-N 122.093 -0.379 . . . . 0.0 111.74 178.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.666 HG23 HE22 ' A' ' 255' ' ' GLN . 17.5 mt -107.52 144.72 15.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . 0.439 ' HA ' ' O ' ' A' ' 300' ' ' LEU . 3.5 mp -124.79 125.86 70.5 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 176.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 252' ' ' ASP . 0.8 OUTLIER -122.16 139.8 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.717 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 172.686 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . 0.48 ' HB ' ' HB3' ' A' ' 252' ' ' ASP . 24.7 m -131.05 123.54 28.92 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 118.527 0.603 . . . . 0.0 110.654 177.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.734 HD23 ' HB3' ' A' ' 251' ' ' PRO . 25.5 mt -100.54 96.48 7.41 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . . . . . . . . . 24.1 mmtm -57.79 125.57 23.59 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -176.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 2.4 t30 62.6 26.87 15.92 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 126.064 1.746 . . . . 0.0 110.894 177.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -103.61 106.33 16.81 Favored 'General case' 0 N--CA 1.424 -1.747 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 7.8 p -79.7 130.79 35.65 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 121.157 0.503 . . . . 0.0 112.226 -178.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . 0.594 HD12 ' HD2' ' A' ' 270' ' ' PRO . 30.3 tp -116.92 136.28 23.23 Favored Pre-proline 0 C--N 1.306 -1.294 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.594 ' HD2' HD12 ' A' ' 269' ' ' LEU . 84.5 Cg_endo -78.71 158.29 28.15 Favored 'Trans proline' 0 N--CA 1.438 -1.76 0 C-N-CA 121.204 1.269 . . . . 0.0 110.391 173.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . 0.476 ' HA ' HE21 ' A' ' 274' ' ' GLN . 5.9 p -64.5 -29.02 70.06 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.476 0.655 . . . . 0.0 111.298 -177.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 7.1 m -61.84 -29.36 70.12 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 125.393 1.477 . . . . 0.0 112.255 -178.246 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.546 HD13 ' HG2' ' A' ' 270' ' ' PRO . 10.4 mp -101.37 0.08 36.41 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-O 121.381 0.61 . . . . 0.0 111.913 -172.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . 0.476 HE21 ' HA ' ' A' ' 271' ' ' THR . 41.3 mt-30 -75.72 142.32 42.46 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 174.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 9.5 ptp180 -164.52 171.05 15.07 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -177.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 23.2 m -140.99 133.36 28.29 Favored 'General case' 0 N--CA 1.418 -2.052 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 176.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.516 ' HB2' ' HB ' ' A' ' 289' ' ' VAL . 1.5 mm? -100.14 111.26 23.55 Favored 'General case' 0 C--N 1.285 -2.208 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.4 79.61 9.4 Favored 'General case' 0 C--N 1.282 -2.348 0 CA-C-O 123.501 1.619 . . . . 0.0 109.518 175.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.422 HG21 ' CE2' ' A' ' 230' ' ' PHE 0.25 1.9 p -86.29 63.69 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.403 -2.815 0 CA-C-N 111.558 -2.565 . . . . 0.0 111.41 -175.555 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -105.97 144.93 32.0 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 113.07 -1.877 . . . . 0.0 106.911 177.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 31.7 t70 68.0 19.45 9.35 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-O 123.157 1.456 . . . . 0.0 110.538 -178.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . 0.405 ' CG ' HG23 ' A' ' 279' ' ' VAL . 41.1 m-85 -91.88 -13.1 31.84 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.171 -0.922 . . . . 0.0 109.101 173.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? 56.76 61.88 2.47 Favored 'General case' 0 CA--C 1.505 -0.768 0 C-N-CA 123.586 0.754 . . . . 0.0 112.569 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' THR . . . . . . . . . . . . . 1.5 p -136.24 170.62 10.48 Favored Pre-proline 0 N--CA 1.433 -1.32 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 178.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.46 -10.35 17.4 Favored 'Trans proline' 0 C--O 1.241 0.652 0 C-N-CA 122.018 1.812 . . . . 0.0 111.802 177.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.6 p -99.15 121.53 49.86 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.016 0 CA-C-O 121.991 0.9 . . . . 0.0 111.071 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -87.92 -41.57 13.08 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.199 -1.364 . . . . 0.0 112.522 -170.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -155.54 132.6 10.76 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -177.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.516 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 39.1 t -96.78 129.89 46.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 172.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . . . . . . . . . 57.1 m -136.38 128.16 29.11 Favored 'General case' 0 C--N 1.293 -1.89 0 O-C-N 121.822 -0.549 . . . . 0.0 111.037 -178.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.64 ' HB2' HG12 ' A' ' 228' ' ' ILE . 53.5 tp -109.92 123.91 50.45 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 177.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -131.05 130.88 43.81 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . 0.466 ' HB3' HD23 ' A' ' 269' ' ' LEU . 17.7 ptt180 -79.51 137.18 37.1 Favored 'General case' 0 N--CA 1.415 -2.198 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.535 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 16.1 tp -99.96 -177.35 3.52 Favored 'General case' 0 C--N 1.285 -2.201 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 -179.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.535 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 17.7 t-20 -45.22 -66.26 0.42 Allowed 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.217 1.007 . . . . 0.0 112.078 -177.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -118.67 -3.54 10.82 Favored 'General case' 0 CA--C 1.498 -1.02 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.062 174.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -110.22 173.17 6.45 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.308 -170.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.515 ' HB ' HD12 ' A' ' 264' ' ' LEU . 86.5 m -115.19 131.96 56.76 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 174.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . 0.577 ' HA ' ' O ' ' A' ' 262' ' ' VAL . 20.4 tt0 -124.84 130.82 53.13 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.172 -174.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.581 HD11 HG21 ' A' ' 228' ' ' ILE . 1.2 mm? -94.71 142.27 27.65 Favored 'General case' 0 CA--C 1.467 -2.212 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.01 172.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' ILE . . . . . . . . . . . . . 50.7 mt -129.01 108.51 17.19 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.568 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 172.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . 0.576 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 58.7 mt -114.14 103.38 15.27 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.813 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -177.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 5.5 m -75.79 129.93 37.81 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 -174.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 15.4 p -128.38 172.18 11.34 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 122.587 0.355 . . . . 0.0 110.817 -177.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -156.22 137.53 13.86 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 90.69 -169.65 34.25 Favored Glycine 0 N--CA 1.436 -1.344 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -87.33 129.78 34.88 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 177.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' TRP . . . . . 0.704 ' CZ3' ' HB2' ' A' ' 310' ' ' LEU . 57.4 p-90 -147.24 163.87 35.0 Favored 'General case' 0 C--N 1.293 -1.861 0 C-N-CA 120.397 -0.521 . . . . 0.0 110.476 -174.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -125.63 142.64 51.41 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -178.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . 0.704 ' HB2' ' CZ3' ' A' ' 308' ' ' TRP . 19.1 tp -116.87 139.35 50.73 Favored 'General case' 0 C--O 1.249 1.045 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.952 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.557 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 89.8 t -134.68 108.96 11.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 174.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . 0.584 ' HA ' ' O ' ' A' ' 321' ' ' THR . 19.7 t30 -98.45 129.28 45.06 Favored 'General case' 0 CA--C 1.454 -2.749 0 C-N-CA 119.759 -0.776 . . . . 0.0 111.006 177.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -119.93 121.42 38.95 Favored 'General case' 0 N--CA 1.384 -3.763 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.932 -178.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 22.1 t -84.75 105.81 15.82 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 174.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -73.69 -36.93 65.34 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.717 0.77 . . . . 0.0 110.481 -176.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -156.32 162.5 27.37 Favored Pre-proline 0 C--N 1.295 -1.802 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 -177.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.39 96.19 0.23 Allowed 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 121.505 1.47 . . . . 0.0 111.56 -178.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 125.72 -24.93 5.7 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 -178.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -100.08 116.22 31.59 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 122.244 -0.562 . . . . 0.0 109.638 -179.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -116.45 164.97 13.77 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.811 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . 0.584 ' O ' ' HA ' ' A' ' 312' ' ' ASN . 90.8 m -152.68 108.9 3.38 Favored 'General case' 0 C--N 1.275 -2.665 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.455 -173.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . 0.49 ' HB3' HD11 ' A' ' 310' ' ' LEU . 81.2 m-85 -97.03 108.18 20.86 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -179.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . 0.557 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 37.0 tt0 -96.25 108.04 20.47 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -179.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.517 HG23 ' CE3' ' A' ' 308' ' ' TRP . 0.4 OUTLIER -101.86 105.25 17.63 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.17 0 CA-C-O 121.3 0.572 . . . . 0.0 110.951 179.385 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.93 157.57 36.44 Favored Pre-proline 0 N--CA 1.466 0.346 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.57 131.81 8.56 Favored 'Trans proline' 0 C--O 1.246 0.925 0 C-N-CA 121.988 1.792 . . . . 0.0 110.133 172.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . 0.485 ' HE3' ' O ' ' A' ' 308' ' ' TRP . 41.0 ttmt -96.13 123.27 39.68 Favored 'General case' 0 C--N 1.303 -1.447 0 CA-C-N 116.582 -0.281 . . . . 0.0 110.587 -175.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -121.72 18.61 11.12 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-O 122.121 0.962 . . . . 0.0 109.451 172.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 . . . . . 0 C--N 1.295 -1.771 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.809 -179.788 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' MET . . . . . . . . . . . . . 66.9 mtt . . . . . 0 N--CA 1.471 0.597 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -90.76 -29.67 12.94 Favored Glycine 0 C--N 1.307 -1.048 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.739 -178.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' SER . . . . . . . . . . . . . 18.1 t -99.91 159.52 15.01 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 -177.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 16.6 m -81.19 127.56 32.8 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.616 -177.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -89.74 140.38 29.64 Favored 'General case' 0 CA--C 1.501 -0.94 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 172.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' HIS . . . . . . . . . . . . . 23.5 m-70 71.16 90.14 0.1 Allowed 'General case' 0 CA--C 1.5 -0.953 0 O-C-N 124.414 1.071 . . . . 0.0 108.285 -166.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' HIS . . . . . 0.414 ' O ' ' HD2' ' A' ' 200' ' ' HIS . 72.3 m-70 -81.24 -4.21 54.8 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.766 -175.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 61.6 m80 68.05 37.87 2.87 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.911 0.884 . . . . 0.0 111.041 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . 0.414 ' HD2' ' O ' ' A' ' 198' ' ' HIS . 55.9 m-70 -129.03 149.13 50.98 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.784 177.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -132.02 110.47 10.76 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.84 177.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' GLY . . . . . . . . . . . . . . . -93.92 -83.22 1.57 Allowed Glycine 0 C--N 1.303 -1.296 0 N-CA-C 108.241 -1.944 . . . . 0.0 108.241 171.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.49 -33.82 0.05 OUTLIER 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.53 -0.335 . . . . 0.0 110.865 172.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . 0.294 34.5 m 50.25 98.47 0.04 OUTLIER Pre-proline 0 N--CA 1.485 1.276 0 C-N-CA 124.974 1.31 . . . . 0.0 113.642 -177.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -58.42 -47.92 17.51 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.212 1.942 . . . . 0.0 110.689 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -141.71 130.78 23.28 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 176.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -112.92 148.6 18.52 Favored Glycine 0 C--N 1.297 -1.597 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 177.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' SER . . . . . . . . . . . . . 32.7 t -131.19 92.71 3.24 Favored 'General case' 0 N--CA 1.429 -1.512 0 CA-C-O 121.313 0.577 . . . . 0.0 110.856 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' HIS . . . . . . . . . . . . . 42.6 m-70 -124.85 -12.55 7.05 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.598 174.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' MET . . . . . . . . . . . . . 26.0 mmt 66.12 0.52 1.67 Allowed 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 125.593 1.557 . . . . 0.0 112.983 178.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' ALA . . . . . . . . . . . . . . . -93.24 4.56 53.78 Favored 'General case' 0 C--N 1.309 -1.152 0 CA-C-O 120.981 0.42 . . . . 0.0 111.314 -176.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 16.4 m -81.88 85.41 6.67 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-O 121.389 0.614 . . . . 0.0 109.484 178.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' MET . . . . . . . . . . . . . 48.6 ttp -75.99 -42.48 48.07 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.451 -177.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 33.2 m -82.71 120.61 25.81 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . -66.75 -38.88 93.41 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.897 -0.592 . . . . 0.0 112.609 -177.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 135.98 -20.58 3.6 Favored Glycine 0 C--N 1.307 -1.056 0 C-N-CA 120.142 -1.028 . . . . 0.0 112.27 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -94.67 111.9 23.66 Favored 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 176.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 68.84 103.78 0.06 Allowed 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 123.928 0.891 . . . . 0.0 112.827 -177.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 24.9 mmt -81.71 79.55 8.25 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 176.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . -109.16 -132.78 6.61 Favored Glycine 0 N--CA 1.43 -1.725 0 CA-C-N 115.625 -0.716 . . . . 0.0 112.123 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' ARG . . . . . . . . . . . . . 30.4 ptt180 -169.77 137.07 1.65 Allowed 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 123.737 0.815 . . . . 0.0 110.593 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -95.75 112.7 4.47 Favored Glycine 0 N--CA 1.426 -2.033 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -178.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 27.3 t -100.97 95.22 6.45 Favored 'General case' 0 N--CA 1.414 -2.242 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -178.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' LYS . . . . . . . . . . . . . 26.7 mtpp -100.72 6.65 44.01 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . 0.446 ' C ' HD23 ' A' ' 245' ' ' LEU . 5.6 tp60 69.04 170.73 0.3 Allowed 'General case' 0 CA--C 1.555 1.159 0 C-N-CA 124.745 1.218 . . . . 0.0 109.399 -174.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . 0.701 ' HA ' ' O ' ' A' ' 243' ' ' ALA . 7.0 m -59.11 114.89 2.82 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 -168.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -142.44 168.45 19.7 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.343 -177.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' ILE . . . . . 0.617 HG12 ' HB2' ' A' ' 291' ' ' LEU . 2.2 pp -128.13 163.09 32.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.766 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -151.41 157.33 42.25 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' PHE . . . . . 0.55 ' CD2' HG11 ' A' ' 279' ' ' VAL . 87.7 t80 -129.7 135.47 48.53 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.31 177.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 5.1 ptm180 -154.7 155.58 34.85 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 124.095 0.958 . . . . 0.0 108.993 177.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.409 ' HE3' HG22 ' A' ' 284' ' ' THR . 53.5 mtpt -105.27 157.74 17.09 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 175.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -155.72 153.06 29.35 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' GLY . . . . . . . . . . . . . . . 72.8 -114.31 4.77 Favored Glycine 0 N--CA 1.437 -1.28 0 C-N-CA 121.189 -0.529 . . . . 0.0 111.785 178.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -134.53 93.91 3.12 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-O 120.539 0.209 . . . . 0.0 110.869 -179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' ASN . . . . . 0.435 ' O ' ' HD3' ' A' ' 285' ' ' PRO . 93.4 m-20 66.93 17.6 10.54 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 174.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -82.15 140.4 33.79 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' GLY . . . . . . . . . . . . . . . -99.31 113.49 4.74 Favored Glycine 0 N--CA 1.432 -1.604 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 2.3 mp -105.13 111.53 34.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 CA-C-O 121.618 0.723 . . . . 0.0 110.263 -178.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' ILE . . . . . . . . . . . . . 3.6 mp -97.93 112.66 30.52 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 174.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' GLU . . . . . . . . . . . . . 73.0 mt-10 -89.3 143.77 26.59 Favored 'General case' 0 N--CA 1.408 -2.548 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 176.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' LEU . . . . . . . . . . . . . 12.2 tp -133.14 130.39 39.15 Favored 'General case' 0 C--N 1.263 -3.175 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.099 -176.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' ALA . . . . . 0.701 ' O ' ' HA ' ' A' ' 226' ' ' THR . . . -116.86 102.24 9.22 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 176.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' ALA . . . . . . . . . . . . . . . -109.43 91.15 3.53 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . 0.446 HD23 ' C ' ' A' ' 225' ' ' GLN . 2.7 mm? -77.68 113.18 15.27 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.547 -175.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' GLY . . . . . . . . . . . . . . . 114.79 -10.85 21.06 Favored Glycine 0 C--N 1.298 -1.531 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.319 178.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -100.73 124.31 46.17 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -178.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' ALA . . . . . . . . . . . . . . . -103.82 -29.64 10.88 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -175.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' GLY . . . . . . . . . . . . . . . -85.89 -161.51 35.18 Favored Glycine 0 CA--C 1.503 -0.68 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 -103.48 143.02 25.79 Favored Pre-proline 0 C--N 1.303 -1.43 0 CA-C-N 117.847 0.824 . . . . 0.0 110.688 176.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.79 ' HB3' HD13 ' A' ' 264' ' ' LEU . 10.7 Cg_endo -64.6 172.03 7.4 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 123.108 2.539 . . . . 0.0 111.267 175.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -89.93 119.65 30.48 Favored 'General case' 0 C--N 1.274 -2.681 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' ILE . . . . . 0.402 HG12 HD22 ' A' ' 312' ' ' ASN . 2.7 mp -102.46 127.65 55.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-O 121.57 0.7 . . . . 0.0 111.385 178.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' SER . . . . . 0.72 ' HB2' ' HB ' ' A' ' 261' ' ' ILE . 73.6 m -115.73 115.48 26.41 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 125.297 1.439 . . . . 0.0 108.217 175.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -101.15 113.85 27.26 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -175.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' GLN . . . . . 0.62 ' HB2' ' O ' ' A' ' 259' ' ' HIS . 14.5 mm100 -116.92 166.03 12.64 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 174.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -77.07 -41.99 40.07 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.488 179.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -84.04 -14.75 49.79 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 -174.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . 0.62 ' O ' ' HB2' ' A' ' 256' ' ' GLN . 49.8 p-80 -171.77 162.31 6.17 Favored 'General case' 0 C--O 1.21 -0.995 0 CA-C-O 120.628 0.251 . . . . 0.0 111.041 175.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . 0.419 ' HB ' ' HB ' ' A' ' 302' ' ' ILE . 19.5 mt -106.9 145.2 14.74 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 177.602 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' ILE . . . . . 0.72 ' HB ' ' HB2' ' A' ' 254' ' ' SER . 3.6 mp -122.11 123.4 68.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 175.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.504 ' HB ' ' HB2' ' A' ' 300' ' ' LEU . 37.8 t -124.7 128.19 73.23 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.04 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 178.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 298' ' ' THR . 7.6 m -124.27 124.04 41.55 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-O 121.538 0.685 . . . . 0.0 111.503 -177.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.79 HD13 ' HB3' ' A' ' 251' ' ' PRO . 1.9 mm? -95.32 103.13 14.98 Favored 'General case' 0 CA--C 1.47 -2.119 0 N-CA-C 105.42 -2.067 . . . . 0.0 105.42 173.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' LYS . . . . . 0.464 ' HA ' ' OD2' ' A' ' 297' ' ' ASP . 17.3 ttmm -76.38 137.95 40.11 Favored 'General case' 0 N--CA 1.383 -3.788 0 O-C-N 123.72 0.638 . . . . 0.0 110.779 -177.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' ASN . . . . . . . . . . . . . 8.7 t30 70.44 27.71 3.87 Favored 'General case' 0 CA--C 1.548 0.881 0 O-C-N 124.864 1.352 . . . . 0.0 109.957 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' HIS . . . . . . . . . . . . . 36.1 t60 -124.27 108.02 11.8 Favored 'General case' 0 C--O 1.206 -1.185 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -178.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' THR . . . . . . . . . . . . . 7.2 p -90.48 114.66 26.88 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 113.207 0.817 . . . . 0.0 113.207 -176.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' LEU . . . . . 0.492 HD12 ' HD2' ' A' ' 270' ' ' PRO . 19.7 tp -93.3 133.19 28.87 Favored Pre-proline 0 C--N 1.318 -0.8 0 C-N-CA 123.077 0.551 . . . . 0.0 110.468 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' PRO . . . . . 0.492 ' HD2' HD12 ' A' ' 269' ' ' LEU . 80.9 Cg_endo -78.98 157.03 26.94 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.218 1.945 . . . . 0.0 112.117 173.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' THR . . . . . . . . . . . . . 23.6 p -62.36 -35.04 77.89 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -177.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 13.7 m -65.85 -18.3 65.24 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 123.707 0.803 . . . . 0.0 111.709 -176.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' LEU . . . . . 0.426 HD13 ' O ' ' A' ' 226' ' ' THR . 95.0 mt -105.21 -13.91 15.54 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.446 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -83.78 114.38 21.58 Favored 'General case' 0 N--CA 1.428 -1.53 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . 0.405 ' CG ' HD11 ' A' ' 228' ' ' ILE . 6.1 ptp180 -144.94 175.96 9.83 Favored 'General case' 0 C--N 1.287 -2.11 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -174.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' SER . . . . . . . . . . . . . 48.9 m -134.4 138.55 44.92 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-O 121.275 0.559 . . . . 0.0 110.177 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.533 ' O ' ' HG3' ' A' ' 288' ' ' LYS . 2.0 mm? -91.96 150.38 21.04 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 105.123 -2.177 . . . . 0.0 105.123 174.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -86.49 -60.69 1.92 Allowed 'General case' 0 C--N 1.274 -2.693 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 177.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' VAL . . . . . 0.55 HG11 ' CD2' ' A' ' 230' ' ' PHE 0.342 30.8 m 49.41 19.32 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 174.016 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -74.19 140.2 44.95 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 173.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' ASP . . . . . . . . . . . . . 28.8 t70 73.77 16.92 3.71 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.935 1.294 . . . . 0.0 111.402 -178.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -80.61 -11.86 59.58 Favored 'General case' 0 CA--C 1.514 -0.414 0 O-C-N 121.351 -0.843 . . . . 0.0 111.016 173.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 60.98 61.26 1.66 Allowed 'General case' 0 CA--C 1.497 -1.062 0 C-N-CA 123.336 0.654 . . . . 0.0 111.361 -178.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' THR . . . . . 0.409 HG22 ' HE3' ' A' ' 232' ' ' LYS . 1.6 p -137.6 168.06 17.97 Favored Pre-proline 0 C--N 1.292 -1.911 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 177.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 236' ' ' ASN . 18.4 Cg_exo -69.46 -23.35 32.27 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 121.467 1.445 . . . . 0.0 110.822 176.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' VAL . . . . . . . . . . . . . 2.0 p -85.31 122.31 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.181 0 CA-C-O 122.254 1.026 . . . . 0.0 110.401 179.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -89.23 -37.93 14.61 Favored 'General case' 0 C--N 1.284 -2.252 0 CA-C-N 114.488 -1.233 . . . . 0.0 110.465 -174.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . 0.533 ' HG3' ' O ' ' A' ' 277' ' ' LEU . 56.3 tttp -159.47 137.6 10.36 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.67 -178.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.416 ' HB ' ' HB2' ' A' ' 277' ' ' LEU . 42.8 t -103.47 128.86 56.23 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' THR . . . . . 0.46 ' HB ' ' HB ' ' A' ' 301' ' ' ILE . 90.6 m -135.14 121.26 20.04 Favored 'General case' 0 C--N 1.297 -1.706 0 CA-C-O 120.743 0.306 . . . . 0.0 110.591 -179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' LEU . . . . . 0.617 ' HB2' HG12 ' A' ' 228' ' ' ILE . 0.0 OUTLIER -101.08 122.96 44.49 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 177.537 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -119.56 135.26 54.87 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 -176.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -83.58 142.59 30.73 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 174.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . 0.436 ' HG ' ' H ' ' A' ' 295' ' ' ASN . 12.9 tp -120.13 -174.17 2.72 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 176.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' ASN . . . . . 0.436 ' H ' ' HG ' ' A' ' 294' ' ' LEU . 20.2 t-20 -72.35 -51.55 20.09 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 118.908 0.776 . . . . 0.0 111.565 -172.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -115.55 -3.94 12.3 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.611 -177.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' ASP . . . . . 0.464 ' OD2' ' HA ' ' A' ' 265' ' ' LYS . 3.7 m-20 -133.13 169.3 17.06 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.58 0.705 . . . . 0.0 110.671 -170.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' A' ' 263' ' ' THR . 62.6 m -113.37 126.74 55.69 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 172.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -119.71 122.57 41.75 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-O 121.441 0.639 . . . . 0.0 110.099 -173.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.504 ' HB2' ' HB ' ' A' ' 262' ' ' VAL . 0.1 OUTLIER -97.63 135.87 38.82 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 178.149 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' ILE . . . . . 0.46 ' HB ' ' HB ' ' A' ' 290' ' ' THR . 48.7 mt -124.83 109.73 23.1 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.315 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' ILE . . . . . 0.419 ' HB ' ' HB ' ' A' ' 260' ' ' ILE . 68.5 mt -114.65 101.24 12.11 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.274 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -178.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 21.0 m -68.91 134.14 49.17 Favored 'General case' 0 C--N 1.308 -1.211 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -177.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' THR . . . . . . . . . . . . . 10.6 p -136.98 167.32 21.72 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -177.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' ALA . . . . . . . . . . . . . . . -148.87 151.16 34.21 Favored 'General case' 0 C--O 1.251 1.173 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.321 178.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' GLY . . . . . . . . . . . . . . . 76.71 -157.18 47.13 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.087 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -99.98 141.99 32.06 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 176.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' TRP . . . . . 0.406 ' CE3' HG13 ' A' ' 324' ' ' VAL . 68.6 p-90 -154.84 167.58 29.79 Favored 'General case' 0 C--N 1.291 -1.96 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.756 -176.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -122.57 135.59 54.67 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' LEU . . . . . . . . . . . . . 1.3 tt -104.69 113.99 27.92 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.415 -0.514 . . . . 0.0 109.715 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' VAL . . . . . 0.577 ' HB ' ' HB3' ' A' ' 323' ' ' GLN . 98.4 t -108.08 107.3 22.46 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 172.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' ASN . . . . . 0.402 HD22 HG12 ' A' ' 253' ' ' ILE . 20.2 p30 -98.07 121.15 39.65 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.781 0.8 . . . . 0.0 110.429 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -122.91 148.62 45.23 Favored 'General case' 0 C--N 1.3 -1.586 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.777 -175.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' SER . . . . . . . . . . . . . 32.6 t -115.63 116.63 28.44 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 170.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -77.92 -34.83 51.14 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 122.152 0.977 . . . . 0.0 109.036 -179.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' ALA . . . . . . . . . . . . . . . -161.43 155.31 18.65 Favored Pre-proline 0 C--N 1.29 -2.016 0 N-CA-C 104.161 -2.533 . . . . 0.0 104.161 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -60.73 94.93 0.11 Allowed 'Trans proline' 0 C--O 1.244 0.804 0 C-N-CA 122.239 1.96 . . . . 0.0 112.339 -176.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' GLY . . . . . . . . . . . . . . . 136.16 -25.7 3.16 Favored Glycine 0 N--CA 1.433 -1.528 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.24 -179.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -107.32 116.32 31.72 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -116.28 164.61 14.25 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-O 122.138 0.97 . . . . 0.0 111.037 -175.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' THR . . . . . . . . . . . . . 39.6 m -151.49 125.45 9.17 Favored 'General case' 0 C--N 1.269 -2.902 0 CA-C-N 114.394 -1.275 . . . . 0.0 108.893 -177.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -109.69 105.07 14.19 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 175.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' GLN . . . . . 0.577 ' HB3' ' HB ' ' A' ' 311' ' ' VAL . 7.3 tt0 -94.17 103.11 15.16 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -178.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' VAL . . . . . 0.406 HG13 ' CE3' ' A' ' 308' ' ' TRP . 86.7 t -94.71 99.37 9.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.867 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -89.9 151.41 45.29 Favored Pre-proline 0 C--N 1.315 -0.916 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -77.97 132.84 11.99 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 121.546 1.497 . . . . 0.0 110.513 174.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 327' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -104.35 127.14 51.96 Favored 'General case' 0 CA--C 1.484 -1.582 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 178.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 328' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -96.5 165.9 11.94 Favored 'General case' 0 C--N 1.268 -2.958 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -177.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 329' ' ' GLN . . . . . . . . . . . . . 20.7 mp0 . . . . . 0 C--N 1.313 -1.004 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -178.323 . . . . . . . . 0 0 . 1 stop_ save_